<SEC-DOCUMENT>0000010795-22-000040.txt : 20220506
<SEC-HEADER>0000010795-22-000040.hdr.sgml : 20220506
<ACCEPTANCE-DATETIME>20220505115701
ACCESSION NUMBER:		0000010795-22-000040
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		63
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220505
DATE AS OF CHANGE:		20220505

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BECTON DICKINSON & CO
		CENTRAL INDEX KEY:			0000010795
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				220760120
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-04802
		FILM NUMBER:		22895030

	BUSINESS ADDRESS:	
		STREET 1:		ONE BECTON DR
		CITY:			FRANKLIN LAKES
		STATE:			NJ
		ZIP:			07417-1880
		BUSINESS PHONE:		2018476800

	MAIL ADDRESS:	
		STREET 1:		ONE BECTON DR
		CITY:			FRANKLIN LAKE
		STATE:			NJ
		ZIP:			07417
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>bdx-20220331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:e602671e-4fe1-4961-adbb-f9dd82a282de,g:36534b56-6db4-48ab-9f63-2a72d6bb30f2,d:cb36c8b3bd0b41458d5570d492469671--><html xmlns:bdx="http://www.bd.com/20220331" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bdx-20220331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80L2ZyYWc6YTExYTdhNDBhYmFmNGVjZThjMTY3ZDcyMTY4NDMzYWIvdGFibGU6YjI4MTYyOTAxNzNiNDM2MWIxNGE2M2E3NDI1MDhjYjkvdGFibGVyYW5nZTpiMjgxNjI5MDE3M2I0MzYxYjE0YTYzYTc0MjUwOGNiOV8yLTEtMS0xLTYxMjgx_a4eec151-9640-4ec5-a634-fd2452575a8f">0000010795</ix:nonNumeric><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80L2ZyYWc6YTExYTdhNDBhYmFmNGVjZThjMTY3ZDcyMTY4NDMzYWIvdGFibGU6YjI4MTYyOTAxNzNiNDM2MWIxNGE2M2E3NDI1MDhjYjkvdGFibGVyYW5nZTpiMjgxNjI5MDE3M2I0MzYxYjE0YTYzYTc0MjUwOGNiOV8zLTEtMS0xLTYxMjgx_08b19f18-a2fc-44c4-94bf-5c7a56070a4d">9/30</ix:nonNumeric><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80L2ZyYWc6YTExYTdhNDBhYmFmNGVjZThjMTY3ZDcyMTY4NDMzYWIvdGFibGU6YjI4MTYyOTAxNzNiNDM2MWIxNGE2M2E3NDI1MDhjYjkvdGFibGVyYW5nZTpiMjgxNjI5MDE3M2I0MzYxYjE0YTYzYTc0MjUwOGNiOV80LTEtMS0xLTYxMjgx_25d3b3f6-bd71-4a5d-af14-53326a0597f2">2022</ix:nonNumeric><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80L2ZyYWc6YTExYTdhNDBhYmFmNGVjZThjMTY3ZDcyMTY4NDMzYWIvdGFibGU6YjI4MTYyOTAxNzNiNDM2MWIxNGE2M2E3NDI1MDhjYjkvdGFibGVyYW5nZTpiMjgxNjI5MDE3M2I0MzYxYjE0YTYzYTc0MjUwOGNiOV81LTEtMS0xLTYxMjgx_8e538d73-a5b1-4de6-8e72-09c512a5122e">Q2</ix:nonNumeric><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80L2ZyYWc6YTExYTdhNDBhYmFmNGVjZThjMTY3ZDcyMTY4NDMzYWIvdGFibGU6YjI4MTYyOTAxNzNiNDM2MWIxNGE2M2E3NDI1MDhjYjkvdGFibGVyYW5nZTpiMjgxNjI5MDE3M2I0MzYxYjE0YTYzYTc0MjUwOGNiOV82LTEtMS0xLTYxMjgx_f95c659a-4411-4e25-a052-a0ab4df7f12c">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bdx-20220331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if21c0d03c63b44e085b66c88ee86f42d_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4df50108c1fb4841b44726d5c08d57f7_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia15276c5615b4d56a856c2a1f3802281_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.000dueDecember152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8b05442c045413ca34e2d68fe1e3294_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.900dueDecember152026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59870493567442b2b5898f3382bd261a_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.401dueMay242023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8bc22d2da56460b8728cbbf75e236a1_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes3.020dueMay242025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3f625ad61544610912ab0da5ade95c6_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0.632dueJune42023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f1fc3248ed8431cb579e0478a450c5f_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.208dueJune42026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69585d30ad2447d1ac69fce1f20e5da4_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1213NotesDueFebruary122036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f19c1acbe03446ea643c73bc09f6386_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0000DueAugust132023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97abaf17fc984c8496d82b047da581a9_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0034DueAugust132025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ia9971035716346c99974380b024f6257_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f49a7b80b0c4a37acc78faacd1def8e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fb7d149583e4cbbb4ba841be5866113_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3c1843bb7b44edabe19cee43be62817_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e75e43373c14b1eae872a1d4dd08fc3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia89314df24664e74a252364fc091e358_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ec379b37d724046b6a043294e406405_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61cdc5a7fb1f402985abc66f5ca9909b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1104298cf0f746fa8b00a8e2dbb7eea4_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefdb0b0a3f294705ae8463fd402aa8f3_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f577fd449564742befb8a5b86459eeb_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2332d63e32a54c098fd20d5b1542bb16_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3f954158bd0474497e7bf9c2a23536b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i081ee5a5852e407c84e3e572849b152b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cc557aa2f8d480daebdcbf52be025e5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1344f18c36641fc8d87799098076721_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfee3de793164af9b845b6842e2d9376_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ccb08051b764c64846def77e74cebc1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d31a13945d64153886cacad6bf05af2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id71dace7ba3b4742baa7ca689c30873b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cda69a93a124d77b34442ef82673b2d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id251a2ed05f94abfb442c3b00935484d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea8a760ffe4c4852a215ec13b1e39b19_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4e6e39ebb924eb88e298367603c6efa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2889486ea2246ac8bbb298a59bd2634_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56c3903f09b94c6b872822313f7d17c0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c2306c70486435080a9eb6d50933f3b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7e94317b56c4ee39ee10b7b86f2988d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95ca0513273e493d9f458220ba54c5fa_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id300f100b3b74d869d299c38e13eff73_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i543caecc83554a22bc382fd13fe58144_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfe5c0b260644978b5979c61385ae9f5_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icedd1d99c22048f7924f50a371090298_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3c9b45cb60c4c73bbca1766d2ee8583_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i535a03f509b14bbdb82ee8d0fff4154f_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id659b030b22b452f98d9897c4a1db5f2_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf0ffad15f524c22b5a8910cf0242018_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i725012b63b26440eabbde5cc7e83e9c7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia274107f0cb9495e9b2745222febc134_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f80f3e926434e23bc7a4ffbf84d5ff6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if85711d4c58a411e8be877e7ad67842a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63448b71f13c4d649cdc22ef4a0b5d5a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10091875590248f6a43b7b9c1e05c6bc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05807d0c88fa4fe9973f0d6abc7b86b7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21bb6c6eb0934bbf97ecaab0350f75d5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b08323b925d40d1b59c94d01b6f7ede_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ca7af80178f409190ac109fee156034_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81c8d0ef92a54994aba64d18915d02d8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00ac086edd1e4ab1b000dc60c50ccd89_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cb4ecbb78e74ce3a938ab69f4bdf1f4_I20130924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2013-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13da3ad4178f4ecebb53a625e7acba1b_I20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ee43d89fee945a3adb8a3285fa956d4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9c0efef45cd4a01bad737fb01fada74_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b579acbced54178ac7040056cec1930_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i324ed7a0bfda4e7e83cf84119d3ae93e_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0fedadbd75d4a4985c2b754543d38db_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b405f3959cc475c9b732b9beb5bba7b_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88e64c73fc1047fa8d2dbbd0264a3c84_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f7ed54a259b40c1a2765645e71832fa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69e96ef1d0e74452ab61f2dcd1b57fe4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65465a86c8c5442a8b980080054fe48e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cba383a1c1a43a7b184a8631be117d0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72f72d97c18d4a168adf04b6afab2aec_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice9518fb765048f791d1eb268ac30699_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b672c8a1e23415c954ddf66aac1e984_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b29fdbef54342949881c713e16d539c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9193c0d5b9c4b2581040114a4cd2dfd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4d95beb50b14c9c95a3d75c68b47d91_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if967b9c04df3495bbc795bfd1f8099af_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbfa81272476483894faf8a5f285efa0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ed40f315c6c4f97a754a6eb72927dc8_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb4e8d00d339433fac2d8c00fd206825_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i977201e5251e4da78e41ec15b3b96c80_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7a0d188409c454e90b59907b43f24ad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0692d1be0c384a95b3c84dd3b71fea18_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0aa1afa266db408b8ce7249358da4cb7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i465aa0dfa2c14f119d5e5bef56c57bb8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5877d216df964262bf4bb845d95a59f7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b2de3cd4f2a4be79b23ac6da588eaf4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b94674394f84d6eb4053788dc6d572f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac6b1a8c16e3470fac8737acad5b180f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4995a156954f4d75a765e0acb8fb54b4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i770c080a4a784b18b9b4b99e56348d1a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d3a36d935bf4fd8b6132f2d1ef29307_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib76ec6f5ea814d30b2c30ad474c85f94_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea6c161bd8a340f98a4fddd063587010_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49a7de59e6ff4225a49a75d990be29bd_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i308403a24c2a42c89b1d7a4ab555184c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bdx:ShareBasedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7022abe219c14c9dacdbd2ec440a8b4f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bdx:ShareBasedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9450f0155c94e31b2c13ad94e0092f6_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bdx:ShareBasedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic97169545d0c475da35e8da8837b02ab_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bdx:ShareBasedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75602a2f46c546e4828064853912e326_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">bdx:HerniaProductClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>bdx:claim</xbrli:measure></xbrli:unit><xbrli:context id="if223ecc9d5a1493093a44d337a8b72c5_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:GA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>bdx:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="i8dde9c84ea4543b2b7c7c39ef33a1b38_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bdx:ProductsandorServicesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77f35a0dc2c74215877faf40ae0e7e6f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1d78d581b6244569d9e8062bb55187d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bdx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>bdx:segment</xbrli:measure></xbrli:unit><xbrli:context id="iaa780c179d9147f593395d6d7fa5230b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic134ea116f1f45ebbe076cc6b3883b12_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i340e57a3d1d14dfc9f75038a3782eea0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if21e1acbe96f4463853f0759d0def48f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40c8b727b83d4d65bfa6146011860c12_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdf68331391d4a60891ceb9f056a868d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e361a94baa3404eb086646266f9b158_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0da5380262d43adabe75276ea0c956e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a826d3478c74b2f862d397c207ca730_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14a0d9a15f7b4cfda8ba40724beaa8f3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d18979bf4274db5b94b3dd46371c7eb_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i511c4b1286af42da970bfdec12deee00_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2de60d3992b4498818e40d41cedf3b0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2962a3b3ece8403a9b742d6cb9eae7d3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0688f0ec5b0547ea87efa9cb59b990bb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57ad6025694d4bc9842594f621d8e8b5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia61a8d596fa14163ae52254c542a2d2a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e45310057c44542954ea2308480623d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18a195ea4996436ea00c1fc948c4276f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9bfe78cbe96428981538b45e6d35614_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e98ac2861aa4dbeae2a682badb428b8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib70cc365667f4336beae810b00d3718e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb66231fcb80447fb881ab131dc5c869_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48a7a52cac944ef7baa6f046beb6ae79_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73d03a6b37c240468966cf15263452df_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf0e9eb78ff74a85867e0df2d636c7c4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd9d0f9e33a441088614cd71f9e278ef_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e12b1fd86e446be863efb9d8984c607_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3f69fb977594b96b982d5a4addde48f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i692aef30e2ff4aa7bc63ceaa2db430fd_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d43be5f09354422addda0ddfc3d7608_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i940c14b99d604a85b8b181419f29ede7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f7bdb867ae3463d9c34411ef80fa2c1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie34d48eb7b4446bfb0293bb837aeb3b0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b8004628d1e40ddafce5ca3460f538d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8934938ea33340a68081e896f906c075_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i227211b2a9c741c790ebb3da7e40fdd8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8771dc3c63ee411d88344fdd1cdf5d53_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf374326006b442487c8d86757ee49e4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdae0dea69a64aa6842f66ae27d93e5a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63bb60fd8ef84f56b6fbc6e0af2cf599_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cef8fc053634cdfa0e350495e1fc255_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9318f7e4aad4511b48ac65d5232b805_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaaa5c962e4048c591c863e8916d33f5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i228cd1a05f9444a282107d55ea9e185c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fdb31b0ba7847828199578de1e0dc44_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia05764f1126a47f598e5a5be57d911f3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8f952d3c2504bee86897ac95714403d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia09b9950f6054a568db0ceb8606d7a4e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfa7fb2c614545b7b9f7b5805cfe5911_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8cf56e8b5924da2a53cda0c0754e42c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b6c283c3e1b4712b95db13abf677cc8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d34d9c802ca4ce89fb381c9211b0f26_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec0f21890bcd495ba23516dc79fc968d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d03895e938f463db61347f7756e8411_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2f63b307eb24de4a2da726044ee4dcf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49cc19ad914c4f87aefe3e1e90b2e0aa_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86808c33fe15413ca3ab8f07fc04dc6a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia256fef2c90740d7abec4bdfd7e9ea6f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76036e4d4be84f3780130dbd8809095d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib25903c74b6b4ce196304dfabbeed3fe_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9129b920a74c4190bf2674bf5c66ddcd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05e3efc2d5234dc5b5696fc25c2fe1f9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i560004a02b284824a2315cd4721a5d83_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2bc50912e054b8ca37e29049b909c87_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e73be5facd24817b1a1fea9021a8238_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i918494be3dba48dd95f60dbc329ce595_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e6353525444488e906055b04513b780_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07d77974120f4be69403ea9d0e2b2e32_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4c3e29343e9492485a767d68a8ece48_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ecc4a1c1e25473c8e517f0c14b82e15_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9b2088e5e1d40f1925f5a9ce6d60363_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b27826b341541bc92d8a45b8d75c050_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i963a32bbdc9f4165b5fd4ec11f3bf96f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc7dd7466d954173933100f7a158c392_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i272105b422984b0abce278efc90ccf80_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d49a5857b8c46e8be9a20f21635d62e_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28c8afa29af14a569e645ef1aacc226c_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if28ca15d9d5d48078024960d0e23e05e_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01375e7a7d6d4d5ea8993c57a7fa9646_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i016a8ef65bb04b5d92fe312250253498_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id51f443d02834ad4869eb954f45c6f30_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b392253b2d848fba4cbe7cbca8862ce_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic10db11a119f49bd8880ae734593b26a_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54288602bb02449f862cb8e8556ce749_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e9a88dddb1141dc93f661547e4e852a_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a080ccb675240cc9c4a8ba434c764a5_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc933a06c8ba4f988cefb9809c807501_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id727ab7528c748339d239f9af4abbbd5_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa9d6dfaff1145718f4ec2ddd0e9060f_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e9adc19251c445fbb25842e71b25fb9_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie088a67ab37944269b87738d47fd8cf2_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a1cfd5cb6684b57a644e4700794e7d6_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c4fee3d5348442f81d98e5c491d7567_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i796262ed3fae4763be2037f02515b572_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7915ffe1e48e473e87a7bc4a597611ff_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21781684a6e54835a086fb4dfd07518b_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99f983046ba64a3597abb01c16866c07_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43464f5ca80d4e9faacc0d26f58b60be_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1e45e6c38b342e0afa75849e1554f02_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i744dcd2988294c748fdd6de59fed0010_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28fd1a5379ed4068bcbe236046b009ac_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93c8dc026e904d27a8674f1b2ae7b64f_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26cd80537ace4f54bd459856e6733c22_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabc734319b0040bb91b53f1b5bda469e_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i177c01abfa574925aead9aa3b4f63e18_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63fca4aedfee493386b300cd94f770a4_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaaee6092a88498e8faa501905f4bdd7_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2a56afd740743baa1b574805fc29871_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibade6b68690841a8be0464af51c331d0_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic17e46520cc6412c8bc1e89dea2e9c8c_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f73d2d072b8450a80571d1bce774ce0_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i676297c812f4459e9be4e29ff85f5ad8_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39bc71985bfc4e1d839721692c03a9fe_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fa5bfe82d7249b0937b40509556d515_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i618873a9001446c181b8ef34ab0bcc4a_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bd3786e38494554a16139e13fdeb54f_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6348050d88d4f97a3775186bc1a6569_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i061dc82dc32444aea21f1c81faebbe0a_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69b2c199b94f4ca691703156805bd41c_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68bb6db7dc06423d8874cf17e8b85add_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71898030bd194581a5f573edac52a467_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2312cfcd8087400e988b97e474a47c77_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49af90b2d616488a86c54d3c262d0d5c_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i048c0649ac044507a024682c29947104_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a7ced2e82944f6681b9ed34294d5014_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcc85f190816497f95bf2249ad0e8450_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81e5b85ab7764c6fb0daf9c82f0b4781_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i238fa27398184872a8e61d69996c8840_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1a0f1ebdf1b403798c14fedfa564a35_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c39abcfe82b42aa90ff2907f3304dcc_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05b4f4dee6a8495d833675a95be35a26_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35931f5fa1204157bac1212583f72af6_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2e4a485f90041afbb049fac8eb52965_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief518885d18a472cb30a5c4921e2b0b5_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fc225adea9a4eb3bcf21fd3444ec41d_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e49adc428d94084bfc47a4543444f50_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b2f6430ba9a49438e7cc7a603637f4c_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d46849ffcb74aa2aa512d3c1f68b33b_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie157a03ce0f049c998b7c29069311c61_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c1dd439278f4be0a9a792057b61e38a_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4143ec09dd4b481a8e155333bd4dc4fa_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa3b379319c34f67af75703550c4c252_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3b61621dfcc434bbe4ce2f31653255a_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic959ae392a3e4d8b9d97860c881fa2e6_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff32a50b2bf54f4cbef3c832096888da_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58032061b0ff454095c538f1f3c4d0ec_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief3a64ff7d9d4ad5984439fa90316773_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67d9bfcd7b3a4d56b5197daa366d5b0f_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1ab3086e3eb4dc39a17c1ff6b4efb91_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4994dbb56dd942c3b109fdbcdbc65a09_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c3f5953274d42d8883cc70bb1ab9bf9_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if77c23c0dcc049008fcc1ec1e19316f0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3e301035b4a4bdfb65e05d08198eeff_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbf9dc05d6fa4d8fba50f123e716eafe_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4567c9a64f984e07827c5c6c6ccf5cc3_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52b453b110a6487198bf393e02c8324c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46d46821d3124f169527dd86c47ecdcf_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d66dba8cd4a42fb969a3a9bfe7dc2a5_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib171c4d8e98248f48d26babd2d37afa5_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i909ad880c3244bdfb8b75a0b85cf397e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd843e5598ca484abfc9deff353549de_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icecf16d531934c9e94ad3aa80cd5fe9b_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i459c088c116949f6a7759e05b502302e_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb8b77375efd4b3b80608dbb0eff1722_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd645833eba34cf7bc7e14df93e204c3_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc4467fbe0ee44db93c2873c8d0afa22_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9157cafcaafb4b5db2bc2a4e28325ccd_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief564af42a4c42e893aff8bd1fbca00a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i779636b30adc455b80382ee10bb0ad6b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00226f2a049945c4926cc6902c33c132_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie28fdaf2e6bb47bf9633a15831cda54b_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c9691d61a39453087be7034f4483fbc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifeff7a1ec077409a9bc93ab1ff3aefb4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i720075ccfd224b55a2643c326f989fbb_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice9b08a1614b40ec92a118dec841b8fc_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i535aa5beb8df4def94ad38003c699670_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibceac69f309e466680f1ada28542ef16_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia886aaf5c1bb402ab373ae9e4fcf70f5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if19b6df31d1041d988f2b6d0d6f8be9a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff71ea0dd54b4de39f65ab020e2a67d5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1bf7117c8f74af382b1902e9716b58b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcba64985bd94892898f333e81f805c3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bdx:ProductRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7852dda3e9644e0b9e2ced2925cb5cbc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bdx:ProductRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i287c272785094449aeae5d0789e8dd30_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f7c055feadd4023a2ccc660f06149c5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice2f69b4e89a4d6d841af8ccf0210a6d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9046b05ebed642d6a4080928d23692fd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbbba24d92744e1995760747da6b3a07_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib93696a0600a4388af7001d55ce60a56_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67af69e0e74849ab8b12161f932216a2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09024c8954c042e89264bf944c8b11d6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieefa6c2ca96747e29b4e14f0c03cdff8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id060ca4c054d4caf9f5955f598b66769_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib65ad792e22f44688a73a18522ef2873_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14595206756547be8dcca594e49423d1_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0368fb62ba6e46fc84e60d8e4f32776e_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8c068d6acc740b4a2839bff2df64cb2_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id36e592a22714e45927e00fe0abd06f9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i647adccb5a5d4a46861649299a5f578e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bf06b24db6d4d5e95c8dc424db65f4e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57f20120eb6d496fa8dff3eee45b0eea_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a5fc6a2293a4c8cad09d8ce4967369a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1831573910a04a449ed2198ba1794eb7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9044e5284eec498888c80d53fd6d7cac_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7eeef21c695425a92ba5420343f8392_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3329662597a43ae9d4393dca9eb9b23_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcc3814ef1924ae9ba38f953eba0d814_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bb6311653a447e9a0a4ba8c0ad8ead6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic331fa12abcc49f1ad32ee75878ba71b_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72c4b04b5d954d97bccd5b64279416fd_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd8707ce2b41458880bbba5f3ae0a677_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5436992d57d34fa79e5f22c386b9e551_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63b89c37783a44039baca463093a5ae6_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f5fc4cc7e7f4dc586a55406beefd6ac_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a1a0aef0db24a0987e1ebb88ed95290_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54dd618396ea42518487e230f0e9e1b6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73542df9b6064c0d93564b9e09ce34ef_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e68b8c00a5b4b0795a14cc4e86be66d_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i179698c711414fb0a6c8ff99db9ee285_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:FixedToFloatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7bf11422da34344806862a0903b17bd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:FixedToFloatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i413682d5f90848fd9283e81e36ef64c3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie68b5ca8e1784fe9bdac444023023ac8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6435fd6a9e9049458f90d13308c412be_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3374a91073fd4143896356601c7a0524_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11df0428ff4c47c59e767601738aa11a_D20211001-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fe40a686952436da2991e9275d47220_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5845caed52ce4da4b4f7325c57203c22_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes5000DueFebruary152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i26418175d8c34a61b6aa277d1076d5b4_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes6750DueFebruary152030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i624a854f791c444da897e1e70f2d8eaa_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:FloatingRateNotesDueJune62022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf5d860aadcd4dc18e87ac829cc865d8_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:FloatingRateNotesDueJune62022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6c6a8360d284859b924495a95a1b82f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:FloatingRateNotesDueJune62022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib929424705fe416e91cbcae5e6409cf0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bdx:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9481af032d5d48ff9483bc7a0054b2a8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bb9f175be97441e81ee4fb5f8665671_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="icb36c8b3bd0b41458d5570d492469671_1"></div><div style="min-height:40.5pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGV4dHJlZ2lvbjplZDJiZDMwODVmMzE0N2Q2ODExMTQ3YmQxMjg0YjBlZl8xNjQ3_78951ec3-5eab-41c0-8e79-ad4491b0fd5b">10-Q</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:0.1%"></td><td style="width:2.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6OTVmZmZiYzJhZGZhNDE5OWJjOTZlNjBlY2RmZDJiZWEvdGFibGVyYW5nZTo5NWZmZmJjMmFkZmE0MTk5YmM5NmU2MGVjZGZkMmJlYV8wLTAtMS0xLTYxMjgx_124ca80b-d133-4417-b7fa-6c148212e052">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGV4dHJlZ2lvbjplZDJiZDMwODVmMzE0N2Q2ODExMTQ3YmQxMjg0YjBlZl8xMzI_efed6559-c1a8-4534-833b-5d600d20d2b9">March 31, 2022</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6MzgwZjBjN2JhYmYzNGYwNTkzZTUwOWE0NTA4YWQwYzAvdGFibGVyYW5nZTozODBmMGM3YmFiZjM0ZjA1OTNlNTA5YTQ1MDhhZDBjMF8wLTAtMS0xLTYxMjgx_d29fa1bf-7d27-43e1-818b-226d39fae9da">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGV4dHJlZ2lvbjplZDJiZDMwODVmMzE0N2Q2ODExMTQ3YmQxMjg0YjBlZl8xNjQy_07ce67de-bc4a-4abd-aa23-2186dafa5f5c">001-4802</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGV4dHJlZ2lvbjplZDJiZDMwODVmMzE0N2Q2ODExMTQ3YmQxMjg0YjBlZl8xNjQz_3043331c-a88e-4db8-8b85-6189578c5a55">Becton, Dickinson and Company</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.545%"><tr><td style="width:1.0%"></td><td style="width:13.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.877%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.153%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.211%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6OGI5OWY4MDBlNmFiNDA2NTg4NTQzMDUxNzViYTAwOWEvdGFibGVyYW5nZTo4Yjk5ZjgwMGU2YWI0MDY1ODg1NDMwNTE3NWJhMDA5YV8wLTAtMS0xLTYxMjgx_94a1e63f-69e9-4776-8d82-5939482b6392">New Jersey</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6OGI5OWY4MDBlNmFiNDA2NTg4NTQzMDUxNzViYTAwOWEvdGFibGVyYW5nZTo4Yjk5ZjgwMGU2YWI0MDY1ODg1NDMwNTE3NWJhMDA5YV8wLTUtMS0xLTYxMjgx_5f35fdb4-0c52-47f2-96db-26ee79bf1b6a">22-0760120</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6OGI5OWY4MDBlNmFiNDA2NTg4NTQzMDUxNzViYTAwOWEvdGFibGVyYW5nZTo4Yjk5ZjgwMGU2YWI0MDY1ODg1NDMwNTE3NWJhMDA5YV8zLTAtMS0xLTYxMjgx_4d9235b4-00dd-4bd7-bf7b-7a0b10475e34">1 Becton Drive,</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6OGI5OWY4MDBlNmFiNDA2NTg4NTQzMDUxNzViYTAwOWEvdGFibGVyYW5nZTo4Yjk5ZjgwMGU2YWI0MDY1ODg1NDMwNTE3NWJhMDA5YV8zLTEtMS0xLTYxMjgx_8725f04e-8854-4552-9f58-12aff03472b1">Franklin Lakes,</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6OGI5OWY4MDBlNmFiNDA2NTg4NTQzMDUxNzViYTAwOWEvdGFibGVyYW5nZTo4Yjk5ZjgwMGU2YWI0MDY1ODg1NDMwNTE3NWJhMDA5YV8zLTItMS0xLTYxMjgx_e23e00f8-8d91-4f36-8d81-13f7fcb57bfd">New Jersey</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6OGI5OWY4MDBlNmFiNDA2NTg4NTQzMDUxNzViYTAwOWEvdGFibGVyYW5nZTo4Yjk5ZjgwMGU2YWI0MDY1ODg1NDMwNTE3NWJhMDA5YV8zLTMtMS0xLTYxMjgx_95cae5de-5b3c-4de3-b2b4-fd99e5efa875">07417-1880</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6OGI5OWY4MDBlNmFiNDA2NTg4NTQzMDUxNzViYTAwOWEvdGFibGVyYW5nZTo4Yjk5ZjgwMGU2YWI0MDY1ODg1NDMwNTE3NWJhMDA5YV8zLTUtMS0xLTYxMjgx_ec08985b-bb98-46ca-bfc4-002a46ab3cc8">(201)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6OGI5OWY4MDBlNmFiNDA2NTg4NTQzMDUxNzViYTAwOWEvdGFibGVyYW5nZTo4Yjk5ZjgwMGU2YWI0MDY1ODg1NDMwNTE3NWJhMDA5YV8zLTYtMS0xLTYxMjgx_0b0843b2-4190-455a-9539-5dc09f0629c7">847-6800</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices) (Zip Code)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Registrant&#8217;s telephone number, including area code) </span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:41.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.182%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title of Each Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Name of Each Exchange on Which Registered </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if21c0d03c63b44e085b66c88ee86f42d_D20211001-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8xLTAtMS0xLTYxMjgx_abe1718e-da5a-4798-8247-c33076659d2e">Common stock, par value $1.00</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if21c0d03c63b44e085b66c88ee86f42d_D20211001-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8xLTItMS0xLTYxMjgx_1b7f91f6-f77a-47bf-8e2b-e243e6771400">BDX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if21c0d03c63b44e085b66c88ee86f42d_D20211001-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8xLTQtMS0xLTYxMjgx_6cd06a68-2e5f-451d-93f0-5b599debec62">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4df50108c1fb4841b44726d5c08d57f7_D20211001-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8yLTAtMS0xLTYxMjgx_dff85ee9-0b46-49cd-a5fd-26512bd98fdf">Depositary Shares, each representing a 1/20th interest in a share of 6.00% Mandatory Convertible Preferred Stock, Series B</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4df50108c1fb4841b44726d5c08d57f7_D20211001-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8yLTItMS0xLTYxMjgx_c7324e78-81bc-4818-8c2c-7cce31928e26">BDXB</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4df50108c1fb4841b44726d5c08d57f7_D20211001-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8yLTQtMS0xLTYxMjgx_afffcf1e-5ca6-4eca-aba0-091ac1e6c487">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia15276c5615b4d56a856c2a1f3802281_D20211001-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8zLTAtMS0xLTYxMjgx_e510d56e-15f8-4591-b478-9328dc5f004c">1.000% Notes due December 15, 2022</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia15276c5615b4d56a856c2a1f3802281_D20211001-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8zLTItMS0xLTYxMjgx_bad272a4-1696-4b7f-b723-f0789bb7a1de">BDX22A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia15276c5615b4d56a856c2a1f3802281_D20211001-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8zLTQtMS0xLTYxMjgx_94b7f2cc-5b04-4055-8977-ea242e97e1e5">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia8b05442c045413ca34e2d68fe1e3294_D20211001-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV80LTAtMS0xLTYxMjgx_4ef0c1e5-86fe-4435-bc06-d362a805d28f">1.900% Notes due December 15, 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia8b05442c045413ca34e2d68fe1e3294_D20211001-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV80LTItMS0xLTYxMjgx_eb08e1b5-5ac9-4723-b669-fd5883bff2a7">BDX26</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia8b05442c045413ca34e2d68fe1e3294_D20211001-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV80LTQtMS0xLTYxMjgx_179f3652-c43c-4298-bedd-0cf44ff87d56">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i59870493567442b2b5898f3382bd261a_D20211001-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV81LTAtMS0xLTYxMjgx_5518c7e3-7f1c-42ed-88b1-33d1304de73f">1.401% Notes due May 24, 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i59870493567442b2b5898f3382bd261a_D20211001-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV81LTItMS0xLTYxMjgx_6222e288-f66f-4905-883b-6295c745cecf">BDX23A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i59870493567442b2b5898f3382bd261a_D20211001-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV81LTQtMS0xLTYxMjgx_b99ef7a8-35e9-442f-81f0-6c567c1ca868">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id8bc22d2da56460b8728cbbf75e236a1_D20211001-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV82LTAtMS0xLTYxMjgx_15a30936-1cef-4045-9e26-df3c3600b27c">3.020% Notes due May 24, 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id8bc22d2da56460b8728cbbf75e236a1_D20211001-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV82LTItMS0xLTYxMjgx_15be5873-3a7a-4953-9db2-0c6f68cdcf40">BDX25</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id8bc22d2da56460b8728cbbf75e236a1_D20211001-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV82LTQtMS0xLTYxMjgx_814c3bf8-00c4-4cba-820a-83f5ef689ca9">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic3f625ad61544610912ab0da5ade95c6_D20211001-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV83LTAtMS0xLTYxMjgx_bf8caf84-d281-43ff-9751-5b17c571b3f9">0.632% Notes due June 4, 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic3f625ad61544610912ab0da5ade95c6_D20211001-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV83LTItMS0xLTYxMjgx_c41f431e-8077-414b-8820-bc540bed1249">BDX/23A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic3f625ad61544610912ab0da5ade95c6_D20211001-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV83LTQtMS0xLTYxMjgx_7fb6848d-0bde-44a1-95da-e8e0967b7c36">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6f1fc3248ed8431cb579e0478a450c5f_D20211001-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV84LTAtMS0xLTYxMjgx_f5f2e894-8ab5-4b79-abd2-9b2de06a529e">1.208% Notes due June 4, 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6f1fc3248ed8431cb579e0478a450c5f_D20211001-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV84LTItMS0xLTYxMjgx_5edf9163-e65c-418e-8025-9e663d6f18e0">BDX/26A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6f1fc3248ed8431cb579e0478a450c5f_D20211001-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV84LTQtMS0xLTYxMjgx_8d0e558e-8dac-4d69-a02d-f0af7785136d">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i69585d30ad2447d1ac69fce1f20e5da4_D20211001-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV85LTAtMS0xLTYxMjgx_dcb5f0be-5f5e-482c-8029-6dd8bb4d60b7">1.213% Notes due February 12, 2036</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i69585d30ad2447d1ac69fce1f20e5da4_D20211001-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV85LTItMS0xLTYxMjgx_9082310b-4939-49b5-9ea2-a8086ef284af">BDX/36</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i69585d30ad2447d1ac69fce1f20e5da4_D20211001-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV85LTQtMS0xLTYxMjgx_47b17ba0-df5d-4453-bf46-37621d899df1">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0f19c1acbe03446ea643c73bc09f6386_D20211001-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8xMC0wLTEtMS02MTI4MQ_0459c407-fb68-4019-bc40-6e87c38d8d07">0.000% Notes due August 13, 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0f19c1acbe03446ea643c73bc09f6386_D20211001-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8xMC0yLTEtMS02MTI4MQ_ec10dd07-29ee-4fbf-a36f-8dcbaaa8be72">BDX23B</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0f19c1acbe03446ea643c73bc09f6386_D20211001-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8xMC00LTEtMS02MTI4MQ_08bbeec4-f32d-46bf-839a-cdb91e3e0e23">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97abaf17fc984c8496d82b047da581a9_D20211001-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8xMS0wLTEtMS02MTI4MQ_a6c64650-0ec5-457a-be07-dee73ab80dfa">0.034% Notes due August 13, 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97abaf17fc984c8496d82b047da581a9_D20211001-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8xMS0yLTEtMS02MTI4MQ_3269c095-6830-40c2-aeb4-9507bb576a96">BDX25A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97abaf17fc984c8496d82b047da581a9_D20211001-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8xMS00LTEtMS02MTI4MQ_df319ad1-70a7-4def-b9a7-4489125f4441">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGV4dHJlZ2lvbjplZDJiZDMwODVmMzE0N2Q2ODExMTQ3YmQxMjg0YjBlZl8xNjQ0_8742e1da-e07f-4802-8dcf-b4e3b83b82a7">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGV4dHJlZ2lvbjplZDJiZDMwODVmMzE0N2Q2ODExMTQ3YmQxMjg0YjBlZl8xNjQ1_322d2c9e-22ac-4670-be1f-87ec3cfc268d">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160; &#9744;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.695%"><tr><td style="width:1.0%"></td><td style="width:32.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.275%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ZDBlMzJmNDUyNmJiNGYxYmI0M2Q3NGM0MjdjMzRiN2IvdGFibGVyYW5nZTpkMGUzMmY0NTI2YmI0ZjFiYjQzZDc0YzQyN2MzNGI3Yl8wLTAtMS0xLTYxMjgx_a0a6eeb1-d8d3-4d11-93df-f962b4117c71">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ZDBlMzJmNDUyNmJiNGYxYmI0M2Q3NGM0MjdjMzRiN2IvdGFibGVyYW5nZTpkMGUzMmY0NTI2YmI0ZjFiYjQzZDc0YzQyN2MzNGI3Yl8xLTYtMS0xLTYxMjgx_b6ec177b-dd9e-4713-99c0-e31ad0d1f82a">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ZDBlMzJmNDUyNmJiNGYxYmI0M2Q3NGM0MjdjMzRiN2IvdGFibGVyYW5nZTpkMGUzMmY0NTI2YmI0ZjFiYjQzZDc0YzQyN2MzNGI3Yl8yLTItMS0xLTYxMjgx_3f812388-58bd-4cef-83c0-da62812af67f">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;<ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGV4dHJlZ2lvbjplZDJiZDMwODVmMzE0N2Q2ODExMTQ3YmQxMjg0YjBlZl8xNjQ2_80b1ba45-6634-45ce-aaa5-a499399f4503">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No&#160;&#160;&#9746;</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="shares" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGV4dHJlZ2lvbjplZDJiZDMwODVmMzE0N2Q2ODExMTQ3YmQxMjg0YjBlZl8xNTgx_9f43af64-813e-4ca2-9a90-eedda02b6edf">285,064,629</ix:nonFraction> shares of Common Stock, $1.00 par value, outstanding at March&#160;31, 2022.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div></div></div><div id="icb36c8b3bd0b41458d5570d492469671_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended March&#160;31, 2022</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Number</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Part I.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icb36c8b3bd0b41458d5570d492469671_13">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icb36c8b3bd0b41458d5570d492469671_16">Condensed Consolidated Statements of Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#icb36c8b3bd0b41458d5570d492469671_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icb36c8b3bd0b41458d5570d492469671_19">Condensed Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#icb36c8b3bd0b41458d5570d492469671_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icb36c8b3bd0b41458d5570d492469671_22">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#icb36c8b3bd0b41458d5570d492469671_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icb36c8b3bd0b41458d5570d492469671_25">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#icb36c8b3bd0b41458d5570d492469671_25">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icb36c8b3bd0b41458d5570d492469671_28">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#icb36c8b3bd0b41458d5570d492469671_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icb36c8b3bd0b41458d5570d492469671_67">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#icb36c8b3bd0b41458d5570d492469671_67">20</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icb36c8b3bd0b41458d5570d492469671_70">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#icb36c8b3bd0b41458d5570d492469671_70">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icb36c8b3bd0b41458d5570d492469671_73">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#icb36c8b3bd0b41458d5570d492469671_73">36</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Part II.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icb36c8b3bd0b41458d5570d492469671_76">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icb36c8b3bd0b41458d5570d492469671_79">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#icb36c8b3bd0b41458d5570d492469671_79">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icb36c8b3bd0b41458d5570d492469671_82">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#icb36c8b3bd0b41458d5570d492469671_82">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icb36c8b3bd0b41458d5570d492469671_85">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#icb36c8b3bd0b41458d5570d492469671_85">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icb36c8b3bd0b41458d5570d492469671_88">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#icb36c8b3bd0b41458d5570d492469671_88">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icb36c8b3bd0b41458d5570d492469671_91">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#icb36c8b3bd0b41458d5570d492469671_91">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icb36c8b3bd0b41458d5570d492469671_94">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#icb36c8b3bd0b41458d5570d492469671_94">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icb36c8b3bd0b41458d5570d492469671_97">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#icb36c8b3bd0b41458d5570d492469671_97">39</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icb36c8b3bd0b41458d5570d492469671_100">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#icb36c8b3bd0b41458d5570d492469671_100">40</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="icb36c8b3bd0b41458d5570d492469671_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ITEM&#160;1. FINANCIAL STATEMENTS</span></div><div id="icb36c8b3bd0b41458d5570d492469671_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Millions of dollars, except per share data</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.070%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.219%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMi0xLTEtMS02MTI4MQ_a89d74fd-3c93-4005-8d08-3d8fe2b4f4ea">5,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMi0zLTEtMS02MTI4MQ_38578bf0-f935-42ba-9d25-54c0416d1961">4,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMi01LTEtMS02MTI4MQ_af4470ae-dcee-452a-91bf-50d398637e0e">10,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMi03LTEtMS02MTI4MQ_a7239d06-23d4-4322-b41e-07b3c6943edc">10,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMy0xLTEtMS02MTI4MQ_8ed825ae-4d15-4d33-81fb-16b5950ed27f">2,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMy0zLTEtMS02MTI4MQ_f72d6220-32cf-4763-819e-5e7fdf59dafa">2,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMy01LTEtMS02MTI4MQ_9668e514-c749-4c55-9b01-7804695a53d9">5,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMy03LTEtMS02MTI4MQ_290bec77-c357-4a9a-ac2f-ae64fdc83f5c">5,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNC0xLTEtMS02MTI4MQ_36890998-8e2a-42c3-bafa-7dfc90dccb23">1,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNC0zLTEtMS02MTI4MQ_e4a5e1a2-1e20-487f-b5ff-c87cad38973b">1,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNC01LTEtMS02MTI4MQ_9fc90023-1776-49c7-a8f1-27346d98a4b6">2,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNC03LTEtMS02MTI4MQ_68b1b465-691d-4a0c-be7f-fe8b380ac0f0">2,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNS0xLTEtMS02MTI4MQ_58ed3037-7c53-4a23-9013-884207649025">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNS0zLTEtMS02MTI4MQ_e63c7d49-8f64-45b3-97f2-8502014c1b68">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNS01LTEtMS02MTI4MQ_df62f842-2f12-4d78-98d8-1c4ac103227a">673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNS03LTEtMS02MTI4MQ_32cd162c-94cd-493f-9a7b-61ae61bb3255">608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration and restructuring expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNi0xLTEtMS02MTI4MQ_d97db90b-fe64-451a-ad0c-3fd347db460c">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNi0zLTEtMS02MTI4MQ_74810813-19be-4b44-b768-a236d994742b">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNi01LTEtMS02MTI4MQ_0c2b3643-28f9-46bc-bed5-03df80850297">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNi03LTEtMS02MTI4MQ_cbf5943d-daff-424e-8977-5baf1330cb89">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNy0xLTEtMS02MTI4MQ_7819e884-8995-4770-8234-36e00cb74cee">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNy0zLTEtMS02MTI4MQ_8158b944-9466-4881-942f-eeaa9000ae3d">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNy01LTEtMS02MTI4MQ_b06ceffe-5d49-4ea1-ae1a-43b3d25a78b7">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNy03LTEtMS02MTI4MQ_75f5e74e-31e4-498a-91f7-cfe358168580">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating Costs and Expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfOC0xLTEtMS02MTI4MQ_b21c81e2-fc53-4a1b-81b6-b0723e23824b">4,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfOC0zLTEtMS02MTI4MQ_df7e62da-f734-4983-8703-359ff5f3692c">4,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfOC01LTEtMS02MTI4MQ_aeb9130e-0d84-4961-93a7-4cbb85a4c9b0">8,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfOC03LTEtMS02MTI4MQ_425652a8-872e-4772-ada3-109e63ebb3b9">8,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfOS0xLTEtMS02MTI4MQ_afebc4ea-2018-4126-af4b-c70926f19ff9">652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfOS0zLTEtMS02MTI4MQ_b2b70eaf-f397-4337-bc54-2b8a4df131fd">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfOS01LTEtMS02MTI4MQ_e58849c6-09e0-401e-8dc1-61dfba663956">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfOS03LTEtMS02MTI4MQ_af1c385a-5948-47a9-9b6e-49c4ded5c9c6">1,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTAtMS0xLTEtNjEyODE_2b174342-412c-4d45-9b72-8ef298065427">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTAtMy0xLTEtNjEyODE_11fb9a99-dd2d-4ec5-94e2-6885f38cf413">124</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTAtNS0xLTEtNjEyODE_a57db711-6a0c-4ccb-ba5a-22284379fb2a">199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTAtNy0xLTEtNjEyODE_50d50b60-6f03-4bb5-bce9-4f936fb2d84d">242</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTEtMS0xLTEtNjEyODE_05e4981f-2343-4a45-a21c-c12384501de6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTEtMy0xLTEtNjEyODE_363ec43e-6a12-47e8-adb1-b4e7bbee4a56">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTEtNS0xLTEtNjEyODE_d9a832a8-37bf-40a2-b44f-0d4a0c857d25">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTEtNy0xLTEtNjEyODE_ab13ecdd-13e8-49ea-9d21-213f1d460359">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTItMS0xLTEtNjEyODE_cf71cd2b-ab70-4988-937c-258cff9ae244">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTItMy0xLTEtNjEyODE_d99a2cb8-df76-45c5-ad82-5f923a885f2b">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTItNS0xLTEtNjEyODE_9d2be59f-bf4a-4d41-a954-167fcd5f6326">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTItNy0xLTEtNjEyODE_26c7a586-a748-4e7b-9680-6ead8903ffac">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income Before Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTMtMS0xLTEtNjEyODE_263830a1-65e2-486a-aac7-539a3f508d1b">525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTMtMy0xLTEtNjEyODE_2a52730c-904e-4bc9-9356-0f306d8e4903">305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTMtNS0xLTEtNjEyODE_54cedcd7-dc42-4be9-be20-71fb3de17e5d">1,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTMtNy0xLTEtNjEyODE_af5bb7b9-ba18-4b93-9222-0b2adc0f5968">1,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTQtMS0xLTEtNjEyODE_fabd7829-9c5d-45c7-bb03-18b9f47605e1">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTQtMy0xLTEtNjEyODE_925cc5ab-b409-4219-9ab8-a413e8e4ad3a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTQtNS0xLTEtNjEyODE_ef40aa78-a8da-42ef-b1d6-a92eb19a5314">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTQtNy0xLTEtNjEyODE_95423143-c2cf-4398-8a93-ba3931dc31e9">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTUtMS0xLTEtNjEyODE_1a8d55cf-c79a-4a7a-bb2d-957d6d2193ad">454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTUtMy0xLTEtNjEyODE_a15be862-b3c6-4022-b8d3-8cf38bc2bd8d">299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTUtNS0xLTEtNjEyODE_843c0769-3a7d-4167-8547-2e66fe654b23">1,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTUtNy0xLTEtNjEyODE_ae36fbd5-f5ab-4087-8a9b-0efe33c91719">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTYtMS0xLTEtNjEyODE_93b207bf-0354-40db-9d5f-aba1c31855d9">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTYtMy0xLTEtNjEyODE_25e5adf1-53d8-4416-9d0d-b7812652213d">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTYtNS0xLTEtNjEyODE_0550cec7-3c9a-4c87-8955-47c90f42c509">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTYtNy0xLTEtNjEyODE_e25998b3-1ed9-4cd4-a12e-9894c1cbd66e">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income applicable to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTctMS0xLTEtNjEyODE_654e8361-24ba-469c-a229-ba1570ae898c">431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTctMy0xLTEtNjEyODE_5f1fbc57-7616-4a77-bf80-d4e7ecbcbe47">277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTctNS0xLTEtNjEyODE_7c2b68cf-05dc-4888-a0a1-92d223083089">1,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTctNy0xLTEtNjEyODE_133b706a-c85f-4be9-966f-811b3e2f6c75">1,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic Earnings per Share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjAtMS0xLTEtNjEyODE_1190055b-5c2e-4d78-af7c-161c8df6e2c1">1.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjAtMy0xLTEtNjEyODE_8a8cf7d5-21ff-4ee1-9723-d1f8629d6b96">0.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjAtNS0xLTEtNjEyODE_3a631c27-ce3d-4325-90f7-3d2ec6715a93">3.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjAtNy0xLTEtNjEyODE_57b7cbf2-c13a-430e-9392-b2fedae66007">4.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings per Share</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjEtMS0xLTEtNjEyODE_8a2ea5c0-7710-4a55-bd22-5343ad73f135">1.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjEtMy0xLTEtNjEyODE_5a0ee021-b914-4ce4-ab5f-dff240a6e845">0.94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjEtNS0xLTEtNjEyODE_d6f9f07d-f4c0-41dd-b458-1a6b92f6a374">3.78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjEtNy0xLTEtNjEyODE_95ec5c9d-7300-4431-b048-014ce4c13ae2">4.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends per Common Share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjItMS0xLTEtNjEyODE_3bf62444-1613-4c7c-be50-c1ec4c335c71">0.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjItMy0xLTEtNjEyODE_299598c4-1d5f-4777-8059-16824b9cabbb">0.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjItNS0xLTEtNjEyODE_c6893456-8bc4-48e5-9c03-601c2d155890">1.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjItNy0xLTEtNjEyODE_5a8ef55d-61cb-4fdd-b008-12b679b5d065">1.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts may not add due to rounding.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="icb36c8b3bd0b41458d5570d492469671_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Millions of dollars</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfMi0xLTEtMS02MTI4MQ_1a8d55cf-c79a-4a7a-bb2d-957d6d2193ad">454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfMi0zLTEtMS02MTI4MQ_a15be862-b3c6-4022-b8d3-8cf38bc2bd8d">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfMi01LTEtMS02MTI4MQ_843c0769-3a7d-4167-8547-2e66fe654b23">1,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfMi03LTEtMS02MTI4MQ_ae36fbd5-f5ab-4087-8a9b-0efe33c91719">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income (Loss), Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNC0xLTEtMS02MTI4MQ_b37f308b-89e6-4649-afb0-7c7e0c90c6f1">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNC0zLTEtMS02MTI4MQ_15d0aaa2-adc9-441e-bc24-cecf516c0d73">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNC01LTEtMS02MTI4MQ_751cb6d7-beef-42d7-8474-c41887cce0c4">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNC03LTEtMS02MTI4MQ_58606627-99ab-4d5b-af8a-b40460a4efb5">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension and postretirement plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNS0xLTEtMS02MTI4MQ_b2c34ddb-e123-432f-99d1-58341393a0f3">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNS0zLTEtMS02MTI4MQ_723bbfff-436b-4c65-b00f-c29e6ff127d2">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNS01LTEtMS02MTI4MQ_19c12086-590c-4982-b903-ba705780ab61">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNS03LTEtMS02MTI4MQ_085f85fd-5b16-4325-ad42-e0b4d4b014a9">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNi0xLTEtMS02MTI4MQ_ca65ed5d-d27e-444c-a7d4-404e2b17db65">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNi0zLTEtMS02MTI4MQ_aaf2d744-40dd-40e2-9c00-f913c7f4a0b3">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNi01LTEtMS02MTI4MQ_67f5c04c-5fc1-4416-af3d-e14cc6fd619a">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNi03LTEtMS02MTI4MQ_5658c11c-426f-4667-988e-d75e41a70c70">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income, Net of Tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNy0xLTEtMS02MTI4MQ_ae9f21b0-0612-4674-a075-828a808c732e">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNy0zLTEtMS02MTI4MQ_d9db1823-4de7-4b3d-8bcb-815e3a9b69dd">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNy01LTEtMS02MTI4MQ_ce334d09-75d0-4633-ac78-6c363ebefb68">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNy03LTEtMS02MTI4MQ_6c479fd0-3cde-4ff7-b7d3-cb9db8b589d5">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive Income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfOC0xLTEtMS02MTI4MQ_d82a6845-45de-4441-857d-6dd57ae9f70e">586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfOC0zLTEtMS02MTI4MQ_b5aa1739-1661-453f-96b5-a1c1fa9475e1">384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfOC01LTEtMS02MTI4MQ_7789fcc9-f949-4e2f-872e-e5670eeda99a">1,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfOC03LTEtMS02MTI4MQ_05728528-7ccf-40dd-9425-36e939fec750">1,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts may not add due to rounding.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="icb36c8b3bd0b41458d5570d492469671_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Millions of dollars</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.737%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMy0xLTEtMS02MTI4MQ_8f6580d4-2df3-493c-89fb-199098ae5542">3,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMy0zLTEtMS02MTI4MQ_aeaaf961-a0c1-4d87-8039-812f87d97388">2,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNC0xLTEtMS02MTI4MQ_3493a823-5d1e-4621-9181-404889e18194">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNC0zLTEtMS02MTI4MQ_ba62f370-76b3-4713-8d0d-e28a72838814">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:OtherShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNS0xLTEtMS02MTI4MQ_a1e6ee4b-7dc8-4e50-872f-7b9dac9ca175">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:OtherShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNS0zLTEtMS02MTI4MQ_869b5416-90c5-4c02-9aa8-c92c31b1a706">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNi0xLTEtMS02MTI4MQ_6bb09da3-4a4e-46b1-87e3-185e3a3bf1d9">2,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNi0zLTEtMS02MTI4MQ_0ac3f76c-7579-4a39-84b7-5db59769d906">2,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfOC0xLTEtMS02MTI4MQ_b2239d8e-e0cf-4685-8fad-1f02ffef81b8">708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfOC0zLTEtMS02MTI4MQ_fb995bd5-40c9-4831-9ef1-7530a6da6eab">641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfOS0xLTEtMS02MTI4MQ_5ac080d2-7e9f-49ea-9f4c-6b364cac6643">413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfOS0zLTEtMS02MTI4MQ_5ff95e6f-a341-4d5a-a372-6e59b69ca4f1">402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTAtMS0xLTEtNjEyODE_67eb5ec1-feae-43ca-8a7c-a970a895da51">2,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTAtMy0xLTEtNjEyODE_903fc000-8651-4624-9f10-9c60e51a7abb">1,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTEtMS0xLTEtNjEyODE_07dc59ff-d5e9-4087-aa2f-784bb34da229">3,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTEtMy0xLTEtNjEyODE_823bd570-189d-4ad3-83fb-e2a24702ae0c">2,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTMtMS0xLTEtNjEyODE_65afaace-89a8-45d0-8993-e457d2973e03">1,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTMtMy0xLTEtNjEyODE_6adfd6d5-22f7-45f9-9509-4d7a22e73d4e">1,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current Assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTQtMS0xLTEtNjEyODE_dc65a1b1-733f-49be-87b6-ba86c8c7ecd4">10,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTQtMy0xLTEtNjEyODE_fa9c487a-38d7-441c-bf55-b14824d27246">8,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, Plant and Equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTUtMS0xLTEtNjEyODE_8fbbf5a1-f3e4-41b7-9d48-a4a216970533">13,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTUtMy0xLTEtNjEyODE_ab13a7e6-f819-4d39-9434-2cb906ad54ec">12,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less allowances for depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTYtMS0xLTEtNjEyODE_0fd1f0b4-f13a-47d9-be7a-9c2ff444d832">6,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTYtMy0xLTEtNjEyODE_3d9d1d62-6a8e-4a43-b4e2-95204e3cf19e">6,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, Plant and Equipment, Net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTctMS0xLTEtNjEyODE_102a8507-e909-4d9e-b008-8947fac25a7f">6,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTctMy0xLTEtNjEyODE_05ebd6db-1c86-4432-8bc0-66d68f563806">6,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTgtMS0xLTEtNjEyODE_a4045601-5d8d-4fc7-bf0b-613f49a3d58e">24,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTgtMy0xLTEtNjEyODE_f86b83c7-6b0f-4c92-8753-9963c47aa4f8">23,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Technology, Net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="bdx:CoreAndDevelopedTechnologyNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTktMS0xLTEtNjEyODE_195fdafd-f158-46b3-a2f3-381ca5f947eb">9,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="bdx:CoreAndDevelopedTechnologyNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTktMy0xLTEtNjEyODE_dc38574b-ce5e-45ad-a052-0bb71950f9e8">9,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer Relationships, Net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="bdx:FiniteLivedCustomerRelationshipsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjAtMS0xLTEtNjEyODE_0d066fa8-9e39-43d2-8cec-3e5e842e86d3">2,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="bdx:FiniteLivedCustomerRelationshipsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjAtMy0xLTEtNjEyODE_478bf37f-fa68-4bff-ad02-b9df1e063af6">2,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Intangibles, Net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:OtherIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjEtMS0xLTEtNjEyODE_feec27c2-61a7-4f93-953f-e7c69c420cc5">542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:OtherIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjEtMy0xLTEtNjEyODE_12304b79-f680-4070-85d7-ce8c2b303b85">548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjMtMS0xLTEtNjEyODE_2e3aa1b0-abd1-49ca-b559-1bc45b36b4dd">1,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjMtMy0xLTEtNjEyODE_bf65146e-4db8-4455-a8c4-1cae5b2d3295">1,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjQtMS0xLTEtNjEyODE_6cf6da17-c618-4699-8280-8c97f3135133">54,786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjQtMy0xLTEtNjEyODE_fe76a941-7c1e-4aae-8a7d-a40d1badbd10">53,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities and Shareholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjctMS0xLTEtNjEyODE_81c30f46-941c-4f22-be2d-67fc92694673">1,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjctMy0xLTEtNjEyODE_1a30f8d6-b376-4f62-bc1c-30df9ad93ed2">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payables, accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjgtMS0xLTEtNjEyODE_04d8558a-82eb-4bfb-b7d1-729f51c04d94">5,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjgtMy0xLTEtNjEyODE_796b0c6b-dfff-4642-8328-3c17ed84cdfb">6,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzAtMS0xLTEtNjEyODE_5faf7003-69e5-47dd-b095-2644ba007dee">6,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzAtMy0xLTEtNjEyODE_58e47c2e-912d-477c-b88c-561a3582d372">6,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzEtMS0xLTEtNjEyODE_e651beb5-c75b-4e58-ab94-b5055549b110">17,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzEtMy0xLTEtNjEyODE_29f119d2-bcef-4282-a5dd-e33ddb37a1a5">17,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Employee Benefit Obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzItMS0xLTEtNjEyODE_d20aae91-b91a-4fe9-9593-96405f6f3ed9">1,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzItMy0xLTEtNjEyODE_f69ed7e5-92f1-4883-8bfe-9f33eb2f7c0e">1,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Income Taxes and Other Liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzMtMS0xLTEtNjEyODE_8e9eb73b-8275-44ae-b77e-2cc57767316d">4,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzMtMy0xLTEtNjEyODE_9dd425b4-3790-460d-b47d-3dc7fd85c643">5,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and Contingencies (See Note 4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzQtMS0xLTEtNjEyODE_d1b41e12-3554-44c1-bdc8-d14bd9e12486"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzQtMy0xLTEtNjEyODE_acc757af-afa2-4102-8f5b-943ad02b33a3"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzYtMS0xLTEtNjEyODE_3b51af6c-1b2e-44bf-968e-225b1f92ab3c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzYtMy0xLTEtNjEyODE_ad9d5798-2df7-4c5b-99ed-b266be4851c6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzctMS0xLTEtNjEyODE_8e08d811-51e2-4a11-bae0-d16a74b11d7d">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzctMy0xLTEtNjEyODE_6cb239f5-53d5-40b2-ab49-7850ad3a9a00">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in excess of par value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzgtMS0xLTEtNjEyODE_7e8e687b-1306-439d-96fd-0ed0ac37f178">19,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzgtMy0xLTEtNjEyODE_e36e1d0f-f03e-4375-b48e-1b783441f9b4">19,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzktMS0xLTEtNjEyODE_d6697357-cf3d-4a85-aa46-4fd6b4ccd0af">14,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzktMy0xLTEtNjEyODE_5910d7d7-2f25-44fd-a35a-352193ca67bf">13,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="bdx:CommonStockSharesHeldInEmployeeTrust1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDAtMS0xLTEtNjEyODE_d8c9e502-da1c-4ba3-ad0b-6a8d2a68066f">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="bdx:CommonStockSharesHeldInEmployeeTrust1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDAtMy0xLTEtNjEyODE_fdf20bb4-47d1-4e7a-87e2-428d9443e3ab">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDEtMS0xLTEtNjEyODE_3d3263e8-738f-4429-8b87-a75aab513a15">7,866</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDEtMy0xLTEtNjEyODE_e286fb13-e420-4042-89cd-620089d9b26a">7,723</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDItMS0xLTEtNjEyODE_f299053c-7cd5-428d-919f-9582b02c0df7">1,910</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDItMy0xLTEtNjEyODE_dae7a1d7-72d0-4433-9af8-1324b1909a24">2,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 66.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Shareholders&#8217; Equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDMtMS0xLTEtNjEyODE_a8a0145f-7e0e-40bf-a105-1f2202c72cc6">24,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDMtMy0xLTEtNjEyODE_d0fd6b86-ee7c-4af8-affc-fd111e10bb0a">23,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities and Shareholders&#8217; Equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDQtMS0xLTEtNjEyODE_cb8f8819-a76f-4bb2-90c1-591c04327987">54,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDQtMy0xLTEtNjEyODE_6c4f019e-a367-4e51-a6a3-71be475edad0">53,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts may not add due to rounding.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="icb36c8b3bd0b41458d5570d492469671_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Millions of dollars</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.982%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Operating Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMy0xLTEtMS02MTI4MQ_843c0769-3a7d-4167-8547-2e66fe654b23">1,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMy0zLTEtMS02MTI4MQ_ae36fbd5-f5ab-4087-8a9b-0efe33c91719">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to net income to derive net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfNS0xLTEtMS02MTI4MQ_c67bd914-a98d-4a41-932f-8d1b5cbb94a7">1,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfNS0zLTEtMS02MTI4MQ_48d4c38c-eb37-44ce-a8c5-562bd92cf888">1,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfNi0xLTEtMS02MTI4MQ_057e593c-0941-4760-b39c-193f2d4154d3">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfNi0zLTEtMS02MTI4MQ_3bb9abbe-bb0e-4edd-afae-87bee27b576e">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfNy0xLTEtMS02MTI4MQ_092ab1d4-4569-401d-8e96-84285a6326b9">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfNy0zLTEtMS02MTI4MQ_5db877c9-eafb-4806-83ff-22eb5860d814">120</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInOperatingCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfOC0xLTEtMS02MTI4MQ_31661c0d-4a48-4c87-9cd5-e15f0d0d5c39">950</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOperatingCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfOC0zLTEtMS02MTI4MQ_9b7c8853-8fe8-4ea8-808c-85ae1905f667">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" sign="-" name="bdx:IncreaseDecreaseinPensionBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfOS0xLTEtMS02MTI4MQ_a3b3bf82-21ba-4456-a2f6-db8bcef40265">136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="bdx:IncreaseDecreaseinPensionBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfOS0zLTEtMS02MTI4MQ_fad14a00-508e-4129-8f6c-fa92cf16ecb3">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product liability-related charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:LossContingencyLossInPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTItMS0xLTEtNjEyODE_3fe6317d-4697-4bb1-8c47-cb7a0073150d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:LossContingencyLossInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTItMy0xLTEtNjEyODE_817ca8bc-a304-45ec-abfe-96be1f1472cd">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTMtMS0xLTEtNjEyODE_3833b294-5097-4fbe-9dd4-dbb583ab1a4e">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTMtMy0xLTEtNjEyODE_836f6dc0-716b-40f5-bf42-dc0491415197">109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Provided by Operating Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTQtMS0xLTEtNjEyODE_ddd65e2a-f253-4969-a19a-65e30ebc55ff">1,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTQtMy0xLTEtNjEyODE_c490f0b7-d685-440f-89ce-7904dffcd978">2,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Investing Activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTYtMS0xLTEtNjEyODE_f01beb6b-ff8d-49d0-8862-8ea3953769e3">415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTYtMy0xLTEtNjEyODE_0167466d-5ce3-4f0c-8ec5-39c9a80227c0">499</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTktMS0xLTEtNjEyODE_860d4cbc-90b1-4970-abb3-7d0e2cad3ffd">450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTktMy0xLTEtNjEyODE_336b996e-7f9c-4cfe-b86c-bfaf5e9b34a4">179</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjEtMS0xLTEtNjEyODE_e05afcd7-d3a7-4895-92ec-8dc13aaf901d">124</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjEtMy0xLTEtNjEyODE_e0f9b462-5e2c-4885-b98f-7cbca1297b34">186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Used for Investing Activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjItMS0xLTEtNjEyODE_caa4da22-9aeb-4a10-a74f-02675a072387">990</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjItMy0xLTEtNjEyODE_8e07da2a-c753-474c-9d8f-ca34213318de">863</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Financing Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="bdx:ProceedsfromIssuanceofLongTermDebtandTermLoans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjUtMS0xLTEtNjEyODE_82bf1447-bee0-4e9c-bbc0-bd83e7cc8c19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="bdx:ProceedsfromIssuanceofLongTermDebtandTermLoans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjUtMy0xLTEtNjEyODE_73c9403d-5e5f-4aa1-b65a-6974e2c0740f">1,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from debt issued in connection with the spin-off (see Note 12)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjYtMS0xLTEtNzY3NDg_17b95f3f-ccd1-4815-8220-25de200850c2">1,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjYtMy0xLTEtNzY3NDg_fae8ff5c-0158-4af7-a982-09f46eaa515b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjYtMS0xLTEtNjEyODE_015df14d-7747-4c99-81ba-55c529330bb9">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjYtMy0xLTEtNjEyODE_ad46d924-7180-43f5-a067-1540601764fc">1,998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjktMS0xLTEtNjEyODE_ebf95c37-07b7-422a-a2c1-c449af893c8e">541</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjktMy0xLTEtNjEyODE_66840a14-3414-40e0-b771-80695db977de">528</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzAtMS0xLTEtNjEyODE_5bec0503-b9e9-46e2-b42a-89428f043106">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzAtMy0xLTEtNjEyODE_de5b50b8-0001-4413-902a-fe7739b46c87">82</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Provided by (Used for) Financing Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzEtMS0xLTEtNjEyODE_6277666f-9677-4f04-bd13-4711ff3bc4ac">804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzEtMy0xLTEtNjEyODE_c9d7a0d4-e069-4c9b-a7dd-de74c07748be">893</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzItMS0xLTEtNjEyODE_38594e63-511b-442d-9a74-d0b28734267f">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzItMy0xLTEtNjEyODE_04861ed3-1afa-43c3-ac4a-a4834760f446">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash and equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzMtMS0xLTEtNjEyODE_bc9ca248-cd34-4409-a561-a5d0500fb66e">928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzMtMy0xLTEtNjEyODE_7ad2d643-9710-4632-928c-73105c8ee18a">981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opening Cash and Equivalents and Restricted Cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzQtMS0xLTEtNjEyODE_cf9540d7-0bfe-4fbd-bbc6-c07a894853f6">2,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f49a7b80b0c4a37acc78faacd1def8e_I20200930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzQtMy0xLTEtNjEyODE_3528b100-7df8-493f-a8bf-d3d3c489518d">2,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closing Cash and Equivalents and Restricted Cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzUtMS0xLTEtNjEyODE_08c79f6e-a798-4def-811c-7b71ea431354">3,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fb7d149583e4cbbb4ba841be5866113_I20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzUtMy0xLTEtNjEyODE_2bc41220-bf02-4d50-b676-6b1a2ef2992a">3,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts may not add due to rounding.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="icb36c8b3bd0b41458d5570d492469671_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2022</span></div><div id="icb36c8b3bd0b41458d5570d492469671_31"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8211; <ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zMS9mcmFnOjAwZDMxOWMzNDQxNDQ0Njg5OTk0YWMwM2I3MmRmMDczL3RleHRyZWdpb246MDBkMzE5YzM0NDE0NDQ2ODk5OTRhYzAzYjcyZGYwNzNfMjE5Mg_26952a23-552b-40bd-9d86-e57305b5bae9" continuedAt="ic8cb788c46484011a3755adca35fe918" escape="true">Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="ic8cb788c46484011a3755adca35fe918"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and, in the opinion of the management of Becton, Dickinson and Company (the "Company" or "BD"), include all adjustments which are of a normal recurring nature, necessary for a fair presentation of the financial position and the results of operations and cash flows for the periods presented.  However, the financial statements do not include all information and accompanying notes required for a presentation in accordance with U.S. generally accepted accounting principles ("U.S. GAAP").  These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company&#8217;s 2021 Annual Report on Form 10-K.  Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes.  Percentages and earnings per share amounts presented are calculated from the underlying amounts.  The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Spin-Off of Diabetes Care Business</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company named Embecta Corp. (&#8220;Embecta&#8221;) through a distribution of Embecta&#8217;s publicly traded common stock to BD&#8217;s shareholders of record as of the close of business on March 22, 2022 (the &#8220;record date&#8221;).  The Company distributed one share of Embecta common stock for every five common shares of BD outstanding as of the record date.  Shareholders received cash in lieu of fractional shares of Embecta common stock.  The spin-off is expected to qualify as a tax-free transaction for U.S. federal income tax purposes.  Embecta is an independent, publicly traded company focused on diabetes management, and BD retains no ownership interest.  Embecta&#8217;s common stock is listed on NASDAQ under the ticker symbol &#8220;EMBC&#8221;.  The historical financial results of Embecta are included in these condensed consolidated financial statements.  Subsequent to the spin-off, and in future filings, the historical results of the Diabetes Care business will be reflected as discontinued operations in the Company&#8217;s consolidated financial statements.  Disclosures pertaining to Embecta&#8217;s issuance of debt in connection with the spin-off are provided in Note 12.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In connection with the spin-off, the Company and Embecta entered into various agreements to effect the spin-off and provide a framework for the relationship between the Company and Embecta after the spin-off.  Such agreements include the separation and distribution agreement, as well as the following ongoing agreements: a cannula supply agreement, an intellectual property matters agreement, a transition services agreement, manufacturing and supply agreements, a lease agreement, a distribution agreement to support commercial operations, a logistics services agreement and other agreements including an employee matters agreement and a tax matters agreement. Under these agreements the Company will continue to provide certain products and services to Embecta following the spin-off.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="icb36c8b3bd0b41458d5570d492469671_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8211; <ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RleHRyZWdpb246MWZkY2M3NTQyZGYxNDI4MWJkOGY1ZGMzNDRhNTUyNzVfMjEwMg_f4cfb5f7-3209-44de-a8b4-525d16e45d33" continuedAt="i0bf3bf31aea14edaa16eb5aaea57b802" escape="true">Shareholders' Equity</ix:nonNumeric></span></div><ix:continuation id="i0bf3bf31aea14edaa16eb5aaea57b802" continuedAt="i23ec40fdb5ff446396c618c3e61c36a3"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RleHRyZWdpb246MWZkY2M3NTQyZGYxNDI4MWJkOGY1ZGMzNDRhNTUyNzVfMjEwNA_fb93c698-27f7-4251-b5c4-2df9f35ab38f" continuedAt="i51cb54d082124cfe829f90d55384c9c6" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in certain components of shareholders' equity for the first two quarters of fiscal years 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"></td><td style="width:35.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.183%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.027%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock&#160; Issued<br/>at&#160;Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess&#160;of<br/>Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred<br/>Compensation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3c1843bb7b44edabe19cee43be62817_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMi0xLTEtMS02MTI4MQ_3e5c825b-565a-4aa7-85fc-7d11fd8c8244">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e75e43373c14b1eae872a1d4dd08fc3_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMi0zLTEtMS02MTI4MQ_770c5efe-dede-46fe-896a-706aba75e816">19,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89314df24664e74a252364fc091e358_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMi01LTEtMS02MTI4MQ_277c3ec3-a6e0-42d8-8c57-4cbfd06f3306">13,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec379b37d724046b6a043294e406405_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMi03LTEtMS02MTI4MQ_1407a233-4bc4-4909-a643-6e7f413ca5d2">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i61cdc5a7fb1f402985abc66f5ca9909b_I20210930" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMi05LTEtMS02MTI4MQ_f1daca68-dbc9-4c3a-b2de-b23123331e87">80,164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61cdc5a7fb1f402985abc66f5ca9909b_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMi0xMS0xLTEtNjEyODE_7d075588-3dfa-4f56-aadd-d00dfc3356cd">7,723</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1104298cf0f746fa8b00a8e2dbb7eea4_D20211001-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMy01LTEtMS02MTI4MQ_251ff2ec-c3cd-48e6-bf4e-32eac79e8467">677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($<ix:nonFraction unitRef="usdPerShare" contextRef="iefdb0b0a3f294705ae8463fd402aa8f3_D20211001-20211231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfNC0wLTEtMS02MTI4MS90ZXh0cmVnaW9uOjIxNmM2YzZmOTExODQyOGY4Y2Q2NDkzYmRlZDYyMGVlXzIy_3a2a05c2-9ccf-419c-a6cf-ee4943e78405">0.87</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1104298cf0f746fa8b00a8e2dbb7eea4_D20211001-20211231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfNC01LTEtMS02MTI4MQ_99cec42d-b65d-4a8f-87dc-ba6e00d8531d">248</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1104298cf0f746fa8b00a8e2dbb7eea4_D20211001-20211231" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfNS01LTEtMS02MTI4MQ_640bc0f2-d761-4f03-90c6-9eb450249c75">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f577fd449564742befb8a5b86459eeb_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfNi0zLTEtMS02MTI4MQ_b2211a17-5619-479c-b958-83093418a641">71</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2332d63e32a54c098fd20d5b1542bb16_D20211001-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfNi05LTEtMS02MTI4MQ_d9deeabd-af9c-4499-bb2b-3921dfc09330">762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2332d63e32a54c098fd20d5b1542bb16_D20211001-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfNi0xMS0xLTEtNjEyODE_53de73a8-25fb-4f69-9b53-b9fe77d078d6">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f577fd449564742befb8a5b86459eeb_D20211001-20211231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfNy0zLTEtMS02MTI4MQ_1a76319a-0d9a-4566-9661-239b4bf376a2">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2332d63e32a54c098fd20d5b1542bb16_D20211001-20211231" decimals="-3" sign="-" name="bdx:CommonStockHeldInTrustsNetShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfOC05LTEtMS02MTI4MQ_70efa5b7-b8d5-48f8-98c5-557c29b5a77b">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f577fd449564742befb8a5b86459eeb_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfOS0zLTEtMS02MTI4MQ_f44af02b-fda8-40ec-9281-8dd78bae9be4">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2332d63e32a54c098fd20d5b1542bb16_D20211001-20211231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfOS05LTEtMS02MTI4MQ_08241d07-f49d-4239-b879-9a29a2751ac6">462</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2332d63e32a54c098fd20d5b1542bb16_D20211001-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfOS0xMS0xLTEtNjEyODE_9bb73328-1de5-405a-bcc0-3836ba0c18c3">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f954158bd0474497e7bf9c2a23536b_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTEtMS0xLTEtNjEyODE_4496a93d-b687-43af-a747-6bb10bded723">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081ee5a5852e407c84e3e572849b152b_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTEtMy0xLTEtNjEyODE_1e279184-4f59-458f-bc44-098a6e86bac5">19,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cc557aa2f8d480daebdcbf52be025e5_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTEtNS0xLTEtNjEyODE_59dd1360-5414-4afb-ab70-60db2cfa6310">14,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1344f18c36641fc8d87799098076721_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTEtNy0xLTEtNjEyODE_9b8b4d19-435c-46cd-80e6-b432be37ed26">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibfee3de793164af9b845b6842e2d9376_I20211231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTEtOS0xLTEtNjEyODE_6ec4fccd-6466-41d1-a8ac-0acd0a1cbccc">79,869</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfee3de793164af9b845b6842e2d9376_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTEtMTEtMS0xLTYxMjgx_7b2db465-38dc-46ed-b1a4-1b912646b21c">7,855</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb08051b764c64846def77e74cebc1_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTItNS0xLTEtNjEyODE_c3258bb0-d04d-4566-b7e5-75d318d031f3">454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($<ix:nonFraction unitRef="usdPerShare" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTMtMC0xLTEtNjEyODEvdGV4dHJlZ2lvbjo1ZmY3ODFhZDM2MjE0ZDBjYmI4NjExM2VlOTBlZThmNV8yMg_ea4cb970-d9ef-430b-a9d8-fd1ba455194d">0.87</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ccb08051b764c64846def77e74cebc1_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTMtNS0xLTEtNjEyODE_ea465894-5e9a-4e1d-add4-f1557dffdf53">248</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ccb08051b764c64846def77e74cebc1_D20220101-20220331" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTQtNS0xLTEtNjEyODE_15adfad1-4ea0-4813-987c-e2cbaf27aa71">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d31a13945d64153886cacad6bf05af2_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTUtMy0xLTEtNjEyODE_2604b666-3fb3-4661-be51-27444dd0af4b">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id71dace7ba3b4742baa7ca689c30873b_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTUtNy0xLTEtNjEyODE_a14a4245-66e3-4fed-a32f-5d603192ab33">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0cda69a93a124d77b34442ef82673b2d_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTUtOS0xLTEtNjEyODE_846685f8-7996-4042-b9d4-f706d0e85627">284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cda69a93a124d77b34442ef82673b2d_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTUtMTEtMS0xLTYxMjgx_d27a7591-850d-48cb-bb76-0c2de33e9156">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d31a13945d64153886cacad6bf05af2_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTYtMy0xLTEtNjEyODE_1a330469-bcd3-457d-a972-e8c4de9c8263">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d31a13945d64153886cacad6bf05af2_D20220101-20220331" decimals="-6" name="bdx:CommonStockHeldInTrustsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTctMy0xLTEtNjEyODE_c80a337f-e4bd-4c96-abec-c8e014e278e3">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0cda69a93a124d77b34442ef82673b2d_D20220101-20220331" decimals="-3" name="bdx:CommonStockHeldInTrustsNetShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTctOS0xLTEtNjEyODE_ef8b7800-cbea-47fc-b7db-edfadd804a37">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cda69a93a124d77b34442ef82673b2d_D20220101-20220331" decimals="-6" name="bdx:CommonStockHeldInTrustsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTctMTEtMS0xLTYxMjgx_3a18de2e-a10e-4505-b5ea-4733f2a7b04d">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id251a2ed05f94abfb442c3b00935484d_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTgtMS0xLTEtNjEyODE_8f30fbea-6fa3-43e4-9859-8645cf2bf82a">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea8a760ffe4c4852a215ec13b1e39b19_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTgtMy0xLTEtNjEyODE_0fd4a47d-5f70-4e2f-acc4-cd1f8491ce5b">19,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4e6e39ebb924eb88e298367603c6efa_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTgtNS0xLTEtNjEyODE_b52bbca5-c6d2-4139-9d8d-3eba748a2e6d">14,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2889486ea2246ac8bbb298a59bd2634_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTgtNy0xLTEtNjEyODE_09f87752-11b5-42e2-8b25-7096f22199e1">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i56c3903f09b94c6b872822313f7d17c0_I20220331" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTgtOS0xLTEtNjEyODE_3a89dade-e645-4a70-9faf-895b03703804">79,575</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56c3903f09b94c6b872822313f7d17c0_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTgtMTEtMS0xLTYxMjgx_8188ae40-98b9-4b34-8e3d-5e509f42af8d">7,866</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"></td><td style="width:35.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.183%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.027%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock&#160; Issued<br/>at&#160;Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess&#160;of<br/>Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred<br/>Compensation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c2306c70486435080a9eb6d50933f3b_I20200930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMi0xLTEtMS02MTI4MQ_da95cc40-079a-48a8-bb6f-5c48c4cc8dc0">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7e94317b56c4ee39ee10b7b86f2988d_I20200930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMi0zLTEtMS02MTI4MQ_a12e82e4-fc1c-4310-9a5a-cf7df0be05d0">19,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95ca0513273e493d9f458220ba54c5fa_I20200930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMi01LTEtMS02MTI4MQ_3cac4b93-c81f-47a5-8833-b1158b873456">12,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id300f100b3b74d869d299c38e13eff73_I20200930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMi03LTEtMS02MTI4MQ_d53d9e71-3300-4fc1-8d12-7d2edc0c8a57">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i543caecc83554a22bc382fd13fe58144_I20200930" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMi05LTEtMS02MTI4MQ_2aaeedc9-11e3-4299-9e03-21e0522bac83">74,623</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i543caecc83554a22bc382fd13fe58144_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMi0xMS0xLTEtNjEyODE_ebfd74b8-862f-4f5f-aaf3-6f69c8174aa3">6,138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe5c0b260644978b5979c61385ae9f5_D20201001-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMy01LTEtMS02MTI4MQ_c8882158-8384-4820-9788-c50a19892ab3">1,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($<ix:nonFraction unitRef="usdPerShare" contextRef="icedd1d99c22048f7924f50a371090298_D20201001-20201231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfNC0wLTEtMS02MTI4MS90ZXh0cmVnaW9uOjg5YTZlMDE1YjQwZDQwMTk5YWE2ODlhZjVmYTc5Y2RlXzIy_f11776de-ac0b-4208-a615-ae9a351f8c89">0.83</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfe5c0b260644978b5979c61385ae9f5_D20201001-20201231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfNC01LTEtMS02MTI4MQ_20f8dce5-85b9-4aa7-aa25-7d9ace534b18">242</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfe5c0b260644978b5979c61385ae9f5_D20201001-20201231" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfNS01LTEtMS02MTI4MQ_319d0ddd-0657-44d8-9186-a8ac37d94abd">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3c9b45cb60c4c73bbca1766d2ee8583_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfNi0zLTEtMS02MTI4MQ_de933ca1-dd39-4038-885c-53cd85ac2474">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i535a03f509b14bbdb82ee8d0fff4154f_D20201001-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfNi05LTEtMS02MTI4MQ_4bc63f33-9589-490e-bb49-eb376656e2b6">549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i535a03f509b14bbdb82ee8d0fff4154f_D20201001-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfNi0xMS0xLTEtNjEyODE_039e0f48-9c8b-40b7-91f5-e7ea843db0a5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3c9b45cb60c4c73bbca1766d2ee8583_D20201001-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfNy0zLTEtMS02MTI4MQ_8918ae1a-bac7-40d6-9fab-dccca4b69260">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i535a03f509b14bbdb82ee8d0fff4154f_D20201001-20201231" decimals="-3" sign="-" name="bdx:CommonStockHeldInTrustsNetShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfOC05LTEtMS02MTI4MQ_cc2355d0-7fe0-4a11-82f6-fc5261104ec3">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of change in accounting principles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id659b030b22b452f98d9897c4a1db5f2_D20201001-20201231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfOS01LTEtMS02MTI4MQ_58745313-a9cf-4b8b-9666-8a3812edade5">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf0ffad15f524c22b5a8910cf0242018_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTAtMS0xLTEtNjEyODE_0fc0cf07-e7de-4639-a2a1-7c9541d7698d">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i725012b63b26440eabbde5cc7e83e9c7_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTAtMy0xLTEtNjEyODE_b0137f22-52bd-4373-ba37-5ddac482a57f">19,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia274107f0cb9495e9b2745222febc134_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTAtNS0xLTEtNjEyODE_b41a39d7-d803-4ce8-9a13-ad7e2c939b81">13,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f80f3e926434e23bc7a4ffbf84d5ff6_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTAtNy0xLTEtNjEyODE_5799507c-b676-47a9-aea1-7f8bbf6e5c73">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if85711d4c58a411e8be877e7ad67842a_I20201231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTAtOS0xLTEtNjEyODE_bd7a1bf2-dcd2-40cf-bbbe-aeb76facc244">74,080</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if85711d4c58a411e8be877e7ad67842a_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTAtMTEtMS0xLTYxMjgx_bf48ae76-9809-41c3-b68d-68fd58c4588a">6,136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63448b71f13c4d649cdc22ef4a0b5d5a_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTEtNS0xLTEtNjEyODE_6966b9fa-347e-4e30-bf3d-0b5af433409b">299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($<ix:nonFraction unitRef="usdPerShare" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTItMC0xLTEtNjEyODEvdGV4dHJlZ2lvbjpjZjViYjg1YWEwNWE0NzJhYmVjZGQzMjIyYzViNTdhOV8yMg_8664fa79-c37c-4a7b-aadc-546914778b5d">0.83</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63448b71f13c4d649cdc22ef4a0b5d5a_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTItNS0xLTEtNjEyODE_7e17074f-1a45-45ca-9490-2a62e3f5d72a">242</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63448b71f13c4d649cdc22ef4a0b5d5a_D20210101-20210331" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTMtNS0xLTEtNjEyODE_d4682bb5-be9c-4d20-b6e1-5d4a815cfde0">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10091875590248f6a43b7b9c1e05c6bc_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTQtMy0xLTEtNjEyODE_0efe893f-a5a5-428a-b91e-eda9265467b9">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i05807d0c88fa4fe9973f0d6abc7b86b7_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTQtOS0xLTEtNjEyODE_59fdfe2b-d111-4957-94c4-498691fd2c4a">234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05807d0c88fa4fe9973f0d6abc7b86b7_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTQtMTEtMS0xLTYxMjgx_fef4ee61-3ff6-4285-b49d-ac4b4f312816">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10091875590248f6a43b7b9c1e05c6bc_D20210101-20210331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTUtMy0xLTEtNjEyODE_8f856df9-4c95-4f19-86fd-4e5899b45b07">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i05807d0c88fa4fe9973f0d6abc7b86b7_D20210101-20210331" decimals="-3" name="bdx:CommonStockHeldInTrustsNetShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTYtOS0xLTEtNjEyODE_1f7a2a41-ca3e-4ed4-ba6b-fd7d00338882">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21bb6c6eb0934bbf97ecaab0350f75d5_I20210331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTgtMS0xLTEtNjEyODE_1eb12f78-17e8-4aba-b42b-edc8afa71e66">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b08323b925d40d1b59c94d01b6f7ede_I20210331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTgtMy0xLTEtNjEyODE_cf3774d8-f5f2-43a2-aec7-82c8bd72f4de">19,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ca7af80178f409190ac109fee156034_I20210331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTgtNS0xLTEtNjEyODE_a12258ae-eb6a-4f21-a22d-796550efc4e6">13,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c8d0ef92a54994aba64d18915d02d8_I20210331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTgtNy0xLTEtNjEyODE_afdfbce2-3704-492c-aed9-f57d861b2ac1">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i00ac086edd1e4ab1b000dc60c50ccd89_I20210331" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTgtOS0xLTEtNjEyODE_c6c80880-bfee-4180-9781-fa9b39441c0b">73,821</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00ac086edd1e4ab1b000dc60c50ccd89_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTgtMTEtMS0xLTYxMjgx_3f2aecf9-ea60-477c-9531-e01e665dd8d3">6,132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Common stock held in trusts consists of the Company&#8217;s shares held in rabbi trusts in connection with deferred compensation under the Company&#8217;s employee salary and bonus deferral plan and directors&#8217; deferral plan.  During the second quarter of fiscal year 2022, the common stock held in trusts was temporarily replaced with the Company&#8217;s Series C preferred shares to adhere to trust requirements until the Company&#8217;s spin-off of its Diabetes Care business was completed on April 1, 2022.  </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i23ec40fdb5ff446396c618c3e61c36a3"><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><ix:continuation id="i51cb54d082124cfe829f90d55384c9c6"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Represents shares received upon final settlement of an accelerated share repurchase agreement, and the related forward sale contract, entered into during the fourth quarter of fiscal year 2021.  T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he share repurchases were made pursuant to the repurchase program authorized by the Board of Directors on September 24, 2013 for <ix:nonFraction unitRef="shares" contextRef="i8cb4ecbb78e74ce3a938ab69f4bdf1f4_I20130924" decimals="-6" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RleHRyZWdpb246MWZkY2M3NTQyZGYxNDI4MWJkOGY1ZGMzNDRhNTUyNzVfNjY4_83858dce-7d06-42bd-baa9-db411641bff7">10</ix:nonFraction>&#160;million shares, for which there is no expiration date.  In November 2021, the Board of Directors authorized the Company to repurchase up to an additional <ix:nonFraction unitRef="shares" contextRef="i13da3ad4178f4ecebb53a625e7acba1b_I20211130" decimals="-6" name="bdx:StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RleHRyZWdpb246MWZkY2M3NTQyZGYxNDI4MWJkOGY1ZGMzNDRhNTUyNzVfODE3_dcbc94de-688a-4173-94d3-91b343bd0c8a">10</ix:nonFraction>&#160;million shares of BD common stock, for which there is also no expiration date.</span></ix:continuation></div><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RleHRyZWdpb246MWZkY2M3NTQyZGYxNDI4MWJkOGY1ZGMzNDRhNTUyNzVfMjExNg_feefbc76-ff29-40f4-ab4d-220f4c57461a" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components and changes of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the first two quarters of fiscal years 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.426%"><tr><td style="width:1.0%"></td><td style="width:47.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.107%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.107%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.107%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.110%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMS0xLTEtMS02MTI4MQ_dae7a1d7-72d0-4433-9af8-1324b1909a24">2,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ee43d89fee945a3adb8a3285fa956d4_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMS0zLTEtMS02MTI4MQ_5667e640-0a34-4ff3-93c3-6e17a9cf4c21">1,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9c0efef45cd4a01bad737fb01fada74_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMS01LTEtMS02MTI4MQ_fa6ed454-4020-4118-991a-5f57ae8a680a">784</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b579acbced54178ac7040056cec1930_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMS03LTEtMS02MTI4MQ_d6c36e2f-c722-4a2b-9a70-d1882caae26f">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefdb0b0a3f294705ae8463fd402aa8f3_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMi0xLTEtMS02MTI4MQ_e1b035d6-cf9b-4afd-9f0e-91e763c57f8c">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i324ed7a0bfda4e7e83cf84119d3ae93e_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMi0zLTEtMS02MTI4MQ_d09f4b1d-f907-46c9-ade8-ac6236dcec4c">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0fedadbd75d4a4985c2b754543d38db_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMi01LTEtMS02MTI4MQ_f8f404e3-1ebd-4b16-907f-64e755dad5c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b405f3959cc475c9b732b9beb5bba7b_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMi03LTEtMS02MTI4MQ_49ee5ff7-bbda-411f-8eaf-fbaf39c27489">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefdb0b0a3f294705ae8463fd402aa8f3_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMy0xLTEtMS02MTI4MQ_792132a2-107e-41a0-ab15-d26cf1cde428">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i324ed7a0bfda4e7e83cf84119d3ae93e_D20211001-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMy0zLTEtMS02MTI4MQ_067a4202-9f9e-4f43-8c4a-b22b0e835036">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0fedadbd75d4a4985c2b754543d38db_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMy01LTEtMS02MTI4MQ_57b23da6-9524-4123-9a1c-adecb6203910">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b405f3959cc475c9b732b9beb5bba7b_D20211001-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMy03LTEtMS02MTI4MQ_6370dc61-969e-4831-84a4-1beb52046eaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88e64c73fc1047fa8d2dbbd0264a3c84_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNC0xLTEtMS02MTI4MQ_2f0824fa-b4e2-45d9-a28e-f92c1681ecdf">2,043</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f7ed54a259b40c1a2765645e71832fa_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNC0zLTEtMS02MTI4MQ_b2f96806-a571-4d5e-9e98-3f5128305bac">1,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69e96ef1d0e74452ab61f2dcd1b57fe4_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNC01LTEtMS02MTI4MQ_4aac6660-ee87-441c-be7e-5a4a25c76cdc">774</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65465a86c8c5442a8b980080054fe48e_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNC03LTEtMS02MTI4MQ_f91efff5-46e9-4a67-8b7f-8152184e5519">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNS0xLTEtMS02MTI4MQ_5a238acc-130c-4679-a264-0b6ca53edc5e">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cba383a1c1a43a7b184a8631be117d0_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNS0zLTEtMS02MTI4MQ_7f2b8d98-727c-4b47-b6ea-8ab34d37dc17">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72f72d97c18d4a168adf04b6afab2aec_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNS01LTEtMS02MTI4MQ_a7485bce-743a-4687-8225-3f3bb7d090fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice9518fb765048f791d1eb268ac30699_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNS03LTEtMS02MTI4MQ_9376cba1-e4b9-47ca-8974-f0720ce8b0af">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNi0xLTEtMS02MTI4MQ_42f079b5-a5b5-4965-9524-ed4e44659b19">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cba383a1c1a43a7b184a8631be117d0_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNi0zLTEtMS02MTI4MQ_cd752402-b5df-4bff-905c-71921dfac11b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72f72d97c18d4a168adf04b6afab2aec_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNi01LTEtMS02MTI4MQ_74284e25-884a-417a-99a2-9e849c67c1a2">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice9518fb765048f791d1eb268ac30699_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNi03LTEtMS02MTI4MQ_793f1b1c-9009-4bd2-a240-d9fcca724c1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNy0xLTEtMS02MTI4MQ_3c20a6f6-f172-4190-bbdd-6bf0acb3a4bb">1,910</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b672c8a1e23415c954ddf66aac1e984_I20220331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNy0zLTEtMS02MTI4MQ_c3e6998f-5464-4473-b820-270f560d4ca0">1,173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b29fdbef54342949881c713e16d539c_I20220331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNy01LTEtMS02MTI4MQ_e5fb96e7-5f38-4611-8466-42305fe68af2">763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9193c0d5b9c4b2581040114a4cd2dfd_I20220331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNy03LTEtMS02MTI4MQ_e215df57-05ef-4875-9ac9-6a063cc3f9e6">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.134%"><tr><td style="width:1.0%"></td><td style="width:47.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.148%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.148%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.148%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f49a7b80b0c4a37acc78faacd1def8e_I20200930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMS0xLTEtMS02MTI4MQ_bedbbdf5-6d13-4505-9bfd-51bf30e66edd">2,548</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4d95beb50b14c9c95a3d75c68b47d91_I20200930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMS0zLTEtMS02MTI4MQ_cddc93b4-4d1f-4f46-a1a0-29469ac51ef8">1,416</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if967b9c04df3495bbc795bfd1f8099af_I20200930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMS01LTEtMS02MTI4MQ_cadb7603-9454-432f-b523-40d005d937d4">1,040</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbfa81272476483894faf8a5f285efa0_I20200930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMS03LTEtMS02MTI4MQ_66273488-8a48-4d36-bbc0-ec23eae4dacb">91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icedd1d99c22048f7924f50a371090298_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMi0xLTEtMS02MTI4MQ_45f51eef-7cac-4198-8d81-4a220649ad65">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed40f315c6c4f97a754a6eb72927dc8_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMi0zLTEtMS02MTI4MQ_533feeab-380b-40d2-be3f-c2a8d3b3384d">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb4e8d00d339433fac2d8c00fd206825_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMi01LTEtMS02MTI4MQ_570aed9b-eaac-41ea-9c53-095179f5a45a">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977201e5251e4da78e41ec15b3b96c80_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMi03LTEtMS02MTI4MQ_967a73a3-b64e-45c5-aad5-3d8a9a525357">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icedd1d99c22048f7924f50a371090298_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMy0xLTEtMS02MTI4MQ_d370cfaf-923a-40fb-8fc7-667ec3b3cf42">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed40f315c6c4f97a754a6eb72927dc8_D20201001-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMy0zLTEtMS02MTI4MQ_f6740002-e6a6-4563-ba55-e3d00d9cb3e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb4e8d00d339433fac2d8c00fd206825_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMy01LTEtMS02MTI4MQ_b11d51b4-bed2-45d0-b40c-badece380ca3">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977201e5251e4da78e41ec15b3b96c80_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMy03LTEtMS02MTI4MQ_5c524530-7583-4cd4-a712-28fded336957">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7a0d188409c454e90b59907b43f24ad_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNC0xLTEtMS02MTI4MQ_f8e88b78-40fd-45a9-8eef-7b6b51259cfa">2,414</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0692d1be0c384a95b3c84dd3b71fea18_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNC0zLTEtMS02MTI4MQ_7d162e57-4b0b-4529-bb8f-f93a10e023c1">1,352</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aa1afa266db408b8ce7249358da4cb7_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNC01LTEtMS02MTI4MQ_31cf7a33-064c-4755-939c-d4917fabab20">998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i465aa0dfa2c14f119d5e5bef56c57bb8_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNC03LTEtMS02MTI4MQ_b1a53d99-1932-4d21-90ec-224a8d2798d9">62</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNS0xLTEtMS02MTI4MQ_b15c8ffa-4b3f-4ab0-93a2-b4f14daaea3c">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5877d216df964262bf4bb845d95a59f7_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNS0zLTEtMS02MTI4MQ_82ccb32e-da25-49aa-91fc-27e706cd8cb2">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b2de3cd4f2a4be79b23ac6da588eaf4_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNS01LTEtMS02MTI4MQ_9d5b2ba7-5cce-4253-ad54-af35c74c6dc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b94674394f84d6eb4053788dc6d572f_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNS03LTEtMS02MTI4MQ_42c55e3d-1a52-472c-9116-921f15fff2b3">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNi0xLTEtMS02MTI4MQ_b4bcbe50-ef6d-4ea8-93ee-a2de190b8d51">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5877d216df964262bf4bb845d95a59f7_D20210101-20210331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNi0zLTEtMS02MTI4MQ_02968725-feb7-4367-92a8-f98c662cf999">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b2de3cd4f2a4be79b23ac6da588eaf4_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNi01LTEtMS02MTI4MQ_def7957b-08ee-4243-a38b-33fae7658871">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b94674394f84d6eb4053788dc6d572f_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNi03LTEtMS02MTI4MQ_8b5753ce-0edd-438e-981d-70caa7b296be">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fb7d149583e4cbbb4ba841be5866113_I20210331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNy0xLTEtMS02MTI4MQ_f74dd99a-7ab2-4074-a12b-d9030a167ceb">2,329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac6b1a8c16e3470fac8737acad5b180f_I20210331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNy0zLTEtMS02MTI4MQ_3d67320e-3ec3-4ed0-b09b-7b7101221da9">1,367</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4995a156954f4d75a765e0acb8fb54b4_I20210331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNy01LTEtMS02MTI4MQ_c85c2164-af16-4467-9aaa-7963b616895f">982</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i770c080a4a784b18b9b4b99e56348d1a_I20210331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNy03LTEtMS02MTI4MQ_9284fbce-c794-4d61-869d-eed7199e2672">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of foreign currency translation recognized in other comprehensive income during the three and six months ended March&#160;31, 2022 and 2021 included net gains (losses) relating to net investment hedges.  Other comprehensive income relating to benefit plans during the three months ended December 31, 2020 represented a net gain recognized as a result of the Company&#8217;s remeasurement, as of October 31, 2020, of the legacy Bard U.S. defined pension benefit plan upon its merger with the BD defined benefit cash balance pension plan in the first quarter of fiscal year 2021.  The amounts recognized in other comprehensive income relating to cash flow hedges during the three and six months ended March 31, 2022 and 2021 are primarily related to forward starting interest rate swaps.  Additional disclosures regarding amounts the Company recognized in other comprehensive income relating to cash flow hedges during the three and six months ended March&#160;31, 2022 and 2021 are provided in Note 10.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax impacts for amounts recognized in other comprehensive income (loss) before reclassifications and for reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to benefit plans and cash flow hedges during the three and six months ended March&#160;31, 2022 and 2021 were immaterial to the Company's consolidated financial results.</span></div></ix:continuation><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.163%"><tr><td style="width:1.0%"></td><td style="width:48.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.821%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.821%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.821%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.826%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="icb36c8b3bd0b41458d5570d492469671_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3 &#8211; <ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RleHRyZWdpb246MWI2MWNlZGYyYTMyNDhlYTlhNWJhMTUzNWE5ZGViMmJfNDUy_f0ae480f-9907-4282-a34d-fdf64436d9ed" continuedAt="iec35f4a3b5954407b0723676e7deb80c" escape="true">Earnings per Share</ix:nonNumeric></span></div><ix:continuation id="iec35f4a3b5954407b0723676e7deb80c"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RleHRyZWdpb246MWI2MWNlZGYyYTMyNDhlYTlhNWJhMTUzNWE5ZGViMmJfNDU2_fa9c3a4f-49a0-41b1-a392-0669ca13a4be" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:49.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.512%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.461%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.766%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfMi0xLTEtMS02MTI4MQ_211f4b0d-5cd1-43b6-a8f7-53d70d5d32e2">285,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfMi0zLTEtMS02MTI4MQ_f9312118-51be-4163-890b-bde1afb96c56">291,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfMi01LTEtMS02MTI4MQ_3434dd88-dd87-4fe9-b58c-a2fab69b69dc">284,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfMi03LTEtMS02MTI4MQ_9f5b327f-2df4-4f9b-80c1-bd83aacd74b1">290,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from share-based plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfMy0xLTEtMS02MTI4MQ_2113c3c9-ec23-4073-9936-9838a5e471b9">2,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfMy0zLTEtMS02MTI4MQ_f2a5e922-29f3-4300-8c51-fef166a12637">2,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfMy01LTEtMS02MTI4MQ_bf76620e-6b13-4dbe-9f45-32bafa44706a">2,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfMy03LTEtMS02MTI4MQ_c906967a-5b69-4dd4-a956-91c1d754fcd5">2,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from Series C preferred shares (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNC0xLTEtMS03OTE1MA_e0a2fd78-e169-4016-a1d6-d51fbdfa2213">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNC0zLTEtMS03OTE1MA_2ce90dad-bae9-4d92-947c-7dc82d5f6bfd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNC01LTEtMS03OTE1MA_eb6d9cd5-d43b-4a95-a5d9-a71306318a27">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNC03LTEtMS03OTE1MA_c388a442-3e6b-4ba0-bbe2-a9606d09d5b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common and common equivalent shares outstanding &#8211; assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNC0xLTEtMS02MTI4MQ_a897e189-9499-4ff1-afae-ffe8d0cea36d">287,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNC0zLTEtMS02MTI4MQ_c2cd450a-8870-4910-aaa6-c608bdcbfecf">293,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNC01LTEtMS02MTI4MQ_8cbb05af-95ae-4830-b136-e357ec249626">287,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNC03LTEtMS02MTI4MQ_e28e7063-a699-4e93-86d3-860c26c536d3">293,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share equivalents excluded from the diluted shares outstanding calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mandatory convertible preferred stock (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d3a36d935bf4fd8b6132f2d1ef29307_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNy0xLTEtMS02MTI4MQ_8d7ba137-cb45-4989-bfd2-903d9ead5abf">5,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib76ec6f5ea814d30b2c30ad474c85f94_D20210101-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNy0zLTEtMS02MTI4MQ_a0c31aab-f5aa-42bf-856e-a70d9dcb8086">6,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iea6c161bd8a340f98a4fddd063587010_D20211001-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNy01LTEtMS02MTI4MQ_bbe57859-a289-4ad1-957c-b41145ae384d">5,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i49a7de59e6ff4225a49a75d990be29bd_D20201001-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNy03LTEtMS02MTI4MQ_675a82e1-3946-4582-bf2f-4a9f33b5690e">6,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based plans (c)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i308403a24c2a42c89b1d7a4ab555184c_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfOC0xLTEtMS02MTI4MQ_eb10f0da-fc80-4fc5-a139-50efe1e5d5b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7022abe219c14c9dacdbd2ec440a8b4f_D20210101-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfOC0zLTEtMS02MTI4MQ_6c0b539b-5c04-4a72-8560-bbdae503e920">773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib9450f0155c94e31b2c13ad94e0092f6_D20211001-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfOC01LTEtMS02MTI4MQ_d702abba-dea2-42f7-89fa-ac5bd34725f9">676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic97169545d0c475da35e8da8837b02ab_D20201001-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfOC03LTEtMS02MTI4MQ_7c64a86e-378e-473f-a4d8-5a4ab41a6a69">773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Represents dilutive share equivalents from Series C preferred shares that temporarily replaced shares of common stock held in trusts to adhere to trust requirements until the Company&#8217;s spin-off of its Diabetes Care business on April 1, 2022 was completed. </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Excluded from the diluted shares outstanding calculation because the result would have been antidilutive.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Excluded from the diluted earnings per share calculation as the exercise prices of these awards were greater than the average market price of the Company&#8217;s common shares.</span></div></ix:nonNumeric></ix:continuation><div id="icb36c8b3bd0b41458d5570d492469671_40"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8211; <ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80MC9mcmFnOjZmZmI1ODFiNjI4YTRjNTc5MGRmZGFlOTE2NDliMDVjL3RleHRyZWdpb246NmZmYjU4MWI2MjhhNGM1NzkwZGZkYWU5MTY0OWIwNWNfMTMxOTU_37c98227-679e-40f1-8b17-27a649180e77" continuedAt="ib8af58440e0c4acf97b0473a54bcba4d" escape="true">Contingencies</ix:nonNumeric></span></div><ix:continuation id="ib8af58440e0c4acf97b0473a54bcba4d" continuedAt="idf829ca7f97049558b97b443a66cbe5b"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80MC9mcmFnOjZmZmI1ODFiNjI4YTRjNTc5MGRmZGFlOTE2NDliMDVjL3RleHRyZWdpb246NmZmYjU4MWI2MjhhNGM1NzkwZGZkYWU5MTY0OWIwNWNfMTMxOTM_b7b69432-3d89-409d-b754-7703c1c73757" continuedAt="i6895de6acfb0462586b45b3dfd46a593" escape="true">The Company is involved, both as a plaintiff and a defendant, in various legal proceedings that arise in the ordinary course of business, including, without limitation, product liability and environmental matters in certain U.S. and international locations.  Given the uncertain nature of litigation generally, the Company is not able, in all cases, to estimate the amount or range of loss that could result from an unfavorable outcome of litigation in which the Company is a party.  In accordance with U.S. GAAP, the Company establishes accruals to the extent probable future losses are estimable (and in the case of environmental matters, without considering possible third-party recoveries).  With respect to putative class action lawsuits in the United States and certain of the Canadian lawsuits described below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding all or certain of the plaintiffs and their medical conditions; and/or (iii) there are significant factual issues to be resolved.  In addition, there is uncertainty as to the likelihood of a class being certified or the ultimate size of any class.  With respect to the civil investigative demands (&#8220;CIDs&#8221;) served by the Department of Justice which are discussed below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; and/or (ii) there are significant factual and legal issues to be resolved.</ix:nonNumeric></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Liability Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the Company is defending approximately <ix:nonFraction unitRef="claim" contextRef="i75602a2f46c546e4828064853912e326_I20220331" decimals="0" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80MC9mcmFnOjZmZmI1ODFiNjI4YTRjNTc5MGRmZGFlOTE2NDliMDVjL3RleHRyZWdpb246NmZmYjU4MWI2MjhhNGM1NzkwZGZkYWU5MTY0OWIwNWNfMTc1OA_8cc502c6-1a12-4c82-a31d-9ed35cb03a90">28,590</ix:nonFraction> product liability claims involving the Company&#8217;s line of hernia repair devices (collectively, the &#8220;Hernia Product Claims&#8221;).  The majority of those claims are currently pending in a coordinated proceeding in Rhode Island State Court (&#8220;RI&#8221;) and in a federal multi-district litigation (&#8220;MDL&#8221;) established in the Southern District of Ohio, but claims are also pending in other state and/or federal court jurisdictions.  In addition, those claims include multiple putative class actions in Canada.  Generally, the Hernia Product Claims seek damages for personal injury allegedly resulting from use of the products.  From time to time, the Company engages in resolution discussions with plaintiffs&#8217; law firms regarding certain of the Hernia Product Claims, but the Company also intends to vigorously defend Hernia Product Claims that do not settle, including through litigation.  </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The first bellwether trial in the hernia MDL resulted in a complete defense verdict in favor of the Company in September 2021 after over five weeks of trial.  </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The second hernia MDL bellwether resulted in a $<ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-3" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80MC9mcmFnOjZmZmI1ODFiNjI4YTRjNTc5MGRmZGFlOTE2NDliMDVjL3RleHRyZWdpb246NmZmYjU4MWI2MjhhNGM1NzkwZGZkYWU5MTY0OWIwNWNfMjc0ODc3OTA4Nzc5Ng_d2c6583f-d1f3-421c-b7a3-bcbc68b03024">255</ix:nonFraction>&#160;thousand verdict in April 2022 after four weeks of trial. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trials are currently scheduled in various state and/or federal courts, including one currently scheduled for June 2022 in RI.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects additional trials of Hernia Product Claims to take place over the next 12 months.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="idf829ca7f97049558b97b443a66cbe5b" continuedAt="i142b589ef3574019b867fa926c1fdc81"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also continues to be a defendant in certain other mass tort litigation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the Company is defending product liability claims involving the Company&#8217;s line of pelvic mesh products, the majority of which are pending in various federal court jurisdictions and in a coordinated proceeding in New Jersey Superior Court.  Also, as of March&#160;31, 2022, the Company is defending product liability claims involving the Company&#8217;s line of inferior vena cava (&#8220;IVC&#8221;) filter products.  The majority of those claims are pending in various federal court jurisdictions after having been remanded from the MDL in the United States District Court for the District of Arizona.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In most product liability litigations (like those described above), plaintiffs allege a wide variety of claims, ranging from allegations of serious injury caused by the products to efforts to obtain compensation notwithstanding the absence of any injury. In many of these cases, the Company has not yet received and reviewed complete information regarding the plaintiffs and their medical conditions and, consequently, is unable to fully evaluate the claims.  The Company expects that it will receive and review additional information regarding any remaining unsettled product liability matters.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2020, a putative class action captioned Kabak v. Becton, Dickinson and Company, et al., Civ. No. 2:20-cv-02155 (SRC) (CLW), now captioned Industriens Pensionsforsikring v. Becton, Dickinson and Company, et al., was filed in the U.S. District Court for the District of New Jersey against the Company and certain of its officers.  The complaint, which purports to be brought on behalf of all persons (other than defendants) who purchased or otherwise acquired the Company's common stock from November 5, 2019 through February 5, 2020, asserts claims for purported violations of Sections 10 and 20 of the Securities Exchange Act of 1934 and Securities and Exchange Commission (&#8220;SEC&#8221;) Rule 10b-5 promulgated thereunder, and seeks, among other things, damages and costs.  The complaint alleges that defendants concealed certain material information regarding Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps, allegedly rendering certain public statements about the Company&#8217;s business, operations and prospects false or misleading, thereby allegedly causing investors to purchase stock at an inflated price.  The plaintiff filed a second amended complaint to add certain additional factual allegations on February 3, 2021.  This complaint was dismissed on the Company&#8217;s motion on September 15, 2021.  The court&#8217;s dismissal order, however, gave plaintiff an opportunity to replead, which it did on October 29, 2021.  The Company moved to dismiss the newly amended pleading on December 16, 2021.  That motion is fully briefed and pending.  The Company believes that these allegations are without merit and it intends to defend itself vigorously.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2020, a civil action captioned Jankowski v. Forlenza, et al., Civ. No. 2:20-cv-15474, was filed in the U.S. District Court for the District of New Jersey by a shareholder, Ronald Jankowski, derivatively on behalf of the Company, against its individual directors and certain of its officers. The complaint seeks recovery for breach of fiduciary duties by directors and various officers; violations of the Securities Exchange Act of 1934, including sections 10(b), 14(a) and 21D; and insider trading.  In general, the complaint also alleges, among other things, that various directors and/or officers caused the Company to issue purportedly misleading statements and SEC filings regarding Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps, and issue a purportedly misleading proxy statement. The complaint seeks damages, including restitution and disgorgement of profits, and an injunction requiring the Company to undertake remedial measures with respect to certain corporate governance and internal procedures.  A second derivative action, Schranz v. Polen, et al., Civ. No 2:21-cv-01081 (D. N.J.), was filed on January 24, 2021, and the two actions were consolidated.  In March 2021, the Company received letters from two additional shareholders which, in general, mirrored the allegations in the Jankowski and Schranz consolidated actions, and demanded, among other things, that the Board of Directors pursue civil action against members of management for claimed breaches of fiduciary duties. Consistent with New Jersey law, the Board appointed a special committee to review the allegations and demands in the derivative actions and demand letters.  Following an investigation, the special committee determined that no action was warranted, and rejected the shareholders&#8217; demands. The special committee&#8217;s determination has been communicated to counsel for the shareholders.  Should the shareholders continue to pursue their claims in court, the Company will take appropriate steps to seek dismissal of the complaints.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In May 2017, the Company was sued by a competitor in the Northern District of New York, alleging antitrust violations related to certain aspects of the Company&#8217;s medical delivery solutions business in a case captioned AngioDynamics, Inc. v. C. R. Bard, Inc. et al., Civ. No. 1:17-CV-0598.  Motion practice in the case is ongoing.  The Company believes it has meritorious defenses and is vigorously defending the case, which has been set for trial on July 5, 2022. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company received a subpoena from the Enforcement Division of the SEC requesting information from the Company relating to, among other things, Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps.  The Company is cooperating with the SEC and responding to these requests.  The Company cannot anticipate the timing, scope, outcome or possible impact of the investigation, financial or otherwise. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the Department of Justice served the Company and CareFusion with CIDs seeking information regarding certain of CareFusion&#8217;s contracts with the Department of Veteran&#8217;s Affairs for certain products, including Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Pyxis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i142b589ef3574019b867fa926c1fdc81"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">devices, in connection with a civil investigation of possible violations of the False Claims Act, and the government recently expanded the investigation to include several additional contracts.  The government has made several requests for documents and interviews or depositions of Company personnel.  The Company is cooperating with the government and responding to these requests.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company received a CID related to an inquiry initiated by the Northern District of Georgia in 2018.  The requests concern sales and marketing practices with respect to certain aspects of the Company&#8217;s urology business.  The government has made requests for documents and has interviewed employees.  The inquiry is ongoing and the Company is cooperating with the government and responding to its requests. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company was served with a complaint from the New Mexico Attorney General, alleging violations of the state&#8217;s consumer protection laws in connection with the sales and marketing of its IVC filters.  The Company filed its motion to dismiss on December 27, 2021, and intends to vigorously defend itself in the litigation.  As the case is in its early stages, the Company cannot anticipate the timing, scope, outcome or possible impact at present.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company became aware of lawsuits that had been filed against it in state and federal court in Georgia.  The suits were filed by plaintiffs who reside near Company facilities in Covington, GA, where ethylene oxide (&#8220;EtO&#8221;) sterilization activities take place.  There are currently approximately <ix:nonFraction unitRef="lawsuit" contextRef="if223ecc9d5a1493093a44d337a8b72c5_D20211001-20220331" decimals="0" name="bdx:NumberOfEtOSterilizationLawsuitsFiled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80MC9mcmFnOjZmZmI1ODFiNjI4YTRjNTc5MGRmZGFlOTE2NDliMDVjL3RleHRyZWdpb246NmZmYjU4MWI2MjhhNGM1NzkwZGZkYWU5MTY0OWIwNWNfMTAyNTc_a761fed1-6a5f-4278-a8b7-6d11eed67758">210</ix:nonFraction> of such suits.  The claims allege a variety of injuries, including but not limited to multiple types of cancer, allegedly attributable to exposure to EtO in the ambient air.  The Company has meritorious defenses and intends to defend itself vigorously.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also involved both as a plaintiff and a defendant in other legal proceedings and claims that arise in the ordinary course of business.  The Company believes that it has meritorious defenses to these suits pending against the Company and is engaged in a vigorous defense of each of these matters.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot predict the outcome of these other legal matters discussed above, nor can it predict whether any outcome will have a material adverse effect on the Company&#8217;s consolidated results of operations and/or consolidated cash flows.  Accordingly, the Company has made no provisions for these other legal matters in its consolidated results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a potentially responsible party to a number of federal administrative proceedings in the United States brought under the Comprehensive Environment Response, Compensation and Liability Act, also known as &#8220;Superfund,&#8221; and similar state laws.  We also are subject to administrative proceedings under environmental laws in jurisdictions outside the U.S. The affected sites are in varying stages of development.  In some instances, the remedy has been completed, while in others, environmental studies are underway or commencing.  For several sites, there are other potentially responsible parties that may be jointly or severally liable to pay all or part of cleanup costs.  While it is not feasible to predict the outcome of these proceedings, based upon the Company&#8217;s experience, current information and applicable law, the Company does not expect these proceedings to have a material adverse effect on its consolidated results of operations and/or consolidated cash flows.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation Accruals</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly monitors and evaluates the status of product liability and other legal matters, and may, from time-to-time, engage in settlement and mediation discussions taking into consideration developments in the matters and the risks and uncertainties surrounding litigation.  These discussions could result in settlements of one or more of these claims at any time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals for the Company's product liability claims which are discussed above, as well as the related legal defense costs, amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-8" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80MC9mcmFnOjZmZmI1ODFiNjI4YTRjNTc5MGRmZGFlOTE2NDliMDVjL3RleHRyZWdpb246NmZmYjU4MWI2MjhhNGM1NzkwZGZkYWU5MTY0OWIwNWNfMTI2MTc_1c6f45e8-7f20-4687-a761-4dfe82883a49">2.3</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-8" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80MC9mcmFnOjZmZmI1ODFiNjI4YTRjNTc5MGRmZGFlOTE2NDliMDVjL3RleHRyZWdpb246NmZmYjU4MWI2MjhhNGM1NzkwZGZkYWU5MTY0OWIwNWNfMTI2MjQ_35830e09-c4ac-494c-aac5-e77439228b7c">2.5</ix:nonFraction> billion at March&#160;31, 2022 and September&#160;30, 2021, respectively.  These accruals are largely recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Income Taxes and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the Company's condensed consolidated balance sheets. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6895de6acfb0462586b45b3dfd46a593">In view of the uncertainties discussed above, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance.  In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company&#8217;s consolidated results of operations and /or consolidated cash flows.</ix:continuation></span></div></ix:continuation><div id="icb36c8b3bd0b41458d5570d492469671_43"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8211; <ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80My9mcmFnOjg0NWZkOGRmYmRkMjRiODA4ODU1MzRjMWY5ZDNhMTcxL3RleHRyZWdpb246ODQ1ZmQ4ZGZiZGQyNGI4MDg4NTUzNGMxZjlkM2ExNzFfMzk2MA_53fd9ca5-fd28-41dd-9cb1-f2184b491ba0" continuedAt="i87cc1f92e6694229beaf7b045fdbce7f" escape="true">Revenues</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i87cc1f92e6694229beaf7b045fdbce7f" continuedAt="i32f555a79ec24d2898f0f1e89d194a66">The Company&#8217;s policies for recognizing sales have not changed from those described in the Company&#8217;s 2021 Annual Report on Form 10-K.  The Company sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products which are distributed through independent distribution channels and directly by BD through sales representatives.  End-users of the Company's products include healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i32f555a79ec24d2898f0f1e89d194a66"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80My9mcmFnOjg0NWZkOGRmYmRkMjRiODA4ODU1MzRjMWY5ZDNhMTcxL3RleHRyZWdpb246ODQ1ZmQ4ZGZiZGQyNGI4MDg4NTUzNGMxZjlkM2ExNzFfMzk2Mw_decde96b-12e0-407a-a017-aec40e0d59d3" continuedAt="if54e00fb443a4258947f6cb00c4ea20d" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Revenues</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables.  Such estimated credit losses are determined based on historical loss experiences, customer-specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information.  The allowance for doubtful accounts for trade receivables is not material to the Company's consolidated financial results.</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if54e00fb443a4258947f6cb00c4ea20d">The Company's gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized.  Such variable consideration includes rebates, sales discounts and sales returns.</ix:continuation>  The Company&#8217;s rebate liability at March&#160;31, 2022 and September&#160;30, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="bdx:ContractWithCustomerRebateLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80My9mcmFnOjg0NWZkOGRmYmRkMjRiODA4ODU1MzRjMWY5ZDNhMTcxL3RleHRyZWdpb246ODQ1ZmQ4ZGZiZGQyNGI4MDg4NTUzNGMxZjlkM2ExNzFfMTQxMg_c2d05481-75b8-411c-8700-43ee1cc0ce05">585</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="bdx:ContractWithCustomerRebateLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80My9mcmFnOjg0NWZkOGRmYmRkMjRiODA4ODU1MzRjMWY5ZDNhMTcxL3RleHRyZWdpb246ODQ1ZmQ4ZGZiZGQyNGI4MDg4NTUzNGMxZjlkM2ExNzFfMTQxOQ_e9bb0ca5-afac-4f7d-8655-d9572d472437">576</ix:nonFraction>&#160;million, respectively.  The impact of other forms of variable consideration, including sales discounts and sales returns, is not material to the Company's revenues.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of Revenue Arrangements on Consolidated Balance Sheets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized contract costs associated with the costs to fulfill contracts for certain products in the Medication Management Solutions organizational unit are immaterial to the Company's condensed consolidated balance sheets.  Commissions relating to revenues recognized over a period longer than one year are recorded as assets which are amortized over the period over which the revenues underlying the commissions are recognized.  Capitalized contract costs related to such commissions are immaterial to the Company's condensed consolidated balance sheets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities for unearned revenue that is allocable to performance obligations, such as extended warranty and software maintenance contracts, which are performed over time are immaterial to the Company's consolidated financial results.  The Company's liability for product warranties provided under its agreements with customers is not material to its condensed consolidated balance sheets. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's obligations relative to service contracts and pending installations of equipment, primarily in the Company's Medication Management Solutions unit, represent unsatisfied performance obligations of the Company.  The revenues under existing contracts with original expected durations of more than one year, which are attributable to products and/or services that have not yet been installed or provided are estimated to be approximately $<ix:nonFraction unitRef="usd" contextRef="i8dde9c84ea4543b2b7c7c39ef33a1b38_I20220331" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80My9mcmFnOjg0NWZkOGRmYmRkMjRiODA4ODU1MzRjMWY5ZDNhMTcxL3RleHRyZWdpb246ODQ1ZmQ4ZGZiZGQyNGI4MDg4NTUzNGMxZjlkM2ExNzFfMzA4Mg_c171b2e3-a462-48ab-8d3d-047ee6c08305">2.2</ix:nonFraction> billion at March&#160;31, 2022.  The Company expects to recognize the majority of this revenue over the next <ix:nonNumeric contextRef="i77f35a0dc2c74215877faf40ae0e7e6f_I20220331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80My9mcmFnOjg0NWZkOGRmYmRkMjRiODA4ODU1MzRjMWY5ZDNhMTcxL3RleHRyZWdpb246ODQ1ZmQ4ZGZiZGQyNGI4MDg4NTUzNGMxZjlkM2ExNzFfMzE2OQ_c57012a8-6f2a-495c-8a5b-ba8f03a896e1">three years</ix:nonNumeric>.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the Company's Medication Management Solutions, Medication Delivery Solutions, Integrated Diagnostic Solutions, and Biosciences units, some contracts also contain minimum purchase commitments of reagents or other consumables and the future sales of these consumables represent additional unsatisfied performance obligations of the Company.  The revenue attributable to the unsatisfied minimum purchase commitment-related performance obligations, for contracts with original expected durations of more than one year, is estimated to be approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="ia1d78d581b6244569d9e8062bb55187d_I20220331" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80My9mcmFnOjg0NWZkOGRmYmRkMjRiODA4ODU1MzRjMWY5ZDNhMTcxL3RleHRyZWdpb246ODQ1ZmQ4ZGZiZGQyNGI4MDg4NTUzNGMxZjlkM2ExNzFfMzczMA_68d2f706-e1b6-4cbc-8c60-14415a0cbbb2">2.4</ix:nonFraction> billion&#160;at&#160;March&#160;31, 2022. &#160;This revenue will be recognized over the customer relationship periods.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenues</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A disaggregation of the Company's revenues by segment, organizational unit and geographic region is provided in Note 6.</span></div></ix:continuation><div id="icb36c8b3bd0b41458d5570d492469671_46"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8211; <ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RleHRyZWdpb246ZGM3MzQwNzQ4YjE2NGQwZTgwNWI0ZmU5MjE2ZGIxODFfMTIzMw_4524a851-554e-48f8-bb07-f8365f235a8e" continuedAt="ia0c550a6fe5f4ac7b9328fa98488916b" escape="true">Segment Data</ix:nonNumeric></span></div><ix:continuation id="ia0c550a6fe5f4ac7b9328fa98488916b" continuedAt="ib3224986f65f428392c7ae5aebf97a2c"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's organizational structure is based upon <ix:nonFraction unitRef="segment" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RleHRyZWdpb246ZGM3MzQwNzQ4YjE2NGQwZTgwNWI0ZmU5MjE2ZGIxODFfODA_acb75a1b-0e54-47d3-ad07-6f1af0f3241f">three</ix:nonFraction> worldwide business segments: BD Medical (&#8220;Medical&#8221;), BD Life Sciences (&#8220;Life Sciences&#8221;) and BD Interventional (&#8220;Interventional&#8221;).  The Company's segments are strategic businesses that are managed separately because each one develops, manufactures and markets distinct products and services.  Segment disclosures are on a performance basis consistent with internal management reporting.  The Company evaluates performance of its business segments and allocates resources to them primarily based upon segment operating income, which represents revenues reduced by product costs and operating expenses. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RleHRyZWdpb246ZGM3MzQwNzQ4YjE2NGQwZTgwNWI0ZmU5MjE2ZGIxODFfMTIzNQ_a9e4704e-3558-4d3d-9767-359a9be00934" continuedAt="i78adc6348b3346d9860b06d97172a6cd" escape="true">Revenues by segment, organizational unit and geographical areas for the three and six-month periods are detailed below.  The Company has no material intersegment revenues. </ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib3224986f65f428392c7ae5aebf97a2c" continuedAt="i239ab7fa1a5a4ae99171eedd1319757d"><ix:continuation id="i78adc6348b3346d9860b06d97172a6cd"><div style="margin-top:14pt;padding-left:36pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.590%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Medical</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa780c179d9147f593395d6d7fa5230b_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNC0xLTEtMS02MTI4MQ_60b4ea3c-8abe-48ae-9558-c71467155430">588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic134ea116f1f45ebbe076cc6b3883b12_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNC0zLTEtMS02MTI4MQ_cf525a9b-58cf-490c-893e-23d4ff54a660">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i340e57a3d1d14dfc9f75038a3782eea0_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNC01LTEtMS02MTI4MQ_59cc484f-fdeb-4acf-8ae6-57aa6db6edf8">1,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if21e1acbe96f4463853f0759d0def48f_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNC03LTEtMS02MTI4MQ_a805a03c-3e0e-4081-9af0-7eefebfd997f">531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40c8b727b83d4d65bfa6146011860c12_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNC05LTEtMS02MTI4MQ_cfea31fa-b7ec-425c-94cd-c86789d2baee">468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf68331391d4a60891ceb9f056a868d_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNC0xMS0xLTEtNjEyODE_b2793bff-09ba-4541-8239-09542c15b5ab">999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e361a94baa3404eb086646266f9b158_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNS0xLTEtMS02MTI4MQ_e3da9363-2d6b-4ddc-aeb8-c13f0639a879">461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0da5380262d43adabe75276ea0c956e_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNS0zLTEtMS02MTI4MQ_c59af716-0b85-4911-a434-f6ba5820d5c0">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a826d3478c74b2f862d397c207ca730_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNS01LTEtMS02MTI4MQ_8f25fa8e-8403-42e4-ac41-61504b5c71e4">604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14a0d9a15f7b4cfda8ba40724beaa8f3_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNS03LTEtMS02MTI4MQ_c551a131-ae9b-4b1d-b91b-77e063c424a6">440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d18979bf4274db5b94b3dd46371c7eb_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNS05LTEtMS02MTI4MQ_55c0c079-3925-4f77-aa55-7037d4bc12f9">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511c4b1286af42da970bfdec12deee00_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNS0xMS0xLTEtNjEyODE_460f7997-d439-42df-a151-bb429ad01c98">566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2de60d3992b4498818e40d41cedf3b0_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNi0xLTEtMS02MTI4MQ_fc699b84-5884-42ef-bbfd-e60647cb6f04">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2962a3b3ece8403a9b742d6cb9eae7d3_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNi0zLTEtMS02MTI4MQ_bf35e4c0-5780-464c-84ed-e83270835063">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0688f0ec5b0547ea87efa9cb59b990bb_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNi01LTEtMS02MTI4MQ_21036b7d-4de1-4ee7-98f8-c0c16c1431df">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57ad6025694d4bc9842594f621d8e8b5_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNi03LTEtMS02MTI4MQ_fa692f88-6fb5-43ff-bbc4-075b5b4f278f">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia61a8d596fa14163ae52254c542a2d2a_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNi05LTEtMS02MTI4MQ_b7724a6d-b0b7-49e1-9378-a3acf9c2f976">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e45310057c44542954ea2308480623d_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNi0xMS0xLTEtNjEyODE_7d2dfa09-374e-4b14-8ed4-2a7210bfae0c">284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18a195ea4996436ea00c1fc948c4276f_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNy0xLTEtMS02MTI4MQ_16c808fd-43dd-4857-98ce-e4b0a85b5701">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9bfe78cbe96428981538b45e6d35614_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNy0zLTEtMS02MTI4MQ_79d6a1dc-3ef2-4e89-b241-65170a4710b9">376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e98ac2861aa4dbeae2a682badb428b8_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNy01LTEtMS02MTI4MQ_dc25554c-1b90-4726-927f-e1fb12083877">501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib70cc365667f4336beae810b00d3718e_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNy03LTEtMS02MTI4MQ_7eb7d7a0-630c-4ce6-ba83-d903ab3ef5be">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb66231fcb80447fb881ab131dc5c869_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNy05LTEtMS02MTI4MQ_28e68694-1334-4021-8b74-2f5cb91a4079">361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48a7a52cac944ef7baa6f046beb6ae79_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNy0xMS0xLTEtNjEyODE_95fff32c-cf94-4d04-add7-11b4d669d8f1">462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73d03a6b37c240468966cf15263452df_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfOC0xLTEtMS02MTI4MQ_2063cbde-79fc-4dad-898e-2b7ea855fbca">1,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0e9eb78ff74a85867e0df2d636c7c4_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfOC0zLTEtMS02MTI4MQ_b68ccbf6-9054-4631-8923-8583f730e5f8">1,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd9d0f9e33a441088614cd71f9e278ef_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfOC01LTEtMS02MTI4MQ_36cc9f2f-7b7a-44e0-9090-4f4a4c6f28f1">2,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e12b1fd86e446be863efb9d8984c607_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfOC03LTEtMS02MTI4MQ_962e59b3-368f-4c2b-b01f-957bf1fb9c6c">1,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3f69fb977594b96b982d5a4addde48f_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfOC05LTEtMS02MTI4MQ_03bbbb09-7c61-4e10-b528-f1ef99000198">1,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i692aef30e2ff4aa7bc63ceaa2db430fd_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfOC0xMS0xLTEtNjEyODE_bab28912-a7b7-4a97-a008-a4eb2b5321e0">2,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Life Sciences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d43be5f09354422addda0ddfc3d7608_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTEtMS0xLTEtNjEyODE_eee8901e-8d32-42b7-96e2-e20e26571dc6">618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i940c14b99d604a85b8b181419f29ede7_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTEtMy0xLTEtNjEyODE_06085305-7f38-43eb-a618-e8b04bcc6ab2">532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7bdb867ae3463d9c34411ef80fa2c1_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTEtNS0xLTEtNjEyODE_f8eef789-5c0c-4261-a733-4e56ece4d3e4">1,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34d48eb7b4446bfb0293bb837aeb3b0_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTEtNy0xLTEtNjEyODE_bdd9003d-04e8-42f6-afd1-bcb3bbf9400f">454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b8004628d1e40ddafce5ca3460f538d_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTEtOS0xLTEtNjEyODE_1d898e36-b266-4163-aa15-cf26639f697f">807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8934938ea33340a68081e896f906c075_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTEtMTEtMS0xLTYxMjgx_33d9e199-96e3-48ab-93d6-2c3d811c55fb">1,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i227211b2a9c741c790ebb3da7e40fdd8_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTItMS0xLTEtNjEyODE_9fb97b8b-02a4-46e4-a7d2-943a9c154580">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8771dc3c63ee411d88344fdd1cdf5d53_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTItMy0xLTEtNjEyODE_a56b61a5-bff9-4f7e-90c3-f28e9e78ca18">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf374326006b442487c8d86757ee49e4_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTItNS0xLTEtNjEyODE_04c14d89-1256-45e4-a8df-09500fc86cdd">335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdae0dea69a64aa6842f66ae27d93e5a_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTItNy0xLTEtNjEyODE_87db5281-b8e9-4f8b-b813-18cf95571144">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bb60fd8ef84f56b6fbc6e0af2cf599_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTItOS0xLTEtNjEyODE_bc092f17-1c2b-426c-94f6-ed977de697a1">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cef8fc053634cdfa0e350495e1fc255_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTItMTEtMS0xLTYxMjgx_24bf03f3-ad90-4c1c-8140-eb5b09d468d1">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9318f7e4aad4511b48ac65d5232b805_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTMtMS0xLTEtNjEyODE_77217d72-24f3-4795-aed2-98e5da370d43">747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaaa5c962e4048c591c863e8916d33f5_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTMtMy0xLTEtNjEyODE_6027aa12-efc4-4cb6-a32b-2a30267d6ac4">738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228cd1a05f9444a282107d55ea9e185c_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTMtNS0xLTEtNjEyODE_a0f60c58-ed9d-4c05-a73a-612869b3a0c4">1,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdb31b0ba7847828199578de1e0dc44_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTMtNy0xLTEtNjEyODE_06ed7302-ba0a-4627-9a1a-63ce821e2ce9">576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia05764f1126a47f598e5a5be57d911f3_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTMtOS0xLTEtNjEyODE_a9c006a5-aa9e-4771-97a7-003efa640f0c">1,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8f952d3c2504bee86897ac95714403d_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTMtMTEtMS0xLTYxMjgx_157b2625-b44e-4f18-924e-8d9b0ff18279">1,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Interventional</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia09b9950f6054a568db0ceb8606d7a4e_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTYtMS0xLTEtNjEyODE_39613956-a2ea-4361-80f6-4ceac5fa2e02">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfa7fb2c614545b7b9f7b5805cfe5911_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTYtMy0xLTEtNjEyODE_9041daf0-00c9-431e-948a-835ca878b913">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8cf56e8b5924da2a53cda0c0754e42c_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTYtNS0xLTEtNjEyODE_965cc6db-db13-460d-90ba-cec75169fc75">340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b6c283c3e1b4712b95db13abf677cc8_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTYtNy0xLTEtNjEyODE_ff5632e4-1599-4a6f-be74-2bfa2000d9f6">227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d34d9c802ca4ce89fb381c9211b0f26_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTYtOS0xLTEtNjEyODE_5fabaf4f-d46d-4ff9-963e-5026d69ac685">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec0f21890bcd495ba23516dc79fc968d_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTYtMTEtMS0xLTYxMjgx_9223719d-f447-46b4-bcac-492788fe9ac9">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d03895e938f463db61347f7756e8411_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTctMS0xLTEtNjEyODE_2e5a57e3-86e1-4f32-a0ad-6223ac8f7c4b">240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2f63b307eb24de4a2da726044ee4dcf_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTctMy0xLTEtNjEyODE_43189040-8ef6-49c7-94c5-1f3d81ed8dc4">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49cc19ad914c4f87aefe3e1e90b2e0aa_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTctNS0xLTEtNjEyODE_049f0dc1-8811-4160-bca2-63eb668c8e73">450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86808c33fe15413ca3ab8f07fc04dc6a_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTctNy0xLTEtNjEyODE_955696e8-80cc-452e-bc20-bb1269b60c7b">222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia256fef2c90740d7abec4bdfd7e9ea6f_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTctOS0xLTEtNjEyODE_41b418a4-12e2-4411-8733-658082de7967">198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76036e4d4be84f3780130dbd8809095d_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTctMTEtMS0xLTYxMjgx_35e871f3-1696-4348-bed5-e5aacf53d8c1">420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib25903c74b6b4ce196304dfabbeed3fe_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTgtMS0xLTEtNjEyODE_95b3832d-14f8-4d34-9ef0-d4e7e1bfec59">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9129b920a74c4190bf2674bf5c66ddcd_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTgtMy0xLTEtNjEyODE_1bca4e83-9834-4481-b15c-d8537f1e9d59">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05e3efc2d5234dc5b5696fc25c2fe1f9_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTgtNS0xLTEtNjEyODE_e23b4da9-ec2f-40c3-9d11-1fc2a16b0712">320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i560004a02b284824a2315cd4721a5d83_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTgtNy0xLTEtNjEyODE_13f12c11-1aca-4852-b646-3cf9d388600b">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2bc50912e054b8ca37e29049b909c87_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTgtOS0xLTEtNjEyODE_b6ad8d5b-a0a0-404f-bb4e-6ca2516fe88a">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e73be5facd24817b1a1fea9021a8238_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTgtMTEtMS0xLTYxMjgx_9c626392-183c-4c14-b8fe-60ae6bb1376f">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i918494be3dba48dd95f60dbc329ce595_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTktMS0xLTEtNjEyODE_cc46fca8-c612-43c1-bb45-b6dda86db46f">746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6353525444488e906055b04513b780_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTktMy0xLTEtNjEyODE_91838c89-a6b8-41ff-af78-6f8772cec858">364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d77974120f4be69403ea9d0e2b2e32_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTktNS0xLTEtNjEyODE_74bd75bd-9965-4951-8a05-6914ff4170f8">1,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4c3e29343e9492485a767d68a8ece48_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTktNy0xLTEtNjEyODE_722de244-eed6-4f9a-aaa7-75a12409c6bc">666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ecc4a1c1e25473c8e517f0c14b82e15_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTktOS0xLTEtNjEyODE_b3848864-1b9f-4eb8-ad23-46e64b5f13f0">345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b2088e5e1d40f1925f5a9ce6d60363_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTktMTEtMS0xLTYxMjgx_34d422eb-0fb1-4c04-ae6c-8a85b4621ce7">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Company revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b27826b341541bc92d8a45b8d75c050_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMjEtMS0xLTEtNjEyODE_7103e631-23fd-44ed-8b91-f6dfca3b5372">2,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i963a32bbdc9f4165b5fd4ec11f3bf96f_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMjEtMy0xLTEtNjEyODE_bb009365-83df-4e7b-8755-1f1c98d24201">2,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMjEtNS0xLTEtNjEyODE_a89d74fd-3c93-4005-8d08-3d8fe2b4f4ea">5,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc7dd7466d954173933100f7a158c392_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMjEtNy0xLTEtNjEyODE_ab221477-0074-4076-b185-519cd0383c7d">2,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i272105b422984b0abce278efc90ccf80_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMjEtOS0xLTEtNjEyODE_8d4c88c8-1573-423b-87d4-42bf07f650d7">2,446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMjEtMTEtMS0xLTYxMjgx_38578bf0-f935-42ba-9d25-54c0416d1961">4,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:31.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.624%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Medical</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d49a5857b8c46e8be9a20f21635d62e_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNS0xLTEtMS02MTI4MQ_c8a276fd-c23e-42ce-97ce-ffda832bd70e">1,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28c8afa29af14a569e645ef1aacc226c_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNS0zLTEtMS02MTI4MQ_aff13dbc-6e62-447f-9904-a3bc176508c8">915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ca15d9d5d48078024960d0e23e05e_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNS01LTEtMS02MTI4MQ_b254833c-bf64-4efa-badc-dc36945346cb">2,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01375e7a7d6d4d5ea8993c57a7fa9646_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNS03LTEtMS02MTI4MQ_a7cb61ee-48f3-404c-bfa5-b23527edf122">1,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i016a8ef65bb04b5d92fe312250253498_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNS05LTEtMS02MTI4MQ_f4606ce2-a767-4557-b9bb-5068e962e1a3">908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id51f443d02834ad4869eb954f45c6f30_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNS0xMS0xLTEtNjEyODE_90fe0646-4d4d-458c-813c-80f016f5dd5e">2,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b392253b2d848fba4cbe7cbca8862ce_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNi0xLTEtMS02MTI4MQ_dabcb5ca-58af-4864-84cf-2eacd845d658">945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic10db11a119f49bd8880ae734593b26a_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNi0zLTEtMS02MTI4MQ_3e0de2ec-1b31-4ddf-81fa-7ee5222b87f4">286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54288602bb02449f862cb8e8556ce749_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNi01LTEtMS02MTI4MQ_73c645c0-aec7-48d3-a838-92619821fbc9">1,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e9a88dddb1141dc93f661547e4e852a_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNi03LTEtMS02MTI4MQ_627a31c3-758a-4b64-8739-6bc48996f4e5">917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a080ccb675240cc9c4a8ba434c764a5_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNi05LTEtMS02MTI4MQ_fefc3010-29be-4749-9126-a4192f41bf0b">278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc933a06c8ba4f988cefb9809c807501_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNi0xMS0xLTEtNjEyODE_d99ba75d-dc47-41f0-90f8-a53eb63bb105">1,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id727ab7528c748339d239f9af4abbbd5_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNy0xLTEtMS02MTI4MQ_5ae93e58-a8cd-4c2e-b6b5-bdb4f60e6044">291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa9d6dfaff1145718f4ec2ddd0e9060f_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNy0zLTEtMS02MTI4MQ_864955d5-6ae3-4203-993a-c3794a0c391c">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e9adc19251c445fbb25842e71b25fb9_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNy01LTEtMS02MTI4MQ_54086899-c79e-4642-b397-1a24c2e2719f">561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie088a67ab37944269b87738d47fd8cf2_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNy03LTEtMS02MTI4MQ_8122fc04-5887-401a-a8ac-5f6a5ffdbc05">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a1cfd5cb6684b57a644e4700794e7d6_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNy05LTEtMS02MTI4MQ_2e65288c-93be-4496-874b-0c41808daa7c">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4fee3d5348442f81d98e5c491d7567_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNy0xMS0xLTEtNjEyODE_2d29b982-6469-4a2d-bb5d-9975326fd0a9">569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i796262ed3fae4763be2037f02515b572_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOC0xLTEtMS02MTI4MQ_3a1dea24-013b-4258-9f6e-867d48759914">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7915ffe1e48e473e87a7bc4a597611ff_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOC0zLTEtMS02MTI4MQ_cc509092-a8fa-4309-a9ed-43f698759cde">670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21781684a6e54835a086fb4dfd07518b_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOC01LTEtMS02MTI4MQ_956b8418-0fa3-4c9c-aa2f-d23f623215f0">898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99f983046ba64a3597abb01c16866c07_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOC03LTEtMS02MTI4MQ_df6750ac-e30f-4a69-b953-f3ec57bddf8e">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43464f5ca80d4e9faacc0d26f58b60be_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOC05LTEtMS02MTI4MQ_b996b1d5-9480-4d0e-907b-cb8019f05bb4">621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e45e6c38b342e0afa75849e1554f02_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOC0xMS0xLTEtNjEyODE_f321b2c3-c631-4d97-ac03-a88c45423ef0">801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i744dcd2988294c748fdd6de59fed0010_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOS0xLTEtMS02MTI4MQ_d2da7a3d-9e22-4fc2-99fe-c1ad1c11c814">2,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28fd1a5379ed4068bcbe236046b009ac_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOS0zLTEtMS02MTI4MQ_97fee755-b1da-4f00-9a50-d49313739cc4">2,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93c8dc026e904d27a8674f1b2ae7b64f_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOS01LTEtMS02MTI4MQ_4103d571-3a2c-4727-b32c-12060c4c914b">4,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26cd80537ace4f54bd459856e6733c22_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOS03LTEtMS02MTI4MQ_6ce84029-7bd1-4d26-835f-c01c473e5a90">2,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabc734319b0040bb91b53f1b5bda469e_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOS05LTEtMS02MTI4MQ_05b0a081-934d-4a81-9dd1-7c095a053d68">2,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i177c01abfa574925aead9aa3b4f63e18_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOS0xMS0xLTEtNjEyODE_f2e74c0a-8e8e-4945-ba48-7fce006e02bd">4,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Life Sciences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63fca4aedfee493386b300cd94f770a4_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTItMS0xLTEtNjEyODE_144cb070-ff97-400a-a0bd-9405f5595465">1,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaaee6092a88498e8faa501905f4bdd7_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTItMy0xLTEtNjEyODE_e2b47a45-8ee4-4650-a814-3383225983f4">1,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2a56afd740743baa1b574805fc29871_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTItNS0xLTEtNjEyODE_2ee15ec8-e411-41e6-ad7e-5b721c3655a2">2,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibade6b68690841a8be0464af51c331d0_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTItNy0xLTEtNjEyODE_c18d742e-acba-4534-90b9-8942c32e4450">1,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic17e46520cc6412c8bc1e89dea2e9c8c_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTItOS0xLTEtNjEyODE_3a074c55-5e85-4cd1-85f6-c857a31a7205">1,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f73d2d072b8450a80571d1bce774ce0_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTItMTEtMS0xLTYxMjgx_5dec5f16-5825-4725-aa1f-68681f7d10d3">2,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i676297c812f4459e9be4e29ff85f5ad8_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTMtMS0xLTEtNjEyODE_afc0cc18-8077-47ba-8fb7-c318c7bf1ae1">258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39bc71985bfc4e1d839721692c03a9fe_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTMtMy0xLTEtNjEyODE_2e327a7b-11f1-4d87-9818-56adfa1b3eae">416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa5bfe82d7249b0937b40509556d515_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTMtNS0xLTEtNjEyODE_97c03b39-e8a9-4d66-9781-dbd7f9f13ceb">674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i618873a9001446c181b8ef34ab0bcc4a_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTMtNy0xLTEtNjEyODE_1281e8d4-176b-4b38-99cb-ee93c3d5826f">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bd3786e38494554a16139e13fdeb54f_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTMtOS0xLTEtNjEyODE_9a789c3f-4af3-4fdb-9bef-f513972364c2">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6348050d88d4f97a3775186bc1a6569_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTMtMTEtMS0xLTYxMjgx_9c44f703-9c07-41a2-bb7e-3ac8fe17100a">637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i061dc82dc32444aea21f1c81faebbe0a_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTQtMS0xLTEtNjEyODE_0bb83341-4776-4abc-8a11-9e3b7c9b3b3b">1,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69b2c199b94f4ca691703156805bd41c_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTQtMy0xLTEtNjEyODE_ecda49d9-35da-402f-a7e1-5a11b7fbcf7e">1,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68bb6db7dc06423d8874cf17e8b85add_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTQtNS0xLTEtNjEyODE_0b1e1436-3ea5-49fd-80e1-f4966ce237b2">2,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71898030bd194581a5f573edac52a467_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTQtNy0xLTEtNjEyODE_a44cabe4-7a59-4dd4-9e5a-8eb47fb2c762">1,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2312cfcd8087400e988b97e474a47c77_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTQtOS0xLTEtNjEyODE_460c0ef7-5c61-4936-9026-17e8d0bf5c42">1,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49af90b2d616488a86c54d3c262d0d5c_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTQtMTEtMS0xLTYxMjgx_91106e8a-3ff8-4b0f-b6df-884e18190efc">3,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Interventional</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i048c0649ac044507a024682c29947104_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTctMS0xLTEtNjEyODE_7d102e89-b932-4b56-a223-c6476e550bfa">549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a7ced2e82944f6681b9ed34294d5014_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTctMy0xLTEtNjEyODE_056ae7e2-e5df-4ef7-a338-fbd24e5589ff">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcc85f190816497f95bf2249ad0e8450_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTctNS0xLTEtNjEyODE_99a532e3-5dfb-42cb-b33f-3434c68f60af">701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81e5b85ab7764c6fb0daf9c82f0b4781_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTctNy0xLTEtNjEyODE_f620f4f4-192d-47a1-b9f9-b92072e61a10">489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i238fa27398184872a8e61d69996c8840_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTctOS0xLTEtNjEyODE_7c21c8ea-680e-4cf2-99db-02eef4d0289c">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1a0f1ebdf1b403798c14fedfa564a35_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTctMTEtMS0xLTYxMjgx_d69e1a3c-0841-4e1c-a6f5-1c50b424972d">624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c39abcfe82b42aa90ff2907f3304dcc_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTgtMS0xLTEtNjEyODE_54266fef-1dd2-4349-9759-907873d88295">457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b4f4dee6a8495d833675a95be35a26_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTgtMy0xLTEtNjEyODE_3a64160e-4764-4135-9fb5-90e66705e9d4">407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35931f5fa1204157bac1212583f72af6_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTgtNS0xLTEtNjEyODE_b53632d8-68df-4ee5-9c5b-afd9181c7a53">863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e4a485f90041afbb049fac8eb52965_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTgtNy0xLTEtNjEyODE_c1885108-0333-4dcd-9c66-d28a909fd3a1">454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief518885d18a472cb30a5c4921e2b0b5_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTgtOS0xLTEtNjEyODE_75eb861a-0073-4868-b05e-21d37abb2d82">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc225adea9a4eb3bcf21fd3444ec41d_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTgtMTEtMS0xLTYxMjgx_86528277-9c31-4f28-92e4-cc81623463a2">846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e49adc428d94084bfc47a4543444f50_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTktMS0xLTEtNjEyODE_e8972fad-d076-40e0-b8da-5bcc02f7b714">492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2f6430ba9a49438e7cc7a603637f4c_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTktMy0xLTEtNjEyODE_ef6eb211-a49f-4376-a63b-085d4f23ea38">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d46849ffcb74aa2aa512d3c1f68b33b_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTktNS0xLTEtNjEyODE_d62bdcea-2239-45a8-852d-d86e1ba44ee8">661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie157a03ce0f049c998b7c29069311c61_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTktNy0xLTEtNjEyODE_49495dcc-7d43-479f-a644-86ac29a99e40">445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c1dd439278f4be0a9a792057b61e38a_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTktOS0xLTEtNjEyODE_7b5192ed-5f57-49c0-afee-c43990dfbf09">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4143ec09dd4b481a8e155333bd4dc4fa_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTktMTEtMS0xLTYxMjgx_c9852ba4-17f3-4831-bc0f-ad1a598169a7">616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa3b379319c34f67af75703550c4c252_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjAtMS0xLTEtNjEyODE_419164ae-1849-408a-a22a-bb2f50892600">1,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3b61621dfcc434bbe4ce2f31653255a_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjAtMy0xLTEtNjEyODE_8cacb738-a67f-4ca4-9294-eaa056fc939d">727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic959ae392a3e4d8b9d97860c881fa2e6_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjAtNS0xLTEtNjEyODE_b5e0b968-b098-418f-8111-7c6d9705f89c">2,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff32a50b2bf54f4cbef3c832096888da_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjAtNy0xLTEtNjEyODE_78b70487-1964-47fc-b965-5c0a4314547d">1,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58032061b0ff454095c538f1f3c4d0ec_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjAtOS0xLTEtNjEyODE_c72d1530-9000-4fb7-8ff5-5209e55b80d6">698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief3a64ff7d9d4ad5984439fa90316773_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjAtMTEtMS0xLTYxMjgx_f3790dea-deff-4d6b-9fcb-1cd3a896403d">2,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Company revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67d9bfcd7b3a4d56b5197daa366d5b0f_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjItMS0xLTEtNjEyODE_4732dacd-27b4-4fd9-b40e-c9ab39d2d63a">5,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1ab3086e3eb4dc39a17c1ff6b4efb91_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjItMy0xLTEtNjEyODE_1fc5e169-d106-49ae-bbff-fb5e7030297d">4,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjItNS0xLTEtNjEyODE_af4470ae-dcee-452a-91bf-50d398637e0e">10,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4994dbb56dd942c3b109fdbcdbc65a09_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjItNy0xLTEtNjEyODE_fc3a23d6-ad32-4d5d-af4c-ace5202e2e10">5,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c3f5953274d42d8883cc70bb1ab9bf9_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjItOS0xLTEtNjEyODE_53d56784-4e2f-42db-855f-43bf3e9636ad">4,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjItMTEtMS0xLTYxMjgx_a7239d06-23d4-4322-b41e-07b3c6943edc">10,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i239ab7fa1a5a4ae99171eedd1319757d" continuedAt="i361065e820ed4735854c6eaf396797bf"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RleHRyZWdpb246ZGM3MzQwNzQ4YjE2NGQwZTgwNWI0ZmU5MjE2ZGIxODFfMTIyOA_8aabacfa-c1b9-4635-aaa7-b74256c2e112" continuedAt="i827d33f8f4a349c8a02a446d7ca90233" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment income for the three and six-month periods was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.260%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Income Before Income Taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd9d0f9e33a441088614cd71f9e278ef_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMy0xLTEtMS02MTI4MQ_aa969896-5a57-4bca-9435-2ae23a36cf6b">615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i692aef30e2ff4aa7bc63ceaa2db430fd_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMy0zLTEtMS02MTI4MQ_39201ace-8ae0-42ab-92b6-8dc3f4564281">634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93c8dc026e904d27a8674f1b2ae7b64f_D20211001-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMy01LTEtMS02MTI4MQ_25eaef26-5805-4dc6-9556-ebd33d744d12">1,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i177c01abfa574925aead9aa3b4f63e18_D20201001-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMy03LTEtMS02MTI4MQ_77f0eb66-b17c-4b19-8f7a-6b2a88adb32c">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228cd1a05f9444a282107d55ea9e185c_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNC0xLTEtMS02MTI4MQ_6be1d0ad-d496-465a-bc19-79180539a912">475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8f952d3c2504bee86897ac95714403d_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNC0zLTEtMS02MTI4MQ_5343568c-1f6c-4b7e-96c6-74c768492cf0">548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68bb6db7dc06423d8874cf17e8b85add_D20211001-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNC01LTEtMS02MTI4MQ_70a296ec-396c-4f4b-a858-d2c242330bde">1,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49af90b2d616488a86c54d3c262d0d5c_D20201001-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNC03LTEtMS02MTI4MQ_a47bfc86-970c-44cc-821f-36b3825f86f3">1,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d77974120f4be69403ea9d0e2b2e32_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNS0xLTEtMS02MTI4MQ_9409f709-2e1c-4e59-b603-93385a658941">280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b2088e5e1d40f1925f5a9ce6d60363_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNS0zLTEtMS02MTI4MQ_c8e5e440-71c9-49cf-ab05-9734ea51c7fa">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic959ae392a3e4d8b9d97860c881fa2e6_D20211001-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNS01LTEtMS02MTI4MQ_015934f7-4575-48c7-990c-e55fdf6bd72b">544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief3a64ff7d9d4ad5984439fa90316773_D20201001-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNS03LTEtMS02MTI4MQ_d92134a1-6e07-4e8e-a79a-d83b5318c092">511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Segment Operating Income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if77c23c0dcc049008fcc1ec1e19316f0_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNi0xLTEtMS02MTI4MQ_4ee3ab36-0e47-4ef7-81ff-cc8ee47fe342">1,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3e301035b4a4bdfb65e05d08198eeff_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNi0zLTEtMS02MTI4MQ_bca9ef97-f18c-4b40-bd7d-ec52c68a4abe">1,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbf9dc05d6fa4d8fba50f123e716eafe_D20211001-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNi01LTEtMS02MTI4MQ_3f5fbc5e-80cf-4119-8ba5-8452e4ff912a">2,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4567c9a64f984e07827c5c6c6ccf5cc3_D20201001-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNi03LTEtMS02MTI4MQ_83ad4033-b5d6-4d5c-beb8-0b0e00fa81bc">3,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration and restructuring expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52b453b110a6487198bf393e02c8324c_D20220101-20220331" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNy0xLTEtMS02MTI4MQ_0edc0fdf-4b78-48f7-8b03-3206a2fcce41">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46d46821d3124f169527dd86c47ecdcf_D20210101-20210331" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNy0zLTEtMS02MTI4MQ_676a361f-a8d8-436d-8dfb-57cb13c7a398">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d66dba8cd4a42fb969a3a9bfe7dc2a5_D20211001-20220331" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNy01LTEtMS02MTI4MQ_8cf0bbbb-fe9e-4e7c-a45f-34e424d05398">62</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib171c4d8e98248f48d26babd2d37afa5_D20201001-20210331" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNy03LTEtMS02MTI4MQ_82de74b9-d832-460e-a8e2-1314e926a520">102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net interest expense </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52b453b110a6487198bf393e02c8324c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfOS0xLTEtMS02MTI4MQ_ff954f51-0b52-4356-b84d-f4b66dd615c0">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46d46821d3124f169527dd86c47ecdcf_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfOS0zLTEtMS02MTI4MQ_9beb1f02-60b2-4ea1-a57e-70f2f3eba3e8">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d66dba8cd4a42fb969a3a9bfe7dc2a5_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfOS01LTEtMS02MTI4MQ_304dad7f-c7c2-4347-8309-7cbbf85d91c4">195</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib171c4d8e98248f48d26babd2d37afa5_D20201001-20210331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfOS03LTEtMS02MTI4MQ_7bdcfc3b-963b-4051-a376-f48df53a7580">238</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other unallocated items (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i909ad880c3244bdfb8b75a0b85cf397e_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMTAtMS0xLTEtNjEyODE_efacb799-616c-4e1c-8062-d4f0b1d777c5">717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd843e5598ca484abfc9deff353549de_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMTAtMy0xLTEtNjEyODE_1edd39f5-3767-4f69-b2e5-f432d516d32a">913</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icecf16d531934c9e94ad3aa80cd5fe9b_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMTAtNS0xLTEtNjEyODE_b2afb4bc-cfc5-4ee7-81ea-76395c689791">1,378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i459c088c116949f6a7759e05b502302e_D20201001-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMTAtNy0xLTEtNjEyODE_994f0794-aa1d-4c20-bf89-99126e1444ff">1,529</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Income Before Income Taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMTEtMS0xLTEtNjEyODE_263830a1-65e2-486a-aac7-539a3f508d1b">525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMTEtMy0xLTEtNjEyODE_2a52730c-904e-4bc9-9356-0f306d8e4903">305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMTEtNS0xLTEtNjEyODE_54cedcd7-dc42-4be9-be20-71fb3de17e5d">1,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMTEtNy0xLTEtNjEyODE_af5bb7b9-ba18-4b93-9222-0b2adc0f5968">1,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">The amounts for the three and six months ended March&#160;31, 2022 include a noncash asset impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ifb8b77375efd4b3b80608dbb0eff1722_D20220101-20220331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RleHRyZWdpb246ZGM3MzQwNzQ4YjE2NGQwZTgwNWI0ZmU5MjE2ZGIxODFfMzg0ODI5MDcwMzk1Nw_3d14a148-d309-4daf-83bc-f9f0c3334473"><ix:nonFraction unitRef="usd" contextRef="idd645833eba34cf7bc7e14df93e204c3_D20211001-20220331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RleHRyZWdpb246ZGM3MzQwNzQ4YjE2NGQwZTgwNWI0ZmU5MjE2ZGIxODFfMzg0ODI5MDcwMzk1Nw_59d8f043-7019-4de6-95ce-d5a3dcafdfeb">54</ix:nonFraction></ix:nonFraction>&#160;million recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Medical segment.</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><ix:continuation id="i361065e820ed4735854c6eaf396797bf" continuedAt="if39339e92823431196419469c9b2923a"><ix:continuation id="i827d33f8f4a349c8a02a446d7ca90233" continuedAt="ib0af45b4a6c34dc2a3ab7f5b06e40d0e"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Primarily comprised of foreign exchange, certain general and administrative expenses and share-based compensation expense.  The amounts for the three and six months ended March&#160;31, 2021 also included pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="ibc4467fbe0ee44db93c2873c8d0afa22_D20210101-20210331" decimals="-6" name="us-gaap:ProductLiabilityAccrualPeriodExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RleHRyZWdpb246ZGM3MzQwNzQ4YjE2NGQwZTgwNWI0ZmU5MjE2ZGIxODFfNjU5NzA2OTc2OTUxOA_ec107304-573a-4376-9368-17c4b8245039"><ix:nonFraction unitRef="usd" contextRef="i9157cafcaafb4b5db2bc2a4e28325ccd_D20201001-20210331" decimals="-6" name="us-gaap:ProductLiabilityAccrualPeriodExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RleHRyZWdpb246ZGM3MzQwNzQ4YjE2NGQwZTgwNWI0ZmU5MjE2ZGIxODFfNjU5NzA2OTc2OTUxOA_ef99dd7c-bb3a-4398-9f24-99a32d0ebf0c">296</ix:nonFraction></ix:nonFraction>&#160;million recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense, net </span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if39339e92823431196419469c9b2923a"><ix:continuation id="ib0af45b4a6c34dc2a3ab7f5b06e40d0e">related to certain product liability matters, including the related legal defense costs, which are further discussed in Note 4.</ix:continuation></ix:continuation> </span></div><div id="icb36c8b3bd0b41458d5570d492469671_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8211; <ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RleHRyZWdpb246ZTE5YjVhNGQ2OWE1NDliNjg2YmJjNzFmYzdmODZkMjhfNzMx_caedf7d8-95df-4e5b-a822-d34948352cbb" continuedAt="i3070c69cd9f94a9e931e83b002054969" escape="true">Benefit Plans</ix:nonNumeric></span></div><ix:continuation id="i3070c69cd9f94a9e931e83b002054969"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has defined benefit pension plans covering certain employees in the United States and certain international locations.  The measurement date used for these plans is September&#160;30.</span></div><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RleHRyZWdpb246ZTE5YjVhNGQ2OWE1NDliNjg2YmJjNzFmYzdmODZkMjhfNzM1_81893eff-5b72-4a14-a0a5-b3c385d76df9" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net pension cost included the following components for the three and six-month periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:45.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.629%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief564af42a4c42e893aff8bd1fbca00a_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfMi0xLTEtMS02MTI4MQ_33e31bc9-2d61-42c3-808f-4912771f7061">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i779636b30adc455b80382ee10bb0ad6b_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfMi0zLTEtMS02MTI4MQ_3eeb6b29-d690-46cb-8bff-4e57ec66e8ce">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00226f2a049945c4926cc6902c33c132_D20211001-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfMi01LTEtMS02MTI4MQ_65db7822-404d-4f9b-ae25-fbb6969746be">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28fdaf2e6bb47bf9633a15831cda54b_D20201001-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfMi03LTEtMS02MTI4MQ_98194ce0-658d-47fe-8a81-b1f1ff9c7d98">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief564af42a4c42e893aff8bd1fbca00a_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfMy0xLTEtMS02MTI4MQ_e122bf17-a893-4ba1-995f-4edc8bf6045a">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i779636b30adc455b80382ee10bb0ad6b_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfMy0zLTEtMS02MTI4MQ_eb7e4158-74d1-4d7c-bfda-9480188a6f92">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00226f2a049945c4926cc6902c33c132_D20211001-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfMy01LTEtMS02MTI4MQ_fb465f56-6ebb-4fa0-825e-88f3fead56fa">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28fdaf2e6bb47bf9633a15831cda54b_D20201001-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfMy03LTEtMS02MTI4MQ_5414aae5-a2ae-481d-a708-b225794f6aef">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief564af42a4c42e893aff8bd1fbca00a_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNC0xLTEtMS02MTI4MQ_148b6839-c042-4201-bc54-65696ee98784">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i779636b30adc455b80382ee10bb0ad6b_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNC0zLTEtMS02MTI4MQ_7bd08180-dd84-4d83-9a7f-c60fdba878ac">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00226f2a049945c4926cc6902c33c132_D20211001-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNC01LTEtMS02MTI4MQ_b94605b3-794e-4e46-80c0-a8ca64f1d2ae">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie28fdaf2e6bb47bf9633a15831cda54b_D20201001-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNC03LTEtMS02MTI4MQ_41b607dc-9729-4285-9107-41b9caa944ee">89</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief564af42a4c42e893aff8bd1fbca00a_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNS0xLTEtMS02MTI4MQ_1f6ee821-bd07-4899-9921-cdeb926d4511">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i779636b30adc455b80382ee10bb0ad6b_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNS0zLTEtMS02MTI4MQ_a90e8cc5-863f-41dd-a0e7-f57b052583fc">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00226f2a049945c4926cc6902c33c132_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNS01LTEtMS02MTI4MQ_94241698-8c11-4633-929b-2710780b6edd">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie28fdaf2e6bb47bf9633a15831cda54b_D20201001-20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNS03LTEtMS02MTI4MQ_ed507584-263b-4a73-9921-3cbe6c79a751">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief564af42a4c42e893aff8bd1fbca00a_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNi0xLTEtMS02MTI4MQ_c63e8fa8-4cb4-4d7c-bc53-431747a42121">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i779636b30adc455b80382ee10bb0ad6b_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNi0zLTEtMS02MTI4MQ_5fab023f-6b81-480c-874c-77a62d443ff1">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00226f2a049945c4926cc6902c33c132_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNi01LTEtMS02MTI4MQ_d379ea5f-c094-4fce-93f4-f859a29f0027">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28fdaf2e6bb47bf9633a15831cda54b_D20201001-20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNi03LTEtMS02MTI4MQ_b52ef9f2-dfbf-4949-93c8-cca2bd41bdf2">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief564af42a4c42e893aff8bd1fbca00a_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNy0xLTEtMS02MTI4MQ_391e3417-9fbc-4206-989b-c823caf1481c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i779636b30adc455b80382ee10bb0ad6b_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNy0zLTEtMS02MTI4MQ_f1569ea9-2553-4386-9108-746845ca7c8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00226f2a049945c4926cc6902c33c132_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNy01LTEtMS02MTI4MQ_11885280-80b0-4eff-a915-c06955922bd9">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28fdaf2e6bb47bf9633a15831cda54b_D20201001-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNy03LTEtMS02MTI4MQ_e9c98356-d724-49da-907b-69069fa02b7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief564af42a4c42e893aff8bd1fbca00a_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfOC0xLTEtMS02MTI4MQ_c709214b-ee0d-4b01-bf3b-c36d8152a737">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i779636b30adc455b80382ee10bb0ad6b_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfOC0zLTEtMS02MTI4MQ_7f9a3aa6-8041-474d-bb66-202d427047c9">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00226f2a049945c4926cc6902c33c132_D20211001-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfOC01LTEtMS02MTI4MQ_4fc87802-c706-4eb4-87f3-a7a9122ae8de">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28fdaf2e6bb47bf9633a15831cda54b_D20201001-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfOC03LTEtMS02MTI4MQ_ad9c2b55-d9c4-4a75-a80d-5a50a61c9f79">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts provided above for amortization of prior service credit and amortization of loss represent the reclassifications of prior service credits and net actuarial losses that were recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in prior periods.  All components of the Company&#8217;s net periodic pension cost, aside from service cost, are recorded to&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;on its condensed consolidated statements of income.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="icb36c8b3bd0b41458d5570d492469671_52"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 &#8211; <ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RleHRyZWdpb246ZmMzNzE4YTIwZWY1NDI5ODhhMjkxN2RkMWFiMjU5YjVfNTgx_0bd657f2-ed85-43f3-9c99-80483d793c75" continuedAt="i17269a64534d4fdab86e81dded09824e" escape="true">Business Restructuring Charges</ix:nonNumeric></span></div><ix:continuation id="i17269a64534d4fdab86e81dded09824e"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred restructuring costs during the six months ended March&#160;31, 2022, primarily in connection with the Company's simplification and other cost saving initiatives, which were largely recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-related integration and restructuring expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  These simplification and other costs saving initiatives are focused on reducing complexity, enhancing product quality, refining customer experience, and improving cost efficiency across all of the Company&#8217;s segments.  <ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RleHRyZWdpb246ZmMzNzE4YTIwZWY1NDI5ODhhMjkxN2RkMWFiMjU5YjVfNTgz_31095348-1427-4ff8-93e9-adb6e8ad4fed" continuedAt="i517335c4472c49e3b34590437bb0a6a0" escape="true">Restructuring liability activity for the six months ended March&#160;31, 2022 was as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i517335c4472c49e3b34590437bb0a6a0"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.456%"><tr><td style="width:1.0%"></td><td style="width:36.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.686%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.041%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee<br/>Termination</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c9691d61a39453087be7034f4483fbc_I20210930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfMS0xLTEtMS02MTI4MQ_adb600d7-e29e-4f53-a5e1-75890dd763bc">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeff7a1ec077409a9bc93ab1ff3aefb4_I20210930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfMS0zLTEtMS02MTI4MQ_68f1e793-8961-4f78-b874-acdabda31f6c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfMS01LTEtMS02MTI4MQ_ff481b67-71a6-45a7-acad-67b4533fc58a">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i720075ccfd224b55a2643c326f989fbb_D20211001-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfMy0xLTEtMS02MTI4MQ_a8f4f86f-7307-4bd6-867b-dda796171838">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice9b08a1614b40ec92a118dec841b8fc_D20211001-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfMy0zLTEtMS02MTI4MQ_7f7e5f24-e17d-467f-8c6e-5a47b86b5874">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfMy01LTEtMS02MTI4MQ_a5ade528-6d5b-49bd-a5e0-60085386e65d">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i720075ccfd224b55a2643c326f989fbb_D20211001-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfNC0xLTEtMS02MTI4MQ_55a42532-419d-445e-b5d5-bcad3e870e6e">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice9b08a1614b40ec92a118dec841b8fc_D20211001-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfNC0zLTEtMS02MTI4MQ_ade13db0-02d1-40a8-87c2-42519b5dcfb2">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfNC01LTEtMS02MTI4MQ_9bbca45f-4157-4df3-bab7-24253a5125f6">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i535aa5beb8df4def94ad38003c699670_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfNy0xLTEtMS02MTI4MQ_af385a0e-ecc1-4763-91bc-14dfa6817c38">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibceac69f309e466680f1ada28542ef16_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfNy0zLTEtMS02MTI4MQ_73ea9132-c308-457a-92a9-f85eede6c615">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfNy01LTEtMS02MTI4MQ_8ee3671a-5618-4ff6-a48a-ec5dcb3ef2d4">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-top:3pt;text-indent:-18pt"><span><br/></span></div><div id="icb36c8b3bd0b41458d5570d492469671_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8211; <ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RleHRyZWdpb246YmVmOTQ3NjIzMWU1NGJkYWIwMjhhMWQwMjc3Mjg3MzNfMzYw_36f8469c-d303-45fc-b402-60b4bcf5ae4a" continuedAt="i62c0f479fcff4611aa84f024812e4b32" escape="true">Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="i62c0f479fcff4611aa84f024812e4b32"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RleHRyZWdpb246YmVmOTQ3NjIzMWU1NGJkYWIwMjhhMWQwMjc3Mjg3MzNfMzcx_1ef2b23f-8d44-4f54-a458-be3e9aebd19b" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia886aaf5c1bb402ab373ae9e4fcf70f5_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMy0xLTEtMS02MTI4MQ_e8d27b93-b5d2-49f9-acb2-c9f7a939555f">14,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia886aaf5c1bb402ab373ae9e4fcf70f5_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMy0zLTEtMS02MTI4MQ_59fb91ed-7d26-4463-9b70-a12a8db8e184">5,491</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia886aaf5c1bb402ab373ae9e4fcf70f5_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMy01LTEtMS02MTI4MQ_30d5c07f-8bf0-440b-87ae-fc61b12f4e73">9,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if19b6df31d1041d988f2b6d0d6f8be9a_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMy03LTEtMS02MTI4MQ_e0012ffe-0d85-45a1-93a9-58129e1ca279">14,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if19b6df31d1041d988f2b6d0d6f8be9a_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMy05LTEtMS02MTI4MQ_24dab4a7-34e5-4620-a2a7-af880d0c201d">4,983</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if19b6df31d1041d988f2b6d0d6f8be9a_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMy0xMS0xLTEtNjEyODE_8474c3d5-8022-48d1-860a-5585ccbf8200">9,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff71ea0dd54b4de39f65ab020e2a67d5_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNC0xLTEtMS02MTI4MQ_be4a4cd2-b903-4105-bf82-4d3470560d67">4,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff71ea0dd54b4de39f65ab020e2a67d5_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNC0zLTEtMS02MTI4MQ_4def9180-2cb2-4512-9a5b-ef4d28095adc">2,005</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff71ea0dd54b4de39f65ab020e2a67d5_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNC01LTEtMS02MTI4MQ_c111f44d-40dc-431e-85cb-184d9099273d">2,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1bf7117c8f74af382b1902e9716b58b_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNC03LTEtMS02MTI4MQ_898583e3-c964-4ebc-a4ad-daee5f9cac4b">4,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1bf7117c8f74af382b1902e9716b58b_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNC05LTEtMS02MTI4MQ_d24f3cac-866f-4510-b75b-0fd3415916ba">1,839</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1bf7117c8f74af382b1902e9716b58b_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNC0xMS0xLTEtNjEyODE_aa5fd793-7f71-4256-814f-6540f46d7de1">2,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcba64985bd94892898f333e81f805c3_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNS0xLTEtMS02MTI4MQ_1025803b-0a09-496b-bd29-1db63883cf04">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifcba64985bd94892898f333e81f805c3_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNS0zLTEtMS02MTI4MQ_8719b474-dfba-4d0a-b4ec-598fae34ed3f">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcba64985bd94892898f333e81f805c3_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNS01LTEtMS02MTI4MQ_94400ac5-68d1-4289-8cf6-150d2b55abfe">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7852dda3e9644e0b9e2ced2925cb5cbc_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNS03LTEtMS02MTI4MQ_07145b5a-61f1-4272-8c9e-1e45ac267c64">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7852dda3e9644e0b9e2ced2925cb5cbc_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNS05LTEtMS02MTI4MQ_4cb86a80-7469-40d4-b0de-9db3ac0a5647">83</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7852dda3e9644e0b9e2ced2925cb5cbc_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNS0xMS0xLTEtNjEyODE_e9900822-f77a-4e03-9293-5c3cd8f279e7">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i287c272785094449aeae5d0789e8dd30_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNi0xLTEtMS02MTI4MQ_528cf97e-cc37-4afe-90d5-f9833f761870">408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i287c272785094449aeae5d0789e8dd30_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNi0zLTEtMS02MTI4MQ_0536423c-45b3-4eb0-a6e7-9cddfb99c012">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i287c272785094449aeae5d0789e8dd30_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNi01LTEtMS02MTI4MQ_6cd65c99-2be8-4fc4-af6b-a8f62397e0cd">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7c055feadd4023a2ccc660f06149c5_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNi03LTEtMS02MTI4MQ_c3f999dc-3b50-44ed-95ea-8708ece6395b">409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7c055feadd4023a2ccc660f06149c5_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNi05LTEtMS02MTI4MQ_849ff7fa-2e2e-4fd7-a35b-d9149817186e">137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7c055feadd4023a2ccc660f06149c5_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNi0xMS0xLTEtNjEyODE_a92d5354-57e4-4da0-905f-1bffd4958377">271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2f69b4e89a4d6d841af8ccf0210a6d_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNy0xLTEtMS02MTI4MQ_7e70c95a-a0be-445e-bdea-d2187f2abbe5">543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice2f69b4e89a4d6d841af8ccf0210a6d_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNy0zLTEtMS02MTI4MQ_a0d3bdf9-ea38-4dbc-83ab-5174147ac959">343</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2f69b4e89a4d6d841af8ccf0210a6d_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNy01LTEtMS02MTI4MQ_77fb1758-abf4-413d-99af-179478f1c202">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9046b05ebed642d6a4080928d23692fd_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNy03LTEtMS02MTI4MQ_e51c9305-3263-4589-b6c2-f9a76e08ebc5">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9046b05ebed642d6a4080928d23692fd_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNy05LTEtMS02MTI4MQ_f7bd634c-312d-461a-8c88-5c8023effbd0">342</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9046b05ebed642d6a4080928d23692fd_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNy0xMS0xLTEtNjEyODE_043df392-36f1-48a2-a942-d13b2447c80d">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfOC0xLTEtMS02MTI4MQ_7aba219c-a133-4693-955c-cb024a354ee8">20,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfOC0zLTEtMS02MTI4MQ_35545a7e-22a2-4900-9b88-7a20ee1169a2">8,067</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfOC01LTEtMS02MTI4MQ_db250503-6520-472d-9de8-cd55c992c253">12,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfOC03LTEtMS02MTI4MQ_ff2480a4-222a-4e0e-bf66-68912f8491e4">20,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfOC05LTEtMS02MTI4MQ_4e39391c-a502-44ca-bdcf-c8eb8f40d9ab">7,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfOC0xMS0xLTEtNjEyODE_3ef6a1fa-5f9d-44f8-9adb-ba8008e7c9a2">12,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbbba24d92744e1995760747da6b3a07_I20220331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMTAtMS0xLTEtNjEyODE_01ac3990-b33e-41c6-8c72-6173bf807143">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib93696a0600a4388af7001d55ce60a56_I20210930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMTAtNy0xLTEtNjEyODE_4756e03f-0a4d-42e3-9e19-4236b8f454ee">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67af69e0e74849ab8b12161f932216a2_I20220331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMTEtMS0xLTEtNjEyODE_8747201a-60e1-4df8-bfff-a3a0b4558839">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09024c8954c042e89264bf944c8b11d6_I20210930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMTEtNy0xLTEtNjEyODE_1b81deb7-0378-4003-9f50-a558bea60867">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMTItMS0xLTEtNjEyODE_0868b866-1590-4483-a16a-c66b317094f3">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMTItNy0xLTEtNjEyODE_7cd05071-ca16-4df5-82a9-917e7520c11d">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible amortization expense for the three months ended&#160;March&#160;31, 2022 and 2021&#160;was $<ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RleHRyZWdpb246YmVmOTQ3NjIzMWU1NGJkYWIwMjhhMWQwMjc3Mjg3MzNfMTM5_8b953fc7-cb88-4fb9-8346-87ca5870cd5a">352</ix:nonFraction> million&#160;and $<ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RleHRyZWdpb246YmVmOTQ3NjIzMWU1NGJkYWIwMjhhMWQwMjc3Mjg3MzNfMTQ2_6e6befa2-da36-4edf-8c6d-4c2533674bc6">350</ix:nonFraction> million, respectively.  Intangible amortization expense for the six months ended&#160;March&#160;31, 2022 and 2021&#160;was $<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RleHRyZWdpb246YmVmOTQ3NjIzMWU1NGJkYWIwMjhhMWQwMjc3Mjg3MzNfMjc0ODc3OTA2OTk1Mw_2768f1d8-7eb5-48cd-b89a-6ffc822057f7">707</ix:nonFraction> million&#160;and $<ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RleHRyZWdpb246YmVmOTQ3NjIzMWU1NGJkYWIwMjhhMWQwMjc3Mjg3MzNfMjc0ODc3OTA2OTk1Nw_f96796d2-306c-4cc5-8efd-522342d7fb41">698</ix:nonFraction> million, respectively. </span></div><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RleHRyZWdpb246YmVmOTQ3NjIzMWU1NGJkYWIwMjhhMWQwMjc3Mjg3MzNfMzU5_7c2f63bd-5f6a-4cab-a51b-5f9da74aa83f" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"><tr><td style="width:1.0%"></td><td style="width:38.713%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life&#160;Sciences</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interventional</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieefa6c2ca96747e29b4e14f0c03cdff8_I20210930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfMS0xLTEtMS02MTI4MQ_8903ce12-3772-4bd0-9a6c-d77761d5db1c">10,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id060ca4c054d4caf9f5955f598b66769_I20210930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfMS0zLTEtMS02MTI4MQ_637b15b9-d7e9-4570-8c18-06220fb461bd">836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib65ad792e22f44688a73a18522ef2873_I20210930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfMS01LTEtMS02MTI4MQ_cfef0cff-5c42-464c-bef1-9862ad27f78e">12,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfMS03LTEtMS02MTI4MQ_bda2b99e-6c46-4a8c-892c-c1c0286df66d">23,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14595206756547be8dcca594e49423d1_D20211001-20220331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfMi0xLTEtMS02MTI4MQ_08ea051d-d9b0-49e2-95a9-72036bebe963">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0368fb62ba6e46fc84e60d8e4f32776e_D20211001-20220331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfMi0zLTEtMS02MTI4MQ_c4bdb1ce-049d-4f5f-aa80-fdad5737f85c">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c068d6acc740b4a2839bff2df64cb2_D20211001-20220331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfMi01LTEtMS02MTI4MQ_0bce2d53-aca7-4025-b1e2-d6588ed8404c">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfMi03LTEtMS02MTI4MQ_f4d34e6a-a840-4ac3-802a-5ca32f59c416">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price allocation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14595206756547be8dcca594e49423d1_D20211001-20220331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNC0xLTEtMS02MTI4MQ_a6d64160-2a09-4f11-8856-cdf2eb831386">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0368fb62ba6e46fc84e60d8e4f32776e_D20211001-20220331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNC0zLTEtMS02MTI4MQ_c3158cd3-ae96-4fdf-a34e-fccb02a630f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8c068d6acc740b4a2839bff2df64cb2_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNC01LTEtMS02MTI4MQ_bd166fbb-c3d1-4e96-95d8-f69fa9f16ec6">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNC03LTEtMS02MTI4MQ_18a4cdc9-ca8e-4708-94f7-d672ac3e9c89">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14595206756547be8dcca594e49423d1_D20211001-20220331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNS0xLTEtMS02MTI4MQ_3313508e-2997-4d16-88c5-2d76b31c8380">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0368fb62ba6e46fc84e60d8e4f32776e_D20211001-20220331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNS0zLTEtMS02MTI4MQ_fda12787-e4e4-4b2d-8081-36e150a1f806">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8c068d6acc740b4a2839bff2df64cb2_D20211001-20220331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNS01LTEtMS02MTI4MQ_eb203b7e-e32e-43a4-bbee-97da7b9a820e">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNS03LTEtMS02MTI4MQ_c1af93b7-d509-4c2e-9611-3cc49739e7e0">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id36e592a22714e45927e00fe0abd06f9_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNi0xLTEtMS02MTI4MQ_90157579-e477-4ad4-8429-e20e3d94e20d">10,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i647adccb5a5d4a46861649299a5f578e_I20220331" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNi0zLTEtMS02MTI4MQ_a36f9bd8-3e3d-4bb0-b580-3e80b51838b7">902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bf06b24db6d4d5e95c8dc424db65f4e_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNi01LTEtMS02MTI4MQ_dc9863ee-c225-4cd9-a8ad-c49b8054a6dd">12,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNi03LTEtMS02MTI4MQ_a4045601-5d8d-4fc7-bf0b-613f49a3d58e">24,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.</span></div></ix:nonNumeric></ix:continuation><div id="icb36c8b3bd0b41458d5570d492469671_58"></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 &#8211; <ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RleHRyZWdpb246NWI2NTc3MzYyNTJkNDRlNGI1MTA5ODRkYzQwNzI3YjRfNjA1MQ_c5ed8383-4bd1-4fe6-a803-f18da3262afc" continuedAt="i3c9e5c7ea9d6442c8cf069ff1bbd926b" escape="true">Derivative Instruments and Hedging Activities</ix:nonNumeric></span></div><ix:continuation id="i3c9e5c7ea9d6442c8cf069ff1bbd926b" continuedAt="i6770c006404a4dad959aa2e3769c9637"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RleHRyZWdpb246NWI2NTc3MzYyNTJkNDRlNGI1MTA5ODRkYzQwNzI3YjRfNjA0Nw_1304674e-ca4b-4485-bfff-57ced2e5a954" continuedAt="i519b2d6c9d8040209b9c842c9398027f" escape="true">The Company uses derivative instruments to mitigate certain exposures.  The Company does not enter into derivative financial instruments for trading or speculative purposes.</ix:nonNumeric>  The effects these derivative instruments and hedged items had on the Company&#8217;s balance sheets and the fair values of the derivatives outstanding at March&#160;31, 2022 and September&#160;30, 2021 were not material.  The effects on the Company&#8217;s financial performance and cash flows are provided below.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risks and Related Strategies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has foreign currency exposures throughout Europe, Greater Asia, Canada and Latin America.  Transactional currency exposures that arise from entering into transactions, generally on an intercompany basis, in non-hyperinflationary countries that are denominated in currencies other than the functional currency are mitigated primarily through the use of forward contracts.  In order to mitigate foreign currency exposure relating to its investments in certain foreign subsidiaries, the Company has hedged the currency risk associated with those investments with certain instruments, such as foreign currency-denominated debt and cross-currency swaps, which are designated as net investment hedges, as well as currency exchange contracts. </span></div><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RleHRyZWdpb246NWI2NTc3MzYyNTJkNDRlNGI1MTA5ODRkYzQwNzI3YjRfNjA2Mw_ca448734-5e8f-4bc7-9c0c-16cc2c3f986f" continuedAt="i383a4933552f443aa02d0283dacaa4ae" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s foreign currency-related derivative instruments as of March&#160;31, 2022 and September&#160;30, 2021 were as follows:</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.210%"><tr><td style="width:1.0%"></td><td style="width:36.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undesignated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57f20120eb6d496fa8dff3eee45b0eea_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmY0ZGY0NGYxODI3YTRiMDA4NTcxYWVjN2I0MTJlYzg1L3RhYmxlcmFuZ2U6ZjRkZjQ0ZjE4MjdhNGIwMDg1NzFhZWM3YjQxMmVjODVfMS0zLTEtMS02MTI4MQ_a634f7c5-29b3-4897-8ac0-84bbe0f6d862">1,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a5fc6a2293a4c8cad09d8ce4967369a_I20210930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmY0ZGY0NGYxODI3YTRiMDA4NTcxYWVjN2I0MTJlYzg1L3RhYmxlcmFuZ2U6ZjRkZjQ0ZjE4MjdhNGIwMDg1NzFhZWM3YjQxMmVjODVfMS01LTEtMS02MTI4MQ_b644f923-c0de-483c-86ce-1c9e734d7665">2,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1831573910a04a449ed2198ba1794eb7_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmY0ZGY0NGYxODI3YTRiMDA4NTcxYWVjN2I0MTJlYzg1L3RhYmxlcmFuZ2U6ZjRkZjQ0ZjE4MjdhNGIwMDg1NzFhZWM3YjQxMmVjODVfMi0zLTEtMS02MTI4MQ_176e66bc-c080-4d67-9888-37328bc54736">2,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9044e5284eec498888c80d53fd6d7cac_I20210930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmY0ZGY0NGYxODI3YTRiMDA4NTcxYWVjN2I0MTJlYzg1L3RhYmxlcmFuZ2U6ZjRkZjQ0ZjE4MjdhNGIwMDg1NzFhZWM3YjQxMmVjODVfMi01LTEtMS02MTI4MQ_2ce5ab99-b3ab-45ca-a6a7-a7e8e26e6580">2,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (c)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7eeef21c695425a92ba5420343f8392_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmY0ZGY0NGYxODI3YTRiMDA4NTcxYWVjN2I0MTJlYzg1L3RhYmxlcmFuZ2U6ZjRkZjQ0ZjE4MjdhNGIwMDg1NzFhZWM3YjQxMmVjODVfMy0zLTEtMS02MTI4MQ_488b4e43-ed71-4d11-86c0-cf5e31cf1768">1,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3329662597a43ae9d4393dca9eb9b23_I20210930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmY0ZGY0NGYxODI3YTRiMDA4NTcxYWVjN2I0MTJlYzg1L3RhYmxlcmFuZ2U6ZjRkZjQ0ZjE4MjdhNGIwMDg1NzFhZWM3YjQxMmVjODVfMy01LTEtMS02MTI4MQ_c9102c8a-7505-42ba-940a-81400b15ce0b">1,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables.  Gains and losses on these instruments are recognized immediately in income.  These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments.  Net amounts recognized in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, during the three and six months ended March&#160;31, 2022 and 2021 were immaterial to the Company's consolidated financial results.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents foreign currency-denominated long-term notes outstanding which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents cross-currency swaps which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains or losses relating to the net investment hedges, which are attributable to changes in the foreign currencies to U.S. dollar spot exchange rates, are recorded as accumulated foreign currency translation in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon the termination of a net investment hedge, any net gain or loss included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relative to the investment hedge remains until the foreign subsidiary investment is disposed of or is substantially liquidated.  </span></div><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RleHRyZWdpb246NWI2NTc3MzYyNTJkNDRlNGI1MTA5ODRkYzQwNzI3YjRfNjA2Ng_edf8ca7a-b9f8-4e49-8642-0e1793dab033" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains (losses) recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the Company's net investment hedges for the three and six-month periods were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:45.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.629%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcc3814ef1924ae9ba38f953eba0d814_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmQ4ODhmN2VlYzA0NjQyYTI5MjQ5NGQxZDRjYzNmNzFhL3RhYmxlcmFuZ2U6ZDg4OGY3ZWVjMDQ2NDJhMjkyNDk0ZDFkNGNjM2Y3MWFfMi0xLTEtMS02MTI4MQ_6f6c67f8-1ed6-4e2b-a90c-027f5ae2ebb8">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb6311653a447e9a0a4ba8c0ad8ead6_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmQ4ODhmN2VlYzA0NjQyYTI5MjQ5NGQxZDRjYzNmNzFhL3RhYmxlcmFuZ2U6ZDg4OGY3ZWVjMDQ2NDJhMjkyNDk0ZDFkNGNjM2Y3MWFfMi0zLTEtMS02MTI4MQ_c7ccc1dd-cfe0-43f8-bf2c-b8f8289dffff">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic331fa12abcc49f1ad32ee75878ba71b_D20211001-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmQ4ODhmN2VlYzA0NjQyYTI5MjQ5NGQxZDRjYzNmNzFhL3RhYmxlcmFuZ2U6ZDg4OGY3ZWVjMDQ2NDJhMjkyNDk0ZDFkNGNjM2Y3MWFfMi01LTEtMS02MTI4MQ_0df0e0e7-1ef8-4e1b-ac39-6a33bdfa8dc6">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72c4b04b5d954d97bccd5b64279416fd_D20201001-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmQ4ODhmN2VlYzA0NjQyYTI5MjQ5NGQxZDRjYzNmNzFhL3RhYmxlcmFuZ2U6ZDg4OGY3ZWVjMDQ2NDJhMjkyNDk0ZDFkNGNjM2Y3MWFfMi03LTEtMS02MTI4MQ_3ff7ede9-ea2e-43ef-8820-9110e5e17376">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd8707ce2b41458880bbba5f3ae0a677_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmQ4ODhmN2VlYzA0NjQyYTI5MjQ5NGQxZDRjYzNmNzFhL3RhYmxlcmFuZ2U6ZDg4OGY3ZWVjMDQ2NDJhMjkyNDk0ZDFkNGNjM2Y3MWFfMy0xLTEtMS02MTI4MQ_2cf7f846-966d-40b3-b11b-22466c8cbbdf">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5436992d57d34fa79e5f22c386b9e551_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmQ4ODhmN2VlYzA0NjQyYTI5MjQ5NGQxZDRjYzNmNzFhL3RhYmxlcmFuZ2U6ZDg4OGY3ZWVjMDQ2NDJhMjkyNDk0ZDFkNGNjM2Y3MWFfMy0zLTEtMS02MTI4MQ_d774aa6b-6287-48db-9be1-6e2285daa91e">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63b89c37783a44039baca463093a5ae6_D20211001-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmQ4ODhmN2VlYzA0NjQyYTI5MjQ5NGQxZDRjYzNmNzFhL3RhYmxlcmFuZ2U6ZDg4OGY3ZWVjMDQ2NDJhMjkyNDk0ZDFkNGNjM2Y3MWFfMy01LTEtMS02MTI4MQ_1fedbd6a-eac5-417d-8938-e017dc753a41">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f5fc4cc7e7f4dc586a55406beefd6ac_D20201001-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmQ4ODhmN2VlYzA0NjQyYTI5MjQ5NGQxZDRjYzNmNzFhL3RhYmxlcmFuZ2U6ZDg4OGY3ZWVjMDQ2NDJhMjkyNDk0ZDFkNGNjM2Y3MWFfMy03LTEtMS02MTI4MQ_14df27ff-c349-4454-9e83-cad35ab61f39">84</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risks and Related Strategies</span></div><ix:continuation id="i519b2d6c9d8040209b9c842c9398027f" continuedAt="ie0f84b30399941d09f73d59d609d92ac"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a mix of fixed and variable rate debt to manage its interest rate exposure, and periodically uses interest rate swaps to manage such exposures.  Under these interest rate swaps, the Company exchanges, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. These swaps are designated as either cash flow or fair value hedges.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of the interest rate swaps designated as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk) are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If interest rate derivatives designated as cash flow hedges are terminated, the balance in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6770c006404a4dad959aa2e3769c9637" continuedAt="ia72595b52fb04005ac0dedec5c24f074"><div style="margin-top:9pt"><ix:continuation id="ie0f84b30399941d09f73d59d609d92ac" continuedAt="id5c03d3d5b334920aa6a652784fde3b2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">attributable to those derivatives is reclassified into earnings, within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense,</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id5c03d3d5b334920aa6a652784fde3b2" continuedAt="i48a45266c162463a8391404ff90dad07"> over the remaining life of the hedged debt.</ix:continuation> The amounts reclassified from accumulated other comprehensive income relating to cash flow hedges during the three and six months ended March&#160;31, 2022 and 2021, as well as the amounts expected to be reclassified within the next 12 months, are not material to the Company's consolidated financial results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded net after-tax gains of $<ix:nonFraction unitRef="usd" contextRef="i1a1a0aef0db24a0987e1ebb88ed95290_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RleHRyZWdpb246NWI2NTc3MzYyNTJkNDRlNGI1MTA5ODRkYzQwNzI3YjRfMjc0ODc3OTA3NTY4Mg_512aa696-c160-41e2-910a-e093aac65622">43</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i54dd618396ea42518487e230f0e9e1b6_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RleHRyZWdpb246NWI2NTc3MzYyNTJkNDRlNGI1MTA5ODRkYzQwNzI3YjRfNDIzMw_853535d9-5e91-4146-8f6d-bb86c080fcb1">78</ix:nonFraction>&#160;million during the three months ended March&#160;31, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i73542df9b6064c0d93564b9e09ce34ef_D20211001-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RleHRyZWdpb246NWI2NTc3MzYyNTJkNDRlNGI1MTA5ODRkYzQwNzI3YjRfMjc0ODc3OTA3NTc4NQ_c5b2e603-9eb5-4926-9c26-954bc1666043">39</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i8e68b8c00a5b4b0795a14cc4e86be66d_D20201001-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RleHRyZWdpb246NWI2NTc3MzYyNTJkNDRlNGI1MTA5ODRkYzQwNzI3YjRfMjc0ODc3OTA3NTU3NA_602124a5-1ae6-427d-b7bf-2c6570a877c0">105</ix:nonFraction>&#160;million during the six months ended March&#160;31, 2022 and 2021, respectively, in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to interest rate hedges.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i48a45266c162463a8391404ff90dad07">For interest rate swaps designated as fair value hedges (i.e., hedges against the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt due to changes in market interest rates.</ix:continuation>  Amounts recorded during the three and six months ended March&#160;31, 2022 and 2021 were immaterial to the Company's consolidated financial results. </span></div><ix:continuation id="i383a4933552f443aa02d0283dacaa4ae" continuedAt="i5443182615d14a65be1ebb28b87a1b64"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s interest rate-related derivative instruments as of March&#160;31, 2022 and September&#160;30, 2021 were as follows: </span></div><div style="margin-top:3pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"><tr><td style="width:1.0%"></td><td style="width:39.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i179698c711414fb0a6c8ff99db9ee285_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmZhZWYyZjI2Mzg5YTRiOWE5ODc1ZWVhOGQ0MjA3ZjM1L3RhYmxlcmFuZ2U6ZmFlZjJmMjYzODlhNGI5YTk4NzVlZWE4ZDQyMDdmMzVfMS0zLTEtMS02MTI4MQ_1165e220-6643-438d-8516-5f0da4961dd8">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bf11422da34344806862a0903b17bd_I20210930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmZhZWYyZjI2Mzg5YTRiOWE5ODc1ZWVhOGQ0MjA3ZjM1L3RhYmxlcmFuZ2U6ZmFlZjJmMjYzODlhNGI5YTk4NzVlZWE4ZDQyMDdmMzVfMS01LTEtMS02MTI4MQ_29171a62-53a8-4ddc-af9e-ca8a7c31c6a5">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i413682d5f90848fd9283e81e36ef64c3_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmZhZWYyZjI2Mzg5YTRiOWE5ODc1ZWVhOGQ0MjA3ZjM1L3RhYmxlcmFuZ2U6ZmFlZjJmMjYzODlhNGI5YTk4NzVlZWE4ZDQyMDdmMzVfMi0zLTEtMS02MTI4MQ_5a77af26-9e88-46ba-b170-48cbb33f54dc">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68b5ca8e1784fe9bdac444023023ac8_I20210930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmZhZWYyZjI2Mzg5YTRiOWE5ODc1ZWVhOGQ0MjA3ZjM1L3RhYmxlcmFuZ2U6ZmFlZjJmMjYzODlhNGI5YTk4NzVlZWE4ZDQyMDdmMzVfMi01LTEtMS02MTI4MQ_7a9a3b01-0e12-4c4c-8cbf-f52d017ef6a9">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents fixed-to-floating interest rate swap agreements the Company entered into to convert the interest payments on certain long-term notes from the fixed rate to a floating interest rate based on LIBOR.  </span></div></ix:continuation><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5443182615d14a65be1ebb28b87a1b64" continuedAt="i176a23396b9f4f809a420089d92a8444">(b)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="i176a23396b9f4f809a420089d92a8444">Represents interest rate derivatives entered into to mitigate exposure to interest rate risk related to future debt issuances.</ix:continuation>  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Risk Exposures</span></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia72595b52fb04005ac0dedec5c24f074">The Company purchases resins, which are oil-based components used in the manufacture of certain products.  Significant increases in world oil prices that lead to increases in resin purchase costs could impact future operating results.  From time to time, the Company has managed price risks associated with these commodity purchases through commodity derivative forward contracts.  The Company's outstanding commodity derivative forward contracts at March&#160;31, 2022 were immaterial to the Company's consolidated financial results and the Company had <ix:nonFraction unitRef="usd" contextRef="i6435fd6a9e9049458f90d13308c412be_I20210930" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RleHRyZWdpb246NWI2NTc3MzYyNTJkNDRlNGI1MTA5ODRkYzQwNzI3YjRfNTk4MA_485d6dd0-8d0c-4b9f-aeb1-dae92b95ee22">no</ix:nonFraction> outstanding commodity derivative forward contracts at September&#160;30, 2021.</ix:continuation> </span></div><div><span><br/></span></div><div id="icb36c8b3bd0b41458d5570d492469671_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11 &#8211; <ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMjY4NQ_171ed317-b820-4b91-b04c-edef353fef11" continuedAt="i2625a25a0f554450886694c08e2ab2a5" escape="true">Financial Instruments and Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i2625a25a0f554450886694c08e2ab2a5" continuedAt="i7a37f04cb5914265aae24faff5ca2243"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMjY5MA_751f0bfd-a394-4160-849e-44f8ea05a1c6" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following reconciles cash and equivalents and restricted cash reported within the Company's consolidated balance sheets at March&#160;31, 2022 and September&#160;30, 2021 to the total of these amounts shown on the Company's consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:327.75pt"><tr><td style="width:1.0pt"></td><td style="width:166.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:75.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:75.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjM1YmEzMzcxNjRlMzQ4NTZiOGUyNjA5MDQ1ZDA0ZjQ4L3RhYmxlcmFuZ2U6MzViYTMzNzE2NGUzNDg1NmI4ZTI2MDkwNDVkMDRmNDhfMS0xLTEtMS02MTI4MQ_8f6580d4-2df3-493c-89fb-199098ae5542">3,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjM1YmEzMzcxNjRlMzQ4NTZiOGUyNjA5MDQ1ZDA0ZjQ4L3RhYmxlcmFuZ2U6MzViYTMzNzE2NGUzNDg1NmI4ZTI2MDkwNDVkMDRmNDhfMS0zLTEtMS02MTI4MQ_aeaaf961-a0c1-4d87-8039-812f87d97388">2,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjM1YmEzMzcxNjRlMzQ4NTZiOGUyNjA5MDQ1ZDA0ZjQ4L3RhYmxlcmFuZ2U6MzViYTMzNzE2NGUzNDg1NmI4ZTI2MDkwNDVkMDRmNDhfMi0xLTEtMS02MTI4MQ_3493a823-5d1e-4621-9181-404889e18194">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjM1YmEzMzcxNjRlMzQ4NTZiOGUyNjA5MDQ1ZDA0ZjQ4L3RhYmxlcmFuZ2U6MzViYTMzNzE2NGUzNDg1NmI4ZTI2MDkwNDVkMDRmNDhfMi0zLTEtMS02MTI4MQ_ba62f370-76b3-4713-8d0d-e28a72838814">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjM1YmEzMzcxNjRlMzQ4NTZiOGUyNjA5MDQ1ZDA0ZjQ4L3RhYmxlcmFuZ2U6MzViYTMzNzE2NGUzNDg1NmI4ZTI2MDkwNDVkMDRmNDhfMy0xLTEtMS02MTI4MQ_08c79f6e-a798-4def-811c-7b71ea431354">3,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjM1YmEzMzcxNjRlMzQ4NTZiOGUyNjA5MDQ1ZDA0ZjQ4L3RhYmxlcmFuZ2U6MzViYTMzNzE2NGUzNDg1NmI4ZTI2MDkwNDVkMDRmNDhfMy0zLTEtMS02MTI4MQ_cf9540d7-0bfe-4fbd-bbc6-c07a894853f6">2,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMjY4Mg_7e57df13-e723-4cb9-ba7a-bf9f4407cc72" escape="true">Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase.</ix:nonNumeric>  <ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMjY3Nw_123c9fe0-9db1-46d9-a524-a16d139d321f" escape="true">Restricted cash consists of cash restricted from withdrawal and usage except for certain product liability matters.</ix:nonNumeric></span></div><ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMjY3NA_201dcbe7-0051-4f1c-864b-03d0b5faeab2" continuedAt="i01e8a3d92d964203a154a498922d08a6" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s financial instruments are as follows:</span></div><div style="margin-top:9pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.842%"><tr><td style="width:1.0%"></td><td style="width:40.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Institutional money market accounts and ultra-short bond fund (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOmIwOWZlYmJkZDU5NjQ0YTZhMTEzMGYxZmVjMTQyNTk1L3RhYmxlcmFuZ2U6YjA5ZmViYmRkNTk2NDRhNmExMTMwZjFmZWMxNDI1OTVfMS0zLTEtMS02MTI4MQ_282fe6ce-b4d0-4bc0-88b9-57ddb9de824f">609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOmIwOWZlYmJkZDU5NjQ0YTZhMTEzMGYxZmVjMTQyNTk1L3RhYmxlcmFuZ2U6YjA5ZmViYmRkNTk2NDRhNmExMTMwZjFmZWMxNDI1OTVfMS01LTEtMS02MTI4MQ_c798f097-84ed-4809-af54-43aaad112031">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOmIwOWZlYmJkZDU5NjQ0YTZhMTEzMGYxZmVjMTQyNTk1L3RhYmxlcmFuZ2U6YjA5ZmViYmRkNTk2NDRhNmExMTMwZjFmZWMxNDI1OTVfMi0zLTEtMS02MTI4MQ_466a14ee-299f-47f1-9293-3c79fd1aa28c">1,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOmIwOWZlYmJkZDU5NjQ0YTZhMTEzMGYxZmVjMTQyNTk1L3RhYmxlcmFuZ2U6YjA5ZmViYmRkNTk2NDRhNmExMTMwZjFmZWMxNDI1OTVfMi01LTEtMS02MTI4MQ_2e640679-665d-496d-abeb-5aa342a7d487">503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt (b)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:LoansPayableFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOmIwOWZlYmJkZDU5NjQ0YTZhMTEzMGYxZmVjMTQyNTk1L3RhYmxlcmFuZ2U6YjA5ZmViYmRkNTk2NDRhNmExMTMwZjFmZWMxNDI1OTVfMy0zLTEtMS02MTI4MQ_ca9664ab-b226-4839-a11f-6d6ed4175089">17,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:LoansPayableFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOmIwOWZlYmJkZDU5NjQ0YTZhMTEzMGYxZmVjMTQyNTk1L3RhYmxlcmFuZ2U6YjA5ZmViYmRkNTk2NDRhNmExMTMwZjFmZWMxNDI1OTVfMy01LTEtMS02MTI4MQ_d86cb756-1481-4d25-a315-2c3e7a687cbd">18,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">These financial instruments are recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated balance sheets.  The institutional money market accounts permit daily redemption.  <ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMjY4Mw_7e4293b5-8da9-4bd5-a8a2-82b54d59cf99" continuedAt="i5f9fea1079a64091943c5b6ec186dbfb" escape="true">The fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions.</ix:nonNumeric> </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7a37f04cb5914265aae24faff5ca2243" continuedAt="i047a1502233844118d3d4756a9a70107"><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><ix:continuation id="i01e8a3d92d964203a154a498922d08a6"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="i5f9fea1079a64091943c5b6ec186dbfb" continuedAt="ib79786aeca0b431182b412d8193e4c8b">Long-term debt is recorded at amortized cost.  The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.</ix:continuation></span></ix:continuation></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib79786aeca0b431182b412d8193e4c8b">Short-term investments are held to their maturities and are carried at cost, which approximates fair value.  The short-term investments consist of instruments with maturities greater than <ix:nonNumeric contextRef="i3374a91073fd4143896356601c7a0524_D20211001-20220331" name="bdx:MaturityPeriodOfShortTermInvestment" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMTI2Mw_6db9f998-5b82-4961-a7de-4ea8d25a1017">three months</ix:nonNumeric> and less than <ix:nonNumeric contextRef="i11df0428ff4c47c59e767601738aa11a_D20211001-20220331" name="bdx:MaturityPeriodOfShortTermInvestment" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMTI4MA_292709cd-807c-4aa4-aef6-a3e45e5514d0">one year</ix:nonNumeric>.</ix:continuation>  All other instruments measured by the Company at fair value, including derivatives and contingent consideration liabilities, are immaterial to the Company's consolidated balance sheets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nonrecurring Fair Value Measurements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of fiscal year 2022, the Company recorded a noncash asset impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ifb8b77375efd4b3b80608dbb0eff1722_D20220101-20220331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMjc0ODc3OTA3MjI4Nw_e59fac69-51e5-44fc-88db-cf23b95ea9d1">54</ix:nonFraction>&#160;million to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the Medical segment.  In the first quarter of fiscal year 2021, the Company recorded charges to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $<ix:nonFraction unitRef="usd" contextRef="i1fe40a686952436da2991e9275d47220_D20201001-20201231" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMTYwNw_c8c5231c-6515-4351-8a85-9e4d4789b0fe">34</ix:nonFraction>&#160;million to write down the carrying value of certain fixed assets.  The amounts recognized were recorded to adjust the carrying amount of assets to the assets' fair values, which were estimated, based upon a market participant's perspective, using Level 3 inputs, including values estimated using the income approach.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transfers of trade receivables</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the normal course of its business activities, the Company transfers certain trade receivable assets to third parties under factoring agreements.  Per the terms of these agreements, the Company surrenders control over its trade receivables upon transfer.&#160; Accordingly, the Company accounts for the transfers as sales of trade receivables by recognizing an increase to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and a decrease to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade receivables, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when proceeds from the transactions are received.&#160; The costs incurred by the Company in connection with factoring activities were not material to its consolidated financial results.  <ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMjY3OA_2d6defd0-81df-478a-8c67-4ade6b6949e3" continuedAt="i278d6de215654f8cb5ad939df31f0d86" escape="true">The amounts transferred and yet to be remitted under factoring arrangements are provided below.</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><ix:continuation id="i278d6de215654f8cb5ad939df31f0d86" continuedAt="ic47f2912cd5f4b1abafd880effeaab21"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:39.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables transferred to third parties under factoring arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331" decimals="-6" name="bdx:TransfersOfFinancialAssetsDuringThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjQ3ODg3MzMwNGU0NDQ5MGNiMWM4NWE1ZTk1ODNhYzQ4L3RhYmxlcmFuZ2U6NDc4ODczMzA0ZTQ0NDkwY2IxYzg1YTVlOTU4M2FjNDhfMi0xLTEtMS02MTI4MQ_ef94ba13-85ad-41b6-822d-b5d70bfa0361">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331" decimals="-6" name="bdx:TransfersOfFinancialAssetsDuringThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjQ3ODg3MzMwNGU0NDQ5MGNiMWM4NWE1ZTk1ODNhYzQ4L3RhYmxlcmFuZ2U6NDc4ODczMzA0ZTQ0NDkwY2IxYzg1YTVlOTU4M2FjNDhfMi0zLTEtMS02MTI4MQ_2dcf782e-c03e-4775-aeb8-45e492114298">364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" decimals="-6" name="bdx:TransfersOfFinancialAssetsDuringThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjQ3ODg3MzMwNGU0NDQ5MGNiMWM4NWE1ZTk1ODNhYzQ4L3RhYmxlcmFuZ2U6NDc4ODczMzA0ZTQ0NDkwY2IxYzg1YTVlOTU4M2FjNDhfMi01LTEtMS02MTI4MQ_633f7aef-a911-4b19-a957-a23119d14b63">478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331" decimals="-6" name="bdx:TransfersOfFinancialAssetsDuringThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjQ3ODg3MzMwNGU0NDQ5MGNiMWM4NWE1ZTk1ODNhYzQ4L3RhYmxlcmFuZ2U6NDc4ODczMzA0ZTQ0NDkwY2IxYzg1YTVlOTU4M2FjNDhfMi03LTEtMS02MTI4MQ_6d22b050-b41d-44ca-801c-aba0bb75f4d6">856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><ix:continuation id="i047a1502233844118d3d4756a9a70107"><ix:continuation id="ic47f2912cd5f4b1abafd880effeaab21"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:56.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.810%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.628%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.813%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts yet to be collected and remitted to the third parties</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjQwMmM0MzM2M2FlNTQ4MWY5OWMwOTVkMWFmZDk3YjQxL3RhYmxlcmFuZ2U6NDAyYzQzMzYzYWU1NDgxZjk5YzA5NWQxYWZkOTdiNDFfMS0xLTEtMS02NDgwNA_e79d43b0-4940-4635-8b99-52ed442b6657">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjQwMmM0MzM2M2FlNTQ4MWY5OWMwOTVkMWFmZDk3YjQxL3RhYmxlcmFuZ2U6NDAyYzQzMzYzYWU1NDgxZjk5YzA5NWQxYWZkOTdiNDFfMS0zLTEtMS02NDgwNA_99d3ea65-9a12-4b1e-8d8b-98be5db4d7f7">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="icb36c8b3bd0b41458d5570d492469671_64"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12 &#8211; <ix:nonNumeric contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMTMwMA_936ed484-1a70-4fec-ab4f-e207309f82df" continuedAt="i9f884df05d28491bb4739f09bb2a4810" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="i9f884df05d28491bb4739f09bb2a4810" continuedAt="i18e1a9264a624e2d81d895b4b0bf5e20"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, Embecta, as a wholly-owned subsidiary of the Company, issued $<ix:nonFraction unitRef="usd" contextRef="i5845caed52ce4da4b4f7325c57203c22_I20220228" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMTA0_e26ac9a4-8c57-48ec-93da-74e2d42180e0">500</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i5845caed52ce4da4b4f7325c57203c22_I20220228" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMTEw_f0e9b55a-84bb-4809-96c8-9f0f161bf5a6">5.000</ix:nonFraction>% senior secured notes due February 15, 2030, in advance of the Company&#8217;s spin-off of Embecta, which is further discussed in Note 1.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the spin-off was effective on April 1, 2022, $<ix:nonFraction unitRef="usd" contextRef="i26418175d8c34a61b6aa277d1076d5b4_I20220401" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMjc0ODc3OTA3NDM3Ng_e6de284d-5e9b-4806-a4fe-ce1b3e56826f">200</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i26418175d8c34a61b6aa277d1076d5b4_I20220401" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMjc0ODc3OTA3NDM5MA_5555f323-0628-424c-ab85-ac5547a11143">6.750</ix:nonFraction>% senior secured notes issued by Embecta and due February 15, 2030 were exchanged for $<ix:nonFraction unitRef="usd" contextRef="i624a854f791c444da897e1e70f2d8eaa_I20220401" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMjc0ODc3OTA3NDM5OA_c0348da9-8385-46ea-abdb-a1069b9210c1">199</ix:nonFraction>&#160;million of the aggregate principal amount outstanding on the Company&#8217;s Floating Rate Notes due June 6, 2022, which were purchased through a tender offer.  The carrying value of the long-term notes tendered was $<ix:nonFraction unitRef="usd" contextRef="ibf5d860aadcd4dc18e87ac829cc865d8_I20220401" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMjc0ODc3OTA3NDQxMg_608a13df-8075-4e41-9cc2-78702f465463">199</ix:nonFraction>&#160;million, and the Company recognized a loss on this debt extinguishment of $<ix:nonFraction unitRef="usd" contextRef="if6c6a8360d284859b924495a95a1b82f_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMjc0ODc3OTA3NDQyNA_e7f9163a-d5a3-4093-9379-b5140442d94a">2</ix:nonFraction>&#160;million, which will be recorded in the third quarter of fiscal year 2022 within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on the Company&#8217;s condensed consolidated statements of income.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in connection with the spin-off, on March 31, 2022 Embecta issued a senior secured term loan facility with an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="ib929424705fe416e91cbcae5e6409cf0_I20220331" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfOTMy_8b66a1df-4617-4c20-9520-4945a35c086b">950</ix:nonFraction>&#160;million and a senior secured revolving credit facility providing borrowings of up to $<ix:nonFraction unitRef="usd" contextRef="i9481af032d5d48ff9483bc7a0054b2a8_I20220331" decimals="-6" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMTAxMg_dfa02c69-640b-4cb4-aeda-f392bcddbdaf">500</ix:nonFraction>&#160;million that was undrawn at March 31, 2022 and at the spin-off date. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The borrowings from the <ix:nonFraction unitRef="number" contextRef="i5845caed52ce4da4b4f7325c57203c22_I20220228" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMTA5OTUxMTY0MjAwNw_f0e9b55a-84bb-4809-96c8-9f0f161bf5a6">5.000</ix:nonFraction>% senior secured notes due February 15, 2030 and the senior secured term loan facility were included within the Company's condensed consolidated balance sheet at March 31, 2022.  The senior secured notes and credit agreement for the term loan and revolving credit facilities were guaranteed on an unsecured, unsubordinated basis solely by the Company prior to the spin-off date.  The Company&#8217;s guarantees automatically and unconditionally terminated upon the consummation of the spin-off on April 1, 2022.</span></div></ix:continuation><div style="margin-top:9pt"><ix:continuation id="i18e1a9264a624e2d81d895b4b0bf5e20"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2022, Embecta used a portion of the proceeds from the financing transactions discussed above to make a cash distribution of approximately $<ix:nonFraction unitRef="usd" contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMTI1MQ_2d60174b-f9e7-4d79-93e9-6739b643bf86">1.266</ix:nonFraction>&#160;billion to the Company.  On April 1, 2022, an additional $<ix:nonFraction unitRef="usd" contextRef="i8bb9f175be97441e81ee4fb5f8665671_I20220401" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMjc0ODc3OTA3OTkxMA_b6d5e01b-9e22-4bbe-8670-e3a577ec5c7e">197</ix:nonFraction>&#160;million was distributed to the Company through the exchange of the senior secured notes discussed above</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="icb36c8b3bd0b41458d5570d492469671_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following commentary should be read in conjunction with the condensed consolidated financial statements and accompanying notes presented in this report.  Within the tables presented throughout this discussion, certain columns may not add due to the use of rounded numbers for disclosure purposes.  Percentages and earnings per share amounts presented are calculated from the underlying amounts.  References to years throughout this discussion relate to our fiscal years, which end on September 30.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Becton, Dickinson and Company (&#8220;BD&#8221;) is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company's organizational structure is based upon three principal business segments, BD Medical (&#8220;Medical&#8221;), BD Life Sciences (&#8220;Life Sciences&#8221;) and BD Interventional (&#8220;Interventional&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD&#8217;s products are manufactured and sold worldwide. Our products are marketed in the United States and internationally through independent distribution channels and directly to end-users by BD and independent sales representatives. We organize our operations outside the United States as follows: EMEA (which includes Europe, the Middle East and Africa); Greater Asia (which includes countries in Greater China, Japan, South Asia, Southeast Asia, Korea, Australia and New Zealand); Latin America (which includes Mexico, Central America, the Caribbean and South America); and Canada. We continue to pursue growth opportunities in emerging markets, which include the following geographic regions: Eastern Europe, the Middle East, Africa, Latin America and certain countries within Greater Asia. We are primarily focused on certain countries whose healthcare systems are expanding. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BD&#8217;s Spin-Off of Diabetes Care</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the end of our second quarter, on April 1, 2022, BD completed the separation and distribution of Embecta, formerly BD's Diabetes Care business, into a separate, publicly-traded company.  Additional disclosures regarding our spin-off of the Diabetes Care business are provided in Note 1 in the Notes to Condensed Consolidated Financial Statements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Trends Affecting Results of Operations</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, our products are manufactured and sold worldwide, which exposes our operations, supply chain and suppliers to various global macroeconomic factors. The factors which are currently most impactful to our operating results include the following: </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inflation, which has increased the costs of raw materials, components, labor, energy, and logistical services; </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Availability of skilled labor, global energy sources, raw materials and electrical components; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Constrained logistics capacity related to the movement of goods around the globe.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shortages of certain raw materials and components, delays in global transportation and the scarcity of labor in our manufacturing facilities are contributing to product backlogs and increasing our lead times in some of our product lines. During our fiscal year 2022, significant inflationary pressures are impacting our supply chain costs in certain areas. Our raw material and freight costs have been particularly impacted and these increased costs are pressuring our operating expenses and the costs of our investments.  We are mitigating these inflationary pressures through the following:</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Driving strategic procurement initiatives to leverage alternatives sources of raw material and transportation;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Intensifying continuous improvement programs in our manufacturing and distribution facilities;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Continuing strategic rationalization programs across multiple product lines as part of our simplification strategy; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Optimizing our sales through product allocation and price initiatives.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to drive volatility in global economic conditions as governments around the world implement various measures to slow and control the ongoing spread of the virus. Resurgences in COVID-19 infections or new strains of the virus may affect the prioritization of acute and non-acute healthcare utilization, which may temporarily weaken future demand for certain of our products. The pandemic has also contributed to the inflationary pressures and supply chain disruptions discussed above and these challenges could persist if governments continue to impose lockdowns, quarantine requirements and other restrictions in order to control rates of COVID-19 infections, such as in China. Additionally, the pandemic has escalated challenges that existed for global healthcare systems prior to the pandemic, such as staffing shortages, including nursing shortages, and budget constraints. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While resurgences of COVID-19 infections have continued to occur in various countries around the world, demand for our SARS-CoV-2 diagnostics tests and injection devices used for COVID-19 vaccinations has declined from levels reached during the highest peaks in COVID-19 infections.  As discussed below, our second quarter fiscal year 2022 revenues in our Life Sciences segment reflected sales related to COVID-19-only diagnostic testing on the BD Veritor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Plus and BD Max</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Systems of $214 million, compared with revenues from such testing products in the prior-year period of $474 million.  During the second quarter of fiscal year 2022, revenues in our Life Sciences segment benefited from high demand for our new combination influenza/COVID-19 testing assays.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Geopolitical conditions may also impact our operations. Our operations in Russia and Ukraine are not material to our financial results, and as such, the conflict between Russia and Ukraine has not materially impacted our results of operations to date.  However, the continuation of the Russia-Ukraine military conflict and/or an escalation of the conflict beyond its current scope may weaken the global economy and could result in additional inflationary pressures and supply chain constraints.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the significant uncertainty that exists relative to the duration and overall impact of the macroeconomic factors discussed above, our future operating performance, particularly in the short-term, may be subject to volatility. The impacts of macroeconomic conditions on our business, results of operations, financial condition and cash flows is dependent on certain factors, including those discussed in Item&#160;1A. Risk Factors in this report and in our 2021 Annual Report on Form 10-K (the &#8220;2021 Annual Report&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Financial Results and Financial Condition</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022, worldwide revenues of $5.011 billion increased 2.1% from the prior-year period.  This increase reflected the following impacts:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.871%"><tr><td style="width:1.0%"></td><td style="width:71.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.758%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (decrease) in current-period revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volume</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period-over-period decline in revenues related to COVID-19-only testing </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pricing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in revenues from the prior-year period</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As noted above, our second quarter fiscal year 2022 revenues reflected sales related to COVID-19-only diagnostic testing on the BD Veritor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Plus and BD Max</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Systems of $214 million, compared with revenues from testing products in the prior-year period of $474 million.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Volume growth in the second quarter of fiscal year 2022 was driven by demand for our core products and reflected the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical segment revenues reflected strong demand in the Medication Delivery Solutions, Medication Management Solutions and Pharmaceutical Systems units.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Life Sciences segment revenues reflected strong demand for core products in both units.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interventional segment revenues reflected strong demand across all units, as well as a favorable comparison to the prior-year period decline in revenues which resulted from resurgences in COVID-19 infections.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our BD 2025 strategy for growth is anchored in three pillars: grow, simplify and empower.  As we execute this strategy, we continue to invest in research and development, strategic tuck-in acquisitions, geographic expansion, and new product programs to drive further revenue and profit growth. Our ability to sustain our long-term growth will depend on a number of factors, including our ability to expand our core business (including geographical expansion), develop innovative new products, and continue to improve operating efficiency and organizational effectiveness. As further discussed above, current global economic conditions have been relatively volatile due to various macroeconomic factors. We have mitigated the inflationary pressures on our businesses through the various strategies discussed above.  However, there can be no assurance that we will be able to effectively mitigate such inflationary pressures in future periods, and an inability to offset inflationary pressures, at least in part, through the strategies discussed above could adversely impact our results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from operating activities were&#160;$1.118 billion&#160;in the first six months of fiscal year 2022.  At March&#160;31, 2022, we had $3.335 billion in cash and equivalents and short-term investments, including restricted cash.  We continued to return value to our shareholders in the form of dividends.  During the first six months of fiscal year 2022, we paid cash dividends of $541 million, including $496 million paid to common shareholders and $45 million paid to preferred shareholders.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each reporting period, we face currency exposure that arises from translating the results of our worldwide operations to the U.S. dollar at exchange rates that fluctuate from the beginning of such period.  A stronger U.S. dollar, compared to the prior-year </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period, resulted in an unfavorable foreign currency translation impact to our revenues during the second quarter of fiscal year 2022.  A favorable foreign currency impact to our earnings during the second quarter of fiscal year 2022 resulted from current-period sales of inventory recorded on our consolidated balance sheet in fiscal year 2021, when the U.S. dollar was weaker.  We evaluate our results of operations on both a reported and a foreign currency-neutral basis, which excludes the impact of fluctuations in foreign currency exchange rates. As exchange rates are an important factor in understanding period-to-period comparisons, we believe the presentation of results on a foreign currency-neutral basis in addition to reported results helps improve investors&#8217; ability to understand our operating results and evaluate our performance in comparison to prior periods. Foreign currency-neutral ("FXN") information compares results between periods as if exchange rates had remained constant period-over-period. We use results on a foreign currency-neutral basis as one measure to evaluate our performance. We calculate foreign currency-neutral percentages by converting our current-period local currency financial results using the prior-period foreign currency exchange rates and comparing these adjusted amounts to our current-period results. These results should be considered in addition to, not as a substitute for, results reported in accordance with U.S. generally accepted accounting principles ("GAAP"). Results on a foreign currency-neutral basis, as we present them, may not be comparable to similarly titled measures used by other companies and are not measures of performance presented in accordance with U.S. GAAP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Segment</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes second quarter Medical revenues by organizational unit:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:36.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.481%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medical Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,311&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Medication Delivery Solutions unit&#8217;s revenue growth in the second quarter of 2022 reflected strong U.S. demand for core offerings that was driven by competitive gains for catheters and vascular care products, as well as by improved healthcare utilization in the current-year period. This revenue growth was partially offset by lower vaccination sales compared with the prior-year period. In the Medication Management Solutions unit, revenue growth reflected strong growth in global placements of dispensing systems in both acute and non-acute settings, as well as infusion pump sales and the utilization of sets in </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">international markets. The Diabetes Care unit&#8217;s revenue decline reflected the accelerated timing of U.S. orders into the first quarter of our fiscal year 2022. The Pharmaceutical Systems unit&#8217;s revenue growth in the second quarter of 2022 was driven by demand for our pre-filled devices and is enabled by capacity expansion investments.  The Pharmaceutical Systems unit&#8217;s current-period revenues also benefited from continued expansion of service offerings.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:34.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medical Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical segment income for the three and six-month periods is provided below. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.607%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical segment income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Segment income as % of Medical revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">27.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div style="margin-top:1pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical segment's income in the second quarter reflected lower gross profit margin and higher operating expenses as discussed in greater detail below:   </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Medical segment&#8217;s lower gross profit margin in the second quarter of 2022 compared with the second quarter of 2021 primarily reflected higher raw material and freight costs, as well as a noncash asset impairment charge of $54 million. These unfavorable impacts to the Medical segment&#8217;s second quarter gross margin were partially offset by lower manufacturing costs resulting from continuous improvement projects which enhanced the efficiency of our operations, as well as favorable impacts from foreign currency translation and price initiatives. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Selling and administrative expense as a percentage of revenues was higher in the second quarter of 2022 compared with the second quarter of 2021, which reflected the curtailment of certain selling, travel and other administrative activities in the prior-year period due to the COVID-19 pandemic, as well as higher shipping costs in the current-year period.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Research and development expense as a percentage of revenues was higher in the second quarter of 2022 compared with the second quarter of 2021, which reflected the timing of project spending and our continued reinvestment in the segment&#8217;s growth initiatives.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Life Sciences Segment</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes second quarter Life Sciences revenues by organizational unit:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:39.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.671%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Life Sciences Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,485&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,586&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As previously discussed above, the Integrated Diagnostic Solutions unit&#8217;s revenues related to COVID-19-only diagnostic testing on the BD Veritor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Plus and BD Max</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Systems in the second quarter of 2022 were $214 million, compared with revenues from such testing products in the prior-year period of $474 million. The Integrated Diagnostic Solutions unit&#8217;s second quarter revenues were favorably impacted by a recovery of routine lab testing to pre-pandemic levels, as well as high demand for the new combination influenza/COVID-19 testing assays which was driven by stronger adoption of our broader respiratory panel and the timing of dealer stocking.  Second quarter revenues in the Integrated Diagnostic Solutions unit were unfavorably impacted to a limited extent by supply chain challenges, as well as by pandemic-related lockdowns imposed by China.  The Biosciences unit's revenue growth in the second quarter of 2022 reflected strong demand for research reagents, which was primarily driven by a return of lab utilization to pre-pandemic levels. The Biosciences unit's sales of instruments in the second quarter of 2022 were unfavorably impacted by a backlog which resulted from constraints on supplies of electronic components.  </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"></td><td style="width:43.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.171%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.171%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.171%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.171%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.425%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Life Sciences Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,565&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Life Sciences segment income for the three and six-month periods is provided below.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:49.194%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.673%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences segment income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Segment income as % of Life Sciences revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">34.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">42.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div style="margin-top:1pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Life Sciences segment's income in the second quarter reflected lower gross profit margin and higher operating expenses as discussed in greater detail below: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Life Sciences segment&#8217;s lower gross profit margin in the second quarter of 2022 compared with the second quarter of 2021 primarily reflected the decline in COVID-19-only testing revenues compared with the prior-period, as well as higher raw material and freight costs. These unfavorable impacts were partially offset by lower manufacturing costs resulting from continuous improvement projects, product mix, and price initiatives.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Selling and administrative expense as a percentage of revenues was higher in the second quarter of 2022 compared with the second quarter of 2021, primarily due to the current-period decline in revenues.  Higher selling and administrative expense as a percentage of revenues in the current-year period also reflected the curtailment of certain selling, travel and other administrative activities in the prior-year period due to the COVID-19 pandemic.  </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Research and development expense as a percentage of revenues was higher in the second quarter of 2022 compared with the second quarter of 2021, primarily due to the current-period decline in revenues and our continued reinvestment in the segment&#8217;s growth initiatives.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interventional Segment</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes second quarter Interventional revenues by organizational unit:</span></div><div style="margin-bottom:6pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:36.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.481%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Interventional Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Second quarter 2022 revenue growth in the Surgery unit reflected double-digit growth in revenues for hernia, biosurgery and infection prevention platforms; the unit&#8217;s prior-period revenues were impacted by a decline that was driven by resurgences of COVID-19 infections.  The Surgery unit&#8217;s current-period revenues also benefited from its acquisitions of Tepha, Inc., which occurred in the fourth quarter of fiscal year 2021, and Tissuemed, Ltd., which occurred in the first quarter of fiscal year 2022.  Second quarter revenues in the Peripheral Intervention unit reflected strong demand across its end-stage kidney disease, oncology and peripheral vascular platforms, as well as a benefit from the unit&#8217;s acquisition of Venclose, Inc., which occurred in the first quarter of fiscal year 2022.  The Urology and Critical Care unit&#8217;s revenue growth in the second quarter of 2022 reflected strong demand for acute urology products and the unit's targeted temperature management platform. Second quarter revenues in the Interventional segment also reflected strong international growth across each of its organizational units.   </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:34.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Interventional Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interventional segment income for the three and six-month periods is provided below.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.607%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional segment income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Segment income as % of Interventional revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Interventional segment's income in the second quarter reflected higher gross profit margin as discussed in greater detail below:  </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Interventional segment&#8217;s higher gross profit margin in the second quarter of 2022 compared with the second quarter of 2021 primarily reflected higher revenues in the current-year period compared with the prior-year period, as well as current-period price initiatives. Gross profit margin in the prior-year period was unfavorably impacted by product quality-related expenses.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Selling and administrative expense as a percentage of revenues was higher in the second quarter of 2022 compared with the second quarter of 2021, which benefited from the curtailment of certain selling, travel and other administrative activities due to the COVID-19 pandemic in the prior year.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Research and development expense as a percentage of revenues was lower in the second quarter of 2022 compared with the second quarter of 2021, as the increase in current-period revenues outpaced the timing of project spending.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geographic Revenues</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD&#8217;s worldwide second quarter revenues by geography were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:24.054%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.258%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,011&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,907&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. revenue growth in the second quarter of 2022 was primarily driven by a recovery of routine lab testing to pre-pandemic levels and high demand for the new combination influenza/COVID-19 testing assays in the Life Sciences segment's Integrated Diagnostic Solutions unit. U.S. revenues in the second quarter of 2022 also reflected strong sales in the Medical segment&#8217;s Medication Delivery Solutions, Medication Management Solutions and Pharmaceutical Systems units, as well as by strong sales in all three of the Interventional segment&#8217;s units.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decline in international revenues in the second quarter of 2022 was primarily driven by an unfavorable comparison to the prior-year quarter, which substantially benefited from sales in the Life Sciences segment's Integrated Diagnostic Solutions unit related to COVID-19 diagnostic testing, as further discussed above. This decline in international revenues in the second quarter of 2022 was partially offset by strong sales in the Medical segment&#8217;s Medication Management Solutions and Pharmaceutical Systems units, as well as by strong sales in the Life Sciences segment&#8217;s Biosciences unit. All three of the Interventional segment&#8217;s units contributed to international revenue growth in the second quarter of 2022, particularly the Surgery and Peripheral Intervention units.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging market revenues were as follows and reflected growth in Greater Asia, including China, and Latin America:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:34.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging markets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Specified Items</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reflected in the financial results for the three and six-month periods of fiscal years 2022 and 2021 were the following specified items:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.450%"><tr><td style="width:1.0%"></td><td style="width:46.503%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.296%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.296%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.313%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.317%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration costs (a)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation and related costs (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European regulatory initiative-related costs (d)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment gains/losses and asset impairments (e)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction gain/loss, product and other litigation-related matters (f)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impacts of debt extinguishment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total specified items</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: tax impact of specified items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax impact of specified items</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Represents amounts associated with acquisition-related integration and restructuring activities which are primarily recorded in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-related integration and restructuring expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and are further discussed below.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Represents costs which were primarily recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and were incurred for consulting, legal, tax, other advisory services, as well as interest expense that was associated with the spin-off of BD's Diabetes Care business.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Includes amortization and other adjustments related to the purchase accounting for acquisitions impacting identified intangible assets and valuation of fixed assets and debt.  BD&#8217;s amortization expense is primarily recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Represents costs incurred to develop processes and systems to establish initial compliance with the European Union Medical Device Regulation and the European Union In Vitro Diagnostic Medical Device Regulation, which represent a significant, unusual change to the existing regulatory framework. We consider these costs to be duplicative of previously incurred costs and/or one-off costs, which are limited to a specific period of time. These expenses, which are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, include the cost of labor, other services and consulting (in particular, research and development and clinical trials) and supplies, travel and other miscellaneous costs.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Includes a noncash asset impairment charge recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $54 million in the Medical segment, as well as losses recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (expense) income, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relating to certain investments.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.01pt">Includes charges of $35 million and $37 million recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2022 and 2021, respectively, to adjust the estimate of future product remediation costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts in 2021 also include charges of $296 million in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to record product liability reserves, including related legal defense costs, as further discussed below. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit Margin</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit margin for the three and six-month periods of fiscal year 2022 compared with the prior-year periods in fiscal year 2021 reflected the following impacts:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"><tr><td style="width:1.0%"></td><td style="width:60.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.621%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.331%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three-month period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six-month period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021  gross profit margin % </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of purchase accounting adjustments and other specified items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period-over-period decline in COVID-19-only testing profitability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating performance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022  gross profit margin %</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impacts of other specified items on gross profit margin in the three and six-month periods of 2022 included a noncash asset impairment charge of $54 million in the Medical segment. Operating performance in the three and six-month periods of 2022 reflected our efforts to mitigate higher raw material costs through leveraging our ongoing continuous improvement projects and implementing price initiatives.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of operating expenses for the three and six-month periods of fiscal years 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.531%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease) in basis points</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease) in basis points</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration and restructuring expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Selling and administrative expense</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Higher selling and administrative expense as a percentage of revenues in the three and six-month periods of 2022 compared with the prior-year periods reflected higher shipping costs in the current-year periods, as well as the curtailment of certain selling, travel and other administrative activities in the prior-year periods due to the COVID-19 pandemic. Higher selling and administrative expense as a percentage of revenues in the six-month period of 2022 also reflected the current-period decline in revenues. Selling and administrative expense as a percentage of revenues in the three and six-month periods of 2022 was favorably impacted by foreign currency translation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Research and development expense</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense as a percentage of revenues in the three and six-month periods of 2022 was higher compared with the prior-year periods, which primarily reflected the timing of project spending. Spending in both the current and prior-year periods reflected our continued commitment to drive innovation and growth with new products and platforms. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Acquisition-related integration and restructuring expense</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition-related integration and restructuring expense in the three and six-month periods of 2022 and 2021 included restructuring costs related to simplification and other cost saving initiatives, as well as system integration costs. Costs in the three and six-month periods of 2021 also included integration costs incurred due to our acquisition of C.R. Bard, Inc. in the first quarter of fiscal year 2018.  For further disclosures regarding restructuring costs, refer to Note 8 in the Notes to Condensed Consolidated Financial Statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other operating expense, net</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating expense in the three and six-month periods of 2022 primarily included consulting, legal, tax and other advisory expenses associated with the spin-off of BD's Diabetes Care business. Other operating expense in the three and six-month periods of 2021 represents charges of $296 million to record product liability reserves, including related legal defense costs. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nonoperating Income</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Net interest expense</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components for the three and six-month periods of fiscal years 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.087%"><tr><td style="width:1.0%"></td><td style="width:40.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net interest expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(238)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lower interest expense in the current-year periods compared with the prior-year periods primarily reflected lower overall interest rates on debt outstanding as a result of prior-year refinancing activities.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax rates for the three and six-month periods of fiscal years 2022 and 2021 are provided below.  </span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.315%"><tr><td style="width:1.0%"></td><td style="width:51.007%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.674%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Impact, in basis points, from specified items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1,010)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(380)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(260)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The effective income tax rate for the three-month period of fiscal year 2022 reflected a tax impact from specified items that was less favorable compared with the benefit associated with specified items recognized in the prior-year period. The effective income tax rate for the six-month period reflected a tax impact from specified items that was more favorable compared with the benefit recognized in the prior-year period, as well as a favorable impact relating to the timing of certain discrete items.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income and Diluted Earnings per Share</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net Income and Diluted Earnings per Share for the three and six-month periods of fiscal years 2022 and 2021 were as follows:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.678%"><tr><td style="width:1.0%"></td><td style="width:51.193%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.358%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.445%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income (Millions of dollars)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings per Share</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.94&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.78&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.28&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unfavorable impact-specified items</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.04)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Favorable impact-foreign currency translation</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:1pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our condensed consolidated statements of cash flows:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.257%"><tr><td style="width:1.0%"></td><td style="width:70.255%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.459%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.461%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used for)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(990)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(863)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Flows from Operating Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from operating activities in the first six months of fiscal year 2022 reflected net income, adjusted by a change in operating assets and liabilities that was a net use of cash.  This net use of cash primarily reflected lower levels of accounts payable and accrued expenses and higher levels of inventory and prepaid expenses, partially offset by lower levels of trade receivables. Cash flows from operating activities in the current-year period additionally reflected a discretionary cash contribution of $134 million to fund our pension obligation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from operating activities in the first six months of fiscal year 2021 reflected net income, adjusted by a change in operating assets and liabilities that was a net source of cash. This net source of cash primarily reflected lower levels of trade receivables, partially offset by higher levels of inventory and prepaid expenses, as well as lower levels of accounts payable and accrued expenses.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Flows from Investing Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in capital expenditures are focused on projects that enhance our cost structure and manufacturing capabilities, as well as support our BD 2025 strategy for growth and simplification.&#160;Net outflows from investing activities in the first six months of fiscal year 2022 included capital expenditure-related outflows of $415 million, compared with $499 million in the prior-year period. Net outflows from investing activities in the first six months of fiscal year 2022 also included cash payments of $450 million relating to various strategic acquisitions we have executed as part of our growth strategy, including our acquisitions of Scanwell Health, Inc, Tissuemed, Ltd., and Venclose, Inc.  Net outflows from investing activities in the first six months of fiscal year 2021 included cash payments related to acquisitions of $179 million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Flows from Financing Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash from financing activities in the first six months of fiscal years 2022 and 2021 included the following significant cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.163%"><tr><td style="width:1.0%"></td><td style="width:62.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.981%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash inflow (outflow)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from debt issued in connection with the spin-off</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,998)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(541)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(528)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional disclosures regarding the debt issued in connection with the spin-off are provided in Note 12 in the Notes to Condensed Consolidated Financial Statements.</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain measures relating to our total debt were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.210%"><tr><td style="width:1.0%"></td><td style="width:63.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average cost of total debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt as a percentage of total capital*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt;padding-left:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Represents shareholders&#8217; equity, net non-current deferred income tax liabilities, and debt.</span></div><div style="margin-top:9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Short-Term Investments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, total worldwide cash and equivalents and short-term investments, including restricted cash, were approximately $3.335 billion. These assets were largely held in the United States. We regularly review the amount of cash and short-term investments held outside of the United States and our historical foreign earnings are used to fund foreign investments or meet foreign working capital and property, plant and equipment expenditure needs. To fund cash needs in the United States, we rely on ongoing cash flow from U.S. operations, access to capital markets and remittances from foreign subsidiaries of earnings that are not considered to be permanently reinvested. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Facilities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a five-year senior unsecured revolving credit facility in place which will expire in September 2026.  The credit facility provides borrowings of up to $2.75 billion, with separate sub-limits of $100 million for letters of credit and swingline loans.  The expiration date of the credit facility may be extended for up to two additional one year periods, subject to certain restrictions (including the consent of the lenders). The credit facility provides that we may, subject to additional commitments by lenders, request an additional $500 million of financing, for a maximum aggregate commitment under the credit facility of up to $3.25 billion. Proceeds from this facility may be used for general corporate purposes. There were no borrowings outstanding under the revolving credit facility at March&#160;31, 2022.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement for our revolving credit facility contains the following financial covenants.  We were in compliance with these covenants, as applicable, as of March&#160;31, 2022.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are required to have a leverage coverage ratio of no more than:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">4.25-to-1 as of the last day of each fiscal quarter following the closing of the credit facility; or</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">4.75-to-1 for the four full fiscal quarters following the consummation of a material acquisition. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have informal lines of credit outside the United States. We may, from time to time, access the commercial paper market as we manage working capital over the normal course of our business activities.  We had no commercial paper borrowings outstanding as of March&#160;31, 2022. Also, over the normal course of our business activities, we transfer certain trade receivable assets to third parties under factoring agreements.  Additional disclosures regarding sales of trade receivable assets are provided in Note 11 in the Notes to Condensed Consolidated Financial Statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Access to Capital and Credit Ratings</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate credit ratings with the rating agencies Standard &amp; Poor's Ratings Services, Moody's Investor Service and Fitch Ratings at March&#160;31, 2022 were unchanged compared with our ratings at September&#160;30, 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lower corporate debt ratings and downgrades of our corporate credit ratings or other credit ratings may increase our cost of borrowing.  We believe that given our debt ratings, our financial management policies, our ability to generate cash flow and the non-cyclical, geographically diversified nature of our businesses, we would have access to additional short-term and long-term capital should the need arise.  A rating reflects only the view of a rating agency and is not a recommendation to buy, sell or hold securities.  Ratings can be revised upward or downward at any time by a rating agency if such rating agency decides that circumstances warrant such a change.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continually evaluate our accounts receivables for potential credit losses, particularly those resulting from sales to government-owned or government-supported healthcare facilities in certain countries, as payment may be dependent upon the financial stability and creditworthiness of those countries&#8217; national economies. In addition to continually evaluating all governmental receivables for potential credit losses based upon historical loss experiences, we also evaluate such receivables based upon the availability of government funding and reimbursement practices. We believe the current reserves related to all </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">governmental receivables are adequate and that these receivables will not have a material adverse impact on our financial position or liquidity.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have not experienced a significant increased risk of credit losses in general as a result of the COVID-19 pandemic.  No assurances can be given that the risk of credit losses will not increase in the future given the uncertainty around the duration of the pandemic and its economic impact.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes to our critical accounting policies from those disclosed in our 2021 Annual Report.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">FDA Warning Letter</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 11, 2018, BD received a Warning Letter from the FDA with respect to our former BD Preanalytical Systems ("PAS") unit, citing certain alleged violations of quality system regulations and of law. The Warning Letter states that, until BD resolves the outstanding issues covered by the Warning Letter, the FDA will not clear or approve any premarket submissions for Class III devices to which the non-conformances are reasonably related or grant requests for certificates to foreign governments. BD has worked closely with the FDA and implemented corrective actions to address the quality management system concerns identified in the warning letter. In March 2020, the FDA conducted a subsequent inspection of PAS, which it classified as Voluntary Action Indicated, which means the FDA will not take or recommend any administrative or regulatory action as a result of the unit&#8217;s response to the observations associated with the quality management concerns in the inspection. BD continues to work with the FDA to generate additional clinical evidence and file 510(k)s as remaining commitments associated with the Warning Letter. In January 2022, BD received FDA clearance for its BD Vacutainer&#174; ACD Blood Collection Tubes used in immunohematology. The FDA review of these remaining commitments is ongoing and no assurances can be given regarding further action by the FDA as a result of these commitments, including but not limited to action pursuant to the Warning Letter.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consent Order &#8212; Covington, Georgia, USA</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2019, BD entered into a consent order with the Environmental Protection Division of the Georgia Department of Natural Resources (the &#8220;EPD&#8221;), following the filing of a complaint and motion for temporary restraining order by the EPD seeking to enjoin BD from continuing sterilization operations at its Covington, Georgia facility. Under the terms of the consent order, which has been amended two times upon mutual agreement of BD and EPD, BD voluntarily agreed to a number of operational changes at its Covington and Madison, Georgia facilities, as well as at its distribution center in Covington, designed to further reduce ethylene oxide emissions, including but not limited to operating at a reduced capacity until successful implementation of fugitive emission control technology, ongoing ambient air monitoring and operational controls at such facilities. Following submission of data relating to the implementation of these operational changes, BD was permitted to return to normal operations in December 2021 at its facilities in Georgia in accordance with the operating conditions set forth in its permit applications, including a condition to continue ambient air monitoring. However, BD&#8217;s sterilization operations in Georgia remain subject to the EPD&#8217;s final approval of BD&#8217;s permit applications and could be subject to additional restrictions.  BD has business continuity plans in place to mitigate the impact of any additional restrictions on our operations at these facilities, although it is possible that these plans will not be able to fully offset such impact, especially considering the reduced capacity of third-party sterilization service providers and the regulatory timelines associated with transferring sterilization operations for regulated products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At a broader level, several states have increased the regulatory requirements associated with the use and emission of ethylene oxide, the most frequently used sterilant for medical devices and health care products in the U.S. This increased regulation could require BD or sterilization service providers, including providers used by BD, to temporarily suspend operations to install additional fugitive emissions control technology, limit the use of ethylene oxide or take other actions, which would further reduce the available capacity of third-party providers to sterilize medical devices and health care products. A few states have filed lawsuits to require additional air quality controls and expand limitations on the use of ethylene oxide at sterilization facilities. For example, in December 2020, the State of New Mexico filed a lawsuit seeking a temporary restraining order and a preliminary and permanent injunction against a major medical device sterilizer, which sterilizes certain of our surgery products, to reduce ethylene oxide emissions associated with their sterilization process. On the federal level, in late 2019, the U.S. Environmental Protection Agency provided notice that it would be conducting rulemaking to reconsider federal regulations applicable to the use and emission of ethylene oxide. If any such proceedings or rulemaking result in the suspension of sterilization operations at BD or at medical device sterilizers used by BD, or otherwise limit the availability of third-party sterilization capacity, this could interrupt or otherwise adversely impact production of certain of our products. BD has business </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">continuity plans in place to mitigate the impact of any such disruptions, although these plans may not be able to fully offset such impact, for the reasons noted above.</span></div><div style="margin-top:6pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consent Decree with FDA</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, our BD Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pump organizational unit is operating under an amended consent decree entered into by CareFusion (the &#8220;Consent Decree&#8221;) that includes all infusion pumps manufactured by or for CareFusion 303, Inc., the organizational unit that manufactures and sells Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps in the United States.&#160; </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following an inspection that began in March 2020 of our Medication Management Systems facility (CareFusion 303, Inc.) in San Diego, California, the FDA issued to BD a Form 483 Notice (the &#8220;Form 483 Notice&#8221;) that contains a number of observations of non-conformance with quality system regulations. In addition, in December 2021, the FDA issued to CareFusion 303, Inc. a letter of non-compliance with respect to the Consent Decree (the &#8220;Non-Compliance Letter&#8221;) stating that, among other things, it had determined that certain of BD&#8217;s corrective actions with respect to the Form 483 Notice appeared to be adequate, some were still in progress such that adequacy could not be determined yet, and certain others were not adequate (e.g., complaint handling and corrective and preventive actions (CAPA), design verification and medical device reporting). Per the terms of the Non-Compliance Letter, CareFusion 303, Inc. provided the FDA with a proposed comprehensive corrective action plan and has retained an independent expert to conduct periodic audits of CareFusion 303, Inc. infusion pump facilities over the next four years. CareFusion 303, Inc. will update its corrective action plan to address any observations that may arise during the course of these audits, and these updates, as well as the audit reports, will be shared with FDA in accordance with the terms of the Non-Compliance Letter. The FDA&#8217;s review of the items raised in the Form 483 Notice and Non-Compliance Letter remains ongoing, and no assurances can be given regarding further action by the FDA as a result of the observations, including but not limited to action pursuant to the Consent Decree, or that the corrective actions proposed by CareFusion 303, Inc. will be adequate to address these observations. Additionally, we cannot currently predict the amount of additional monetary investment that will be incurred to resolve this matter or the matter&#8217;s ultimate impact on our business. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consent Decree authorizes the FDA, in the event of any violations in the future, to order us to cease manufacturing and distributing infusion pumps, recall products and take other actions. We may be required to pay damages of $15,000 per day per violation if we fail to comply with any provision of the Consent Decree, up to $15 million per year. We may also be subject to future proceedings and litigation relating to the matters addressed in the Consent Decree, including, but not limited to, additional fines, penalties, other monetary remedies, and expansion of the terms of the Consent Decree.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are undertaking certain remediation of our BD Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System, and are currently shipping the product in the United States, only in cases of medical necessity and to remediate recalled software versions. As previously disclosed, we submitted our 510(k) premarket notification to the FDA for the BD Alaris&#8482; System in April 2021. The 510(k) submission is intended to bring the regulatory clearance for the BD Alaris&#8482; System up-to-date, address open recall issues and provide other updates and features, including a new version of BD Alaris&#8482; System software that will provide clinical, operational and cybersecurity updates. We will not be able to fully resume commercial operations for the BD Alaris&#8482; System in the United States until BD&#8217;s 510(k) submission relating to the product has been cleared by the FDA. No assurances can be given as to when or if clearance will be obtained from the FDA.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of risks relating to the regulations to which we are subject, see Part I, Item 1A, of our 2021 Annual Report.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Statement Regarding Forward-Looking Statements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report includes forward-looking statements within the meaning of the federal securities laws.  BD and its representatives may also, from time to time, make certain forward-looking statements in publicly released materials, both written and oral, including statements contained in filings with the SEC, press releases, and our reports to shareholders. Forward-looking statements may be identified by the use of words such as &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;anticipate,&#8221; &#8220;estimate&#8221; and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance (including volume growth, pricing, sales and earnings per share growth, and cash flows) and statements regarding our strategy for growth, future product development, regulatory approvals, competitive position and expenditures.  All statements that address our future operating performance or events or developments that we expect or anticipate will occur in the future are forward-looking statements.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are, and will be, based on management&#8217;s then-current views and assumptions regarding future events, developments and operating performance, and speak only as of their dates.  Investors should realize that if underlying assumptions prove inaccurate, or risks or uncertainties materialize, actual results could vary materially from our expectations and projections.  Investors are therefore cautioned not to place undue reliance on any forward-looking statements.  Furthermore, we undertake no obligation to update or revise any forward-looking statements after the date they are made, whether as a result </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of new information, future events and developments or otherwise, except as required by applicable law or regulations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are some important factors that could cause our actual results to differ from our expectations in any forward-looking statements.  The Russia and Ukraine conflict may also heighten the impact of certain of these factors described below and the Risk Factors in our 2021 Annual Report.  For further discussion of certain of these factors, see Item&#160;1A. Risk Factors in this report and in our 2021 Annual Report.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Any impact of the COVID-19 pandemic, including resurgences in COVID-19 infections or new strains of the virus, may have on our business, the global economy&#8217;s recovery and the global healthcare system, which may include decreases in the demand for our products, disruptions to our operations (including employee absenteeism) or disruptions to our supply chain.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Factors such as the rate of vaccination, the effectiveness of vaccines against different strains, the rate of infections, and competitive factors that could impact the demand and pricing for our COVID-19 diagnostics testing.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of inflation and disruptions in our global supply chain including fluctuations in the cost and availability of oil-based resins and other raw materials, as well as certain components, used in the production or sterilization of our products, transportation constraints, product shortages, energy shortages or increased energy costs, labor shortages in the United States and elsewhere, increased operating and labor costs, the ability to maintain favorable supplier and service arrangements and relationships (particularly with respect to sole-source suppliers and sterilization services), and the potential adverse effects of any disruption in the availability of such items and services.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Weakness in the global economy and financial markets, which could increase the cost of operating our business, weaken demand for our products and services, negatively impact the prices we can charge for our products and services, or impair our ability to produce our products.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The risks associated with the spin-off of our former Diabetes Care business, including factors that could adversely affect our ability to realize the expected benefits of the spin-off, or the qualification of the spin-off as a tax-free transaction for U.S. federal income tax purposes.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competitive factors that could adversely affect our operations, including new product introductions and technologies (for example, new forms of drug delivery) by our current or future competitors, consolidation or strategic alliances among healthcare companies, distributors and/or payers of healthcare to improve their competitive position or develop new models for the delivery of healthcare, increased pricing pressure due to the impact of low-cost manufacturers, patents attained by competitors (particularly as patents on our products expire), new entrants into our markets and changes in the practice of medicine.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks relating to our overall level of indebtedness, including our ability to service our debt and refinance our indebtedness, which is dependent upon the capital markets and our overall financial condition at such time.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The adverse financial impact resulting from unfavorable changes in foreign currency exchange rates.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regional, national and foreign economic factors, including inflation, deflation and fluctuations in interest rates, and their potential effect on our operating performance.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to achieve our projected level or mix of product sales, as our earnings forecasts are based on projected sales volumes and pricing of many product types, some of which are more profitable than others.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in reimbursement practices of governments or third-party payers, or adverse decisions relating to our products by such payers, which could reduce demand for our products or the price we can charge for such products.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost containment efforts in the U.S. or in other countries in which we do business, such as alternative payment reform and increased use of competitive bidding and tenders, including, without limitation, any expansion of the volume-based procurement process in China or implementation of similar cost containment efforts.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in the domestic and foreign healthcare industry or in medical practices that result in a reduction in procedures using our products or increased pricing pressures, including cost reduction measures instituted by and the continued consolidation among healthcare providers.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of changes in U.S. federal laws and policies that could affect fiscal and tax policies, healthcare and international trade, including import and export regulation and international trade agreements. In particular, tariffs or other trade barriers imposed by the U.S. or other countries could adversely impact our supply chain costs or otherwise adversely impact our results of operations.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Security breaches of our information systems or our products, which could impair our ability to conduct business, result in the loss of BD trade secrets or otherwise compromise sensitive information of BD or its customers, suppliers and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other business partners, or of customers' patients, including sensitive personal data, or result in product efficacy or safety concerns for certain of our products, and result in actions by regulatory bodies or civil litigation.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Difficulties inherent in product development, including the potential inability to successfully continue technological innovation, successfully complete clinical trials, obtain and maintain regulatory approvals and registrations in the United States and abroad, obtain intellectual property protection for our products, obtain coverage and adequate reimbursement for new products, or gain and maintain market approval of products, as well as the possibility of infringement claims by competitors with respect to patents or other intellectual property rights, all of which could preclude or delay commercialization of a product. Delays in obtaining necessary approvals or clearances from the FDA or other regulatory agencies or changes in the regulatory process may also delay product launches and increase development costs.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of business combinations or divestitures, including any volatility in earnings relating to acquisition-related costs, and our ability to successfully integrate any business we may acquire.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to penetrate or expand our operations in emerging markets, which depends on local economic and political conditions, and how well we are able to make necessary infrastructure enhancements to production facilities and distribution networks.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Conditions in international markets, including social and political conditions, civil unrest, terrorist activity, governmental changes, restrictions on the ability to transfer capital across borders, tariffs and other protectionist measures, difficulties in protecting and enforcing our intellectual property rights and governmental expropriation of assets. Our international operations also increase our compliance risks, including risks under the Foreign Corrupt Practices Act and other anti-corruption laws, as well as regulatory and privacy laws.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Deficit reduction efforts or other actions that reduce the availability of government funding for healthcare and research, which could weaken demand for our products and result in additional pricing pressures, as well as create potential collection risks associated with such sales.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Fluctuations in university or U.S. and international governmental funding and policies for life sciences research.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Fluctuations in the demand for products we sell to pharmaceutical companies that are used to manufacture, or are sold with, the products of such companies, as a result of funding constraints, consolidation or otherwise.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effects of climate change, weather, regulatory or other events that adversely impact our supply chain, including our ability to manufacture our products (particularly where production of a product line or sterilization operations are concentrated in one or more plants), source materials or components or services from suppliers (including sole-source suppliers) that are needed for such manufacturing (including sterilization), or provide products to our customers, including events that impact key distributors. </span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Natural disasters, including the impacts of climate change, hurricanes, tornadoes, windstorms, fires, earthquakes and floods and other extreme weather events, global health pandemics, war, terrorism, labor disruptions and international conflicts that could cause significant economic disruption and political and social instability, resulting in decreased demand for our products, or adversely affecting our manufacturing and distribution capabilities or causing interruptions in our supply chain.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pending and potential future litigation or other proceedings asserting, and/or investigations concerning and/or subpoenas and requests seeking information with respect to, alleged violations of law (including in connection with federal and/or state healthcare programs (such as Medicare or Medicaid) and/or sales and marketing practices (such as investigative subpoenas and the civil investigative demands received by BD)), potential anti-corruption and related internal control violations under the Foreign Corrupt Practices Act, antitrust claims, securities law claims, product liability (which may involve lawsuits seeking class action status or seeking to establish multi-district litigation proceedings, including pending claims relating to our hernia repair implant products, surgical continence products for women and vena cava filter products), claims with respect to environmental matters, data privacy breaches and patent infringement, and the availability or collectability of insurance relating to any such claims.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">New or changing laws and regulations affecting our domestic and foreign operations, or changes in enforcement practices, including laws relating to trade, monetary and fiscal policies, taxation (including tax reforms that could adversely impact multinational corporations), sales practices, environmental protection, price controls, and licensing and regulatory requirements for new products and products in the post-marketing phase. In particular, the U.S. and other countries may impose new requirements regarding registration, labeling or prohibited materials that may require us to re-register products already on the market or otherwise impact our ability to market our products. Environmental laws, particularly with respect to the emission of greenhouse gases, are also becoming more stringent throughout the world, which may increase our costs of operations or necessitate changes in our manufacturing plants or processes or those of our suppliers, or result in liability to BD.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Product efficacy or safety concerns regarding our products resulting in product holds or recalls, regulatory action on the part of the FDA or foreign counterparts (including restrictions on future product clearances and civil penalties), declining sales and product liability claims, and damage to our reputation. As a result of the CareFusion acquisition, our U.S. infusion pump business is operating under a Consent Decree with the FDA. The Consent Decree authorizes the FDA, in the event of any violations in the future, to order our U.S. infusion pump business to cease manufacturing and distributing products, recall products or take other actions, and order the payment of significant monetary damages if the business subject to the decree fails to comply with any provision of the Consent Decree.  We are undertaking certain remediation of our BD Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System, and are currently shipping the product in the U.S., only in cases of medical necessity and to remediate recalled software versions. We will not be able to fully resume commercial operations for the BD Alaris System in the U.S. until BD&#8217;s 510(k) submission relating to the product has been cleared by the FDA. No assurances can be given as to when or if clearance will be obtained from the FDA.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of adverse media exposure or other publicity regarding BD&#8217;s business or operations, including the effect on BD&#8217;s reputation or demand for its products.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of market fluctuations on the value of assets in BD&#8217;s pension plans and on actuarial interest rate and asset return assumptions, which could require BD to make additional contributions to the plans or increase our pension plan expense.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to obtain the anticipated benefits of restructuring programs, if any, that we may undertake.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Issuance of new or revised accounting standards by the FASB or the SEC.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing list sets forth many, but not all, of the factors that could impact our ability to achieve results described in any forward-looking statements. Investors should understand that it is not possible to predict or identify all such factors and should not consider this list to be a complete statement of all potential risks and uncertainties.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="icb36c8b3bd0b41458d5570d492469671_70"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;3.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in information reported since the end of the fiscal year ended September&#160;30, 2021.</span></div><div id="icb36c8b3bd0b41458d5570d492469671_73"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controls and Procedures</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation was carried out by BD&#8217;s management, with the participation of BD&#8217;s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of BD&#8217;s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934) as of March&#160;31, 2022.  Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were, as of the end of the period covered by this report, effective and designed to ensure that material information relating to BD and its consolidated subsidiaries would be made known to them by others within these entities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during the fiscal quarter ended March&#160;31, 2022 identified in connection with the above-referenced evaluation that have materially affected, or are reasonably likely to materially affect, BD&#8217;s internal control over financial reporting.</span></div><div style="margin-top:3pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="icb36c8b3bd0b41458d5570d492469671_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART II - OTHER INFORMATION</span></div><div id="icb36c8b3bd0b41458d5570d492469671_79"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Proceedings</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved, both as a plaintiff and a defendant, in various legal proceedings, including product liability and environmental matters as set forth in our 2021 Annual Report, and in Note 4 of the Notes to Condensed Consolidated Financial Statements in this report, which is incorporated herein by reference.  </span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="icb36c8b3bd0b41458d5570d492469671_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;1A.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risk Factors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the risk factors previously disclosed in Part I, Item&#160;1A, of our 2021 Annual Report, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">except as follows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The military conflict between Russia and Ukraine may adversely affect our business, financial condition and results of operations. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the global nature of our business, political, economic, social and other conditions in non-U.S. countries and regions, including geopolitical risks such as the current military conflict between Russia and Ukraine, may adversely affect our business, financial condition and results of operations. The military conflict in Ukraine has increased global economic and political uncertainty. Furthermore, governments in the U.S., United Kingdom, and European Union have each imposed export controls on certain products and financial and economic sanctions on certain industry sectors and parties in Russia, and additional controls and sanctions could be enacted in the future. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are actively monitoring the situation in Russia and Ukraine and assessing its impact on our business, including our suppliers and customers. We have no manufacturing facilities or significant operations in Russia or Ukraine and as such, to date, the conflict between Russia and Ukraine has not had a material impact on our business, financial condition or results of operations. However, it is possible that the conflict in Ukraine may escalate or expand, and the scope, extent and duration of the military action, current or future sanctions and resulting market and geopolitical disruptions could be significant.  We cannot predict the impact the conflict may have on the global economy or our business, financial condition and operations in the future. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Russia and Ukraine conflict may also heighten the impact of other risks factors described in our 2021 Annual Report. These potential effects could include but are not limited to increased inflation; volatility in prices for transportation, energy, commodities and other raw materials; constraints on the availability of commodities and other raw materials; disruptions in the global supply chain; decreased demand for certain of our products; disruptions to our global technology infrastructure, including through cyberattacks, ransom attacks or cyber-intrusion; adverse changes in international trade policies and relations; increased exposure to foreign currency fluctuations; and constraints, volatility or disruptions in the credit and capital markets. </span></div><div><span><br/></span></div><div id="icb36c8b3bd0b41458d5570d492469671_85"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;2.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below sets forth certain information regarding our purchases of common stock of BD during the quarter ended March&#160;31, 2022.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Issuer Purchases of Equity Securities</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:36.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.733%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the three months ended March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total&#160;Number&#160;of<br/>Shares&#160;Purchased (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average&#160;Price<br/>Paid per<br/>Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total&#160;Number&#160;of<br/>Shares&#160;Purchased<br/>as Part of<br/>Publicly<br/>Announced&#160;Plans<br/>or Programs </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maximum&#160;Number<br/>of&#160;Shares&#160;that&#160;May<br/>Yet Be Purchased<br/>Under&#160;the&#160;Plans&#160;or<br/>Programs (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1 &#8211; 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256.38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,753,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1 &#8211; 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,753,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1 &#8211; 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,753,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,513&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.81&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,753,131&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Includes 1,513 shares purchased during the quarter in open market transactions by the trust relating to BD&#8217;s Deferred Compensation and Retirement Benefit Restoration Plan and 1996 Directors&#8217; Deferral Plan.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Includes 753,131 shares under a repurchase program authorized by the Board of Directors on September&#160;24, 2013, and 10,000,000 shares under a repurchase program authorized by the Board of Directors on November 3, 2021.  There is no expiration date for either program.  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="icb36c8b3bd0b41458d5570d492469671_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;3.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Defaults Upon Senior Securities</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="icb36c8b3bd0b41458d5570d492469671_91"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Mine Safety Disclosures</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="icb36c8b3bd0b41458d5570d492469671_94"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;5.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Information</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="icb36c8b3bd0b41458d5570d492469671_97"></div><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;6.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibits</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:6.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.741%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000119312522080554/d293484dex31.htm">3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Certificate of Designation of Series C Junior Participating Redeemable Preferred Stock (incorporated by reference to Exhibit 3.1 to the registrant&#8217;s Current Report on Form 8-K dated March 21, 2022). </span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex2203312022.htm">22</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Subsidiary Issuer of Guaranteed Securities.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex3103312022.htm">31</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certifications of Chief Executive Officer and Chief Financial Officer, pursuant to SEC Rule 13a - 14(a).</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex3203312022.htm">32</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certifications of Chief Executive Officer and Chief Financial Officer, pursuant to Rule 13a - 14(b) and Section 1350 of Chapter 63 of Title 18 of the U.S. Code.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from this report, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Income, (iii) the Condensed Consolidated Statements of Comprehensive Income, (iv) the Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="icb36c8b3bd0b41458d5570d492469671_100"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:54.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Becton,&#160;Dickinson&#160;and&#160;Company</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: May&#160;5, 2022 </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:54.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Christopher J. DelOrefice</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher J. DelOrefice</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Thomas J. Spoerel</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas J. Spoerel</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Controller and Chief Accounting Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22
<SEQUENCE>2
<FILENAME>ex2203312022.htm
<DESCRIPTION>EX-22
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i5dffdc8032724a0a84ac2aaf32d4b943_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Exhibit 22</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">Subsidiary Issuers of Guaranteed Securities</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">As of March 31, 2022, Becton, Dickinson and Company (&#8220;BD&#8221;) is the guarantor of the senior unsecured registered notes listed below issued by Becton Dickinson Euro Finance S.&#224; r.l. (&#8220;BD Finance&#8221;). BD owns, directly or indirectly, 100% of BD Finance.</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">Becton Dickinson Euro Finance S.&#224; r.l. </font></div><div style="margin-bottom:8pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">0.334% Notes due August 13, 2028</font></div><div style="margin-bottom:0.08pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.336% Notes due August 13, 2041</font></div><div style="margin-bottom:0.08pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.213% Notes due February 12, 2036</font></div><div style="margin-bottom:0.08pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.208% Notes due June 4, 2026</font></div><div style="margin-bottom:0.08pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">0.632% Notes due June 4, 2023</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>3
<FILENAME>ex3103312022.htm
<DESCRIPTION>EX-31
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3916dbf591d441b49220988e4191f1d9_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION</font></div><div style="margin-bottom:10pt;margin-top:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Thomas E. Polen, certify that&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Becton, Dickinson and Company&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;5, 2022 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.689%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Thomas E. Polen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas E. Polen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer and President</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:12pt;text-align:center;text-indent:18pt"><font><br></font></div><div style="margin-bottom:10pt;margin-top:12pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION</font></div><div style="margin-bottom:10pt;margin-top:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christopher J. DelOrefice, certify that&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Becton, Dickinson and Company&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;5, 2022 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.689%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Christopher J. DelOrefice</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher J. DelOrefice</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer </font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>ex3203312022.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ifc1bb1952303454aa29e4d4baddcfd38_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div style="margin-top:12pt;text-align:center;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Quarterly Report on Form 10-Q of Becton, Dickinson and Company for the quarter ended March&#160;31, 2022 (the &#8220;Report&#8221;) for the purpose of complying with Rule 13a &#8211; 14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section&#160;1350 of Chapter 63 of Title 18 of the United States Code.</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Thomas E. Polen, the Chief Executive Officer of Becton, Dickinson and Company, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">such Report fully complies with the requirements of Section&#160;13(a) of the Exchange Act&#59; and</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Becton, Dickinson and Company.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;5, 2022 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.689%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Thomas E. Polen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Thomas E. Polen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-indent:27pt"><font><br></font></div><div style="text-align:center;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-indent:27pt"><font><br></font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Quarterly Report on Form 10-Q of Becton, Dickinson and Company for the quarter ended March&#160;31, 2022 (the &#8220;Report&#8221;) for the purpose of complying with Rule 13a &#8211; 14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section&#160;1350 of Chapter 63 of Title 18 of the United States Code.</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christopher J. DelOrefice, the Chief Financial Officer of Becton, Dickinson and Company, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">such Report fully complies with the requirements of Section&#160;13(a) of the Exchange Act&#59; and</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Becton, Dickinson and Company.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;5, 2022 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.689%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Christopher J. DelOrefice</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Christopher J. DelOrefice</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>bdx-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e602671e-4fe1-4961-adbb-f9dd82a282de,g:36534b56-6db4-48ab-9f63-2a72d6bb30f2-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bdx="http://www.bd.com/20220331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bd.com/20220331">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.bd.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofIncome" roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofIncome">
        <link:definition>1001002 - Statement - Condensed Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome">
        <link:definition>1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.bd.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1003004 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.bd.com/role/BasisofPresentation">
        <link:definition>2101101 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.bd.com/role/ShareholdersEquity">
        <link:definition>2102102 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.bd.com/role/ShareholdersEquityTables">
        <link:definition>2303301 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails" roleURI="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails">
        <link:definition>2404401 - Disclosure - Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail" roleURI="http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail">
        <link:definition>2405402 - Disclosure - Shareholders' Equity - Accumulated Other Comprehensive Income (Loss) - Components and Changes of Accumulated Other Comprehensive Income (Loss) (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.bd.com/role/EarningsPerShare">
        <link:definition>2106103 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.bd.com/role/EarningsPerShareTables">
        <link:definition>2307302 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail" roleURI="http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail">
        <link:definition>2408403 - Disclosure - Earnings Per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings per Share (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.bd.com/role/Contingencies">
        <link:definition>2109104 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesPolicies" roleURI="http://www.bd.com/role/ContingenciesPolicies">
        <link:definition>2210201 - Disclosure - Contingencies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesDetail" roleURI="http://www.bd.com/role/ContingenciesDetail">
        <link:definition>2411404 - Disclosure - Contingencies (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenues" roleURI="http://www.bd.com/role/Revenues">
        <link:definition>2112105 - Disclosure - Revenues</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesDetails" roleURI="http://www.bd.com/role/RevenuesDetails">
        <link:definition>2413405 - Disclosure - Revenues (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesDetails_1" roleURI="http://www.bd.com/role/RevenuesDetails_1">
        <link:definition>2413405 - Disclosure - Revenues (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentData" roleURI="http://www.bd.com/role/SegmentData">
        <link:definition>2114106 - Disclosure - Segment Data</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataTables" roleURI="http://www.bd.com/role/SegmentDataTables">
        <link:definition>2315303 - Disclosure - Segment Data (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataAdditionalInformationDetail" roleURI="http://www.bd.com/role/SegmentDataAdditionalInformationDetail">
        <link:definition>2416406 - Disclosure - Segment Data - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataRevenuesbyGeographicAreasDetail" roleURI="http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail">
        <link:definition>2417407 - Disclosure - Segment Data - Revenues by Geographic Areas (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataFinancialInformationforCompanysSegmentsDetail" roleURI="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail">
        <link:definition>2418408 - Disclosure - Segment Data - Financial Information for Company's Segments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlans" roleURI="http://www.bd.com/role/BenefitPlans">
        <link:definition>2119107 - Disclosure - Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansTables" roleURI="http://www.bd.com/role/BenefitPlansTables">
        <link:definition>2320304 - Disclosure - Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansDetail" roleURI="http://www.bd.com/role/BenefitPlansDetail">
        <link:definition>2421409 - Disclosure - Benefit Plans (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessRestructuringCharges" roleURI="http://www.bd.com/role/BusinessRestructuringCharges">
        <link:definition>2122108 - Disclosure - Business Restructuring Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessRestructuringChargesTables" roleURI="http://www.bd.com/role/BusinessRestructuringChargesTables">
        <link:definition>2323305 - Disclosure - Business Restructuring Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessRestructuringChargesDetail" roleURI="http://www.bd.com/role/BusinessRestructuringChargesDetail">
        <link:definition>2424410 - Disclosure - Business Restructuring Charges (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssets" roleURI="http://www.bd.com/role/IntangibleAssets">
        <link:definition>2125109 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsTables" roleURI="http://www.bd.com/role/IntangibleAssetsTables">
        <link:definition>2326306 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsComponentsofIntangibleAssetsDetail" roleURI="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail">
        <link:definition>2427411 - Disclosure - Intangible Assets - Components of Intangible Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAdditionalInformationDetail" roleURI="http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail">
        <link:definition>2428412 - Disclosure - Intangible Assets - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail" roleURI="http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail">
        <link:definition>2429413 - Disclosure - Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivities" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities">
        <link:definition>2130110 - Disclosure - Derivative Instruments and Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesTables" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables">
        <link:definition>2331307 - Disclosure - Derivative Instruments and Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail">
        <link:definition>2432414 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail">
        <link:definition>2433415 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails">
        <link:definition>2434416 - Disclosure - Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurements" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements">
        <link:definition>2135111 - Disclosure - Financial Instruments and Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsTables" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables">
        <link:definition>2336308 - Disclosure - Financial Instruments and Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails">
        <link:definition>2437417 - Disclosure - Financial Instruments and Fair Value Measurements - Cash and Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails">
        <link:definition>2438418 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail">
        <link:definition>2439419 - Disclosure - Financial Instruments and Fair Value Measurements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails">
        <link:definition>2440420 - Disclosure - Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.bd.com/role/Debt">
        <link:definition>2141112 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDetail" roleURI="http://www.bd.com/role/DebtDetail">
        <link:definition>2442421 - Disclosure - Debt (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bdx_MedicationDeliverySolutionsMember" abstract="true" name="MedicationDeliverySolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_HerniaProductClaimsMember" abstract="true" name="HerniaProductClaimsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes0000DueAugust132023Member" abstract="true" name="Notes0000DueAugust132023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes1.208dueJune42026Member" abstract="true" name="Notes1.208dueJune42026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes5000DueFebruary152030Member" abstract="true" name="Notes5000DueFebruary152030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_CoreAndDevelopedTechnologyNet" abstract="false" name="CoreAndDevelopedTechnologyNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_IncreaseDecreaseinPensionBenefitObligation" abstract="false" name="IncreaseDecreaseinPensionBenefitObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" abstract="true" name="FiniteAndIndefiniteLivedIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bdx_BiosciencesMember" abstract="true" name="BiosciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_InterventionalMember" abstract="true" name="InterventionalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" abstract="false" name="StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_OrganizationalUnitDomain" abstract="true" name="OrganizationalUnitDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_FixedToFloatingMember" abstract="true" name="FixedToFloatingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ProductRightsMember" abstract="true" name="ProductRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" abstract="true" name="FiniteAndIndefiniteLivedIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bdx_Notes1213NotesDueFebruary122036Member" abstract="true" name="Notes1213NotesDueFebruary122036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ProductsandorServicesMember" abstract="true" name="ProductsandorServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes1.401dueMay242023Member" abstract="true" name="Notes1.401dueMay242023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_PharmaceuticalSystemsMember" abstract="true" name="PharmaceuticalSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_PeripheralInterventionMember" abstract="true" name="PeripheralInterventionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_UrologyandCriticalCareMember" abstract="true" name="UrologyandCriticalCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes1.000dueDecember152022Member" abstract="true" name="Notes1.000dueDecember152022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_FiniteLivedCustomerRelationshipsNet" abstract="false" name="FiniteLivedCustomerRelationshipsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans" abstract="false" name="ProceedsfromIssuanceofLongTermDebtandTermLoans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_SurgeryMember" abstract="true" name="SurgeryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_MedicalMember" abstract="true" name="MedicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_TransfersOfFinancialAssetsDuringThePeriod" abstract="false" name="TransfersOfFinancialAssetsDuringThePeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_CommonStockSharesHeldInEmployeeTrust1" abstract="false" name="CommonStockSharesHeldInEmployeeTrust1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_CommonStockHeldInTrustsAcquired" abstract="false" name="CommonStockHeldInTrustsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_Notes6750DueFebruary152030Member" abstract="true" name="Notes6750DueFebruary152030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_CommonStockHeldInTrustsNetShares" abstract="false" name="CommonStockHeldInTrustsNetShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_OrganizationalUnitAxis" abstract="true" name="OrganizationalUnitAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bdx_FloatingRateNotesDueJune62022Member" abstract="true" name="FloatingRateNotesDueJune62022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ForeignCurrencyDenominatedDebtMember" abstract="true" name="ForeignCurrencyDenominatedDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes0.632dueJune42023Member" abstract="true" name="Notes0.632dueJune42023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes3.020dueMay242025Member" abstract="true" name="Notes3.020dueMay242025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_DiabetesCareMember" abstract="true" name="DiabetesCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_IntegratedDiagnosticSolutionsMember" abstract="true" name="IntegratedDiagnosticSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ShareBasedCompensationMember" abstract="true" name="ShareBasedCompensationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ConsumablesMember" abstract="true" name="ConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_MaturityPeriodOfShortTermInvestment" abstract="false" name="MaturityPeriodOfShortTermInvestment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bdx_MedicationManagementSolutionsMember" abstract="true" name="MedicationManagementSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_NumberOfEtOSterilizationLawsuitsFiled" abstract="false" name="NumberOfEtOSterilizationLawsuitsFiled" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bdx_LifeSciencesMember" abstract="true" name="LifeSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_AcquisitionRelatedCostsAndRestructuringCharges" abstract="false" name="AcquisitionRelatedCostsAndRestructuringCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_Notes1.900dueDecember152026Member" abstract="true" name="Notes1.900dueDecember152026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" abstract="false" name="FairValueOfDebtClassifiedFromLongTermToShortTerm" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_Notes0034DueAugust132025Member" abstract="true" name="Notes0034DueAugust132025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ContractWithCustomerRebateLiability" abstract="false" name="ContractWithCustomerRebateLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>bdx-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e602671e-4fe1-4961-adbb-f9dd82a282de,g:36534b56-6db4-48ab-9f63-2a72d6bb30f2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="bdx-20220331.xsd#CondensedConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86e0710f-da19-4ecd-a51c-113a28343b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_31de80aa-226c-411d-8cbd-138db656df4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86e0710f-da19-4ecd-a51c-113a28343b61" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_31de80aa-226c-411d-8cbd-138db656df4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_223ba0c6-8aab-4a47-a442-ca19f654eb47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86e0710f-da19-4ecd-a51c-113a28343b61" xlink:to="loc_us-gaap_OperatingIncomeLoss_223ba0c6-8aab-4a47-a442-ca19f654eb47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_9e0c8a1b-32cb-4bf1-b0ef-781734846bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86e0710f-da19-4ecd-a51c-113a28343b61" xlink:to="loc_us-gaap_InvestmentIncomeInterest_9e0c8a1b-32cb-4bf1-b0ef-781734846bb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_960c5466-760b-4e80-b3a8-fa58457644c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86e0710f-da19-4ecd-a51c-113a28343b61" xlink:to="loc_us-gaap_InterestExpense_960c5466-760b-4e80-b3a8-fa58457644c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_53cbc783-1a30-4e49-b20e-2bad08d852c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_13afcc09-1b71-4dab-9606-9d70aab66766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_53cbc783-1a30-4e49-b20e-2bad08d852c2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_13afcc09-1b71-4dab-9606-9d70aab66766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1569cce4-5465-4ce1-8d1c-a2d07afcbd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_53cbc783-1a30-4e49-b20e-2bad08d852c2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1569cce4-5465-4ce1-8d1c-a2d07afcbd4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2d203ccd-f917-466c-962b-99322b1949b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_386e463c-398a-447e-83aa-e19267950ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2d203ccd-f917-466c-962b-99322b1949b8" xlink:to="loc_us-gaap_NetIncomeLoss_386e463c-398a-447e-83aa-e19267950ce2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_3d771f90-e2f6-4357-b28a-af406962e183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2d203ccd-f917-466c-962b-99322b1949b8" xlink:to="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_3d771f90-e2f6-4357-b28a-af406962e183" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_8d3708b9-c74b-4139-9c9c-c5b952d10bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_aeb506da-cbc7-49cb-af2e-4f4422f8c43e" xlink:href="bdx-20220331.xsd#bdx_AcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8d3708b9-c74b-4139-9c9c-c5b952d10bdc" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_aeb506da-cbc7-49cb-af2e-4f4422f8c43e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2ded92df-89d1-4476-a706-6eb4ae119299" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8d3708b9-c74b-4139-9c9c-c5b952d10bdc" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2ded92df-89d1-4476-a706-6eb4ae119299" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c9e7914c-beac-4680-b67c-3e7a51078422" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8d3708b9-c74b-4139-9c9c-c5b952d10bdc" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c9e7914c-beac-4680-b67c-3e7a51078422" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_4641d951-3533-42e8-a0bc-ded98abf127c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8d3708b9-c74b-4139-9c9c-c5b952d10bdc" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_4641d951-3533-42e8-a0bc-ded98abf127c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_f8cc6118-cb5e-4c53-9e5c-8f5781994086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8d3708b9-c74b-4139-9c9c-c5b952d10bdc" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_f8cc6118-cb5e-4c53-9e5c-8f5781994086" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e9451b08-1ee9-423b-ba1d-67e6387602bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8e34f255-36d2-43ac-9e82-ab3b76cdc7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e9451b08-1ee9-423b-ba1d-67e6387602bc" xlink:to="loc_us-gaap_Revenues_8e34f255-36d2-43ac-9e82-ab3b76cdc7a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_cd2121e1-4ed1-4561-a8d6-2fa8c289c48d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e9451b08-1ee9-423b-ba1d-67e6387602bc" xlink:to="loc_us-gaap_CostsAndExpenses_cd2121e1-4ed1-4561-a8d6-2fa8c289c48d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="bdx-20220331.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_56b7a3f7-8c2e-42da-9bec-81bda00ec66c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_8256ce8a-1f75-4f21-8868-cd3ddd0cebda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_56b7a3f7-8c2e-42da-9bec-81bda00ec66c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_8256ce8a-1f75-4f21-8868-cd3ddd0cebda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a581a79f-218d-4d3d-a07b-fe4a3ec0794e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_56b7a3f7-8c2e-42da-9bec-81bda00ec66c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a581a79f-218d-4d3d-a07b-fe4a3ec0794e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_d7484dea-504c-4e10-95b7-19e037732461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_56b7a3f7-8c2e-42da-9bec-81bda00ec66c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_d7484dea-504c-4e10-95b7-19e037732461" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1d61afd4-b030-48be-af76-fcc2f66b0669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c46a0e1e-863f-46a4-aedc-545bd9c5118e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1d61afd4-b030-48be-af76-fcc2f66b0669" xlink:to="loc_us-gaap_NetIncomeLoss_c46a0e1e-863f-46a4-aedc-545bd9c5118e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_85913b64-eb2b-4122-a835-c18817e72684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1d61afd4-b030-48be-af76-fcc2f66b0669" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_85913b64-eb2b-4122-a835-c18817e72684" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="bdx-20220331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b01069d6-e421-4b18-b765-5708e2a7d548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_af5f0e92-3317-40e5-8db1-896561bbb4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b01069d6-e421-4b18-b765-5708e2a7d548" xlink:to="loc_us-gaap_PreferredStockValue_af5f0e92-3317-40e5-8db1-896561bbb4cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_06bab6c1-35a9-4e13-b1eb-849e8951274f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b01069d6-e421-4b18-b765-5708e2a7d548" xlink:to="loc_us-gaap_CommonStockValue_06bab6c1-35a9-4e13-b1eb-849e8951274f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e457f2e4-4821-453d-aaf1-b2d087a4d55d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b01069d6-e421-4b18-b765-5708e2a7d548" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e457f2e4-4821-453d-aaf1-b2d087a4d55d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_689d519d-b4ee-4cec-b93d-3935f0880e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b01069d6-e421-4b18-b765-5708e2a7d548" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_689d519d-b4ee-4cec-b93d-3935f0880e27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockSharesHeldInEmployeeTrust1_30ff8685-8d75-4f4b-92d9-432588499cb9" xlink:href="bdx-20220331.xsd#bdx_CommonStockSharesHeldInEmployeeTrust1"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b01069d6-e421-4b18-b765-5708e2a7d548" xlink:to="loc_bdx_CommonStockSharesHeldInEmployeeTrust1_30ff8685-8d75-4f4b-92d9-432588499cb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_0bf8c1ae-8b96-4515-9e18-a2f734e3e111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b01069d6-e421-4b18-b765-5708e2a7d548" xlink:to="loc_us-gaap_TreasuryStockValue_0bf8c1ae-8b96-4515-9e18-a2f734e3e111" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4b0d1868-840a-4eb1-9829-6f45e89d3d84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b01069d6-e421-4b18-b765-5708e2a7d548" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4b0d1868-840a-4eb1-9829-6f45e89d3d84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_70ce7336-acb9-47b8-93a0-3b2d6abc770c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_891bd5e2-7ef3-4163-be2d-a381d560993b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_70ce7336-acb9-47b8-93a0-3b2d6abc770c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_891bd5e2-7ef3-4163-be2d-a381d560993b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermInvestments_6fa69576-8ab7-433a-8179-64f9063cd552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_70ce7336-acb9-47b8-93a0-3b2d6abc770c" xlink:to="loc_us-gaap_OtherShortTermInvestments_6fa69576-8ab7-433a-8179-64f9063cd552" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_77bbe63c-087a-4791-aae1-df99588faa41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_70ce7336-acb9-47b8-93a0-3b2d6abc770c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_77bbe63c-087a-4791-aae1-df99588faa41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_5c0774a2-564a-4294-8265-59623cde73e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_70ce7336-acb9-47b8-93a0-3b2d6abc770c" xlink:to="loc_us-gaap_InventoryNet_5c0774a2-564a-4294-8265-59623cde73e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_ff7049e9-e3b5-4887-8cea-a8d7bbd89982" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_70ce7336-acb9-47b8-93a0-3b2d6abc770c" xlink:to="loc_us-gaap_OtherAssetsCurrent_ff7049e9-e3b5-4887-8cea-a8d7bbd89982" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_bed12402-ec97-483b-9ac5-a9e3cf007260" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_70ce7336-acb9-47b8-93a0-3b2d6abc770c" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_bed12402-ec97-483b-9ac5-a9e3cf007260" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_18c06c14-df9e-4de7-af43-85141181991b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c60104d6-6158-43b1-b7ab-5e95e7bcc9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_18c06c14-df9e-4de7-af43-85141181991b" xlink:to="loc_us-gaap_AssetsCurrent_c60104d6-6158-43b1-b7ab-5e95e7bcc9ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_bf37ab7c-60e7-4075-b1be-0f5f0efc70c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_18c06c14-df9e-4de7-af43-85141181991b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_bf37ab7c-60e7-4075-b1be-0f5f0efc70c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_83b9b852-ed60-462b-b06a-70485beb070f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_18c06c14-df9e-4de7-af43-85141181991b" xlink:to="loc_us-gaap_Goodwill_83b9b852-ed60-462b-b06a-70485beb070f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CoreAndDevelopedTechnologyNet_77805b16-49b2-4f25-a3da-571ca91d9eae" xlink:href="bdx-20220331.xsd#bdx_CoreAndDevelopedTechnologyNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_18c06c14-df9e-4de7-af43-85141181991b" xlink:to="loc_bdx_CoreAndDevelopedTechnologyNet_77805b16-49b2-4f25-a3da-571ca91d9eae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteLivedCustomerRelationshipsNet_2eb618ea-1ca7-4c19-8194-49f9c476ddd8" xlink:href="bdx-20220331.xsd#bdx_FiniteLivedCustomerRelationshipsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_18c06c14-df9e-4de7-af43-85141181991b" xlink:to="loc_bdx_FiniteLivedCustomerRelationshipsNet_2eb618ea-1ca7-4c19-8194-49f9c476ddd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet_42c84caa-b256-4a76-ba42-e89bf729742a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_18c06c14-df9e-4de7-af43-85141181991b" xlink:to="loc_us-gaap_OtherIntangibleAssetsNet_42c84caa-b256-4a76-ba42-e89bf729742a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_eb407562-51b2-4f05-9246-bab587eceac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_18c06c14-df9e-4de7-af43-85141181991b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_eb407562-51b2-4f05-9246-bab587eceac0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_0f30afd3-7ac0-4a0e-b66d-f81dcacb3026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_a0ad4f51-78e2-4816-bfe3-7e0ce43b6f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0f30afd3-7ac0-4a0e-b66d-f81dcacb3026" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_a0ad4f51-78e2-4816-bfe3-7e0ce43b6f0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_b2e78c32-9b78-448e-9408-378b13ef4453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0f30afd3-7ac0-4a0e-b66d-f81dcacb3026" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_b2e78c32-9b78-448e-9408-378b13ef4453" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_54154c50-46d9-4056-ba23-a592472c4e83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0f30afd3-7ac0-4a0e-b66d-f81dcacb3026" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_54154c50-46d9-4056-ba23-a592472c4e83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d2d3f580-a3b0-4852-81f3-da45d530d490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_fe2d3dc1-f899-4c9a-ae17-489ac9cd34eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_d2d3f580-a3b0-4852-81f3-da45d530d490" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_fe2d3dc1-f899-4c9a-ae17-489ac9cd34eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5bd6abbc-7e16-447e-b845-728fbd37ff3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_d2d3f580-a3b0-4852-81f3-da45d530d490" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5bd6abbc-7e16-447e-b845-728fbd37ff3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_051b65e7-ed04-4f81-91b8-7d9580ef48c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f020fa0d-c416-48e7-b958-7372bf29c108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_051b65e7-ed04-4f81-91b8-7d9580ef48c5" xlink:to="loc_us-gaap_LiabilitiesCurrent_f020fa0d-c416-48e7-b958-7372bf29c108" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_25b9eaa6-9a3b-4efd-a98e-b7e2e353755e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_051b65e7-ed04-4f81-91b8-7d9580ef48c5" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_25b9eaa6-9a3b-4efd-a98e-b7e2e353755e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_3fbb66ad-fb49-4375-9fe0-f684b49661cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_051b65e7-ed04-4f81-91b8-7d9580ef48c5" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_3fbb66ad-fb49-4375-9fe0-f684b49661cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_aa077ef2-e0ad-4c79-a591-a93cbb9b54e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_051b65e7-ed04-4f81-91b8-7d9580ef48c5" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_aa077ef2-e0ad-4c79-a591-a93cbb9b54e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_3db2585e-759d-4586-b8f0-db1a0baf8343" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_051b65e7-ed04-4f81-91b8-7d9580ef48c5" xlink:to="loc_us-gaap_CommitmentsAndContingencies_3db2585e-759d-4586-b8f0-db1a0baf8343" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cdfa9800-59d3-4116-9fd5-824cfb7d8d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_051b65e7-ed04-4f81-91b8-7d9580ef48c5" xlink:to="loc_us-gaap_StockholdersEquity_cdfa9800-59d3-4116-9fd5-824cfb7d8d3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_aa0092b0-68fb-42fe-ad5b-f0027bbca26f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_b9edef8e-bec5-471c-bc47-f8698d9dce45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_aa0092b0-68fb-42fe-ad5b-f0027bbca26f" xlink:to="loc_us-gaap_DebtCurrent_b9edef8e-bec5-471c-bc47-f8698d9dce45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e8c208be-b440-42a0-9d3f-0c6c5e3fed13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_aa0092b0-68fb-42fe-ad5b-f0027bbca26f" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e8c208be-b440-42a0-9d3f-0c6c5e3fed13" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="bdx-20220331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5201cf63-6097-4a89-a16b-8e8e69b716a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_da3da2ff-46b8-49f2-bcc0-cb3c15a55420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5201cf63-6097-4a89-a16b-8e8e69b716a3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_da3da2ff-46b8-49f2-bcc0-cb3c15a55420" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d31002e9-702b-4706-a0ec-02f8a1ba3ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5201cf63-6097-4a89-a16b-8e8e69b716a3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d31002e9-702b-4706-a0ec-02f8a1ba3ff9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1739fcf9-64ae-4687-86c5-197e8617be8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5201cf63-6097-4a89-a16b-8e8e69b716a3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1739fcf9-64ae-4687-86c5-197e8617be8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3ec483d7-2467-4727-93dc-764dcb9a913a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5201cf63-6097-4a89-a16b-8e8e69b716a3" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3ec483d7-2467-4727-93dc-764dcb9a913a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b77b6ce0-015a-4e61-9792-8d153d1983f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_60a8e2ac-d9dc-44bf-9d80-e5d36d8a1b47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b77b6ce0-015a-4e61-9792-8d153d1983f0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_60a8e2ac-d9dc-44bf-9d80-e5d36d8a1b47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c2e7d77f-da80-4505-b8b2-d1c4ffb28750" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b77b6ce0-015a-4e61-9792-8d153d1983f0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c2e7d77f-da80-4505-b8b2-d1c4ffb28750" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_74d024ff-0dae-4ae6-ac11-eab195e514c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b77b6ce0-015a-4e61-9792-8d153d1983f0" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_74d024ff-0dae-4ae6-ac11-eab195e514c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_244ba1fc-c419-401a-8fb0-1468ef46bfdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_73bd6499-d378-4747-a482-16d81af907a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_244ba1fc-c419-401a-8fb0-1468ef46bfdb" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_73bd6499-d378-4747-a482-16d81af907a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IncreaseDecreaseinPensionBenefitObligation_bbfd36e6-c2f9-4135-98ed-1fb41955d8e7" xlink:href="bdx-20220331.xsd#bdx_IncreaseDecreaseinPensionBenefitObligation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_244ba1fc-c419-401a-8fb0-1468ef46bfdb" xlink:to="loc_bdx_IncreaseDecreaseinPensionBenefitObligation_bbfd36e6-c2f9-4135-98ed-1fb41955d8e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_40606a98-0334-4e2c-b9c8-7323d7d10a19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_244ba1fc-c419-401a-8fb0-1468ef46bfdb" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_40606a98-0334-4e2c-b9c8-7323d7d10a19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_b81f1b59-924b-4629-a518-b00a05fb5883" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_244ba1fc-c419-401a-8fb0-1468ef46bfdb" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_b81f1b59-924b-4629-a518-b00a05fb5883" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b54824e7-5b31-49a7-9f3a-0b0c23b4f30a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_244ba1fc-c419-401a-8fb0-1468ef46bfdb" xlink:to="loc_us-gaap_ShareBasedCompensation_b54824e7-5b31-49a7-9f3a-0b0c23b4f30a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_dcd192a7-aa4c-4a57-9ad0-d4d95e153ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_244ba1fc-c419-401a-8fb0-1468ef46bfdb" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapital_dcd192a7-aa4c-4a57-9ad0-d4d95e153ee1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_fc883b3a-423a-4523-8b9d-e8c95f03fd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_244ba1fc-c419-401a-8fb0-1468ef46bfdb" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_fc883b3a-423a-4523-8b9d-e8c95f03fd9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4d0faf9b-490f-414b-a0c4-7591d9e9e634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_244ba1fc-c419-401a-8fb0-1468ef46bfdb" xlink:to="loc_us-gaap_NetIncomeLoss_4d0faf9b-490f-414b-a0c4-7591d9e9e634" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6b7625b6-86ee-49c5-8a7d-79ace6af791f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans_b4dc3367-5fee-4d51-8b09-fe7147b1f5f3" xlink:href="bdx-20220331.xsd#bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6b7625b6-86ee-49c5-8a7d-79ace6af791f" xlink:to="loc_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans_b4dc3367-5fee-4d51-8b09-fe7147b1f5f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_60e0a3d2-e6db-455c-9601-04e83a4276cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6b7625b6-86ee-49c5-8a7d-79ace6af791f" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_60e0a3d2-e6db-455c-9601-04e83a4276cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_0c310e98-830e-4201-8a70-9aae1352fd05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6b7625b6-86ee-49c5-8a7d-79ace6af791f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_0c310e98-830e-4201-8a70-9aae1352fd05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_a9f90814-9bb6-49ea-ae19-d5423d99e2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6b7625b6-86ee-49c5-8a7d-79ace6af791f" xlink:to="loc_us-gaap_PaymentsOfDividends_a9f90814-9bb6-49ea-ae19-d5423d99e2f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_48757d52-753f-40f2-9af8-4057ed0bfbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6b7625b6-86ee-49c5-8a7d-79ace6af791f" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_48757d52-753f-40f2-9af8-4057ed0bfbb4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_61f2244c-6027-4e96-a402-dfe97942a5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_e98a520a-ef1a-489d-b6f2-718e88603c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_61f2244c-6027-4e96-a402-dfe97942a5f6" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_e98a520a-ef1a-489d-b6f2-718e88603c0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_5ddf4a15-63de-4cf4-8636-fc06bc5280b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_61f2244c-6027-4e96-a402-dfe97942a5f6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_5ddf4a15-63de-4cf4-8636-fc06bc5280b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2ed605c5-1b1b-4e9a-a176-89893f51f9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_61f2244c-6027-4e96-a402-dfe97942a5f6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2ed605c5-1b1b-4e9a-a176-89893f51f9c1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#SegmentDataFinancialInformationforCompanysSegmentsDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_023283ef-4e07-402c-b505-815394bcfbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_18a319af-1467-4378-a78c-df8b14c84e32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_023283ef-4e07-402c-b505-815394bcfbc5" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_18a319af-1467-4378-a78c-df8b14c84e32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a8832c45-e288-4d1f-a9d2-324896652b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_023283ef-4e07-402c-b505-815394bcfbc5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a8832c45-e288-4d1f-a9d2-324896652b59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_23ea26bc-0857-4c31-8414-cee970f7c0fb" xlink:href="bdx-20220331.xsd#bdx_AcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_023283ef-4e07-402c-b505-815394bcfbc5" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_23ea26bc-0857-4c31-8414-cee970f7c0fb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#BenefitPlansDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/BenefitPlansDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2ab1f14e-3f24-4c79-87fe-ad577dd73b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_0ed2cb02-43d2-442a-a903-85103e4cc4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2ab1f14e-3f24-4c79-87fe-ad577dd73b2e" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_0ed2cb02-43d2-442a-a903-85103e4cc4ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_10a35a97-821a-454b-92b9-80af5230d800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2ab1f14e-3f24-4c79-87fe-ad577dd73b2e" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_10a35a97-821a-454b-92b9-80af5230d800" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_064641a8-563c-4692-99d6-8ff63a78d13e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2ab1f14e-3f24-4c79-87fe-ad577dd73b2e" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_064641a8-563c-4692-99d6-8ff63a78d13e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_3d9563fc-ce49-4606-a448-870b7ad1b9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2ab1f14e-3f24-4c79-87fe-ad577dd73b2e" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_3d9563fc-ce49-4606-a448-870b7ad1b9ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_1c7d3c13-1eea-4cf0-87b8-1d5bb4a3f6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2ab1f14e-3f24-4c79-87fe-ad577dd73b2e" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_1c7d3c13-1eea-4cf0-87b8-1d5bb4a3f6cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_49982693-25db-4cf6-8886-be0a3cce5790" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2ab1f14e-3f24-4c79-87fe-ad577dd73b2e" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_49982693-25db-4cf6-8886-be0a3cce5790" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#IntangibleAssetsComponentsofIntangibleAssetsDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b91bac63-3b6d-4912-886e-173ee6d51d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3d94c20b-7b1b-4b73-95c9-0fe545b4e567" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b91bac63-3b6d-4912-886e-173ee6d51d1d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3d94c20b-7b1b-4b73-95c9-0fe545b4e567" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3bc569c2-6f0b-4ef9-b848-d92c3be08409" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b91bac63-3b6d-4912-886e-173ee6d51d1d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3bc569c2-6f0b-4ef9-b848-d92c3be08409" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="bdx-20220331.xsd#FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dd4bf878-fa5b-4409-9801-8abcc2ef4e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e6e23ca9-0172-4340-8872-848e7f193839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dd4bf878-fa5b-4409-9801-8abcc2ef4e8b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e6e23ca9-0172-4340-8872-848e7f193839" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_6240879c-a70f-4fc1-8f43-69849aca60c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dd4bf878-fa5b-4409-9801-8abcc2ef4e8b" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_6240879c-a70f-4fc1-8f43-69849aca60c7" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>bdx-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e602671e-4fe1-4961-adbb-f9dd82a282de,g:36534b56-6db4-48ab-9f63-2a72d6bb30f2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bd.com/role/CoverPage" xlink:type="simple" xlink:href="bdx-20220331.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/CoverPage" xlink:type="extended" id="i42ab115ea74741288c4240351b94bd23_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_a0472a9e-7eab-43d1-ae71-0202749cdaf2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_DocumentType_a0472a9e-7eab-43d1-ae71-0202749cdaf2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_bdb26964-3a6f-4b96-8199-d56c457c1100" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_DocumentQuarterlyReport_bdb26964-3a6f-4b96-8199-d56c457c1100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a675835a-b85c-48d1-8cae-21af71c67717" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_DocumentPeriodEndDate_a675835a-b85c-48d1-8cae-21af71c67717" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_82debf04-31e8-4017-b304-1e10e1b1e652" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_DocumentTransitionReport_82debf04-31e8-4017-b304-1e10e1b1e652" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_281a150f-11b2-403b-befc-62c64882bd6d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityFileNumber_281a150f-11b2-403b-befc-62c64882bd6d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_4516ff59-61b0-4c88-bf46-df805d31f1c8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityRegistrantName_4516ff59-61b0-4c88-bf46-df805d31f1c8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_fa9ebadc-7ca0-47e2-a1aa-796acbb455b7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityCentralIndexKey_fa9ebadc-7ca0-47e2-a1aa-796acbb455b7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_23f2aac6-17ec-49db-8d38-d474bfa3f6e5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_CurrentFiscalYearEndDate_23f2aac6-17ec-49db-8d38-d474bfa3f6e5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_5805a9da-3ea6-41cb-80a5-508f0d0a6d53" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_DocumentFiscalYearFocus_5805a9da-3ea6-41cb-80a5-508f0d0a6d53" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_b0381a86-eb47-42f2-b1db-16de766a5e5e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_DocumentFiscalPeriodFocus_b0381a86-eb47-42f2-b1db-16de766a5e5e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f3c71fe1-cfcc-4a0b-b121-9b279aab9085" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_AmendmentFlag_f3c71fe1-cfcc-4a0b-b121-9b279aab9085" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_92ff34ae-aabc-41c9-8562-87845a2bf976" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityIncorporationStateCountryCode_92ff34ae-aabc-41c9-8562-87845a2bf976" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_057bdee7-9b4a-4d0e-b36c-5c8ae62fadee" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityTaxIdentificationNumber_057bdee7-9b4a-4d0e-b36c-5c8ae62fadee" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_69ce6a50-99d4-4d61-a6c8-b5c35baf4e21" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityAddressAddressLine1_69ce6a50-99d4-4d61-a6c8-b5c35baf4e21" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_26ff16d8-db2d-4b23-9ab4-757df289cc09" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityAddressCityOrTown_26ff16d8-db2d-4b23-9ab4-757df289cc09" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ff56ec5e-413a-41a0-8f02-f5705a7ab415" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityAddressStateOrProvince_ff56ec5e-413a-41a0-8f02-f5705a7ab415" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2c98dd3d-6fc7-4837-8726-8d42b2519fc6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityAddressPostalZipCode_2c98dd3d-6fc7-4837-8726-8d42b2519fc6" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_bd910b89-e9de-4977-943e-23060f3940c2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_CityAreaCode_bd910b89-e9de-4977-943e-23060f3940c2" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3fc1fbeb-8708-4d7e-b8b5-de786bdd8a5e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_LocalPhoneNumber_3fc1fbeb-8708-4d7e-b8b5-de786bdd8a5e" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_96699d0e-505d-40d8-b95b-e6b4a086210d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_Security12bTitle_96699d0e-505d-40d8-b95b-e6b4a086210d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_2024590f-6a64-4b0f-89cd-f1be2b502bec" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_TradingSymbol_2024590f-6a64-4b0f-89cd-f1be2b502bec" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_ac5e64d3-f271-4a93-adc4-3c3a2a3a4bf3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_SecurityExchangeName_ac5e64d3-f271-4a93-adc4-3c3a2a3a4bf3" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_606ccf37-2392-4878-9b83-4e8083acdab0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityCurrentReportingStatus_606ccf37-2392-4878-9b83-4e8083acdab0" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_117fd114-c692-4528-97dc-e8a6241da76f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityInteractiveDataCurrent_117fd114-c692-4528-97dc-e8a6241da76f" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_26aaadb4-e1f0-4d82-8e12-1af35c0985a3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityFilerCategory_26aaadb4-e1f0-4d82-8e12-1af35c0985a3" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_33c0ed7e-048e-4d73-9958-85c2059b6125" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntitySmallBusiness_33c0ed7e-048e-4d73-9958-85c2059b6125" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_32e355ec-b7db-45e4-89cd-1f64ee8a3482" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityEmergingGrowthCompany_32e355ec-b7db-45e4-89cd-1f64ee8a3482" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_4021c280-3284-4b3f-ab48-d80b76215920" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityShellCompany_4021c280-3284-4b3f-ab48-d80b76215920" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_bc974c9e-75fd-4691-87d2-ab5b2c8d75d5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_bc974c9e-75fd-4691-87d2-ab5b2c8d75d5" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_da9238b3-424e-4f28-8d77-10e0ec133b41" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntitiesTable_da9238b3-424e-4f28-8d77-10e0ec133b41" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_6d8bfc37-3961-4bbb-99ed-f3bf74d0a1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_da9238b3-424e-4f28-8d77-10e0ec133b41" xlink:to="loc_us-gaap_StatementClassOfStockAxis_6d8bfc37-3961-4bbb-99ed-f3bf74d0a1c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6d8bfc37-3961-4bbb-99ed-f3bf74d0a1c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6d8bfc37-3961-4bbb-99ed-f3bf74d0a1c7" xlink:to="loc_us-gaap_ClassOfStockDomain_6d8bfc37-3961-4bbb-99ed-f3bf74d0a1c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6d8bfc37-3961-4bbb-99ed-f3bf74d0a1c7" xlink:to="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b275911f-a45f-4218-b57c-87e79857be80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_us-gaap_CommonStockMember_b275911f-a45f-4218-b57c-87e79857be80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_6889d36c-35d7-419b-817e-d391c61c6932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_6889d36c-35d7-419b-817e-d391c61c6932" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.000dueDecember152022Member_634bb3e5-ec50-4868-8b6c-20a9204c64cb" xlink:href="bdx-20220331.xsd#bdx_Notes1.000dueDecember152022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_bdx_Notes1.000dueDecember152022Member_634bb3e5-ec50-4868-8b6c-20a9204c64cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.900dueDecember152026Member_137c1538-ecb8-4190-adbb-851b08991fb5" xlink:href="bdx-20220331.xsd#bdx_Notes1.900dueDecember152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_bdx_Notes1.900dueDecember152026Member_137c1538-ecb8-4190-adbb-851b08991fb5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.401dueMay242023Member_67459fa4-d973-4b49-8861-1f6636a4ebab" xlink:href="bdx-20220331.xsd#bdx_Notes1.401dueMay242023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_bdx_Notes1.401dueMay242023Member_67459fa4-d973-4b49-8861-1f6636a4ebab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.020dueMay242025Member_9e79818c-e453-4566-88e3-9fbc0f8896fc" xlink:href="bdx-20220331.xsd#bdx_Notes3.020dueMay242025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_bdx_Notes3.020dueMay242025Member_9e79818c-e453-4566-88e3-9fbc0f8896fc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0.632dueJune42023Member_dfd0d856-e03a-4b7c-b547-35058e5edef7" xlink:href="bdx-20220331.xsd#bdx_Notes0.632dueJune42023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_bdx_Notes0.632dueJune42023Member_dfd0d856-e03a-4b7c-b547-35058e5edef7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.208dueJune42026Member_73653311-f4b1-4f5b-bc5c-9b36d1ffd1e7" xlink:href="bdx-20220331.xsd#bdx_Notes1.208dueJune42026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_bdx_Notes1.208dueJune42026Member_73653311-f4b1-4f5b-bc5c-9b36d1ffd1e7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1213NotesDueFebruary122036Member_923d3886-60c0-45c0-bcb6-d6328d37495e" xlink:href="bdx-20220331.xsd#bdx_Notes1213NotesDueFebruary122036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_bdx_Notes1213NotesDueFebruary122036Member_923d3886-60c0-45c0-bcb6-d6328d37495e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0000DueAugust132023Member_d1561611-bcf6-465e-8160-9b7cd742489e" xlink:href="bdx-20220331.xsd#bdx_Notes0000DueAugust132023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_bdx_Notes0000DueAugust132023Member_d1561611-bcf6-465e-8160-9b7cd742489e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0034DueAugust132025Member_5314ab4e-eb4c-4d1e-8083-bb8d66059431" xlink:href="bdx-20220331.xsd#bdx_Notes0034DueAugust132025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_bdx_Notes0034DueAugust132025Member_5314ab4e-eb4c-4d1e-8083-bb8d66059431" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_75c73b2b-dc31-4b26-a57e-3317dd22e6e7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_da9238b3-424e-4f28-8d77-10e0ec133b41" xlink:to="loc_dei_EntityListingsExchangeAxis_75c73b2b-dc31-4b26-a57e-3317dd22e6e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_75c73b2b-dc31-4b26-a57e-3317dd22e6e7_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_75c73b2b-dc31-4b26-a57e-3317dd22e6e7" xlink:to="loc_dei_ExchangeDomain_75c73b2b-dc31-4b26-a57e-3317dd22e6e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_09c6c824-e6fe-4cfb-a5d0-7f63cacaefcf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_75c73b2b-dc31-4b26-a57e-3317dd22e6e7" xlink:to="loc_dei_ExchangeDomain_09c6c824-e6fe-4cfb-a5d0-7f63cacaefcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_546cfe34-8924-4a2a-984c-82107f7974c1" xlink:href="https://xbrl.sec.gov/exch/2021/exch-2021.xsd#exch_XNYS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_09c6c824-e6fe-4cfb-a5d0-7f63cacaefcf" xlink:to="loc_exch_XNYS_546cfe34-8924-4a2a-984c-82107f7974c1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails" xlink:type="simple" xlink:href="bdx-20220331.xsd#ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails" xlink:type="extended" id="ied786723a3c540e9ad61b99dcd3f58f4_ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_25036b42-7261-44ed-adcf-52d8a4b3b912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_StockholdersEquity_25036b42-7261-44ed-adcf-52d8a4b3b912" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_ef7cf3b0-d8be-4fa6-82a0-f11d2dc027bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_TreasuryStockShares_ef7cf3b0-d8be-4fa6-82a0-f11d2dc027bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_101f802c-3edb-47d6-92c2-cae1121519e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_NetIncomeLoss_101f802c-3edb-47d6-92c2-cae1121519e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_5bffd5cb-698e-4264-859e-85f731d6b28f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_DividendsCommonStockCash_5bffd5cb-698e-4264-859e-85f731d6b28f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStock_1307fcc7-7333-46ab-a979-b78c49c0a55f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_DividendsPreferredStock_1307fcc7-7333-46ab-a979-b78c49c0a55f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9071d523-9ce1-49e7-8c6c-a0d4232acbfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9071d523-9ce1-49e7-8c6c-a0d4232acbfb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1d0c0947-46b6-4631-81d9-7109bde8b3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1d0c0947-46b6-4631-81d9-7109bde8b3a7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4d7f0a30-694a-4407-b4da-cf6402067df2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4d7f0a30-694a-4407-b4da-cf6402067df2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockHeldInTrustsNetShares_b821ea05-65a4-45bb-8980-aaa8bf717e8e" xlink:href="bdx-20220331.xsd#bdx_CommonStockHeldInTrustsNetShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_bdx_CommonStockHeldInTrustsNetShares_b821ea05-65a4-45bb-8980-aaa8bf717e8e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_eb644247-83d1-4b31-bd73-9d66050ad23f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_eb644247-83d1-4b31-bd73-9d66050ad23f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_74f20c55-a40e-449b-8aeb-cc9662da5912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_74f20c55-a40e-449b-8aeb-cc9662da5912" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockHeldInTrustsAcquired_f04ca510-cad1-4cea-9e10-6d590fd1e91e" xlink:href="bdx-20220331.xsd#bdx_CommonStockHeldInTrustsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_bdx_CommonStockHeldInTrustsAcquired_f04ca510-cad1-4cea-9e10-6d590fd1e91e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_4e77300a-b203-47c2-95fc-617cbe0055e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_StockholdersEquityOther_4e77300a-b203-47c2-95fc-617cbe0055e7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_961ac131-0e73-4b62-8be9-1e653c8592c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_fb0a1078-d448-47fe-80fc-081b5c926824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_16549682-30e1-4737-bf4e-214818420991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_16549682-30e1-4737-bf4e-214818420991" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_3bc413a7-66d1-42ce-a539-3da613f51123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_3bc413a7-66d1-42ce-a539-3da613f51123" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_94bc220b-c420-4866-acc0-467e4dcdbf4e" xlink:href="bdx-20220331.xsd#bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_94bc220b-c420-4866-acc0-467e4dcdbf4e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ba1c9316-35b5-49aa-a388-194c0723b5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_StatementTable_ba1c9316-35b5-49aa-a388-194c0723b5d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d93e791e-06dd-4ce3-b3c8-df10d85587cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ba1c9316-35b5-49aa-a388-194c0723b5d6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d93e791e-06dd-4ce3-b3c8-df10d85587cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d93e791e-06dd-4ce3-b3c8-df10d85587cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d93e791e-06dd-4ce3-b3c8-df10d85587cf" xlink:to="loc_us-gaap_EquityComponentDomain_d93e791e-06dd-4ce3-b3c8-df10d85587cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8df3ffaa-3988-4d24-ba4f-46cc4713261a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d93e791e-06dd-4ce3-b3c8-df10d85587cf" xlink:to="loc_us-gaap_EquityComponentDomain_8df3ffaa-3988-4d24-ba4f-46cc4713261a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_20d2b6c3-fc40-4acf-bb05-a1518df78fde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8df3ffaa-3988-4d24-ba4f-46cc4713261a" xlink:to="loc_us-gaap_CommonStockMember_20d2b6c3-fc40-4acf-bb05-a1518df78fde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8c6f1ab1-b31a-4366-ab5f-89167ac01b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8df3ffaa-3988-4d24-ba4f-46cc4713261a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8c6f1ab1-b31a-4366-ab5f-89167ac01b0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_351fa519-00d6-4d63-bd35-2a0bdfc2d99b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8df3ffaa-3988-4d24-ba4f-46cc4713261a" xlink:to="loc_us-gaap_RetainedEarningsMember_351fa519-00d6-4d63-bd35-2a0bdfc2d99b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_e9e7d2e7-123c-4cbc-b631-a782e7d8583e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8df3ffaa-3988-4d24-ba4f-46cc4713261a" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_e9e7d2e7-123c-4cbc-b631-a782e7d8583e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_c097ce70-f41f-4a24-9cba-96ee448469a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8df3ffaa-3988-4d24-ba4f-46cc4713261a" xlink:to="loc_us-gaap_TreasuryStockMember_c097ce70-f41f-4a24-9cba-96ee448469a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_33b4fa04-58f8-4ff8-b438-75aeb8f11869" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ba1c9316-35b5-49aa-a388-194c0723b5d6" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_33b4fa04-58f8-4ff8-b438-75aeb8f11869" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_33b4fa04-58f8-4ff8-b438-75aeb8f11869_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_33b4fa04-58f8-4ff8-b438-75aeb8f11869" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_33b4fa04-58f8-4ff8-b438-75aeb8f11869_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f556558a-3849-41f2-9b90-bc5bb2606a0f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_33b4fa04-58f8-4ff8-b438-75aeb8f11869" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f556558a-3849-41f2-9b90-bc5bb2606a0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9ffb8c30-fa23-44c4-8b98-32edf3538079" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f556558a-3849-41f2-9b90-bc5bb2606a0f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9ffb8c30-fa23-44c4-8b98-32edf3538079" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail" xlink:type="extended" id="ieb0ff50aa969438a81957ef1e15dbe97_ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b1525734-3e09-4af9-9629-7ed6ba40ff83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_62d1bdb9-3fe9-4fa1-8eb9-eaaba0e36b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b1525734-3e09-4af9-9629-7ed6ba40ff83" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_62d1bdb9-3fe9-4fa1-8eb9-eaaba0e36b8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_588c9e7d-b48d-4937-aa6d-62bd8532333d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_62d1bdb9-3fe9-4fa1-8eb9-eaaba0e36b8f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_588c9e7d-b48d-4937-aa6d-62bd8532333d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_96bb6cbe-ee6c-400f-8658-2e6b30c156a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_62d1bdb9-3fe9-4fa1-8eb9-eaaba0e36b8f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_96bb6cbe-ee6c-400f-8658-2e6b30c156a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5199d3cf-4b6b-4543-95b7-59887f96fe01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_62d1bdb9-3fe9-4fa1-8eb9-eaaba0e36b8f" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5199d3cf-4b6b-4543-95b7-59887f96fe01" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5a5da863-33e6-4a90-90fc-50140a4227a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c1369bdf-b379-4ace-bfd6-678c456a3e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b1525734-3e09-4af9-9629-7ed6ba40ff83" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c1369bdf-b379-4ace-bfd6-678c456a3e4a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6564227c-804d-4aeb-8304-fc7eda9c1be1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c1369bdf-b379-4ace-bfd6-678c456a3e4a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6564227c-804d-4aeb-8304-fc7eda9c1be1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6564227c-804d-4aeb-8304-fc7eda9c1be1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6564227c-804d-4aeb-8304-fc7eda9c1be1" xlink:to="loc_us-gaap_EquityComponentDomain_6564227c-804d-4aeb-8304-fc7eda9c1be1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ef1ccad1-12a8-4b82-9322-9b28df22705e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6564227c-804d-4aeb-8304-fc7eda9c1be1" xlink:to="loc_us-gaap_EquityComponentDomain_ef1ccad1-12a8-4b82-9322-9b28df22705e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_78ef6dce-d3af-4dfc-8be6-e94efcefa684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ef1ccad1-12a8-4b82-9322-9b28df22705e" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_78ef6dce-d3af-4dfc-8be6-e94efcefa684" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b73399fd-f987-4b37-b7e6-c6276c0706db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ef1ccad1-12a8-4b82-9322-9b28df22705e" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b73399fd-f987-4b37-b7e6-c6276c0706db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_3a016595-6c85-471e-8552-cbc317d3489b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ef1ccad1-12a8-4b82-9322-9b28df22705e" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_3a016595-6c85-471e-8552-cbc317d3489b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail" xlink:type="extended" id="i8796efb8dcf84e38b5c1de34b5cde084_EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_61416361-3c46-4055-8d99-9a43651c022a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b2e41f3a-b2df-4d7b-8df2-6fc80460ff35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_61416361-3c46-4055-8d99-9a43651c022a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b2e41f3a-b2df-4d7b-8df2-6fc80460ff35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1ab386b3-e04f-4fba-ba43-0426f28818bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_61416361-3c46-4055-8d99-9a43651c022a" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1ab386b3-e04f-4fba-ba43-0426f28818bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_318f20c4-8ecd-431b-ad28-f2a37613ddef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1ab386b3-e04f-4fba-ba43-0426f28818bb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_318f20c4-8ecd-431b-ad28-f2a37613ddef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_318f20c4-8ecd-431b-ad28-f2a37613ddef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_318f20c4-8ecd-431b-ad28-f2a37613ddef" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_318f20c4-8ecd-431b-ad28-f2a37613ddef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5e01231e-baec-4590-9195-ae848de0f689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_318f20c4-8ecd-431b-ad28-f2a37613ddef" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5e01231e-baec-4590-9195-ae848de0f689" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_0fb03cab-6e07-4e9d-a8a7-b89a03ae70e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5e01231e-baec-4590-9195-ae848de0f689" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_0fb03cab-6e07-4e9d-a8a7-b89a03ae70e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationMember_6f9ac244-372b-48f2-b9b6-acba03b2fa06" xlink:href="bdx-20220331.xsd#bdx_ShareBasedCompensationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5e01231e-baec-4590-9195-ae848de0f689" xlink:to="loc_bdx_ShareBasedCompensationMember_6f9ac244-372b-48f2-b9b6-acba03b2fa06" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/ContingenciesDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#ContingenciesDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/ContingenciesDetail" xlink:type="extended" id="i33652305f13d438fa0ca704b9abdf78e_ContingenciesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_3cd6224d-a13d-4f8c-a703-dbd4646c109b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_f2c7b33b-fc28-42e8-90d4-8cca18ceeb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3cd6224d-a13d-4f8c-a703-dbd4646c109b" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_f2c7b33b-fc28-42e8-90d4-8cca18ceeb1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_416ace7d-4406-4424-b3ed-b27568f0ec01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3cd6224d-a13d-4f8c-a703-dbd4646c109b" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_416ace7d-4406-4424-b3ed-b27568f0ec01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfEtOSterilizationLawsuitsFiled_63ffa991-9d49-4edc-9f54-d1adab7e8c95" xlink:href="bdx-20220331.xsd#bdx_NumberOfEtOSterilizationLawsuitsFiled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3cd6224d-a13d-4f8c-a703-dbd4646c109b" xlink:to="loc_bdx_NumberOfEtOSterilizationLawsuitsFiled_63ffa991-9d49-4edc-9f54-d1adab7e8c95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2fa73811-52e0-440b-89e7-cdd953b3a2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3cd6224d-a13d-4f8c-a703-dbd4646c109b" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2fa73811-52e0-440b-89e7-cdd953b3a2cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d8cc84cf-cd8b-4ccc-821b-427e857f9914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_3cd6224d-a13d-4f8c-a703-dbd4646c109b" xlink:to="loc_us-gaap_LossContingenciesTable_d8cc84cf-cd8b-4ccc-821b-427e857f9914" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_eb066c1f-2ded-4511-8e68-d7205ee924ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d8cc84cf-cd8b-4ccc-821b-427e857f9914" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_eb066c1f-2ded-4511-8e68-d7205ee924ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_eb066c1f-2ded-4511-8e68-d7205ee924ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_eb066c1f-2ded-4511-8e68-d7205ee924ae" xlink:to="loc_us-gaap_LossContingencyNatureDomain_eb066c1f-2ded-4511-8e68-d7205ee924ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_f9cc44d7-4e83-4d7f-b805-dd940f280690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_eb066c1f-2ded-4511-8e68-d7205ee924ae" xlink:to="loc_us-gaap_LossContingencyNatureDomain_f9cc44d7-4e83-4d7f-b805-dd940f280690" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_HerniaProductClaimsMember_fe3ea724-0f78-4179-99a8-87bef845a8fd" xlink:href="bdx-20220331.xsd#bdx_HerniaProductClaimsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_f9cc44d7-4e83-4d7f-b805-dd940f280690" xlink:to="loc_bdx_HerniaProductClaimsMember_fe3ea724-0f78-4179-99a8-87bef845a8fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_34b00d4c-2c02-4286-b20e-bb75cd2f46e1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d8cc84cf-cd8b-4ccc-821b-427e857f9914" xlink:to="loc_srt_StatementGeographicalAxis_34b00d4c-2c02-4286-b20e-bb75cd2f46e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_34b00d4c-2c02-4286-b20e-bb75cd2f46e1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_34b00d4c-2c02-4286-b20e-bb75cd2f46e1" xlink:to="loc_srt_SegmentGeographicalDomain_34b00d4c-2c02-4286-b20e-bb75cd2f46e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0bcb3737-9773-4b0b-aa60-67bc4133f4a5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_34b00d4c-2c02-4286-b20e-bb75cd2f46e1" xlink:to="loc_srt_SegmentGeographicalDomain_0bcb3737-9773-4b0b-aa60-67bc4133f4a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_GA_58556198-87f0-4c2d-8edb-386003eb53b6" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_GA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0bcb3737-9773-4b0b-aa60-67bc4133f4a5" xlink:to="loc_stpr_GA_58556198-87f0-4c2d-8edb-386003eb53b6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/RevenuesDetails" xlink:type="simple" xlink:href="bdx-20220331.xsd#RevenuesDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/RevenuesDetails" xlink:type="extended" id="i25cfac9eaecb41f9946136fb322def8a_RevenuesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_2691400e-210b-40e3-b557-ef9dab99bf44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ContractWithCustomerRebateLiability_4129529e-ea13-4c5e-bbce-f83e0f1e633b" xlink:href="bdx-20220331.xsd#bdx_ContractWithCustomerRebateLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2691400e-210b-40e3-b557-ef9dab99bf44" xlink:to="loc_bdx_ContractWithCustomerRebateLiability_4129529e-ea13-4c5e-bbce-f83e0f1e633b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_39d68793-3e6a-405a-bd78-cfb261e7d6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2691400e-210b-40e3-b557-ef9dab99bf44" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_39d68793-3e6a-405a-bd78-cfb261e7d6d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_c8c39446-4554-46de-88cb-3891e821c012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2691400e-210b-40e3-b557-ef9dab99bf44" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_c8c39446-4554-46de-88cb-3891e821c012" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b02f4990-d3e4-4cae-8c14-0583482cc6ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2691400e-210b-40e3-b557-ef9dab99bf44" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b02f4990-d3e4-4cae-8c14-0583482cc6ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_f1aedba6-e08d-48d3-b125-2332230b5f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b02f4990-d3e4-4cae-8c14-0583482cc6ee" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_f1aedba6-e08d-48d3-b125-2332230b5f0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_93052dce-2423-469b-8a8a-127660e77423" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b02f4990-d3e4-4cae-8c14-0583482cc6ee" xlink:to="loc_srt_ProductOrServiceAxis_93052dce-2423-469b-8a8a-127660e77423" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_93052dce-2423-469b-8a8a-127660e77423_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_93052dce-2423-469b-8a8a-127660e77423" xlink:to="loc_srt_ProductsAndServicesDomain_93052dce-2423-469b-8a8a-127660e77423_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5ce1f828-43b0-4fd2-8e64-9815a9c1067b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_93052dce-2423-469b-8a8a-127660e77423" xlink:to="loc_srt_ProductsAndServicesDomain_5ce1f828-43b0-4fd2-8e64-9815a9c1067b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProductsandorServicesMember_e60c8b17-7025-4203-af7a-bd69a632c8b9" xlink:href="bdx-20220331.xsd#bdx_ProductsandorServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5ce1f828-43b0-4fd2-8e64-9815a9c1067b" xlink:to="loc_bdx_ProductsandorServicesMember_e60c8b17-7025-4203-af7a-bd69a632c8b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ConsumablesMember_28cbec08-0a6d-434d-abaa-2a45dff1f05b" xlink:href="bdx-20220331.xsd#bdx_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5ce1f828-43b0-4fd2-8e64-9815a9c1067b" xlink:to="loc_bdx_ConsumablesMember_28cbec08-0a6d-434d-abaa-2a45dff1f05b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/RevenuesDetails_1" xlink:type="simple" xlink:href="bdx-20220331.xsd#RevenuesDetails_1"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/RevenuesDetails_1" xlink:type="extended" id="i662f830227a9420e82924e1c5c799e4f_RevenuesDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_2691400e-210b-40e3-b557-ef9dab99bf44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ContractWithCustomerRebateLiability_4129529e-ea13-4c5e-bbce-f83e0f1e633b" xlink:href="bdx-20220331.xsd#bdx_ContractWithCustomerRebateLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2691400e-210b-40e3-b557-ef9dab99bf44" xlink:to="loc_bdx_ContractWithCustomerRebateLiability_4129529e-ea13-4c5e-bbce-f83e0f1e633b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_39d68793-3e6a-405a-bd78-cfb261e7d6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2691400e-210b-40e3-b557-ef9dab99bf44" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_39d68793-3e6a-405a-bd78-cfb261e7d6d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_c8c39446-4554-46de-88cb-3891e821c012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2691400e-210b-40e3-b557-ef9dab99bf44" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_c8c39446-4554-46de-88cb-3891e821c012" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b02f4990-d3e4-4cae-8c14-0583482cc6ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2691400e-210b-40e3-b557-ef9dab99bf44" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b02f4990-d3e4-4cae-8c14-0583482cc6ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_93052dce-2423-469b-8a8a-127660e77423" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b02f4990-d3e4-4cae-8c14-0583482cc6ee" xlink:to="loc_srt_ProductOrServiceAxis_93052dce-2423-469b-8a8a-127660e77423" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_93052dce-2423-469b-8a8a-127660e77423_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_93052dce-2423-469b-8a8a-127660e77423" xlink:to="loc_srt_ProductsAndServicesDomain_93052dce-2423-469b-8a8a-127660e77423_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5ce1f828-43b0-4fd2-8e64-9815a9c1067b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_93052dce-2423-469b-8a8a-127660e77423" xlink:to="loc_srt_ProductsAndServicesDomain_5ce1f828-43b0-4fd2-8e64-9815a9c1067b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProductsandorServicesMember_e60c8b17-7025-4203-af7a-bd69a632c8b9" xlink:href="bdx-20220331.xsd#bdx_ProductsandorServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5ce1f828-43b0-4fd2-8e64-9815a9c1067b" xlink:to="loc_bdx_ProductsandorServicesMember_e60c8b17-7025-4203-af7a-bd69a632c8b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ConsumablesMember_28cbec08-0a6d-434d-abaa-2a45dff1f05b" xlink:href="bdx-20220331.xsd#bdx_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5ce1f828-43b0-4fd2-8e64-9815a9c1067b" xlink:to="loc_bdx_ConsumablesMember_28cbec08-0a6d-434d-abaa-2a45dff1f05b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#SegmentDataRevenuesbyGeographicAreasDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail" xlink:type="extended" id="iac9508c68b7a49a4a8bcdce1b72b48b6_SegmentDataRevenuesbyGeographicAreasDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c3915842-6546-4d46-867f-cf69de1b4146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_be839a17-a7ea-4cbb-b7ac-bd201996fba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c3915842-6546-4d46-867f-cf69de1b4146" xlink:to="loc_us-gaap_Revenues_be839a17-a7ea-4cbb-b7ac-bd201996fba9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f3b77d04-07a1-4f5e-a8a6-683fa2f118ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c3915842-6546-4d46-867f-cf69de1b4146" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f3b77d04-07a1-4f5e-a8a6-683fa2f118ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitAxis_bbf9e778-76e4-422d-812f-5035256f9783" xlink:href="bdx-20220331.xsd#bdx_OrganizationalUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f3b77d04-07a1-4f5e-a8a6-683fa2f118ce" xlink:to="loc_bdx_OrganizationalUnitAxis_bbf9e778-76e4-422d-812f-5035256f9783" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitDomain_bbf9e778-76e4-422d-812f-5035256f9783_default" xlink:href="bdx-20220331.xsd#bdx_OrganizationalUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bdx_OrganizationalUnitAxis_bbf9e778-76e4-422d-812f-5035256f9783" xlink:to="loc_bdx_OrganizationalUnitDomain_bbf9e778-76e4-422d-812f-5035256f9783_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:href="bdx-20220331.xsd#bdx_OrganizationalUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bdx_OrganizationalUnitAxis_bbf9e778-76e4-422d-812f-5035256f9783" xlink:to="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicationDeliverySolutionsMember_b7da86ae-8b9e-4780-aa18-9b311767f78f" xlink:href="bdx-20220331.xsd#bdx_MedicationDeliverySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:to="loc_bdx_MedicationDeliverySolutionsMember_b7da86ae-8b9e-4780-aa18-9b311767f78f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicationManagementSolutionsMember_6469966e-8433-4b21-9e8c-5cca082f606e" xlink:href="bdx-20220331.xsd#bdx_MedicationManagementSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:to="loc_bdx_MedicationManagementSolutionsMember_6469966e-8433-4b21-9e8c-5cca082f606e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DiabetesCareMember_68c33e9d-3863-4ef8-bb9c-8f018d28291f" xlink:href="bdx-20220331.xsd#bdx_DiabetesCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:to="loc_bdx_DiabetesCareMember_68c33e9d-3863-4ef8-bb9c-8f018d28291f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PharmaceuticalSystemsMember_b352650e-c176-4fc7-a4f8-1f45f0deb4d8" xlink:href="bdx-20220331.xsd#bdx_PharmaceuticalSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:to="loc_bdx_PharmaceuticalSystemsMember_b352650e-c176-4fc7-a4f8-1f45f0deb4d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IntegratedDiagnosticSolutionsMember_8f873472-2980-48a9-ac0c-0496912dc131" xlink:href="bdx-20220331.xsd#bdx_IntegratedDiagnosticSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:to="loc_bdx_IntegratedDiagnosticSolutionsMember_8f873472-2980-48a9-ac0c-0496912dc131" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_BiosciencesMember_5a64dd40-607f-4250-a085-391ba8415be8" xlink:href="bdx-20220331.xsd#bdx_BiosciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:to="loc_bdx_BiosciencesMember_5a64dd40-607f-4250-a085-391ba8415be8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SurgeryMember_b9ee849d-ab93-4147-b205-2fa6c03eb527" xlink:href="bdx-20220331.xsd#bdx_SurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:to="loc_bdx_SurgeryMember_b9ee849d-ab93-4147-b205-2fa6c03eb527" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PeripheralInterventionMember_363caf69-49d7-4ba5-9fc9-c913ac0cbcba" xlink:href="bdx-20220331.xsd#bdx_PeripheralInterventionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:to="loc_bdx_PeripheralInterventionMember_363caf69-49d7-4ba5-9fc9-c913ac0cbcba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_UrologyandCriticalCareMember_6540aaaa-d799-414e-a4e0-7268e46a0ca3" xlink:href="bdx-20220331.xsd#bdx_UrologyandCriticalCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:to="loc_bdx_UrologyandCriticalCareMember_6540aaaa-d799-414e-a4e0-7268e46a0ca3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a6b03d67-f3d4-440f-9a26-1bddae523363" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f3b77d04-07a1-4f5e-a8a6-683fa2f118ce" xlink:to="loc_srt_StatementGeographicalAxis_a6b03d67-f3d4-440f-9a26-1bddae523363" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a6b03d67-f3d4-440f-9a26-1bddae523363_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_a6b03d67-f3d4-440f-9a26-1bddae523363" xlink:to="loc_srt_SegmentGeographicalDomain_a6b03d67-f3d4-440f-9a26-1bddae523363_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c7bde105-1833-4dcf-b74f-8fc08cbf1eb5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_a6b03d67-f3d4-440f-9a26-1bddae523363" xlink:to="loc_srt_SegmentGeographicalDomain_c7bde105-1833-4dcf-b74f-8fc08cbf1eb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_c02d4c05-de3a-4498-b680-f8f316d1fa3e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c7bde105-1833-4dcf-b74f-8fc08cbf1eb5" xlink:to="loc_country_US_c02d4c05-de3a-4498-b680-f8f316d1fa3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_28bffcf4-bd24-4e95-87a8-50d3e98b6cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c7bde105-1833-4dcf-b74f-8fc08cbf1eb5" xlink:to="loc_us-gaap_NonUsMember_28bffcf4-bd24-4e95-87a8-50d3e98b6cc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_686c23bb-dd31-43c3-9283-51cd43869546" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f3b77d04-07a1-4f5e-a8a6-683fa2f118ce" xlink:to="loc_srt_ConsolidationItemsAxis_686c23bb-dd31-43c3-9283-51cd43869546" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_686c23bb-dd31-43c3-9283-51cd43869546_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_686c23bb-dd31-43c3-9283-51cd43869546" xlink:to="loc_srt_ConsolidationItemsDomain_686c23bb-dd31-43c3-9283-51cd43869546_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b664aa67-f0d8-4a79-9aac-191cfdf6fdc8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_686c23bb-dd31-43c3-9283-51cd43869546" xlink:to="loc_srt_ConsolidationItemsDomain_b664aa67-f0d8-4a79-9aac-191cfdf6fdc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_ee61105c-2fde-4342-a39c-9224384c9700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b664aa67-f0d8-4a79-9aac-191cfdf6fdc8" xlink:to="loc_us-gaap_OperatingSegmentsMember_ee61105c-2fde-4342-a39c-9224384c9700" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1035c73a-1ab0-4526-aaea-9d780d4eb7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f3b77d04-07a1-4f5e-a8a6-683fa2f118ce" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1035c73a-1ab0-4526-aaea-9d780d4eb7e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1035c73a-1ab0-4526-aaea-9d780d4eb7e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1035c73a-1ab0-4526-aaea-9d780d4eb7e2" xlink:to="loc_us-gaap_SegmentDomain_1035c73a-1ab0-4526-aaea-9d780d4eb7e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5ae36e6a-003f-4c07-910b-2c912f247a46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1035c73a-1ab0-4526-aaea-9d780d4eb7e2" xlink:to="loc_us-gaap_SegmentDomain_5ae36e6a-003f-4c07-910b-2c912f247a46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_18242d9e-7092-4882-b2a4-f4f0d13ef963" xlink:href="bdx-20220331.xsd#bdx_MedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5ae36e6a-003f-4c07-910b-2c912f247a46" xlink:to="loc_bdx_MedicalMember_18242d9e-7092-4882-b2a4-f4f0d13ef963" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_e2254663-6b51-45b1-8019-11b9630acb07" xlink:href="bdx-20220331.xsd#bdx_LifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5ae36e6a-003f-4c07-910b-2c912f247a46" xlink:to="loc_bdx_LifeSciencesMember_e2254663-6b51-45b1-8019-11b9630acb07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember_0afa86c7-2863-4cc6-8afe-944345115e32" xlink:href="bdx-20220331.xsd#bdx_InterventionalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5ae36e6a-003f-4c07-910b-2c912f247a46" xlink:to="loc_bdx_InterventionalMember_0afa86c7-2863-4cc6-8afe-944345115e32" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#SegmentDataFinancialInformationforCompanysSegmentsDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail" xlink:type="extended" id="i25c2db0f7bf54898801cb28d07f16e23_SegmentDataFinancialInformationforCompanysSegmentsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e31e301b-3136-422f-8b37-e466a99f513f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_9003cb74-1658-4110-bd56-b0478a4a8501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e31e301b-3136-422f-8b37-e466a99f513f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_9003cb74-1658-4110-bd56-b0478a4a8501" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_6c0c08e4-00aa-4653-b401-1fff4864dc58" xlink:href="bdx-20220331.xsd#bdx_AcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e31e301b-3136-422f-8b37-e466a99f513f" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_6c0c08e4-00aa-4653-b401-1fff4864dc58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_a347187f-9de6-41e5-9416-363efce225fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e31e301b-3136-422f-8b37-e466a99f513f" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_a347187f-9de6-41e5-9416-363efce225fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_909958ea-c477-46f3-949b-93328472d52b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e31e301b-3136-422f-8b37-e466a99f513f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_909958ea-c477-46f3-949b-93328472d52b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_ec5d8918-6401-464d-8181-38114d81d620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e31e301b-3136-422f-8b37-e466a99f513f" xlink:to="loc_us-gaap_AssetImpairmentCharges_ec5d8918-6401-464d-8181-38114d81d620" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_340c6318-af28-4fc4-8e2d-5536ddf3910a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e31e301b-3136-422f-8b37-e466a99f513f" xlink:to="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_340c6318-af28-4fc4-8e2d-5536ddf3910a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c5ccb352-7dbc-4c43-910f-eceed1f07c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e31e301b-3136-422f-8b37-e466a99f513f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c5ccb352-7dbc-4c43-910f-eceed1f07c3f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5d48ae32-eadf-4917-8925-0b189f73470e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c5ccb352-7dbc-4c43-910f-eceed1f07c3f" xlink:to="loc_srt_ConsolidationItemsAxis_5d48ae32-eadf-4917-8925-0b189f73470e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5d48ae32-eadf-4917-8925-0b189f73470e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_5d48ae32-eadf-4917-8925-0b189f73470e" xlink:to="loc_srt_ConsolidationItemsDomain_5d48ae32-eadf-4917-8925-0b189f73470e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_263193e5-67e5-478b-9d62-0c44d5134dab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_5d48ae32-eadf-4917-8925-0b189f73470e" xlink:to="loc_srt_ConsolidationItemsDomain_263193e5-67e5-478b-9d62-0c44d5134dab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_5f1f22d4-990b-4df7-81f4-12f4f1fd9c25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_263193e5-67e5-478b-9d62-0c44d5134dab" xlink:to="loc_us-gaap_OperatingSegmentsMember_5f1f22d4-990b-4df7-81f4-12f4f1fd9c25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_5e12c99c-0a27-4898-9f4f-70ffa1603aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_263193e5-67e5-478b-9d62-0c44d5134dab" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_5e12c99c-0a27-4898-9f4f-70ffa1603aa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_bbf08cd5-f5bf-4f30-8f57-59f8a9a9b236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_263193e5-67e5-478b-9d62-0c44d5134dab" xlink:to="loc_us-gaap_CorporateNonSegmentMember_bbf08cd5-f5bf-4f30-8f57-59f8a9a9b236" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_72cc564c-76ff-41fe-986c-7cd123b19968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c5ccb352-7dbc-4c43-910f-eceed1f07c3f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_72cc564c-76ff-41fe-986c-7cd123b19968" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_72cc564c-76ff-41fe-986c-7cd123b19968_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_72cc564c-76ff-41fe-986c-7cd123b19968" xlink:to="loc_us-gaap_SegmentDomain_72cc564c-76ff-41fe-986c-7cd123b19968_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fa8ac460-e17a-4e55-b314-dcb11b51d2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_72cc564c-76ff-41fe-986c-7cd123b19968" xlink:to="loc_us-gaap_SegmentDomain_fa8ac460-e17a-4e55-b314-dcb11b51d2ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_f9920b81-90d6-4417-b9eb-e5cfb12dcdc1" xlink:href="bdx-20220331.xsd#bdx_MedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fa8ac460-e17a-4e55-b314-dcb11b51d2ee" xlink:to="loc_bdx_MedicalMember_f9920b81-90d6-4417-b9eb-e5cfb12dcdc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_1b765065-f07f-4145-bd63-fb9ab4d33f9b" xlink:href="bdx-20220331.xsd#bdx_LifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fa8ac460-e17a-4e55-b314-dcb11b51d2ee" xlink:to="loc_bdx_LifeSciencesMember_1b765065-f07f-4145-bd63-fb9ab4d33f9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember_0509f9c5-71bb-4974-aac0-ad33520423f0" xlink:href="bdx-20220331.xsd#bdx_InterventionalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fa8ac460-e17a-4e55-b314-dcb11b51d2ee" xlink:to="loc_bdx_InterventionalMember_0509f9c5-71bb-4974-aac0-ad33520423f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4644bc27-3bdf-4427-b7e4-714e35f2b3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c5ccb352-7dbc-4c43-910f-eceed1f07c3f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4644bc27-3bdf-4427-b7e4-714e35f2b3e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4644bc27-3bdf-4427-b7e4-714e35f2b3e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4644bc27-3bdf-4427-b7e4-714e35f2b3e5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4644bc27-3bdf-4427-b7e4-714e35f2b3e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fd8577ec-f14b-41df-bd2d-790f0303618c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4644bc27-3bdf-4427-b7e4-714e35f2b3e5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fd8577ec-f14b-41df-bd2d-790f0303618c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_25a8dc69-86a1-402b-9c2a-e6db088ca1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fd8577ec-f14b-41df-bd2d-790f0303618c" xlink:to="loc_us-gaap_CostOfSalesMember_25a8dc69-86a1-402b-9c2a-e6db088ca1bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_4199c025-06e8-4cad-a947-410ff755a19c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fd8577ec-f14b-41df-bd2d-790f0303618c" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_4199c025-06e8-4cad-a947-410ff755a19c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#BenefitPlansDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/BenefitPlansDetail" xlink:type="extended" id="i60cad69cd5314bd2a336db7eda032636_BenefitPlansDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2117afe0-5da9-4945-a823-98a77ada9ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_edf03e00-71d3-4aa8-83e2-1c6509d48110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2117afe0-5da9-4945-a823-98a77ada9ab0" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_edf03e00-71d3-4aa8-83e2-1c6509d48110" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_8f9ecb53-5121-4a74-b91e-91bd95006a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2117afe0-5da9-4945-a823-98a77ada9ab0" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_8f9ecb53-5121-4a74-b91e-91bd95006a41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_a07740e3-4802-4708-8879-de4d49b1a787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2117afe0-5da9-4945-a823-98a77ada9ab0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_a07740e3-4802-4708-8879-de4d49b1a787" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_b1e50dc6-b33b-4750-8c47-c8ac88a3df09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2117afe0-5da9-4945-a823-98a77ada9ab0" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_b1e50dc6-b33b-4750-8c47-c8ac88a3df09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_44e61377-5a79-4099-ae2a-3be21a0d0536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2117afe0-5da9-4945-a823-98a77ada9ab0" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_44e61377-5a79-4099-ae2a-3be21a0d0536" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_edee12dc-473b-446b-b113-fb20b63dfad1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2117afe0-5da9-4945-a823-98a77ada9ab0" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_edee12dc-473b-446b-b113-fb20b63dfad1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_4668dda5-35b1-4941-bad1-5bc469ab84d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2117afe0-5da9-4945-a823-98a77ada9ab0" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_4668dda5-35b1-4941-bad1-5bc469ab84d8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a2316ea0-f271-4ad9-914d-fdfb6fe3a6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2117afe0-5da9-4945-a823-98a77ada9ab0" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a2316ea0-f271-4ad9-914d-fdfb6fe3a6b7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_a2839de1-13ac-42d1-b795-daaf7e3fc6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a2316ea0-f271-4ad9-914d-fdfb6fe3a6b7" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_a2839de1-13ac-42d1-b795-daaf7e3fc6ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a2839de1-13ac-42d1-b795-daaf7e3fc6ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a2839de1-13ac-42d1-b795-daaf7e3fc6ae" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a2839de1-13ac-42d1-b795-daaf7e3fc6ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_4525a1ce-ef30-4df6-b00a-9947e392cecd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a2839de1-13ac-42d1-b795-daaf7e3fc6ae" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_4525a1ce-ef30-4df6-b00a-9947e392cecd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_034dd193-2a59-489a-9ccf-d1d3ec4d9434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_4525a1ce-ef30-4df6-b00a-9947e392cecd" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_034dd193-2a59-489a-9ccf-d1d3ec4d9434" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/BusinessRestructuringChargesDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#BusinessRestructuringChargesDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/BusinessRestructuringChargesDetail" xlink:type="extended" id="if36f6ab66d3c49ecb965d50fd1a0f1ba_BusinessRestructuringChargesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_3dce52e3-6365-447c-8f91-314d21444f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_396ae9b4-958f-4f87-bfa2-5aae20712210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_3dce52e3-6365-447c-8f91-314d21444f23" xlink:to="loc_us-gaap_RestructuringReserveRollForward_396ae9b4-958f-4f87-bfa2-5aae20712210" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_3f02661c-f0ff-43ac-b458-dc80e49b5503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_396ae9b4-958f-4f87-bfa2-5aae20712210" xlink:to="loc_us-gaap_RestructuringReserve_3f02661c-f0ff-43ac-b458-dc80e49b5503" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_2406155d-70b6-429a-bc66-1f7fe49ed4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_396ae9b4-958f-4f87-bfa2-5aae20712210" xlink:to="loc_us-gaap_RestructuringCharges_2406155d-70b6-429a-bc66-1f7fe49ed4a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_9228ea8c-9455-49a0-87d1-a729eb132fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_396ae9b4-958f-4f87-bfa2-5aae20712210" xlink:to="loc_us-gaap_PaymentsForRestructuring_9228ea8c-9455-49a0-87d1-a729eb132fb0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_c5f63d1f-c72a-4538-95f9-aace6583c526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0ed0c9ed-2fb3-4992-9bf0-ee50a6bafe98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_3dce52e3-6365-447c-8f91-314d21444f23" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0ed0c9ed-2fb3-4992-9bf0-ee50a6bafe98" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_2cb40ae1-02a4-4b2f-9c54-d360ea5c9351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0ed0c9ed-2fb3-4992-9bf0-ee50a6bafe98" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_2cb40ae1-02a4-4b2f-9c54-d360ea5c9351" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_2cb40ae1-02a4-4b2f-9c54-d360ea5c9351_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_2cb40ae1-02a4-4b2f-9c54-d360ea5c9351" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_2cb40ae1-02a4-4b2f-9c54-d360ea5c9351_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_b8680ef7-9f57-42f5-b9cc-780b9b97f76c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_2cb40ae1-02a4-4b2f-9c54-d360ea5c9351" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_b8680ef7-9f57-42f5-b9cc-780b9b97f76c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_fe8405d8-0a14-4dd8-9408-88772bcc185b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_b8680ef7-9f57-42f5-b9cc-780b9b97f76c" xlink:to="loc_us-gaap_EmployeeSeveranceMember_fe8405d8-0a14-4dd8-9408-88772bcc185b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_1d6c0f07-51d8-48ed-8115-15f19617bfda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_b8680ef7-9f57-42f5-b9cc-780b9b97f76c" xlink:to="loc_us-gaap_OtherRestructuringMember_1d6c0f07-51d8-48ed-8115-15f19617bfda" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#IntangibleAssetsComponentsofIntangibleAssetsDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail" xlink:type="extended" id="i997371848c3e468d9a75cd977da85548_IntangibleAssetsComponentsofIntangibleAssetsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_27b82056-8039-49a2-bda2-1986cc4a50a2" xlink:href="bdx-20220331.xsd#bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_59052f6a-e926-422d-b0fc-bcf035108d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_27b82056-8039-49a2-bda2-1986cc4a50a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_59052f6a-e926-422d-b0fc-bcf035108d48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ecdfa555-f57b-4508-a19a-8e478b1973ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_27b82056-8039-49a2-bda2-1986cc4a50a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ecdfa555-f57b-4508-a19a-8e478b1973ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e128d312-bbdd-43f5-be84-550425c7b440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_27b82056-8039-49a2-bda2-1986cc4a50a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e128d312-bbdd-43f5-be84-550425c7b440" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_223198ee-86aa-46b3-ac50-84ad9d1dc1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_27b82056-8039-49a2-bda2-1986cc4a50a2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_223198ee-86aa-46b3-ac50-84ad9d1dc1e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_279372a3-c59c-45ec-b934-8a8fd015a5ce" xlink:href="bdx-20220331.xsd#bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_27b82056-8039-49a2-bda2-1986cc4a50a2" xlink:to="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_279372a3-c59c-45ec-b934-8a8fd015a5ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f95e1065-d868-4269-86f5-79680092b431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_279372a3-c59c-45ec-b934-8a8fd015a5ce" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f95e1065-d868-4269-86f5-79680092b431" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f95e1065-d868-4269-86f5-79680092b431_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f95e1065-d868-4269-86f5-79680092b431" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f95e1065-d868-4269-86f5-79680092b431_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cef9932-4852-455a-9c55-949a008263e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f95e1065-d868-4269-86f5-79680092b431" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cef9932-4852-455a-9c55-949a008263e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_f663095f-c8f6-450d-a288-bec8e0a78bba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cef9932-4852-455a-9c55-949a008263e5" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_f663095f-c8f6-450d-a288-bec8e0a78bba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_c86e464e-8878-48a8-b8e6-23d353846ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cef9932-4852-455a-9c55-949a008263e5" xlink:to="loc_us-gaap_CustomerRelationshipsMember_c86e464e-8878-48a8-b8e6-23d353846ae4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProductRightsMember_24104b7c-b7b4-463f-a155-7ae66ffc082a" xlink:href="bdx-20220331.xsd#bdx_ProductRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cef9932-4852-455a-9c55-949a008263e5" xlink:to="loc_bdx_ProductRightsMember_24104b7c-b7b4-463f-a155-7ae66ffc082a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_42a87557-5c03-45b3-9176-98afe6f70a07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cef9932-4852-455a-9c55-949a008263e5" xlink:to="loc_us-gaap_TrademarksMember_42a87557-5c03-45b3-9176-98afe6f70a07" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember_cb2c4743-4bb6-4405-8fa0-51d3e9315a03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cef9932-4852-455a-9c55-949a008263e5" xlink:to="loc_us-gaap_IntellectualPropertyMember_cb2c4743-4bb6-4405-8fa0-51d3e9315a03" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9dedf1bb-7ecd-430e-bf23-c2d3487b26b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_279372a3-c59c-45ec-b934-8a8fd015a5ce" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9dedf1bb-7ecd-430e-bf23-c2d3487b26b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9dedf1bb-7ecd-430e-bf23-c2d3487b26b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9dedf1bb-7ecd-430e-bf23-c2d3487b26b4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9dedf1bb-7ecd-430e-bf23-c2d3487b26b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_36b6ecac-12ea-4670-a6bb-68d6ed040112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9dedf1bb-7ecd-430e-bf23-c2d3487b26b4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_36b6ecac-12ea-4670-a6bb-68d6ed040112" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_c506bc24-c865-48b3-8054-5dc9f8c04ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_36b6ecac-12ea-4670-a6bb-68d6ed040112" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_c506bc24-c865-48b3-8054-5dc9f8c04ffd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_12397fa1-eed7-4a76-8cef-e55c21b20e52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_36b6ecac-12ea-4670-a6bb-68d6ed040112" xlink:to="loc_us-gaap_TrademarksMember_12397fa1-eed7-4a76-8cef-e55c21b20e52" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail" xlink:type="extended" id="i0bfc8e11540c406c81023288017638e4_IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_b40316c0-8034-4e15-b50a-0f578be34014" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_c7f0e7c9-2274-44cf-8d4a-4a6229093c19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_b40316c0-8034-4e15-b50a-0f578be34014" xlink:to="loc_us-gaap_GoodwillRollForward_c7f0e7c9-2274-44cf-8d4a-4a6229093c19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e37c0791-687b-4834-8ab1-5d46d93a6483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_c7f0e7c9-2274-44cf-8d4a-4a6229093c19" xlink:to="loc_us-gaap_Goodwill_e37c0791-687b-4834-8ab1-5d46d93a6483" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_2345ca05-314a-4dc3-9dcd-1ac41bac7312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_c7f0e7c9-2274-44cf-8d4a-4a6229093c19" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_2345ca05-314a-4dc3-9dcd-1ac41bac7312" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_7cfd1875-2908-4645-81f4-f7944eed8f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_c7f0e7c9-2274-44cf-8d4a-4a6229093c19" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_7cfd1875-2908-4645-81f4-f7944eed8f6b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_8e687d82-5e69-4367-9d28-f02ee95deaa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_c7f0e7c9-2274-44cf-8d4a-4a6229093c19" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_8e687d82-5e69-4367-9d28-f02ee95deaa0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_405043d3-fcb1-4296-8aa2-c525ac357abf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_8d404c8b-1c2d-440f-a9b2-8548bfcba862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_b40316c0-8034-4e15-b50a-0f578be34014" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_8d404c8b-1c2d-440f-a9b2-8548bfcba862" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_363dfebc-1070-4131-b273-2dcff8f2f036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8d404c8b-1c2d-440f-a9b2-8548bfcba862" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_363dfebc-1070-4131-b273-2dcff8f2f036" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_363dfebc-1070-4131-b273-2dcff8f2f036_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_363dfebc-1070-4131-b273-2dcff8f2f036" xlink:to="loc_us-gaap_SegmentDomain_363dfebc-1070-4131-b273-2dcff8f2f036_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0b854ad0-41ac-4f45-afbe-a66d90f68aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_363dfebc-1070-4131-b273-2dcff8f2f036" xlink:to="loc_us-gaap_SegmentDomain_0b854ad0-41ac-4f45-afbe-a66d90f68aa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_2d8da8d3-95ba-41af-99aa-123b0bd1d19d" xlink:href="bdx-20220331.xsd#bdx_MedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0b854ad0-41ac-4f45-afbe-a66d90f68aa6" xlink:to="loc_bdx_MedicalMember_2d8da8d3-95ba-41af-99aa-123b0bd1d19d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_3d8176c4-5575-4f66-957c-059f81a2d544" xlink:href="bdx-20220331.xsd#bdx_LifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0b854ad0-41ac-4f45-afbe-a66d90f68aa6" xlink:to="loc_bdx_LifeSciencesMember_3d8176c4-5575-4f66-957c-059f81a2d544" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember_b5ea1df6-cf4a-4106-a616-40df15dbd463" xlink:href="bdx-20220331.xsd#bdx_InterventionalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0b854ad0-41ac-4f45-afbe-a66d90f68aa6" xlink:to="loc_bdx_InterventionalMember_b5ea1df6-cf4a-4106-a616-40df15dbd463" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" xlink:type="extended" id="i66c50b7b387c48119db2f38a77f957c6_DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_629924e8-e476-449e-bce8-d5643695e1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_63747329-de16-40ef-82a2-773fee3b37bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_629924e8-e476-449e-bce8-d5643695e1f4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_63747329-de16-40ef-82a2-773fee3b37bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_5da4be60-4d0a-4888-88e7-5897bcd2d850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_629924e8-e476-449e-bce8-d5643695e1f4" xlink:to="loc_us-gaap_DerivativeNotionalAmount_5da4be60-4d0a-4888-88e7-5897bcd2d850" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_96317ab6-0873-42f0-82fa-f8195d5d9808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_629924e8-e476-449e-bce8-d5643695e1f4" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_96317ab6-0873-42f0-82fa-f8195d5d9808" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4ae4e63f-7f3f-4995-921d-86c10abd4148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_96317ab6-0873-42f0-82fa-f8195d5d9808" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4ae4e63f-7f3f-4995-921d-86c10abd4148" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4ae4e63f-7f3f-4995-921d-86c10abd4148_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4ae4e63f-7f3f-4995-921d-86c10abd4148" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4ae4e63f-7f3f-4995-921d-86c10abd4148_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a341efdd-4cd6-4fbc-beb4-bae15d7589ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4ae4e63f-7f3f-4995-921d-86c10abd4148" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a341efdd-4cd6-4fbc-beb4-bae15d7589ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_a3c7d762-a702-4a77-93de-b37cc56928c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a341efdd-4cd6-4fbc-beb4-bae15d7589ec" xlink:to="loc_us-gaap_InterestRateSwapMember_a3c7d762-a702-4a77-93de-b37cc56928c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_5ee0ba55-82df-44e9-bf13-bd77d23eae89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a341efdd-4cd6-4fbc-beb4-bae15d7589ec" xlink:to="loc_us-gaap_CommodityContractMember_5ee0ba55-82df-44e9-bf13-bd77d23eae89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a0df4c21-5227-4d34-aed0-d79823d6c73a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_96317ab6-0873-42f0-82fa-f8195d5d9808" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a0df4c21-5227-4d34-aed0-d79823d6c73a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a0df4c21-5227-4d34-aed0-d79823d6c73a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a0df4c21-5227-4d34-aed0-d79823d6c73a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a0df4c21-5227-4d34-aed0-d79823d6c73a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4cd2afec-6a1d-4c1e-a526-324f778b5cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a0df4c21-5227-4d34-aed0-d79823d6c73a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4cd2afec-6a1d-4c1e-a526-324f778b5cf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_2df126f6-c521-454a-acb7-11c0e8b405d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4cd2afec-6a1d-4c1e-a526-324f778b5cf6" xlink:to="loc_us-gaap_CashFlowHedgingMember_2df126f6-c521-454a-acb7-11c0e8b405d7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail" xlink:type="extended" id="ie7df07847167472b9f4d7dbbbc311d39_DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f8a1715f-ec7d-498e-a710-a3d719186193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_842cedce-acfb-4b7a-8454-b05cfb8bd833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f8a1715f-ec7d-498e-a710-a3d719186193" xlink:to="loc_us-gaap_DerivativeNotionalAmount_842cedce-acfb-4b7a-8454-b05cfb8bd833" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_cd6f06f0-15b5-4470-8539-cda94c4f483a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f8a1715f-ec7d-498e-a710-a3d719186193" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_cd6f06f0-15b5-4470-8539-cda94c4f483a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_16272518-c11d-4641-ad71-b38f8e789725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_cd6f06f0-15b5-4470-8539-cda94c4f483a" xlink:to="loc_us-gaap_DebtInstrumentAxis_16272518-c11d-4641-ad71-b38f8e789725" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_16272518-c11d-4641-ad71-b38f8e789725_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_16272518-c11d-4641-ad71-b38f8e789725" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_16272518-c11d-4641-ad71-b38f8e789725_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_84ef6a4d-fd6c-46c0-a3d5-754f9c07d08f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_16272518-c11d-4641-ad71-b38f8e789725" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_84ef6a4d-fd6c-46c0-a3d5-754f9c07d08f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtMember_0e82737e-a5bb-4525-9e3e-0921812591c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_84ef6a4d-fd6c-46c0-a3d5-754f9c07d08f" xlink:to="loc_us-gaap_DebtMember_0e82737e-a5bb-4525-9e3e-0921812591c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e0bf3d67-414c-45d1-b83e-69b93c445548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_cd6f06f0-15b5-4470-8539-cda94c4f483a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e0bf3d67-414c-45d1-b83e-69b93c445548" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e0bf3d67-414c-45d1-b83e-69b93c445548_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e0bf3d67-414c-45d1-b83e-69b93c445548" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e0bf3d67-414c-45d1-b83e-69b93c445548_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1c70a3eb-bca6-4c73-915b-b1a7b082ba78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e0bf3d67-414c-45d1-b83e-69b93c445548" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1c70a3eb-bca6-4c73-915b-b1a7b082ba78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_245b774e-074f-4632-b431-e363417636e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1c70a3eb-bca6-4c73-915b-b1a7b082ba78" xlink:to="loc_us-gaap_ForeignExchangeContractMember_245b774e-074f-4632-b431-e363417636e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_a11f40b1-78c7-40f2-82bc-a0b24c80a78a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1c70a3eb-bca6-4c73-915b-b1a7b082ba78" xlink:to="loc_us-gaap_CurrencySwapMember_a11f40b1-78c7-40f2-82bc-a0b24c80a78a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FixedToFloatingMember_8a23833f-ee61-4918-8209-ac34daefe8c2" xlink:href="bdx-20220331.xsd#bdx_FixedToFloatingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1c70a3eb-bca6-4c73-915b-b1a7b082ba78" xlink:to="loc_bdx_FixedToFloatingMember_8a23833f-ee61-4918-8209-ac34daefe8c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_06dfd3d0-524f-41ce-bb1b-ac9367922936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1c70a3eb-bca6-4c73-915b-b1a7b082ba78" xlink:to="loc_us-gaap_InterestRateSwapMember_06dfd3d0-524f-41ce-bb1b-ac9367922936" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_328e931b-48eb-4753-bb64-20b9232cab24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_cd6f06f0-15b5-4470-8539-cda94c4f483a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_328e931b-48eb-4753-bb64-20b9232cab24" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_328e931b-48eb-4753-bb64-20b9232cab24_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_328e931b-48eb-4753-bb64-20b9232cab24" xlink:to="loc_us-gaap_HedgingRelationshipDomain_328e931b-48eb-4753-bb64-20b9232cab24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1251c4be-4adb-4392-b3e3-d4cf0378833c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_328e931b-48eb-4753-bb64-20b9232cab24" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1251c4be-4adb-4392-b3e3-d4cf0378833c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_5c52a09f-1269-45a0-b750-88f02cb8bec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1251c4be-4adb-4392-b3e3-d4cf0378833c" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_5c52a09f-1269-45a0-b750-88f02cb8bec4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_1cedfb9c-41d1-40cb-b1e3-415251e1df2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1251c4be-4adb-4392-b3e3-d4cf0378833c" xlink:to="loc_us-gaap_FairValueHedgingMember_1cedfb9c-41d1-40cb-b1e3-415251e1df2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_ae80953c-f395-4675-ab0f-374d274782f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1251c4be-4adb-4392-b3e3-d4cf0378833c" xlink:to="loc_us-gaap_CashFlowHedgingMember_ae80953c-f395-4675-ab0f-374d274782f9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails" xlink:type="simple" xlink:href="bdx-20220331.xsd#DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails" xlink:type="extended" id="i17f1737ddf184aa8a81ed410508d2d2c_DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_30bc0b37-97f2-42b7-9328-eecf09615788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6b983f32-1398-4713-bc0b-2db95f04a401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_30bc0b37-97f2-42b7-9328-eecf09615788" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6b983f32-1398-4713-bc0b-2db95f04a401" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_f99f3621-0b13-4972-8249-c50dac7ed248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_30bc0b37-97f2-42b7-9328-eecf09615788" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_f99f3621-0b13-4972-8249-c50dac7ed248" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_9fa38c4c-e15b-4886-83b9-06722b2ce39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_30bc0b37-97f2-42b7-9328-eecf09615788" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_9fa38c4c-e15b-4886-83b9-06722b2ce39e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_31451686-937c-46c3-b847-b9e957faa700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_9fa38c4c-e15b-4886-83b9-06722b2ce39e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_31451686-937c-46c3-b847-b9e957faa700" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_31451686-937c-46c3-b847-b9e957faa700_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_31451686-937c-46c3-b847-b9e957faa700" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_31451686-937c-46c3-b847-b9e957faa700_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cd45307b-1bd7-4a85-9c05-920df7720794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_31451686-937c-46c3-b847-b9e957faa700" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cd45307b-1bd7-4a85-9c05-920df7720794" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ForeignCurrencyDenominatedDebtMember_c3d54b26-1bff-4b4c-8979-1b13cd2a500a" xlink:href="bdx-20220331.xsd#bdx_ForeignCurrencyDenominatedDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cd45307b-1bd7-4a85-9c05-920df7720794" xlink:to="loc_bdx_ForeignCurrencyDenominatedDebtMember_c3d54b26-1bff-4b4c-8979-1b13cd2a500a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_f074e5c6-9337-4210-a622-c5e63004b3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cd45307b-1bd7-4a85-9c05-920df7720794" xlink:to="loc_us-gaap_CurrencySwapMember_f074e5c6-9337-4210-a622-c5e63004b3b1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail" xlink:type="extended" id="i43ed9b1743014d339b52bfe5823d9fda_FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b755bb5d-613e-4e60-9051-d17dec411387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MaturityPeriodOfShortTermInvestment_f93cbee7-8052-4f3a-a79e-dc0967516a05" xlink:href="bdx-20220331.xsd#bdx_MaturityPeriodOfShortTermInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b755bb5d-613e-4e60-9051-d17dec411387" xlink:to="loc_bdx_MaturityPeriodOfShortTermInvestment_f93cbee7-8052-4f3a-a79e-dc0967516a05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_e52e28d2-f5ba-48c7-9c63-c518c2a77b47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b755bb5d-613e-4e60-9051-d17dec411387" xlink:to="loc_us-gaap_AssetImpairmentCharges_e52e28d2-f5ba-48c7-9c63-c518c2a77b47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8de62069-4cf0-453f-acb4-a3b6c3b7c91b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b755bb5d-613e-4e60-9051-d17dec411387" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8de62069-4cf0-453f-acb4-a3b6c3b7c91b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_13342ac5-de66-480e-b300-967dcfee906b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8de62069-4cf0-453f-acb4-a3b6c3b7c91b" xlink:to="loc_srt_RangeAxis_13342ac5-de66-480e-b300-967dcfee906b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_13342ac5-de66-480e-b300-967dcfee906b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_13342ac5-de66-480e-b300-967dcfee906b" xlink:to="loc_srt_RangeMember_13342ac5-de66-480e-b300-967dcfee906b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3f3c6a0f-85bf-4183-bb75-234baeff990a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_13342ac5-de66-480e-b300-967dcfee906b" xlink:to="loc_srt_RangeMember_3f3c6a0f-85bf-4183-bb75-234baeff990a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_94ff4bde-a7b1-41b7-ab73-2aadd18c6504" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3f3c6a0f-85bf-4183-bb75-234baeff990a" xlink:to="loc_srt_MinimumMember_94ff4bde-a7b1-41b7-ab73-2aadd18c6504" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a00d0bd1-b29d-405d-ab18-d1b2ec524894" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3f3c6a0f-85bf-4183-bb75-234baeff990a" xlink:to="loc_srt_MaximumMember_a00d0bd1-b29d-405d-ab18-d1b2ec524894" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_44af9640-0a7f-48c4-be36-2ca378b895ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8de62069-4cf0-453f-acb4-a3b6c3b7c91b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_44af9640-0a7f-48c4-be36-2ca378b895ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_44af9640-0a7f-48c4-be36-2ca378b895ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_44af9640-0a7f-48c4-be36-2ca378b895ec" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_44af9640-0a7f-48c4-be36-2ca378b895ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5da8b811-d20c-4733-a74f-6d75794e17aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_44af9640-0a7f-48c4-be36-2ca378b895ec" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5da8b811-d20c-4733-a74f-6d75794e17aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_1aa87e3a-9dc9-48c3-9ddf-e4b67eaaaa19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5da8b811-d20c-4733-a74f-6d75794e17aa" xlink:to="loc_us-gaap_CostOfSalesMember_1aa87e3a-9dc9-48c3-9ddf-e4b67eaaaa19" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/DebtDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#DebtDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/DebtDetail" xlink:type="extended" id="i01abf30ee5c443cc961c48165f085171_DebtDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_419ce8de-aeb1-46b1-94a2-0a61b31fa939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_590914dd-657a-4566-b55f-9aad4758ec63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_419ce8de-aeb1-46b1-94a2-0a61b31fa939" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_590914dd-657a-4566-b55f-9aad4758ec63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b1a1d6a2-216e-488e-ad1f-52ba61b9b54a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_419ce8de-aeb1-46b1-94a2-0a61b31fa939" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b1a1d6a2-216e-488e-ad1f-52ba61b9b54a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_5af20673-f47e-4a23-81dd-b4ca4fb1f5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_419ce8de-aeb1-46b1-94a2-0a61b31fa939" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_5af20673-f47e-4a23-81dd-b4ca4fb1f5d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_6f5dc267-a464-4102-a4fa-df7c855c0c95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_419ce8de-aeb1-46b1-94a2-0a61b31fa939" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_6f5dc267-a464-4102-a4fa-df7c855c0c95" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_13960370-9976-4fab-b9cf-d685f58a728e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_419ce8de-aeb1-46b1-94a2-0a61b31fa939" xlink:to="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_13960370-9976-4fab-b9cf-d685f58a728e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_f3b91570-4624-4bb3-a2fa-d26da6bb619f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_419ce8de-aeb1-46b1-94a2-0a61b31fa939" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_f3b91570-4624-4bb3-a2fa-d26da6bb619f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_0cc9f707-c407-454a-8483-636fcf625b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_419ce8de-aeb1-46b1-94a2-0a61b31fa939" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_0cc9f707-c407-454a-8483-636fcf625b9a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c9dbf7cc-c513-4be0-b51a-77f16a9bf458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_419ce8de-aeb1-46b1-94a2-0a61b31fa939" xlink:to="loc_us-gaap_DebtInstrumentTable_c9dbf7cc-c513-4be0-b51a-77f16a9bf458" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dabdd5aa-43fc-42a6-b806-479002c92145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c9dbf7cc-c513-4be0-b51a-77f16a9bf458" xlink:to="loc_us-gaap_DebtInstrumentAxis_dabdd5aa-43fc-42a6-b806-479002c92145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dabdd5aa-43fc-42a6-b806-479002c92145_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_dabdd5aa-43fc-42a6-b806-479002c92145" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dabdd5aa-43fc-42a6-b806-479002c92145_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9215216c-cd83-4754-be71-bf13868ee717" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_dabdd5aa-43fc-42a6-b806-479002c92145" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9215216c-cd83-4754-be71-bf13868ee717" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes5000DueFebruary152030Member_2f64d6b6-684e-4b94-bd43-bc1e1b1ae9a5" xlink:href="bdx-20220331.xsd#bdx_Notes5000DueFebruary152030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9215216c-cd83-4754-be71-bf13868ee717" xlink:to="loc_bdx_Notes5000DueFebruary152030Member_2f64d6b6-684e-4b94-bd43-bc1e1b1ae9a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes6750DueFebruary152030Member_0d286fd6-4aac-4637-ae04-a33167fd5c79" xlink:href="bdx-20220331.xsd#bdx_Notes6750DueFebruary152030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9215216c-cd83-4754-be71-bf13868ee717" xlink:to="loc_bdx_Notes6750DueFebruary152030Member_0d286fd6-4aac-4637-ae04-a33167fd5c79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FloatingRateNotesDueJune62022Member_b9707a94-dbf3-42fc-a6d4-c75a690a925e" xlink:href="bdx-20220331.xsd#bdx_FloatingRateNotesDueJune62022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9215216c-cd83-4754-be71-bf13868ee717" xlink:to="loc_bdx_FloatingRateNotesDueJune62022Member_b9707a94-dbf3-42fc-a6d4-c75a690a925e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_02ce7da1-5f1c-49ef-8a17-1ae6187916ad" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c9dbf7cc-c513-4be0-b51a-77f16a9bf458" xlink:to="loc_srt_RangeAxis_02ce7da1-5f1c-49ef-8a17-1ae6187916ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_02ce7da1-5f1c-49ef-8a17-1ae6187916ad_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_02ce7da1-5f1c-49ef-8a17-1ae6187916ad" xlink:to="loc_srt_RangeMember_02ce7da1-5f1c-49ef-8a17-1ae6187916ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_18696579-09af-4738-abc5-386c448311c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_02ce7da1-5f1c-49ef-8a17-1ae6187916ad" xlink:to="loc_srt_RangeMember_18696579-09af-4738-abc5-386c448311c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_df9a2f16-4597-4af3-a922-522c27a72295" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_18696579-09af-4738-abc5-386c448311c2" xlink:to="loc_srt_MaximumMember_df9a2f16-4597-4af3-a922-522c27a72295" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f513a3cf-0e14-46e3-b8f0-a3b54b19b081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c9dbf7cc-c513-4be0-b51a-77f16a9bf458" xlink:to="loc_us-gaap_CreditFacilityAxis_f513a3cf-0e14-46e3-b8f0-a3b54b19b081" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f513a3cf-0e14-46e3-b8f0-a3b54b19b081_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_f513a3cf-0e14-46e3-b8f0-a3b54b19b081" xlink:to="loc_us-gaap_CreditFacilityDomain_f513a3cf-0e14-46e3-b8f0-a3b54b19b081_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_47d03fef-6b79-4515-bd85-631e03bd752f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_f513a3cf-0e14-46e3-b8f0-a3b54b19b081" xlink:to="loc_us-gaap_CreditFacilityDomain_47d03fef-6b79-4515-bd85-631e03bd752f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TermLoanFacilityMember_cd199d6f-e784-446d-9ae8-d77e60f55e44" xlink:href="bdx-20220331.xsd#bdx_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_47d03fef-6b79-4515-bd85-631e03bd752f" xlink:to="loc_bdx_TermLoanFacilityMember_cd199d6f-e784-446d-9ae8-d77e60f55e44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b5064bc8-0f4e-44f4-afe8-43a90a3ddd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_47d03fef-6b79-4515-bd85-631e03bd752f" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b5064bc8-0f4e-44f4-afe8-43a90a3ddd9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1cc4de10-1af3-491d-9bb6-d7e81651a0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c9dbf7cc-c513-4be0-b51a-77f16a9bf458" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1cc4de10-1af3-491d-9bb6-d7e81651a0ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1cc4de10-1af3-491d-9bb6-d7e81651a0ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1cc4de10-1af3-491d-9bb6-d7e81651a0ba" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1cc4de10-1af3-491d-9bb6-d7e81651a0ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_95609ba8-fbcc-433f-bf84-12bd52b5f12d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1cc4de10-1af3-491d-9bb6-d7e81651a0ba" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_95609ba8-fbcc-433f-bf84-12bd52b5f12d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ef0ad85d-7af4-4fa2-a4dc-39d1e8201cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_95609ba8-fbcc-433f-bf84-12bd52b5f12d" xlink:to="loc_us-gaap_SubsequentEventMember_ef0ad85d-7af4-4fa2-a4dc-39d1e8201cf7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_06708606-ea35-401f-8206-34e671baeea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c9dbf7cc-c513-4be0-b51a-77f16a9bf458" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_06708606-ea35-401f-8206-34e671baeea6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_06708606-ea35-401f-8206-34e671baeea6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_06708606-ea35-401f-8206-34e671baeea6" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_06708606-ea35-401f-8206-34e671baeea6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_835dfd51-7468-49f5-930c-b660e7b02881" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_06708606-ea35-401f-8206-34e671baeea6" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_835dfd51-7468-49f5-930c-b660e7b02881" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_b01d83bf-6d42-46fe-8218-c4a6c431b340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_835dfd51-7468-49f5-930c-b660e7b02881" xlink:to="loc_us-gaap_LongTermDebtMember_b01d83bf-6d42-46fe-8218-c4a6c431b340" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>bdx-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e602671e-4fe1-4961-adbb-f9dd82a282de,g:36534b56-6db4-48ab-9f63-2a72d6bb30f2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_NetIncomeLoss_2fc8b314-49d6-4125-85a9-d73bbd5257f0_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_04ccd631-ea0d-4ad0-bd90-e159cb6640d6_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_c1699a90-b2f5-4586-b1ff-c86f683ee026_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_ea937f03-90d2-417c-8610-bab7595e4965_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_PharmaceuticalSystemsMember_1eec517d-b575-4c46-bb17-115aeb9137c5_terseLabel_en-US" xlink:label="lab_bdx_PharmaceuticalSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Systems</link:label>
    <link:label id="lab_bdx_PharmaceuticalSystemsMember_label_en-US" xlink:label="lab_bdx_PharmaceuticalSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Systems [Member]</link:label>
    <link:label id="lab_bdx_PharmaceuticalSystemsMember_documentation_en-US" xlink:label="lab_bdx_PharmaceuticalSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Systems [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PharmaceuticalSystemsMember" xlink:href="bdx-20220331.xsd#bdx_PharmaceuticalSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_PharmaceuticalSystemsMember" xlink:to="lab_bdx_PharmaceuticalSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_15c94e48-de83-4d6e-9ec4-bfc550b94619_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_8f8ce692-8589-487c-9118-241593885339_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_f09463f4-4747-45f7-9fd8-ae3e03928723_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_2282ad8c-262a-47f3-adf4-b2cdc1e40ebf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_5cb3a47d-7458-4402-8c10-79141a120360_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a9a3d0b4-b664-4a7b-987c-412bbe78e880_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_80ab4b11-05a2-4341-b0ff-312a2bfe7d57_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_3b98b4a5-45dd-44c4-8d1c-c254ef7d9fa6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_49b1e538-731d-4391-acc3-63d64884d2ce_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_fbb9e456-3018-4477-9deb-518ed174df2b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_348ded02-a0be-4b98-bd65-57c002f923e4_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in excess of par value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_e1f3adc4-4ff7-45ca-8729-4c769760d1dc_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_6e8bf414-13b1-4b1a-ab94-54f6b4b69e74_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPreferredStock_1bbb38d7-a6a6-4ba8-af31-3d94930f8981_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsPreferredStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred dividends</link:label>
    <link:label id="lab_us-gaap_DividendsPreferredStock_label_en-US" xlink:label="lab_us-gaap_DividendsPreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPreferredStock" xlink:to="lab_us-gaap_DividendsPreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_a667db48-9d4e-4bd1-9abf-2c0c7d134fd0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_bb425050-268f-4636-928c-8f674a01cae5_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_00f3c00f-8a4e-4c11-8638-478400b4865a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_f2993bec-c232-41a3-8763-93c9d85fa778_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_6e7d838b-fdea-4c89-ae4f-c41502624db2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt issued in connection with the spin-off (see Note 12)</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Other Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_8332dd0e-186d-4ca9-a6b4-ee3618cb5bcf_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e68f7994-adaf-46cf-8400-5f30654bdd39_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_43f4bd01-a7a9-466a-88d7-65fd07f494b2_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_aafd5a05-1d5d-4356-90ba-f6bdee211343_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price allocation adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_000093a5-70d3-4cb0-a9f3-d29fefd3d906_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value hedges</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_93092ed7-06c6-4ff5-8dd9-240c3d76f690_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1.900dueDecember152026Member_2e133702-8218-450a-8eb6-68e59af5d9f7_terseLabel_en-US" xlink:label="lab_bdx_Notes1.900dueDecember152026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.900% due December 15, 2026</link:label>
    <link:label id="lab_bdx_Notes1.900dueDecember152026Member_label_en-US" xlink:label="lab_bdx_Notes1.900dueDecember152026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.900% due December 15, 2026 [Member]</link:label>
    <link:label id="lab_bdx_Notes1.900dueDecember152026Member_documentation_en-US" xlink:label="lab_bdx_Notes1.900dueDecember152026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.900% due December 15, 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.900dueDecember152026Member" xlink:href="bdx-20220331.xsd#bdx_Notes1.900dueDecember152026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1.900dueDecember152026Member" xlink:to="lab_bdx_Notes1.900dueDecember152026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_6374275c-bafe-48c1-a13f-cfa9d605e374_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c1d4d038-4f60-406e-bf41-95b1fed80547_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_994b8d30-1107-449c-a090-005c38645e65_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_6714bb67-d1ed-451c-815d-93e940741cc6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restructuring Accrual Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_159629ff-b1c3-4371-ad2f-85572dc64250_terseLabel_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired in-process research and development</link:label>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unclassified Indefinite-lived Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:to="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_22d73d59-536c-4980-a1ec-46274f4a323d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share equivalents excluded from the diluted shares outstanding calculation (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ConsumablesMember_ddf09474-ebfc-4183-ad5a-cb39df92f2de_terseLabel_en-US" xlink:label="lab_bdx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables</link:label>
    <link:label id="lab_bdx_ConsumablesMember_label_en-US" xlink:label="lab_bdx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:label id="lab_bdx_ConsumablesMember_documentation_en-US" xlink:label="lab_bdx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ConsumablesMember" xlink:href="bdx-20220331.xsd#bdx_ConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ConsumablesMember" xlink:to="lab_bdx_ConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_SurgeryMember_ac97ab60-baf1-482c-8345-f842b9c8ee19_terseLabel_en-US" xlink:label="lab_bdx_SurgeryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgery</link:label>
    <link:label id="lab_bdx_SurgeryMember_label_en-US" xlink:label="lab_bdx_SurgeryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgery [Member]</link:label>
    <link:label id="lab_bdx_SurgeryMember_documentation_en-US" xlink:label="lab_bdx_SurgeryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgery [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SurgeryMember" xlink:href="bdx-20220331.xsd#bdx_SurgeryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_SurgeryMember" xlink:to="lab_bdx_SurgeryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_b243f3f7-17e6-43b2-9359-c003a0405b5f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_6f299655-7d97-4b68-bc4e-843a0814edfd_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability-related charge</link:label>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_label_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Loss in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyLossInPeriod" xlink:to="lab_us-gaap_LossContingencyLossInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_738e5935-244b-4522-af2b-44aabe669188_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ContractWithCustomerRebateLiability_09015f6c-a18c-422a-b7fe-d6b16a88e51b_terseLabel_en-US" xlink:label="lab_bdx_ContractWithCustomerRebateLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebate liability</link:label>
    <link:label id="lab_bdx_ContractWithCustomerRebateLiability_label_en-US" xlink:label="lab_bdx_ContractWithCustomerRebateLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Rebate Liability</link:label>
    <link:label id="lab_bdx_ContractWithCustomerRebateLiability_documentation_en-US" xlink:label="lab_bdx_ContractWithCustomerRebateLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Rebate Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ContractWithCustomerRebateLiability" xlink:href="bdx-20220331.xsd#bdx_ContractWithCustomerRebateLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ContractWithCustomerRebateLiability" xlink:to="lab_bdx_ContractWithCustomerRebateLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_4ab8f797-6330-4043-9785-84425a114ca6_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Employee Benefit Obligations</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_MedicationDeliverySolutionsMember_5ed9a54a-90b6-4f45-9b80-5e873d2d33f8_terseLabel_en-US" xlink:label="lab_bdx_MedicationDeliverySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Delivery Solutions</link:label>
    <link:label id="lab_bdx_MedicationDeliverySolutionsMember_label_en-US" xlink:label="lab_bdx_MedicationDeliverySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Delivery Solutions [Member]</link:label>
    <link:label id="lab_bdx_MedicationDeliverySolutionsMember_documentation_en-US" xlink:label="lab_bdx_MedicationDeliverySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Delivery Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicationDeliverySolutionsMember" xlink:href="bdx-20220331.xsd#bdx_MedicationDeliverySolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_MedicationDeliverySolutionsMember" xlink:to="lab_bdx_MedicationDeliverySolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_2bcc3f8b-7957-46f2-82a4-73b06f06268a_terseLabel_en-US" xlink:label="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" xlink:href="bdx-20220331.xsd#bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" xlink:to="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_ab40b9ae-3e4f-4146-b627-44c497fdf92a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_8b8c685c-6988-4c6a-a912-0b1c9c8cd2ef_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_3540f5eb-9f37-4e2e-9472-20a6d459f7f7_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationMember_e6a4baf8-36d7-40b4-b444-1d430f1ee765_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationMember_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation [Member]</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationMember_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationMember" xlink:href="bdx-20220331.xsd#bdx_ShareBasedCompensationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationMember" xlink:to="lab_bdx_ShareBasedCompensationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_4ae97bf8-51ea-4146-b760-609e6ef75929_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_7144c90f-7b5d-44ca-9033-91fd7b532d4f_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_0328e52d-2d02-48ad-97fb-abc5fecd99ee_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_818908f9-6164-4013-a225-dd8b6cd0190e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ForeignCurrencyDenominatedDebtMember_f9b3346a-68d6-45a6-a060-4398cef83d5f_terseLabel_en-US" xlink:label="lab_bdx_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency-Denominated Debt</link:label>
    <link:label id="lab_bdx_ForeignCurrencyDenominatedDebtMember_label_en-US" xlink:label="lab_bdx_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency-Denominated Debt [Member]</link:label>
    <link:label id="lab_bdx_ForeignCurrencyDenominatedDebtMember_documentation_en-US" xlink:label="lab_bdx_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign-Currency Denominated Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ForeignCurrencyDenominatedDebtMember" xlink:href="bdx-20220331.xsd#bdx_ForeignCurrencyDenominatedDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ForeignCurrencyDenominatedDebtMember" xlink:to="lab_bdx_ForeignCurrencyDenominatedDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_42030e18-3e2f-4e79-9571-405032169201_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_22cabce2-6f4a-467e-9fa7-72c9bb8f06ac_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages awarded</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_1064dd56-5635-457c-a1af-234ae3afa7be_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_0f4c3d96-313d-436c-8f77-61989cd50b9f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_CommonStockSharesHeldInEmployeeTrust1_40ab3f55-3939-498a-9a9d-239abb92edcd_terseLabel_en-US" xlink:label="lab_bdx_CommonStockSharesHeldInEmployeeTrust1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_bdx_CommonStockSharesHeldInEmployeeTrust1_label_en-US" xlink:label="lab_bdx_CommonStockSharesHeldInEmployeeTrust1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Held in Employee Trust1</link:label>
    <link:label id="lab_bdx_CommonStockSharesHeldInEmployeeTrust1_documentation_en-US" xlink:label="lab_bdx_CommonStockSharesHeldInEmployeeTrust1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of common stock issued to a trust (for example, but not limited to, rabbi trust) set up specifically to accumulate stock for the sole purpose of distribution to participating employees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockSharesHeldInEmployeeTrust1" xlink:href="bdx-20220331.xsd#bdx_CommonStockSharesHeldInEmployeeTrust1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_CommonStockSharesHeldInEmployeeTrust1" xlink:to="lab_bdx_CommonStockSharesHeldInEmployeeTrust1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_478d474c-554e-4356-a3c4-b8cb4b593392_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_44b73bcc-f72a-49f7-95a0-e7b33e02b44f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_2659d6bc-9068-48e7-aa82-469fbdf926be_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service credit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes0.632dueJune42023Member_fae06360-1f24-497a-bb60-85affcbcb7ad_terseLabel_en-US" xlink:label="lab_bdx_Notes0.632dueJune42023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.632% due June 4, 2023</link:label>
    <link:label id="lab_bdx_Notes0.632dueJune42023Member_label_en-US" xlink:label="lab_bdx_Notes0.632dueJune42023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.632% due June 4, 2023 [Member]</link:label>
    <link:label id="lab_bdx_Notes0.632dueJune42023Member_documentation_en-US" xlink:label="lab_bdx_Notes0.632dueJune42023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.632% due June 4, 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0.632dueJune42023Member" xlink:href="bdx-20220331.xsd#bdx_Notes0.632dueJune42023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes0.632dueJune42023Member" xlink:to="lab_bdx_Notes0.632dueJune42023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_e508a92e-b770-4f4b-bf44-a5c824101504_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchased face amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_bbfea4bd-a2a8-4b8c-95da-49e7c2075ddf_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4d8ad402-21f6-442b-a5a8-199714c8cea7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0e8aca5c-1979-4204-bb81-8b08a8f31945_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a2f6c795-9e68-442c-a617-a03864f9fb74_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_f6c49eb3-9486-4797-983c-fcfbb2046562_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_bc212964-f58a-4b48-9a6d-26ab181ac33a_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of principal business segments (segment)</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_9377c4ca-27eb-4b09-893c-013cc75b7d8c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic Earnings per Share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9bee1c15-4692-43f3-892b-6e00f70e475c_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_469b6542-2407-43d8-b5c5-b38767e8a530_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending claims</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_CommonStockHeldInTrustsNetShares_f94f97c7-3225-4157-88e9-70ad83a032e4_terseLabel_en-US" xlink:label="lab_bdx_CommonStockHeldInTrustsNetShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock held in trusts, net (in shares)</link:label>
    <link:label id="lab_bdx_CommonStockHeldInTrustsNetShares_label_en-US" xlink:label="lab_bdx_CommonStockHeldInTrustsNetShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Held In Trusts Net Shares</link:label>
    <link:label id="lab_bdx_CommonStockHeldInTrustsNetShares_documentation_en-US" xlink:label="lab_bdx_CommonStockHeldInTrustsNetShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of common stock shares held in trust.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockHeldInTrustsNetShares" xlink:href="bdx-20220331.xsd#bdx_CommonStockHeldInTrustsNetShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_CommonStockHeldInTrustsNetShares" xlink:to="lab_bdx_CommonStockHeldInTrustsNetShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a145e1c4-e06a-4bcb-a336-0128e55609f9_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit pension and postretirement plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_FiniteLivedCustomerRelationshipsNet_3adaad75-44a4-48a0-ac67-4c07538701ea_terseLabel_en-US" xlink:label="lab_bdx_FiniteLivedCustomerRelationshipsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships, Net</link:label>
    <link:label id="lab_bdx_FiniteLivedCustomerRelationshipsNet_label_en-US" xlink:label="lab_bdx_FiniteLivedCustomerRelationshipsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Customer Relationships Net</link:label>
    <link:label id="lab_bdx_FiniteLivedCustomerRelationshipsNet_documentation_en-US" xlink:label="lab_bdx_FiniteLivedCustomerRelationshipsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net carrying amount as of the balance sheet date of an asset acquired in a business combination representing a favorable existing relationship with customers having a finite beneficial life.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteLivedCustomerRelationshipsNet" xlink:href="bdx-20220331.xsd#bdx_FiniteLivedCustomerRelationshipsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_FiniteLivedCustomerRelationshipsNet" xlink:to="lab_bdx_FiniteLivedCustomerRelationshipsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_a169a270-ebe8-4849-8ea1-8727d3774d73_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_OrganizationalUnitDomain_e5a9171f-9151-40b4-afcb-02cea38d7502_terseLabel_en-US" xlink:label="lab_bdx_OrganizationalUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Unit [Domain]</link:label>
    <link:label id="lab_bdx_OrganizationalUnitDomain_label_en-US" xlink:label="lab_bdx_OrganizationalUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Unit [Domain]</link:label>
    <link:label id="lab_bdx_OrganizationalUnitDomain_documentation_en-US" xlink:label="lab_bdx_OrganizationalUnitDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Organizational Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitDomain" xlink:href="bdx-20220331.xsd#bdx_OrganizationalUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_OrganizationalUnitDomain" xlink:to="lab_bdx_OrganizationalUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XNYS_d989ae41-d05e-4e4b-8227-582d81e12056_terseLabel_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC.</link:label>
    <link:label id="lab_exch_XNYS_label_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS" xlink:href="https://xbrl.sec.gov/exch/2021/exch-2021.xsd#exch_XNYS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNYS" xlink:to="lab_exch_XNYS" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsCurrent_9c75263c-4eab-4718-94c2-13b53aa07eb7_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsCurrent_e50e5cee-567d-435e-bee6-1f362dce1321_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Investments, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:to="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6ecaf8dc-2856-4f4e-a7f9-5a8889101de2_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_9c9157e6-15fe-49fe-9269-992361eee7c8_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_05ad4872-e1f6-47c4-9f9c-d4521979a3fe_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_cd4641a6-8587-4258-941f-9e3940342016_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of change in accounting principles</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ProductsandorServicesMember_988e27cb-6a32-4323-9d98-35369a8250f3_terseLabel_en-US" xlink:label="lab_bdx_ProductsandorServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and/or Services</link:label>
    <link:label id="lab_bdx_ProductsandorServicesMember_label_en-US" xlink:label="lab_bdx_ProductsandorServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and/or Services [Member]</link:label>
    <link:label id="lab_bdx_ProductsandorServicesMember_documentation_en-US" xlink:label="lab_bdx_ProductsandorServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and/or Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProductsandorServicesMember" xlink:href="bdx-20220331.xsd#bdx_ProductsandorServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ProductsandorServicesMember" xlink:to="lab_bdx_ProductsandorServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_MedicalMember_36df521b-aa96-4cab-a7d2-2822b81440a2_terseLabel_en-US" xlink:label="lab_bdx_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical</link:label>
    <link:label id="lab_bdx_MedicalMember_label_en-US" xlink:label="lab_bdx_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical [Member]</link:label>
    <link:label id="lab_bdx_MedicalMember_documentation_en-US" xlink:label="lab_bdx_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember" xlink:href="bdx-20220331.xsd#bdx_MedicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_MedicalMember" xlink:to="lab_bdx_MedicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_7a2a5190-0609-4b3c-917b-c4ae1ee99410_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_d763fac1-b90f-4d5c-9974-74af97ad96b6_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_dd323063-760d-49f5-8ab4-737f8506db1b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_70e5d840-ac98-4b5c-9ff2-0ba731961ac9_terseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1.208dueJune42026Member_ce951c25-abe5-4a56-8b93-2e32759eea06_terseLabel_en-US" xlink:label="lab_bdx_Notes1.208dueJune42026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.208% due June 4, 2026</link:label>
    <link:label id="lab_bdx_Notes1.208dueJune42026Member_label_en-US" xlink:label="lab_bdx_Notes1.208dueJune42026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.208% due June 4, 2026 [Member]</link:label>
    <link:label id="lab_bdx_Notes1.208dueJune42026Member_documentation_en-US" xlink:label="lab_bdx_Notes1.208dueJune42026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.208% due June 4, 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.208dueJune42026Member" xlink:href="bdx-20220331.xsd#bdx_Notes1.208dueJune42026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1.208dueJune42026Member" xlink:to="lab_bdx_Notes1.208dueJune42026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_f222d2c2-df2a-4897-87bc-5d98bfb8aed2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_c8277c58-1626-400b-a9da-22670c2baf73_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_NumberOfEtOSterilizationLawsuitsFiled_d16f60ee-f5cf-42a5-b618-9c0892f1ce48_terseLabel_en-US" xlink:label="lab_bdx_NumberOfEtOSterilizationLawsuitsFiled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of EtO lawsuits filed</link:label>
    <link:label id="lab_bdx_NumberOfEtOSterilizationLawsuitsFiled_label_en-US" xlink:label="lab_bdx_NumberOfEtOSterilizationLawsuitsFiled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of EtO Sterilization Lawsuits Filed</link:label>
    <link:label id="lab_bdx_NumberOfEtOSterilizationLawsuitsFiled_documentation_en-US" xlink:label="lab_bdx_NumberOfEtOSterilizationLawsuitsFiled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of EtO Sterilization Lawsuits Filed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfEtOSterilizationLawsuitsFiled" xlink:href="bdx-20220331.xsd#bdx_NumberOfEtOSterilizationLawsuitsFiled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_NumberOfEtOSterilizationLawsuitsFiled" xlink:to="lab_bdx_NumberOfEtOSterilizationLawsuitsFiled" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_9a1a93d6-54e2-4872-8516-53c91bfef256_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd818d6a-0e6a-41f1-a61e-2fc44f889edf_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_2fcf8b09-97cc-48db-82b0-2448cd5c3c0f_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_4472a0bb-ca5a-450e-948c-493a977b59f3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_d57ad77a-64e8-4907-971d-0a2a97297e1a_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Starting Interest Rate Swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_b620a262-0634-46d0-bf58-cce429706c86_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_33772a6a-790f-4ab1-b2f4-14372430178f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables, accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_5fc773e9-089c-41e0-b101-00b94c554959_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_7736546b-524a-4e6d-847e-eb39941e5c47_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_ce1579ea-0608-4bcb-98fe-a74cbc4732a4_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_382da323-30d2-467c-bfd1-9272af1572b8_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_2cd5ea8c-394c-49fc-b102-5a547c6daf9c_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8cf6585e-679d-4c5f-b1fb-8510062532f7_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3f2dc564-3bfa-4026-ba93-c33f465d7d24_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_fdcb10ba-f8c7-4aab-b868-40a90f928434_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_de32a27e-29f6-49bc-b9a5-67144411c6ae_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_5b43cd9f-588f-4861-90b7-b44bb9a25eff_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_9de9639c-89dd-4a7a-8257-00687791d7df_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_3572e248-015e-4ac9-9974-c69ce9e99b89_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_924c560b-cd82-4329-9c1a-fc1286fd1606_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_b8f1e1b9-1201-4b7a-9f00-e3a1ec38703e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4ba8b23a-9b0c-47d4-bb7d-1bf3abeadeb8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_8aca6ec7-81cb-4817-8427-6193aa703ba9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_3cce892b-7a18-421b-a454-4db6b2367d2a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_77c20aba-3e08-49f8-8e2e-aee6b82d8ec9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_2031a8b3-a0cf-4476-802c-dbea87138502_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation, Share-based Payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:to="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_427ed268-c02b-492a-ba27-920f143c0ebe_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_d56b25f6-2b56-4473-87df-793b17d43a24_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_52491d57-4f06-4019-9a96-a6fc41454e03_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_57ce0eaa-11d3-43a0-94e4-be473d9ac8b0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories:</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_3e16271f-cf60-4d55-9bc5-3155920c9752_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_28460e49-b5c9-4830-8a20-d65a54b47ce0_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d3f06884-f8c2-4ec1-a411-fd57a8ff827a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ace9451f-bf1d-43bd-8aee-9d53df7c4925_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c5df2fba-22d1-4a12-9834-aec2abecde4c_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_150f7b16-6f15-484f-a13b-499eab9cc73b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_dc07ea37-d4eb-4535-8845-00145d01e6b1_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_0a22651c-e13c-4125-a1f0-c7b8ec2ee497_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_39be5bac-61fa-4d7e-bda7-85d971176757_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Operating Costs and Expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_83b11ef5-31b4-4a11-89d4-77dc7cb734af_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Area</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4d6b0682-3941-405e-b55c-78cee8f6247f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_99e416d1-0ef0-4b25-8408-49cbdac42866_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_4809edea-d69e-4241-b81c-9082a325d8bc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_15421d0f-23bf-44e1-b0d5-daed7849a13f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_5f1c7f75-440c-485f-8645-5cfd138c4f50_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_3c9e207a-456b-48b3-a5b1-4effc462b7e4_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_2a02f0a9-cd73-42ad-ae30-2dae5c12dfa7_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_8230fc54-73ca-42c8-aad3-1c29cdf9af9e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net interest expense</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_HerniaProductClaimsMember_f9591ee3-a5f3-4b10-81a7-c9a72167c2f9_terseLabel_en-US" xlink:label="lab_bdx_HerniaProductClaimsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hernia Product Claims</link:label>
    <link:label id="lab_bdx_HerniaProductClaimsMember_label_en-US" xlink:label="lab_bdx_HerniaProductClaimsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HerniaProductClaims [Member]</link:label>
    <link:label id="lab_bdx_HerniaProductClaimsMember_documentation_en-US" xlink:label="lab_bdx_HerniaProductClaimsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HerniaProductClaims [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_HerniaProductClaimsMember" xlink:href="bdx-20220331.xsd#bdx_HerniaProductClaimsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_HerniaProductClaimsMember" xlink:to="lab_bdx_HerniaProductClaimsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_4c37d56e-b76b-40a5-9706-0acd43524618_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_3c37b244-2224-40a5-89ae-b8746c6c0126_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends per Common Share (USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_d166ac72-efe3-4555-b90b-7ef65d5ec110_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_952a5934-b171-452f-af38-136ff0f9478d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished products</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_f2248f2a-6365-4704-8a76-e37abcf38e2f_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_a04c0c33-b8f4-40b5-9031-0c3fe5bb89de_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_f02c9f0c-b39b-4119-a4cb-544ca4e490c1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gains (losses) recorded to Accumulated other comprehensive income (loss), gross</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_15b0c061-74dd-407a-a379-882ee583fbda_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1.000dueDecember152022Member_687467f3-7f20-4d4d-924a-a5ca4874f5dc_terseLabel_en-US" xlink:label="lab_bdx_Notes1.000dueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.000% due December 15, 2022</link:label>
    <link:label id="lab_bdx_Notes1.000dueDecember152022Member_label_en-US" xlink:label="lab_bdx_Notes1.000dueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.000% due December 15, 2022 [Member]</link:label>
    <link:label id="lab_bdx_Notes1.000dueDecember152022Member_documentation_en-US" xlink:label="lab_bdx_Notes1.000dueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.000% due December 15, 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.000dueDecember152022Member" xlink:href="bdx-20220331.xsd#bdx_Notes1.000dueDecember152022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1.000dueDecember152022Member" xlink:to="lab_bdx_Notes1.000dueDecember152022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_0f97ca91-001f-4f77-af90-6f8fe9cb0f86_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_76559ff7-a706-4691-879d-11d99754c994_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock&#160; Issued at&#160;Par&#160;Value</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsNet_63d6a97c-44e6-482a-bb29-a58da0157329_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangibles, Net</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsNet" xlink:to="lab_us-gaap_OtherIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_75b8e239-3b1a-423e-ae3a-acba06ae89aa_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Data</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_119b3eb1-d6e6-43f3-9410-6b7dfdca14fa_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_db3064c4-0d86-4bc3-ba88-5341c34577e1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_cef7b0ea-5198-4a89-af0f-7727f409ef03_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_5fbfecea-6fd2-4bdf-bd07-9df2931401c0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_4226476a-ab5b-4ff3-a2fa-558b2fbf29b8_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_87d27b60-52aa-4b3d-8463-a6f664ead7a5_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in Excess&#160;of Par&#160;Value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans_271576fb-e741-4d14-a0fd-ed6d8fa6a9b5_terseLabel_en-US" xlink:label="lab_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term debt</link:label>
    <link:label id="lab_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans_label_en-US" xlink:label="lab_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt and Term Loans</link:label>
    <link:label id="lab_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans_documentation_en-US" xlink:label="lab_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer, and term loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans" xlink:href="bdx-20220331.xsd#bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans" xlink:to="lab_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_cbcd7e89-d1dd-424f-af45-478d99740207_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_9b6815b0-ad4f-4832-bf78-f649f64affec_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_2223d9d4-18df-4543-b623-e68bbedeb4db_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_5cdf6865-73a7-4031-ba54-2c91166054af_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_GA_37d05316-156a-4a7b-acba-d927dc58274c_terseLabel_en-US" xlink:label="lab_stpr_GA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GEORGIA</link:label>
    <link:label id="lab_stpr_GA_label_en-US" xlink:label="lab_stpr_GA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GEORGIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_GA" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_GA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_GA" xlink:to="lab_stpr_GA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_2f0075a2-21be-4b22-8dd9-9690337f9036_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_633771eb-7ef0-4e7e-af37-d25c882cf72a_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairment charge</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_a2723ef9-2884-4d42-b51d-e2a1e95def95_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount of derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_InterventionalMember_8c43c24d-4a5a-4212-b88c-a1247a8b0030_terseLabel_en-US" xlink:label="lab_bdx_InterventionalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional</link:label>
    <link:label id="lab_bdx_InterventionalMember_db4e82ec-3ada-4247-98ce-fa762e37b1ef_verboseLabel_en-US" xlink:label="lab_bdx_InterventionalMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional</link:label>
    <link:label id="lab_bdx_InterventionalMember_label_en-US" xlink:label="lab_bdx_InterventionalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional [Member]</link:label>
    <link:label id="lab_bdx_InterventionalMember_documentation_en-US" xlink:label="lab_bdx_InterventionalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember" xlink:href="bdx-20220331.xsd#bdx_InterventionalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_InterventionalMember" xlink:to="lab_bdx_InterventionalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_cbf8bc0b-6a01-4fcb-b193-8f89845191ac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (expense) income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_67802c47-d89f-4d13-b317-695ad1a1fc7c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b6d3662d-5527-4acb-afd8-c350e2fdc1b8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_294eeff0-a94d-4ca6-b79a-d250b7f58cef_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Gain (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:to="lab_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_dbc132c9-8d87-4c12-9007-c5e5bb5a4c29_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact_471812e0-a44c-4a15-85ba-e6a4d7c8517b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock dividends</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Dividends, Income Statement Impact</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_a21f7fab-6b70-4cb6-8f83-d6c17de151c9_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_2c515296-57f4-4d81-b7bd-c74c6518564f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_2d12f2c7-e176-4352-8ecd-38d8b8456ddf_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_2e562342-8565-49ca-af96-94f21198ea6d_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_e869de1e-0b2d-40f2-aadc-fdc989b3b21b_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_55952135-6b4f-44b6-9e8e-e0146ab9a41a_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_455aab07-70c7-429e-86f9-e1eebc8b58e3_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_UrologyandCriticalCareMember_1efb1212-a02f-47da-82e2-0a36a3ec3512_terseLabel_en-US" xlink:label="lab_bdx_UrologyandCriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Urology and Critical Care</link:label>
    <link:label id="lab_bdx_UrologyandCriticalCareMember_label_en-US" xlink:label="lab_bdx_UrologyandCriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Urology and Critical Care [Member]</link:label>
    <link:label id="lab_bdx_UrologyandCriticalCareMember_documentation_en-US" xlink:label="lab_bdx_UrologyandCriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Urology and Critical Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_UrologyandCriticalCareMember" xlink:href="bdx-20220331.xsd#bdx_UrologyandCriticalCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_UrologyandCriticalCareMember" xlink:to="lab_bdx_UrologyandCriticalCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_b4d318cb-09a5-4988-a393-24c60a6cac48_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock</link:label>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemablePreferredStockMember" xlink:to="lab_us-gaap_RedeemablePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d3ddf763-1f00-4bcd-bac3-8e80d83e5059_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapital_a7188735-9637-4250-a810-e9dc9b43eed3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapital_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_bda860c5-e9bb-4e10-a995-8b65bcc6f98a_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_4901c828-e18e-4494-ad32-cbb564fffa29_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_38ec2929-6c53-48ea-b146-ea8351991d9e_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_daf95afb-ad7e-484f-8b65-8551c2371e59_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_b1b2a442-6032-47a6-87cf-7224c8aaebb7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_eba7bbff-2020-4ce9-9267-0df0da575aba_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_13f38a85-7bac-45b8-a4c2-b803e5b84151_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net pension cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_ae2d290f-e5e4-41cd-aebd-38dcfae6d869_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_887322d7-4d3c-4761-8b35-5e75b2608d35_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_61ec805f-0508-43e2-9056-4bd533fcc69b_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b740c725-52da-48dc-b379-255a0252d283_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_d35bdb30-2169-4bca-a547-e8db65c33f36_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_544425a4-ad9a-4b0e-bc48-4da92703651a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_3df03bd0-c41d-4ef7-a024-75c9f7cb7b50_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2d4e8663-11bb-475c-a5c3-86c1ce0c48b5_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_529e189c-38a8-444a-84f8-6b4d9f60bae9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_caaf6321-7f1e-4570-8ef7-0671de4a1ac1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_6f30f4c2-36d0-417a-b62f-3f4518f098d5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1213NotesDueFebruary122036Member_5d6f4fb4-ff13-4dc2-8345-e06c78edfc47_terseLabel_en-US" xlink:label="lab_bdx_Notes1213NotesDueFebruary122036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.213% Notes due February 12, 2036</link:label>
    <link:label id="lab_bdx_Notes1213NotesDueFebruary122036Member_label_en-US" xlink:label="lab_bdx_Notes1213NotesDueFebruary122036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.213% Notes due February 12, 2036 [Member]</link:label>
    <link:label id="lab_bdx_Notes1213NotesDueFebruary122036Member_documentation_en-US" xlink:label="lab_bdx_Notes1213NotesDueFebruary122036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.213% Notes due February 12, 2036</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1213NotesDueFebruary122036Member" xlink:href="bdx-20220331.xsd#bdx_Notes1213NotesDueFebruary122036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1213NotesDueFebruary122036Member" xlink:to="lab_bdx_Notes1213NotesDueFebruary122036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_d6ac716a-4de6-4df7-a8b5-47a55ab25b10_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_68856522-fe6c-4600-837d-e47e06955367_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_FloatingRateNotesDueJune62022Member_3733756b-2415-4aae-9231-3e314c01e55c_terseLabel_en-US" xlink:label="lab_bdx_FloatingRateNotesDueJune62022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due June62022</link:label>
    <link:label id="lab_bdx_FloatingRateNotesDueJune62022Member_label_en-US" xlink:label="lab_bdx_FloatingRateNotesDueJune62022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due June62022 [Member]</link:label>
    <link:label id="lab_bdx_FloatingRateNotesDueJune62022Member_documentation_en-US" xlink:label="lab_bdx_FloatingRateNotesDueJune62022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due June62022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FloatingRateNotesDueJune62022Member" xlink:href="bdx-20220331.xsd#bdx_FloatingRateNotesDueJune62022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_FloatingRateNotesDueJune62022Member" xlink:to="lab_bdx_FloatingRateNotesDueJune62022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_edbb65be-2a15-43f4-aca2-aca31afa3609_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_612dea05-77cf-4458-ac45-424252f210ef_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes6750DueFebruary152030Member_0e6b02f2-b136-49d7-8e88-99fc76c38e5c_terseLabel_en-US" xlink:label="lab_bdx_Notes6750DueFebruary152030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 6.750% due February 15, 2030</link:label>
    <link:label id="lab_bdx_Notes6750DueFebruary152030Member_label_en-US" xlink:label="lab_bdx_Notes6750DueFebruary152030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 6.750% due February 15, 2030 [Member]</link:label>
    <link:label id="lab_bdx_Notes6750DueFebruary152030Member_documentation_en-US" xlink:label="lab_bdx_Notes6750DueFebruary152030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 6.750% due February 15, 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes6750DueFebruary152030Member" xlink:href="bdx-20220331.xsd#bdx_Notes6750DueFebruary152030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes6750DueFebruary152030Member" xlink:to="lab_bdx_Notes6750DueFebruary152030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_6d188ab1-0f71-4336-be7a-beb61e3decff_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntellectualPropertyMember_cc84fcd1-d662-47f2-a356-c43cc6ff0b31_terseLabel_en-US" xlink:label="lab_us-gaap_IntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and other</link:label>
    <link:label id="lab_us-gaap_IntellectualPropertyMember_label_en-US" xlink:label="lab_us-gaap_IntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntellectualPropertyMember" xlink:to="lab_us-gaap_IntellectualPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_6ba5213c-95aa-4ab8-8597-56583ac8f429_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_1bc9f471-f80e-4da2-bbb2-a7579bda8f15_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_FixedToFloatingMember_b523666a-2748-41f8-b26e-c7d12b36c63b_terseLabel_en-US" xlink:label="lab_bdx_FixedToFloatingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps</link:label>
    <link:label id="lab_bdx_FixedToFloatingMember_label_en-US" xlink:label="lab_bdx_FixedToFloatingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed To Floating [Member]</link:label>
    <link:label id="lab_bdx_FixedToFloatingMember_documentation_en-US" xlink:label="lab_bdx_FixedToFloatingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed To Floating [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FixedToFloatingMember" xlink:href="bdx-20220331.xsd#bdx_FixedToFloatingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_FixedToFloatingMember" xlink:to="lab_bdx_FixedToFloatingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_62b6b6f4-bc46-450e-a050-0c43421baaa9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Information for Company's Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_499bfa60-f471-4f93-b0d8-0ed135ce464b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Shareholders Equity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c83dcdaf-517a-49dc-8253-d6f91d6e8632_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b7e1b280-70ae-4dde-93e4-8570c2005f13_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_53c34e26-51cf-4b57-90b2-6b058b4f9a3c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_97ea183d-5952-4369-81d5-db00d50d21bf_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_62b328be-dc2a-4d72-9eb8-beba736671ca_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_aee520b2-6008-4b61-844a-4f5a202ef7c3_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_db6f31c7-9820-4fff-b29f-6af003961647_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_f80e8981-238b-40e8-abff-15cdd5fe966a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_ccdf8de0-ffc2-4ca8-8081-dabf688cf7e3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_38b6e481-b7aa-4072-aae5-f4382fc6000e_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_OrganizationalUnitAxis_958a58d6-8df3-4df6-833e-91c4d6224a6c_terseLabel_en-US" xlink:label="lab_bdx_OrganizationalUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Unit [Axis]</link:label>
    <link:label id="lab_bdx_OrganizationalUnitAxis_label_en-US" xlink:label="lab_bdx_OrganizationalUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Unit [Axis]</link:label>
    <link:label id="lab_bdx_OrganizationalUnitAxis_documentation_en-US" xlink:label="lab_bdx_OrganizationalUnitAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitAxis" xlink:href="bdx-20220331.xsd#bdx_OrganizationalUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_OrganizationalUnitAxis" xlink:to="lab_bdx_OrganizationalUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_107b0e8b-8c7d-463f-a38f-b8775bf4d995_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1.401dueMay242023Member_91c7a6b6-af91-43fb-b903-e8ccdfb6c5df_terseLabel_en-US" xlink:label="lab_bdx_Notes1.401dueMay242023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.401% due May 24, 2023</link:label>
    <link:label id="lab_bdx_Notes1.401dueMay242023Member_label_en-US" xlink:label="lab_bdx_Notes1.401dueMay242023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.401% due May 24, 2023 [Member]</link:label>
    <link:label id="lab_bdx_Notes1.401dueMay242023Member_documentation_en-US" xlink:label="lab_bdx_Notes1.401dueMay242023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.401% due May 24, 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.401dueMay242023Member" xlink:href="bdx-20220331.xsd#bdx_Notes1.401dueMay242023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1.401dueMay242023Member" xlink:to="lab_bdx_Notes1.401dueMay242023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5fd92289-134e-4199-ac75-64f667c2b67e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued for share-based compensation and other plans, net (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_47d704b4-5acc-4237-824a-ccfad585d68c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of change in accounting principles</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_255662f8-eab2-4643-b660-182137e3d66c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4f37544a-78be-4490-baf8-3fd480350e4e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gains (losses) recorded to Accumulated other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_81d6f1d0-c995-452b-9b7d-864f90982de7_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:to="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_8d2d39e3-4c28-41bb-8606-876719efcd2c_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_c6b4ea84-ff83-4496-8a43-26d70e1cebbc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes0000DueAugust132023Member_c6fca8c2-30b9-482c-8022-91466b2b5920_terseLabel_en-US" xlink:label="lab_bdx_Notes0000DueAugust132023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.000% due August 13, 2023</link:label>
    <link:label id="lab_bdx_Notes0000DueAugust132023Member_label_en-US" xlink:label="lab_bdx_Notes0000DueAugust132023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.000% due August 13, 2023 [Member]</link:label>
    <link:label id="lab_bdx_Notes0000DueAugust132023Member_documentation_en-US" xlink:label="lab_bdx_Notes0000DueAugust132023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.000% due August 13, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0000DueAugust132023Member" xlink:href="bdx-20220331.xsd#bdx_Notes0000DueAugust132023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes0000DueAugust132023Member" xlink:to="lab_bdx_Notes0000DueAugust132023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_4c58325a-27e6-4383-a602-484335ec80f3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_091da7cd-cf08-4ff8-a880-1da0e1037f2e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued for share-based compensation and other plans, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_f35f6e8e-ef3e-422e-8684-6477b8809db9_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_dde474de-e647-4b50-aa90-56eb545024e1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableFairValueDisclosure_99607251-d8f1-48d5-bafb-1cb71dec466f_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LoansPayableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LoansPayableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableFairValueDisclosure" xlink:to="lab_us-gaap_LoansPayableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_669e0c94-e56d-4aa9-a205-f687b355446a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c5678e33-4db7-4933-825f-539f12af4c9f_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_0ca0e9ff-7d96-4ffa-a510-dd79bf7c5cfd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_0a3457b0-c3af-40e8-ad07-f2d3bb0ad1d1_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_574ac07a-498f-4062-8e3f-52624be7c75a_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_a529513e-bce5-49b4-8000-14d027ccfce0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommodityContractMember_2494f658-2ec1-4e1d-8756-93103911808c_terseLabel_en-US" xlink:label="lab_us-gaap_CommodityContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Contract</link:label>
    <link:label id="lab_us-gaap_CommodityContractMember_label_en-US" xlink:label="lab_us-gaap_CommodityContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommodityContractMember" xlink:to="lab_us-gaap_CommodityContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_56bf948b-5615-49fb-9568-c2fa78da76bc_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes5000DueFebruary152030Member_6521b000-5c13-49a1-b603-86664c150ea2_terseLabel_en-US" xlink:label="lab_bdx_Notes5000DueFebruary152030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 5.000% due February 15, 2030</link:label>
    <link:label id="lab_bdx_Notes5000DueFebruary152030Member_label_en-US" xlink:label="lab_bdx_Notes5000DueFebruary152030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 5.000% due February 15, 2030 [Member]</link:label>
    <link:label id="lab_bdx_Notes5000DueFebruary152030Member_documentation_en-US" xlink:label="lab_bdx_Notes5000DueFebruary152030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 5.000% due February 15, 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes5000DueFebruary152030Member" xlink:href="bdx-20220331.xsd#bdx_Notes5000DueFebruary152030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes5000DueFebruary152030Member" xlink:to="lab_bdx_Notes5000DueFebruary152030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_507777d4-9abd-4b33-97f1-ffc0f23f21a1_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_e023312d-5432-4396-a2ef-ba213f1bf3be_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod_ceec0c76-507f-4da6-ae07-53719de85427_terseLabel_en-US" xlink:label="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables transferred to third parties under factoring arrangements</link:label>
    <link:label id="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod_label_en-US" xlink:label="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers of financial assets during the period.</link:label>
    <link:label id="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod_documentation_en-US" xlink:label="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers of financial assets during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TransfersOfFinancialAssetsDuringThePeriod" xlink:href="bdx-20220331.xsd#bdx_TransfersOfFinancialAssetsDuringThePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_TransfersOfFinancialAssetsDuringThePeriod" xlink:to="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_d4fc881e-8c1f-4d07-93ab-256e605e3bc7_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_TermLoanFacilityMember_1ec20176-4247-43ec-9add-4311a379c637_terseLabel_en-US" xlink:label="lab_bdx_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility</link:label>
    <link:label id="lab_bdx_TermLoanFacilityMember_label_en-US" xlink:label="lab_bdx_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_bdx_TermLoanFacilityMember_documentation_en-US" xlink:label="lab_bdx_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TermLoanFacilityMember" xlink:href="bdx-20220331.xsd#bdx_TermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_TermLoanFacilityMember" xlink:to="lab_bdx_TermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_MedicationManagementSolutionsMember_f8cb7c8f-de98-455f-ae0b-e8b43e52235a_terseLabel_en-US" xlink:label="lab_bdx_MedicationManagementSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Management Solutions</link:label>
    <link:label id="lab_bdx_MedicationManagementSolutionsMember_label_en-US" xlink:label="lab_bdx_MedicationManagementSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Management Solutions [Member]</link:label>
    <link:label id="lab_bdx_MedicationManagementSolutionsMember_documentation_en-US" xlink:label="lab_bdx_MedicationManagementSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Management Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicationManagementSolutionsMember" xlink:href="bdx-20220331.xsd#bdx_MedicationManagementSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_MedicationManagementSolutionsMember" xlink:to="lab_bdx_MedicationManagementSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_fb87a39b-58e1-4e25-9784-ffa34ef96b60_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_fe581d6e-c7e9-40ff-9baf-d5ffffc05f0d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_7074fca0-a23c-4916-8c66-77f92a1b7b9c_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_675f55ef-0f9f-4a39-9ec7-077e7fa8a2fe_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income applicable to common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_05bae670-de62-4c75-b93c-b08f9471b3c5_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_79c3e48c-add9-4aad-8f10-4eea798926be_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_34240e35-244a-4e2d-b948-85633562e97c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_cc3e6208-fac9-487e-a3a1-511d51cb73ec_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_ba088f32-2df7-4733-adee-3cefa9fb3fe2_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_8ecc211e-d677-49d9-80e0-e8b01f4240f5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, expected timing of satisfaction (in years)</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_6e736d96-bc0d-4356-8ca7-33bf22194cbf_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_ffbce65c-d9f8-4a5d-a53f-982d453a9786_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_9270c3b0-1c04-48aa-b390-d3a2b4accb02_terseLabel_en-US" xlink:label="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional shares authorized to be repurchased (in shares)</link:label>
    <link:label id="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Additional Shares Authorized to be Repurchased</link:label>
    <link:label id="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_documentation_en-US" xlink:label="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Additional Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" xlink:href="bdx-20220331.xsd#bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" xlink:to="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_772969d4-fb29-44d3-9254-127c32b81699_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_bf02c9aa-8b4c-4222-bcc7-b5978dc4c784_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_ca725b21-8bc4-4417-882c-f94868720049_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_9d98b67b-0f1e-432f-a893-8876dd99b734_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_395676e2-f02c-42e6-a113-9911dab7cfc7_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average common shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_CommonStockHeldInTrustsAcquired_5878d841-f7ad-4335-9e3c-27ecde5feb8e_negatedTerseLabel_en-US" xlink:label="lab_bdx_CommonStockHeldInTrustsAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock held in trusts, net</link:label>
    <link:label id="lab_bdx_CommonStockHeldInTrustsAcquired_label_en-US" xlink:label="lab_bdx_CommonStockHeldInTrustsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Held in Trusts, Acquired</link:label>
    <link:label id="lab_bdx_CommonStockHeldInTrustsAcquired_documentation_en-US" xlink:label="lab_bdx_CommonStockHeldInTrustsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Held in Trusts, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockHeldInTrustsAcquired" xlink:href="bdx-20220331.xsd#bdx_CommonStockHeldInTrustsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_CommonStockHeldInTrustsAcquired" xlink:to="lab_bdx_CommonStockHeldInTrustsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_69def8ee-e644-4480-98c5-2b33b050b9e0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted Earnings per Share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_f66c8353-f1f1-4cf0-b28a-eef1b593f107_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtMember_bf1ecaa1-63c5-44eb-b2c5-646693ae3ad5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency-Denominated Debt</link:label>
    <link:label id="lab_us-gaap_DebtMember_label_en-US" xlink:label="lab_us-gaap_DebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtMember" xlink:to="lab_us-gaap_DebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_cf310bf1-2bbb-4c74-ae62-aeb92e3e9377_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive share equivalents from share-based plans (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_fa965850-7f8a-4cce-99dc-666814f89610_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment hedges</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_04e3e01c-ecc4-46c4-9941-8c951f2562ae_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_ad7d3b42-a04e-4f2a-bf69-cb7a852d581b_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1de2a4c6-0d82-42fb-b8fd-7590017e1a4a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_e20b2b55-f475-4276-9d55-fc7710814a77_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ef0daf09-e926-499b-9d0f-6879d2fe4aa1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_829a3e39-0aa6-41b0-a834-50f66cb8c935_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_ead3b361-29c5-40cf-9229-7ec30eb139e8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Termination</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1f2f3263-68d1-4610-b90d-c100ce74a941_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used for) Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_fb044a80-3031-4361-8932-62ef5a699a84_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0f3f25b7-2708-4785-b63f-5dae07571cc0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_e37a0c58-8a6a-46ac-9e3f-3cd1b486e731_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments and Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_74833686-2fda-4fc9-8bd2-a9c82589e88d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to expense</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ProductRightsMember_da9f966d-bf7f-4d42-a88a-99c767a9baab_terseLabel_en-US" xlink:label="lab_bdx_ProductRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product rights</link:label>
    <link:label id="lab_bdx_ProductRightsMember_label_en-US" xlink:label="lab_bdx_ProductRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Rights [Member]</link:label>
    <link:label id="lab_bdx_ProductRightsMember_documentation_en-US" xlink:label="lab_bdx_ProductRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired technological intellectual property and know how, as well as product marketing rights.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProductRightsMember" xlink:href="bdx-20220331.xsd#bdx_ProductRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ProductRightsMember" xlink:to="lab_bdx_ProductRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_871e7b03-8f70-4652-be6f-4fe3412560ec_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_3441c429-510a-4c19-924d-c3eebc50fa3a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_df0e712a-da60-496b-afee-135826287fad_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_10051134-cbcf-4a30-b1ad-6fdfe3996c6b_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_962e7069-738d-4b44-84d0-e1367942df1e_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockMember" xlink:to="lab_us-gaap_ConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_e2b1159a-ffcf-40f7-9110-6b202e1f4ab7_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive share equivalents from Series C preferred shares (shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_ae660a9e-753e-4bcb-8fb2-f352e7128712_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expense, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_5fd34336-ebe4-4fd9-aa2d-90bbffc6f893_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_f5c77b76-b69a-407f-b410-d7ff30236524_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_453d30e5-0da9-47de-9910-9c502ab72114_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized to be repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d4660980-53ba-4030-b79f-13c4dc391ac8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_925d5c36-e679-4652-a580-56baa5f36c0c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_cfc7c9fa-8e5d-408b-b55b-f2c7e0bef360_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm_6df0c24a-b670-40ec-ac55-75d58a142c0a_terseLabel_en-US" xlink:label="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm_label_en-US" xlink:label="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of Debt Classified From Long Term To Short Term</link:label>
    <link:label id="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm_documentation_en-US" xlink:label="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of Debt Classified From Long Term To Short Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" xlink:href="bdx-20220331.xsd#bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" xlink:to="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_aba11223-f15f-47a6-a2cf-cac665989c01_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_30c35623-bb0f-411c-8621-b125b4309adf_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_595da0c2-0b78-4cf6-b1f0-ecd4475766bb_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_47ebaa36-7c57-47f3-b24c-e63d46f23e0f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_28b9516a-3955-4be3-84e2-287f3639ff33_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_cc8b3086-f50f-41d6-946a-350c2fbba13f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_96eff2b5-7b01-43df-8fd5-b830fef59ee9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_52bb9c7e-36b3-42b5-a61f-fb2ea5e957bc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_95301cb8-c57a-4611-ad54-8840232d62b9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_5b9f338d-4c38-4043-a2d8-a3cf1392e158_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_cb760866-b6c8-4e5f-902d-0a3a9b2be8d0_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2120a4cd-970d-4c59-a710-73c7b5f77043_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified into income, net of taxes</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_e0581182-941a-4f29-8443-e23d11564b17_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing capacity of credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_ba359eb8-b23b-48bf-a4b4-67cb5157e5d0_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_c2df32fa-24b5-4000-96f3-a5d9afd4b1ca_verboseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_0603cc6a-2201-441b-8fc2-c691744ebe95_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_38323dd2-a580-43f3-87dd-316f727e587a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_IncreaseDecreaseinPensionBenefitObligation_86efc4d8-cd4a-4863-8141-698e100c44f2_terseLabel_en-US" xlink:label="lab_bdx_IncreaseDecreaseinPensionBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension obligation</link:label>
    <link:label id="lab_bdx_IncreaseDecreaseinPensionBenefitObligation_label_en-US" xlink:label="lab_bdx_IncreaseDecreaseinPensionBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Pension Benefit Obligation</link:label>
    <link:label id="lab_bdx_IncreaseDecreaseinPensionBenefitObligation_documentation_en-US" xlink:label="lab_bdx_IncreaseDecreaseinPensionBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase (decrease) in obligation for pension benefits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IncreaseDecreaseinPensionBenefitObligation" xlink:href="bdx-20220331.xsd#bdx_IncreaseDecreaseinPensionBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_IncreaseDecreaseinPensionBenefitObligation" xlink:to="lab_bdx_IncreaseDecreaseinPensionBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_8b3bf580-e9d7-4437-b39c-b86317548277_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes0034DueAugust132025Member_8e967e3b-4608-40c6-9ce9-63d5995818df_terseLabel_en-US" xlink:label="lab_bdx_Notes0034DueAugust132025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.034% due August 13, 2025</link:label>
    <link:label id="lab_bdx_Notes0034DueAugust132025Member_label_en-US" xlink:label="lab_bdx_Notes0034DueAugust132025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.034% due August 13, 2025 [Member]</link:label>
    <link:label id="lab_bdx_Notes0034DueAugust132025Member_documentation_en-US" xlink:label="lab_bdx_Notes0034DueAugust132025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.034% due August 13, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0034DueAugust132025Member" xlink:href="bdx-20220331.xsd#bdx_Notes0034DueAugust132025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes0034DueAugust132025Member" xlink:to="lab_bdx_Notes0034DueAugust132025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_f31af5f3-15f1-4b10-bff3-61f0bb9734e3_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_6e61fb72-e363-490a-afe0-579be90cc83b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of long-term notes</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_d8ab5784-5910-49f1-b3b0-65e24488da33_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_510df592-57c7-4e9b-be1f-2b266756f84f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_2e55756a-8cb8-4331-b6b9-a75e7880b4c5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt obligations</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e1e93cfc-1be3-457a-b931-5e687d73a9e0_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening Cash and Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a6594422-3a65-483b-b218-23887888e3ec_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing Cash and Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6e93997d-8364-4f3a-bfdd-8dbacb4c7c00_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_10626776-8aad-4945-99a6-369bd330c558_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_4ece3c87-c4ea-4d72-ae2c-9d8fac389a71_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_a693cb99-7b15-4df6-b083-7d88e309dff7_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c2550400-7ff9-491f-9e32-5477ee0eb44f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_541da743-daa4-4062-acda-115afe5b3cfa_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_27b9bd39-0aa9-4fc9-b76a-6551cb7761aa_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_b33e33f2-2205-4b1b-8ad5-ebd8ac87e776_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_dfc7c117-acc9-463e-a38f-98300bc669d4_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_267d28ff-8f56-441d-8787-84ef9adadd08_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6657cd8e-9378-4083-9971-83e978aa36db_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Institutional money market accounts and ultra-short bond fund</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_f7b363d3-f500-4951-9aca-abb01d7f5304_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_7ce91862-1b4f-40cb-a204-3eeb2f6f0047_terseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts yet to be collected and remitted to the third parties</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e2269cf5-e0e5-4a92-9c5c-08464447c557_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average common and common equivalent shares outstanding - assuming dilution (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_686e1f07-1b2b-48aa-a327-de4badffa4a8_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_61851ce7-792d-4e20-9376-eff3b8c329d4_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_fba42a17-f4c3-40f0-8009-401160aa5a06_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_db90e151-3e86-4ede-b1ed-c4a35b9d9719_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Pension and Postretirement Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0cabcf49-eaa1-4ca3-913f-364c9879b434_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_7e7a51b6-d31c-49eb-a502-585ecae88f81_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_d2a9e81f-f45a-43dc-a05a-c7a5029711e6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_51087afe-cfa8-4cfb-be2d-90efda4f5604_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Swaps</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_05c873c2-e8e8-42e0-a953-ccb59b0d9490_terseLabel_en-US" xlink:label="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_documentation_en-US" xlink:label="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" xlink:href="bdx-20220331.xsd#bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherShortTermInvestments_e91b7234-1191-43e8-82a2-947310124d3a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_OtherShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_OtherShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherShortTermInvestments" xlink:to="lab_us-gaap_OtherShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_1d0bc73c-bb1d-4f78-a037-9924aa6463ec_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f0a46b97-7b30-4e4a-82cd-4695422663a4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_06420968-ef88-43c8-bc62-3e01bffa5d24_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Used for Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_19d95360-0151-488f-ba93-201f5cd39bc3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less allowances for depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_PeripheralInterventionMember_1563f108-f90f-49db-863a-66eacc6d1c25_terseLabel_en-US" xlink:label="lab_bdx_PeripheralInterventionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peripheral Intervention</link:label>
    <link:label id="lab_bdx_PeripheralInterventionMember_label_en-US" xlink:label="lab_bdx_PeripheralInterventionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peripheral Intervention [Member]</link:label>
    <link:label id="lab_bdx_PeripheralInterventionMember_documentation_en-US" xlink:label="lab_bdx_PeripheralInterventionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peripheral Intervention [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PeripheralInterventionMember" xlink:href="bdx-20220331.xsd#bdx_PeripheralInterventionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_PeripheralInterventionMember" xlink:to="lab_bdx_PeripheralInterventionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_1bd5cc8f-733b-4f5d-b02e-9c18be7f17df_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_IntegratedDiagnosticSolutionsMember_ce573cdc-7d50-4115-b10e-6969cbaa8cae_terseLabel_en-US" xlink:label="lab_bdx_IntegratedDiagnosticSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integrated Diagnostic Solutions</link:label>
    <link:label id="lab_bdx_IntegratedDiagnosticSolutionsMember_label_en-US" xlink:label="lab_bdx_IntegratedDiagnosticSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integrated Diagnostic Solutions [Member]</link:label>
    <link:label id="lab_bdx_IntegratedDiagnosticSolutionsMember_documentation_en-US" xlink:label="lab_bdx_IntegratedDiagnosticSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integrated Diagnostic Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IntegratedDiagnosticSolutionsMember" xlink:href="bdx-20220331.xsd#bdx_IntegratedDiagnosticSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_IntegratedDiagnosticSolutionsMember" xlink:to="lab_bdx_IntegratedDiagnosticSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_0b8d8d52-dd5c-4385-8681-144f651c0db1_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_29ad2ba9-29b0-4dec-ad3e-4fb448143db5_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_eb00529f-32f5-43e9-832f-b3b4d783a623_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_MaturityPeriodOfShortTermInvestment_2d83e1b6-11cf-423c-8a21-347233a622e0_terseLabel_en-US" xlink:label="lab_bdx_MaturityPeriodOfShortTermInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity period of short-term investments at the time of purchase</link:label>
    <link:label id="lab_bdx_MaturityPeriodOfShortTermInvestment_label_en-US" xlink:label="lab_bdx_MaturityPeriodOfShortTermInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity Period Of Short Term Investment</link:label>
    <link:label id="lab_bdx_MaturityPeriodOfShortTermInvestment_documentation_en-US" xlink:label="lab_bdx_MaturityPeriodOfShortTermInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The maturity period of time deposits classified as short-term investments in the consolidated balance sheet.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MaturityPeriodOfShortTermInvestment" xlink:href="bdx-20220331.xsd#bdx_MaturityPeriodOfShortTermInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_MaturityPeriodOfShortTermInvestment" xlink:to="lab_bdx_MaturityPeriodOfShortTermInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_454fec5e-2ec6-429b-8935-58513a99f928_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_LifeSciencesMember_9939c7c4-60ac-4c7a-b900-e3ff935bc8a8_terseLabel_en-US" xlink:label="lab_bdx_LifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Sciences</link:label>
    <link:label id="lab_bdx_LifeSciencesMember_601e4946-10e8-4e56-86ba-29d45291bec8_verboseLabel_en-US" xlink:label="lab_bdx_LifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life&#160;Sciences</link:label>
    <link:label id="lab_bdx_LifeSciencesMember_label_en-US" xlink:label="lab_bdx_LifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Sciences [Member]</link:label>
    <link:label id="lab_bdx_LifeSciencesMember_documentation_en-US" xlink:label="lab_bdx_LifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Sciences [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember" xlink:href="bdx-20220331.xsd#bdx_LifeSciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_LifeSciencesMember" xlink:to="lab_bdx_LifeSciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_36b06ddf-fecd-49ba-81c3-1387178472c6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_88b8ec18-d3d1-46b7-ba54-b4c5c4e3b386_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes3.020dueMay242025Member_2bb071d5-3bf0-467a-b0b0-1c78629ceabd_terseLabel_en-US" xlink:label="lab_bdx_Notes3.020dueMay242025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.020% due May 24, 2025</link:label>
    <link:label id="lab_bdx_Notes3.020dueMay242025Member_label_en-US" xlink:label="lab_bdx_Notes3.020dueMay242025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.020% due May 24, 2025 [Member]</link:label>
    <link:label id="lab_bdx_Notes3.020dueMay242025Member_documentation_en-US" xlink:label="lab_bdx_Notes3.020dueMay242025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.020% due May 24, 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.020dueMay242025Member" xlink:href="bdx-20220331.xsd#bdx_Notes3.020dueMay242025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes3.020dueMay242025Member" xlink:to="lab_bdx_Notes3.020dueMay242025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_64803db0-225a-4556-90e3-dd6589b058df_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DiabetesCareMember_c6d9e26c-4b6c-4241-9d03-24f28d551e21_terseLabel_en-US" xlink:label="lab_bdx_DiabetesCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes Care</link:label>
    <link:label id="lab_bdx_DiabetesCareMember_label_en-US" xlink:label="lab_bdx_DiabetesCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes Care [Member]</link:label>
    <link:label id="lab_bdx_DiabetesCareMember_documentation_en-US" xlink:label="lab_bdx_DiabetesCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DiabetesCareMember" xlink:href="bdx-20220331.xsd#bdx_DiabetesCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DiabetesCareMember" xlink:to="lab_bdx_DiabetesCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_CoreAndDevelopedTechnologyNet_eb09e185-3439-408d-af20-c004152de96b_terseLabel_en-US" xlink:label="lab_bdx_CoreAndDevelopedTechnologyNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology, Net</link:label>
    <link:label id="lab_bdx_CoreAndDevelopedTechnologyNet_label_en-US" xlink:label="lab_bdx_CoreAndDevelopedTechnologyNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core And Developed Technology Net</link:label>
    <link:label id="lab_bdx_CoreAndDevelopedTechnologyNet_documentation_en-US" xlink:label="lab_bdx_CoreAndDevelopedTechnologyNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets arising from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CoreAndDevelopedTechnologyNet" xlink:href="bdx-20220331.xsd#bdx_CoreAndDevelopedTechnologyNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_CoreAndDevelopedTechnologyNet" xlink:to="lab_bdx_CoreAndDevelopedTechnologyNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_85ff8501-08dd-4e8b-a40a-7335b2c9c3cc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_3b375589-bc70-4b75-891d-353c8786e9d4_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_b0c97ce1-92a6-419d-832c-2f49a4e7e29e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_707270a9-06bd-4629-8557-4d50f75e0411_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductLiabilityAccrualPeriodExpense_342887f5-027c-462c-add7-1fc76bcf4ba4_terseLabel_en-US" xlink:label="lab_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability accrual, period expense</link:label>
    <link:label id="lab_us-gaap_ProductLiabilityAccrualPeriodExpense_label_en-US" xlink:label="lab_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Accrual, Period Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:to="lab_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_5608a23b-f09c-44e7-be70-84993dae0991_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_2ac0d418-2e43-465a-b223-bdff2fe9260a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_bbfc022f-a0fb-4064-8bcd-af7de13370d2_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_ab4758d9-ff6a-4600-b76e-b22654b11b84_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_b4871a0e-ce9f-4650-b580-f5a57ee31ca0_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_BiosciencesMember_8d97fa23-e9ac-4662-89bc-fb862e72cd34_terseLabel_en-US" xlink:label="lab_bdx_BiosciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biosciences</link:label>
    <link:label id="lab_bdx_BiosciencesMember_label_en-US" xlink:label="lab_bdx_BiosciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biosciences [Member]</link:label>
    <link:label id="lab_bdx_BiosciencesMember_documentation_en-US" xlink:label="lab_bdx_BiosciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biosciences [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_BiosciencesMember" xlink:href="bdx-20220331.xsd#bdx_BiosciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_BiosciencesMember" xlink:to="lab_bdx_BiosciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_d739b1fa-ef9a-457f-9a00-3e5279b4b74c_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_6b78cb88-35c9-4270-b754-e9d419912879_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_dd8e38ad-8d59-4529-8314-941245573819_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_b619cd87-0e01-431e-adaf-6159232639d5_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_6d85bd97-ea4c-45c2-b664-d12c848b9e82_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Goodwill by Business Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8261f609-d449-45b5-b67d-87dbe8709e3d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to net income to derive net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_a6731cc6-7c9f-4df4-b472-b8cdc8d4a801_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges_2a8c15f6-02dd-453b-b8ec-64cb12f0e921_verboseLabel_en-US" xlink:label="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related integration and restructuring expense</link:label>
    <link:label id="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges_696fb446-b5ec-4324-a026-2f8bc7b71c51_negatedLabel_en-US" xlink:label="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integration and restructuring expense</link:label>
    <link:label id="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges_label_en-US" xlink:label="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Related Costs And Restructuring Charges</link:label>
    <link:label id="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges_documentation_en-US" xlink:label="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; business integration costs, systems integration and conversion costs, and severance and other employee-related costs; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Additionally includes the amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:href="bdx-20220331.xsd#bdx_AcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:to="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_a3119585-1bc0-4fff-b030-c24246d14a95_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_e5f69514-b745-40dc-ab0c-d5374887973c_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_831841bf-b6b9-471a-bd22-28d639ce95ca_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit&#160;Plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>bdx-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e602671e-4fe1-4961-adbb-f9dd82a282de,g:36534b56-6db4-48ab-9f63-2a72d6bb30f2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bd.com/role/CoverPage" xlink:type="simple" xlink:href="bdx-20220331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b8bbedf0-8fc2-4f6b-84b3-5af77b8a2e5b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_da9238b3-424e-4f28-8d77-10e0ec133b41" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b8bbedf0-8fc2-4f6b-84b3-5af77b8a2e5b" xlink:to="loc_dei_EntitiesTable_da9238b3-424e-4f28-8d77-10e0ec133b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_6d8bfc37-3961-4bbb-99ed-f3bf74d0a1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_da9238b3-424e-4f28-8d77-10e0ec133b41" xlink:to="loc_us-gaap_StatementClassOfStockAxis_6d8bfc37-3961-4bbb-99ed-f3bf74d0a1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6d8bfc37-3961-4bbb-99ed-f3bf74d0a1c7" xlink:to="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b275911f-a45f-4218-b57c-87e79857be80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_us-gaap_CommonStockMember_b275911f-a45f-4218-b57c-87e79857be80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_6889d36c-35d7-419b-817e-d391c61c6932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_6889d36c-35d7-419b-817e-d391c61c6932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.000dueDecember152022Member_634bb3e5-ec50-4868-8b6c-20a9204c64cb" xlink:href="bdx-20220331.xsd#bdx_Notes1.000dueDecember152022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_bdx_Notes1.000dueDecember152022Member_634bb3e5-ec50-4868-8b6c-20a9204c64cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.900dueDecember152026Member_137c1538-ecb8-4190-adbb-851b08991fb5" xlink:href="bdx-20220331.xsd#bdx_Notes1.900dueDecember152026Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_bdx_Notes1.900dueDecember152026Member_137c1538-ecb8-4190-adbb-851b08991fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.401dueMay242023Member_67459fa4-d973-4b49-8861-1f6636a4ebab" xlink:href="bdx-20220331.xsd#bdx_Notes1.401dueMay242023Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_bdx_Notes1.401dueMay242023Member_67459fa4-d973-4b49-8861-1f6636a4ebab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.020dueMay242025Member_9e79818c-e453-4566-88e3-9fbc0f8896fc" xlink:href="bdx-20220331.xsd#bdx_Notes3.020dueMay242025Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_bdx_Notes3.020dueMay242025Member_9e79818c-e453-4566-88e3-9fbc0f8896fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0.632dueJune42023Member_dfd0d856-e03a-4b7c-b547-35058e5edef7" xlink:href="bdx-20220331.xsd#bdx_Notes0.632dueJune42023Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_bdx_Notes0.632dueJune42023Member_dfd0d856-e03a-4b7c-b547-35058e5edef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.208dueJune42026Member_73653311-f4b1-4f5b-bc5c-9b36d1ffd1e7" xlink:href="bdx-20220331.xsd#bdx_Notes1.208dueJune42026Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_bdx_Notes1.208dueJune42026Member_73653311-f4b1-4f5b-bc5c-9b36d1ffd1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1213NotesDueFebruary122036Member_923d3886-60c0-45c0-bcb6-d6328d37495e" xlink:href="bdx-20220331.xsd#bdx_Notes1213NotesDueFebruary122036Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_bdx_Notes1213NotesDueFebruary122036Member_923d3886-60c0-45c0-bcb6-d6328d37495e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0000DueAugust132023Member_d1561611-bcf6-465e-8160-9b7cd742489e" xlink:href="bdx-20220331.xsd#bdx_Notes0000DueAugust132023Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_bdx_Notes0000DueAugust132023Member_d1561611-bcf6-465e-8160-9b7cd742489e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0034DueAugust132025Member_5314ab4e-eb4c-4d1e-8083-bb8d66059431" xlink:href="bdx-20220331.xsd#bdx_Notes0034DueAugust132025Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_5075e587-3ff3-4ad9-8d3f-dffc86b20636" xlink:to="loc_bdx_Notes0034DueAugust132025Member_5314ab4e-eb4c-4d1e-8083-bb8d66059431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_75c73b2b-dc31-4b26-a57e-3317dd22e6e7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_da9238b3-424e-4f28-8d77-10e0ec133b41" xlink:to="loc_dei_EntityListingsExchangeAxis_75c73b2b-dc31-4b26-a57e-3317dd22e6e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_09c6c824-e6fe-4cfb-a5d0-7f63cacaefcf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_75c73b2b-dc31-4b26-a57e-3317dd22e6e7" xlink:to="loc_dei_ExchangeDomain_09c6c824-e6fe-4cfb-a5d0-7f63cacaefcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_546cfe34-8924-4a2a-984c-82107f7974c1" xlink:href="https://xbrl.sec.gov/exch/2021/exch-2021.xsd#exch_XNYS"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_09c6c824-e6fe-4cfb-a5d0-7f63cacaefcf" xlink:to="loc_exch_XNYS_546cfe34-8924-4a2a-984c-82107f7974c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_da9238b3-424e-4f28-8d77-10e0ec133b41" xlink:to="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_a0472a9e-7eab-43d1-ae71-0202749cdaf2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_DocumentType_a0472a9e-7eab-43d1-ae71-0202749cdaf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_bdb26964-3a6f-4b96-8199-d56c457c1100" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_DocumentQuarterlyReport_bdb26964-3a6f-4b96-8199-d56c457c1100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a675835a-b85c-48d1-8cae-21af71c67717" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_DocumentPeriodEndDate_a675835a-b85c-48d1-8cae-21af71c67717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_82debf04-31e8-4017-b304-1e10e1b1e652" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_DocumentTransitionReport_82debf04-31e8-4017-b304-1e10e1b1e652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_281a150f-11b2-403b-befc-62c64882bd6d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityFileNumber_281a150f-11b2-403b-befc-62c64882bd6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_4516ff59-61b0-4c88-bf46-df805d31f1c8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityRegistrantName_4516ff59-61b0-4c88-bf46-df805d31f1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_fa9ebadc-7ca0-47e2-a1aa-796acbb455b7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityCentralIndexKey_fa9ebadc-7ca0-47e2-a1aa-796acbb455b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_23f2aac6-17ec-49db-8d38-d474bfa3f6e5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_CurrentFiscalYearEndDate_23f2aac6-17ec-49db-8d38-d474bfa3f6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_5805a9da-3ea6-41cb-80a5-508f0d0a6d53" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_DocumentFiscalYearFocus_5805a9da-3ea6-41cb-80a5-508f0d0a6d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_b0381a86-eb47-42f2-b1db-16de766a5e5e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_DocumentFiscalPeriodFocus_b0381a86-eb47-42f2-b1db-16de766a5e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f3c71fe1-cfcc-4a0b-b121-9b279aab9085" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_AmendmentFlag_f3c71fe1-cfcc-4a0b-b121-9b279aab9085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_92ff34ae-aabc-41c9-8562-87845a2bf976" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityIncorporationStateCountryCode_92ff34ae-aabc-41c9-8562-87845a2bf976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_057bdee7-9b4a-4d0e-b36c-5c8ae62fadee" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityTaxIdentificationNumber_057bdee7-9b4a-4d0e-b36c-5c8ae62fadee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_69ce6a50-99d4-4d61-a6c8-b5c35baf4e21" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityAddressAddressLine1_69ce6a50-99d4-4d61-a6c8-b5c35baf4e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_26ff16d8-db2d-4b23-9ab4-757df289cc09" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityAddressCityOrTown_26ff16d8-db2d-4b23-9ab4-757df289cc09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ff56ec5e-413a-41a0-8f02-f5705a7ab415" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityAddressStateOrProvince_ff56ec5e-413a-41a0-8f02-f5705a7ab415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2c98dd3d-6fc7-4837-8726-8d42b2519fc6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityAddressPostalZipCode_2c98dd3d-6fc7-4837-8726-8d42b2519fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_bd910b89-e9de-4977-943e-23060f3940c2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_CityAreaCode_bd910b89-e9de-4977-943e-23060f3940c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3fc1fbeb-8708-4d7e-b8b5-de786bdd8a5e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_LocalPhoneNumber_3fc1fbeb-8708-4d7e-b8b5-de786bdd8a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_96699d0e-505d-40d8-b95b-e6b4a086210d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_Security12bTitle_96699d0e-505d-40d8-b95b-e6b4a086210d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_2024590f-6a64-4b0f-89cd-f1be2b502bec" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_TradingSymbol_2024590f-6a64-4b0f-89cd-f1be2b502bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_ac5e64d3-f271-4a93-adc4-3c3a2a3a4bf3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_SecurityExchangeName_ac5e64d3-f271-4a93-adc4-3c3a2a3a4bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_606ccf37-2392-4878-9b83-4e8083acdab0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityCurrentReportingStatus_606ccf37-2392-4878-9b83-4e8083acdab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_117fd114-c692-4528-97dc-e8a6241da76f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityInteractiveDataCurrent_117fd114-c692-4528-97dc-e8a6241da76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_26aaadb4-e1f0-4d82-8e12-1af35c0985a3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityFilerCategory_26aaadb4-e1f0-4d82-8e12-1af35c0985a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_33c0ed7e-048e-4d73-9958-85c2059b6125" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntitySmallBusiness_33c0ed7e-048e-4d73-9958-85c2059b6125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_32e355ec-b7db-45e4-89cd-1f64ee8a3482" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityEmergingGrowthCompany_32e355ec-b7db-45e4-89cd-1f64ee8a3482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_4021c280-3284-4b3f-ab48-d80b76215920" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityShellCompany_4021c280-3284-4b3f-ab48-d80b76215920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_bc974c9e-75fd-4691-87d2-ab5b2c8d75d5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_cd410888-e074-4c93-ab82-88de7c21d614" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_bc974c9e-75fd-4691-87d2-ab5b2c8d75d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="bdx-20220331.xsd#CondensedConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a8924566-84b9-46f3-bd2d-7591523089cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_us-gaap_Revenues_a8924566-84b9-46f3-bd2d-7591523089cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ec552827-c6e1-4e29-819e-6e1636ba8617" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ec552827-c6e1-4e29-819e-6e1636ba8617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6549b7d3-750f-4f6c-bd19-0cde45b45eae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6549b7d3-750f-4f6c-bd19-0cde45b45eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c42f3ce8-35c1-44d7-8180-9a678be681e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c42f3ce8-35c1-44d7-8180-9a678be681e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_642c5a97-35aa-4509-9fb8-75fa3efa82ac" xlink:href="bdx-20220331.xsd#bdx_AcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_642c5a97-35aa-4509-9fb8-75fa3efa82ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_ff8746a2-6129-4a12-a3b6-82980a1d4610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_ff8746a2-6129-4a12-a3b6-82980a1d4610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_1c277697-2d0a-4938-b000-41ec289f8b52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_us-gaap_CostsAndExpenses_1c277697-2d0a-4938-b000-41ec289f8b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_83c94a5f-4448-491b-95f2-2f898aa3c1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_us-gaap_OperatingIncomeLoss_83c94a5f-4448-491b-95f2-2f898aa3c1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_09912d08-d355-42ff-b78b-aba0555d8efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_us-gaap_InterestExpense_09912d08-d355-42ff-b78b-aba0555d8efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_ad7655a3-e309-4a0a-b25a-fe8861a67f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_us-gaap_InvestmentIncomeInterest_ad7655a3-e309-4a0a-b25a-fe8861a67f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_df3f8241-bc20-42ac-b70c-39d8828b226b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_df3f8241-bc20-42ac-b70c-39d8828b226b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d2fadda3-a18d-4dbe-ba94-b8e8b6b2fe5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d2fadda3-a18d-4dbe-ba94-b8e8b6b2fe5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_97cf3ba3-ffe0-4dba-86d9-7d4f8b9ad68c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_97cf3ba3-ffe0-4dba-86d9-7d4f8b9ad68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cd7de4da-0495-4078-a8bb-e77c601d44fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_us-gaap_NetIncomeLoss_cd7de4da-0495-4078-a8bb-e77c601d44fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_9af056cc-0e82-4342-a076-816c2a8c9785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_9af056cc-0e82-4342-a076-816c2a8c9785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_afd214d3-3cb1-472b-b759-503e9258583e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_afd214d3-3cb1-472b-b759-503e9258583e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e15d2d59-65d9-41f6-8bd0-f5fe06ee5127" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_us-gaap_EarningsPerShareBasic_e15d2d59-65d9-41f6-8bd0-f5fe06ee5127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d8e4c582-3d92-4aff-b15c-b3b3808534de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d8e4c582-3d92-4aff-b15c-b3b3808534de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_8f97ece0-a093-4500-a188-919c20d50b79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4d457fd5-2be0-4237-a09e-06beca40a046" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_8f97ece0-a093-4500-a188-919c20d50b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="bdx-20220331.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3462bea3-275b-49d5-b808-956994f79268" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3156e661-5453-472d-ab09-b3473b595874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3462bea3-275b-49d5-b808-956994f79268" xlink:to="loc_us-gaap_NetIncomeLoss_3156e661-5453-472d-ab09-b3473b595874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_91ce9d3c-1398-4262-a653-fe68ad08e2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3462bea3-275b-49d5-b808-956994f79268" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_91ce9d3c-1398-4262-a653-fe68ad08e2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_04573e80-86a4-4cde-a4a4-422894b4aeb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_91ce9d3c-1398-4262-a653-fe68ad08e2ef" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_04573e80-86a4-4cde-a4a4-422894b4aeb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4a98f607-fd27-46ac-b74d-9368f5433566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_91ce9d3c-1398-4262-a653-fe68ad08e2ef" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4a98f607-fd27-46ac-b74d-9368f5433566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_885d7aea-2e83-4080-9718-203827be2a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_91ce9d3c-1398-4262-a653-fe68ad08e2ef" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_885d7aea-2e83-4080-9718-203827be2a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a5f823fd-ca35-4c75-9513-342224e48e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_91ce9d3c-1398-4262-a653-fe68ad08e2ef" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a5f823fd-ca35-4c75-9513-342224e48e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_9186858a-bc02-4444-934b-a07feb3283bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3462bea3-275b-49d5-b808-956994f79268" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_9186858a-bc02-4444-934b-a07feb3283bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="bdx-20220331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d848c1f7-a20e-4edc-852f-2492c0bda861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_8aee5563-5e73-41fd-ad58-e92176b62a52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d848c1f7-a20e-4edc-852f-2492c0bda861" xlink:to="loc_us-gaap_AssetsAbstract_8aee5563-5e73-41fd-ad58-e92176b62a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_c4fc138f-e869-4ecb-943d-296edf8fc880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8aee5563-5e73-41fd-ad58-e92176b62a52" xlink:to="loc_us-gaap_AssetsCurrentAbstract_c4fc138f-e869-4ecb-943d-296edf8fc880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c9abb9d3-d423-44b4-b22c-d69260fcd34b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c4fc138f-e869-4ecb-943d-296edf8fc880" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c9abb9d3-d423-44b4-b22c-d69260fcd34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_c3817bfa-5e69-4958-ad0b-bb3a0bf30f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c4fc138f-e869-4ecb-943d-296edf8fc880" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_c3817bfa-5e69-4958-ad0b-bb3a0bf30f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermInvestments_b01d9800-e026-4eb1-9a70-f0aa52a99912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c4fc138f-e869-4ecb-943d-296edf8fc880" xlink:to="loc_us-gaap_OtherShortTermInvestments_b01d9800-e026-4eb1-9a70-f0aa52a99912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_26d1f3c6-24d9-4a86-ba3e-377089fea613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c4fc138f-e869-4ecb-943d-296edf8fc880" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_26d1f3c6-24d9-4a86-ba3e-377089fea613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_2154fa6f-981e-4828-a23a-5ef9e5d2b1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c4fc138f-e869-4ecb-943d-296edf8fc880" xlink:to="loc_us-gaap_InventoryNetAbstract_2154fa6f-981e-4828-a23a-5ef9e5d2b1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_6af06af8-4197-4fc4-9ddb-57fe31e4e3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_2154fa6f-981e-4828-a23a-5ef9e5d2b1f3" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_6af06af8-4197-4fc4-9ddb-57fe31e4e3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9aac85b6-c0f7-4896-a50e-9c562b818f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_2154fa6f-981e-4828-a23a-5ef9e5d2b1f3" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9aac85b6-c0f7-4896-a50e-9c562b818f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_df4892f2-5171-49b3-97a1-7160837e0f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_2154fa6f-981e-4828-a23a-5ef9e5d2b1f3" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_df4892f2-5171-49b3-97a1-7160837e0f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_6c099d57-08ad-4279-8245-47f489ba8586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_2154fa6f-981e-4828-a23a-5ef9e5d2b1f3" xlink:to="loc_us-gaap_InventoryNet_6c099d57-08ad-4279-8245-47f489ba8586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_00d38f35-ab1f-4ebf-a723-d0d75fe3a51d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c4fc138f-e869-4ecb-943d-296edf8fc880" xlink:to="loc_us-gaap_OtherAssetsCurrent_00d38f35-ab1f-4ebf-a723-d0d75fe3a51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cb2ba033-6e41-4a45-b2ae-ded640f1779e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c4fc138f-e869-4ecb-943d-296edf8fc880" xlink:to="loc_us-gaap_AssetsCurrent_cb2ba033-6e41-4a45-b2ae-ded640f1779e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6e9e9ab4-5760-4dcd-9252-3c6becfa93d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8aee5563-5e73-41fd-ad58-e92176b62a52" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6e9e9ab4-5760-4dcd-9252-3c6becfa93d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c767d0d7-83fb-4a00-8ada-332624298d07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8aee5563-5e73-41fd-ad58-e92176b62a52" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c767d0d7-83fb-4a00-8ada-332624298d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8cb2f4b1-6c16-42ad-ae30-b63efcb6205a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8aee5563-5e73-41fd-ad58-e92176b62a52" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8cb2f4b1-6c16-42ad-ae30-b63efcb6205a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_08830f6e-9494-4723-a7d9-18c48ab3d720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8aee5563-5e73-41fd-ad58-e92176b62a52" xlink:to="loc_us-gaap_Goodwill_08830f6e-9494-4723-a7d9-18c48ab3d720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CoreAndDevelopedTechnologyNet_09c282f8-ec34-4146-b314-02b9ad6c5a0a" xlink:href="bdx-20220331.xsd#bdx_CoreAndDevelopedTechnologyNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8aee5563-5e73-41fd-ad58-e92176b62a52" xlink:to="loc_bdx_CoreAndDevelopedTechnologyNet_09c282f8-ec34-4146-b314-02b9ad6c5a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteLivedCustomerRelationshipsNet_53251347-3a2b-497b-b5cd-9a2db7949774" xlink:href="bdx-20220331.xsd#bdx_FiniteLivedCustomerRelationshipsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8aee5563-5e73-41fd-ad58-e92176b62a52" xlink:to="loc_bdx_FiniteLivedCustomerRelationshipsNet_53251347-3a2b-497b-b5cd-9a2db7949774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet_c794d19b-707b-494d-a008-d7a51587032e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8aee5563-5e73-41fd-ad58-e92176b62a52" xlink:to="loc_us-gaap_OtherIntangibleAssetsNet_c794d19b-707b-494d-a008-d7a51587032e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_37ab102f-a905-4317-a1f8-ae0d1b6ce550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8aee5563-5e73-41fd-ad58-e92176b62a52" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_37ab102f-a905-4317-a1f8-ae0d1b6ce550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_156696bf-1c71-4bb1-9561-3a4fad5cec5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8aee5563-5e73-41fd-ad58-e92176b62a52" xlink:to="loc_us-gaap_Assets_156696bf-1c71-4bb1-9561-3a4fad5cec5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f85b666-9828-4583-a354-cc0c3a172a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d848c1f7-a20e-4edc-852f-2492c0bda861" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f85b666-9828-4583-a354-cc0c3a172a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_809f6e59-2c3d-4430-8754-9666d05a3bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f85b666-9828-4583-a354-cc0c3a172a6c" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_809f6e59-2c3d-4430-8754-9666d05a3bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_24b92431-62b1-41bd-abc9-8e46790ff54a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_809f6e59-2c3d-4430-8754-9666d05a3bf6" xlink:to="loc_us-gaap_DebtCurrent_24b92431-62b1-41bd-abc9-8e46790ff54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_c36bf333-8d89-49eb-bbb3-f16b78d0b12a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_809f6e59-2c3d-4430-8754-9666d05a3bf6" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_c36bf333-8d89-49eb-bbb3-f16b78d0b12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b64ac655-ae6a-4069-be97-02fe36c3dea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_809f6e59-2c3d-4430-8754-9666d05a3bf6" xlink:to="loc_us-gaap_LiabilitiesCurrent_b64ac655-ae6a-4069-be97-02fe36c3dea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_3bb49c0e-4e42-4d4b-b0de-a0e989dbce78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f85b666-9828-4583-a354-cc0c3a172a6c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_3bb49c0e-4e42-4d4b-b0de-a0e989dbce78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_57b4a1dc-ca2e-4c4f-bb84-80358e8a282e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f85b666-9828-4583-a354-cc0c3a172a6c" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_57b4a1dc-ca2e-4c4f-bb84-80358e8a282e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7fb3b0e1-ef66-4ac4-8fa1-d19053864b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f85b666-9828-4583-a354-cc0c3a172a6c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7fb3b0e1-ef66-4ac4-8fa1-d19053864b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_1ec31721-f27a-476f-94a3-bb5a4490ea87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f85b666-9828-4583-a354-cc0c3a172a6c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_1ec31721-f27a-476f-94a3-bb5a4490ea87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_43158ff2-e564-4ec4-83db-4be774bf3280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f85b666-9828-4583-a354-cc0c3a172a6c" xlink:to="loc_us-gaap_StockholdersEquityAbstract_43158ff2-e564-4ec4-83db-4be774bf3280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_2b36f62f-d4c7-4622-a672-f14562655c15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43158ff2-e564-4ec4-83db-4be774bf3280" xlink:to="loc_us-gaap_PreferredStockValue_2b36f62f-d4c7-4622-a672-f14562655c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ea074adc-38fe-4c9f-8344-be2d9da57f75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43158ff2-e564-4ec4-83db-4be774bf3280" xlink:to="loc_us-gaap_CommonStockValue_ea074adc-38fe-4c9f-8344-be2d9da57f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5ea8f724-0051-4179-8629-4557dde47e63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43158ff2-e564-4ec4-83db-4be774bf3280" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5ea8f724-0051-4179-8629-4557dde47e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_437a9c7c-85d8-45f2-921f-672f916e5c01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43158ff2-e564-4ec4-83db-4be774bf3280" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_437a9c7c-85d8-45f2-921f-672f916e5c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockSharesHeldInEmployeeTrust1_1e00544c-34d9-44f2-a5b3-e94440e6847a" xlink:href="bdx-20220331.xsd#bdx_CommonStockSharesHeldInEmployeeTrust1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43158ff2-e564-4ec4-83db-4be774bf3280" xlink:to="loc_bdx_CommonStockSharesHeldInEmployeeTrust1_1e00544c-34d9-44f2-a5b3-e94440e6847a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_afe3f2fe-51ac-4387-8c32-969e593fe275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43158ff2-e564-4ec4-83db-4be774bf3280" xlink:to="loc_us-gaap_TreasuryStockValue_afe3f2fe-51ac-4387-8c32-969e593fe275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1356ba3a-fa91-472e-aa54-ec5adf554ede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43158ff2-e564-4ec4-83db-4be774bf3280" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1356ba3a-fa91-472e-aa54-ec5adf554ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_38ac061c-3656-4403-973e-bbcdb814b3bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43158ff2-e564-4ec4-83db-4be774bf3280" xlink:to="loc_us-gaap_StockholdersEquity_38ac061c-3656-4403-973e-bbcdb814b3bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5b8bfbfa-b2ad-42c7-a996-ea0d0f9a565c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f85b666-9828-4583-a354-cc0c3a172a6c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_5b8bfbfa-b2ad-42c7-a996-ea0d0f9a565c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="bdx-20220331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_bd5002a0-c230-475a-bddc-2ed80081e542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_152b784f-ef83-4309-a48b-bb2b8bfadc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bd5002a0-c230-475a-bddc-2ed80081e542" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_152b784f-ef83-4309-a48b-bb2b8bfadc5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5a7ba600-44ba-4c90-88cc-db140223b84e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_152b784f-ef83-4309-a48b-bb2b8bfadc5a" xlink:to="loc_us-gaap_NetIncomeLoss_5a7ba600-44ba-4c90-88cc-db140223b84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d0b60bb9-043f-47ca-b3eb-e78a654c76d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_152b784f-ef83-4309-a48b-bb2b8bfadc5a" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d0b60bb9-043f-47ca-b3eb-e78a654c76d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_72869d31-0a78-46f0-a630-ad7a6cd4f1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d0b60bb9-043f-47ca-b3eb-e78a654c76d8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_72869d31-0a78-46f0-a630-ad7a6cd4f1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ed6a8baa-daea-43a0-a912-ac0392b9fe34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d0b60bb9-043f-47ca-b3eb-e78a654c76d8" xlink:to="loc_us-gaap_ShareBasedCompensation_ed6a8baa-daea-43a0-a912-ac0392b9fe34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_b1e94778-075f-493a-a5b6-66bf9ca70134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d0b60bb9-043f-47ca-b3eb-e78a654c76d8" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_b1e94778-075f-493a-a5b6-66bf9ca70134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_77d1cad9-b054-4dc6-a5ce-c3247abbe94f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d0b60bb9-043f-47ca-b3eb-e78a654c76d8" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapital_77d1cad9-b054-4dc6-a5ce-c3247abbe94f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IncreaseDecreaseinPensionBenefitObligation_5589cc83-ecc4-41ce-ae4a-4e8892dc9d24" xlink:href="bdx-20220331.xsd#bdx_IncreaseDecreaseinPensionBenefitObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d0b60bb9-043f-47ca-b3eb-e78a654c76d8" xlink:to="loc_bdx_IncreaseDecreaseinPensionBenefitObligation_5589cc83-ecc4-41ce-ae4a-4e8892dc9d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_773e8d83-9f2f-4955-b110-bfefd792b232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d0b60bb9-043f-47ca-b3eb-e78a654c76d8" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_773e8d83-9f2f-4955-b110-bfefd792b232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_89965cbd-3ccf-4c59-a673-0cc666b4cc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d0b60bb9-043f-47ca-b3eb-e78a654c76d8" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_89965cbd-3ccf-4c59-a673-0cc666b4cc5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2df62f8e-f456-4e90-b96d-6cd20b5dfc00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d0b60bb9-043f-47ca-b3eb-e78a654c76d8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2df62f8e-f456-4e90-b96d-6cd20b5dfc00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4f8fabdd-b35b-4d9b-9cc5-aa8e6be64106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bd5002a0-c230-475a-bddc-2ed80081e542" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4f8fabdd-b35b-4d9b-9cc5-aa8e6be64106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2fe0d732-7e4b-48f1-8e41-5481da62dec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4f8fabdd-b35b-4d9b-9cc5-aa8e6be64106" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2fe0d732-7e4b-48f1-8e41-5481da62dec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_23ea52c8-973b-4377-bf4a-3d897033f3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4f8fabdd-b35b-4d9b-9cc5-aa8e6be64106" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_23ea52c8-973b-4377-bf4a-3d897033f3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_65d5097e-19f5-466b-85e9-37df3c85fc98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4f8fabdd-b35b-4d9b-9cc5-aa8e6be64106" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_65d5097e-19f5-466b-85e9-37df3c85fc98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_405945c3-d259-44e7-ac56-e10d70d573e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4f8fabdd-b35b-4d9b-9cc5-aa8e6be64106" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_405945c3-d259-44e7-ac56-e10d70d573e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2f9a6e2a-854a-4a50-afab-a8e6dbbe2818" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bd5002a0-c230-475a-bddc-2ed80081e542" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2f9a6e2a-854a-4a50-afab-a8e6dbbe2818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans_cb3d2b2c-6bde-41c0-b2b8-47ee89f6985e" xlink:href="bdx-20220331.xsd#bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2f9a6e2a-854a-4a50-afab-a8e6dbbe2818" xlink:to="loc_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans_cb3d2b2c-6bde-41c0-b2b8-47ee89f6985e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_3bb1b01f-40e2-4d80-8246-157980a2c621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2f9a6e2a-854a-4a50-afab-a8e6dbbe2818" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_3bb1b01f-40e2-4d80-8246-157980a2c621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_2f47eaf6-98aa-45cf-a569-dae0761de330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2f9a6e2a-854a-4a50-afab-a8e6dbbe2818" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_2f47eaf6-98aa-45cf-a569-dae0761de330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_2df4ea0d-dbd6-4bdc-9ece-c2978c730bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2f9a6e2a-854a-4a50-afab-a8e6dbbe2818" xlink:to="loc_us-gaap_PaymentsOfDividends_2df4ea0d-dbd6-4bdc-9ece-c2978c730bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_cf26c978-0ee0-4ebb-827c-514fd950fc4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2f9a6e2a-854a-4a50-afab-a8e6dbbe2818" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_cf26c978-0ee0-4ebb-827c-514fd950fc4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_25de7652-320c-43fa-8ce3-bcae009e7c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2f9a6e2a-854a-4a50-afab-a8e6dbbe2818" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_25de7652-320c-43fa-8ce3-bcae009e7c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7305039a-bd0b-43fb-bc1c-0c135fa8fa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bd5002a0-c230-475a-bddc-2ed80081e542" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7305039a-bd0b-43fb-bc1c-0c135fa8fa2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ddaa6c20-e658-42d1-89f0-28c2e81891e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bd5002a0-c230-475a-bddc-2ed80081e542" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ddaa6c20-e658-42d1-89f0-28c2e81891e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8ca88c22-faf4-4534-ad6d-80f9d9f421c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bd5002a0-c230-475a-bddc-2ed80081e542" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8ca88c22-faf4-4534-ad6d-80f9d9f421c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_53cbe59c-55f8-4c1c-b4a8-7efcef30fed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bd5002a0-c230-475a-bddc-2ed80081e542" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_53cbe59c-55f8-4c1c-b4a8-7efcef30fed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BasisofPresentation" xlink:type="simple" xlink:href="bdx-20220331.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3846c3c5-4d1d-4f0b-a7d7-e6132a7ca02a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_6579f64e-8f75-40fa-be26-15924de09c30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3846c3c5-4d1d-4f0b-a7d7-e6132a7ca02a" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_6579f64e-8f75-40fa-be26-15924de09c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="bdx-20220331.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_af2c9d9b-7a92-4cac-8b06-9940f1c099e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_a863d317-b275-475c-a061-c6c22c3258a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_af2c9d9b-7a92-4cac-8b06-9940f1c099e2" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_a863d317-b275-475c-a061-c6c22c3258a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="bdx-20220331.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_305f7180-f2f8-4c29-a5e4-bb2959970080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_f5a4a937-1bf9-407f-8c91-80ed55248b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_305f7180-f2f8-4c29-a5e4-bb2959970080" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_f5a4a937-1bf9-407f-8c91-80ed55248b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_cde26382-7ee9-480f-814c-f3dcd189fefc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_305f7180-f2f8-4c29-a5e4-bb2959970080" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_cde26382-7ee9-480f-814c-f3dcd189fefc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails" xlink:type="simple" xlink:href="bdx-20220331.xsd#ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_6217670c-5541-48fb-9a80-70c931232cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ba1c9316-35b5-49aa-a388-194c0723b5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_6217670c-5541-48fb-9a80-70c931232cb0" xlink:to="loc_us-gaap_StatementTable_ba1c9316-35b5-49aa-a388-194c0723b5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d93e791e-06dd-4ce3-b3c8-df10d85587cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ba1c9316-35b5-49aa-a388-194c0723b5d6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d93e791e-06dd-4ce3-b3c8-df10d85587cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8df3ffaa-3988-4d24-ba4f-46cc4713261a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d93e791e-06dd-4ce3-b3c8-df10d85587cf" xlink:to="loc_us-gaap_EquityComponentDomain_8df3ffaa-3988-4d24-ba4f-46cc4713261a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_20d2b6c3-fc40-4acf-bb05-a1518df78fde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8df3ffaa-3988-4d24-ba4f-46cc4713261a" xlink:to="loc_us-gaap_CommonStockMember_20d2b6c3-fc40-4acf-bb05-a1518df78fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8c6f1ab1-b31a-4366-ab5f-89167ac01b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8df3ffaa-3988-4d24-ba4f-46cc4713261a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8c6f1ab1-b31a-4366-ab5f-89167ac01b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_351fa519-00d6-4d63-bd35-2a0bdfc2d99b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8df3ffaa-3988-4d24-ba4f-46cc4713261a" xlink:to="loc_us-gaap_RetainedEarningsMember_351fa519-00d6-4d63-bd35-2a0bdfc2d99b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_e9e7d2e7-123c-4cbc-b631-a782e7d8583e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8df3ffaa-3988-4d24-ba4f-46cc4713261a" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_e9e7d2e7-123c-4cbc-b631-a782e7d8583e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_c097ce70-f41f-4a24-9cba-96ee448469a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8df3ffaa-3988-4d24-ba4f-46cc4713261a" xlink:to="loc_us-gaap_TreasuryStockMember_c097ce70-f41f-4a24-9cba-96ee448469a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_33b4fa04-58f8-4ff8-b438-75aeb8f11869" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ba1c9316-35b5-49aa-a388-194c0723b5d6" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_33b4fa04-58f8-4ff8-b438-75aeb8f11869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f556558a-3849-41f2-9b90-bc5bb2606a0f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_33b4fa04-58f8-4ff8-b438-75aeb8f11869" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f556558a-3849-41f2-9b90-bc5bb2606a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9ffb8c30-fa23-44c4-8b98-32edf3538079" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f556558a-3849-41f2-9b90-bc5bb2606a0f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9ffb8c30-fa23-44c4-8b98-32edf3538079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ba1c9316-35b5-49aa-a388-194c0723b5d6" xlink:to="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_25036b42-7261-44ed-adcf-52d8a4b3b912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_StockholdersEquity_25036b42-7261-44ed-adcf-52d8a4b3b912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_ef7cf3b0-d8be-4fa6-82a0-f11d2dc027bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_TreasuryStockShares_ef7cf3b0-d8be-4fa6-82a0-f11d2dc027bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_101f802c-3edb-47d6-92c2-cae1121519e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_NetIncomeLoss_101f802c-3edb-47d6-92c2-cae1121519e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_5bffd5cb-698e-4264-859e-85f731d6b28f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_DividendsCommonStockCash_5bffd5cb-698e-4264-859e-85f731d6b28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStock_1307fcc7-7333-46ab-a979-b78c49c0a55f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_DividendsPreferredStock_1307fcc7-7333-46ab-a979-b78c49c0a55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9071d523-9ce1-49e7-8c6c-a0d4232acbfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9071d523-9ce1-49e7-8c6c-a0d4232acbfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1d0c0947-46b6-4631-81d9-7109bde8b3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1d0c0947-46b6-4631-81d9-7109bde8b3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4d7f0a30-694a-4407-b4da-cf6402067df2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4d7f0a30-694a-4407-b4da-cf6402067df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockHeldInTrustsNetShares_b821ea05-65a4-45bb-8980-aaa8bf717e8e" xlink:href="bdx-20220331.xsd#bdx_CommonStockHeldInTrustsNetShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_bdx_CommonStockHeldInTrustsNetShares_b821ea05-65a4-45bb-8980-aaa8bf717e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_eb644247-83d1-4b31-bd73-9d66050ad23f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_eb644247-83d1-4b31-bd73-9d66050ad23f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_74f20c55-a40e-449b-8aeb-cc9662da5912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_74f20c55-a40e-449b-8aeb-cc9662da5912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockHeldInTrustsAcquired_f04ca510-cad1-4cea-9e10-6d590fd1e91e" xlink:href="bdx-20220331.xsd#bdx_CommonStockHeldInTrustsAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_bdx_CommonStockHeldInTrustsAcquired_f04ca510-cad1-4cea-9e10-6d590fd1e91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_4e77300a-b203-47c2-95fc-617cbe0055e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_StockholdersEquityOther_4e77300a-b203-47c2-95fc-617cbe0055e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_961ac131-0e73-4b62-8be9-1e653c8592c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_StockholdersEquity_961ac131-0e73-4b62-8be9-1e653c8592c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_fb0a1078-d448-47fe-80fc-081b5c926824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_TreasuryStockShares_fb0a1078-d448-47fe-80fc-081b5c926824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_16549682-30e1-4737-bf4e-214818420991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_16549682-30e1-4737-bf4e-214818420991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_3bc413a7-66d1-42ce-a539-3da613f51123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_3bc413a7-66d1-42ce-a539-3da613f51123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_94bc220b-c420-4866-acc0-467e4dcdbf4e" xlink:href="bdx-20220331.xsd#bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9cddc87-4561-496e-892c-5c1b483db1c0" xlink:to="loc_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_94bc220b-c420-4866-acc0-467e4dcdbf4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_3cfbd35b-17ab-4054-adde-af43ece43536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c1369bdf-b379-4ace-bfd6-678c456a3e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_3cfbd35b-17ab-4054-adde-af43ece43536" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c1369bdf-b379-4ace-bfd6-678c456a3e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6564227c-804d-4aeb-8304-fc7eda9c1be1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c1369bdf-b379-4ace-bfd6-678c456a3e4a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6564227c-804d-4aeb-8304-fc7eda9c1be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ef1ccad1-12a8-4b82-9322-9b28df22705e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6564227c-804d-4aeb-8304-fc7eda9c1be1" xlink:to="loc_us-gaap_EquityComponentDomain_ef1ccad1-12a8-4b82-9322-9b28df22705e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_78ef6dce-d3af-4dfc-8be6-e94efcefa684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ef1ccad1-12a8-4b82-9322-9b28df22705e" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_78ef6dce-d3af-4dfc-8be6-e94efcefa684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b73399fd-f987-4b37-b7e6-c6276c0706db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ef1ccad1-12a8-4b82-9322-9b28df22705e" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b73399fd-f987-4b37-b7e6-c6276c0706db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_3a016595-6c85-471e-8552-cbc317d3489b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ef1ccad1-12a8-4b82-9322-9b28df22705e" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_3a016595-6c85-471e-8552-cbc317d3489b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b1525734-3e09-4af9-9629-7ed6ba40ff83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c1369bdf-b379-4ace-bfd6-678c456a3e4a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b1525734-3e09-4af9-9629-7ed6ba40ff83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_62d1bdb9-3fe9-4fa1-8eb9-eaaba0e36b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b1525734-3e09-4af9-9629-7ed6ba40ff83" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_62d1bdb9-3fe9-4fa1-8eb9-eaaba0e36b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_588c9e7d-b48d-4937-aa6d-62bd8532333d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_62d1bdb9-3fe9-4fa1-8eb9-eaaba0e36b8f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_588c9e7d-b48d-4937-aa6d-62bd8532333d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_96bb6cbe-ee6c-400f-8658-2e6b30c156a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_62d1bdb9-3fe9-4fa1-8eb9-eaaba0e36b8f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_96bb6cbe-ee6c-400f-8658-2e6b30c156a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5199d3cf-4b6b-4543-95b7-59887f96fe01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_62d1bdb9-3fe9-4fa1-8eb9-eaaba0e36b8f" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5199d3cf-4b6b-4543-95b7-59887f96fe01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5a5da863-33e6-4a90-90fc-50140a4227a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_62d1bdb9-3fe9-4fa1-8eb9-eaaba0e36b8f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5a5da863-33e6-4a90-90fc-50140a4227a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/EarningsPerShare" xlink:type="simple" xlink:href="bdx-20220331.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3b6bbdb8-8fb9-4a99-a0cb-1eca024bb227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_9e93a6bc-03ff-4451-a1c6-09151f613a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3b6bbdb8-8fb9-4a99-a0cb-1eca024bb227" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_9e93a6bc-03ff-4451-a1c6-09151f613a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="bdx-20220331.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9c66e5fd-1ade-4c36-ba42-f09d8380444f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_3aa91a65-1dcb-4a7b-a3b6-92165f1341d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9c66e5fd-1ade-4c36-ba42-f09d8380444f" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_3aa91a65-1dcb-4a7b-a3b6-92165f1341d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9490ab11-e9bb-4a4a-83b3-329a327d1b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ffd579ac-b9f6-4a6b-b4b9-1cb6e0058b75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9490ab11-e9bb-4a4a-83b3-329a327d1b4e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ffd579ac-b9f6-4a6b-b4b9-1cb6e0058b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_07ba4896-495d-4b31-a415-5b3b403a97de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9490ab11-e9bb-4a4a-83b3-329a327d1b4e" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_07ba4896-495d-4b31-a415-5b3b403a97de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_f0101aa9-6a86-49d9-beb6-beb00a58b91e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9490ab11-e9bb-4a4a-83b3-329a327d1b4e" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_f0101aa9-6a86-49d9-beb6-beb00a58b91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bbbe578f-5e94-44e1-a9a8-23e46f8944ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9490ab11-e9bb-4a4a-83b3-329a327d1b4e" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bbbe578f-5e94-44e1-a9a8-23e46f8944ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1ab386b3-e04f-4fba-ba43-0426f28818bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9490ab11-e9bb-4a4a-83b3-329a327d1b4e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1ab386b3-e04f-4fba-ba43-0426f28818bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_318f20c4-8ecd-431b-ad28-f2a37613ddef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1ab386b3-e04f-4fba-ba43-0426f28818bb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_318f20c4-8ecd-431b-ad28-f2a37613ddef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5e01231e-baec-4590-9195-ae848de0f689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_318f20c4-8ecd-431b-ad28-f2a37613ddef" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5e01231e-baec-4590-9195-ae848de0f689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_0fb03cab-6e07-4e9d-a8a7-b89a03ae70e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5e01231e-baec-4590-9195-ae848de0f689" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_0fb03cab-6e07-4e9d-a8a7-b89a03ae70e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationMember_6f9ac244-372b-48f2-b9b6-acba03b2fa06" xlink:href="bdx-20220331.xsd#bdx_ShareBasedCompensationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5e01231e-baec-4590-9195-ae848de0f689" xlink:to="loc_bdx_ShareBasedCompensationMember_6f9ac244-372b-48f2-b9b6-acba03b2fa06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_61416361-3c46-4055-8d99-9a43651c022a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1ab386b3-e04f-4fba-ba43-0426f28818bb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_61416361-3c46-4055-8d99-9a43651c022a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b2e41f3a-b2df-4d7b-8df2-6fc80460ff35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_61416361-3c46-4055-8d99-9a43651c022a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b2e41f3a-b2df-4d7b-8df2-6fc80460ff35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/Contingencies" xlink:type="simple" xlink:href="bdx-20220331.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5bf72eac-af2e-429a-993d-e1463466c640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_dd9dc189-06a3-48be-97cf-160ee7b51624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5bf72eac-af2e-429a-993d-e1463466c640" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_dd9dc189-06a3-48be-97cf-160ee7b51624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ContingenciesPolicies" xlink:type="simple" xlink:href="bdx-20220331.xsd#ContingenciesPolicies"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ContingenciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ef01005c-0e88-4471-acaa-02f7a1d07efa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_370cec05-17f7-4128-b623-6b4d78befe5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ef01005c-0e88-4471-acaa-02f7a1d07efa" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_370cec05-17f7-4128-b623-6b4d78befe5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_eb9622d7-81ad-4097-a323-178045827400" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ef01005c-0e88-4471-acaa-02f7a1d07efa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_eb9622d7-81ad-4097-a323-178045827400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_7e1b3639-bc3d-4261-a671-77cddf11bf3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ef01005c-0e88-4471-acaa-02f7a1d07efa" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_7e1b3639-bc3d-4261-a671-77cddf11bf3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_7930f2ac-71ac-4ed7-a040-de954698142b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ef01005c-0e88-4471-acaa-02f7a1d07efa" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_7930f2ac-71ac-4ed7-a040-de954698142b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_c9c7183d-a2c3-433a-9f96-6629c1fa5f38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ef01005c-0e88-4471-acaa-02f7a1d07efa" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_c9c7183d-a2c3-433a-9f96-6629c1fa5f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_6bf7fb76-9955-49ea-9a78-6cd4e0c48b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ef01005c-0e88-4471-acaa-02f7a1d07efa" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_6bf7fb76-9955-49ea-9a78-6cd4e0c48b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ContingenciesDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#ContingenciesDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ContingenciesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_aead892f-e84e-400f-8e0c-e481bb021028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d8cc84cf-cd8b-4ccc-821b-427e857f9914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_aead892f-e84e-400f-8e0c-e481bb021028" xlink:to="loc_us-gaap_LossContingenciesTable_d8cc84cf-cd8b-4ccc-821b-427e857f9914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_eb066c1f-2ded-4511-8e68-d7205ee924ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d8cc84cf-cd8b-4ccc-821b-427e857f9914" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_eb066c1f-2ded-4511-8e68-d7205ee924ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_f9cc44d7-4e83-4d7f-b805-dd940f280690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_eb066c1f-2ded-4511-8e68-d7205ee924ae" xlink:to="loc_us-gaap_LossContingencyNatureDomain_f9cc44d7-4e83-4d7f-b805-dd940f280690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_HerniaProductClaimsMember_fe3ea724-0f78-4179-99a8-87bef845a8fd" xlink:href="bdx-20220331.xsd#bdx_HerniaProductClaimsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_f9cc44d7-4e83-4d7f-b805-dd940f280690" xlink:to="loc_bdx_HerniaProductClaimsMember_fe3ea724-0f78-4179-99a8-87bef845a8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_34b00d4c-2c02-4286-b20e-bb75cd2f46e1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d8cc84cf-cd8b-4ccc-821b-427e857f9914" xlink:to="loc_srt_StatementGeographicalAxis_34b00d4c-2c02-4286-b20e-bb75cd2f46e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0bcb3737-9773-4b0b-aa60-67bc4133f4a5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_34b00d4c-2c02-4286-b20e-bb75cd2f46e1" xlink:to="loc_srt_SegmentGeographicalDomain_0bcb3737-9773-4b0b-aa60-67bc4133f4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_GA_58556198-87f0-4c2d-8edb-386003eb53b6" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_GA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0bcb3737-9773-4b0b-aa60-67bc4133f4a5" xlink:to="loc_stpr_GA_58556198-87f0-4c2d-8edb-386003eb53b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_3cd6224d-a13d-4f8c-a703-dbd4646c109b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d8cc84cf-cd8b-4ccc-821b-427e857f9914" xlink:to="loc_us-gaap_LossContingenciesLineItems_3cd6224d-a13d-4f8c-a703-dbd4646c109b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_f2c7b33b-fc28-42e8-90d4-8cca18ceeb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3cd6224d-a13d-4f8c-a703-dbd4646c109b" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_f2c7b33b-fc28-42e8-90d4-8cca18ceeb1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_416ace7d-4406-4424-b3ed-b27568f0ec01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3cd6224d-a13d-4f8c-a703-dbd4646c109b" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_416ace7d-4406-4424-b3ed-b27568f0ec01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfEtOSterilizationLawsuitsFiled_63ffa991-9d49-4edc-9f54-d1adab7e8c95" xlink:href="bdx-20220331.xsd#bdx_NumberOfEtOSterilizationLawsuitsFiled"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3cd6224d-a13d-4f8c-a703-dbd4646c109b" xlink:to="loc_bdx_NumberOfEtOSterilizationLawsuitsFiled_63ffa991-9d49-4edc-9f54-d1adab7e8c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2fa73811-52e0-440b-89e7-cdd953b3a2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3cd6224d-a13d-4f8c-a703-dbd4646c109b" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2fa73811-52e0-440b-89e7-cdd953b3a2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/Revenues" xlink:type="simple" xlink:href="bdx-20220331.xsd#Revenues"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/Revenues" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f32f9297-134a-4f45-b5f5-80e9377cf3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_85d4d943-95db-4075-be4b-fc809e7894ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f32f9297-134a-4f45-b5f5-80e9377cf3a5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_85d4d943-95db-4075-be4b-fc809e7894ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/RevenuesDetails" xlink:type="simple" xlink:href="bdx-20220331.xsd#RevenuesDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/RevenuesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_be32111a-7398-4451-9b8a-2ceb228ab318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b02f4990-d3e4-4cae-8c14-0583482cc6ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_be32111a-7398-4451-9b8a-2ceb228ab318" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b02f4990-d3e4-4cae-8c14-0583482cc6ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_f1aedba6-e08d-48d3-b125-2332230b5f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b02f4990-d3e4-4cae-8c14-0583482cc6ee" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_f1aedba6-e08d-48d3-b125-2332230b5f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_93052dce-2423-469b-8a8a-127660e77423" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b02f4990-d3e4-4cae-8c14-0583482cc6ee" xlink:to="loc_srt_ProductOrServiceAxis_93052dce-2423-469b-8a8a-127660e77423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5ce1f828-43b0-4fd2-8e64-9815a9c1067b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_93052dce-2423-469b-8a8a-127660e77423" xlink:to="loc_srt_ProductsAndServicesDomain_5ce1f828-43b0-4fd2-8e64-9815a9c1067b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProductsandorServicesMember_e60c8b17-7025-4203-af7a-bd69a632c8b9" xlink:href="bdx-20220331.xsd#bdx_ProductsandorServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5ce1f828-43b0-4fd2-8e64-9815a9c1067b" xlink:to="loc_bdx_ProductsandorServicesMember_e60c8b17-7025-4203-af7a-bd69a632c8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ConsumablesMember_28cbec08-0a6d-434d-abaa-2a45dff1f05b" xlink:href="bdx-20220331.xsd#bdx_ConsumablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5ce1f828-43b0-4fd2-8e64-9815a9c1067b" xlink:to="loc_bdx_ConsumablesMember_28cbec08-0a6d-434d-abaa-2a45dff1f05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_2691400e-210b-40e3-b557-ef9dab99bf44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b02f4990-d3e4-4cae-8c14-0583482cc6ee" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_2691400e-210b-40e3-b557-ef9dab99bf44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ContractWithCustomerRebateLiability_4129529e-ea13-4c5e-bbce-f83e0f1e633b" xlink:href="bdx-20220331.xsd#bdx_ContractWithCustomerRebateLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2691400e-210b-40e3-b557-ef9dab99bf44" xlink:to="loc_bdx_ContractWithCustomerRebateLiability_4129529e-ea13-4c5e-bbce-f83e0f1e633b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_39d68793-3e6a-405a-bd78-cfb261e7d6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2691400e-210b-40e3-b557-ef9dab99bf44" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_39d68793-3e6a-405a-bd78-cfb261e7d6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_c8c39446-4554-46de-88cb-3891e821c012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2691400e-210b-40e3-b557-ef9dab99bf44" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_c8c39446-4554-46de-88cb-3891e821c012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/RevenuesDetails_1" xlink:type="simple" xlink:href="bdx-20220331.xsd#RevenuesDetails_1"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/RevenuesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentData" xlink:type="simple" xlink:href="bdx-20220331.xsd#SegmentData"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SegmentData" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bcb75ed0-5a2e-4b7d-b6bc-855b3701fb5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_32341926-497b-4358-9c34-4fde6b04a5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bcb75ed0-5a2e-4b7d-b6bc-855b3701fb5d" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_32341926-497b-4358-9c34-4fde6b04a5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataTables" xlink:type="simple" xlink:href="bdx-20220331.xsd#SegmentDataTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SegmentDataTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d6ab267c-dc80-49ff-abc1-5312cb7cb755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_e02554b8-7074-437c-8af9-e597089f4814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d6ab267c-dc80-49ff-abc1-5312cb7cb755" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_e02554b8-7074-437c-8af9-e597089f4814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_a503d454-5807-4520-9001-c276272ff640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d6ab267c-dc80-49ff-abc1-5312cb7cb755" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_a503d454-5807-4520-9001-c276272ff640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#SegmentDataAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SegmentDataAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_12e491ba-a00f-4ead-a3c6-86a9c77fff05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_171416e0-93d1-4bd5-b208-95ad1db42c71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_12e491ba-a00f-4ead-a3c6-86a9c77fff05" xlink:to="loc_us-gaap_NumberOfOperatingSegments_171416e0-93d1-4bd5-b208-95ad1db42c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#SegmentDataRevenuesbyGeographicAreasDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_9dfe441e-d88a-44ee-8de5-dc20c82a5e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f3b77d04-07a1-4f5e-a8a6-683fa2f118ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9dfe441e-d88a-44ee-8de5-dc20c82a5e2a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f3b77d04-07a1-4f5e-a8a6-683fa2f118ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitAxis_bbf9e778-76e4-422d-812f-5035256f9783" xlink:href="bdx-20220331.xsd#bdx_OrganizationalUnitAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f3b77d04-07a1-4f5e-a8a6-683fa2f118ce" xlink:to="loc_bdx_OrganizationalUnitAxis_bbf9e778-76e4-422d-812f-5035256f9783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:href="bdx-20220331.xsd#bdx_OrganizationalUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitAxis_bbf9e778-76e4-422d-812f-5035256f9783" xlink:to="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicationDeliverySolutionsMember_b7da86ae-8b9e-4780-aa18-9b311767f78f" xlink:href="bdx-20220331.xsd#bdx_MedicationDeliverySolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:to="loc_bdx_MedicationDeliverySolutionsMember_b7da86ae-8b9e-4780-aa18-9b311767f78f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicationManagementSolutionsMember_6469966e-8433-4b21-9e8c-5cca082f606e" xlink:href="bdx-20220331.xsd#bdx_MedicationManagementSolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:to="loc_bdx_MedicationManagementSolutionsMember_6469966e-8433-4b21-9e8c-5cca082f606e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DiabetesCareMember_68c33e9d-3863-4ef8-bb9c-8f018d28291f" xlink:href="bdx-20220331.xsd#bdx_DiabetesCareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:to="loc_bdx_DiabetesCareMember_68c33e9d-3863-4ef8-bb9c-8f018d28291f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PharmaceuticalSystemsMember_b352650e-c176-4fc7-a4f8-1f45f0deb4d8" xlink:href="bdx-20220331.xsd#bdx_PharmaceuticalSystemsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:to="loc_bdx_PharmaceuticalSystemsMember_b352650e-c176-4fc7-a4f8-1f45f0deb4d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IntegratedDiagnosticSolutionsMember_8f873472-2980-48a9-ac0c-0496912dc131" xlink:href="bdx-20220331.xsd#bdx_IntegratedDiagnosticSolutionsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:to="loc_bdx_IntegratedDiagnosticSolutionsMember_8f873472-2980-48a9-ac0c-0496912dc131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_BiosciencesMember_5a64dd40-607f-4250-a085-391ba8415be8" xlink:href="bdx-20220331.xsd#bdx_BiosciencesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:to="loc_bdx_BiosciencesMember_5a64dd40-607f-4250-a085-391ba8415be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SurgeryMember_b9ee849d-ab93-4147-b205-2fa6c03eb527" xlink:href="bdx-20220331.xsd#bdx_SurgeryMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:to="loc_bdx_SurgeryMember_b9ee849d-ab93-4147-b205-2fa6c03eb527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PeripheralInterventionMember_363caf69-49d7-4ba5-9fc9-c913ac0cbcba" xlink:href="bdx-20220331.xsd#bdx_PeripheralInterventionMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:to="loc_bdx_PeripheralInterventionMember_363caf69-49d7-4ba5-9fc9-c913ac0cbcba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_UrologyandCriticalCareMember_6540aaaa-d799-414e-a4e0-7268e46a0ca3" xlink:href="bdx-20220331.xsd#bdx_UrologyandCriticalCareMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_0b56b859-1faf-4ab5-ae73-a9f2ed57d1b5" xlink:to="loc_bdx_UrologyandCriticalCareMember_6540aaaa-d799-414e-a4e0-7268e46a0ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a6b03d67-f3d4-440f-9a26-1bddae523363" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f3b77d04-07a1-4f5e-a8a6-683fa2f118ce" xlink:to="loc_srt_StatementGeographicalAxis_a6b03d67-f3d4-440f-9a26-1bddae523363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c7bde105-1833-4dcf-b74f-8fc08cbf1eb5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_a6b03d67-f3d4-440f-9a26-1bddae523363" xlink:to="loc_srt_SegmentGeographicalDomain_c7bde105-1833-4dcf-b74f-8fc08cbf1eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_c02d4c05-de3a-4498-b680-f8f316d1fa3e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c7bde105-1833-4dcf-b74f-8fc08cbf1eb5" xlink:to="loc_country_US_c02d4c05-de3a-4498-b680-f8f316d1fa3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_28bffcf4-bd24-4e95-87a8-50d3e98b6cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c7bde105-1833-4dcf-b74f-8fc08cbf1eb5" xlink:to="loc_us-gaap_NonUsMember_28bffcf4-bd24-4e95-87a8-50d3e98b6cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_686c23bb-dd31-43c3-9283-51cd43869546" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f3b77d04-07a1-4f5e-a8a6-683fa2f118ce" xlink:to="loc_srt_ConsolidationItemsAxis_686c23bb-dd31-43c3-9283-51cd43869546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b664aa67-f0d8-4a79-9aac-191cfdf6fdc8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_686c23bb-dd31-43c3-9283-51cd43869546" xlink:to="loc_srt_ConsolidationItemsDomain_b664aa67-f0d8-4a79-9aac-191cfdf6fdc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_ee61105c-2fde-4342-a39c-9224384c9700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b664aa67-f0d8-4a79-9aac-191cfdf6fdc8" xlink:to="loc_us-gaap_OperatingSegmentsMember_ee61105c-2fde-4342-a39c-9224384c9700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1035c73a-1ab0-4526-aaea-9d780d4eb7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f3b77d04-07a1-4f5e-a8a6-683fa2f118ce" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1035c73a-1ab0-4526-aaea-9d780d4eb7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5ae36e6a-003f-4c07-910b-2c912f247a46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1035c73a-1ab0-4526-aaea-9d780d4eb7e2" xlink:to="loc_us-gaap_SegmentDomain_5ae36e6a-003f-4c07-910b-2c912f247a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_18242d9e-7092-4882-b2a4-f4f0d13ef963" xlink:href="bdx-20220331.xsd#bdx_MedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5ae36e6a-003f-4c07-910b-2c912f247a46" xlink:to="loc_bdx_MedicalMember_18242d9e-7092-4882-b2a4-f4f0d13ef963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_e2254663-6b51-45b1-8019-11b9630acb07" xlink:href="bdx-20220331.xsd#bdx_LifeSciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5ae36e6a-003f-4c07-910b-2c912f247a46" xlink:to="loc_bdx_LifeSciencesMember_e2254663-6b51-45b1-8019-11b9630acb07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember_0afa86c7-2863-4cc6-8afe-944345115e32" xlink:href="bdx-20220331.xsd#bdx_InterventionalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5ae36e6a-003f-4c07-910b-2c912f247a46" xlink:to="loc_bdx_InterventionalMember_0afa86c7-2863-4cc6-8afe-944345115e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c3915842-6546-4d46-867f-cf69de1b4146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f3b77d04-07a1-4f5e-a8a6-683fa2f118ce" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_c3915842-6546-4d46-867f-cf69de1b4146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_be839a17-a7ea-4cbb-b7ac-bd201996fba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c3915842-6546-4d46-867f-cf69de1b4146" xlink:to="loc_us-gaap_Revenues_be839a17-a7ea-4cbb-b7ac-bd201996fba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#SegmentDataFinancialInformationforCompanysSegmentsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2b6e8580-5eeb-4213-b469-549a34d6af7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c5ccb352-7dbc-4c43-910f-eceed1f07c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2b6e8580-5eeb-4213-b469-549a34d6af7d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c5ccb352-7dbc-4c43-910f-eceed1f07c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5d48ae32-eadf-4917-8925-0b189f73470e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c5ccb352-7dbc-4c43-910f-eceed1f07c3f" xlink:to="loc_srt_ConsolidationItemsAxis_5d48ae32-eadf-4917-8925-0b189f73470e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_263193e5-67e5-478b-9d62-0c44d5134dab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_5d48ae32-eadf-4917-8925-0b189f73470e" xlink:to="loc_srt_ConsolidationItemsDomain_263193e5-67e5-478b-9d62-0c44d5134dab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_5f1f22d4-990b-4df7-81f4-12f4f1fd9c25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_263193e5-67e5-478b-9d62-0c44d5134dab" xlink:to="loc_us-gaap_OperatingSegmentsMember_5f1f22d4-990b-4df7-81f4-12f4f1fd9c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_5e12c99c-0a27-4898-9f4f-70ffa1603aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_263193e5-67e5-478b-9d62-0c44d5134dab" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_5e12c99c-0a27-4898-9f4f-70ffa1603aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_bbf08cd5-f5bf-4f30-8f57-59f8a9a9b236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_263193e5-67e5-478b-9d62-0c44d5134dab" xlink:to="loc_us-gaap_CorporateNonSegmentMember_bbf08cd5-f5bf-4f30-8f57-59f8a9a9b236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_72cc564c-76ff-41fe-986c-7cd123b19968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c5ccb352-7dbc-4c43-910f-eceed1f07c3f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_72cc564c-76ff-41fe-986c-7cd123b19968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fa8ac460-e17a-4e55-b314-dcb11b51d2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_72cc564c-76ff-41fe-986c-7cd123b19968" xlink:to="loc_us-gaap_SegmentDomain_fa8ac460-e17a-4e55-b314-dcb11b51d2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_f9920b81-90d6-4417-b9eb-e5cfb12dcdc1" xlink:href="bdx-20220331.xsd#bdx_MedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fa8ac460-e17a-4e55-b314-dcb11b51d2ee" xlink:to="loc_bdx_MedicalMember_f9920b81-90d6-4417-b9eb-e5cfb12dcdc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_1b765065-f07f-4145-bd63-fb9ab4d33f9b" xlink:href="bdx-20220331.xsd#bdx_LifeSciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fa8ac460-e17a-4e55-b314-dcb11b51d2ee" xlink:to="loc_bdx_LifeSciencesMember_1b765065-f07f-4145-bd63-fb9ab4d33f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember_0509f9c5-71bb-4974-aac0-ad33520423f0" xlink:href="bdx-20220331.xsd#bdx_InterventionalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fa8ac460-e17a-4e55-b314-dcb11b51d2ee" xlink:to="loc_bdx_InterventionalMember_0509f9c5-71bb-4974-aac0-ad33520423f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4644bc27-3bdf-4427-b7e4-714e35f2b3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c5ccb352-7dbc-4c43-910f-eceed1f07c3f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4644bc27-3bdf-4427-b7e4-714e35f2b3e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fd8577ec-f14b-41df-bd2d-790f0303618c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4644bc27-3bdf-4427-b7e4-714e35f2b3e5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fd8577ec-f14b-41df-bd2d-790f0303618c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_25a8dc69-86a1-402b-9c2a-e6db088ca1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fd8577ec-f14b-41df-bd2d-790f0303618c" xlink:to="loc_us-gaap_CostOfSalesMember_25a8dc69-86a1-402b-9c2a-e6db088ca1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_4199c025-06e8-4cad-a947-410ff755a19c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fd8577ec-f14b-41df-bd2d-790f0303618c" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_4199c025-06e8-4cad-a947-410ff755a19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e31e301b-3136-422f-8b37-e466a99f513f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c5ccb352-7dbc-4c43-910f-eceed1f07c3f" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_e31e301b-3136-422f-8b37-e466a99f513f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_9003cb74-1658-4110-bd56-b0478a4a8501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e31e301b-3136-422f-8b37-e466a99f513f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_9003cb74-1658-4110-bd56-b0478a4a8501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_6c0c08e4-00aa-4653-b401-1fff4864dc58" xlink:href="bdx-20220331.xsd#bdx_AcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e31e301b-3136-422f-8b37-e466a99f513f" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_6c0c08e4-00aa-4653-b401-1fff4864dc58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_a347187f-9de6-41e5-9416-363efce225fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e31e301b-3136-422f-8b37-e466a99f513f" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_a347187f-9de6-41e5-9416-363efce225fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_909958ea-c477-46f3-949b-93328472d52b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e31e301b-3136-422f-8b37-e466a99f513f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_909958ea-c477-46f3-949b-93328472d52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_ec5d8918-6401-464d-8181-38114d81d620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e31e301b-3136-422f-8b37-e466a99f513f" xlink:to="loc_us-gaap_AssetImpairmentCharges_ec5d8918-6401-464d-8181-38114d81d620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_340c6318-af28-4fc4-8e2d-5536ddf3910a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e31e301b-3136-422f-8b37-e466a99f513f" xlink:to="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_340c6318-af28-4fc4-8e2d-5536ddf3910a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlans" xlink:type="simple" xlink:href="bdx-20220331.xsd#BenefitPlans"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_219469b4-3804-402f-8c1b-9afc1fd43a16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_41632963-ac33-4c62-871d-162703155f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_219469b4-3804-402f-8c1b-9afc1fd43a16" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_41632963-ac33-4c62-871d-162703155f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansTables" xlink:type="simple" xlink:href="bdx-20220331.xsd#BenefitPlansTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BenefitPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_eedff745-b176-4f90-b3e1-86666127085f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_3fb181c1-cf68-4f6d-80ef-4272959eeff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_eedff745-b176-4f90-b3e1-86666127085f" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_3fb181c1-cf68-4f6d-80ef-4272959eeff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#BenefitPlansDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BenefitPlansDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_94d1524f-19da-43d7-8e45-4b86bc6697fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a2316ea0-f271-4ad9-914d-fdfb6fe3a6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_94d1524f-19da-43d7-8e45-4b86bc6697fb" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a2316ea0-f271-4ad9-914d-fdfb6fe3a6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_a2839de1-13ac-42d1-b795-daaf7e3fc6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a2316ea0-f271-4ad9-914d-fdfb6fe3a6b7" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_a2839de1-13ac-42d1-b795-daaf7e3fc6ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_4525a1ce-ef30-4df6-b00a-9947e392cecd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a2839de1-13ac-42d1-b795-daaf7e3fc6ae" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_4525a1ce-ef30-4df6-b00a-9947e392cecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_034dd193-2a59-489a-9ccf-d1d3ec4d9434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_4525a1ce-ef30-4df6-b00a-9947e392cecd" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_034dd193-2a59-489a-9ccf-d1d3ec4d9434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2117afe0-5da9-4945-a823-98a77ada9ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a2316ea0-f271-4ad9-914d-fdfb6fe3a6b7" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2117afe0-5da9-4945-a823-98a77ada9ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_edf03e00-71d3-4aa8-83e2-1c6509d48110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2117afe0-5da9-4945-a823-98a77ada9ab0" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_edf03e00-71d3-4aa8-83e2-1c6509d48110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_8f9ecb53-5121-4a74-b91e-91bd95006a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2117afe0-5da9-4945-a823-98a77ada9ab0" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_8f9ecb53-5121-4a74-b91e-91bd95006a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_a07740e3-4802-4708-8879-de4d49b1a787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2117afe0-5da9-4945-a823-98a77ada9ab0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_a07740e3-4802-4708-8879-de4d49b1a787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_b1e50dc6-b33b-4750-8c47-c8ac88a3df09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2117afe0-5da9-4945-a823-98a77ada9ab0" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_b1e50dc6-b33b-4750-8c47-c8ac88a3df09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_44e61377-5a79-4099-ae2a-3be21a0d0536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2117afe0-5da9-4945-a823-98a77ada9ab0" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_44e61377-5a79-4099-ae2a-3be21a0d0536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_edee12dc-473b-446b-b113-fb20b63dfad1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2117afe0-5da9-4945-a823-98a77ada9ab0" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_edee12dc-473b-446b-b113-fb20b63dfad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_4668dda5-35b1-4941-bad1-5bc469ab84d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2117afe0-5da9-4945-a823-98a77ada9ab0" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_4668dda5-35b1-4941-bad1-5bc469ab84d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BusinessRestructuringCharges" xlink:type="simple" xlink:href="bdx-20220331.xsd#BusinessRestructuringCharges"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BusinessRestructuringCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4706647e-c613-45e8-8be4-d97801df51cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_0e71a7d5-64d7-4b72-802d-73d614f708ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4706647e-c613-45e8-8be4-d97801df51cf" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_0e71a7d5-64d7-4b72-802d-73d614f708ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BusinessRestructuringChargesTables" xlink:type="simple" xlink:href="bdx-20220331.xsd#BusinessRestructuringChargesTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BusinessRestructuringChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d2e0ad7e-2544-45cf-aa02-4583a2e208da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_b8338530-7c96-4fc1-98ef-88e0f5f00ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d2e0ad7e-2544-45cf-aa02-4583a2e208da" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_b8338530-7c96-4fc1-98ef-88e0f5f00ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BusinessRestructuringChargesDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#BusinessRestructuringChargesDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BusinessRestructuringChargesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a475bbdd-3929-48be-997b-22fb53d70655" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0ed0c9ed-2fb3-4992-9bf0-ee50a6bafe98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a475bbdd-3929-48be-997b-22fb53d70655" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0ed0c9ed-2fb3-4992-9bf0-ee50a6bafe98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_2cb40ae1-02a4-4b2f-9c54-d360ea5c9351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0ed0c9ed-2fb3-4992-9bf0-ee50a6bafe98" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_2cb40ae1-02a4-4b2f-9c54-d360ea5c9351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_b8680ef7-9f57-42f5-b9cc-780b9b97f76c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_2cb40ae1-02a4-4b2f-9c54-d360ea5c9351" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_b8680ef7-9f57-42f5-b9cc-780b9b97f76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_fe8405d8-0a14-4dd8-9408-88772bcc185b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_b8680ef7-9f57-42f5-b9cc-780b9b97f76c" xlink:to="loc_us-gaap_EmployeeSeveranceMember_fe8405d8-0a14-4dd8-9408-88772bcc185b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_1d6c0f07-51d8-48ed-8115-15f19617bfda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_b8680ef7-9f57-42f5-b9cc-780b9b97f76c" xlink:to="loc_us-gaap_OtherRestructuringMember_1d6c0f07-51d8-48ed-8115-15f19617bfda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_3dce52e3-6365-447c-8f91-314d21444f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0ed0c9ed-2fb3-4992-9bf0-ee50a6bafe98" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_3dce52e3-6365-447c-8f91-314d21444f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_396ae9b4-958f-4f87-bfa2-5aae20712210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_3dce52e3-6365-447c-8f91-314d21444f23" xlink:to="loc_us-gaap_RestructuringReserveRollForward_396ae9b4-958f-4f87-bfa2-5aae20712210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_3f02661c-f0ff-43ac-b458-dc80e49b5503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_396ae9b4-958f-4f87-bfa2-5aae20712210" xlink:to="loc_us-gaap_RestructuringReserve_3f02661c-f0ff-43ac-b458-dc80e49b5503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_2406155d-70b6-429a-bc66-1f7fe49ed4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_396ae9b4-958f-4f87-bfa2-5aae20712210" xlink:to="loc_us-gaap_RestructuringCharges_2406155d-70b6-429a-bc66-1f7fe49ed4a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_9228ea8c-9455-49a0-87d1-a729eb132fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_396ae9b4-958f-4f87-bfa2-5aae20712210" xlink:to="loc_us-gaap_PaymentsForRestructuring_9228ea8c-9455-49a0-87d1-a729eb132fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_c5f63d1f-c72a-4538-95f9-aace6583c526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_396ae9b4-958f-4f87-bfa2-5aae20712210" xlink:to="loc_us-gaap_RestructuringReserve_c5f63d1f-c72a-4538-95f9-aace6583c526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssets" xlink:type="simple" xlink:href="bdx-20220331.xsd#IntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e4da733d-c9ac-4644-9319-27965daae955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_8f7b8608-6c17-4381-850e-49386069c4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e4da733d-c9ac-4644-9319-27965daae955" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_8f7b8608-6c17-4381-850e-49386069c4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsTables" xlink:type="simple" xlink:href="bdx-20220331.xsd#IntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6c59e23a-c2f1-45ac-a025-bbe258daa128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_787f4f39-575f-43c4-8524-41dd2eed5160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6c59e23a-c2f1-45ac-a025-bbe258daa128" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_787f4f39-575f-43c4-8524-41dd2eed5160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_ec4d46be-9611-487b-a90e-a8112308856a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6c59e23a-c2f1-45ac-a025-bbe258daa128" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_ec4d46be-9611-487b-a90e-a8112308856a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#IntangibleAssetsComponentsofIntangibleAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ae079c26-9e6e-4ed9-afe8-e455f6abb6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_279372a3-c59c-45ec-b934-8a8fd015a5ce" xlink:href="bdx-20220331.xsd#bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ae079c26-9e6e-4ed9-afe8-e455f6abb6c8" xlink:to="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_279372a3-c59c-45ec-b934-8a8fd015a5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f95e1065-d868-4269-86f5-79680092b431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_279372a3-c59c-45ec-b934-8a8fd015a5ce" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f95e1065-d868-4269-86f5-79680092b431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cef9932-4852-455a-9c55-949a008263e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f95e1065-d868-4269-86f5-79680092b431" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cef9932-4852-455a-9c55-949a008263e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_f663095f-c8f6-450d-a288-bec8e0a78bba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cef9932-4852-455a-9c55-949a008263e5" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_f663095f-c8f6-450d-a288-bec8e0a78bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_c86e464e-8878-48a8-b8e6-23d353846ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cef9932-4852-455a-9c55-949a008263e5" xlink:to="loc_us-gaap_CustomerRelationshipsMember_c86e464e-8878-48a8-b8e6-23d353846ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProductRightsMember_24104b7c-b7b4-463f-a155-7ae66ffc082a" xlink:href="bdx-20220331.xsd#bdx_ProductRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cef9932-4852-455a-9c55-949a008263e5" xlink:to="loc_bdx_ProductRightsMember_24104b7c-b7b4-463f-a155-7ae66ffc082a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_42a87557-5c03-45b3-9176-98afe6f70a07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cef9932-4852-455a-9c55-949a008263e5" xlink:to="loc_us-gaap_TrademarksMember_42a87557-5c03-45b3-9176-98afe6f70a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember_cb2c4743-4bb6-4405-8fa0-51d3e9315a03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cef9932-4852-455a-9c55-949a008263e5" xlink:to="loc_us-gaap_IntellectualPropertyMember_cb2c4743-4bb6-4405-8fa0-51d3e9315a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9dedf1bb-7ecd-430e-bf23-c2d3487b26b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_279372a3-c59c-45ec-b934-8a8fd015a5ce" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9dedf1bb-7ecd-430e-bf23-c2d3487b26b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_36b6ecac-12ea-4670-a6bb-68d6ed040112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9dedf1bb-7ecd-430e-bf23-c2d3487b26b4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_36b6ecac-12ea-4670-a6bb-68d6ed040112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_c506bc24-c865-48b3-8054-5dc9f8c04ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_36b6ecac-12ea-4670-a6bb-68d6ed040112" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_c506bc24-c865-48b3-8054-5dc9f8c04ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_12397fa1-eed7-4a76-8cef-e55c21b20e52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_36b6ecac-12ea-4670-a6bb-68d6ed040112" xlink:to="loc_us-gaap_TrademarksMember_12397fa1-eed7-4a76-8cef-e55c21b20e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_27b82056-8039-49a2-bda2-1986cc4a50a2" xlink:href="bdx-20220331.xsd#bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_279372a3-c59c-45ec-b934-8a8fd015a5ce" xlink:to="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_27b82056-8039-49a2-bda2-1986cc4a50a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_59052f6a-e926-422d-b0fc-bcf035108d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_27b82056-8039-49a2-bda2-1986cc4a50a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_59052f6a-e926-422d-b0fc-bcf035108d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ecdfa555-f57b-4508-a19a-8e478b1973ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_27b82056-8039-49a2-bda2-1986cc4a50a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ecdfa555-f57b-4508-a19a-8e478b1973ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e128d312-bbdd-43f5-be84-550425c7b440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_27b82056-8039-49a2-bda2-1986cc4a50a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e128d312-bbdd-43f5-be84-550425c7b440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_223198ee-86aa-46b3-ac50-84ad9d1dc1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_27b82056-8039-49a2-bda2-1986cc4a50a2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_223198ee-86aa-46b3-ac50-84ad9d1dc1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#IntangibleAssetsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_68cd22ac-59e9-4b14-a42e-bc07228f99c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_5427f60e-4407-4be6-ad5f-8de354153063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_68cd22ac-59e9-4b14-a42e-bc07228f99c4" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_5427f60e-4407-4be6-ad5f-8de354153063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1e81b4f6-b5a8-40c5-bf83-796a87e3ca30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_8d404c8b-1c2d-440f-a9b2-8548bfcba862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1e81b4f6-b5a8-40c5-bf83-796a87e3ca30" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_8d404c8b-1c2d-440f-a9b2-8548bfcba862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_363dfebc-1070-4131-b273-2dcff8f2f036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8d404c8b-1c2d-440f-a9b2-8548bfcba862" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_363dfebc-1070-4131-b273-2dcff8f2f036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0b854ad0-41ac-4f45-afbe-a66d90f68aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_363dfebc-1070-4131-b273-2dcff8f2f036" xlink:to="loc_us-gaap_SegmentDomain_0b854ad0-41ac-4f45-afbe-a66d90f68aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_2d8da8d3-95ba-41af-99aa-123b0bd1d19d" xlink:href="bdx-20220331.xsd#bdx_MedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0b854ad0-41ac-4f45-afbe-a66d90f68aa6" xlink:to="loc_bdx_MedicalMember_2d8da8d3-95ba-41af-99aa-123b0bd1d19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_3d8176c4-5575-4f66-957c-059f81a2d544" xlink:href="bdx-20220331.xsd#bdx_LifeSciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0b854ad0-41ac-4f45-afbe-a66d90f68aa6" xlink:to="loc_bdx_LifeSciencesMember_3d8176c4-5575-4f66-957c-059f81a2d544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember_b5ea1df6-cf4a-4106-a616-40df15dbd463" xlink:href="bdx-20220331.xsd#bdx_InterventionalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0b854ad0-41ac-4f45-afbe-a66d90f68aa6" xlink:to="loc_bdx_InterventionalMember_b5ea1df6-cf4a-4106-a616-40df15dbd463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_b40316c0-8034-4e15-b50a-0f578be34014" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8d404c8b-1c2d-440f-a9b2-8548bfcba862" xlink:to="loc_us-gaap_GoodwillLineItems_b40316c0-8034-4e15-b50a-0f578be34014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_c7f0e7c9-2274-44cf-8d4a-4a6229093c19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_b40316c0-8034-4e15-b50a-0f578be34014" xlink:to="loc_us-gaap_GoodwillRollForward_c7f0e7c9-2274-44cf-8d4a-4a6229093c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e37c0791-687b-4834-8ab1-5d46d93a6483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_c7f0e7c9-2274-44cf-8d4a-4a6229093c19" xlink:to="loc_us-gaap_Goodwill_e37c0791-687b-4834-8ab1-5d46d93a6483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_2345ca05-314a-4dc3-9dcd-1ac41bac7312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_c7f0e7c9-2274-44cf-8d4a-4a6229093c19" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_2345ca05-314a-4dc3-9dcd-1ac41bac7312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_7cfd1875-2908-4645-81f4-f7944eed8f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_c7f0e7c9-2274-44cf-8d4a-4a6229093c19" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_7cfd1875-2908-4645-81f4-f7944eed8f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_8e687d82-5e69-4367-9d28-f02ee95deaa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_c7f0e7c9-2274-44cf-8d4a-4a6229093c19" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_8e687d82-5e69-4367-9d28-f02ee95deaa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_405043d3-fcb1-4296-8aa2-c525ac357abf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_c7f0e7c9-2274-44cf-8d4a-4a6229093c19" xlink:to="loc_us-gaap_Goodwill_405043d3-fcb1-4296-8aa2-c525ac357abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="simple" xlink:href="bdx-20220331.xsd#DerivativeInstrumentsandHedgingActivities"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0342f4eb-e77c-4f46-9421-d335cd435281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_5b367fdf-32f6-4aab-9ab9-c32a5616d009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0342f4eb-e77c-4f46-9421-d335cd435281" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_5b367fdf-32f6-4aab-9ab9-c32a5616d009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="simple" xlink:href="bdx-20220331.xsd#DerivativeInstrumentsandHedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b0c0aa4e-48e1-49cb-849c-61ca524898c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_5e260cdf-ac03-4d8f-bda8-f9a55efb49bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b0c0aa4e-48e1-49cb-849c-61ca524898c9" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_5e260cdf-ac03-4d8f-bda8-f9a55efb49bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e73b9c66-4aa3-481e-a1bc-45c1c2aa7998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b0c0aa4e-48e1-49cb-849c-61ca524898c9" xlink:to="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e73b9c66-4aa3-481e-a1bc-45c1c2aa7998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2270ebde-3418-4bdb-90d4-d6c0644673f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_96317ab6-0873-42f0-82fa-f8195d5d9808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2270ebde-3418-4bdb-90d4-d6c0644673f5" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_96317ab6-0873-42f0-82fa-f8195d5d9808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4ae4e63f-7f3f-4995-921d-86c10abd4148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_96317ab6-0873-42f0-82fa-f8195d5d9808" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4ae4e63f-7f3f-4995-921d-86c10abd4148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a341efdd-4cd6-4fbc-beb4-bae15d7589ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4ae4e63f-7f3f-4995-921d-86c10abd4148" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a341efdd-4cd6-4fbc-beb4-bae15d7589ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_a3c7d762-a702-4a77-93de-b37cc56928c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a341efdd-4cd6-4fbc-beb4-bae15d7589ec" xlink:to="loc_us-gaap_InterestRateSwapMember_a3c7d762-a702-4a77-93de-b37cc56928c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_5ee0ba55-82df-44e9-bf13-bd77d23eae89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a341efdd-4cd6-4fbc-beb4-bae15d7589ec" xlink:to="loc_us-gaap_CommodityContractMember_5ee0ba55-82df-44e9-bf13-bd77d23eae89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a0df4c21-5227-4d34-aed0-d79823d6c73a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_96317ab6-0873-42f0-82fa-f8195d5d9808" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a0df4c21-5227-4d34-aed0-d79823d6c73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4cd2afec-6a1d-4c1e-a526-324f778b5cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a0df4c21-5227-4d34-aed0-d79823d6c73a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4cd2afec-6a1d-4c1e-a526-324f778b5cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_2df126f6-c521-454a-acb7-11c0e8b405d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4cd2afec-6a1d-4c1e-a526-324f778b5cf6" xlink:to="loc_us-gaap_CashFlowHedgingMember_2df126f6-c521-454a-acb7-11c0e8b405d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_629924e8-e476-449e-bce8-d5643695e1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_96317ab6-0873-42f0-82fa-f8195d5d9808" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_629924e8-e476-449e-bce8-d5643695e1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_63747329-de16-40ef-82a2-773fee3b37bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_629924e8-e476-449e-bce8-d5643695e1f4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_63747329-de16-40ef-82a2-773fee3b37bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_5da4be60-4d0a-4888-88e7-5897bcd2d850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_629924e8-e476-449e-bce8-d5643695e1f4" xlink:to="loc_us-gaap_DerivativeNotionalAmount_5da4be60-4d0a-4888-88e7-5897bcd2d850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a77ae098-4696-42a7-a54b-8c3f5c02e561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_cd6f06f0-15b5-4470-8539-cda94c4f483a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a77ae098-4696-42a7-a54b-8c3f5c02e561" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_cd6f06f0-15b5-4470-8539-cda94c4f483a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_16272518-c11d-4641-ad71-b38f8e789725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_cd6f06f0-15b5-4470-8539-cda94c4f483a" xlink:to="loc_us-gaap_DebtInstrumentAxis_16272518-c11d-4641-ad71-b38f8e789725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_84ef6a4d-fd6c-46c0-a3d5-754f9c07d08f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_16272518-c11d-4641-ad71-b38f8e789725" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_84ef6a4d-fd6c-46c0-a3d5-754f9c07d08f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtMember_0e82737e-a5bb-4525-9e3e-0921812591c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_84ef6a4d-fd6c-46c0-a3d5-754f9c07d08f" xlink:to="loc_us-gaap_DebtMember_0e82737e-a5bb-4525-9e3e-0921812591c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e0bf3d67-414c-45d1-b83e-69b93c445548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_cd6f06f0-15b5-4470-8539-cda94c4f483a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e0bf3d67-414c-45d1-b83e-69b93c445548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1c70a3eb-bca6-4c73-915b-b1a7b082ba78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e0bf3d67-414c-45d1-b83e-69b93c445548" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1c70a3eb-bca6-4c73-915b-b1a7b082ba78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_245b774e-074f-4632-b431-e363417636e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1c70a3eb-bca6-4c73-915b-b1a7b082ba78" xlink:to="loc_us-gaap_ForeignExchangeContractMember_245b774e-074f-4632-b431-e363417636e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_a11f40b1-78c7-40f2-82bc-a0b24c80a78a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1c70a3eb-bca6-4c73-915b-b1a7b082ba78" xlink:to="loc_us-gaap_CurrencySwapMember_a11f40b1-78c7-40f2-82bc-a0b24c80a78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FixedToFloatingMember_8a23833f-ee61-4918-8209-ac34daefe8c2" xlink:href="bdx-20220331.xsd#bdx_FixedToFloatingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1c70a3eb-bca6-4c73-915b-b1a7b082ba78" xlink:to="loc_bdx_FixedToFloatingMember_8a23833f-ee61-4918-8209-ac34daefe8c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_06dfd3d0-524f-41ce-bb1b-ac9367922936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1c70a3eb-bca6-4c73-915b-b1a7b082ba78" xlink:to="loc_us-gaap_InterestRateSwapMember_06dfd3d0-524f-41ce-bb1b-ac9367922936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_328e931b-48eb-4753-bb64-20b9232cab24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_cd6f06f0-15b5-4470-8539-cda94c4f483a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_328e931b-48eb-4753-bb64-20b9232cab24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1251c4be-4adb-4392-b3e3-d4cf0378833c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_328e931b-48eb-4753-bb64-20b9232cab24" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1251c4be-4adb-4392-b3e3-d4cf0378833c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_5c52a09f-1269-45a0-b750-88f02cb8bec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1251c4be-4adb-4392-b3e3-d4cf0378833c" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_5c52a09f-1269-45a0-b750-88f02cb8bec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_1cedfb9c-41d1-40cb-b1e3-415251e1df2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1251c4be-4adb-4392-b3e3-d4cf0378833c" xlink:to="loc_us-gaap_FairValueHedgingMember_1cedfb9c-41d1-40cb-b1e3-415251e1df2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_ae80953c-f395-4675-ab0f-374d274782f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1251c4be-4adb-4392-b3e3-d4cf0378833c" xlink:to="loc_us-gaap_CashFlowHedgingMember_ae80953c-f395-4675-ab0f-374d274782f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f8a1715f-ec7d-498e-a710-a3d719186193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_cd6f06f0-15b5-4470-8539-cda94c4f483a" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f8a1715f-ec7d-498e-a710-a3d719186193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_842cedce-acfb-4b7a-8454-b05cfb8bd833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f8a1715f-ec7d-498e-a710-a3d719186193" xlink:to="loc_us-gaap_DerivativeNotionalAmount_842cedce-acfb-4b7a-8454-b05cfb8bd833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails" xlink:type="simple" xlink:href="bdx-20220331.xsd#DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e82ca6dd-2ca0-4863-bcc1-7e437f0c417c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_9fa38c4c-e15b-4886-83b9-06722b2ce39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e82ca6dd-2ca0-4863-bcc1-7e437f0c417c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_9fa38c4c-e15b-4886-83b9-06722b2ce39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_31451686-937c-46c3-b847-b9e957faa700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_9fa38c4c-e15b-4886-83b9-06722b2ce39e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_31451686-937c-46c3-b847-b9e957faa700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cd45307b-1bd7-4a85-9c05-920df7720794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_31451686-937c-46c3-b847-b9e957faa700" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cd45307b-1bd7-4a85-9c05-920df7720794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ForeignCurrencyDenominatedDebtMember_c3d54b26-1bff-4b4c-8979-1b13cd2a500a" xlink:href="bdx-20220331.xsd#bdx_ForeignCurrencyDenominatedDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cd45307b-1bd7-4a85-9c05-920df7720794" xlink:to="loc_bdx_ForeignCurrencyDenominatedDebtMember_c3d54b26-1bff-4b4c-8979-1b13cd2a500a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_f074e5c6-9337-4210-a622-c5e63004b3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cd45307b-1bd7-4a85-9c05-920df7720794" xlink:to="loc_us-gaap_CurrencySwapMember_f074e5c6-9337-4210-a622-c5e63004b3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_30bc0b37-97f2-42b7-9328-eecf09615788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_9fa38c4c-e15b-4886-83b9-06722b2ce39e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_30bc0b37-97f2-42b7-9328-eecf09615788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6b983f32-1398-4713-bc0b-2db95f04a401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_30bc0b37-97f2-42b7-9328-eecf09615788" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6b983f32-1398-4713-bc0b-2db95f04a401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_f99f3621-0b13-4972-8249-c50dac7ed248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_30bc0b37-97f2-42b7-9328-eecf09615788" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_f99f3621-0b13-4972-8249-c50dac7ed248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements" xlink:type="simple" xlink:href="bdx-20220331.xsd#FinancialInstrumentsandFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f65652ae-6849-40cf-aaa9-73afec028bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_b61c54a7-a526-4e66-b9bd-5f4290a8e779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f65652ae-6849-40cf-aaa9-73afec028bfc" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_b61c54a7-a526-4e66-b9bd-5f4290a8e779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables" xlink:type="simple" xlink:href="bdx-20220331.xsd#FinancialInstrumentsandFairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_dc7322b9-dce7-4e81-a1fb-7c8d40f7f1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_e9496eac-9956-4d90-947e-9705059b81a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dc7322b9-dce7-4e81-a1fb-7c8d40f7f1e3" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_e9496eac-9956-4d90-947e-9705059b81a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_0ab55c93-a620-465b-b204-05141d440506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dc7322b9-dce7-4e81-a1fb-7c8d40f7f1e3" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_0ab55c93-a620-465b-b204-05141d440506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_3f13579c-13dd-4618-ade3-45a085e0443c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dc7322b9-dce7-4e81-a1fb-7c8d40f7f1e3" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_3f13579c-13dd-4618-ade3-45a085e0443c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="bdx-20220331.xsd#FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_95168ffd-6d92-49ad-827d-16e5268d7c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_13ea96cf-9673-4b3d-b09e-fc1efaed8c73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_95168ffd-6d92-49ad-827d-16e5268d7c2a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_13ea96cf-9673-4b3d-b09e-fc1efaed8c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_3d2a2423-bd3b-4afc-b7fc-9cf2599ec5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_95168ffd-6d92-49ad-827d-16e5268d7c2a" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_3d2a2423-bd3b-4afc-b7fc-9cf2599ec5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9bb04d15-7a22-4c63-b79d-25d8f05a85b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_95168ffd-6d92-49ad-827d-16e5268d7c2a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9bb04d15-7a22-4c63-b79d-25d8f05a85b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="bdx-20220331.xsd#FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7429a5e3-981b-4c8b-b7bd-78751350cfaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_74e3c150-1cfd-4947-bdb4-099ee602ce9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7429a5e3-981b-4c8b-b7bd-78751350cfaa" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_74e3c150-1cfd-4947-bdb4-099ee602ce9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm_43434a08-dc31-4621-9201-ae0a70ef937a" xlink:href="bdx-20220331.xsd#bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7429a5e3-981b-4c8b-b7bd-78751350cfaa" xlink:to="loc_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm_43434a08-dc31-4621-9201-ae0a70ef937a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableFairValueDisclosure_c22c2c05-8709-4698-8ed4-754bb5ddb64d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7429a5e3-981b-4c8b-b7bd-78751350cfaa" xlink:to="loc_us-gaap_LoansPayableFairValueDisclosure_c22c2c05-8709-4698-8ed4-754bb5ddb64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a0271482-a0a5-49b6-82c1-e68881e33016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8de62069-4cf0-453f-acb4-a3b6c3b7c91b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a0271482-a0a5-49b6-82c1-e68881e33016" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8de62069-4cf0-453f-acb4-a3b6c3b7c91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_13342ac5-de66-480e-b300-967dcfee906b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8de62069-4cf0-453f-acb4-a3b6c3b7c91b" xlink:to="loc_srt_RangeAxis_13342ac5-de66-480e-b300-967dcfee906b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3f3c6a0f-85bf-4183-bb75-234baeff990a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_13342ac5-de66-480e-b300-967dcfee906b" xlink:to="loc_srt_RangeMember_3f3c6a0f-85bf-4183-bb75-234baeff990a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_94ff4bde-a7b1-41b7-ab73-2aadd18c6504" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3f3c6a0f-85bf-4183-bb75-234baeff990a" xlink:to="loc_srt_MinimumMember_94ff4bde-a7b1-41b7-ab73-2aadd18c6504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a00d0bd1-b29d-405d-ab18-d1b2ec524894" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3f3c6a0f-85bf-4183-bb75-234baeff990a" xlink:to="loc_srt_MaximumMember_a00d0bd1-b29d-405d-ab18-d1b2ec524894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_44af9640-0a7f-48c4-be36-2ca378b895ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8de62069-4cf0-453f-acb4-a3b6c3b7c91b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_44af9640-0a7f-48c4-be36-2ca378b895ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5da8b811-d20c-4733-a74f-6d75794e17aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_44af9640-0a7f-48c4-be36-2ca378b895ec" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5da8b811-d20c-4733-a74f-6d75794e17aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_1aa87e3a-9dc9-48c3-9ddf-e4b67eaaaa19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5da8b811-d20c-4733-a74f-6d75794e17aa" xlink:to="loc_us-gaap_CostOfSalesMember_1aa87e3a-9dc9-48c3-9ddf-e4b67eaaaa19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b755bb5d-613e-4e60-9051-d17dec411387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8de62069-4cf0-453f-acb4-a3b6c3b7c91b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b755bb5d-613e-4e60-9051-d17dec411387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MaturityPeriodOfShortTermInvestment_f93cbee7-8052-4f3a-a79e-dc0967516a05" xlink:href="bdx-20220331.xsd#bdx_MaturityPeriodOfShortTermInvestment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b755bb5d-613e-4e60-9051-d17dec411387" xlink:to="loc_bdx_MaturityPeriodOfShortTermInvestment_f93cbee7-8052-4f3a-a79e-dc0967516a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_e52e28d2-f5ba-48c7-9c63-c518c2a77b47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b755bb5d-613e-4e60-9051-d17dec411387" xlink:to="loc_us-gaap_AssetImpairmentCharges_e52e28d2-f5ba-48c7-9c63-c518c2a77b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails" xlink:type="simple" xlink:href="bdx-20220331.xsd#FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ffa35e3e-2591-4e82-8b68-5300182ebbab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TransfersOfFinancialAssetsDuringThePeriod_044bf2c9-5555-44e9-bd76-53fb6b875c9a" xlink:href="bdx-20220331.xsd#bdx_TransfersOfFinancialAssetsDuringThePeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ffa35e3e-2591-4e82-8b68-5300182ebbab" xlink:to="loc_bdx_TransfersOfFinancialAssetsDuringThePeriod_044bf2c9-5555-44e9-bd76-53fb6b875c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_dca8c836-a504-4e79-97cc-79c2551baa8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ffa35e3e-2591-4e82-8b68-5300182ebbab" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_dca8c836-a504-4e79-97cc-79c2551baa8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/Debt" xlink:type="simple" xlink:href="bdx-20220331.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1c2c216a-85b3-4b5b-8160-ab56b0c2fef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_fd2e31f0-6387-44c6-9242-6c32bee53384" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1c2c216a-85b3-4b5b-8160-ab56b0c2fef5" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_fd2e31f0-6387-44c6-9242-6c32bee53384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DebtDetail" xlink:type="simple" xlink:href="bdx-20220331.xsd#DebtDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DebtDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_37fc5b74-ccc6-433e-bc7c-2cbd03af7b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c9dbf7cc-c513-4be0-b51a-77f16a9bf458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_37fc5b74-ccc6-433e-bc7c-2cbd03af7b9c" xlink:to="loc_us-gaap_DebtInstrumentTable_c9dbf7cc-c513-4be0-b51a-77f16a9bf458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dabdd5aa-43fc-42a6-b806-479002c92145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c9dbf7cc-c513-4be0-b51a-77f16a9bf458" xlink:to="loc_us-gaap_DebtInstrumentAxis_dabdd5aa-43fc-42a6-b806-479002c92145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9215216c-cd83-4754-be71-bf13868ee717" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_dabdd5aa-43fc-42a6-b806-479002c92145" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9215216c-cd83-4754-be71-bf13868ee717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes5000DueFebruary152030Member_2f64d6b6-684e-4b94-bd43-bc1e1b1ae9a5" xlink:href="bdx-20220331.xsd#bdx_Notes5000DueFebruary152030Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9215216c-cd83-4754-be71-bf13868ee717" xlink:to="loc_bdx_Notes5000DueFebruary152030Member_2f64d6b6-684e-4b94-bd43-bc1e1b1ae9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes6750DueFebruary152030Member_0d286fd6-4aac-4637-ae04-a33167fd5c79" xlink:href="bdx-20220331.xsd#bdx_Notes6750DueFebruary152030Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9215216c-cd83-4754-be71-bf13868ee717" xlink:to="loc_bdx_Notes6750DueFebruary152030Member_0d286fd6-4aac-4637-ae04-a33167fd5c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FloatingRateNotesDueJune62022Member_b9707a94-dbf3-42fc-a6d4-c75a690a925e" xlink:href="bdx-20220331.xsd#bdx_FloatingRateNotesDueJune62022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9215216c-cd83-4754-be71-bf13868ee717" xlink:to="loc_bdx_FloatingRateNotesDueJune62022Member_b9707a94-dbf3-42fc-a6d4-c75a690a925e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_02ce7da1-5f1c-49ef-8a17-1ae6187916ad" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c9dbf7cc-c513-4be0-b51a-77f16a9bf458" xlink:to="loc_srt_RangeAxis_02ce7da1-5f1c-49ef-8a17-1ae6187916ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_18696579-09af-4738-abc5-386c448311c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_02ce7da1-5f1c-49ef-8a17-1ae6187916ad" xlink:to="loc_srt_RangeMember_18696579-09af-4738-abc5-386c448311c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_df9a2f16-4597-4af3-a922-522c27a72295" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_18696579-09af-4738-abc5-386c448311c2" xlink:to="loc_srt_MaximumMember_df9a2f16-4597-4af3-a922-522c27a72295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f513a3cf-0e14-46e3-b8f0-a3b54b19b081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c9dbf7cc-c513-4be0-b51a-77f16a9bf458" xlink:to="loc_us-gaap_CreditFacilityAxis_f513a3cf-0e14-46e3-b8f0-a3b54b19b081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_47d03fef-6b79-4515-bd85-631e03bd752f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_f513a3cf-0e14-46e3-b8f0-a3b54b19b081" xlink:to="loc_us-gaap_CreditFacilityDomain_47d03fef-6b79-4515-bd85-631e03bd752f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TermLoanFacilityMember_cd199d6f-e784-446d-9ae8-d77e60f55e44" xlink:href="bdx-20220331.xsd#bdx_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_47d03fef-6b79-4515-bd85-631e03bd752f" xlink:to="loc_bdx_TermLoanFacilityMember_cd199d6f-e784-446d-9ae8-d77e60f55e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b5064bc8-0f4e-44f4-afe8-43a90a3ddd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_47d03fef-6b79-4515-bd85-631e03bd752f" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b5064bc8-0f4e-44f4-afe8-43a90a3ddd9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1cc4de10-1af3-491d-9bb6-d7e81651a0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c9dbf7cc-c513-4be0-b51a-77f16a9bf458" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1cc4de10-1af3-491d-9bb6-d7e81651a0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_95609ba8-fbcc-433f-bf84-12bd52b5f12d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1cc4de10-1af3-491d-9bb6-d7e81651a0ba" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_95609ba8-fbcc-433f-bf84-12bd52b5f12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ef0ad85d-7af4-4fa2-a4dc-39d1e8201cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_95609ba8-fbcc-433f-bf84-12bd52b5f12d" xlink:to="loc_us-gaap_SubsequentEventMember_ef0ad85d-7af4-4fa2-a4dc-39d1e8201cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_06708606-ea35-401f-8206-34e671baeea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c9dbf7cc-c513-4be0-b51a-77f16a9bf458" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_06708606-ea35-401f-8206-34e671baeea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_835dfd51-7468-49f5-930c-b660e7b02881" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_06708606-ea35-401f-8206-34e671baeea6" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_835dfd51-7468-49f5-930c-b660e7b02881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_b01d83bf-6d42-46fe-8218-c4a6c431b340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_835dfd51-7468-49f5-930c-b660e7b02881" xlink:to="loc_us-gaap_LongTermDebtMember_b01d83bf-6d42-46fe-8218-c4a6c431b340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_419ce8de-aeb1-46b1-94a2-0a61b31fa939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c9dbf7cc-c513-4be0-b51a-77f16a9bf458" xlink:to="loc_us-gaap_DebtInstrumentLineItems_419ce8de-aeb1-46b1-94a2-0a61b31fa939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_590914dd-657a-4566-b55f-9aad4758ec63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_419ce8de-aeb1-46b1-94a2-0a61b31fa939" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_590914dd-657a-4566-b55f-9aad4758ec63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b1a1d6a2-216e-488e-ad1f-52ba61b9b54a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_419ce8de-aeb1-46b1-94a2-0a61b31fa939" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b1a1d6a2-216e-488e-ad1f-52ba61b9b54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_5af20673-f47e-4a23-81dd-b4ca4fb1f5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_419ce8de-aeb1-46b1-94a2-0a61b31fa939" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_5af20673-f47e-4a23-81dd-b4ca4fb1f5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_6f5dc267-a464-4102-a4fa-df7c855c0c95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_419ce8de-aeb1-46b1-94a2-0a61b31fa939" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_6f5dc267-a464-4102-a4fa-df7c855c0c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_13960370-9976-4fab-b9cf-d685f58a728e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_419ce8de-aeb1-46b1-94a2-0a61b31fa939" xlink:to="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_13960370-9976-4fab-b9cf-d685f58a728e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_f3b91570-4624-4bb3-a2fa-d26da6bb619f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_419ce8de-aeb1-46b1-94a2-0a61b31fa939" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_f3b91570-4624-4bb3-a2fa-d26da6bb619f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_0cc9f707-c407-454a-8483-636fcf625b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_419ce8de-aeb1-46b1-94a2-0a61b31fa939" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_0cc9f707-c407-454a-8483-636fcf625b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268606270536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-4802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Becton, Dickinson and Company<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000010795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-0760120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1 Becton Drive,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Franklin Lakes,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07417-1880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(201)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">847-6800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">285,064,629<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $1.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable Preferred Stock | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Depositary Shares, each representing a 1/20th interest in a share of 6.00% Mandatory Convertible Preferred Stock, Series B<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDXB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.000dueDecember152022Member', window );">Notes 1.000% due December 15, 2022 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.000% Notes due December 15, 2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX22A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.900dueDecember152026Member', window );">Notes 1.900% due December 15, 2026 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.900% Notes due December 15, 2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.401dueMay242023Member', window );">Notes 1.401% due May 24, 2023 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.401% Notes due May 24, 2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX23A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes3.020dueMay242025Member', window );">Notes 3.020% due May 24, 2025 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.020% Notes due May 24, 2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0.632dueJune42023Member', window );">Notes 0.632% due June 4, 2023 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.632% Notes due June 4, 2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX/23A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.208dueJune42026Member', window );">Notes 1.208% due June 4, 2026 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.208% Notes due June 4, 2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX/26A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1213NotesDueFebruary122036Member', window );">Notes 1.213% Notes due February 12, 2036 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.213% Notes due February 12, 2036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX/36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0000DueAugust132023Member', window );">Notes 0.000% due August 13, 2023 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.000% Notes due August 13, 2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX23B<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0034DueAugust132025Member', window );">Notes 0.034% due August 13, 2025 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.034% Notes due August 13, 2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX25A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNYS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNYS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.000dueDecember152022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes1.000dueDecember152022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.900dueDecember152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes1.900dueDecember152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.401dueMay242023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes1.401dueMay242023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes3.020dueMay242025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes3.020dueMay242025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0.632dueJune42023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes0.632dueJune42023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.208dueJune42026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes1.208dueJune42026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1213NotesDueFebruary122036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes1213NotesDueFebruary122036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0000DueAugust132023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes0000DueAugust132023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0034DueAugust132025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes0034DueAugust132025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268606295880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 5,011<span></span>
</td>
<td class="nump">$ 4,907<span></span>
</td>
<td class="nump">$ 10,006<span></span>
</td>
<td class="nump">$ 10,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">2,706<span></span>
</td>
<td class="nump">2,661<span></span>
</td>
<td class="nump">5,278<span></span>
</td>
<td class="nump">5,244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling and administrative expense</a></td>
<td class="nump">1,232<span></span>
</td>
<td class="nump">1,148<span></span>
</td>
<td class="nump">2,456<span></span>
</td>
<td class="nump">2,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">343<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="nump">673<span></span>
</td>
<td class="nump">608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_AcquisitionRelatedCostsAndRestructuringCharges', window );">Acquisition-related integration and restructuring expense</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating expense, net</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">296<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="nump">296<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Operating Costs and Expenses</a></td>
<td class="nump">4,359<span></span>
</td>
<td class="nump">4,473<span></span>
</td>
<td class="nump">8,539<span></span>
</td>
<td class="nump">8,547<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income</a></td>
<td class="nump">652<span></span>
</td>
<td class="nump">434<span></span>
</td>
<td class="nump">1,467<span></span>
</td>
<td class="nump">1,676<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(101)<span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="num">(199)<span></span>
</td>
<td class="num">(242)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (expense) income, net</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income Before Income Taxes</a></td>
<td class="nump">525<span></span>
</td>
<td class="nump">305<span></span>
</td>
<td class="nump">1,248<span></span>
</td>
<td class="nump">1,462<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">454<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="nump">1,131<span></span>
</td>
<td class="nump">1,302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Preferred stock dividends</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income applicable to common shareholders</a></td>
<td class="nump">$ 431<span></span>
</td>
<td class="nump">$ 277<span></span>
</td>
<td class="nump">$ 1,086<span></span>
</td>
<td class="nump">$ 1,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Earnings per Share (USD per share)</a></td>
<td class="nump">$ 1.51<span></span>
</td>
<td class="nump">$ 0.95<span></span>
</td>
<td class="nump">$ 3.81<span></span>
</td>
<td class="nump">$ 4.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Earnings per Share (USD per share)</a></td>
<td class="nump">1.50<span></span>
</td>
<td class="nump">0.94<span></span>
</td>
<td class="nump">3.78<span></span>
</td>
<td class="nump">4.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends per Common Share (USD per share)</a></td>
<td class="nump">$ 0.87<span></span>
</td>
<td class="nump">$ 0.83<span></span>
</td>
<td class="nump">$ 1.74<span></span>
</td>
<td class="nump">$ 1.66<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_AcquisitionRelatedCostsAndRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; business integration costs, systems integration and conversion costs, and severance and other employee-related costs; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Additionally includes the amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_AcquisitionRelatedCostsAndRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268610858088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 454<span></span>
</td>
<td class="nump">$ 299<span></span>
</td>
<td class="nump">$ 1,131<span></span>
</td>
<td class="nump">$ 1,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">78<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Defined benefit pension and postretirement plans</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Cash flow hedges</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income, Net of Tax</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive Income</a></td>
<td class="nump">$ 586<span></span>
</td>
<td class="nump">$ 384<span></span>
</td>
<td class="nump">$ 1,309<span></span>
</td>
<td class="nump">$ 1,521<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268607165064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents</a></td>
<td class="nump">$ 3,147<span></span>
</td>
<td class="nump">$ 2,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Restricted cash</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade receivables, net</a></td>
<td class="nump">2,303<span></span>
</td>
<td class="nump">2,497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Materials</a></td>
<td class="nump">708<span></span>
</td>
<td class="nump">641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">413<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished products</a></td>
<td class="nump">2,137<span></span>
</td>
<td class="nump">1,823<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">3,258<span></span>
</td>
<td class="nump">2,866<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">1,256<span></span>
</td>
<td class="nump">1,072<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">10,152<span></span>
</td>
<td class="nump">8,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment</a></td>
<td class="nump">13,193<span></span>
</td>
<td class="nump">12,942<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less allowances for depreciation and amortization</a></td>
<td class="nump">6,788<span></span>
</td>
<td class="nump">6,549<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net</a></td>
<td class="nump">6,406<span></span>
</td>
<td class="nump">6,393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">24,096<span></span>
</td>
<td class="nump">23,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_CoreAndDevelopedTechnologyNet', window );">Developed Technology, Net</a></td>
<td class="nump">9,044<span></span>
</td>
<td class="nump">9,417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_FiniteLivedCustomerRelationshipsNet', window );">Customer Relationships, Net</a></td>
<td class="nump">2,681<span></span>
</td>
<td class="nump">2,818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Other Intangibles, Net</a></td>
<td class="nump">542<span></span>
</td>
<td class="nump">548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other Assets</a></td>
<td class="nump">1,866<span></span>
</td>
<td class="nump">1,952<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">54,786<span></span>
</td>
<td class="nump">53,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current debt obligations</a></td>
<td class="nump">1,051<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Payables, accrued expenses and other current liabilities</a></td>
<td class="nump">5,605<span></span>
</td>
<td class="nump">6,126<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">6,657<span></span>
</td>
<td class="nump">6,626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">17,584<span></span>
</td>
<td class="nump">17,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Long-Term Employee Benefit Obligations</a></td>
<td class="nump">1,048<span></span>
</td>
<td class="nump">1,228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Deferred Income Taxes and Other Liabilities</a></td>
<td class="nump">4,973<span></span>
</td>
<td class="nump">5,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">365<span></span>
</td>
<td class="nump">365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Capital in excess of par value</a></td>
<td class="nump">19,495<span></span>
</td>
<td class="nump">19,272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">14,416<span></span>
</td>
<td class="nump">13,826<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_CommonStockSharesHeldInEmployeeTrust1', window );">Deferred compensation</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock</a></td>
<td class="num">(7,866)<span></span>
</td>
<td class="num">(7,723)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,910)<span></span>
</td>
<td class="num">(2,088)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders&#8217; Equity</a></td>
<td class="nump">24,525<span></span>
</td>
<td class="nump">23,677<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Shareholders&#8217; Equity</a></td>
<td class="nump">$ 54,786<span></span>
</td>
<td class="nump">$ 53,866<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_CommonStockSharesHeldInEmployeeTrust1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of common stock issued to a trust (for example, but not limited to, rabbi trust) set up specifically to accumulate stock for the sole purpose of distribution to participating employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_CommonStockSharesHeldInEmployeeTrust1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_CoreAndDevelopedTechnologyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible assets arising from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_CoreAndDevelopedTechnologyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_FiniteLivedCustomerRelationshipsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net carrying amount as of the balance sheet date of an asset acquired in a business combination representing a favorable existing relationship with customers having a finite beneficial life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_FiniteLivedCustomerRelationshipsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268609614168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 1,131<span></span>
</td>
<td class="nump">$ 1,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to net income to derive net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,114<span></span>
</td>
<td class="nump">1,113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="num">(80)<span></span>
</td>
<td class="num">(120)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapital', window );">Change in operating assets and liabilities</a></td>
<td class="num">(950)<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_IncreaseDecreaseinPensionBenefitObligation', window );">Pension obligation</a></td>
<td class="num">(136)<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyLossInPeriod', window );">Product liability-related charge</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other, net</a></td>
<td class="num">(101)<span></span>
</td>
<td class="num">(109)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by Operating Activities</a></td>
<td class="nump">1,118<span></span>
</td>
<td class="nump">2,721<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(415)<span></span>
</td>
<td class="num">(499)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="num">(450)<span></span>
</td>
<td class="num">(179)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="num">(124)<span></span>
</td>
<td class="num">(186)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Used for Investing Activities</a></td>
<td class="num">(990)<span></span>
</td>
<td class="num">(863)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans', window );">Proceeds from long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt', window );">Proceeds from debt issued in connection with the spin-off (see Note 12)</a></td>
<td class="nump">1,424<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments of debt</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1,998)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(541)<span></span>
</td>
<td class="num">(528)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="num">(76)<span></span>
</td>
<td class="num">(82)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Provided by (Used for) Financing Activities</a></td>
<td class="nump">804<span></span>
</td>
<td class="num">(893)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and equivalents and restricted cash</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and equivalents and restricted cash</a></td>
<td class="nump">928<span></span>
</td>
<td class="nump">981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Opening Cash and Equivalents and Restricted Cash</a></td>
<td class="nump">2,392<span></span>
</td>
<td class="nump">2,917<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Closing Cash and Equivalents and Restricted Cash</a></td>
<td class="nump">$ 3,320<span></span>
</td>
<td class="nump">$ 3,898<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_IncreaseDecreaseinPensionBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for pension benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_IncreaseDecreaseinPensionBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer, and term loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyLossInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyLossInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268610773496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and, in the opinion of the management of Becton, Dickinson and Company (the "Company" or "BD"), include all adjustments which are of a normal recurring nature, necessary for a fair presentation of the financial position and the results of operations and cash flows for the periods presented.  However, the financial statements do not include all information and accompanying notes required for a presentation in accordance with U.S. generally accepted accounting principles ("U.S. GAAP").  These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company&#8217;s 2021 Annual Report on Form 10-K.  Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes.  Percentages and earnings per share amounts presented are calculated from the underlying amounts.  The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Spin-Off of Diabetes Care Business</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company named Embecta Corp. (&#8220;Embecta&#8221;) through a distribution of Embecta&#8217;s publicly traded common stock to BD&#8217;s shareholders of record as of the close of business on March 22, 2022 (the &#8220;record date&#8221;).  The Company distributed one share of Embecta common stock for every five common shares of BD outstanding as of the record date.  Shareholders received cash in lieu of fractional shares of Embecta common stock.  The spin-off is expected to qualify as a tax-free transaction for U.S. federal income tax purposes.  Embecta is an independent, publicly traded company focused on diabetes management, and BD retains no ownership interest.  Embecta&#8217;s common stock is listed on NASDAQ under the ticker symbol &#8220;EMBC&#8221;.  The historical financial results of Embecta are included in these condensed consolidated financial statements.  Subsequent to the spin-off, and in future filings, the historical results of the Diabetes Care business will be reflected as discontinued operations in the Company&#8217;s consolidated financial statements.  Disclosures pertaining to Embecta&#8217;s issuance of debt in connection with the spin-off are provided in Note 12.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In connection with the spin-off, the Company and Embecta entered into various agreements to effect the spin-off and provide a framework for the relationship between the Company and Embecta after the spin-off.  Such agreements include the separation and distribution agreement, as well as the following ongoing agreements: a cannula supply agreement, an intellectual property matters agreement, a transition services agreement, manufacturing and supply agreements, a lease agreement, a distribution agreement to support commercial operations, a logistics services agreement and other agreements including an employee matters agreement and a tax matters agreement. Under these agreements the Company will continue to provide certain products and services to Embecta following the spin-off.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268609755576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">Shareholders' Equity<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in certain components of shareholders' equity for the first two quarters of fiscal years 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"/><td style="width:35.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.027%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock&#160; Issued<br/>at&#160;Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess&#160;of<br/>Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred<br/>Compensation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,272&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,164)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,723)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($0.87 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(462)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,869)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,855)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($0.87 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,495&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,416&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,575)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,866)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"/><td style="width:35.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.027%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock&#160; Issued<br/>at&#160;Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess&#160;of<br/>Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred<br/>Compensation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,623)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,138)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($0.83 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of change in accounting principles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,522&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,080)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,136)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($0.83 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,341&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,557&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,821)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,132)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Common stock held in trusts consists of the Company&#8217;s shares held in rabbi trusts in connection with deferred compensation under the Company&#8217;s employee salary and bonus deferral plan and directors&#8217; deferral plan.  During the second quarter of fiscal year 2022, the common stock held in trusts was temporarily replaced with the Company&#8217;s Series C preferred shares to adhere to trust requirements until the Company&#8217;s spin-off of its Diabetes Care business was completed on April 1, 2022.  </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Represents shares received upon final settlement of an accelerated share repurchase agreement, and the related forward sale contract, entered into during the fourth quarter of fiscal year 2021.  T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he share repurchases were made pursuant to the repurchase program authorized by the Board of Directors on September 24, 2013 for 10&#160;million shares, for which there is no expiration date.  In November 2021, the Board of Directors authorized the Company to repurchase up to an additional 10&#160;million shares of BD common stock, for which there is also no expiration date.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components and changes of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the first two quarters of fiscal years 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.426%"><tr><td style="width:1.0%"/><td style="width:47.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.107%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.107%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.107%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,292)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(784)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,043)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,251)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(774)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,910)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,173)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(763)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.134%"><tr><td style="width:1.0%"/><td style="width:47.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,548)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,416)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,040)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,414)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,352)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(998)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,329)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,367)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(982)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of foreign currency translation recognized in other comprehensive income during the three and six months ended March&#160;31, 2022 and 2021 included net gains (losses) relating to net investment hedges.  Other comprehensive income relating to benefit plans during the three months ended December 31, 2020 represented a net gain recognized as a result of the Company&#8217;s remeasurement, as of October 31, 2020, of the legacy Bard U.S. defined pension benefit plan upon its merger with the BD defined benefit cash balance pension plan in the first quarter of fiscal year 2021.  The amounts recognized in other comprehensive income relating to cash flow hedges during the three and six months ended March 31, 2022 and 2021 are primarily related to forward starting interest rate swaps.  Additional disclosures regarding amounts the Company recognized in other comprehensive income relating to cash flow hedges during the three and six months ended March&#160;31, 2022 and 2021 are provided in Note 10.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax impacts for amounts recognized in other comprehensive income (loss) before reclassifications and for reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to benefit plans and cash flow hedges during the three and six months ended March&#160;31, 2022 and 2021 were immaterial to the Company's consolidated financial results.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268610759160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings per Share</a></td>
<td class="text">Earnings per Share<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:49.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.512%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.461%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284,961&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from share-based plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from Series C preferred shares (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common and common equivalent shares outstanding &#8211; assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,299&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,547&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,202&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,499&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share equivalents excluded from the diluted shares outstanding calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mandatory convertible preferred stock (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based plans (c)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Represents dilutive share equivalents from Series C preferred shares that temporarily replaced shares of common stock held in trusts to adhere to trust requirements until the Company&#8217;s spin-off of its Diabetes Care business on April 1, 2022 was completed. </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Excluded from the diluted shares outstanding calculation because the result would have been antidilutive.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Excluded from the diluted earnings per share calculation as the exercise prices of these awards were greater than the average market price of the Company&#8217;s common shares.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268610668408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies</a></td>
<td class="text">Contingencies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved, both as a plaintiff and a defendant, in various legal proceedings that arise in the ordinary course of business, including, without limitation, product liability and environmental matters in certain U.S. and international locations.  Given the uncertain nature of litigation generally, the Company is not able, in all cases, to estimate the amount or range of loss that could result from an unfavorable outcome of litigation in which the Company is a party.  In accordance with U.S. GAAP, the Company establishes accruals to the extent probable future losses are estimable (and in the case of environmental matters, without considering possible third-party recoveries).  With respect to putative class action lawsuits in the United States and certain of the Canadian lawsuits described below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding all or certain of the plaintiffs and their medical conditions; and/or (iii) there are significant factual issues to be resolved.  In addition, there is uncertainty as to the likelihood of a class being certified or the ultimate size of any class.  With respect to the civil investigative demands (&#8220;CIDs&#8221;) served by the Department of Justice which are discussed below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; and/or (ii) there are significant factual and legal issues to be resolved.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Liability Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the Company is defending approximately 28,590 product liability claims involving the Company&#8217;s line of hernia repair devices (collectively, the &#8220;Hernia Product Claims&#8221;).  The majority of those claims are currently pending in a coordinated proceeding in Rhode Island State Court (&#8220;RI&#8221;) and in a federal multi-district litigation (&#8220;MDL&#8221;) established in the Southern District of Ohio, but claims are also pending in other state and/or federal court jurisdictions.  In addition, those claims include multiple putative class actions in Canada.  Generally, the Hernia Product Claims seek damages for personal injury allegedly resulting from use of the products.  From time to time, the Company engages in resolution discussions with plaintiffs&#8217; law firms regarding certain of the Hernia Product Claims, but the Company also intends to vigorously defend Hernia Product Claims that do not settle, including through litigation.  </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The first bellwether trial in the hernia MDL resulted in a complete defense verdict in favor of the Company in September 2021 after over five weeks of trial.  </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The second hernia MDL bellwether resulted in a $255&#160;thousand verdict in April 2022 after four weeks of trial. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trials are currently scheduled in various state and/or federal courts, including one currently scheduled for June 2022 in RI.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects additional trials of Hernia Product Claims to take place over the next 12 months.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also continues to be a defendant in certain other mass tort litigation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the Company is defending product liability claims involving the Company&#8217;s line of pelvic mesh products, the majority of which are pending in various federal court jurisdictions and in a coordinated proceeding in New Jersey Superior Court.  Also, as of March&#160;31, 2022, the Company is defending product liability claims involving the Company&#8217;s line of inferior vena cava (&#8220;IVC&#8221;) filter products.  The majority of those claims are pending in various federal court jurisdictions after having been remanded from the MDL in the United States District Court for the District of Arizona.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In most product liability litigations (like those described above), plaintiffs allege a wide variety of claims, ranging from allegations of serious injury caused by the products to efforts to obtain compensation notwithstanding the absence of any injury. In many of these cases, the Company has not yet received and reviewed complete information regarding the plaintiffs and their medical conditions and, consequently, is unable to fully evaluate the claims.  The Company expects that it will receive and review additional information regarding any remaining unsettled product liability matters.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2020, a putative class action captioned Kabak v. Becton, Dickinson and Company, et al., Civ. No. 2:20-cv-02155 (SRC) (CLW), now captioned Industriens Pensionsforsikring v. Becton, Dickinson and Company, et al., was filed in the U.S. District Court for the District of New Jersey against the Company and certain of its officers.  The complaint, which purports to be brought on behalf of all persons (other than defendants) who purchased or otherwise acquired the Company's common stock from November 5, 2019 through February 5, 2020, asserts claims for purported violations of Sections 10 and 20 of the Securities Exchange Act of 1934 and Securities and Exchange Commission (&#8220;SEC&#8221;) Rule 10b-5 promulgated thereunder, and seeks, among other things, damages and costs.  The complaint alleges that defendants concealed certain material information regarding Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps, allegedly rendering certain public statements about the Company&#8217;s business, operations and prospects false or misleading, thereby allegedly causing investors to purchase stock at an inflated price.  The plaintiff filed a second amended complaint to add certain additional factual allegations on February 3, 2021.  This complaint was dismissed on the Company&#8217;s motion on September 15, 2021.  The court&#8217;s dismissal order, however, gave plaintiff an opportunity to replead, which it did on October 29, 2021.  The Company moved to dismiss the newly amended pleading on December 16, 2021.  That motion is fully briefed and pending.  The Company believes that these allegations are without merit and it intends to defend itself vigorously.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2020, a civil action captioned Jankowski v. Forlenza, et al., Civ. No. 2:20-cv-15474, was filed in the U.S. District Court for the District of New Jersey by a shareholder, Ronald Jankowski, derivatively on behalf of the Company, against its individual directors and certain of its officers. The complaint seeks recovery for breach of fiduciary duties by directors and various officers; violations of the Securities Exchange Act of 1934, including sections 10(b), 14(a) and 21D; and insider trading.  In general, the complaint also alleges, among other things, that various directors and/or officers caused the Company to issue purportedly misleading statements and SEC filings regarding Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps, and issue a purportedly misleading proxy statement. The complaint seeks damages, including restitution and disgorgement of profits, and an injunction requiring the Company to undertake remedial measures with respect to certain corporate governance and internal procedures.  A second derivative action, Schranz v. Polen, et al., Civ. No 2:21-cv-01081 (D. N.J.), was filed on January 24, 2021, and the two actions were consolidated.  In March 2021, the Company received letters from two additional shareholders which, in general, mirrored the allegations in the Jankowski and Schranz consolidated actions, and demanded, among other things, that the Board of Directors pursue civil action against members of management for claimed breaches of fiduciary duties. Consistent with New Jersey law, the Board appointed a special committee to review the allegations and demands in the derivative actions and demand letters.  Following an investigation, the special committee determined that no action was warranted, and rejected the shareholders&#8217; demands. The special committee&#8217;s determination has been communicated to counsel for the shareholders.  Should the shareholders continue to pursue their claims in court, the Company will take appropriate steps to seek dismissal of the complaints.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In May 2017, the Company was sued by a competitor in the Northern District of New York, alleging antitrust violations related to certain aspects of the Company&#8217;s medical delivery solutions business in a case captioned AngioDynamics, Inc. v. C. R. Bard, Inc. et al., Civ. No. 1:17-CV-0598.  Motion practice in the case is ongoing.  The Company believes it has meritorious defenses and is vigorously defending the case, which has been set for trial on July 5, 2022. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company received a subpoena from the Enforcement Division of the SEC requesting information from the Company relating to, among other things, Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps.  The Company is cooperating with the SEC and responding to these requests.  The Company cannot anticipate the timing, scope, outcome or possible impact of the investigation, financial or otherwise. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the Department of Justice served the Company and CareFusion with CIDs seeking information regarding certain of CareFusion&#8217;s contracts with the Department of Veteran&#8217;s Affairs for certain products, including Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Pyxis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">devices, in connection with a civil investigation of possible violations of the False Claims Act, and the government recently expanded the investigation to include several additional contracts.  The government has made several requests for documents and interviews or depositions of Company personnel.  The Company is cooperating with the government and responding to these requests.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company received a CID related to an inquiry initiated by the Northern District of Georgia in 2018.  The requests concern sales and marketing practices with respect to certain aspects of the Company&#8217;s urology business.  The government has made requests for documents and has interviewed employees.  The inquiry is ongoing and the Company is cooperating with the government and responding to its requests. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company was served with a complaint from the New Mexico Attorney General, alleging violations of the state&#8217;s consumer protection laws in connection with the sales and marketing of its IVC filters.  The Company filed its motion to dismiss on December 27, 2021, and intends to vigorously defend itself in the litigation.  As the case is in its early stages, the Company cannot anticipate the timing, scope, outcome or possible impact at present.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company became aware of lawsuits that had been filed against it in state and federal court in Georgia.  The suits were filed by plaintiffs who reside near Company facilities in Covington, GA, where ethylene oxide (&#8220;EtO&#8221;) sterilization activities take place.  There are currently approximately 210 of such suits.  The claims allege a variety of injuries, including but not limited to multiple types of cancer, allegedly attributable to exposure to EtO in the ambient air.  The Company has meritorious defenses and intends to defend itself vigorously.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also involved both as a plaintiff and a defendant in other legal proceedings and claims that arise in the ordinary course of business.  The Company believes that it has meritorious defenses to these suits pending against the Company and is engaged in a vigorous defense of each of these matters.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot predict the outcome of these other legal matters discussed above, nor can it predict whether any outcome will have a material adverse effect on the Company&#8217;s consolidated results of operations and/or consolidated cash flows.  Accordingly, the Company has made no provisions for these other legal matters in its consolidated results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a potentially responsible party to a number of federal administrative proceedings in the United States brought under the Comprehensive Environment Response, Compensation and Liability Act, also known as &#8220;Superfund,&#8221; and similar state laws.  We also are subject to administrative proceedings under environmental laws in jurisdictions outside the U.S. The affected sites are in varying stages of development.  In some instances, the remedy has been completed, while in others, environmental studies are underway or commencing.  For several sites, there are other potentially responsible parties that may be jointly or severally liable to pay all or part of cleanup costs.  While it is not feasible to predict the outcome of these proceedings, based upon the Company&#8217;s experience, current information and applicable law, the Company does not expect these proceedings to have a material adverse effect on its consolidated results of operations and/or consolidated cash flows.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation Accruals</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly monitors and evaluates the status of product liability and other legal matters, and may, from time-to-time, engage in settlement and mediation discussions taking into consideration developments in the matters and the risks and uncertainties surrounding litigation.  These discussions could result in settlements of one or more of these claims at any time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals for the Company's product liability claims which are discussed above, as well as the related legal defense costs, amounted to approximately $2.3&#160;billion and $2.5 billion at March&#160;31, 2022 and September&#160;30, 2021, respectively.  These accruals are largely recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Income Taxes and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the Company's condensed consolidated balance sheets. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In view of the uncertainties discussed above, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance.  In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company&#8217;s consolidated results of operations and /or consolidated cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268609739944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues</a></td>
<td class="text">RevenuesThe Company&#8217;s policies for recognizing sales have not changed from those described in the Company&#8217;s 2021 Annual Report on Form 10-K.  The Company sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products which are distributed through independent distribution channels and directly by BD through sales representatives.  End-users of the Company's products include healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Revenues</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables.  Such estimated credit losses are determined based on historical loss experiences, customer-specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information.  The allowance for doubtful accounts for trade receivables is not material to the Company's consolidated financial results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized.  Such variable consideration includes rebates, sales discounts and sales returns.  The Company&#8217;s rebate liability at March&#160;31, 2022 and September&#160;30, 2021 was $585&#160;million and $576&#160;million, respectively.  The impact of other forms of variable consideration, including sales discounts and sales returns, is not material to the Company's revenues.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of Revenue Arrangements on Consolidated Balance Sheets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized contract costs associated with the costs to fulfill contracts for certain products in the Medication Management Solutions organizational unit are immaterial to the Company's condensed consolidated balance sheets.  Commissions relating to revenues recognized over a period longer than one year are recorded as assets which are amortized over the period over which the revenues underlying the commissions are recognized.  Capitalized contract costs related to such commissions are immaterial to the Company's condensed consolidated balance sheets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities for unearned revenue that is allocable to performance obligations, such as extended warranty and software maintenance contracts, which are performed over time are immaterial to the Company's consolidated financial results.  The Company's liability for product warranties provided under its agreements with customers is not material to its condensed consolidated balance sheets. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's obligations relative to service contracts and pending installations of equipment, primarily in the Company's Medication Management Solutions unit, represent unsatisfied performance obligations of the Company.  The revenues under existing contracts with original expected durations of more than one year, which are attributable to products and/or services that have not yet been installed or provided are estimated to be approximately $2.2 billion at March&#160;31, 2022.  The Company expects to recognize the majority of this revenue over the next three years.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the Company's Medication Management Solutions, Medication Delivery Solutions, Integrated Diagnostic Solutions, and Biosciences units, some contracts also contain minimum purchase commitments of reagents or other consumables and the future sales of these consumables represent additional unsatisfied performance obligations of the Company.  The revenue attributable to the unsatisfied minimum purchase commitment-related performance obligations, for contracts with original expected durations of more than one year, is estimated to be approximately&#160;$2.4 billion&#160;at&#160;March&#160;31, 2022. &#160;This revenue will be recognized over the customer relationship periods.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenues</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A disaggregation of the Company's revenues by segment, organizational unit and geographic region is provided in Note 6.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268610742984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Data</a></td>
<td class="text">Segment Data<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's organizational structure is based upon three worldwide business segments: BD Medical (&#8220;Medical&#8221;), BD Life Sciences (&#8220;Life Sciences&#8221;) and BD Interventional (&#8220;Interventional&#8221;).  The Company's segments are strategic businesses that are managed separately because each one develops, manufactures and markets distinct products and services.  Segment disclosures are on a performance basis consistent with internal management reporting.  The Company evaluates performance of its business segments and allocates resources to them primarily based upon segment operating income, which represents revenues reduced by product costs and operating expenses. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by segment, organizational unit and geographical areas for the three and six-month periods are detailed below.  The Company has no material intersegment revenues. </span></div><div style="margin-top:14pt;padding-left:36pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:31.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.590%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Medical</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Life Sciences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,485&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Interventional</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Company revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,204&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,011&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,446&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,907&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:31.058%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.624%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Medical</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Life Sciences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,710&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,855&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Interventional</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,498&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,388&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,086&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Company revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,659&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,347&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,006&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,592&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,631&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,223&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment income for the three and six-month periods was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.260%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Income Before Income Taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Segment Operating Income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,884&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration and restructuring expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net interest expense </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(238)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other unallocated items (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(717)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(913)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,378)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,529)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Income Before Income Taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,462&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">The amounts for the three and six months ended March&#160;31, 2022 include a noncash asset impairment charge of $54&#160;million recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Medical segment.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Primarily comprised of foreign exchange, certain general and administrative expenses and share-based compensation expense.  The amounts for the three and six months ended March&#160;31, 2021 also included pre-tax charges of $296&#160;million recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense, net </span>related to certain product liability matters, including the related legal defense costs, which are further discussed in Note 4.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268610636024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Benefit Plans</a></td>
<td class="text">Benefit Plans<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has defined benefit pension plans covering certain employees in the United States and certain international locations.  The measurement date used for these plans is September&#160;30.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net pension cost included the following components for the three and six-month periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:45.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts provided above for amortization of prior service credit and amortization of loss represent the reclassifications of prior service credits and net actuarial losses that were recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in prior periods.  All components of the Company&#8217;s net periodic pension cost, aside from service cost, are recorded to&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;on its condensed consolidated statements of income.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268609717320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Restructuring Charges<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Business Restructuring Charges</a></td>
<td class="text">Business Restructuring Charges<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred restructuring costs during the six months ended March&#160;31, 2022, primarily in connection with the Company's simplification and other cost saving initiatives, which were largely recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-related integration and restructuring expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  These simplification and other costs saving initiatives are focused on reducing complexity, enhancing product quality, refining customer experience, and improving cost efficiency across all of the Company&#8217;s segments.  Restructuring liability activity for the six months ended March&#160;31, 2022 was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.456%"><tr><td style="width:1.0%"/><td style="width:36.665%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.686%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.041%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee<br/>Termination</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268610628136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text">Intangible Assets<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,983)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,005)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,839)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,287&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,067)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,220&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,385)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,737&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible amortization expense for the three months ended&#160;March&#160;31, 2022 and 2021&#160;was $352 million&#160;and $350 million, respectively.  Intangible amortization expense for the six months ended&#160;March&#160;31, 2022 and 2021&#160;was $707 million&#160;and $698 million, respectively. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"><tr><td style="width:1.0%"/><td style="width:38.713%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.357%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.548%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life&#160;Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interventional</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,255&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price allocation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,223&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,971&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,096&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268610783832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments and Hedging Activities</a></td>
<td class="text">Derivative Instruments and Hedging Activities<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative instruments to mitigate certain exposures.  The Company does not enter into derivative financial instruments for trading or speculative purposes.  The effects these derivative instruments and hedged items had on the Company&#8217;s balance sheets and the fair values of the derivatives outstanding at March&#160;31, 2022 and September&#160;30, 2021 were not material.  The effects on the Company&#8217;s financial performance and cash flows are provided below.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risks and Related Strategies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has foreign currency exposures throughout Europe, Greater Asia, Canada and Latin America.  Transactional currency exposures that arise from entering into transactions, generally on an intercompany basis, in non-hyperinflationary countries that are denominated in currencies other than the functional currency are mitigated primarily through the use of forward contracts.  In order to mitigate foreign currency exposure relating to its investments in certain foreign subsidiaries, the Company has hedged the currency risk associated with those investments with certain instruments, such as foreign currency-denominated debt and cross-currency swaps, which are designated as net investment hedges, as well as currency exchange contracts. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s foreign currency-related derivative instruments as of March&#160;31, 2022 and September&#160;30, 2021 were as follows:</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.210%"><tr><td style="width:1.0%"/><td style="width:36.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.089%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undesignated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (c)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables.  Gains and losses on these instruments are recognized immediately in income.  These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments.  Net amounts recognized in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, during the three and six months ended March&#160;31, 2022 and 2021 were immaterial to the Company's consolidated financial results.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents foreign currency-denominated long-term notes outstanding which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents cross-currency swaps which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains or losses relating to the net investment hedges, which are attributable to changes in the foreign currencies to U.S. dollar spot exchange rates, are recorded as accumulated foreign currency translation in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon the termination of a net investment hedge, any net gain or loss included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relative to the investment hedge remains until the foreign subsidiary investment is disposed of or is substantially liquidated.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains (losses) recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the Company's net investment hedges for the three and six-month periods were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:45.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risks and Related Strategies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a mix of fixed and variable rate debt to manage its interest rate exposure, and periodically uses interest rate swaps to manage such exposures.  Under these interest rate swaps, the Company exchanges, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. These swaps are designated as either cash flow or fair value hedges.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of the interest rate swaps designated as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk) are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If interest rate derivatives designated as cash flow hedges are terminated, the balance in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">attributable to those derivatives is reclassified into earnings, within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the remaining life of the hedged debt. The amounts reclassified from accumulated other comprehensive income relating to cash flow hedges during the three and six months ended March&#160;31, 2022 and 2021, as well as the amounts expected to be reclassified within the next 12 months, are not material to the Company's consolidated financial results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded net after-tax gains of $43&#160;million and $78&#160;million during the three months ended March&#160;31, 2022 and 2021, respectively, and $39&#160;million and $105&#160;million during the six months ended March&#160;31, 2022 and 2021, respectively, in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to interest rate hedges.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For interest rate swaps designated as fair value hedges (i.e., hedges against the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt due to changes in market interest rates.  Amounts recorded during the three and six months ended March&#160;31, 2022 and 2021 were immaterial to the Company's consolidated financial results. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s interest rate-related derivative instruments as of March&#160;31, 2022 and September&#160;30, 2021 were as follows: </span></div><div style="margin-top:3pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"><tr><td style="width:1.0%"/><td style="width:39.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents fixed-to-floating interest rate swap agreements the Company entered into to convert the interest payments on certain long-term notes from the fixed rate to a floating interest rate based on LIBOR.  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents interest rate derivatives entered into to mitigate exposure to interest rate risk related to future debt issuances.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Risk Exposures</span></div>The Company purchases resins, which are oil-based components used in the manufacture of certain products.  Significant increases in world oil prices that lead to increases in resin purchase costs could impact future operating results.  From time to time, the Company has managed price risks associated with these commodity purchases through commodity derivative forward contracts.  The Company's outstanding commodity derivative forward contracts at March&#160;31, 2022 were immaterial to the Company's consolidated financial results and the Company had no outstanding commodity derivative forward contracts at September&#160;30, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268610845560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Financial Instruments and Fair Value Measurements</a></td>
<td class="text">Financial Instruments and Fair Value Measurements<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following reconciles cash and equivalents and restricted cash reported within the Company's consolidated balance sheets at March&#160;31, 2022 and September&#160;30, 2021 to the total of these amounts shown on the Company's consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:327.75pt"><tr><td style="width:1.0pt"/><td style="width:166.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,320&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,392&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase.  Restricted cash consists of cash restricted from withdrawal and usage except for certain product liability matters.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s financial instruments are as follows:</span></div><div style="margin-top:9pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.842%"><tr><td style="width:1.0%"/><td style="width:40.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.978%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.978%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Institutional money market accounts and ultra-short bond fund (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt (b)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">These financial instruments are recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated balance sheets.  The institutional money market accounts permit daily redemption.  The fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions. </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Long-term debt is recorded at amortized cost.  The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments are held to their maturities and are carried at cost, which approximates fair value.  The short-term investments consist of instruments with maturities greater than three months and less than one year.  All other instruments measured by the Company at fair value, including derivatives and contingent consideration liabilities, are immaterial to the Company's consolidated balance sheets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nonrecurring Fair Value Measurements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of fiscal year 2022, the Company recorded a noncash asset impairment charge of $54&#160;million to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the Medical segment.  In the first quarter of fiscal year 2021, the Company recorded charges to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $34&#160;million to write down the carrying value of certain fixed assets.  The amounts recognized were recorded to adjust the carrying amount of assets to the assets' fair values, which were estimated, based upon a market participant's perspective, using Level 3 inputs, including values estimated using the income approach.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transfers of trade receivables</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the normal course of its business activities, the Company transfers certain trade receivable assets to third parties under factoring agreements.  Per the terms of these agreements, the Company surrenders control over its trade receivables upon transfer.&#160; Accordingly, the Company accounts for the transfers as sales of trade receivables by recognizing an increase to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and a decrease to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade receivables, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when proceeds from the transactions are received.&#160; The costs incurred by the Company in connection with factoring activities were not material to its consolidated financial results.  The amounts transferred and yet to be remitted under factoring arrangements are provided below.</span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.248%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.253%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables transferred to third parties under factoring arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"/><td style="width:56.249%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.810%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.628%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.813%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts yet to be collected and remitted to the third parties</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268610809768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, Embecta, as a wholly-owned subsidiary of the Company, issued $500&#160;million of 5.000% senior secured notes due February 15, 2030, in advance of the Company&#8217;s spin-off of Embecta, which is further discussed in Note 1.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the spin-off was effective on April 1, 2022, $200&#160;million of 6.750% senior secured notes issued by Embecta and due February 15, 2030 were exchanged for $199&#160;million of the aggregate principal amount outstanding on the Company&#8217;s Floating Rate Notes due June 6, 2022, which were purchased through a tender offer.  The carrying value of the long-term notes tendered was $199&#160;million, and the Company recognized a loss on this debt extinguishment of $2&#160;million, which will be recorded in the third quarter of fiscal year 2022 within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on the Company&#8217;s condensed consolidated statements of income.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in connection with the spin-off, on March 31, 2022 Embecta issued a senior secured term loan facility with an aggregate principal amount of $950&#160;million and a senior secured revolving credit facility providing borrowings of up to $500&#160;million that was undrawn at March 31, 2022 and at the spin-off date. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The borrowings from the 5.000% senior secured notes due February 15, 2030 and the senior secured term loan facility were included within the Company's condensed consolidated balance sheet at March 31, 2022.  The senior secured notes and credit agreement for the term loan and revolving credit facilities were guaranteed on an unsecured, unsubordinated basis solely by the Company prior to the spin-off date.  The Company&#8217;s guarantees automatically and unconditionally terminated upon the consummation of the spin-off on April 1, 2022.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2022, Embecta used a portion of the proceeds from the financing transactions discussed above to make a cash distribution of approximately $1.266&#160;billion to the Company.  On April 1, 2022, an additional $197&#160;million was distributed to the Company through the exchange of the senior secured notes discussed above</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268609581928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">The Company is involved, both as a plaintiff and a defendant, in various legal proceedings that arise in the ordinary course of business, including, without limitation, product liability and environmental matters in certain U.S. and international locations.  Given the uncertain nature of litigation generally, the Company is not able, in all cases, to estimate the amount or range of loss that could result from an unfavorable outcome of litigation in which the Company is a party.  In accordance with U.S. GAAP, the Company establishes accruals to the extent probable future losses are estimable (and in the case of environmental matters, without considering possible third-party recoveries).  With respect to putative class action lawsuits in the United States and certain of the Canadian lawsuits described below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding all or certain of the plaintiffs and their medical conditions; and/or (iii) there are significant factual issues to be resolved.  In addition, there is uncertainty as to the likelihood of a class being certified or the ultimate size of any class.  With respect to the civil investigative demands (&#8220;CIDs&#8221;) served by the Department of Justice which are discussed below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; and/or (ii) there are significant factual and legal issues to be resolved.In view of the uncertainties discussed above, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance.  In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company&#8217;s consolidated results of operations and /or consolidated cash flows.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Revenues</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables.  Such estimated credit losses are determined based on historical loss experiences, customer-specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information.  The allowance for doubtful accounts for trade receivables is not material to the Company's consolidated financial results.</span></div>The Company's gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized.  Such variable consideration includes rebates, sales discounts and sales returns.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives</a></td>
<td class="text">The Company uses derivative instruments to mitigate certain exposures.  The Company does not enter into derivative financial instruments for trading or speculative purposes.<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a mix of fixed and variable rate debt to manage its interest rate exposure, and periodically uses interest rate swaps to manage such exposures.  Under these interest rate swaps, the Company exchanges, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. These swaps are designated as either cash flow or fair value hedges.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of the interest rate swaps designated as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk) are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If interest rate derivatives designated as cash flow hedges are terminated, the balance in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">attributable to those derivatives is reclassified into earnings, within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense,</span> over the remaining life of the hedged debt.For interest rate swaps designated as fair value hedges (i.e., hedges against the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt due to changes in market interest rates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents</a></td>
<td class="text">Restricted cash consists of cash restricted from withdrawal and usage except for certain product liability matters.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">The fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions.Long-term debt is recorded at amortized cost.  The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.Short-term investments are held to their maturities and are carried at cost, which approximates fair value.  The short-term investments consist of instruments with maturities greater than three months and less than one year.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268612755976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of Shareholders Equity</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in certain components of shareholders' equity for the first two quarters of fiscal years 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"/><td style="width:35.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.027%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock&#160; Issued<br/>at&#160;Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess&#160;of<br/>Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred<br/>Compensation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,272&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,164)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,723)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($0.87 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(462)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,869)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,855)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($0.87 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,495&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,416&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,575)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,866)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"/><td style="width:35.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.027%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock&#160; Issued<br/>at&#160;Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess&#160;of<br/>Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred<br/>Compensation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,623)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,138)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($0.83 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of change in accounting principles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,522&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,080)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,136)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($0.83 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,341&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,557&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,821)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,132)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Common stock held in trusts consists of the Company&#8217;s shares held in rabbi trusts in connection with deferred compensation under the Company&#8217;s employee salary and bonus deferral plan and directors&#8217; deferral plan.  During the second quarter of fiscal year 2022, the common stock held in trusts was temporarily replaced with the Company&#8217;s Series C preferred shares to adhere to trust requirements until the Company&#8217;s spin-off of its Diabetes Care business was completed on April 1, 2022.  </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Represents shares received upon final settlement of an accelerated share repurchase agreement, and the related forward sale contract, entered into during the fourth quarter of fiscal year 2021.  T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he share repurchases were made pursuant to the repurchase program authorized by the Board of Directors on September 24, 2013 for 10&#160;million shares, for which there is no expiration date.  In November 2021, the Board of Directors authorized the Company to repurchase up to an additional 10&#160;million shares of BD common stock, for which there is also no expiration date.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components and changes of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the first two quarters of fiscal years 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.426%"><tr><td style="width:1.0%"/><td style="width:47.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.107%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.107%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.107%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,292)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(784)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,043)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,251)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(774)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,910)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,173)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(763)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.134%"><tr><td style="width:1.0%"/><td style="width:47.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,548)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,416)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,040)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,414)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,352)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(998)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,329)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,367)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(982)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268610651000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:49.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.512%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.461%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284,961&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from share-based plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from Series C preferred shares (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common and common equivalent shares outstanding &#8211; assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,299&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,547&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,202&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,499&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share equivalents excluded from the diluted shares outstanding calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mandatory convertible preferred stock (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based plans (c)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Represents dilutive share equivalents from Series C preferred shares that temporarily replaced shares of common stock held in trusts to adhere to trust requirements until the Company&#8217;s spin-off of its Diabetes Care business on April 1, 2022 was completed. </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Excluded from the diluted shares outstanding calculation because the result would have been antidilutive.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Excluded from the diluted earnings per share calculation as the exercise prices of these awards were greater than the average market price of the Company&#8217;s common shares.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268610821000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Area</a></td>
<td class="text">Revenues by segment, organizational unit and geographical areas for the three and six-month periods are detailed below.  The Company has no material intersegment revenues. <div style="margin-top:14pt;padding-left:36pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:31.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.590%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Medical</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Life Sciences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,485&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Interventional</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Company revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,204&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,011&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,446&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,907&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:31.058%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.624%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Medical</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Life Sciences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,710&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,855&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Interventional</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,498&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,388&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,086&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Company revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,659&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,347&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,006&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,592&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,631&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,223&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Financial Information for Company's Segments</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment income for the three and six-month periods was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.260%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Income Before Income Taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Segment Operating Income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,884&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration and restructuring expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net interest expense </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(238)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other unallocated items (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(717)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(913)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,378)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,529)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Income Before Income Taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,462&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">The amounts for the three and six months ended March&#160;31, 2022 include a noncash asset impairment charge of $54&#160;million recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Medical segment.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Primarily comprised of foreign exchange, certain general and administrative expenses and share-based compensation expense.  The amounts for the three and six months ended March&#160;31, 2021 also included pre-tax charges of $296&#160;million recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense, net </span>related to certain product liability matters, including the related legal defense costs, which are further discussed in Note 4.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268610776888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Net Pension and Postretirement Cost</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net pension cost included the following components for the three and six-month periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:45.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268610824072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Restructuring Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Summary of Restructuring Accrual Activity</a></td>
<td class="text">Restructuring liability activity for the six months ended March&#160;31, 2022 was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.456%"><tr><td style="width:1.0%"/><td style="width:36.665%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.686%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.041%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee<br/>Termination</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268612764088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Components of Intangible Assets</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,983)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,005)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,839)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,287&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,067)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,220&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,385)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,737&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Reconciliation of Goodwill by Business Segment</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"><tr><td style="width:1.0%"/><td style="width:38.713%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.357%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.548%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life&#160;Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interventional</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,255&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price allocation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,223&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,971&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,096&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268610737672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Schedule of Notional Amounts of Outstanding Derivative Positions</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s foreign currency-related derivative instruments as of March&#160;31, 2022 and September&#160;30, 2021 were as follows:</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.210%"><tr><td style="width:1.0%"/><td style="width:36.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.089%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undesignated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (c)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables.  Gains and losses on these instruments are recognized immediately in income.  These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments.  Net amounts recognized in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, during the three and six months ended March&#160;31, 2022 and 2021 were immaterial to the Company's consolidated financial results.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents foreign currency-denominated long-term notes outstanding which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents cross-currency swaps which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s interest rate-related derivative instruments as of March&#160;31, 2022 and September&#160;30, 2021 were as follows: </span></div><div style="margin-top:3pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"><tr><td style="width:1.0%"/><td style="width:39.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents fixed-to-floating interest rate swap agreements the Company entered into to convert the interest payments on certain long-term notes from the fixed rate to a floating interest rate based on LIBOR.  </span></div>(b)Represents interest rate derivatives entered into to mitigate exposure to interest rate risk related to future debt issuances.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains (losses) recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the Company's net investment hedges for the three and six-month periods were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:45.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268610696168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following reconciles cash and equivalents and restricted cash reported within the Company's consolidated balance sheets at March&#160;31, 2022 and September&#160;30, 2021 to the total of these amounts shown on the Company's consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:327.75pt"><tr><td style="width:1.0pt"/><td style="width:166.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,320&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,392&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s financial instruments are as follows:</span></div><div style="margin-top:9pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.842%"><tr><td style="width:1.0%"/><td style="width:40.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.978%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.978%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Institutional money market accounts and ultra-short bond fund (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt (b)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">These financial instruments are recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated balance sheets.  The institutional money market accounts permit daily redemption.  The fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Long-term debt is recorded at amortized cost.  The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock', window );">Transfer of Financial Assets Accounted for as Sales</a></td>
<td class="text">The amounts transferred and yet to be remitted under factoring arrangements are provided below.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.248%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.253%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables transferred to third parties under factoring arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"/><td style="width:56.249%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.810%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.628%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.813%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts yet to be collected and remitted to the third parties</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268605431544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Sep. 24, 2013</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,131<span></span>
</td>
<td class="nump">$ 1,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 24,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends per Common Share (USD per share)</a></td>
<td class="nump">$ 0.87<span></span>
</td>
<td class="nump">$ 0.87<span></span>
</td>
<td class="nump">$ 0.83<span></span>
</td>
<td class="nump">$ 0.83<span></span>
</td>
<td class="nump">$ 1.74<span></span>
</td>
<td class="nump">$ 1.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Number of shares authorized to be repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased', window );">Number of additional shares authorized to be repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock&#160; Issued at&#160;Par&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">$ 365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">365<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Capital in Excess&#160;of Par&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">19,435<span></span>
</td>
<td class="nump">19,272<span></span>
</td>
<td class="nump">19,301<span></span>
</td>
<td class="nump">19,270<span></span>
</td>
<td class="nump">19,272<span></span>
</td>
<td class="nump">19,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Common stock issued for share-based compensation and other plans, net</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(71)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_CommonStockHeldInTrustsAcquired', window );">Common stock held in trusts, net</a></td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">19,495<span></span>
</td>
<td class="nump">19,435<span></span>
</td>
<td class="nump">19,341<span></span>
</td>
<td class="nump">19,301<span></span>
</td>
<td class="nump">19,495<span></span>
</td>
<td class="nump">19,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">14,233<span></span>
</td>
<td class="nump">13,826<span></span>
</td>
<td class="nump">13,522<span></span>
</td>
<td class="nump">12,791<span></span>
</td>
<td class="nump">13,826<span></span>
</td>
<td class="nump">12,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">454<span></span>
</td>
<td class="nump">677<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="nump">1,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Common dividends</a></td>
<td class="num">(248)<span></span>
</td>
<td class="num">(248)<span></span>
</td>
<td class="num">(242)<span></span>
</td>
<td class="num">(242)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Preferred dividends</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">14,416<span></span>
</td>
<td class="nump">14,233<span></span>
</td>
<td class="nump">13,557<span></span>
</td>
<td class="nump">13,522<span></span>
</td>
<td class="nump">14,416<span></span>
</td>
<td class="nump">13,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings | Effect of change in accounting principles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Effect of change in accounting principles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember', window );">Deferred Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Common stock issued for share-based compensation and other plans, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">$ (7,855)<span></span>
</td>
<td class="num">$ (7,723)<span></span>
</td>
<td class="num">$ (6,136)<span></span>
</td>
<td class="num">$ (6,138)<span></span>
</td>
<td class="num">$ (7,723)<span></span>
</td>
<td class="num">$ (6,138)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares)</a></td>
<td class="num">(79,869)<span></span>
</td>
<td class="num">(80,164)<span></span>
</td>
<td class="num">(74,080)<span></span>
</td>
<td class="num">(74,623)<span></span>
</td>
<td class="num">(80,164)<span></span>
</td>
<td class="num">(74,623)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Common stock issued for share-based compensation and other plans, net</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Common stock issued for share-based compensation and other plans, net (in shares)</a></td>
<td class="nump">284<span></span>
</td>
<td class="nump">762<span></span>
</td>
<td class="nump">234<span></span>
</td>
<td class="nump">549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_CommonStockHeldInTrustsNetShares', window );">Common stock held in trusts, net (in shares)</a></td>
<td class="nump">9<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_CommonStockHeldInTrustsAcquired', window );">Common stock held in trusts, net</a></td>
<td class="num">$ (24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (7,866)<span></span>
</td>
<td class="num">$ (7,855)<span></span>
</td>
<td class="num">$ (6,132)<span></span>
</td>
<td class="num">$ (6,136)<span></span>
</td>
<td class="num">$ (7,866)<span></span>
</td>
<td class="num">$ (6,132)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares)</a></td>
<td class="num">(79,575)<span></span>
</td>
<td class="num">(79,869)<span></span>
</td>
<td class="num">(73,821)<span></span>
</td>
<td class="num">(74,080)<span></span>
</td>
<td class="num">(79,575)<span></span>
</td>
<td class="num">(73,821)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_CommonStockHeldInTrustsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock Held in Trusts, Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_CommonStockHeldInTrustsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_CommonStockHeldInTrustsNetShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common stock shares held in trust.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_CommonStockHeldInTrustsNetShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Number of Additional Shares Authorized to be Repurchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268607154776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Accumulated Other Comprehensive Income (Loss) - Components and Changes of Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="num">$ (2,043)<span></span>
</td>
<td class="num">$ (2,088)<span></span>
</td>
<td class="num">$ (2,414)<span></span>
</td>
<td class="num">$ (2,548)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of taxes</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified into income, net of taxes</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">(1,910)<span></span>
</td>
<td class="num">(2,043)<span></span>
</td>
<td class="num">(2,329)<span></span>
</td>
<td class="num">(2,414)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="num">(1,251)<span></span>
</td>
<td class="num">(1,292)<span></span>
</td>
<td class="num">(1,352)<span></span>
</td>
<td class="num">(1,416)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of taxes</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified into income, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">(1,173)<span></span>
</td>
<td class="num">(1,251)<span></span>
</td>
<td class="num">(1,367)<span></span>
</td>
<td class="num">(1,352)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Benefit&#160;Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="num">(774)<span></span>
</td>
<td class="num">(784)<span></span>
</td>
<td class="num">(998)<span></span>
</td>
<td class="num">(1,040)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified into income, net of taxes</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">(763)<span></span>
</td>
<td class="num">(774)<span></span>
</td>
<td class="num">(982)<span></span>
</td>
<td class="num">(998)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(62)<span></span>
</td>
<td class="num">(91)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of taxes</a></td>
<td class="nump">44<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified into income, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="num">$ (17)<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="num">$ (62)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268608640152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings per Share (Detail) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Average common shares outstanding (shares)</a></td>
<td class="nump">285,243<span></span>
</td>
<td class="nump">291,095<span></span>
</td>
<td class="nump">284,961<span></span>
</td>
<td class="nump">290,839<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Dilutive share equivalents from share-based plans (shares)</a></td>
<td class="nump">2,003<span></span>
</td>
<td class="nump">2,452<span></span>
</td>
<td class="nump">2,215<span></span>
</td>
<td class="nump">2,660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Dilutive share equivalents from Series C preferred shares (shares)</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Average common and common equivalent shares outstanding - assuming dilution (shares)</a></td>
<td class="nump">287,299<span></span>
</td>
<td class="nump">293,547<span></span>
</td>
<td class="nump">287,202<span></span>
</td>
<td class="nump">293,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Share equivalents excluded from the diluted shares outstanding calculation (shares)</a></td>
<td class="nump">5,639<span></span>
</td>
<td class="nump">6,169<span></span>
</td>
<td class="nump">5,639<span></span>
</td>
<td class="nump">6,169<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bdx_ShareBasedCompensationMember', window );">Share Based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Share equivalents excluded from the diluted shares outstanding calculation (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">773<span></span>
</td>
<td class="nump">676<span></span>
</td>
<td class="nump">773<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bdx_ShareBasedCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bdx_ShareBasedCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268609562952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>claim </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded</a></td>
<td class="nump">$ 255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency accrual</a></td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_GA', window );">GEORGIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_NumberOfEtOSterilizationLawsuitsFiled', window );">Number of EtO lawsuits filed | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=bdx_HerniaProductClaimsMember', window );">Hernia Product Claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Pending claims | claim</a></td>
<td class="nump">28,590<span></span>
</td>
<td class="nump">28,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_NumberOfEtOSterilizationLawsuitsFiled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of EtO Sterilization Lawsuits Filed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_NumberOfEtOSterilizationLawsuitsFiled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_GA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_GA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=bdx_HerniaProductClaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=bdx_HerniaProductClaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268610923880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenues (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_ContractWithCustomerRebateLiability', window );">Rebate liability</a></td>
<td class="nump">$ 585<span></span>
</td>
<td class="nump">$ 576<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-04-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-04-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01 | Products and/or Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation, amount</a></td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-04-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01 | Consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation, amount</a></td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ContractWithCustomerRebateLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Rebate Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ContractWithCustomerRebateLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-04-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-04-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bdx_ProductsandorServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bdx_ProductsandorServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bdx_ConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bdx_ConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268609467528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of principal business segments (segment)</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268603545224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data - Revenues by Geographic Areas (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 5,011<span></span>
</td>
<td class="nump">$ 4,907<span></span>
</td>
<td class="nump">$ 10,006<span></span>
</td>
<td class="nump">$ 10,223<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">2,416<span></span>
</td>
<td class="nump">2,311<span></span>
</td>
<td class="nump">4,813<span></span>
</td>
<td class="nump">4,572<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,485<span></span>
</td>
<td class="nump">1,586<span></span>
</td>
<td class="nump">2,968<span></span>
</td>
<td class="nump">3,565<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,111<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
<td class="nump">2,225<span></span>
</td>
<td class="nump">2,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">2,807<span></span>
</td>
<td class="nump">2,462<span></span>
</td>
<td class="nump">5,659<span></span>
</td>
<td class="nump">5,592<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,314<span></span>
</td>
<td class="nump">1,220<span></span>
</td>
<td class="nump">2,671<span></span>
</td>
<td class="nump">2,494<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">747<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="nump">1,490<span></span>
</td>
<td class="nump">1,710<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">746<span></span>
</td>
<td class="nump">666<span></span>
</td>
<td class="nump">1,498<span></span>
</td>
<td class="nump">1,388<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">2,204<span></span>
</td>
<td class="nump">2,446<span></span>
</td>
<td class="nump">4,347<span></span>
</td>
<td class="nump">4,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,102<span></span>
</td>
<td class="nump">1,091<span></span>
</td>
<td class="nump">2,142<span></span>
</td>
<td class="nump">2,078<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">738<span></span>
</td>
<td class="nump">1,010<span></span>
</td>
<td class="nump">1,478<span></span>
</td>
<td class="nump">1,855<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">364<span></span>
</td>
<td class="nump">345<span></span>
</td>
<td class="nump">727<span></span>
</td>
<td class="nump">698<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_MedicationDeliverySolutionsMember', window );">Medication Delivery Solutions | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,038<span></span>
</td>
<td class="nump">999<span></span>
</td>
<td class="nump">2,122<span></span>
</td>
<td class="nump">2,006<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_MedicationDeliverySolutionsMember', window );">Medication Delivery Solutions | United States | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">588<span></span>
</td>
<td class="nump">531<span></span>
</td>
<td class="nump">1,207<span></span>
</td>
<td class="nump">1,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_MedicationDeliverySolutionsMember', window );">Medication Delivery Solutions | International | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">450<span></span>
</td>
<td class="nump">468<span></span>
</td>
<td class="nump">915<span></span>
</td>
<td class="nump">908<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_MedicationManagementSolutionsMember', window );">Medication Management Solutions | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">604<span></span>
</td>
<td class="nump">566<span></span>
</td>
<td class="nump">1,231<span></span>
</td>
<td class="nump">1,196<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_MedicationManagementSolutionsMember', window );">Medication Management Solutions | United States | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">461<span></span>
</td>
<td class="nump">440<span></span>
</td>
<td class="nump">945<span></span>
</td>
<td class="nump">917<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_MedicationManagementSolutionsMember', window );">Medication Management Solutions | International | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">286<span></span>
</td>
<td class="nump">278<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_DiabetesCareMember', window );">Diabetes Care | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">273<span></span>
</td>
<td class="nump">284<span></span>
</td>
<td class="nump">561<span></span>
</td>
<td class="nump">569<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_DiabetesCareMember', window );">Diabetes Care | United States | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="nump">291<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_DiabetesCareMember', window );">Diabetes Care | International | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_PharmaceuticalSystemsMember', window );">Pharmaceutical Systems | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">501<span></span>
</td>
<td class="nump">462<span></span>
</td>
<td class="nump">898<span></span>
</td>
<td class="nump">801<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_PharmaceuticalSystemsMember', window );">Pharmaceutical Systems | United States | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">228<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_PharmaceuticalSystemsMember', window );">Pharmaceutical Systems | International | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">376<span></span>
</td>
<td class="nump">361<span></span>
</td>
<td class="nump">670<span></span>
</td>
<td class="nump">621<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_IntegratedDiagnosticSolutionsMember', window );">Integrated Diagnostic Solutions | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,150<span></span>
</td>
<td class="nump">1,261<span></span>
</td>
<td class="nump">2,295<span></span>
</td>
<td class="nump">2,928<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_IntegratedDiagnosticSolutionsMember', window );">Integrated Diagnostic Solutions | United States | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">618<span></span>
</td>
<td class="nump">454<span></span>
</td>
<td class="nump">1,232<span></span>
</td>
<td class="nump">1,469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_IntegratedDiagnosticSolutionsMember', window );">Integrated Diagnostic Solutions | International | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">532<span></span>
</td>
<td class="nump">807<span></span>
</td>
<td class="nump">1,062<span></span>
</td>
<td class="nump">1,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_BiosciencesMember', window );">Biosciences | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">335<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="nump">674<span></span>
</td>
<td class="nump">637<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_BiosciencesMember', window );">Biosciences | United States | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="nump">258<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_BiosciencesMember', window );">Biosciences | International | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">204<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="nump">396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_SurgeryMember', window );">Surgery | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">340<span></span>
</td>
<td class="nump">292<span></span>
</td>
<td class="nump">701<span></span>
</td>
<td class="nump">624<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_SurgeryMember', window );">Surgery | United States | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">268<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="nump">549<span></span>
</td>
<td class="nump">489<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_SurgeryMember', window );">Surgery | International | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_PeripheralInterventionMember', window );">Peripheral Intervention | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">450<span></span>
</td>
<td class="nump">420<span></span>
</td>
<td class="nump">863<span></span>
</td>
<td class="nump">846<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_PeripheralInterventionMember', window );">Peripheral Intervention | United States | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">240<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="nump">457<span></span>
</td>
<td class="nump">454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_PeripheralInterventionMember', window );">Peripheral Intervention | International | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_UrologyandCriticalCareMember', window );">Urology and Critical Care | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">320<span></span>
</td>
<td class="nump">298<span></span>
</td>
<td class="nump">661<span></span>
</td>
<td class="nump">616<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_UrologyandCriticalCareMember', window );">Urology and Critical Care | United States | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">239<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="nump">492<span></span>
</td>
<td class="nump">445<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_UrologyandCriticalCareMember', window );">Urology and Critical Care | International | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 82<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
<td class="nump">$ 171<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_MedicationDeliverySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_MedicationDeliverySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_MedicationManagementSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_MedicationManagementSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_DiabetesCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_DiabetesCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_PharmaceuticalSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_PharmaceuticalSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_IntegratedDiagnosticSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_IntegratedDiagnosticSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_BiosciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_BiosciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_SurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_SurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_PeripheralInterventionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_PeripheralInterventionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_UrologyandCriticalCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_UrologyandCriticalCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268603371256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data - Financial Information for Company's Segments (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_AcquisitionRelatedCostsAndRestructuringCharges', window );">Integration and restructuring expense</a></td>
<td class="num">$ (28)<span></span>
</td>
<td class="num">$ (52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (62)<span></span>
</td>
<td class="num">$ (102)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income Before Income Taxes</a></td>
<td class="nump">525<span></span>
</td>
<td class="nump">305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,248<span></span>
</td>
<td class="nump">1,462<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember', window );">Other Operating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualPeriodExpense', window );">Product liability accrual, period expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (Loss) Before Income Taxes</a></td>
<td class="nump">1,370<span></span>
</td>
<td class="nump">1,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,884<span></span>
</td>
<td class="nump">3,331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (Loss) Before Income Taxes</a></td>
<td class="nump">615<span></span>
</td>
<td class="nump">634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,331<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (Loss) Before Income Taxes</a></td>
<td class="nump">475<span></span>
</td>
<td class="nump">548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,009<span></span>
</td>
<td class="nump">1,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (Loss) Before Income Taxes</a></td>
<td class="nump">280<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">544<span></span>
</td>
<td class="nump">511<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Segment Reconciling Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_AcquisitionRelatedCostsAndRestructuringCharges', window );">Integration and restructuring expense</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(62)<span></span>
</td>
<td class="num">(102)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Net interest expense</a></td>
<td class="num">(100)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(195)<span></span>
</td>
<td class="num">(238)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate, Non-Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (Loss) Before Income Taxes</a></td>
<td class="num">$ (717)<span></span>
</td>
<td class="num">$ (913)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,378)<span></span>
</td>
<td class="num">$ (1,529)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_AcquisitionRelatedCostsAndRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; business integration costs, systems integration and conversion costs, and severance and other employee-related costs; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Additionally includes the amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_AcquisitionRelatedCostsAndRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityAccrualPeriodExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of loss reported during the period pertaining to product liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityAccrualPeriodExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268606368168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Detail) - Pension Plans - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(46)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
<td class="num">(89)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service credit</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of loss</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Settlements</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net pension cost</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268609455128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Restructuring Charges (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">$ 19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to expense</a></td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Termination</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to expense</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to expense</a></td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">$ 3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268606289752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Components of Intangible Assets (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 20,287<span></span>
</td>
<td class="nump">$ 20,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(8,067)<span></span>
</td>
<td class="num">(7,385)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">12,220<span></span>
</td>
<td class="nump">12,737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Unamortized intangible assets</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember', window );">Acquired in-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Unamortized intangible assets</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Unamortized intangible assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">14,535<span></span>
</td>
<td class="nump">14,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(5,491)<span></span>
</td>
<td class="num">(4,983)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">9,044<span></span>
</td>
<td class="nump">9,417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">4,686<span></span>
</td>
<td class="nump">4,658<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,005)<span></span>
</td>
<td class="num">(1,839)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">2,681<span></span>
</td>
<td class="nump">2,818<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bdx_ProductRightsMember', window );">Product rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(82)<span></span>
</td>
<td class="num">(83)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">408<span></span>
</td>
<td class="nump">409<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(146)<span></span>
</td>
<td class="num">(137)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">262<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Patents and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">543<span></span>
</td>
<td class="nump">533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(343)<span></span>
</td>
<td class="num">(342)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 191<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite And Indefinite Lived Intangible Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bdx_ProductRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bdx_ProductRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268609479816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible amortization expense</a></td>
<td class="nump">$ 352<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="nump">$ 707<span></span>
</td>
<td class="nump">$ 698<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268604879736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 23,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase price allocation adjustments</a></td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="num">(80)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">24,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember', window );">Medical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">10,255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase price allocation adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">10,223<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember', window );">Life&#160;Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">836<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase price allocation adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">902<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember', window );">Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">12,810<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase price allocation adjustments</a></td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 12,971<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268609562296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Cash flow hedges</a></td>
<td class="nump">$ 44,000,000<span></span>
</td>
<td class="nump">$ 83,000,000<span></span>
</td>
<td class="nump">$ 37,000,000<span></span>
</td>
<td class="nump">$ 111,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Cash flow hedges</a></td>
<td class="nump">43,000,000<span></span>
</td>
<td class="nump">$ 78,000,000<span></span>
</td>
<td class="nump">39,000,000<span></span>
</td>
<td class="nump">$ 105,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity Contract | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268610984056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="nump">$ 1,486<span></span>
</td>
<td class="nump">$ 2,735<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Cross-Currency Swaps | Net investment hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="nump">1,958<span></span>
</td>
<td class="nump">1,958<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=bdx_FixedToFloatingMember', window );">Interest Rate Swaps | Fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Forward Starting Interest Rate Swaps | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_DebtMember', window );">Foreign Currency-Denominated Debt | Net investment hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="nump">$ 2,419<span></span>
</td>
<td class="nump">$ 2,543<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=bdx_FixedToFloatingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=bdx_FixedToFloatingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_DebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_DebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268609440632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Net gains (losses) recorded to Accumulated other comprehensive income (loss), net of tax</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="num">$ (15)<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=bdx_ForeignCurrencyDenominatedDebtMember', window );">Foreign Currency-Denominated Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Net gains (losses) recorded to Accumulated other comprehensive income (loss), net of tax</a></td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Net gains (losses) recorded to Accumulated other comprehensive income (loss), gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Cross-Currency Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Net gains (losses) recorded to Accumulated other comprehensive income (loss), net of tax</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Net gains (losses) recorded to Accumulated other comprehensive income (loss), gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (84)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=bdx_ForeignCurrencyDenominatedDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=bdx_ForeignCurrencyDenominatedDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268609861336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Cash and Equivalents and Restricted Cash (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents</a></td>
<td class="nump">$ 3,147<span></span>
</td>
<td class="nump">$ 2,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Restricted cash</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and equivalents and restricted cash</a></td>
<td class="nump">$ 3,320<span></span>
</td>
<td class="nump">$ 2,392<span></span>
</td>
<td class="nump">$ 3,898<span></span>
</td>
<td class="nump">$ 2,917<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268609552792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Institutional money market accounts and ultra-short bond fund</a></td>
<td class="nump">$ 609<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm', window );">Current portion of long-term debt</a></td>
<td class="nump">1,056<span></span>
</td>
<td class="nump">503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayableFairValueDisclosure', window );">Long-term debt</a></td>
<td class="nump">$ 17,576<span></span>
</td>
<td class="nump">$ 18,537<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Of Debt Classified From Long Term To Short Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of contractual obligation to pay money on demand or on fixed or determinable dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268609958888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairment charge</a></td>
<td class="nump">$ 54<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_MaturityPeriodOfShortTermInvestment', window );">Maturity period of short-term investments at the time of purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_MaturityPeriodOfShortTermInvestment', window );">Maturity period of short-term investments at the time of purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_MaturityPeriodOfShortTermInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maturity period of time deposits classified as short-term investments in the consolidated balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_MaturityPeriodOfShortTermInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268609878440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdx_TransfersOfFinancialAssetsDuringThePeriod', window );">Trade receivables transferred to third parties under factoring arrangements</a></td>
<td class="nump">$ 323<span></span>
</td>
<td class="nump">$ 364<span></span>
</td>
<td class="nump">$ 478<span></span>
</td>
<td class="nump">$ 856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Amounts yet to be collected and remitted to the third parties</a></td>
<td class="nump">$ 237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_TransfersOfFinancialAssetsDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transfers of financial assets during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_TransfersOfFinancialAssetsDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140268605256408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Carrying value of long-term notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=bdx_TermLoanFacilityMember', window );">Term Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Borrowing capacity of credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes5000DueFebruary152030Member', window );">Notes 5.000% due February 15, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes6750DueFebruary152030Member', window );">Notes 6.750% due February 15, 2030 | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_FloatingRateNotesDueJune62022Member', window );">Floating Rate Notes Due June62022 | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Repurchased face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Loss on debt extinguishment</a></td>
<td class="num">$ (2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_FloatingRateNotesDueJune62022Member', window );">Floating Rate Notes Due June62022 | Subsequent Event | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Carrying value of long-term notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=bdx_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=bdx_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes5000DueFebruary152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes5000DueFebruary152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes6750DueFebruary152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes6750DueFebruary152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_FloatingRateNotesDueJune62022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_FloatingRateNotesDueJune62022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>bdx-20220331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bdx="http://www.bd.com/20220331"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:exch="http://xbrl.sec.gov/exch/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2021"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bdx-20220331.xsd" xlink:type="simple"/>
    <context id="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if21c0d03c63b44e085b66c88ee86f42d_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4df50108c1fb4841b44726d5c08d57f7_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia15276c5615b4d56a856c2a1f3802281_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.000dueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia8b05442c045413ca34e2d68fe1e3294_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.900dueDecember152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i59870493567442b2b5898f3382bd261a_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.401dueMay242023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id8bc22d2da56460b8728cbbf75e236a1_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes3.020dueMay242025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic3f625ad61544610912ab0da5ade95c6_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0.632dueJune42023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6f1fc3248ed8431cb579e0478a450c5f_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.208dueJune42026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i69585d30ad2447d1ac69fce1f20e5da4_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1213NotesDueFebruary122036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0f19c1acbe03446ea643c73bc09f6386_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0000DueAugust132023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i97abaf17fc984c8496d82b047da581a9_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0034DueAugust132025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9439d04ae9f64d88879f7c48614cdf5f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia9971035716346c99974380b024f6257_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i847168ba7901405bb61be4ecfe684012_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6f49a7b80b0c4a37acc78faacd1def8e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2fb7d149583e4cbbb4ba841be5866113_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia3c1843bb7b44edabe19cee43be62817_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2e75e43373c14b1eae872a1d4dd08fc3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia89314df24664e74a252364fc091e358_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2ec379b37d724046b6a043294e406405_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i61cdc5a7fb1f402985abc66f5ca9909b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1104298cf0f746fa8b00a8e2dbb7eea4_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iefdb0b0a3f294705ae8463fd402aa8f3_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6f577fd449564742befb8a5b86459eeb_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2332d63e32a54c098fd20d5b1542bb16_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib3f954158bd0474497e7bf9c2a23536b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i081ee5a5852e407c84e3e572849b152b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3cc557aa2f8d480daebdcbf52be025e5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic1344f18c36641fc8d87799098076721_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibfee3de793164af9b845b6842e2d9376_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8ccb08051b764c64846def77e74cebc1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3d31a13945d64153886cacad6bf05af2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id71dace7ba3b4742baa7ca689c30873b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0cda69a93a124d77b34442ef82673b2d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id251a2ed05f94abfb442c3b00935484d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iea8a760ffe4c4852a215ec13b1e39b19_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib4e6e39ebb924eb88e298367603c6efa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic2889486ea2246ac8bbb298a59bd2634_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i56c3903f09b94c6b872822313f7d17c0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0c2306c70486435080a9eb6d50933f3b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie7e94317b56c4ee39ee10b7b86f2988d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i95ca0513273e493d9f458220ba54c5fa_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id300f100b3b74d869d299c38e13eff73_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i543caecc83554a22bc382fd13fe58144_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibfe5c0b260644978b5979c61385ae9f5_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icedd1d99c22048f7924f50a371090298_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic3c9b45cb60c4c73bbca1766d2ee8583_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i535a03f509b14bbdb82ee8d0fff4154f_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id659b030b22b452f98d9897c4a1db5f2_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibf0ffad15f524c22b5a8910cf0242018_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i725012b63b26440eabbde5cc7e83e9c7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia274107f0cb9495e9b2745222febc134_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5f80f3e926434e23bc7a4ffbf84d5ff6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if85711d4c58a411e8be877e7ad67842a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i63448b71f13c4d649cdc22ef4a0b5d5a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i10091875590248f6a43b7b9c1e05c6bc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i05807d0c88fa4fe9973f0d6abc7b86b7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i21bb6c6eb0934bbf97ecaab0350f75d5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7b08323b925d40d1b59c94d01b6f7ede_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5ca7af80178f409190ac109fee156034_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i81c8d0ef92a54994aba64d18915d02d8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i00ac086edd1e4ab1b000dc60c50ccd89_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8cb4ecbb78e74ce3a938ab69f4bdf1f4_I20130924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2013-09-24</instant>
        </period>
    </context>
    <context id="i13da3ad4178f4ecebb53a625e7acba1b_I20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="i9ee43d89fee945a3adb8a3285fa956d4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie9c0efef45cd4a01bad737fb01fada74_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7b579acbced54178ac7040056cec1930_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i324ed7a0bfda4e7e83cf84119d3ae93e_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia0fedadbd75d4a4985c2b754543d38db_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3b405f3959cc475c9b732b9beb5bba7b_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i88e64c73fc1047fa8d2dbbd0264a3c84_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f7ed54a259b40c1a2765645e71832fa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i69e96ef1d0e74452ab61f2dcd1b57fe4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65465a86c8c5442a8b980080054fe48e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8cba383a1c1a43a7b184a8631be117d0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i72f72d97c18d4a168adf04b6afab2aec_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ice9518fb765048f791d1eb268ac30699_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5b672c8a1e23415c954ddf66aac1e984_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6b29fdbef54342949881c713e16d539c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if9193c0d5b9c4b2581040114a4cd2dfd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id4d95beb50b14c9c95a3d75c68b47d91_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if967b9c04df3495bbc795bfd1f8099af_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifbfa81272476483894faf8a5f285efa0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3ed40f315c6c4f97a754a6eb72927dc8_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibb4e8d00d339433fac2d8c00fd206825_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i977201e5251e4da78e41ec15b3b96c80_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia7a0d188409c454e90b59907b43f24ad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0692d1be0c384a95b3c84dd3b71fea18_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0aa1afa266db408b8ce7249358da4cb7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i465aa0dfa2c14f119d5e5bef56c57bb8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5877d216df964262bf4bb845d95a59f7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1b2de3cd4f2a4be79b23ac6da588eaf4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1b94674394f84d6eb4053788dc6d572f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iac6b1a8c16e3470fac8737acad5b180f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4995a156954f4d75a765e0acb8fb54b4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i770c080a4a784b18b9b4b99e56348d1a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4d3a36d935bf4fd8b6132f2d1ef29307_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib76ec6f5ea814d30b2c30ad474c85f94_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iea6c161bd8a340f98a4fddd063587010_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i49a7de59e6ff4225a49a75d990be29bd_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i308403a24c2a42c89b1d7a4ab555184c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bdx:ShareBasedCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7022abe219c14c9dacdbd2ec440a8b4f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bdx:ShareBasedCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib9450f0155c94e31b2c13ad94e0092f6_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bdx:ShareBasedCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic97169545d0c475da35e8da8837b02ab_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bdx:ShareBasedCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i75602a2f46c546e4828064853912e326_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">bdx:HerniaProductClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if223ecc9d5a1493093a44d337a8b72c5_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:GA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8dde9c84ea4543b2b7c7c39ef33a1b38_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bdx:ProductsandorServicesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i77f35a0dc2c74215877faf40ae0e7e6f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia1d78d581b6244569d9e8062bb55187d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bdx:ConsumablesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaa780c179d9147f593395d6d7fa5230b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic134ea116f1f45ebbe076cc6b3883b12_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i340e57a3d1d14dfc9f75038a3782eea0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if21e1acbe96f4463853f0759d0def48f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i40c8b727b83d4d65bfa6146011860c12_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icdf68331391d4a60891ceb9f056a868d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4e361a94baa3404eb086646266f9b158_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia0da5380262d43adabe75276ea0c956e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1a826d3478c74b2f862d397c207ca730_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i14a0d9a15f7b4cfda8ba40724beaa8f3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2d18979bf4274db5b94b3dd46371c7eb_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i511c4b1286af42da970bfdec12deee00_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie2de60d3992b4498818e40d41cedf3b0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2962a3b3ece8403a9b742d6cb9eae7d3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0688f0ec5b0547ea87efa9cb59b990bb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i57ad6025694d4bc9842594f621d8e8b5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia61a8d596fa14163ae52254c542a2d2a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3e45310057c44542954ea2308480623d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i18a195ea4996436ea00c1fc948c4276f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib9bfe78cbe96428981538b45e6d35614_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9e98ac2861aa4dbeae2a682badb428b8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib70cc365667f4336beae810b00d3718e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icb66231fcb80447fb881ab131dc5c869_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i48a7a52cac944ef7baa6f046beb6ae79_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i73d03a6b37c240468966cf15263452df_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaf0e9eb78ff74a85867e0df2d636c7c4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibd9d0f9e33a441088614cd71f9e278ef_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3e12b1fd86e446be863efb9d8984c607_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie3f69fb977594b96b982d5a4addde48f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i692aef30e2ff4aa7bc63ceaa2db430fd_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6d43be5f09354422addda0ddfc3d7608_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i940c14b99d604a85b8b181419f29ede7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6f7bdb867ae3463d9c34411ef80fa2c1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie34d48eb7b4446bfb0293bb837aeb3b0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4b8004628d1e40ddafce5ca3460f538d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8934938ea33340a68081e896f906c075_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i227211b2a9c741c790ebb3da7e40fdd8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8771dc3c63ee411d88344fdd1cdf5d53_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaf374326006b442487c8d86757ee49e4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibdae0dea69a64aa6842f66ae27d93e5a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i63bb60fd8ef84f56b6fbc6e0af2cf599_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2cef8fc053634cdfa0e350495e1fc255_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id9318f7e4aad4511b48ac65d5232b805_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaaaa5c962e4048c591c863e8916d33f5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i228cd1a05f9444a282107d55ea9e185c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2fdb31b0ba7847828199578de1e0dc44_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia05764f1126a47f598e5a5be57d911f3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie8f952d3c2504bee86897ac95714403d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia09b9950f6054a568db0ceb8606d7a4e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icfa7fb2c614545b7b9f7b5805cfe5911_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia8cf56e8b5924da2a53cda0c0754e42c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5b6c283c3e1b4712b95db13abf677cc8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2d34d9c802ca4ce89fb381c9211b0f26_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iec0f21890bcd495ba23516dc79fc968d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7d03895e938f463db61347f7756e8411_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia2f63b307eb24de4a2da726044ee4dcf_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i49cc19ad914c4f87aefe3e1e90b2e0aa_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i86808c33fe15413ca3ab8f07fc04dc6a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia256fef2c90740d7abec4bdfd7e9ea6f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i76036e4d4be84f3780130dbd8809095d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib25903c74b6b4ce196304dfabbeed3fe_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9129b920a74c4190bf2674bf5c66ddcd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i05e3efc2d5234dc5b5696fc25c2fe1f9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i560004a02b284824a2315cd4721a5d83_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib2bc50912e054b8ca37e29049b909c87_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1e73be5facd24817b1a1fea9021a8238_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i918494be3dba48dd95f60dbc329ce595_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7e6353525444488e906055b04513b780_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i07d77974120f4be69403ea9d0e2b2e32_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie4c3e29343e9492485a767d68a8ece48_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2ecc4a1c1e25473c8e517f0c14b82e15_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia9b2088e5e1d40f1925f5a9ce6d60363_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2b27826b341541bc92d8a45b8d75c050_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i963a32bbdc9f4165b5fd4ec11f3bf96f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibc7dd7466d954173933100f7a158c392_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i272105b422984b0abce278efc90ccf80_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1d49a5857b8c46e8be9a20f21635d62e_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i28c8afa29af14a569e645ef1aacc226c_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if28ca15d9d5d48078024960d0e23e05e_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i01375e7a7d6d4d5ea8993c57a7fa9646_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i016a8ef65bb04b5d92fe312250253498_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id51f443d02834ad4869eb954f45c6f30_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1b392253b2d848fba4cbe7cbca8862ce_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic10db11a119f49bd8880ae734593b26a_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i54288602bb02449f862cb8e8556ce749_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9e9a88dddb1141dc93f661547e4e852a_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3a080ccb675240cc9c4a8ba434c764a5_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icc933a06c8ba4f988cefb9809c807501_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id727ab7528c748339d239f9af4abbbd5_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaa9d6dfaff1145718f4ec2ddd0e9060f_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4e9adc19251c445fbb25842e71b25fb9_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie088a67ab37944269b87738d47fd8cf2_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5a1cfd5cb6684b57a644e4700794e7d6_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6c4fee3d5348442f81d98e5c491d7567_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:DiabetesCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i796262ed3fae4763be2037f02515b572_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7915ffe1e48e473e87a7bc4a597611ff_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i21781684a6e54835a086fb4dfd07518b_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i99f983046ba64a3597abb01c16866c07_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i43464f5ca80d4e9faacc0d26f58b60be_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia1e45e6c38b342e0afa75849e1554f02_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i744dcd2988294c748fdd6de59fed0010_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i28fd1a5379ed4068bcbe236046b009ac_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i93c8dc026e904d27a8674f1b2ae7b64f_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i26cd80537ace4f54bd459856e6733c22_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iabc734319b0040bb91b53f1b5bda469e_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i177c01abfa574925aead9aa3b4f63e18_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i63fca4aedfee493386b300cd94f770a4_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibaaee6092a88498e8faa501905f4bdd7_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id2a56afd740743baa1b574805fc29871_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibade6b68690841a8be0464af51c331d0_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic17e46520cc6412c8bc1e89dea2e9c8c_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7f73d2d072b8450a80571d1bce774ce0_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i676297c812f4459e9be4e29ff85f5ad8_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i39bc71985bfc4e1d839721692c03a9fe_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9fa5bfe82d7249b0937b40509556d515_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i618873a9001446c181b8ef34ab0bcc4a_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2bd3786e38494554a16139e13fdeb54f_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie6348050d88d4f97a3775186bc1a6569_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i061dc82dc32444aea21f1c81faebbe0a_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i69b2c199b94f4ca691703156805bd41c_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i68bb6db7dc06423d8874cf17e8b85add_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i71898030bd194581a5f573edac52a467_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2312cfcd8087400e988b97e474a47c77_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i49af90b2d616488a86c54d3c262d0d5c_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i048c0649ac044507a024682c29947104_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0a7ced2e82944f6681b9ed34294d5014_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idcc85f190816497f95bf2249ad0e8450_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i81e5b85ab7764c6fb0daf9c82f0b4781_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i238fa27398184872a8e61d69996c8840_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia1a0f1ebdf1b403798c14fedfa564a35_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1c39abcfe82b42aa90ff2907f3304dcc_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i05b4f4dee6a8495d833675a95be35a26_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i35931f5fa1204157bac1212583f72af6_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if2e4a485f90041afbb049fac8eb52965_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ief518885d18a472cb30a5c4921e2b0b5_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5fc225adea9a4eb3bcf21fd3444ec41d_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2e49adc428d94084bfc47a4543444f50_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8b2f6430ba9a49438e7cc7a603637f4c_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9d46849ffcb74aa2aa512d3c1f68b33b_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie157a03ce0f049c998b7c29069311c61_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5c1dd439278f4be0a9a792057b61e38a_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4143ec09dd4b481a8e155333bd4dc4fa_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iaa3b379319c34f67af75703550c4c252_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic3b61621dfcc434bbe4ce2f31653255a_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic959ae392a3e4d8b9d97860c881fa2e6_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iff32a50b2bf54f4cbef3c832096888da_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i58032061b0ff454095c538f1f3c4d0ec_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ief3a64ff7d9d4ad5984439fa90316773_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i67d9bfcd7b3a4d56b5197daa366d5b0f_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib1ab3086e3eb4dc39a17c1ff6b4efb91_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4994dbb56dd942c3b109fdbcdbc65a09_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8c3f5953274d42d8883cc70bb1ab9bf9_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if77c23c0dcc049008fcc1ec1e19316f0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if3e301035b4a4bdfb65e05d08198eeff_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icbf9dc05d6fa4d8fba50f123e716eafe_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4567c9a64f984e07827c5c6c6ccf5cc3_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i52b453b110a6487198bf393e02c8324c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i46d46821d3124f169527dd86c47ecdcf_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4d66dba8cd4a42fb969a3a9bfe7dc2a5_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib171c4d8e98248f48d26babd2d37afa5_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i909ad880c3244bdfb8b75a0b85cf397e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icd843e5598ca484abfc9deff353549de_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icecf16d531934c9e94ad3aa80cd5fe9b_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i459c088c116949f6a7759e05b502302e_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifb8b77375efd4b3b80608dbb0eff1722_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idd645833eba34cf7bc7e14df93e204c3_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibc4467fbe0ee44db93c2873c8d0afa22_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9157cafcaafb4b5db2bc2a4e28325ccd_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ief564af42a4c42e893aff8bd1fbca00a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i779636b30adc455b80382ee10bb0ad6b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i00226f2a049945c4926cc6902c33c132_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie28fdaf2e6bb47bf9633a15831cda54b_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0c9691d61a39453087be7034f4483fbc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifeff7a1ec077409a9bc93ab1ff3aefb4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i720075ccfd224b55a2643c326f989fbb_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ice9b08a1614b40ec92a118dec841b8fc_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i535aa5beb8df4def94ad38003c699670_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibceac69f309e466680f1ada28542ef16_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia886aaf5c1bb402ab373ae9e4fcf70f5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if19b6df31d1041d988f2b6d0d6f8be9a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iff71ea0dd54b4de39f65ab020e2a67d5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if1bf7117c8f74af382b1902e9716b58b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifcba64985bd94892898f333e81f805c3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bdx:ProductRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7852dda3e9644e0b9e2ced2925cb5cbc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bdx:ProductRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i287c272785094449aeae5d0789e8dd30_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9f7c055feadd4023a2ccc660f06149c5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ice2f69b4e89a4d6d841af8ccf0210a6d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9046b05ebed642d6a4080928d23692fd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibbbba24d92744e1995760747da6b3a07_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib93696a0600a4388af7001d55ce60a56_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i67af69e0e74849ab8b12161f932216a2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i09024c8954c042e89264bf944c8b11d6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ieefa6c2ca96747e29b4e14f0c03cdff8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id060ca4c054d4caf9f5955f598b66769_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib65ad792e22f44688a73a18522ef2873_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i14595206756547be8dcca594e49423d1_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0368fb62ba6e46fc84e60d8e4f32776e_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib8c068d6acc740b4a2839bff2df64cb2_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id36e592a22714e45927e00fe0abd06f9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i647adccb5a5d4a46861649299a5f578e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5bf06b24db6d4d5e95c8dc424db65f4e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i57f20120eb6d496fa8dff3eee45b0eea_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6a5fc6a2293a4c8cad09d8ce4967369a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1831573910a04a449ed2198ba1794eb7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9044e5284eec498888c80d53fd6d7cac_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie7eeef21c695425a92ba5420343f8392_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id3329662597a43ae9d4393dca9eb9b23_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="idcc3814ef1924ae9ba38f953eba0d814_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9bb6311653a447e9a0a4ba8c0ad8ead6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic331fa12abcc49f1ad32ee75878ba71b_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i72c4b04b5d954d97bccd5b64279416fd_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifd8707ce2b41458880bbba5f3ae0a677_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5436992d57d34fa79e5f22c386b9e551_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i63b89c37783a44039baca463093a5ae6_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8f5fc4cc7e7f4dc586a55406beefd6ac_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1a1a0aef0db24a0987e1ebb88ed95290_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i54dd618396ea42518487e230f0e9e1b6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i73542df9b6064c0d93564b9e09ce34ef_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8e68b8c00a5b4b0795a14cc4e86be66d_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i179698c711414fb0a6c8ff99db9ee285_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:FixedToFloatingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id7bf11422da34344806862a0903b17bd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:FixedToFloatingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i413682d5f90848fd9283e81e36ef64c3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie68b5ca8e1784fe9bdac444023023ac8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6435fd6a9e9049458f90d13308c412be_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3374a91073fd4143896356601c7a0524_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i11df0428ff4c47c59e767601738aa11a_D20211001-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1fe40a686952436da2991e9275d47220_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5845caed52ce4da4b4f7325c57203c22_I20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes5000DueFebruary152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="i26418175d8c34a61b6aa277d1076d5b4_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes6750DueFebruary152030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="i624a854f791c444da897e1e70f2d8eaa_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:FloatingRateNotesDueJune62022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="ibf5d860aadcd4dc18e87ac829cc865d8_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:FloatingRateNotesDueJune62022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="if6c6a8360d284859b924495a95a1b82f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:FloatingRateNotesDueJune62022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib929424705fe416e91cbcae5e6409cf0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bdx:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9481af032d5d48ff9483bc7a0054b2a8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8bb9f175be97441e81ee4fb5f8665671_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="claim">
        <measure>bdx:claim</measure>
    </unit>
    <unit id="lawsuit">
        <measure>bdx:lawsuit</measure>
    </unit>
    <unit id="segment">
        <measure>bdx:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80L2ZyYWc6YTExYTdhNDBhYmFmNGVjZThjMTY3ZDcyMTY4NDMzYWIvdGFibGU6YjI4MTYyOTAxNzNiNDM2MWIxNGE2M2E3NDI1MDhjYjkvdGFibGVyYW5nZTpiMjgxNjI5MDE3M2I0MzYxYjE0YTYzYTc0MjUwOGNiOV8yLTEtMS0xLTYxMjgx_a4eec151-9640-4ec5-a634-fd2452575a8f">0000010795</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80L2ZyYWc6YTExYTdhNDBhYmFmNGVjZThjMTY3ZDcyMTY4NDMzYWIvdGFibGU6YjI4MTYyOTAxNzNiNDM2MWIxNGE2M2E3NDI1MDhjYjkvdGFibGVyYW5nZTpiMjgxNjI5MDE3M2I0MzYxYjE0YTYzYTc0MjUwOGNiOV8zLTEtMS0xLTYxMjgx_08b19f18-a2fc-44c4-94bf-5c7a56070a4d">--09-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80L2ZyYWc6YTExYTdhNDBhYmFmNGVjZThjMTY3ZDcyMTY4NDMzYWIvdGFibGU6YjI4MTYyOTAxNzNiNDM2MWIxNGE2M2E3NDI1MDhjYjkvdGFibGVyYW5nZTpiMjgxNjI5MDE3M2I0MzYxYjE0YTYzYTc0MjUwOGNiOV80LTEtMS0xLTYxMjgx_25d3b3f6-bd71-4a5d-af14-53326a0597f2">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80L2ZyYWc6YTExYTdhNDBhYmFmNGVjZThjMTY3ZDcyMTY4NDMzYWIvdGFibGU6YjI4MTYyOTAxNzNiNDM2MWIxNGE2M2E3NDI1MDhjYjkvdGFibGVyYW5nZTpiMjgxNjI5MDE3M2I0MzYxYjE0YTYzYTc0MjUwOGNiOV81LTEtMS0xLTYxMjgx_8e538d73-a5b1-4de6-8e72-09c512a5122e">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80L2ZyYWc6YTExYTdhNDBhYmFmNGVjZThjMTY3ZDcyMTY4NDMzYWIvdGFibGU6YjI4MTYyOTAxNzNiNDM2MWIxNGE2M2E3NDI1MDhjYjkvdGFibGVyYW5nZTpiMjgxNjI5MDE3M2I0MzYxYjE0YTYzYTc0MjUwOGNiOV82LTEtMS0xLTYxMjgx_f95c659a-4411-4e25-a052-a0ab4df7f12c">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGV4dHJlZ2lvbjplZDJiZDMwODVmMzE0N2Q2ODExMTQ3YmQxMjg0YjBlZl8xNjQ3_78951ec3-5eab-41c0-8e79-ad4491b0fd5b">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6OTVmZmZiYzJhZGZhNDE5OWJjOTZlNjBlY2RmZDJiZWEvdGFibGVyYW5nZTo5NWZmZmJjMmFkZmE0MTk5YmM5NmU2MGVjZGZkMmJlYV8wLTAtMS0xLTYxMjgx_124ca80b-d133-4417-b7fa-6c148212e052">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGV4dHJlZ2lvbjplZDJiZDMwODVmMzE0N2Q2ODExMTQ3YmQxMjg0YjBlZl8xMzI_efed6559-c1a8-4534-833b-5d600d20d2b9">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6MzgwZjBjN2JhYmYzNGYwNTkzZTUwOWE0NTA4YWQwYzAvdGFibGVyYW5nZTozODBmMGM3YmFiZjM0ZjA1OTNlNTA5YTQ1MDhhZDBjMF8wLTAtMS0xLTYxMjgx_d29fa1bf-7d27-43e1-818b-226d39fae9da">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGV4dHJlZ2lvbjplZDJiZDMwODVmMzE0N2Q2ODExMTQ3YmQxMjg0YjBlZl8xNjQy_07ce67de-bc4a-4abd-aa23-2186dafa5f5c">001-4802</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGV4dHJlZ2lvbjplZDJiZDMwODVmMzE0N2Q2ODExMTQ3YmQxMjg0YjBlZl8xNjQz_3043331c-a88e-4db8-8b85-6189578c5a55">Becton, Dickinson and Company</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6OGI5OWY4MDBlNmFiNDA2NTg4NTQzMDUxNzViYTAwOWEvdGFibGVyYW5nZTo4Yjk5ZjgwMGU2YWI0MDY1ODg1NDMwNTE3NWJhMDA5YV8wLTAtMS0xLTYxMjgx_94a1e63f-69e9-4776-8d82-5939482b6392">NJ</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6OGI5OWY4MDBlNmFiNDA2NTg4NTQzMDUxNzViYTAwOWEvdGFibGVyYW5nZTo4Yjk5ZjgwMGU2YWI0MDY1ODg1NDMwNTE3NWJhMDA5YV8wLTUtMS0xLTYxMjgx_5f35fdb4-0c52-47f2-96db-26ee79bf1b6a">22-0760120</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6OGI5OWY4MDBlNmFiNDA2NTg4NTQzMDUxNzViYTAwOWEvdGFibGVyYW5nZTo4Yjk5ZjgwMGU2YWI0MDY1ODg1NDMwNTE3NWJhMDA5YV8zLTAtMS0xLTYxMjgx_4d9235b4-00dd-4bd7-bf7b-7a0b10475e34">1 Becton Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6OGI5OWY4MDBlNmFiNDA2NTg4NTQzMDUxNzViYTAwOWEvdGFibGVyYW5nZTo4Yjk5ZjgwMGU2YWI0MDY1ODg1NDMwNTE3NWJhMDA5YV8zLTEtMS0xLTYxMjgx_8725f04e-8854-4552-9f58-12aff03472b1">Franklin Lakes,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6OGI5OWY4MDBlNmFiNDA2NTg4NTQzMDUxNzViYTAwOWEvdGFibGVyYW5nZTo4Yjk5ZjgwMGU2YWI0MDY1ODg1NDMwNTE3NWJhMDA5YV8zLTItMS0xLTYxMjgx_e23e00f8-8d91-4f36-8d81-13f7fcb57bfd">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6OGI5OWY4MDBlNmFiNDA2NTg4NTQzMDUxNzViYTAwOWEvdGFibGVyYW5nZTo4Yjk5ZjgwMGU2YWI0MDY1ODg1NDMwNTE3NWJhMDA5YV8zLTMtMS0xLTYxMjgx_95cae5de-5b3c-4de3-b2b4-fd99e5efa875">07417-1880</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6OGI5OWY4MDBlNmFiNDA2NTg4NTQzMDUxNzViYTAwOWEvdGFibGVyYW5nZTo4Yjk5ZjgwMGU2YWI0MDY1ODg1NDMwNTE3NWJhMDA5YV8zLTUtMS0xLTYxMjgx_ec08985b-bb98-46ca-bfc4-002a46ab3cc8">(201)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6OGI5OWY4MDBlNmFiNDA2NTg4NTQzMDUxNzViYTAwOWEvdGFibGVyYW5nZTo4Yjk5ZjgwMGU2YWI0MDY1ODg1NDMwNTE3NWJhMDA5YV8zLTYtMS0xLTYxMjgx_0b0843b2-4190-455a-9539-5dc09f0629c7">847-6800</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="if21c0d03c63b44e085b66c88ee86f42d_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8xLTAtMS0xLTYxMjgx_abe1718e-da5a-4798-8247-c33076659d2e">Common stock, par value $1.00</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if21c0d03c63b44e085b66c88ee86f42d_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8xLTItMS0xLTYxMjgx_1b7f91f6-f77a-47bf-8e2b-e243e6771400">BDX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if21c0d03c63b44e085b66c88ee86f42d_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8xLTQtMS0xLTYxMjgx_6cd06a68-2e5f-451d-93f0-5b599debec62">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i4df50108c1fb4841b44726d5c08d57f7_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8yLTAtMS0xLTYxMjgx_dff85ee9-0b46-49cd-a5fd-26512bd98fdf">Depositary Shares, each representing a 1/20th interest in a share of 6.00% Mandatory Convertible Preferred Stock, Series B</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i4df50108c1fb4841b44726d5c08d57f7_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8yLTItMS0xLTYxMjgx_c7324e78-81bc-4818-8c2c-7cce31928e26">BDXB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i4df50108c1fb4841b44726d5c08d57f7_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8yLTQtMS0xLTYxMjgx_afffcf1e-5ca6-4eca-aba0-091ac1e6c487">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ia15276c5615b4d56a856c2a1f3802281_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8zLTAtMS0xLTYxMjgx_e510d56e-15f8-4591-b478-9328dc5f004c">1.000% Notes due December 15, 2022</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia15276c5615b4d56a856c2a1f3802281_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8zLTItMS0xLTYxMjgx_bad272a4-1696-4b7f-b723-f0789bb7a1de">BDX22A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia15276c5615b4d56a856c2a1f3802281_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8zLTQtMS0xLTYxMjgx_94b7f2cc-5b04-4055-8977-ea242e97e1e5">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ia8b05442c045413ca34e2d68fe1e3294_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV80LTAtMS0xLTYxMjgx_4ef0c1e5-86fe-4435-bc06-d362a805d28f">1.900% Notes due December 15, 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia8b05442c045413ca34e2d68fe1e3294_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV80LTItMS0xLTYxMjgx_eb08e1b5-5ac9-4723-b669-fd5883bff2a7">BDX26</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia8b05442c045413ca34e2d68fe1e3294_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV80LTQtMS0xLTYxMjgx_179f3652-c43c-4298-bedd-0cf44ff87d56">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i59870493567442b2b5898f3382bd261a_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV81LTAtMS0xLTYxMjgx_5518c7e3-7f1c-42ed-88b1-33d1304de73f">1.401% Notes due May 24, 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i59870493567442b2b5898f3382bd261a_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV81LTItMS0xLTYxMjgx_6222e288-f66f-4905-883b-6295c745cecf">BDX23A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i59870493567442b2b5898f3382bd261a_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV81LTQtMS0xLTYxMjgx_b99ef7a8-35e9-442f-81f0-6c567c1ca868">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="id8bc22d2da56460b8728cbbf75e236a1_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV82LTAtMS0xLTYxMjgx_15a30936-1cef-4045-9e26-df3c3600b27c">3.020% Notes due May 24, 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="id8bc22d2da56460b8728cbbf75e236a1_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV82LTItMS0xLTYxMjgx_15be5873-3a7a-4953-9db2-0c6f68cdcf40">BDX25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="id8bc22d2da56460b8728cbbf75e236a1_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV82LTQtMS0xLTYxMjgx_814c3bf8-00c4-4cba-820a-83f5ef689ca9">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ic3f625ad61544610912ab0da5ade95c6_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV83LTAtMS0xLTYxMjgx_bf8caf84-d281-43ff-9751-5b17c571b3f9">0.632% Notes due June 4, 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic3f625ad61544610912ab0da5ade95c6_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV83LTItMS0xLTYxMjgx_c41f431e-8077-414b-8820-bc540bed1249">BDX/23A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic3f625ad61544610912ab0da5ade95c6_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV83LTQtMS0xLTYxMjgx_7fb6848d-0bde-44a1-95da-e8e0967b7c36">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i6f1fc3248ed8431cb579e0478a450c5f_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV84LTAtMS0xLTYxMjgx_f5f2e894-8ab5-4b79-abd2-9b2de06a529e">1.208% Notes due June 4, 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i6f1fc3248ed8431cb579e0478a450c5f_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV84LTItMS0xLTYxMjgx_5edf9163-e65c-418e-8025-9e663d6f18e0">BDX/26A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i6f1fc3248ed8431cb579e0478a450c5f_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV84LTQtMS0xLTYxMjgx_8d0e558e-8dac-4d69-a02d-f0af7785136d">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i69585d30ad2447d1ac69fce1f20e5da4_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV85LTAtMS0xLTYxMjgx_dcb5f0be-5f5e-482c-8029-6dd8bb4d60b7">1.213% Notes due February 12, 2036</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i69585d30ad2447d1ac69fce1f20e5da4_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV85LTItMS0xLTYxMjgx_9082310b-4939-49b5-9ea2-a8086ef284af">BDX/36</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i69585d30ad2447d1ac69fce1f20e5da4_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV85LTQtMS0xLTYxMjgx_47b17ba0-df5d-4453-bf46-37621d899df1">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i0f19c1acbe03446ea643c73bc09f6386_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8xMC0wLTEtMS02MTI4MQ_0459c407-fb68-4019-bc40-6e87c38d8d07">0.000% Notes due August 13, 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0f19c1acbe03446ea643c73bc09f6386_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8xMC0yLTEtMS02MTI4MQ_ec10dd07-29ee-4fbf-a36f-8dcbaaa8be72">BDX23B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0f19c1acbe03446ea643c73bc09f6386_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8xMC00LTEtMS02MTI4MQ_08bbeec4-f32d-46bf-839a-cdb91e3e0e23">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i97abaf17fc984c8496d82b047da581a9_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8xMS0wLTEtMS02MTI4MQ_a6c64650-0ec5-457a-be07-dee73ab80dfa">0.034% Notes due August 13, 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i97abaf17fc984c8496d82b047da581a9_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8xMS0yLTEtMS02MTI4MQ_3269c095-6830-40c2-aeb4-9507bb576a96">BDX25A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i97abaf17fc984c8496d82b047da581a9_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ODk4ZjFhYWExNzQ4NDg0ZDk0N2ZhMGEzMTIxODc3OGUvdGFibGVyYW5nZTo4OThmMWFhYTE3NDg0ODRkOTQ3ZmEwYTMxMjE4Nzc4ZV8xMS00LTEtMS02MTI4MQ_df319ad1-70a7-4def-b9a7-4489125f4441">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGV4dHJlZ2lvbjplZDJiZDMwODVmMzE0N2Q2ODExMTQ3YmQxMjg0YjBlZl8xNjQ0_8742e1da-e07f-4802-8dcf-b4e3b83b82a7">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGV4dHJlZ2lvbjplZDJiZDMwODVmMzE0N2Q2ODExMTQ3YmQxMjg0YjBlZl8xNjQ1_322d2c9e-22ac-4670-be1f-87ec3cfc268d">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ZDBlMzJmNDUyNmJiNGYxYmI0M2Q3NGM0MjdjMzRiN2IvdGFibGVyYW5nZTpkMGUzMmY0NTI2YmI0ZjFiYjQzZDc0YzQyN2MzNGI3Yl8wLTAtMS0xLTYxMjgx_a0a6eeb1-d8d3-4d11-93df-f962b4117c71">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ZDBlMzJmNDUyNmJiNGYxYmI0M2Q3NGM0MjdjMzRiN2IvdGFibGVyYW5nZTpkMGUzMmY0NTI2YmI0ZjFiYjQzZDc0YzQyN2MzNGI3Yl8xLTYtMS0xLTYxMjgx_b6ec177b-dd9e-4713-99c0-e31ad0d1f82a">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGFibGU6ZDBlMzJmNDUyNmJiNGYxYmI0M2Q3NGM0MjdjMzRiN2IvdGFibGVyYW5nZTpkMGUzMmY0NTI2YmI0ZjFiYjQzZDc0YzQyN2MzNGI3Yl8yLTItMS0xLTYxMjgx_3f812388-58bd-4cef-83c0-da62812af67f">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGV4dHJlZ2lvbjplZDJiZDMwODVmMzE0N2Q2ODExMTQ3YmQxMjg0YjBlZl8xNjQ2_80b1ba45-6634-45ce-aaa5-a499399f4503">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xL2ZyYWc6ZWQyYmQzMDg1ZjMxNDdkNjgxMTE0N2JkMTI4NGIwZWYvdGV4dHJlZ2lvbjplZDJiZDMwODVmMzE0N2Q2ODExMTQ3YmQxMjg0YjBlZl8xNTgx_9f43af64-813e-4ca2-9a90-eedda02b6edf"
      unitRef="shares">285064629</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Revenues
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMi0xLTEtMS02MTI4MQ_a89d74fd-3c93-4005-8d08-3d8fe2b4f4ea"
      unitRef="usd">5011000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMi0zLTEtMS02MTI4MQ_38578bf0-f935-42ba-9d25-54c0416d1961"
      unitRef="usd">4907000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMi01LTEtMS02MTI4MQ_af4470ae-dcee-452a-91bf-50d398637e0e"
      unitRef="usd">10006000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMi03LTEtMS02MTI4MQ_a7239d06-23d4-4322-b41e-07b3c6943edc"
      unitRef="usd">10223000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMy0xLTEtMS02MTI4MQ_8ed825ae-4d15-4d33-81fb-16b5950ed27f"
      unitRef="usd">2706000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMy0zLTEtMS02MTI4MQ_f72d6220-32cf-4763-819e-5e7fdf59dafa"
      unitRef="usd">2661000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMy01LTEtMS02MTI4MQ_9668e514-c749-4c55-9b01-7804695a53d9"
      unitRef="usd">5278000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMy03LTEtMS02MTI4MQ_290bec77-c357-4a9a-ac2f-ae64fdc83f5c"
      unitRef="usd">5244000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNC0xLTEtMS02MTI4MQ_36890998-8e2a-42c3-bafa-7dfc90dccb23"
      unitRef="usd">1232000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNC0zLTEtMS02MTI4MQ_e4a5e1a2-1e20-487f-b5ff-c87cad38973b"
      unitRef="usd">1148000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNC01LTEtMS02MTI4MQ_9fc90023-1776-49c7-a8f1-27346d98a4b6"
      unitRef="usd">2456000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNC03LTEtMS02MTI4MQ_68b1b465-691d-4a0c-be7f-fe8b380ac0f0"
      unitRef="usd">2298000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNS0xLTEtMS02MTI4MQ_58ed3037-7c53-4a23-9013-884207649025"
      unitRef="usd">343000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNS0zLTEtMS02MTI4MQ_e63c7d49-8f64-45b3-97f2-8502014c1b68"
      unitRef="usd">317000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNS01LTEtMS02MTI4MQ_df62f842-2f12-4d78-98d8-1c4ac103227a"
      unitRef="usd">673000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNS03LTEtMS02MTI4MQ_32cd162c-94cd-493f-9a7b-61ae61bb3255"
      unitRef="usd">608000000</us-gaap:ResearchAndDevelopmentExpense>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNi0xLTEtMS02MTI4MQ_d97db90b-fe64-451a-ad0c-3fd347db460c"
      unitRef="usd">28000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNi0zLTEtMS02MTI4MQ_74810813-19be-4b44-b768-a236d994742b"
      unitRef="usd">52000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNi01LTEtMS02MTI4MQ_0c2b3643-28f9-46bc-bed5-03df80850297"
      unitRef="usd">62000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNi03LTEtMS02MTI4MQ_cbf5943d-daff-424e-8977-5baf1330cb89"
      unitRef="usd">102000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNy0xLTEtMS02MTI4MQ_7819e884-8995-4770-8234-36e00cb74cee"
      unitRef="usd">-49000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNy0zLTEtMS02MTI4MQ_8158b944-9466-4881-942f-eeaa9000ae3d"
      unitRef="usd">-296000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNy01LTEtMS02MTI4MQ_b06ceffe-5d49-4ea1-ae1a-43b3d25a78b7"
      unitRef="usd">-70000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfNy03LTEtMS02MTI4MQ_75f5e74e-31e4-498a-91f7-cfe358168580"
      unitRef="usd">-296000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:CostsAndExpenses
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfOC0xLTEtMS02MTI4MQ_b21c81e2-fc53-4a1b-81b6-b0723e23824b"
      unitRef="usd">4359000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfOC0zLTEtMS02MTI4MQ_df7e62da-f734-4983-8703-359ff5f3692c"
      unitRef="usd">4473000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfOC01LTEtMS02MTI4MQ_aeb9130e-0d84-4961-93a7-4cbb85a4c9b0"
      unitRef="usd">8539000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfOC03LTEtMS02MTI4MQ_425652a8-872e-4772-ada3-109e63ebb3b9"
      unitRef="usd">8547000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfOS0xLTEtMS02MTI4MQ_afebc4ea-2018-4126-af4b-c70926f19ff9"
      unitRef="usd">652000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfOS0zLTEtMS02MTI4MQ_b2b70eaf-f397-4337-bc54-2b8a4df131fd"
      unitRef="usd">434000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfOS01LTEtMS02MTI4MQ_e58849c6-09e0-401e-8dc1-61dfba663956"
      unitRef="usd">1467000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfOS03LTEtMS02MTI4MQ_af1c385a-5948-47a9-9b6e-49c4ded5c9c6"
      unitRef="usd">1676000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTAtMS0xLTEtNjEyODE_2b174342-412c-4d45-9b72-8ef298065427"
      unitRef="usd">101000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTAtMy0xLTEtNjEyODE_11fb9a99-dd2d-4ec5-94e2-6885f38cf413"
      unitRef="usd">124000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTAtNS0xLTEtNjEyODE_a57db711-6a0c-4ccb-ba5a-22284379fb2a"
      unitRef="usd">199000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTAtNy0xLTEtNjEyODE_50d50b60-6f03-4bb5-bce9-4f936fb2d84d"
      unitRef="usd">242000000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTEtMS0xLTEtNjEyODE_05e4981f-2343-4a45-a21c-c12384501de6"
      unitRef="usd">2000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTEtMy0xLTEtNjEyODE_363ec43e-6a12-47e8-adb1-b4e7bbee4a56"
      unitRef="usd">2000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTEtNS0xLTEtNjEyODE_d9a832a8-37bf-40a2-b44f-0d4a0c857d25"
      unitRef="usd">4000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTEtNy0xLTEtNjEyODE_ab13ecdd-13e8-49ea-9d21-213f1d460359"
      unitRef="usd">5000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTItMS0xLTEtNjEyODE_cf71cd2b-ab70-4988-937c-258cff9ae244"
      unitRef="usd">-27000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTItMy0xLTEtNjEyODE_d99a2cb8-df76-45c5-ad82-5f923a885f2b"
      unitRef="usd">-8000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTItNS0xLTEtNjEyODE_9d2be59f-bf4a-4d41-a954-167fcd5f6326"
      unitRef="usd">-24000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTItNy0xLTEtNjEyODE_26c7a586-a748-4e7b-9680-6ead8903ffac"
      unitRef="usd">24000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTMtMS0xLTEtNjEyODE_263830a1-65e2-486a-aac7-539a3f508d1b"
      unitRef="usd">525000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTMtMy0xLTEtNjEyODE_2a52730c-904e-4bc9-9356-0f306d8e4903"
      unitRef="usd">305000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTMtNS0xLTEtNjEyODE_54cedcd7-dc42-4be9-be20-71fb3de17e5d"
      unitRef="usd">1248000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTMtNy0xLTEtNjEyODE_af5bb7b9-ba18-4b93-9222-0b2adc0f5968"
      unitRef="usd">1462000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTQtMS0xLTEtNjEyODE_fabd7829-9c5d-45c7-bb03-18b9f47605e1"
      unitRef="usd">71000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTQtMy0xLTEtNjEyODE_925cc5ab-b409-4219-9ab8-a413e8e4ad3a"
      unitRef="usd">6000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTQtNS0xLTEtNjEyODE_ef40aa78-a8da-42ef-b1d6-a92eb19a5314"
      unitRef="usd">117000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTQtNy0xLTEtNjEyODE_95423143-c2cf-4398-8a93-ba3931dc31e9"
      unitRef="usd">160000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTUtMS0xLTEtNjEyODE_1a8d55cf-c79a-4a7a-bb2d-957d6d2193ad"
      unitRef="usd">454000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTUtMy0xLTEtNjEyODE_a15be862-b3c6-4022-b8d3-8cf38bc2bd8d"
      unitRef="usd">299000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTUtNS0xLTEtNjEyODE_843c0769-3a7d-4167-8547-2e66fe654b23"
      unitRef="usd">1131000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTUtNy0xLTEtNjEyODE_ae36fbd5-f5ab-4087-8a9b-0efe33c91719"
      unitRef="usd">1302000000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTYtMS0xLTEtNjEyODE_93b207bf-0354-40db-9d5f-aba1c31855d9"
      unitRef="usd">23000000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTYtMy0xLTEtNjEyODE_25e5adf1-53d8-4416-9d0d-b7812652213d"
      unitRef="usd">23000000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTYtNS0xLTEtNjEyODE_0550cec7-3c9a-4c87-8955-47c90f42c509"
      unitRef="usd">45000000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTYtNy0xLTEtNjEyODE_e25998b3-1ed9-4cd4-a12e-9894c1cbd66e"
      unitRef="usd">45000000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTctMS0xLTEtNjEyODE_654e8361-24ba-469c-a229-ba1570ae898c"
      unitRef="usd">431000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTctMy0xLTEtNjEyODE_5f1fbc57-7616-4a77-bf80-d4e7ecbcbe47"
      unitRef="usd">277000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTctNS0xLTEtNjEyODE_7c2b68cf-05dc-4888-a0a1-92d223083089"
      unitRef="usd">1086000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMTctNy0xLTEtNjEyODE_133b706a-c85f-4be9-966f-811b3e2f6c75"
      unitRef="usd">1257000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjAtMS0xLTEtNjEyODE_1190055b-5c2e-4d78-af7c-161c8df6e2c1"
      unitRef="usdPerShare">1.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjAtMy0xLTEtNjEyODE_8a8cf7d5-21ff-4ee1-9723-d1f8629d6b96"
      unitRef="usdPerShare">0.95</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjAtNS0xLTEtNjEyODE_3a631c27-ce3d-4325-90f7-3d2ec6715a93"
      unitRef="usdPerShare">3.81</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjAtNy0xLTEtNjEyODE_57b7cbf2-c13a-430e-9392-b2fedae66007"
      unitRef="usdPerShare">4.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjEtMS0xLTEtNjEyODE_8a2ea5c0-7710-4a55-bd22-5343ad73f135"
      unitRef="usdPerShare">1.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjEtMy0xLTEtNjEyODE_5a0ee021-b914-4ce4-ab5f-dff240a6e845"
      unitRef="usdPerShare">0.94</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjEtNS0xLTEtNjEyODE_d6f9f07d-f4c0-41dd-b458-1a6b92f6a374"
      unitRef="usdPerShare">3.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjEtNy0xLTEtNjEyODE_95ec5c9d-7300-4431-b048-014ce4c13ae2"
      unitRef="usdPerShare">4.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjItMS0xLTEtNjEyODE_3bf62444-1613-4c7c-be50-c1ec4c335c71"
      unitRef="usdPerShare">0.87</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjItMy0xLTEtNjEyODE_299598c4-1d5f-4777-8059-16824b9cabbb"
      unitRef="usdPerShare">0.83</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjItNS0xLTEtNjEyODE_c6893456-8bc4-48e5-9c03-601c2d155890"
      unitRef="usdPerShare">1.74</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xNi9mcmFnOjI1MzRlOWFkZGQxZTQzYTFiMTVhM2I4MmU2NmU4ZWNmL3RhYmxlOjcyZDY4N2IxZjE2OTQwZDA4ZTc2YWM2MmJiYTM5MzUyL3RhYmxlcmFuZ2U6NzJkNjg3YjFmMTY5NDBkMDhlNzZhYzYyYmJhMzkzNTJfMjItNy0xLTEtNjEyODE_5a8ef55d-61cb-4fdd-b008-12b679b5d065"
      unitRef="usdPerShare">1.66</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:NetIncomeLoss
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfMi0xLTEtMS02MTI4MQ_1a8d55cf-c79a-4a7a-bb2d-957d6d2193ad"
      unitRef="usd">454000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfMi0zLTEtMS02MTI4MQ_a15be862-b3c6-4022-b8d3-8cf38bc2bd8d"
      unitRef="usd">299000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfMi01LTEtMS02MTI4MQ_843c0769-3a7d-4167-8547-2e66fe654b23"
      unitRef="usd">1131000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfMi03LTEtMS02MTI4MQ_ae36fbd5-f5ab-4087-8a9b-0efe33c91719"
      unitRef="usd">1302000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNC0xLTEtMS02MTI4MQ_b37f308b-89e6-4649-afb0-7c7e0c90c6f1"
      unitRef="usd">78000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNC0zLTEtMS02MTI4MQ_15d0aaa2-adc9-441e-bc24-cecf516c0d73"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNC01LTEtMS02MTI4MQ_751cb6d7-beef-42d7-8474-c41887cce0c4"
      unitRef="usd">119000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNC03LTEtMS02MTI4MQ_58606627-99ab-4d5b-af8a-b40460a4efb5"
      unitRef="usd">50000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNS0xLTEtMS02MTI4MQ_b2c34ddb-e123-432f-99d1-58341393a0f3"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNS0zLTEtMS02MTI4MQ_723bbfff-436b-4c65-b00f-c29e6ff127d2"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNS01LTEtMS02MTI4MQ_19c12086-590c-4982-b903-ba705780ab61"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNS03LTEtMS02MTI4MQ_085f85fd-5b16-4325-ad42-e0b4d4b014a9"
      unitRef="usd">-58000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNi0xLTEtMS02MTI4MQ_ca65ed5d-d27e-444c-a7d4-404e2b17db65"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNi0zLTEtMS02MTI4MQ_aaf2d744-40dd-40e2-9c00-f913c7f4a0b3"
      unitRef="usd">83000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNi01LTEtMS02MTI4MQ_67f5c04c-5fc1-4416-af3d-e14cc6fd619a"
      unitRef="usd">37000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNi03LTEtMS02MTI4MQ_5658c11c-426f-4667-988e-d75e41a70c70"
      unitRef="usd">111000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNy0xLTEtMS02MTI4MQ_ae9f21b0-0612-4674-a075-828a808c732e"
      unitRef="usd">133000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNy0zLTEtMS02MTI4MQ_d9db1823-4de7-4b3d-8bcb-815e3a9b69dd"
      unitRef="usd">85000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNy01LTEtMS02MTI4MQ_ce334d09-75d0-4633-ac78-6c363ebefb68"
      unitRef="usd">178000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfNy03LTEtMS02MTI4MQ_6c479fd0-3cde-4ff7-b7d3-cb9db8b589d5"
      unitRef="usd">219000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfOC0xLTEtMS02MTI4MQ_d82a6845-45de-4441-857d-6dd57ae9f70e"
      unitRef="usd">586000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfOC0zLTEtMS02MTI4MQ_b5aa1739-1661-453f-96b5-a1c1fa9475e1"
      unitRef="usd">384000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfOC01LTEtMS02MTI4MQ_7789fcc9-f949-4e2f-872e-e5670eeda99a"
      unitRef="usd">1309000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8xOS9mcmFnOjQwYTVhYjg4MDkxZjRkMWVhN2ViOWNjZmVlODUyNjBlL3RhYmxlOmU1ZjFiM2EwMzE3YTRlODhhM2NiMDNhZDQ5YTVmMjYzL3RhYmxlcmFuZ2U6ZTVmMWIzYTAzMTdhNGU4OGEzY2IwM2FkNDlhNWYyNjNfOC03LTEtMS02MTI4MQ_05728528-7ccf-40dd-9425-36e939fec750"
      unitRef="usd">1521000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMy0xLTEtMS02MTI4MQ_8f6580d4-2df3-493c-89fb-199098ae5542"
      unitRef="usd">3147000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMy0zLTEtMS02MTI4MQ_aeaaf961-a0c1-4d87-8039-812f87d97388"
      unitRef="usd">2283000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndInvestmentsCurrent
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNC0xLTEtMS02MTI4MQ_3493a823-5d1e-4621-9181-404889e18194"
      unitRef="usd">173000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNC0zLTEtMS02MTI4MQ_ba62f370-76b3-4713-8d0d-e28a72838814"
      unitRef="usd">109000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:OtherShortTermInvestments
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNS0xLTEtMS02MTI4MQ_a1e6ee4b-7dc8-4e50-872f-7b9dac9ca175"
      unitRef="usd">15000000</us-gaap:OtherShortTermInvestments>
    <us-gaap:OtherShortTermInvestments
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNS0zLTEtMS02MTI4MQ_869b5416-90c5-4c02-9aa8-c92c31b1a706"
      unitRef="usd">12000000</us-gaap:OtherShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNi0xLTEtMS02MTI4MQ_6bb09da3-4a4e-46b1-87e3-185e3a3bf1d9"
      unitRef="usd">2303000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNi0zLTEtMS02MTI4MQ_0ac3f76c-7579-4a39-84b7-5db59769d906"
      unitRef="usd">2497000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfOC0xLTEtMS02MTI4MQ_b2239d8e-e0cf-4685-8fad-1f02ffef81b8"
      unitRef="usd">708000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfOC0zLTEtMS02MTI4MQ_fb995bd5-40c9-4831-9ef1-7530a6da6eab"
      unitRef="usd">641000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfOS0xLTEtMS02MTI4MQ_5ac080d2-7e9f-49ea-9f4c-6b364cac6643"
      unitRef="usd">413000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfOS0zLTEtMS02MTI4MQ_5ff95e6f-a341-4d5a-a372-6e59b69ca4f1"
      unitRef="usd">402000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTAtMS0xLTEtNjEyODE_67eb5ec1-feae-43ca-8a7c-a970a895da51"
      unitRef="usd">2137000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTAtMy0xLTEtNjEyODE_903fc000-8651-4624-9f10-9c60e51a7abb"
      unitRef="usd">1823000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTEtMS0xLTEtNjEyODE_07dc59ff-d5e9-4087-aa2f-784bb34da229"
      unitRef="usd">3258000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTEtMy0xLTEtNjEyODE_823bd570-189d-4ad3-83fb-e2a24702ae0c"
      unitRef="usd">2866000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTMtMS0xLTEtNjEyODE_65afaace-89a8-45d0-8993-e457d2973e03"
      unitRef="usd">1256000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTMtMy0xLTEtNjEyODE_6adfd6d5-22f7-45f9-9509-4d7a22e73d4e"
      unitRef="usd">1072000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTQtMS0xLTEtNjEyODE_dc65a1b1-733f-49be-87b6-ba86c8c7ecd4"
      unitRef="usd">10152000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTQtMy0xLTEtNjEyODE_fa9c487a-38d7-441c-bf55-b14824d27246"
      unitRef="usd">8838000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTUtMS0xLTEtNjEyODE_8fbbf5a1-f3e4-41b7-9d48-a4a216970533"
      unitRef="usd">13193000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTUtMy0xLTEtNjEyODE_ab13a7e6-f819-4d39-9434-2cb906ad54ec"
      unitRef="usd">12942000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTYtMS0xLTEtNjEyODE_0fd1f0b4-f13a-47d9-be7a-9c2ff444d832"
      unitRef="usd">6788000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTYtMy0xLTEtNjEyODE_3d9d1d62-6a8e-4a43-b4e2-95204e3cf19e"
      unitRef="usd">6549000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTctMS0xLTEtNjEyODE_102a8507-e909-4d9e-b008-8947fac25a7f"
      unitRef="usd">6406000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTctMy0xLTEtNjEyODE_05ebd6db-1c86-4432-8bc0-66d68f563806"
      unitRef="usd">6393000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTgtMS0xLTEtNjEyODE_a4045601-5d8d-4fc7-bf0b-613f49a3d58e"
      unitRef="usd">24096000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTgtMy0xLTEtNjEyODE_f86b83c7-6b0f-4c92-8753-9963c47aa4f8"
      unitRef="usd">23901000000</us-gaap:Goodwill>
    <bdx:CoreAndDevelopedTechnologyNet
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTktMS0xLTEtNjEyODE_195fdafd-f158-46b3-a2f3-381ca5f947eb"
      unitRef="usd">9044000000</bdx:CoreAndDevelopedTechnologyNet>
    <bdx:CoreAndDevelopedTechnologyNet
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMTktMy0xLTEtNjEyODE_dc38574b-ce5e-45ad-a052-0bb71950f9e8"
      unitRef="usd">9417000000</bdx:CoreAndDevelopedTechnologyNet>
    <bdx:FiniteLivedCustomerRelationshipsNet
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjAtMS0xLTEtNjEyODE_0d066fa8-9e39-43d2-8cec-3e5e842e86d3"
      unitRef="usd">2681000000</bdx:FiniteLivedCustomerRelationshipsNet>
    <bdx:FiniteLivedCustomerRelationshipsNet
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjAtMy0xLTEtNjEyODE_478bf37f-fa68-4bff-ad02-b9df1e063af6"
      unitRef="usd">2818000000</bdx:FiniteLivedCustomerRelationshipsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjEtMS0xLTEtNjEyODE_feec27c2-61a7-4f93-953f-e7c69c420cc5"
      unitRef="usd">542000000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjEtMy0xLTEtNjEyODE_12304b79-f680-4070-85d7-ce8c2b303b85"
      unitRef="usd">548000000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjMtMS0xLTEtNjEyODE_2e3aa1b0-abd1-49ca-b559-1bc45b36b4dd"
      unitRef="usd">1866000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjMtMy0xLTEtNjEyODE_bf65146e-4db8-4455-a8c4-1cae5b2d3295"
      unitRef="usd">1952000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjQtMS0xLTEtNjEyODE_6cf6da17-c618-4699-8280-8c97f3135133"
      unitRef="usd">54786000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjQtMy0xLTEtNjEyODE_fe76a941-7c1e-4aae-8a7d-a40d1badbd10"
      unitRef="usd">53866000000</us-gaap:Assets>
    <us-gaap:DebtCurrent
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjctMS0xLTEtNjEyODE_81c30f46-941c-4f22-be2d-67fc92694673"
      unitRef="usd">1051000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjctMy0xLTEtNjEyODE_1a30f8d6-b376-4f62-bc1c-30df9ad93ed2"
      unitRef="usd">500000000</us-gaap:DebtCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjgtMS0xLTEtNjEyODE_04d8558a-82eb-4bfb-b7d1-729f51c04d94"
      unitRef="usd">5605000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMjgtMy0xLTEtNjEyODE_796b0c6b-dfff-4642-8328-3c17ed84cdfb"
      unitRef="usd">6126000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzAtMS0xLTEtNjEyODE_5faf7003-69e5-47dd-b095-2644ba007dee"
      unitRef="usd">6657000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzAtMy0xLTEtNjEyODE_58e47c2e-912d-477c-b88c-561a3582d372"
      unitRef="usd">6626000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzEtMS0xLTEtNjEyODE_e651beb5-c75b-4e58-ab94-b5055549b110"
      unitRef="usd">17584000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzEtMy0xLTEtNjEyODE_29f119d2-bcef-4282-a5dd-e33ddb37a1a5"
      unitRef="usd">17110000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzItMS0xLTEtNjEyODE_d20aae91-b91a-4fe9-9593-96405f6f3ed9"
      unitRef="usd">1048000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzItMy0xLTEtNjEyODE_f69ed7e5-92f1-4883-8bfe-9f33eb2f7c0e"
      unitRef="usd">1228000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzMtMS0xLTEtNjEyODE_8e9eb73b-8275-44ae-b77e-2cc57767316d"
      unitRef="usd">4973000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzMtMy0xLTEtNjEyODE_9dd425b4-3790-460d-b47d-3dc7fd85c643"
      unitRef="usd">5225000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzQtMS0xLTEtNjEyODE_d1b41e12-3554-44c1-bdc8-d14bd9e12486"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzQtMy0xLTEtNjEyODE_acc757af-afa2-4102-8f5b-943ad02b33a3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzYtMS0xLTEtNjEyODE_3b51af6c-1b2e-44bf-968e-225b1f92ab3c"
      unitRef="usd">2000000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzYtMy0xLTEtNjEyODE_ad9d5798-2df7-4c5b-99ed-b266be4851c6"
      unitRef="usd">2000000</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzctMS0xLTEtNjEyODE_8e08d811-51e2-4a11-bae0-d16a74b11d7d"
      unitRef="usd">365000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzctMy0xLTEtNjEyODE_6cb239f5-53d5-40b2-ab49-7850ad3a9a00"
      unitRef="usd">365000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzgtMS0xLTEtNjEyODE_7e8e687b-1306-439d-96fd-0ed0ac37f178"
      unitRef="usd">19495000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzgtMy0xLTEtNjEyODE_e36e1d0f-f03e-4375-b48e-1b783441f9b4"
      unitRef="usd">19272000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzktMS0xLTEtNjEyODE_d6697357-cf3d-4a85-aa46-4fd6b4ccd0af"
      unitRef="usd">14416000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfMzktMy0xLTEtNjEyODE_5910d7d7-2f25-44fd-a35a-352193ca67bf"
      unitRef="usd">13826000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <bdx:CommonStockSharesHeldInEmployeeTrust1
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDAtMS0xLTEtNjEyODE_d8c9e502-da1c-4ba3-ad0b-6a8d2a68066f"
      unitRef="usd">24000000</bdx:CommonStockSharesHeldInEmployeeTrust1>
    <bdx:CommonStockSharesHeldInEmployeeTrust1
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDAtMy0xLTEtNjEyODE_fdf20bb4-47d1-4e7a-87e2-428d9443e3ab"
      unitRef="usd">23000000</bdx:CommonStockSharesHeldInEmployeeTrust1>
    <us-gaap:TreasuryStockValue
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDEtMS0xLTEtNjEyODE_3d3263e8-738f-4429-8b87-a75aab513a15"
      unitRef="usd">7866000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDEtMy0xLTEtNjEyODE_e286fb13-e420-4042-89cd-620089d9b26a"
      unitRef="usd">7723000000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDItMS0xLTEtNjEyODE_f299053c-7cd5-428d-919f-9582b02c0df7"
      unitRef="usd">-1910000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDItMy0xLTEtNjEyODE_dae7a1d7-72d0-4433-9af8-1324b1909a24"
      unitRef="usd">-2088000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDMtMS0xLTEtNjEyODE_a8a0145f-7e0e-40bf-a105-1f2202c72cc6"
      unitRef="usd">24525000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDMtMy0xLTEtNjEyODE_d0fd6b86-ee7c-4af8-affc-fd111e10bb0a"
      unitRef="usd">23677000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDQtMS0xLTEtNjEyODE_cb8f8819-a76f-4bb2-90c1-591c04327987"
      unitRef="usd">54786000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yMi9mcmFnOmZkZTM2Y2M3NjkzNjQ2MjNiYjlkZGRjNTQyNzYxNTMwL3RhYmxlOmI0MzU5OGFkNGZhODQ5N2I5YzA4NDg4OGQxYmY3ZWZjL3RhYmxlcmFuZ2U6YjQzNTk4YWQ0ZmE4NDk3YjljMDg0ODg4ZDFiZjdlZmNfNDQtMy0xLTEtNjEyODE_6c4f019e-a367-4e51-a6a3-71be475edad0"
      unitRef="usd">53866000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMy0xLTEtMS02MTI4MQ_843c0769-3a7d-4167-8547-2e66fe654b23"
      unitRef="usd">1131000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMy0zLTEtMS02MTI4MQ_ae36fbd5-f5ab-4087-8a9b-0efe33c91719"
      unitRef="usd">1302000000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfNS0xLTEtMS02MTI4MQ_c67bd914-a98d-4a41-932f-8d1b5cbb94a7"
      unitRef="usd">1114000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfNS0zLTEtMS02MTI4MQ_48d4c38c-eb37-44ce-a8c5-562bd92cf888"
      unitRef="usd">1113000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfNi0xLTEtMS02MTI4MQ_057e593c-0941-4760-b39c-193f2d4154d3"
      unitRef="usd">140000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfNi0zLTEtMS02MTI4MQ_3bb9abbe-bb0e-4edd-afae-87bee27b576e"
      unitRef="usd">138000000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfNy0xLTEtMS02MTI4MQ_092ab1d4-4569-401d-8e96-84285a6326b9"
      unitRef="usd">-80000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfNy0zLTEtMS02MTI4MQ_5db877c9-eafb-4806-83ff-22eb5860d814"
      unitRef="usd">-120000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfOC0xLTEtMS02MTI4MQ_31661c0d-4a48-4c87-9cd5-e15f0d0d5c39"
      unitRef="usd">950000000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfOC0zLTEtMS02MTI4MQ_9b7c8853-8fe8-4ea8-808c-85ae1905f667"
      unitRef="usd">-55000000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <bdx:IncreaseDecreaseinPensionBenefitObligation
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfOS0xLTEtMS02MTI4MQ_a3b3bf82-21ba-4456-a2f6-db8bcef40265"
      unitRef="usd">-136000000</bdx:IncreaseDecreaseinPensionBenefitObligation>
    <bdx:IncreaseDecreaseinPensionBenefitObligation
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfOS0zLTEtMS02MTI4MQ_fad14a00-508e-4129-8f6c-fa92cf16ecb3"
      unitRef="usd">45000000</bdx:IncreaseDecreaseinPensionBenefitObligation>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTItMS0xLTEtNjEyODE_3fe6317d-4697-4bb1-8c47-cb7a0073150d"
      unitRef="usd">0</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTItMy0xLTEtNjEyODE_817ca8bc-a304-45ec-abfe-96be1f1472cd"
      unitRef="usd">296000000</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTMtMS0xLTEtNjEyODE_3833b294-5097-4fbe-9dd4-dbb583ab1a4e"
      unitRef="usd">-101000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTMtMy0xLTEtNjEyODE_836f6dc0-716b-40f5-bf42-dc0491415197"
      unitRef="usd">-109000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTQtMS0xLTEtNjEyODE_ddd65e2a-f253-4969-a19a-65e30ebc55ff"
      unitRef="usd">1118000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTQtMy0xLTEtNjEyODE_c490f0b7-d685-440f-89ce-7904dffcd978"
      unitRef="usd">2721000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTYtMS0xLTEtNjEyODE_f01beb6b-ff8d-49d0-8862-8ea3953769e3"
      unitRef="usd">415000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTYtMy0xLTEtNjEyODE_0167466d-5ce3-4f0c-8ec5-39c9a80227c0"
      unitRef="usd">499000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTktMS0xLTEtNjEyODE_860d4cbc-90b1-4970-abb3-7d0e2cad3ffd"
      unitRef="usd">450000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMTktMy0xLTEtNjEyODE_336b996e-7f9c-4cfe-b86c-bfaf5e9b34a4"
      unitRef="usd">179000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjEtMS0xLTEtNjEyODE_e05afcd7-d3a7-4895-92ec-8dc13aaf901d"
      unitRef="usd">124000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjEtMy0xLTEtNjEyODE_e0f9b462-5e2c-4885-b98f-7cbca1297b34"
      unitRef="usd">186000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjItMS0xLTEtNjEyODE_caa4da22-9aeb-4a10-a74f-02675a072387"
      unitRef="usd">-990000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjItMy0xLTEtNjEyODE_8e07da2a-c753-474c-9d8f-ca34213318de"
      unitRef="usd">-863000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <bdx:ProceedsfromIssuanceofLongTermDebtandTermLoans
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjUtMS0xLTEtNjEyODE_82bf1447-bee0-4e9c-bbc0-bd83e7cc8c19"
      unitRef="usd">0</bdx:ProceedsfromIssuanceofLongTermDebtandTermLoans>
    <bdx:ProceedsfromIssuanceofLongTermDebtandTermLoans
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjUtMy0xLTEtNjEyODE_73c9403d-5e5f-4aa1-b65a-6974e2c0740f"
      unitRef="usd">1715000000</bdx:ProceedsfromIssuanceofLongTermDebtandTermLoans>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjYtMS0xLTEtNzY3NDg_17b95f3f-ccd1-4815-8220-25de200850c2"
      unitRef="usd">1424000000</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjYtMy0xLTEtNzY3NDg_fae8ff5c-0158-4af7-a982-09f46eaa515b"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjYtMS0xLTEtNjEyODE_015df14d-7747-4c99-81ba-55c529330bb9"
      unitRef="usd">2000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjYtMy0xLTEtNjEyODE_ad46d924-7180-43f5-a067-1540601764fc"
      unitRef="usd">1998000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDividends
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjktMS0xLTEtNjEyODE_ebf95c37-07b7-422a-a2c1-c449af893c8e"
      unitRef="usd">541000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMjktMy0xLTEtNjEyODE_66840a14-3414-40e0-b771-80695db977de"
      unitRef="usd">528000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzAtMS0xLTEtNjEyODE_5bec0503-b9e9-46e2-b42a-89428f043106"
      unitRef="usd">-76000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzAtMy0xLTEtNjEyODE_de5b50b8-0001-4413-902a-fe7739b46c87"
      unitRef="usd">-82000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzEtMS0xLTEtNjEyODE_6277666f-9677-4f04-bd13-4711ff3bc4ac"
      unitRef="usd">804000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzEtMy0xLTEtNjEyODE_c9d7a0d4-e069-4c9b-a7dd-de74c07748be"
      unitRef="usd">-893000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzItMS0xLTEtNjEyODE_38594e63-511b-442d-9a74-d0b28734267f"
      unitRef="usd">-4000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzItMy0xLTEtNjEyODE_04861ed3-1afa-43c3-ac4a-a4834760f446"
      unitRef="usd">17000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzMtMS0xLTEtNjEyODE_bc9ca248-cd34-4409-a561-a5d0500fb66e"
      unitRef="usd">928000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzMtMy0xLTEtNjEyODE_7ad2d643-9710-4632-928c-73105c8ee18a"
      unitRef="usd">981000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzQtMS0xLTEtNjEyODE_cf9540d7-0bfe-4fbd-bbc6-c07a894853f6"
      unitRef="usd">2392000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6f49a7b80b0c4a37acc78faacd1def8e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzQtMy0xLTEtNjEyODE_3528b100-7df8-493f-a8bf-d3d3c489518d"
      unitRef="usd">2917000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzUtMS0xLTEtNjEyODE_08c79f6e-a798-4def-811c-7b71ea431354"
      unitRef="usd">3320000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2fb7d149583e4cbbb4ba841be5866113_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8yNS9mcmFnOmFiNGJmNTI5ZmNiZTRiOTRhZmVkMzY1YWJmMzk0YjNkL3RhYmxlOjcwOThiOTRlOGIwZjRhZjdhNWZlMjUzZGMzMjE1MmU2L3RhYmxlcmFuZ2U6NzA5OGI5NGU4YjBmNGFmN2E1ZmUyNTNkYzMyMTUyZTZfMzUtMy0xLTEtNjEyODE_2bc41220-bf02-4d50-b676-6b1a2ef2992a"
      unitRef="usd">3898000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zMS9mcmFnOjAwZDMxOWMzNDQxNDQ0Njg5OTk0YWMwM2I3MmRmMDczL3RleHRyZWdpb246MDBkMzE5YzM0NDE0NDQ2ODk5OTRhYzAzYjcyZGYwNzNfMjE5Mg_26952a23-552b-40bd-9d86-e57305b5bae9">Basis of Presentation&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and, in the opinion of the management of Becton, Dickinson and Company (the "Company" or "BD"), include all adjustments which are of a normal recurring nature, necessary for a fair presentation of the financial position and the results of operations and cash flows for the periods presented.  However, the financial statements do not include all information and accompanying notes required for a presentation in accordance with U.S. generally accepted accounting principles ("U.S. GAAP").  These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company&#x2019;s 2021 Annual Report on Form 10-K.  Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes.  Percentages and earnings per share amounts presented are calculated from the underlying amounts.  The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Spin-Off of Diabetes Care Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company named Embecta Corp. (&#x201c;Embecta&#x201d;) through a distribution of Embecta&#x2019;s publicly traded common stock to BD&#x2019;s shareholders of record as of the close of business on March 22, 2022 (the &#x201c;record date&#x201d;).  The Company distributed one share of Embecta common stock for every five common shares of BD outstanding as of the record date.  Shareholders received cash in lieu of fractional shares of Embecta common stock.  The spin-off is expected to qualify as a tax-free transaction for U.S. federal income tax purposes.  Embecta is an independent, publicly traded company focused on diabetes management, and BD retains no ownership interest.  Embecta&#x2019;s common stock is listed on NASDAQ under the ticker symbol &#x201c;EMBC&#x201d;.  The historical financial results of Embecta are included in these condensed consolidated financial statements.  Subsequent to the spin-off, and in future filings, the historical results of the Diabetes Care business will be reflected as discontinued operations in the Company&#x2019;s consolidated financial statements.  Disclosures pertaining to Embecta&#x2019;s issuance of debt in connection with the spin-off are provided in Note 12.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In connection with the spin-off, the Company and Embecta entered into various agreements to effect the spin-off and provide a framework for the relationship between the Company and Embecta after the spin-off.  Such agreements include the separation and distribution agreement, as well as the following ongoing agreements: a cannula supply agreement, an intellectual property matters agreement, a transition services agreement, manufacturing and supply agreements, a lease agreement, a distribution agreement to support commercial operations, a logistics services agreement and other agreements including an employee matters agreement and a tax matters agreement. Under these agreements the Company will continue to provide certain products and services to Embecta following the spin-off.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RleHRyZWdpb246MWZkY2M3NTQyZGYxNDI4MWJkOGY1ZGMzNDRhNTUyNzVfMjEwMg_f4cfb5f7-3209-44de-a8b4-525d16e45d33">Shareholders' Equity&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in certain components of shareholders' equity for the first two quarters of fiscal years 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common&lt;br/&gt;Stock&#160; Issued&lt;br/&gt;at&#160;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Capital in&lt;br/&gt;Excess&#160;of&lt;br/&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred&lt;br/&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&#160;(in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common dividends ($0.87 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued for share-based compensation and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repurchase of common stock (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,855)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common dividends ($0.87 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued for share-based compensation and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,866)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common&lt;br/&gt;Stock&#160; Issued&lt;br/&gt;at&#160;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Capital in&lt;br/&gt;Excess&#160;of&lt;br/&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred&lt;br/&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&#160;(in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common dividends ($0.83 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued for share-based compensation and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of change in accounting principles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common dividends ($0.83 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued for share-based compensation and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;Common stock held in trusts consists of the Company&#x2019;s shares held in rabbi trusts in connection with deferred compensation under the Company&#x2019;s employee salary and bonus deferral plan and directors&#x2019; deferral plan.  During the second quarter of fiscal year 2022, the common stock held in trusts was temporarily replaced with the Company&#x2019;s Series C preferred shares to adhere to trust requirements until the Company&#x2019;s spin-off of its Diabetes Care business was completed on April 1, 2022.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt"&gt;Represents shares received upon final settlement of an accelerated share repurchase agreement, and the related forward sale contract, entered into during the fourth quarter of fiscal year 2021.  T&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;he share repurchases were made pursuant to the repurchase program authorized by the Board of Directors on September 24, 2013 for 10&#160;million shares, for which there is no expiration date.  In November 2021, the Board of Directors authorized the Company to repurchase up to an additional 10&#160;million shares of BD common stock, for which there is also no expiration date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components and changes of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for the first two quarters of fiscal years 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.426%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency&lt;br/&gt;Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Benefit&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,043)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,251)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.134%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency&lt;br/&gt;Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Benefit&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,548)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,352)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(998)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts of foreign currency translation recognized in other comprehensive income during the three and six months ended March&#160;31, 2022 and 2021 included net gains (losses) relating to net investment hedges.  Other comprehensive income relating to benefit plans during the three months ended December 31, 2020 represented a net gain recognized as a result of the Company&#x2019;s remeasurement, as of October 31, 2020, of the legacy Bard U.S. defined pension benefit plan upon its merger with the BD defined benefit cash balance pension plan in the first quarter of fiscal year 2021.  The amounts recognized in other comprehensive income relating to cash flow hedges during the three and six months ended March 31, 2022 and 2021 are primarily related to forward starting interest rate swaps.  Additional disclosures regarding amounts the Company recognized in other comprehensive income relating to cash flow hedges during the three and six months ended March&#160;31, 2022 and 2021 are provided in Note 10.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax impacts for amounts recognized in other comprehensive income (loss) before reclassifications and for reclassifications out of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relating to benefit plans and cash flow hedges during the three and six months ended March&#160;31, 2022 and 2021 were immaterial to the Company's consolidated financial results.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RleHRyZWdpb246MWZkY2M3NTQyZGYxNDI4MWJkOGY1ZGMzNDRhNTUyNzVfMjEwNA_fb93c698-27f7-4251-b5c4-2df9f35ab38f">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in certain components of shareholders' equity for the first two quarters of fiscal years 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common&lt;br/&gt;Stock&#160; Issued&lt;br/&gt;at&#160;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Capital in&lt;br/&gt;Excess&#160;of&lt;br/&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred&lt;br/&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&#160;(in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common dividends ($0.87 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued for share-based compensation and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repurchase of common stock (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,855)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common dividends ($0.87 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued for share-based compensation and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,866)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common&lt;br/&gt;Stock&#160; Issued&lt;br/&gt;at&#160;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Capital in&lt;br/&gt;Excess&#160;of&lt;br/&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred&lt;br/&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&#160;(in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common dividends ($0.83 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued for share-based compensation and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of change in accounting principles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common dividends ($0.83 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued for share-based compensation and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;Common stock held in trusts consists of the Company&#x2019;s shares held in rabbi trusts in connection with deferred compensation under the Company&#x2019;s employee salary and bonus deferral plan and directors&#x2019; deferral plan.  During the second quarter of fiscal year 2022, the common stock held in trusts was temporarily replaced with the Company&#x2019;s Series C preferred shares to adhere to trust requirements until the Company&#x2019;s spin-off of its Diabetes Care business was completed on April 1, 2022.  &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt"&gt;Represents shares received upon final settlement of an accelerated share repurchase agreement, and the related forward sale contract, entered into during the fourth quarter of fiscal year 2021.  T&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;he share repurchases were made pursuant to the repurchase program authorized by the Board of Directors on September 24, 2013 for 10&#160;million shares, for which there is no expiration date.  In November 2021, the Board of Directors authorized the Company to repurchase up to an additional 10&#160;million shares of BD common stock, for which there is also no expiration date.&lt;/span&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="ia3c1843bb7b44edabe19cee43be62817_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMi0xLTEtMS02MTI4MQ_3e5c825b-565a-4aa7-85fc-7d11fd8c8244"
      unitRef="usd">365000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2e75e43373c14b1eae872a1d4dd08fc3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMi0zLTEtMS02MTI4MQ_770c5efe-dede-46fe-896a-706aba75e816"
      unitRef="usd">19272000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia89314df24664e74a252364fc091e358_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMi01LTEtMS02MTI4MQ_277c3ec3-a6e0-42d8-8c57-4cbfd06f3306"
      unitRef="usd">13826000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2ec379b37d724046b6a043294e406405_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMi03LTEtMS02MTI4MQ_1407a233-4bc4-4909-a643-6e7f413ca5d2"
      unitRef="usd">23000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i61cdc5a7fb1f402985abc66f5ca9909b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMi05LTEtMS02MTI4MQ_f1daca68-dbc9-4c3a-b2de-b23123331e87"
      unitRef="shares">80164000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i61cdc5a7fb1f402985abc66f5ca9909b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMi0xMS0xLTEtNjEyODE_7d075588-3dfa-4f56-aadd-d00dfc3356cd"
      unitRef="usd">-7723000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i1104298cf0f746fa8b00a8e2dbb7eea4_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMy01LTEtMS02MTI4MQ_251ff2ec-c3cd-48e6-bf4e-32eac79e8467"
      unitRef="usd">677000000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iefdb0b0a3f294705ae8463fd402aa8f3_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfNC0wLTEtMS02MTI4MS90ZXh0cmVnaW9uOjIxNmM2YzZmOTExODQyOGY4Y2Q2NDkzYmRlZDYyMGVlXzIy_3a2a05c2-9ccf-419c-a6cf-ee4943e78405"
      unitRef="usdPerShare">0.87</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i1104298cf0f746fa8b00a8e2dbb7eea4_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfNC01LTEtMS02MTI4MQ_99cec42d-b65d-4a8f-87dc-ba6e00d8531d"
      unitRef="usd">248000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsPreferredStock
      contextRef="i1104298cf0f746fa8b00a8e2dbb7eea4_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfNS01LTEtMS02MTI4MQ_640bc0f2-d761-4f03-90c6-9eb450249c75"
      unitRef="usd">23000000</us-gaap:DividendsPreferredStock>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6f577fd449564742befb8a5b86459eeb_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfNi0zLTEtMS02MTI4MQ_b2211a17-5619-479c-b958-83093418a641"
      unitRef="usd">-71000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i2332d63e32a54c098fd20d5b1542bb16_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfNi05LTEtMS02MTI4MQ_d9deeabd-af9c-4499-bb2b-3921dfc09330"
      unitRef="shares">762000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2332d63e32a54c098fd20d5b1542bb16_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfNi0xMS0xLTEtNjEyODE_53de73a8-25fb-4f69-9b53-b9fe77d078d6"
      unitRef="usd">19000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6f577fd449564742befb8a5b86459eeb_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfNy0zLTEtMS02MTI4MQ_1a76319a-0d9a-4566-9661-239b4bf376a2"
      unitRef="usd">83000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <bdx:CommonStockHeldInTrustsNetShares
      contextRef="i2332d63e32a54c098fd20d5b1542bb16_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfOC05LTEtMS02MTI4MQ_70efa5b7-b8d5-48f8-98c5-557c29b5a77b"
      unitRef="shares">-5000</bdx:CommonStockHeldInTrustsNetShares>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i6f577fd449564742befb8a5b86459eeb_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfOS0zLTEtMS02MTI4MQ_f44af02b-fda8-40ec-9281-8dd78bae9be4"
      unitRef="usd">-150000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i2332d63e32a54c098fd20d5b1542bb16_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfOS05LTEtMS02MTI4MQ_08241d07-f49d-4239-b879-9a29a2751ac6"
      unitRef="shares">462000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i2332d63e32a54c098fd20d5b1542bb16_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfOS0xMS0xLTEtNjEyODE_9bb73328-1de5-405a-bcc0-3836ba0c18c3"
      unitRef="usd">150000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquity
      contextRef="ib3f954158bd0474497e7bf9c2a23536b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTEtMS0xLTEtNjEyODE_4496a93d-b687-43af-a747-6bb10bded723"
      unitRef="usd">365000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i081ee5a5852e407c84e3e572849b152b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTEtMy0xLTEtNjEyODE_1e279184-4f59-458f-bc44-098a6e86bac5"
      unitRef="usd">19435000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3cc557aa2f8d480daebdcbf52be025e5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTEtNS0xLTEtNjEyODE_59dd1360-5414-4afb-ab70-60db2cfa6310"
      unitRef="usd">14233000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic1344f18c36641fc8d87799098076721_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTEtNy0xLTEtNjEyODE_9b8b4d19-435c-46cd-80e6-b432be37ed26"
      unitRef="usd">24000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="ibfee3de793164af9b845b6842e2d9376_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTEtOS0xLTEtNjEyODE_6ec4fccd-6466-41d1-a8ac-0acd0a1cbccc"
      unitRef="shares">79869000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="ibfee3de793164af9b845b6842e2d9376_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTEtMTEtMS0xLTYxMjgx_7b2db465-38dc-46ed-b1a4-1b912646b21c"
      unitRef="usd">-7855000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i8ccb08051b764c64846def77e74cebc1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTItNS0xLTEtNjEyODE_c3258bb0-d04d-4566-b7e5-75d318d031f3"
      unitRef="usd">454000000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTMtMC0xLTEtNjEyODEvdGV4dHJlZ2lvbjo1ZmY3ODFhZDM2MjE0ZDBjYmI4NjExM2VlOTBlZThmNV8yMg_ea4cb970-d9ef-430b-a9d8-fd1ba455194d"
      unitRef="usdPerShare">0.87</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i8ccb08051b764c64846def77e74cebc1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTMtNS0xLTEtNjEyODE_ea465894-5e9a-4e1d-add4-f1557dffdf53"
      unitRef="usd">248000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsPreferredStock
      contextRef="i8ccb08051b764c64846def77e74cebc1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTQtNS0xLTEtNjEyODE_15adfad1-4ea0-4813-987c-e2cbaf27aa71"
      unitRef="usd">23000000</us-gaap:DividendsPreferredStock>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3d31a13945d64153886cacad6bf05af2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTUtMy0xLTEtNjEyODE_2604b666-3fb3-4661-be51-27444dd0af4b"
      unitRef="usd">-21000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="id71dace7ba3b4742baa7ca689c30873b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTUtNy0xLTEtNjEyODE_a14a4245-66e3-4fed-a32f-5d603192ab33"
      unitRef="usd">1000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i0cda69a93a124d77b34442ef82673b2d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTUtOS0xLTEtNjEyODE_846685f8-7996-4042-b9d4-f706d0e85627"
      unitRef="shares">284000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0cda69a93a124d77b34442ef82673b2d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTUtMTEtMS0xLTYxMjgx_d27a7591-850d-48cb-bb76-0c2de33e9156"
      unitRef="usd">14000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3d31a13945d64153886cacad6bf05af2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTYtMy0xLTEtNjEyODE_1a330469-bcd3-457d-a972-e8c4de9c8263"
      unitRef="usd">56000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <bdx:CommonStockHeldInTrustsAcquired
      contextRef="i3d31a13945d64153886cacad6bf05af2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTctMy0xLTEtNjEyODE_c80a337f-e4bd-4c96-abec-c8e014e278e3"
      unitRef="usd">24000000</bdx:CommonStockHeldInTrustsAcquired>
    <bdx:CommonStockHeldInTrustsNetShares
      contextRef="i0cda69a93a124d77b34442ef82673b2d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTctOS0xLTEtNjEyODE_ef8b7800-cbea-47fc-b7db-edfadd804a37"
      unitRef="shares">9000</bdx:CommonStockHeldInTrustsNetShares>
    <bdx:CommonStockHeldInTrustsAcquired
      contextRef="i0cda69a93a124d77b34442ef82673b2d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTctMTEtMS0xLTYxMjgx_3a18de2e-a10e-4505-b5ea-4733f2a7b04d"
      unitRef="usd">24000000</bdx:CommonStockHeldInTrustsAcquired>
    <us-gaap:StockholdersEquity
      contextRef="id251a2ed05f94abfb442c3b00935484d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTgtMS0xLTEtNjEyODE_8f30fbea-6fa3-43e4-9859-8645cf2bf82a"
      unitRef="usd">365000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iea8a760ffe4c4852a215ec13b1e39b19_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTgtMy0xLTEtNjEyODE_0fd4a47d-5f70-4e2f-acc4-cd1f8491ce5b"
      unitRef="usd">19495000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib4e6e39ebb924eb88e298367603c6efa_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTgtNS0xLTEtNjEyODE_b52bbca5-c6d2-4139-9d8d-3eba748a2e6d"
      unitRef="usd">14416000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic2889486ea2246ac8bbb298a59bd2634_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTgtNy0xLTEtNjEyODE_09f87752-11b5-42e2-8b25-7096f22199e1"
      unitRef="usd">24000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i56c3903f09b94c6b872822313f7d17c0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTgtOS0xLTEtNjEyODE_3a89dade-e645-4a70-9faf-895b03703804"
      unitRef="shares">79575000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i56c3903f09b94c6b872822313f7d17c0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmRkNGU2ZDE3YzRjMzQwNWY4YzRhM2Y1MjA0M2NiOGNmL3RhYmxlcmFuZ2U6ZGQ0ZTZkMTdjNGMzNDA1ZjhjNGEzZjUyMDQzY2I4Y2ZfMTgtMTEtMS0xLTYxMjgx_8188ae40-98b9-4b34-8e3d-5e509f42af8d"
      unitRef="usd">-7866000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0c2306c70486435080a9eb6d50933f3b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMi0xLTEtMS02MTI4MQ_da95cc40-079a-48a8-bb6f-5c48c4cc8dc0"
      unitRef="usd">365000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie7e94317b56c4ee39ee10b7b86f2988d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMi0zLTEtMS02MTI4MQ_a12e82e4-fc1c-4310-9a5a-cf7df0be05d0"
      unitRef="usd">19270000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i95ca0513273e493d9f458220ba54c5fa_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMi01LTEtMS02MTI4MQ_3cac4b93-c81f-47a5-8833-b1158b873456"
      unitRef="usd">12791000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id300f100b3b74d869d299c38e13eff73_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMi03LTEtMS02MTI4MQ_d53d9e71-3300-4fc1-8d12-7d2edc0c8a57"
      unitRef="usd">23000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i543caecc83554a22bc382fd13fe58144_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMi05LTEtMS02MTI4MQ_2aaeedc9-11e3-4299-9e03-21e0522bac83"
      unitRef="shares">74623000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i543caecc83554a22bc382fd13fe58144_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMi0xMS0xLTEtNjEyODE_ebfd74b8-862f-4f5f-aaf3-6f69c8174aa3"
      unitRef="usd">-6138000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ibfe5c0b260644978b5979c61385ae9f5_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMy01LTEtMS02MTI4MQ_c8882158-8384-4820-9788-c50a19892ab3"
      unitRef="usd">1003000000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="icedd1d99c22048f7924f50a371090298_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfNC0wLTEtMS02MTI4MS90ZXh0cmVnaW9uOjg5YTZlMDE1YjQwZDQwMTk5YWE2ODlhZjVmYTc5Y2RlXzIy_f11776de-ac0b-4208-a615-ae9a351f8c89"
      unitRef="usdPerShare">0.83</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="ibfe5c0b260644978b5979c61385ae9f5_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfNC01LTEtMS02MTI4MQ_20f8dce5-85b9-4aa7-aa25-7d9ace534b18"
      unitRef="usd">242000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsPreferredStock
      contextRef="ibfe5c0b260644978b5979c61385ae9f5_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfNS01LTEtMS02MTI4MQ_319d0ddd-0657-44d8-9186-a8ac37d94abd"
      unitRef="usd">23000000</us-gaap:DividendsPreferredStock>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic3c9b45cb60c4c73bbca1766d2ee8583_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfNi0zLTEtMS02MTI4MQ_de933ca1-dd39-4038-885c-53cd85ac2474"
      unitRef="usd">-53000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i535a03f509b14bbdb82ee8d0fff4154f_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfNi05LTEtMS02MTI4MQ_4bc63f33-9589-490e-bb49-eb376656e2b6"
      unitRef="shares">549000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i535a03f509b14bbdb82ee8d0fff4154f_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfNi0xMS0xLTEtNjEyODE_039e0f48-9c8b-40b7-91f5-e7ea843db0a5"
      unitRef="usd">2000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic3c9b45cb60c4c73bbca1766d2ee8583_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfNy0zLTEtMS02MTI4MQ_8918ae1a-bac7-40d6-9fab-dccca4b69260"
      unitRef="usd">83000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <bdx:CommonStockHeldInTrustsNetShares
      contextRef="i535a03f509b14bbdb82ee8d0fff4154f_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfOC05LTEtMS02MTI4MQ_cc2355d0-7fe0-4a11-82f6-fc5261104ec3"
      unitRef="shares">-7000</bdx:CommonStockHeldInTrustsNetShares>
    <us-gaap:StockholdersEquityOther
      contextRef="id659b030b22b452f98d9897c4a1db5f2_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfOS01LTEtMS02MTI4MQ_58745313-a9cf-4b8b-9666-8a3812edade5"
      unitRef="usd">9000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquity
      contextRef="ibf0ffad15f524c22b5a8910cf0242018_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTAtMS0xLTEtNjEyODE_0fc0cf07-e7de-4639-a2a1-7c9541d7698d"
      unitRef="usd">365000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i725012b63b26440eabbde5cc7e83e9c7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTAtMy0xLTEtNjEyODE_b0137f22-52bd-4373-ba37-5ddac482a57f"
      unitRef="usd">19301000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia274107f0cb9495e9b2745222febc134_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTAtNS0xLTEtNjEyODE_b41a39d7-d803-4ce8-9a13-ad7e2c939b81"
      unitRef="usd">13522000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5f80f3e926434e23bc7a4ffbf84d5ff6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTAtNy0xLTEtNjEyODE_5799507c-b676-47a9-aea1-7f8bbf6e5c73"
      unitRef="usd">23000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="if85711d4c58a411e8be877e7ad67842a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTAtOS0xLTEtNjEyODE_bd7a1bf2-dcd2-40cf-bbbe-aeb76facc244"
      unitRef="shares">74080000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="if85711d4c58a411e8be877e7ad67842a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTAtMTEtMS0xLTYxMjgx_bf48ae76-9809-41c3-b68d-68fd58c4588a"
      unitRef="usd">-6136000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i63448b71f13c4d649cdc22ef4a0b5d5a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTEtNS0xLTEtNjEyODE_6966b9fa-347e-4e30-bf3d-0b5af433409b"
      unitRef="usd">299000000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTItMC0xLTEtNjEyODEvdGV4dHJlZ2lvbjpjZjViYjg1YWEwNWE0NzJhYmVjZGQzMjIyYzViNTdhOV8yMg_8664fa79-c37c-4a7b-aadc-546914778b5d"
      unitRef="usdPerShare">0.83</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i63448b71f13c4d649cdc22ef4a0b5d5a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTItNS0xLTEtNjEyODE_7e17074f-1a45-45ca-9490-2a62e3f5d72a"
      unitRef="usd">242000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsPreferredStock
      contextRef="i63448b71f13c4d649cdc22ef4a0b5d5a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTMtNS0xLTEtNjEyODE_d4682bb5-be9c-4d20-b6e1-5d4a815cfde0"
      unitRef="usd">23000000</us-gaap:DividendsPreferredStock>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i10091875590248f6a43b7b9c1e05c6bc_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTQtMy0xLTEtNjEyODE_0efe893f-a5a5-428a-b91e-eda9265467b9"
      unitRef="usd">-15000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i05807d0c88fa4fe9973f0d6abc7b86b7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTQtOS0xLTEtNjEyODE_59fdfe2b-d111-4957-94c4-498691fd2c4a"
      unitRef="shares">234000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i05807d0c88fa4fe9973f0d6abc7b86b7_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTQtMTEtMS0xLTYxMjgx_fef4ee61-3ff6-4285-b49d-ac4b4f312816"
      unitRef="usd">4000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i10091875590248f6a43b7b9c1e05c6bc_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTUtMy0xLTEtNjEyODE_8f856df9-4c95-4f19-86fd-4e5899b45b07"
      unitRef="usd">55000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <bdx:CommonStockHeldInTrustsNetShares
      contextRef="i05807d0c88fa4fe9973f0d6abc7b86b7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTYtOS0xLTEtNjEyODE_1f7a2a41-ca3e-4ed4-ba6b-fd7d00338882"
      unitRef="shares">23000</bdx:CommonStockHeldInTrustsNetShares>
    <us-gaap:StockholdersEquity
      contextRef="i21bb6c6eb0934bbf97ecaab0350f75d5_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTgtMS0xLTEtNjEyODE_1eb12f78-17e8-4aba-b42b-edc8afa71e66"
      unitRef="usd">365000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7b08323b925d40d1b59c94d01b6f7ede_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTgtMy0xLTEtNjEyODE_cf3774d8-f5f2-43a2-aec7-82c8bd72f4de"
      unitRef="usd">19341000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5ca7af80178f409190ac109fee156034_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTgtNS0xLTEtNjEyODE_a12258ae-eb6a-4f21-a22d-796550efc4e6"
      unitRef="usd">13557000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i81c8d0ef92a54994aba64d18915d02d8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTgtNy0xLTEtNjEyODE_afdfbce2-3704-492c-aed9-f57d861b2ac1"
      unitRef="usd">23000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i00ac086edd1e4ab1b000dc60c50ccd89_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTgtOS0xLTEtNjEyODE_c6c80880-bfee-4180-9781-fa9b39441c0b"
      unitRef="shares">73821000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i00ac086edd1e4ab1b000dc60c50ccd89_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOmE5N2I4NGI1ZGY4YzQwYTJhZDEwNTVhNGIxMzgwMGM5L3RhYmxlcmFuZ2U6YTk3Yjg0YjVkZjhjNDBhMmFkMTA1NWE0YjEzODAwYzlfMTgtMTEtMS0xLTYxMjgx_3f2aecf9-ea60-477c-9531-e01e665dd8d3"
      unitRef="usd">-6132000000</us-gaap:StockholdersEquity>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="i8cb4ecbb78e74ce3a938ab69f4bdf1f4_I20130924"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RleHRyZWdpb246MWZkY2M3NTQyZGYxNDI4MWJkOGY1ZGMzNDRhNTUyNzVfNjY4_83858dce-7d06-42bd-baa9-db411641bff7"
      unitRef="shares">10000000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <bdx:StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased
      contextRef="i13da3ad4178f4ecebb53a625e7acba1b_I20211130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RleHRyZWdpb246MWZkY2M3NTQyZGYxNDI4MWJkOGY1ZGMzNDRhNTUyNzVfODE3_dcbc94de-688a-4173-94d3-91b343bd0c8a"
      unitRef="shares">10000000</bdx:StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RleHRyZWdpb246MWZkY2M3NTQyZGYxNDI4MWJkOGY1ZGMzNDRhNTUyNzVfMjExNg_feefbc76-ff29-40f4-ab4d-220f4c57461a">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components and changes of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for the first two quarters of fiscal years 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.426%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency&lt;br/&gt;Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Benefit&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,043)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,251)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.134%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency&lt;br/&gt;Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Benefit&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,548)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,352)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(998)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMS0xLTEtMS02MTI4MQ_dae7a1d7-72d0-4433-9af8-1324b1909a24"
      unitRef="usd">-2088000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9ee43d89fee945a3adb8a3285fa956d4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMS0zLTEtMS02MTI4MQ_5667e640-0a34-4ff3-93c3-6e17a9cf4c21"
      unitRef="usd">-1292000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie9c0efef45cd4a01bad737fb01fada74_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMS01LTEtMS02MTI4MQ_fa6ed454-4020-4118-991a-5f57ae8a680a"
      unitRef="usd">-784000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7b579acbced54178ac7040056cec1930_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMS03LTEtMS02MTI4MQ_d6c36e2f-c722-4a2b-9a70-d1882caae26f"
      unitRef="usd">-10000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iefdb0b0a3f294705ae8463fd402aa8f3_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMi0xLTEtMS02MTI4MQ_e1b035d6-cf9b-4afd-9f0e-91e763c57f8c"
      unitRef="usd">34000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i324ed7a0bfda4e7e83cf84119d3ae93e_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMi0zLTEtMS02MTI4MQ_d09f4b1d-f907-46c9-ade8-ac6236dcec4c"
      unitRef="usd">41000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia0fedadbd75d4a4985c2b754543d38db_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMi01LTEtMS02MTI4MQ_f8f404e3-1ebd-4b16-907f-64e755dad5c5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3b405f3959cc475c9b732b9beb5bba7b_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMi03LTEtMS02MTI4MQ_49ee5ff7-bbda-411f-8eaf-fbaf39c27489"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iefdb0b0a3f294705ae8463fd402aa8f3_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMy0xLTEtMS02MTI4MQ_792132a2-107e-41a0-ab15-d26cf1cde428"
      unitRef="usd">-11000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i324ed7a0bfda4e7e83cf84119d3ae93e_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMy0zLTEtMS02MTI4MQ_067a4202-9f9e-4f43-8c4a-b22b0e835036"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia0fedadbd75d4a4985c2b754543d38db_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMy01LTEtMS02MTI4MQ_57b23da6-9524-4123-9a1c-adecb6203910"
      unitRef="usd">-11000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3b405f3959cc475c9b732b9beb5bba7b_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfMy03LTEtMS02MTI4MQ_6370dc61-969e-4831-84a4-1beb52046eaa"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i88e64c73fc1047fa8d2dbbd0264a3c84_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNC0xLTEtMS02MTI4MQ_2f0824fa-b4e2-45d9-a28e-f92c1681ecdf"
      unitRef="usd">-2043000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1f7ed54a259b40c1a2765645e71832fa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNC0zLTEtMS02MTI4MQ_b2f96806-a571-4d5e-9e98-3f5128305bac"
      unitRef="usd">-1251000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i69e96ef1d0e74452ab61f2dcd1b57fe4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNC01LTEtMS02MTI4MQ_4aac6660-ee87-441c-be7e-5a4a25c76cdc"
      unitRef="usd">-774000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i65465a86c8c5442a8b980080054fe48e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNC03LTEtMS02MTI4MQ_f91efff5-46e9-4a67-8b7f-8152184e5519"
      unitRef="usd">-17000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNS0xLTEtMS02MTI4MQ_5a238acc-130c-4679-a264-0b6ca53edc5e"
      unitRef="usd">122000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8cba383a1c1a43a7b184a8631be117d0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNS0zLTEtMS02MTI4MQ_7f2b8d98-727c-4b47-b6ea-8ab34d37dc17"
      unitRef="usd">78000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i72f72d97c18d4a168adf04b6afab2aec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNS01LTEtMS02MTI4MQ_a7485bce-743a-4687-8225-3f3bb7d090fe"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ice9518fb765048f791d1eb268ac30699_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNS03LTEtMS02MTI4MQ_9376cba1-e4b9-47ca-8974-f0720ce8b0af"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNi0xLTEtMS02MTI4MQ_42f079b5-a5b5-4965-9524-ed4e44659b19"
      unitRef="usd">-11000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8cba383a1c1a43a7b184a8631be117d0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNi0zLTEtMS02MTI4MQ_cd752402-b5df-4bff-905c-71921dfac11b"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i72f72d97c18d4a168adf04b6afab2aec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNi01LTEtMS02MTI4MQ_74284e25-884a-417a-99a2-9e849c67c1a2"
      unitRef="usd">-11000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ice9518fb765048f791d1eb268ac30699_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNi03LTEtMS02MTI4MQ_793f1b1c-9009-4bd2-a240-d9fcca724c1b"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNy0xLTEtMS02MTI4MQ_3c20a6f6-f172-4190-bbdd-6bf0acb3a4bb"
      unitRef="usd">-1910000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5b672c8a1e23415c954ddf66aac1e984_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNy0zLTEtMS02MTI4MQ_c3e6998f-5464-4473-b820-270f560d4ca0"
      unitRef="usd">-1173000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6b29fdbef54342949881c713e16d539c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNy01LTEtMS02MTI4MQ_e5fb96e7-5f38-4611-8466-42305fe68af2"
      unitRef="usd">-763000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if9193c0d5b9c4b2581040114a4cd2dfd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjU2MDU4ODIyNDZkMjQ2OGFhYjc5NzQzOGExNjJiYjYwL3RhYmxlcmFuZ2U6NTYwNTg4MjI0NmQyNDY4YWFiNzk3NDM4YTE2MmJiNjBfNy03LTEtMS02MTI4MQ_e215df57-05ef-4875-9ac9-6a063cc3f9e6"
      unitRef="usd">28000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6f49a7b80b0c4a37acc78faacd1def8e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMS0xLTEtMS02MTI4MQ_bedbbdf5-6d13-4505-9bfd-51bf30e66edd"
      unitRef="usd">-2548000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id4d95beb50b14c9c95a3d75c68b47d91_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMS0zLTEtMS02MTI4MQ_cddc93b4-4d1f-4f46-a1a0-29469ac51ef8"
      unitRef="usd">-1416000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if967b9c04df3495bbc795bfd1f8099af_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMS01LTEtMS02MTI4MQ_cadb7603-9454-432f-b523-40d005d937d4"
      unitRef="usd">-1040000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ifbfa81272476483894faf8a5f285efa0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMS03LTEtMS02MTI4MQ_66273488-8a48-4d36-bbc0-ec23eae4dacb"
      unitRef="usd">-91000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icedd1d99c22048f7924f50a371090298_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMi0xLTEtMS02MTI4MQ_45f51eef-7cac-4198-8d81-4a220649ad65"
      unitRef="usd">115000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3ed40f315c6c4f97a754a6eb72927dc8_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMi0zLTEtMS02MTI4MQ_533feeab-380b-40d2-be3f-c2a8d3b3384d"
      unitRef="usd">64000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ibb4e8d00d339433fac2d8c00fd206825_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMi01LTEtMS02MTI4MQ_570aed9b-eaac-41ea-9c53-095179f5a45a"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i977201e5251e4da78e41ec15b3b96c80_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMi03LTEtMS02MTI4MQ_967a73a3-b64e-45c5-aad5-3d8a9a525357"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="icedd1d99c22048f7924f50a371090298_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMy0xLTEtMS02MTI4MQ_d370cfaf-923a-40fb-8fc7-667ec3b3cf42"
      unitRef="usd">-19000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3ed40f315c6c4f97a754a6eb72927dc8_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMy0zLTEtMS02MTI4MQ_f6740002-e6a6-4563-ba55-e3d00d9cb3e8"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ibb4e8d00d339433fac2d8c00fd206825_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMy01LTEtMS02MTI4MQ_b11d51b4-bed2-45d0-b40c-badece380ca3"
      unitRef="usd">-18000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i977201e5251e4da78e41ec15b3b96c80_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfMy03LTEtMS02MTI4MQ_5c524530-7583-4cd4-a712-28fded336957"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia7a0d188409c454e90b59907b43f24ad_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNC0xLTEtMS02MTI4MQ_f8e88b78-40fd-45a9-8eef-7b6b51259cfa"
      unitRef="usd">-2414000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0692d1be0c384a95b3c84dd3b71fea18_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNC0zLTEtMS02MTI4MQ_7d162e57-4b0b-4529-bb8f-f93a10e023c1"
      unitRef="usd">-1352000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0aa1afa266db408b8ce7249358da4cb7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNC01LTEtMS02MTI4MQ_31cf7a33-064c-4755-939c-d4917fabab20"
      unitRef="usd">-998000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i465aa0dfa2c14f119d5e5bef56c57bb8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNC03LTEtMS02MTI4MQ_b1a53d99-1932-4d21-90ec-224a8d2798d9"
      unitRef="usd">-62000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNS0xLTEtMS02MTI4MQ_b15c8ffa-4b3f-4ab0-93a2-b4f14daaea3c"
      unitRef="usd">64000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i5877d216df964262bf4bb845d95a59f7_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNS0zLTEtMS02MTI4MQ_82ccb32e-da25-49aa-91fc-27e706cd8cb2"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1b2de3cd4f2a4be79b23ac6da588eaf4_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNS01LTEtMS02MTI4MQ_9d5b2ba7-5cce-4253-ad54-af35c74c6dc6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1b94674394f84d6eb4053788dc6d572f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNS03LTEtMS02MTI4MQ_42c55e3d-1a52-472c-9116-921f15fff2b3"
      unitRef="usd">78000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNi0xLTEtMS02MTI4MQ_b4bcbe50-ef6d-4ea8-93ee-a2de190b8d51"
      unitRef="usd">-21000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i5877d216df964262bf4bb845d95a59f7_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNi0zLTEtMS02MTI4MQ_02968725-feb7-4367-92a8-f98c662cf999"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i1b2de3cd4f2a4be79b23ac6da588eaf4_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNi01LTEtMS02MTI4MQ_def7957b-08ee-4243-a38b-33fae7658871"
      unitRef="usd">-16000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i1b94674394f84d6eb4053788dc6d572f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNi03LTEtMS02MTI4MQ_8b5753ce-0edd-438e-981d-70caa7b296be"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2fb7d149583e4cbbb4ba841be5866113_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNy0xLTEtMS02MTI4MQ_f74dd99a-7ab2-4074-a12b-d9030a167ceb"
      unitRef="usd">-2329000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iac6b1a8c16e3470fac8737acad5b180f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNy0zLTEtMS02MTI4MQ_3d67320e-3ec3-4ed0-b09b-7b7101221da9"
      unitRef="usd">-1367000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4995a156954f4d75a765e0acb8fb54b4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNy01LTEtMS02MTI4MQ_c85c2164-af16-4467-9aaa-7963b616895f"
      unitRef="usd">-982000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i770c080a4a784b18b9b4b99e56348d1a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNC9mcmFnOjFmZGNjNzU0MmRmMTQyODFiZDhmNWRjMzQ0YTU1Mjc1L3RhYmxlOjI4OGU4NGE1NTRlODQzOGM4ZTNhZmVmZmUyMGU1MWYxL3RhYmxlcmFuZ2U6Mjg4ZTg0YTU1NGU4NDM4YzhlM2FmZWZmZTIwZTUxZjFfNy03LTEtMS02MTI4MQ_9284fbce-c794-4d61-869d-eed7199e2672"
      unitRef="usd">21000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RleHRyZWdpb246MWI2MWNlZGYyYTMyNDhlYTlhNWJhMTUzNWE5ZGViMmJfNDUy_f0ae480f-9907-4282-a34d-fdf64436d9ed">Earnings per Share&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.461%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive share equivalents from share-based plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive share equivalents from Series C preferred shares (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average common and common equivalent shares outstanding &#x2013; assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share equivalents excluded from the diluted shares outstanding calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mandatory convertible preferred stock (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based plans (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;Represents dilutive share equivalents from Series C preferred shares that temporarily replaced shares of common stock held in trusts to adhere to trust requirements until the Company&#x2019;s spin-off of its Diabetes Care business on April 1, 2022 was completed. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt"&gt;Excluded from the diluted shares outstanding calculation because the result would have been antidilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;Excluded from the diluted earnings per share calculation as the exercise prices of these awards were greater than the average market price of the Company&#x2019;s common shares.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RleHRyZWdpb246MWI2MWNlZGYyYTMyNDhlYTlhNWJhMTUzNWE5ZGViMmJfNDU2_fa9c3a4f-49a0-41b1-a392-0669ca13a4be">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.461%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive share equivalents from share-based plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive share equivalents from Series C preferred shares (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average common and common equivalent shares outstanding &#x2013; assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share equivalents excluded from the diluted shares outstanding calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mandatory convertible preferred stock (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based plans (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;Represents dilutive share equivalents from Series C preferred shares that temporarily replaced shares of common stock held in trusts to adhere to trust requirements until the Company&#x2019;s spin-off of its Diabetes Care business on April 1, 2022 was completed. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt"&gt;Excluded from the diluted shares outstanding calculation because the result would have been antidilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;Excluded from the diluted earnings per share calculation as the exercise prices of these awards were greater than the average market price of the Company&#x2019;s common shares.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfMi0xLTEtMS02MTI4MQ_211f4b0d-5cd1-43b6-a8f7-53d70d5d32e2"
      unitRef="shares">285243000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfMi0zLTEtMS02MTI4MQ_f9312118-51be-4163-890b-bde1afb96c56"
      unitRef="shares">291095000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfMi01LTEtMS02MTI4MQ_3434dd88-dd87-4fe9-b58c-a2fab69b69dc"
      unitRef="shares">284961000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfMi03LTEtMS02MTI4MQ_9f5b327f-2df4-4f9b-80c1-bd83aacd74b1"
      unitRef="shares">290839000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfMy0xLTEtMS02MTI4MQ_2113c3c9-ec23-4073-9936-9838a5e471b9"
      unitRef="shares">2003000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfMy0zLTEtMS02MTI4MQ_f2a5e922-29f3-4300-8c51-fef166a12637"
      unitRef="shares">2452000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfMy01LTEtMS02MTI4MQ_bf76620e-6b13-4dbe-9f45-32bafa44706a"
      unitRef="shares">2215000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfMy03LTEtMS02MTI4MQ_c906967a-5b69-4dd4-a956-91c1d754fcd5"
      unitRef="shares">2660000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNC0xLTEtMS03OTE1MA_e0a2fd78-e169-4016-a1d6-d51fbdfa2213"
      unitRef="shares">53000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNC0zLTEtMS03OTE1MA_2ce90dad-bae9-4d92-947c-7dc82d5f6bfd"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNC01LTEtMS03OTE1MA_eb6d9cd5-d43b-4a95-a5d9-a71306318a27"
      unitRef="shares">26000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNC03LTEtMS03OTE1MA_c388a442-3e6b-4ba0-bbe2-a9606d09d5b8"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNC0xLTEtMS02MTI4MQ_a897e189-9499-4ff1-afae-ffe8d0cea36d"
      unitRef="shares">287299000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNC0zLTEtMS02MTI4MQ_c2cd450a-8870-4910-aaa6-c608bdcbfecf"
      unitRef="shares">293547000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNC01LTEtMS02MTI4MQ_8cbb05af-95ae-4830-b136-e357ec249626"
      unitRef="shares">287202000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNC03LTEtMS02MTI4MQ_e28e7063-a699-4e93-86d3-860c26c536d3"
      unitRef="shares">293499000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4d3a36d935bf4fd8b6132f2d1ef29307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNy0xLTEtMS02MTI4MQ_8d7ba137-cb45-4989-bfd2-903d9ead5abf"
      unitRef="shares">5639000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib76ec6f5ea814d30b2c30ad474c85f94_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNy0zLTEtMS02MTI4MQ_a0c31aab-f5aa-42bf-856e-a70d9dcb8086"
      unitRef="shares">6169000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iea6c161bd8a340f98a4fddd063587010_D20211001-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNy01LTEtMS02MTI4MQ_bbe57859-a289-4ad1-957c-b41145ae384d"
      unitRef="shares">5639000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i49a7de59e6ff4225a49a75d990be29bd_D20201001-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfNy03LTEtMS02MTI4MQ_675a82e1-3946-4582-bf2f-4a9f33b5690e"
      unitRef="shares">6169000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i308403a24c2a42c89b1d7a4ab555184c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfOC0xLTEtMS02MTI4MQ_eb10f0da-fc80-4fc5-a139-50efe1e5d5b4"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7022abe219c14c9dacdbd2ec440a8b4f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfOC0zLTEtMS02MTI4MQ_6c0b539b-5c04-4a72-8560-bbdae503e920"
      unitRef="shares">773000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib9450f0155c94e31b2c13ad94e0092f6_D20211001-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfOC01LTEtMS02MTI4MQ_d702abba-dea2-42f7-89fa-ac5bd34725f9"
      unitRef="shares">676000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic97169545d0c475da35e8da8837b02ab_D20201001-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV8zNy9mcmFnOjFiNjFjZWRmMmEzMjQ4ZWE5YTViYTE1MzVhOWRlYjJiL3RhYmxlOmFiNWQ3NzdjM2FiOTQ0Yzg5ZTVhNTQ3NjU0MTU5NzhlL3RhYmxlcmFuZ2U6YWI1ZDc3N2MzYWI5NDRjODllNWE1NDc2NTQxNTk3OGVfOC03LTEtMS02MTI4MQ_7c64a86e-378e-473f-a4d8-5a4ab41a6a69"
      unitRef="shares">773000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80MC9mcmFnOjZmZmI1ODFiNjI4YTRjNTc5MGRmZGFlOTE2NDliMDVjL3RleHRyZWdpb246NmZmYjU4MWI2MjhhNGM1NzkwZGZkYWU5MTY0OWIwNWNfMTMxOTU_37c98227-679e-40f1-8b17-27a649180e77">Contingencies&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved, both as a plaintiff and a defendant, in various legal proceedings that arise in the ordinary course of business, including, without limitation, product liability and environmental matters in certain U.S. and international locations.  Given the uncertain nature of litigation generally, the Company is not able, in all cases, to estimate the amount or range of loss that could result from an unfavorable outcome of litigation in which the Company is a party.  In accordance with U.S. GAAP, the Company establishes accruals to the extent probable future losses are estimable (and in the case of environmental matters, without considering possible third-party recoveries).  With respect to putative class action lawsuits in the United States and certain of the Canadian lawsuits described below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding all or certain of the plaintiffs and their medical conditions; and/or (iii) there are significant factual issues to be resolved.  In addition, there is uncertainty as to the likelihood of a class being certified or the ultimate size of any class.  With respect to the civil investigative demands (&#x201c;CIDs&#x201d;) served by the Department of Justice which are discussed below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; and/or (ii) there are significant factual and legal issues to be resolved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Product Liability Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the Company is defending approximately 28,590 product liability claims involving the Company&#x2019;s line of hernia repair devices (collectively, the &#x201c;Hernia Product Claims&#x201d;).  The majority of those claims are currently pending in a coordinated proceeding in Rhode Island State Court (&#x201c;RI&#x201d;) and in a federal multi-district litigation (&#x201c;MDL&#x201d;) established in the Southern District of Ohio, but claims are also pending in other state and/or federal court jurisdictions.  In addition, those claims include multiple putative class actions in Canada.  Generally, the Hernia Product Claims seek damages for personal injury allegedly resulting from use of the products.  From time to time, the Company engages in resolution discussions with plaintiffs&#x2019; law firms regarding certain of the Hernia Product Claims, but the Company also intends to vigorously defend Hernia Product Claims that do not settle, including through litigation.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The first bellwether trial in the hernia MDL resulted in a complete defense verdict in favor of the Company in September 2021 after over five weeks of trial.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The second hernia MDL bellwether resulted in a $255&#160;thousand verdict in April 2022 after four weeks of trial. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trials are currently scheduled in various state and/or federal courts, including one currently scheduled for June 2022 in RI.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expects additional trials of Hernia Product Claims to take place over the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also continues to be a defendant in certain other mass tort litigation.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the Company is defending product liability claims involving the Company&#x2019;s line of pelvic mesh products, the majority of which are pending in various federal court jurisdictions and in a coordinated proceeding in New Jersey Superior Court.  Also, as of March&#160;31, 2022, the Company is defending product liability claims involving the Company&#x2019;s line of inferior vena cava (&#x201c;IVC&#x201d;) filter products.  The majority of those claims are pending in various federal court jurisdictions after having been remanded from the MDL in the United States District Court for the District of Arizona.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In most product liability litigations (like those described above), plaintiffs allege a wide variety of claims, ranging from allegations of serious injury caused by the products to efforts to obtain compensation notwithstanding the absence of any injury. In many of these cases, the Company has not yet received and reviewed complete information regarding the plaintiffs and their medical conditions and, consequently, is unable to fully evaluate the claims.  The Company expects that it will receive and review additional information regarding any remaining unsettled product liability matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 27, 2020, a putative class action captioned Kabak v. Becton, Dickinson and Company, et al., Civ. No. 2:20-cv-02155 (SRC) (CLW), now captioned Industriens Pensionsforsikring v. Becton, Dickinson and Company, et al., was filed in the U.S. District Court for the District of New Jersey against the Company and certain of its officers.  The complaint, which purports to be brought on behalf of all persons (other than defendants) who purchased or otherwise acquired the Company's common stock from November 5, 2019 through February 5, 2020, asserts claims for purported violations of Sections 10 and 20 of the Securities Exchange Act of 1934 and Securities and Exchange Commission (&#x201c;SEC&#x201d;) Rule 10b-5 promulgated thereunder, and seeks, among other things, damages and costs.  The complaint alleges that defendants concealed certain material information regarding Alaris&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; infusion pumps, allegedly rendering certain public statements about the Company&#x2019;s business, operations and prospects false or misleading, thereby allegedly causing investors to purchase stock at an inflated price.  The plaintiff filed a second amended complaint to add certain additional factual allegations on February 3, 2021.  This complaint was dismissed on the Company&#x2019;s motion on September 15, 2021.  The court&#x2019;s dismissal order, however, gave plaintiff an opportunity to replead, which it did on October 29, 2021.  The Company moved to dismiss the newly amended pleading on December 16, 2021.  That motion is fully briefed and pending.  The Company believes that these allegations are without merit and it intends to defend itself vigorously.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 2, 2020, a civil action captioned Jankowski v. Forlenza, et al., Civ. No. 2:20-cv-15474, was filed in the U.S. District Court for the District of New Jersey by a shareholder, Ronald Jankowski, derivatively on behalf of the Company, against its individual directors and certain of its officers. The complaint seeks recovery for breach of fiduciary duties by directors and various officers; violations of the Securities Exchange Act of 1934, including sections 10(b), 14(a) and 21D; and insider trading.  In general, the complaint also alleges, among other things, that various directors and/or officers caused the Company to issue purportedly misleading statements and SEC filings regarding Alaris&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; infusion pumps, and issue a purportedly misleading proxy statement. The complaint seeks damages, including restitution and disgorgement of profits, and an injunction requiring the Company to undertake remedial measures with respect to certain corporate governance and internal procedures.  A second derivative action, Schranz v. Polen, et al., Civ. No 2:21-cv-01081 (D. N.J.), was filed on January 24, 2021, and the two actions were consolidated.  In March 2021, the Company received letters from two additional shareholders which, in general, mirrored the allegations in the Jankowski and Schranz consolidated actions, and demanded, among other things, that the Board of Directors pursue civil action against members of management for claimed breaches of fiduciary duties. Consistent with New Jersey law, the Board appointed a special committee to review the allegations and demands in the derivative actions and demand letters.  Following an investigation, the special committee determined that no action was warranted, and rejected the shareholders&#x2019; demands. The special committee&#x2019;s determination has been communicated to counsel for the shareholders.  Should the shareholders continue to pursue their claims in court, the Company will take appropriate steps to seek dismissal of the complaints.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In May 2017, the Company was sued by a competitor in the Northern District of New York, alleging antitrust violations related to certain aspects of the Company&#x2019;s medical delivery solutions business in a case captioned AngioDynamics, Inc. v. C. R. Bard, Inc. et al., Civ. No. 1:17-CV-0598.  Motion practice in the case is ongoing.  The Company believes it has meritorious defenses and is vigorously defending the case, which has been set for trial on July 5, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, the Company received a subpoena from the Enforcement Division of the SEC requesting information from the Company relating to, among other things, Alaris&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; infusion pumps.  The Company is cooperating with the SEC and responding to these requests.  The Company cannot anticipate the timing, scope, outcome or possible impact of the investigation, financial or otherwise. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2019, the Department of Justice served the Company and CareFusion with CIDs seeking information regarding certain of CareFusion&#x2019;s contracts with the Department of Veteran&#x2019;s Affairs for certain products, including Alaris&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and Pyxis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;devices, in connection with a civil investigation of possible violations of the False Claims Act, and the government recently expanded the investigation to include several additional contracts.  The government has made several requests for documents and interviews or depositions of Company personnel.  The Company is cooperating with the government and responding to these requests.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2021, the Company received a CID related to an inquiry initiated by the Northern District of Georgia in 2018.  The requests concern sales and marketing practices with respect to certain aspects of the Company&#x2019;s urology business.  The government has made requests for documents and has interviewed employees.  The inquiry is ongoing and the Company is cooperating with the government and responding to its requests. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2021, the Company was served with a complaint from the New Mexico Attorney General, alleging violations of the state&#x2019;s consumer protection laws in connection with the sales and marketing of its IVC filters.  The Company filed its motion to dismiss on December 27, 2021, and intends to vigorously defend itself in the litigation.  As the case is in its early stages, the Company cannot anticipate the timing, scope, outcome or possible impact at present.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the Company became aware of lawsuits that had been filed against it in state and federal court in Georgia.  The suits were filed by plaintiffs who reside near Company facilities in Covington, GA, where ethylene oxide (&#x201c;EtO&#x201d;) sterilization activities take place.  There are currently approximately 210 of such suits.  The claims allege a variety of injuries, including but not limited to multiple types of cancer, allegedly attributable to exposure to EtO in the ambient air.  The Company has meritorious defenses and intends to defend itself vigorously.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also involved both as a plaintiff and a defendant in other legal proceedings and claims that arise in the ordinary course of business.  The Company believes that it has meritorious defenses to these suits pending against the Company and is engaged in a vigorous defense of each of these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company cannot predict the outcome of these other legal matters discussed above, nor can it predict whether any outcome will have a material adverse effect on the Company&#x2019;s consolidated results of operations and/or consolidated cash flows.  Accordingly, the Company has made no provisions for these other legal matters in its consolidated results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a potentially responsible party to a number of federal administrative proceedings in the United States brought under the Comprehensive Environment Response, Compensation and Liability Act, also known as &#x201c;Superfund,&#x201d; and similar state laws.  We also are subject to administrative proceedings under environmental laws in jurisdictions outside the U.S. The affected sites are in varying stages of development.  In some instances, the remedy has been completed, while in others, environmental studies are underway or commencing.  For several sites, there are other potentially responsible parties that may be jointly or severally liable to pay all or part of cleanup costs.  While it is not feasible to predict the outcome of these proceedings, based upon the Company&#x2019;s experience, current information and applicable law, the Company does not expect these proceedings to have a material adverse effect on its consolidated results of operations and/or consolidated cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation Accruals&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company regularly monitors and evaluates the status of product liability and other legal matters, and may, from time-to-time, engage in settlement and mediation discussions taking into consideration developments in the matters and the risks and uncertainties surrounding litigation.  These discussions could result in settlements of one or more of these claims at any time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accruals for the Company's product liability claims which are discussed above, as well as the related legal defense costs, amounted to approximately $2.3&#160;billion and $2.5 billion at March&#160;31, 2022 and September&#160;30, 2021, respectively.  These accruals are largely recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Income Taxes and Other Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on the Company's condensed consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In view of the uncertainties discussed above, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance.  In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company&#x2019;s consolidated results of operations and /or consolidated cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80MC9mcmFnOjZmZmI1ODFiNjI4YTRjNTc5MGRmZGFlOTE2NDliMDVjL3RleHRyZWdpb246NmZmYjU4MWI2MjhhNGM1NzkwZGZkYWU5MTY0OWIwNWNfMTMxOTM_b7b69432-3d89-409d-b754-7703c1c73757">The Company is involved, both as a plaintiff and a defendant, in various legal proceedings that arise in the ordinary course of business, including, without limitation, product liability and environmental matters in certain U.S. and international locations.  Given the uncertain nature of litigation generally, the Company is not able, in all cases, to estimate the amount or range of loss that could result from an unfavorable outcome of litigation in which the Company is a party.  In accordance with U.S. GAAP, the Company establishes accruals to the extent probable future losses are estimable (and in the case of environmental matters, without considering possible third-party recoveries).  With respect to putative class action lawsuits in the United States and certain of the Canadian lawsuits described below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding all or certain of the plaintiffs and their medical conditions; and/or (iii) there are significant factual issues to be resolved.  In addition, there is uncertainty as to the likelihood of a class being certified or the ultimate size of any class.  With respect to the civil investigative demands (&#x201c;CIDs&#x201d;) served by the Department of Justice which are discussed below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; and/or (ii) there are significant factual and legal issues to be resolved.In view of the uncertainties discussed above, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance.  In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company&#x2019;s consolidated results of operations and /or consolidated cash flows.</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i75602a2f46c546e4828064853912e326_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80MC9mcmFnOjZmZmI1ODFiNjI4YTRjNTc5MGRmZGFlOTE2NDliMDVjL3RleHRyZWdpb246NmZmYjU4MWI2MjhhNGM1NzkwZGZkYWU5MTY0OWIwNWNfMTc1OA_8cc502c6-1a12-4c82-a31d-9ed35cb03a90"
      unitRef="claim">28590</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80MC9mcmFnOjZmZmI1ODFiNjI4YTRjNTc5MGRmZGFlOTE2NDliMDVjL3RleHRyZWdpb246NmZmYjU4MWI2MjhhNGM1NzkwZGZkYWU5MTY0OWIwNWNfMjc0ODc3OTA4Nzc5Ng_d2c6583f-d1f3-421c-b7a3-bcbc68b03024"
      unitRef="usd">255000</us-gaap:LossContingencyDamagesAwardedValue>
    <bdx:NumberOfEtOSterilizationLawsuitsFiled
      contextRef="if223ecc9d5a1493093a44d337a8b72c5_D20211001-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80MC9mcmFnOjZmZmI1ODFiNjI4YTRjNTc5MGRmZGFlOTE2NDliMDVjL3RleHRyZWdpb246NmZmYjU4MWI2MjhhNGM1NzkwZGZkYWU5MTY0OWIwNWNfMTAyNTc_a761fed1-6a5f-4278-a8b7-6d11eed67758"
      unitRef="lawsuit">210</bdx:NumberOfEtOSterilizationLawsuitsFiled>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80MC9mcmFnOjZmZmI1ODFiNjI4YTRjNTc5MGRmZGFlOTE2NDliMDVjL3RleHRyZWdpb246NmZmYjU4MWI2MjhhNGM1NzkwZGZkYWU5MTY0OWIwNWNfMTI2MTc_1c6f45e8-7f20-4687-a761-4dfe82883a49"
      unitRef="usd">2300000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80MC9mcmFnOjZmZmI1ODFiNjI4YTRjNTc5MGRmZGFlOTE2NDliMDVjL3RleHRyZWdpb246NmZmYjU4MWI2MjhhNGM1NzkwZGZkYWU5MTY0OWIwNWNfMTI2MjQ_35830e09-c4ac-494c-aac5-e77439228b7c"
      unitRef="usd">2500000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80My9mcmFnOjg0NWZkOGRmYmRkMjRiODA4ODU1MzRjMWY5ZDNhMTcxL3RleHRyZWdpb246ODQ1ZmQ4ZGZiZGQyNGI4MDg4NTUzNGMxZjlkM2ExNzFfMzk2MA_53fd9ca5-fd28-41dd-9cb1-f2184b491ba0">RevenuesThe Company&#x2019;s policies for recognizing sales have not changed from those described in the Company&#x2019;s 2021 Annual Report on Form 10-K.  The Company sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products which are distributed through independent distribution channels and directly by BD through sales representatives.  End-users of the Company's products include healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Measurement of Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables.  Such estimated credit losses are determined based on historical loss experiences, customer-specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information.  The allowance for doubtful accounts for trade receivables is not material to the Company's consolidated financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized.  Such variable consideration includes rebates, sales discounts and sales returns.  The Company&#x2019;s rebate liability at March&#160;31, 2022 and September&#160;30, 2021 was $585&#160;million and $576&#160;million, respectively.  The impact of other forms of variable consideration, including sales discounts and sales returns, is not material to the Company's revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Effects of Revenue Arrangements on Consolidated Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized contract costs associated with the costs to fulfill contracts for certain products in the Medication Management Solutions organizational unit are immaterial to the Company's condensed consolidated balance sheets.  Commissions relating to revenues recognized over a period longer than one year are recorded as assets which are amortized over the period over which the revenues underlying the commissions are recognized.  Capitalized contract costs related to such commissions are immaterial to the Company's condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities for unearned revenue that is allocable to performance obligations, such as extended warranty and software maintenance contracts, which are performed over time are immaterial to the Company's consolidated financial results.  The Company's liability for product warranties provided under its agreements with customers is not material to its condensed consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Remaining Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's obligations relative to service contracts and pending installations of equipment, primarily in the Company's Medication Management Solutions unit, represent unsatisfied performance obligations of the Company.  The revenues under existing contracts with original expected durations of more than one year, which are attributable to products and/or services that have not yet been installed or provided are estimated to be approximately $2.2 billion at March&#160;31, 2022.  The Company expects to recognize the majority of this revenue over the next three years.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Within the Company's Medication Management Solutions, Medication Delivery Solutions, Integrated Diagnostic Solutions, and Biosciences units, some contracts also contain minimum purchase commitments of reagents or other consumables and the future sales of these consumables represent additional unsatisfied performance obligations of the Company.  The revenue attributable to the unsatisfied minimum purchase commitment-related performance obligations, for contracts with original expected durations of more than one year, is estimated to be approximately&#160;$2.4 billion&#160;at&#160;March&#160;31, 2022. &#160;This revenue will be recognized over the customer relationship periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A disaggregation of the Company's revenues by segment, organizational unit and geographic region is provided in Note 6.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80My9mcmFnOjg0NWZkOGRmYmRkMjRiODA4ODU1MzRjMWY5ZDNhMTcxL3RleHRyZWdpb246ODQ1ZmQ4ZGZiZGQyNGI4MDg4NTUzNGMxZjlkM2ExNzFfMzk2Mw_decde96b-12e0-407a-a017-aec40e0d59d3">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Measurement of Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables.  Such estimated credit losses are determined based on historical loss experiences, customer-specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information.  The allowance for doubtful accounts for trade receivables is not material to the Company's consolidated financial results.&lt;/span&gt;&lt;/div&gt;The Company's gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized.  Such variable consideration includes rebates, sales discounts and sales returns.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <bdx:ContractWithCustomerRebateLiability
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80My9mcmFnOjg0NWZkOGRmYmRkMjRiODA4ODU1MzRjMWY5ZDNhMTcxL3RleHRyZWdpb246ODQ1ZmQ4ZGZiZGQyNGI4MDg4NTUzNGMxZjlkM2ExNzFfMTQxMg_c2d05481-75b8-411c-8700-43ee1cc0ce05"
      unitRef="usd">585000000</bdx:ContractWithCustomerRebateLiability>
    <bdx:ContractWithCustomerRebateLiability
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80My9mcmFnOjg0NWZkOGRmYmRkMjRiODA4ODU1MzRjMWY5ZDNhMTcxL3RleHRyZWdpb246ODQ1ZmQ4ZGZiZGQyNGI4MDg4NTUzNGMxZjlkM2ExNzFfMTQxOQ_e9bb0ca5-afac-4f7d-8655-d9572d472437"
      unitRef="usd">576000000</bdx:ContractWithCustomerRebateLiability>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i8dde9c84ea4543b2b7c7c39ef33a1b38_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80My9mcmFnOjg0NWZkOGRmYmRkMjRiODA4ODU1MzRjMWY5ZDNhMTcxL3RleHRyZWdpb246ODQ1ZmQ4ZGZiZGQyNGI4MDg4NTUzNGMxZjlkM2ExNzFfMzA4Mg_c171b2e3-a462-48ab-8d3d-047ee6c08305"
      unitRef="usd">2200000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i77f35a0dc2c74215877faf40ae0e7e6f_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80My9mcmFnOjg0NWZkOGRmYmRkMjRiODA4ODU1MzRjMWY5ZDNhMTcxL3RleHRyZWdpb246ODQ1ZmQ4ZGZiZGQyNGI4MDg4NTUzNGMxZjlkM2ExNzFfMzE2OQ_c57012a8-6f2a-495c-8a5b-ba8f03a896e1">P3Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ia1d78d581b6244569d9e8062bb55187d_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80My9mcmFnOjg0NWZkOGRmYmRkMjRiODA4ODU1MzRjMWY5ZDNhMTcxL3RleHRyZWdpb246ODQ1ZmQ4ZGZiZGQyNGI4MDg4NTUzNGMxZjlkM2ExNzFfMzczMA_68d2f706-e1b6-4cbc-8c60-14415a0cbbb2"
      unitRef="usd">2400000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RleHRyZWdpb246ZGM3MzQwNzQ4YjE2NGQwZTgwNWI0ZmU5MjE2ZGIxODFfMTIzMw_4524a851-554e-48f8-bb07-f8365f235a8e">Segment Data&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's organizational structure is based upon three worldwide business segments: BD Medical (&#x201c;Medical&#x201d;), BD Life Sciences (&#x201c;Life Sciences&#x201d;) and BD Interventional (&#x201c;Interventional&#x201d;).  The Company's segments are strategic businesses that are managed separately because each one develops, manufactures and markets distinct products and services.  Segment disclosures are on a performance basis consistent with internal management reporting.  The Company evaluates performance of its business segments and allocates resources to them primarily based upon segment operating income, which represents revenues reduced by product costs and operating expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by segment, organizational unit and geographical areas for the three and six-month periods are detailed below.  The Company has no material intersegment revenues. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medication Delivery Solutions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medication Management Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integrated Diagnostic Solutions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgery&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Intervention&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Critical Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Company revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medication Delivery Solutions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medication Management Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integrated Diagnostic Solutions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgery&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Intervention&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Critical Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Company revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment income for the three and six-month periods was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Income Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Segment Operating Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration and restructuring expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net interest expense &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(238)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other unallocated items (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,529)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Income Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;The amounts for the three and six months ended March&#160;31, 2022 include a noncash asset impairment charge of $54&#160;million recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the Medical segment.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt"&gt;Primarily comprised of foreign exchange, certain general and administrative expenses and share-based compensation expense.  The amounts for the three and six months ended March&#160;31, 2021 also included pre-tax charges of $296&#160;million recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other operating expense, net &lt;/span&gt;related to certain product liability matters, including the related legal defense costs, which are further discussed in Note 4.</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RleHRyZWdpb246ZGM3MzQwNzQ4YjE2NGQwZTgwNWI0ZmU5MjE2ZGIxODFfODA_acb75a1b-0e54-47d3-ad07-6f1af0f3241f"
      unitRef="segment">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RleHRyZWdpb246ZGM3MzQwNzQ4YjE2NGQwZTgwNWI0ZmU5MjE2ZGIxODFfMTIzNQ_a9e4704e-3558-4d3d-9767-359a9be00934">Revenues by segment, organizational unit and geographical areas for the three and six-month periods are detailed below.  The Company has no material intersegment revenues. &lt;div style="margin-top:14pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medication Delivery Solutions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medication Management Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integrated Diagnostic Solutions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgery&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Intervention&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Critical Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Company revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medication Delivery Solutions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medication Management Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integrated Diagnostic Solutions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgery&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Intervention&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Critical Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Company revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="iaa780c179d9147f593395d6d7fa5230b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNC0xLTEtMS02MTI4MQ_60b4ea3c-8abe-48ae-9558-c71467155430"
      unitRef="usd">588000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic134ea116f1f45ebbe076cc6b3883b12_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNC0zLTEtMS02MTI4MQ_cf525a9b-58cf-490c-893e-23d4ff54a660"
      unitRef="usd">450000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i340e57a3d1d14dfc9f75038a3782eea0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNC01LTEtMS02MTI4MQ_59cc484f-fdeb-4acf-8ae6-57aa6db6edf8"
      unitRef="usd">1038000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if21e1acbe96f4463853f0759d0def48f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNC03LTEtMS02MTI4MQ_a805a03c-3e0e-4081-9af0-7eefebfd997f"
      unitRef="usd">531000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i40c8b727b83d4d65bfa6146011860c12_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNC05LTEtMS02MTI4MQ_cfea31fa-b7ec-425c-94cd-c86789d2baee"
      unitRef="usd">468000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icdf68331391d4a60891ceb9f056a868d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNC0xMS0xLTEtNjEyODE_b2793bff-09ba-4541-8239-09542c15b5ab"
      unitRef="usd">999000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4e361a94baa3404eb086646266f9b158_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNS0xLTEtMS02MTI4MQ_e3da9363-2d6b-4ddc-aeb8-c13f0639a879"
      unitRef="usd">461000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia0da5380262d43adabe75276ea0c956e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNS0zLTEtMS02MTI4MQ_c59af716-0b85-4911-a434-f6ba5820d5c0"
      unitRef="usd">143000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1a826d3478c74b2f862d397c207ca730_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNS01LTEtMS02MTI4MQ_8f25fa8e-8403-42e4-ac41-61504b5c71e4"
      unitRef="usd">604000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i14a0d9a15f7b4cfda8ba40724beaa8f3_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNS03LTEtMS02MTI4MQ_c551a131-ae9b-4b1d-b91b-77e063c424a6"
      unitRef="usd">440000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2d18979bf4274db5b94b3dd46371c7eb_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNS05LTEtMS02MTI4MQ_55c0c079-3925-4f77-aa55-7037d4bc12f9"
      unitRef="usd">126000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i511c4b1286af42da970bfdec12deee00_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNS0xMS0xLTEtNjEyODE_460f7997-d439-42df-a151-bb429ad01c98"
      unitRef="usd">566000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie2de60d3992b4498818e40d41cedf3b0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNi0xLTEtMS02MTI4MQ_fc699b84-5884-42ef-bbfd-e60647cb6f04"
      unitRef="usd">140000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2962a3b3ece8403a9b742d6cb9eae7d3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNi0zLTEtMS02MTI4MQ_bf35e4c0-5780-464c-84ed-e83270835063"
      unitRef="usd">133000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0688f0ec5b0547ea87efa9cb59b990bb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNi01LTEtMS02MTI4MQ_21036b7d-4de1-4ee7-98f8-c0c16c1431df"
      unitRef="usd">273000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i57ad6025694d4bc9842594f621d8e8b5_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNi03LTEtMS02MTI4MQ_fa692f88-6fb5-43ff-bbc4-075b5b4f278f"
      unitRef="usd">148000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia61a8d596fa14163ae52254c542a2d2a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNi05LTEtMS02MTI4MQ_b7724a6d-b0b7-49e1-9378-a3acf9c2f976"
      unitRef="usd">135000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e45310057c44542954ea2308480623d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNi0xMS0xLTEtNjEyODE_7d2dfa09-374e-4b14-8ed4-2a7210bfae0c"
      unitRef="usd">284000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i18a195ea4996436ea00c1fc948c4276f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNy0xLTEtMS02MTI4MQ_16c808fd-43dd-4857-98ce-e4b0a85b5701"
      unitRef="usd">125000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib9bfe78cbe96428981538b45e6d35614_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNy0zLTEtMS02MTI4MQ_79d6a1dc-3ef2-4e89-b241-65170a4710b9"
      unitRef="usd">376000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9e98ac2861aa4dbeae2a682badb428b8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNy01LTEtMS02MTI4MQ_dc25554c-1b90-4726-927f-e1fb12083877"
      unitRef="usd">501000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib70cc365667f4336beae810b00d3718e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNy03LTEtMS02MTI4MQ_7eb7d7a0-630c-4ce6-ba83-d903ab3ef5be"
      unitRef="usd">100000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icb66231fcb80447fb881ab131dc5c869_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNy05LTEtMS02MTI4MQ_28e68694-1334-4021-8b74-2f5cb91a4079"
      unitRef="usd">361000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i48a7a52cac944ef7baa6f046beb6ae79_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfNy0xMS0xLTEtNjEyODE_95fff32c-cf94-4d04-add7-11b4d669d8f1"
      unitRef="usd">462000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i73d03a6b37c240468966cf15263452df_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfOC0xLTEtMS02MTI4MQ_2063cbde-79fc-4dad-898e-2b7ea855fbca"
      unitRef="usd">1314000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaf0e9eb78ff74a85867e0df2d636c7c4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfOC0zLTEtMS02MTI4MQ_b68ccbf6-9054-4631-8923-8583f730e5f8"
      unitRef="usd">1102000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibd9d0f9e33a441088614cd71f9e278ef_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfOC01LTEtMS02MTI4MQ_36cc9f2f-7b7a-44e0-9090-4f4a4c6f28f1"
      unitRef="usd">2416000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e12b1fd86e446be863efb9d8984c607_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfOC03LTEtMS02MTI4MQ_962e59b3-368f-4c2b-b01f-957bf1fb9c6c"
      unitRef="usd">1220000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie3f69fb977594b96b982d5a4addde48f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfOC05LTEtMS02MTI4MQ_03bbbb09-7c61-4e10-b528-f1ef99000198"
      unitRef="usd">1091000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i692aef30e2ff4aa7bc63ceaa2db430fd_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfOC0xMS0xLTEtNjEyODE_bab28912-a7b7-4a97-a008-a4eb2b5321e0"
      unitRef="usd">2311000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6d43be5f09354422addda0ddfc3d7608_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTEtMS0xLTEtNjEyODE_eee8901e-8d32-42b7-96e2-e20e26571dc6"
      unitRef="usd">618000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i940c14b99d604a85b8b181419f29ede7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTEtMy0xLTEtNjEyODE_06085305-7f38-43eb-a618-e8b04bcc6ab2"
      unitRef="usd">532000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f7bdb867ae3463d9c34411ef80fa2c1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTEtNS0xLTEtNjEyODE_f8eef789-5c0c-4261-a733-4e56ece4d3e4"
      unitRef="usd">1150000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie34d48eb7b4446bfb0293bb837aeb3b0_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTEtNy0xLTEtNjEyODE_bdd9003d-04e8-42f6-afd1-bcb3bbf9400f"
      unitRef="usd">454000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4b8004628d1e40ddafce5ca3460f538d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTEtOS0xLTEtNjEyODE_1d898e36-b266-4163-aa15-cf26639f697f"
      unitRef="usd">807000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8934938ea33340a68081e896f906c075_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTEtMTEtMS0xLTYxMjgx_33d9e199-96e3-48ab-93d6-2c3d811c55fb"
      unitRef="usd">1261000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i227211b2a9c741c790ebb3da7e40fdd8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTItMS0xLTEtNjEyODE_9fb97b8b-02a4-46e4-a7d2-943a9c154580"
      unitRef="usd">129000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8771dc3c63ee411d88344fdd1cdf5d53_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTItMy0xLTEtNjEyODE_a56b61a5-bff9-4f7e-90c3-f28e9e78ca18"
      unitRef="usd">206000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaf374326006b442487c8d86757ee49e4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTItNS0xLTEtNjEyODE_04c14d89-1256-45e4-a8df-09500fc86cdd"
      unitRef="usd">335000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibdae0dea69a64aa6842f66ae27d93e5a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTItNy0xLTEtNjEyODE_87db5281-b8e9-4f8b-b813-18cf95571144"
      unitRef="usd">121000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i63bb60fd8ef84f56b6fbc6e0af2cf599_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTItOS0xLTEtNjEyODE_bc092f17-1c2b-426c-94f6-ed977de697a1"
      unitRef="usd">204000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2cef8fc053634cdfa0e350495e1fc255_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTItMTEtMS0xLTYxMjgx_24bf03f3-ad90-4c1c-8140-eb5b09d468d1"
      unitRef="usd">325000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id9318f7e4aad4511b48ac65d5232b805_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTMtMS0xLTEtNjEyODE_77217d72-24f3-4795-aed2-98e5da370d43"
      unitRef="usd">747000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaaaa5c962e4048c591c863e8916d33f5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTMtMy0xLTEtNjEyODE_6027aa12-efc4-4cb6-a32b-2a30267d6ac4"
      unitRef="usd">738000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i228cd1a05f9444a282107d55ea9e185c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTMtNS0xLTEtNjEyODE_a0f60c58-ed9d-4c05-a73a-612869b3a0c4"
      unitRef="usd">1485000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2fdb31b0ba7847828199578de1e0dc44_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTMtNy0xLTEtNjEyODE_06ed7302-ba0a-4627-9a1a-63ce821e2ce9"
      unitRef="usd">576000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia05764f1126a47f598e5a5be57d911f3_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTMtOS0xLTEtNjEyODE_a9c006a5-aa9e-4771-97a7-003efa640f0c"
      unitRef="usd">1010000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie8f952d3c2504bee86897ac95714403d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTMtMTEtMS0xLTYxMjgx_157b2625-b44e-4f18-924e-8d9b0ff18279"
      unitRef="usd">1586000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia09b9950f6054a568db0ceb8606d7a4e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTYtMS0xLTEtNjEyODE_39613956-a2ea-4361-80f6-4ceac5fa2e02"
      unitRef="usd">268000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icfa7fb2c614545b7b9f7b5805cfe5911_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTYtMy0xLTEtNjEyODE_9041daf0-00c9-431e-948a-835ca878b913"
      unitRef="usd">72000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia8cf56e8b5924da2a53cda0c0754e42c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTYtNS0xLTEtNjEyODE_965cc6db-db13-460d-90ba-cec75169fc75"
      unitRef="usd">340000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5b6c283c3e1b4712b95db13abf677cc8_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTYtNy0xLTEtNjEyODE_ff5632e4-1599-4a6f-be74-2bfa2000d9f6"
      unitRef="usd">227000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2d34d9c802ca4ce89fb381c9211b0f26_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTYtOS0xLTEtNjEyODE_5fabaf4f-d46d-4ff9-963e-5026d69ac685"
      unitRef="usd">65000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iec0f21890bcd495ba23516dc79fc968d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTYtMTEtMS0xLTYxMjgx_9223719d-f447-46b4-bcac-492788fe9ac9"
      unitRef="usd">292000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7d03895e938f463db61347f7756e8411_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTctMS0xLTEtNjEyODE_2e5a57e3-86e1-4f32-a0ad-6223ac8f7c4b"
      unitRef="usd">240000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia2f63b307eb24de4a2da726044ee4dcf_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTctMy0xLTEtNjEyODE_43189040-8ef6-49c7-94c5-1f3d81ed8dc4"
      unitRef="usd">210000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i49cc19ad914c4f87aefe3e1e90b2e0aa_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTctNS0xLTEtNjEyODE_049f0dc1-8811-4160-bca2-63eb668c8e73"
      unitRef="usd">450000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i86808c33fe15413ca3ab8f07fc04dc6a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTctNy0xLTEtNjEyODE_955696e8-80cc-452e-bc20-bb1269b60c7b"
      unitRef="usd">222000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia256fef2c90740d7abec4bdfd7e9ea6f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTctOS0xLTEtNjEyODE_41b418a4-12e2-4411-8733-658082de7967"
      unitRef="usd">198000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i76036e4d4be84f3780130dbd8809095d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTctMTEtMS0xLTYxMjgx_35e871f3-1696-4348-bed5-e5aacf53d8c1"
      unitRef="usd">420000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib25903c74b6b4ce196304dfabbeed3fe_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTgtMS0xLTEtNjEyODE_95b3832d-14f8-4d34-9ef0-d4e7e1bfec59"
      unitRef="usd">239000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9129b920a74c4190bf2674bf5c66ddcd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTgtMy0xLTEtNjEyODE_1bca4e83-9834-4481-b15c-d8537f1e9d59"
      unitRef="usd">82000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i05e3efc2d5234dc5b5696fc25c2fe1f9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTgtNS0xLTEtNjEyODE_e23b4da9-ec2f-40c3-9d11-1fc2a16b0712"
      unitRef="usd">320000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i560004a02b284824a2315cd4721a5d83_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTgtNy0xLTEtNjEyODE_13f12c11-1aca-4852-b646-3cf9d388600b"
      unitRef="usd">217000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib2bc50912e054b8ca37e29049b909c87_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTgtOS0xLTEtNjEyODE_b6ad8d5b-a0a0-404f-bb4e-6ca2516fe88a"
      unitRef="usd">82000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1e73be5facd24817b1a1fea9021a8238_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTgtMTEtMS0xLTYxMjgx_9c626392-183c-4c14-b8fe-60ae6bb1376f"
      unitRef="usd">298000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i918494be3dba48dd95f60dbc329ce595_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTktMS0xLTEtNjEyODE_cc46fca8-c612-43c1-bb45-b6dda86db46f"
      unitRef="usd">746000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7e6353525444488e906055b04513b780_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTktMy0xLTEtNjEyODE_91838c89-a6b8-41ff-af78-6f8772cec858"
      unitRef="usd">364000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i07d77974120f4be69403ea9d0e2b2e32_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTktNS0xLTEtNjEyODE_74bd75bd-9965-4951-8a05-6914ff4170f8"
      unitRef="usd">1111000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie4c3e29343e9492485a767d68a8ece48_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTktNy0xLTEtNjEyODE_722de244-eed6-4f9a-aaa7-75a12409c6bc"
      unitRef="usd">666000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2ecc4a1c1e25473c8e517f0c14b82e15_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTktOS0xLTEtNjEyODE_b3848864-1b9f-4eb8-ad23-46e64b5f13f0"
      unitRef="usd">345000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia9b2088e5e1d40f1925f5a9ce6d60363_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMTktMTEtMS0xLTYxMjgx_34d422eb-0fb1-4c04-ae6c-8a85b4621ce7"
      unitRef="usd">1011000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2b27826b341541bc92d8a45b8d75c050_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMjEtMS0xLTEtNjEyODE_7103e631-23fd-44ed-8b91-f6dfca3b5372"
      unitRef="usd">2807000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i963a32bbdc9f4165b5fd4ec11f3bf96f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMjEtMy0xLTEtNjEyODE_bb009365-83df-4e7b-8755-1f1c98d24201"
      unitRef="usd">2204000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMjEtNS0xLTEtNjEyODE_a89d74fd-3c93-4005-8d08-3d8fe2b4f4ea"
      unitRef="usd">5011000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibc7dd7466d954173933100f7a158c392_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMjEtNy0xLTEtNjEyODE_ab221477-0074-4076-b185-519cd0383c7d"
      unitRef="usd">2462000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i272105b422984b0abce278efc90ccf80_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMjEtOS0xLTEtNjEyODE_8d4c88c8-1573-423b-87d4-42bf07f650d7"
      unitRef="usd">2446000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjRkNDMxNDczM2JhYzQwMjc5ZWQ5ODdjN2EyNDk3MmQ1L3RhYmxlcmFuZ2U6NGQ0MzE0NzMzYmFjNDAyNzllZDk4N2M3YTI0OTcyZDVfMjEtMTEtMS0xLTYxMjgx_38578bf0-f935-42ba-9d25-54c0416d1961"
      unitRef="usd">4907000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1d49a5857b8c46e8be9a20f21635d62e_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNS0xLTEtMS02MTI4MQ_c8a276fd-c23e-42ce-97ce-ffda832bd70e"
      unitRef="usd">1207000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i28c8afa29af14a569e645ef1aacc226c_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNS0zLTEtMS02MTI4MQ_aff13dbc-6e62-447f-9904-a3bc176508c8"
      unitRef="usd">915000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if28ca15d9d5d48078024960d0e23e05e_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNS01LTEtMS02MTI4MQ_b254833c-bf64-4efa-badc-dc36945346cb"
      unitRef="usd">2122000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i01375e7a7d6d4d5ea8993c57a7fa9646_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNS03LTEtMS02MTI4MQ_a7cb61ee-48f3-404c-bfa5-b23527edf122"
      unitRef="usd">1099000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i016a8ef65bb04b5d92fe312250253498_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNS05LTEtMS02MTI4MQ_f4606ce2-a767-4557-b9bb-5068e962e1a3"
      unitRef="usd">908000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id51f443d02834ad4869eb954f45c6f30_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNS0xMS0xLTEtNjEyODE_90fe0646-4d4d-458c-813c-80f016f5dd5e"
      unitRef="usd">2006000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1b392253b2d848fba4cbe7cbca8862ce_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNi0xLTEtMS02MTI4MQ_dabcb5ca-58af-4864-84cf-2eacd845d658"
      unitRef="usd">945000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic10db11a119f49bd8880ae734593b26a_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNi0zLTEtMS02MTI4MQ_3e0de2ec-1b31-4ddf-81fa-7ee5222b87f4"
      unitRef="usd">286000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i54288602bb02449f862cb8e8556ce749_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNi01LTEtMS02MTI4MQ_73c645c0-aec7-48d3-a838-92619821fbc9"
      unitRef="usd">1231000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9e9a88dddb1141dc93f661547e4e852a_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNi03LTEtMS02MTI4MQ_627a31c3-758a-4b64-8739-6bc48996f4e5"
      unitRef="usd">917000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3a080ccb675240cc9c4a8ba434c764a5_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNi05LTEtMS02MTI4MQ_fefc3010-29be-4749-9126-a4192f41bf0b"
      unitRef="usd">278000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icc933a06c8ba4f988cefb9809c807501_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNi0xMS0xLTEtNjEyODE_d99ba75d-dc47-41f0-90f8-a53eb63bb105"
      unitRef="usd">1196000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id727ab7528c748339d239f9af4abbbd5_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNy0xLTEtMS02MTI4MQ_5ae93e58-a8cd-4c2e-b6b5-bdb4f60e6044"
      unitRef="usd">291000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaa9d6dfaff1145718f4ec2ddd0e9060f_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNy0zLTEtMS02MTI4MQ_864955d5-6ae3-4203-993a-c3794a0c391c"
      unitRef="usd">271000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4e9adc19251c445fbb25842e71b25fb9_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNy01LTEtMS02MTI4MQ_54086899-c79e-4642-b397-1a24c2e2719f"
      unitRef="usd">561000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie088a67ab37944269b87738d47fd8cf2_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNy03LTEtMS02MTI4MQ_8122fc04-5887-401a-a8ac-5f6a5ffdbc05"
      unitRef="usd">298000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5a1cfd5cb6684b57a644e4700794e7d6_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNy05LTEtMS02MTI4MQ_2e65288c-93be-4496-874b-0c41808daa7c"
      unitRef="usd">271000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6c4fee3d5348442f81d98e5c491d7567_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfNy0xMS0xLTEtNjEyODE_2d29b982-6469-4a2d-bb5d-9975326fd0a9"
      unitRef="usd">569000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i796262ed3fae4763be2037f02515b572_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOC0xLTEtMS02MTI4MQ_3a1dea24-013b-4258-9f6e-867d48759914"
      unitRef="usd">228000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7915ffe1e48e473e87a7bc4a597611ff_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOC0zLTEtMS02MTI4MQ_cc509092-a8fa-4309-a9ed-43f698759cde"
      unitRef="usd">670000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i21781684a6e54835a086fb4dfd07518b_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOC01LTEtMS02MTI4MQ_956b8418-0fa3-4c9c-aa2f-d23f623215f0"
      unitRef="usd">898000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i99f983046ba64a3597abb01c16866c07_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOC03LTEtMS02MTI4MQ_df6750ac-e30f-4a69-b953-f3ec57bddf8e"
      unitRef="usd">180000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i43464f5ca80d4e9faacc0d26f58b60be_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOC05LTEtMS02MTI4MQ_b996b1d5-9480-4d0e-907b-cb8019f05bb4"
      unitRef="usd">621000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia1e45e6c38b342e0afa75849e1554f02_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOC0xMS0xLTEtNjEyODE_f321b2c3-c631-4d97-ac03-a88c45423ef0"
      unitRef="usd">801000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i744dcd2988294c748fdd6de59fed0010_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOS0xLTEtMS02MTI4MQ_d2da7a3d-9e22-4fc2-99fe-c1ad1c11c814"
      unitRef="usd">2671000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i28fd1a5379ed4068bcbe236046b009ac_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOS0zLTEtMS02MTI4MQ_97fee755-b1da-4f00-9a50-d49313739cc4"
      unitRef="usd">2142000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i93c8dc026e904d27a8674f1b2ae7b64f_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOS01LTEtMS02MTI4MQ_4103d571-3a2c-4727-b32c-12060c4c914b"
      unitRef="usd">4813000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i26cd80537ace4f54bd459856e6733c22_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOS03LTEtMS02MTI4MQ_6ce84029-7bd1-4d26-835f-c01c473e5a90"
      unitRef="usd">2494000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iabc734319b0040bb91b53f1b5bda469e_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOS05LTEtMS02MTI4MQ_05b0a081-934d-4a81-9dd1-7c095a053d68"
      unitRef="usd">2078000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i177c01abfa574925aead9aa3b4f63e18_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfOS0xMS0xLTEtNjEyODE_f2e74c0a-8e8e-4945-ba48-7fce006e02bd"
      unitRef="usd">4572000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i63fca4aedfee493386b300cd94f770a4_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTItMS0xLTEtNjEyODE_144cb070-ff97-400a-a0bd-9405f5595465"
      unitRef="usd">1232000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibaaee6092a88498e8faa501905f4bdd7_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTItMy0xLTEtNjEyODE_e2b47a45-8ee4-4650-a814-3383225983f4"
      unitRef="usd">1062000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id2a56afd740743baa1b574805fc29871_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTItNS0xLTEtNjEyODE_2ee15ec8-e411-41e6-ad7e-5b721c3655a2"
      unitRef="usd">2295000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibade6b68690841a8be0464af51c331d0_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTItNy0xLTEtNjEyODE_c18d742e-acba-4534-90b9-8942c32e4450"
      unitRef="usd">1469000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic17e46520cc6412c8bc1e89dea2e9c8c_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTItOS0xLTEtNjEyODE_3a074c55-5e85-4cd1-85f6-c857a31a7205"
      unitRef="usd">1459000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7f73d2d072b8450a80571d1bce774ce0_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTItMTEtMS0xLTYxMjgx_5dec5f16-5825-4725-aa1f-68681f7d10d3"
      unitRef="usd">2928000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i676297c812f4459e9be4e29ff85f5ad8_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTMtMS0xLTEtNjEyODE_afc0cc18-8077-47ba-8fb7-c318c7bf1ae1"
      unitRef="usd">258000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i39bc71985bfc4e1d839721692c03a9fe_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTMtMy0xLTEtNjEyODE_2e327a7b-11f1-4d87-9818-56adfa1b3eae"
      unitRef="usd">416000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9fa5bfe82d7249b0937b40509556d515_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTMtNS0xLTEtNjEyODE_97c03b39-e8a9-4d66-9781-dbd7f9f13ceb"
      unitRef="usd">674000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i618873a9001446c181b8ef34ab0bcc4a_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTMtNy0xLTEtNjEyODE_1281e8d4-176b-4b38-99cb-ee93c3d5826f"
      unitRef="usd">241000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2bd3786e38494554a16139e13fdeb54f_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTMtOS0xLTEtNjEyODE_9a789c3f-4af3-4fdb-9bef-f513972364c2"
      unitRef="usd">396000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie6348050d88d4f97a3775186bc1a6569_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTMtMTEtMS0xLTYxMjgx_9c44f703-9c07-41a2-bb7e-3ac8fe17100a"
      unitRef="usd">637000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i061dc82dc32444aea21f1c81faebbe0a_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTQtMS0xLTEtNjEyODE_0bb83341-4776-4abc-8a11-9e3b7c9b3b3b"
      unitRef="usd">1490000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i69b2c199b94f4ca691703156805bd41c_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTQtMy0xLTEtNjEyODE_ecda49d9-35da-402f-a7e1-5a11b7fbcf7e"
      unitRef="usd">1478000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i68bb6db7dc06423d8874cf17e8b85add_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTQtNS0xLTEtNjEyODE_0b1e1436-3ea5-49fd-80e1-f4966ce237b2"
      unitRef="usd">2968000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i71898030bd194581a5f573edac52a467_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTQtNy0xLTEtNjEyODE_a44cabe4-7a59-4dd4-9e5a-8eb47fb2c762"
      unitRef="usd">1710000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2312cfcd8087400e988b97e474a47c77_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTQtOS0xLTEtNjEyODE_460c0ef7-5c61-4936-9026-17e8d0bf5c42"
      unitRef="usd">1855000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i49af90b2d616488a86c54d3c262d0d5c_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTQtMTEtMS0xLTYxMjgx_91106e8a-3ff8-4b0f-b6df-884e18190efc"
      unitRef="usd">3565000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i048c0649ac044507a024682c29947104_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTctMS0xLTEtNjEyODE_7d102e89-b932-4b56-a223-c6476e550bfa"
      unitRef="usd">549000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0a7ced2e82944f6681b9ed34294d5014_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTctMy0xLTEtNjEyODE_056ae7e2-e5df-4ef7-a338-fbd24e5589ff"
      unitRef="usd">152000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idcc85f190816497f95bf2249ad0e8450_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTctNS0xLTEtNjEyODE_99a532e3-5dfb-42cb-b33f-3434c68f60af"
      unitRef="usd">701000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i81e5b85ab7764c6fb0daf9c82f0b4781_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTctNy0xLTEtNjEyODE_f620f4f4-192d-47a1-b9f9-b92072e61a10"
      unitRef="usd">489000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i238fa27398184872a8e61d69996c8840_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTctOS0xLTEtNjEyODE_7c21c8ea-680e-4cf2-99db-02eef4d0289c"
      unitRef="usd">135000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia1a0f1ebdf1b403798c14fedfa564a35_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTctMTEtMS0xLTYxMjgx_d69e1a3c-0841-4e1c-a6f5-1c50b424972d"
      unitRef="usd">624000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1c39abcfe82b42aa90ff2907f3304dcc_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTgtMS0xLTEtNjEyODE_54266fef-1dd2-4349-9759-907873d88295"
      unitRef="usd">457000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i05b4f4dee6a8495d833675a95be35a26_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTgtMy0xLTEtNjEyODE_3a64160e-4764-4135-9fb5-90e66705e9d4"
      unitRef="usd">407000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i35931f5fa1204157bac1212583f72af6_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTgtNS0xLTEtNjEyODE_b53632d8-68df-4ee5-9c5b-afd9181c7a53"
      unitRef="usd">863000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if2e4a485f90041afbb049fac8eb52965_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTgtNy0xLTEtNjEyODE_c1885108-0333-4dcd-9c66-d28a909fd3a1"
      unitRef="usd">454000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ief518885d18a472cb30a5c4921e2b0b5_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTgtOS0xLTEtNjEyODE_75eb861a-0073-4868-b05e-21d37abb2d82"
      unitRef="usd">392000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5fc225adea9a4eb3bcf21fd3444ec41d_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTgtMTEtMS0xLTYxMjgx_86528277-9c31-4f28-92e4-cc81623463a2"
      unitRef="usd">846000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2e49adc428d94084bfc47a4543444f50_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTktMS0xLTEtNjEyODE_e8972fad-d076-40e0-b8da-5bcc02f7b714"
      unitRef="usd">492000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8b2f6430ba9a49438e7cc7a603637f4c_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTktMy0xLTEtNjEyODE_ef6eb211-a49f-4376-a63b-085d4f23ea38"
      unitRef="usd">168000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9d46849ffcb74aa2aa512d3c1f68b33b_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTktNS0xLTEtNjEyODE_d62bdcea-2239-45a8-852d-d86e1ba44ee8"
      unitRef="usd">661000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie157a03ce0f049c998b7c29069311c61_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTktNy0xLTEtNjEyODE_49495dcc-7d43-479f-a644-86ac29a99e40"
      unitRef="usd">445000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5c1dd439278f4be0a9a792057b61e38a_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTktOS0xLTEtNjEyODE_7b5192ed-5f57-49c0-afee-c43990dfbf09"
      unitRef="usd">171000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4143ec09dd4b481a8e155333bd4dc4fa_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMTktMTEtMS0xLTYxMjgx_c9852ba4-17f3-4831-bc0f-ad1a598169a7"
      unitRef="usd">616000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaa3b379319c34f67af75703550c4c252_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjAtMS0xLTEtNjEyODE_419164ae-1849-408a-a22a-bb2f50892600"
      unitRef="usd">1498000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic3b61621dfcc434bbe4ce2f31653255a_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjAtMy0xLTEtNjEyODE_8cacb738-a67f-4ca4-9294-eaa056fc939d"
      unitRef="usd">727000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic959ae392a3e4d8b9d97860c881fa2e6_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjAtNS0xLTEtNjEyODE_b5e0b968-b098-418f-8111-7c6d9705f89c"
      unitRef="usd">2225000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iff32a50b2bf54f4cbef3c832096888da_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjAtNy0xLTEtNjEyODE_78b70487-1964-47fc-b965-5c0a4314547d"
      unitRef="usd">1388000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i58032061b0ff454095c538f1f3c4d0ec_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjAtOS0xLTEtNjEyODE_c72d1530-9000-4fb7-8ff5-5209e55b80d6"
      unitRef="usd">698000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ief3a64ff7d9d4ad5984439fa90316773_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjAtMTEtMS0xLTYxMjgx_f3790dea-deff-4d6b-9fcb-1cd3a896403d"
      unitRef="usd">2086000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i67d9bfcd7b3a4d56b5197daa366d5b0f_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjItMS0xLTEtNjEyODE_4732dacd-27b4-4fd9-b40e-c9ab39d2d63a"
      unitRef="usd">5659000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib1ab3086e3eb4dc39a17c1ff6b4efb91_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjItMy0xLTEtNjEyODE_1fc5e169-d106-49ae-bbff-fb5e7030297d"
      unitRef="usd">4347000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjItNS0xLTEtNjEyODE_af4470ae-dcee-452a-91bf-50d398637e0e"
      unitRef="usd">10006000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4994dbb56dd942c3b109fdbcdbc65a09_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjItNy0xLTEtNjEyODE_fc3a23d6-ad32-4d5d-af4c-ace5202e2e10"
      unitRef="usd">5592000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8c3f5953274d42d8883cc70bb1ab9bf9_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjItOS0xLTEtNjEyODE_53d56784-4e2f-42db-855f-43bf3e9636ad"
      unitRef="usd">4631000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOjVkOTlhMGVmN2E4MDQ4ZjY5YWMwZGI0ZjAyYjAzMjZjL3RhYmxlcmFuZ2U6NWQ5OWEwZWY3YTgwNDhmNjlhYzBkYjRmMDJiMDMyNmNfMjItMTEtMS0xLTYxMjgx_a7239d06-23d4-4322-b41e-07b3c6943edc"
      unitRef="usd">10223000000</us-gaap:Revenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RleHRyZWdpb246ZGM3MzQwNzQ4YjE2NGQwZTgwNWI0ZmU5MjE2ZGIxODFfMTIyOA_8aabacfa-c1b9-4635-aaa7-b74256c2e112">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment income for the three and six-month periods was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Income Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Segment Operating Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration and restructuring expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net interest expense &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(238)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other unallocated items (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,529)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Income Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;The amounts for the three and six months ended March&#160;31, 2022 include a noncash asset impairment charge of $54&#160;million recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the Medical segment.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt"&gt;Primarily comprised of foreign exchange, certain general and administrative expenses and share-based compensation expense.  The amounts for the three and six months ended March&#160;31, 2021 also included pre-tax charges of $296&#160;million recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other operating expense, net &lt;/span&gt;related to certain product liability matters, including the related legal defense costs, which are further discussed in Note 4.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ibd9d0f9e33a441088614cd71f9e278ef_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMy0xLTEtMS02MTI4MQ_aa969896-5a57-4bca-9435-2ae23a36cf6b"
      unitRef="usd">615000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i692aef30e2ff4aa7bc63ceaa2db430fd_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMy0zLTEtMS02MTI4MQ_39201ace-8ae0-42ab-92b6-8dc3f4564281"
      unitRef="usd">634000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i93c8dc026e904d27a8674f1b2ae7b64f_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMy01LTEtMS02MTI4MQ_25eaef26-5805-4dc6-9556-ebd33d744d12"
      unitRef="usd">1331000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i177c01abfa574925aead9aa3b4f63e18_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMy03LTEtMS02MTI4MQ_77f0eb66-b17c-4b19-8f7a-6b2a88adb32c"
      unitRef="usd">1300000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i228cd1a05f9444a282107d55ea9e185c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNC0xLTEtMS02MTI4MQ_6be1d0ad-d496-465a-bc19-79180539a912"
      unitRef="usd">475000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ie8f952d3c2504bee86897ac95714403d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNC0zLTEtMS02MTI4MQ_5343568c-1f6c-4b7e-96c6-74c768492cf0"
      unitRef="usd">548000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i68bb6db7dc06423d8874cf17e8b85add_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNC01LTEtMS02MTI4MQ_70a296ec-396c-4f4b-a858-d2c242330bde"
      unitRef="usd">1009000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i49af90b2d616488a86c54d3c262d0d5c_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNC03LTEtMS02MTI4MQ_a47bfc86-970c-44cc-821f-36b3825f86f3"
      unitRef="usd">1521000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i07d77974120f4be69403ea9d0e2b2e32_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNS0xLTEtMS02MTI4MQ_9409f709-2e1c-4e59-b603-93385a658941"
      unitRef="usd">280000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia9b2088e5e1d40f1925f5a9ce6d60363_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNS0zLTEtMS02MTI4MQ_c8e5e440-71c9-49cf-ab05-9734ea51c7fa"
      unitRef="usd">209000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ic959ae392a3e4d8b9d97860c881fa2e6_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNS01LTEtMS02MTI4MQ_015934f7-4575-48c7-990c-e55fdf6bd72b"
      unitRef="usd">544000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ief3a64ff7d9d4ad5984439fa90316773_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNS03LTEtMS02MTI4MQ_d92134a1-6e07-4e8e-a79a-d83b5318c092"
      unitRef="usd">511000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if77c23c0dcc049008fcc1ec1e19316f0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNi0xLTEtMS02MTI4MQ_4ee3ab36-0e47-4ef7-81ff-cc8ee47fe342"
      unitRef="usd">1370000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if3e301035b4a4bdfb65e05d08198eeff_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNi0zLTEtMS02MTI4MQ_bca9ef97-f18c-4b40-bd7d-ec52c68a4abe"
      unitRef="usd">1392000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="icbf9dc05d6fa4d8fba50f123e716eafe_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNi01LTEtMS02MTI4MQ_3f5fbc5e-80cf-4119-8ba5-8452e4ff912a"
      unitRef="usd">2884000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i4567c9a64f984e07827c5c6c6ccf5cc3_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNi03LTEtMS02MTI4MQ_83ad4033-b5d6-4d5c-beb8-0b0e00fa81bc"
      unitRef="usd">3331000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="i52b453b110a6487198bf393e02c8324c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNy0xLTEtMS02MTI4MQ_0edc0fdf-4b78-48f7-8b03-3206a2fcce41"
      unitRef="usd">28000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="i46d46821d3124f169527dd86c47ecdcf_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNy0zLTEtMS02MTI4MQ_676a361f-a8d8-436d-8dfb-57cb13c7a398"
      unitRef="usd">52000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="i4d66dba8cd4a42fb969a3a9bfe7dc2a5_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNy01LTEtMS02MTI4MQ_8cf0bbbb-fe9e-4e7c-a45f-34e424d05398"
      unitRef="usd">62000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="ib171c4d8e98248f48d26babd2d37afa5_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfNy03LTEtMS02MTI4MQ_82de74b9-d832-460e-a8e2-1314e926a520"
      unitRef="usd">102000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i52b453b110a6487198bf393e02c8324c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfOS0xLTEtMS02MTI4MQ_ff954f51-0b52-4356-b84d-f4b66dd615c0"
      unitRef="usd">-100000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i46d46821d3124f169527dd86c47ecdcf_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfOS0zLTEtMS02MTI4MQ_9beb1f02-60b2-4ea1-a57e-70f2f3eba3e8"
      unitRef="usd">-122000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i4d66dba8cd4a42fb969a3a9bfe7dc2a5_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfOS01LTEtMS02MTI4MQ_304dad7f-c7c2-4347-8309-7cbbf85d91c4"
      unitRef="usd">-195000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ib171c4d8e98248f48d26babd2d37afa5_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfOS03LTEtMS02MTI4MQ_7bdcfc3b-963b-4051-a376-f48df53a7580"
      unitRef="usd">-238000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i909ad880c3244bdfb8b75a0b85cf397e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMTAtMS0xLTEtNjEyODE_efacb799-616c-4e1c-8062-d4f0b1d777c5"
      unitRef="usd">-717000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="icd843e5598ca484abfc9deff353549de_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMTAtMy0xLTEtNjEyODE_1edd39f5-3767-4f69-b2e5-f432d516d32a"
      unitRef="usd">-913000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="icecf16d531934c9e94ad3aa80cd5fe9b_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMTAtNS0xLTEtNjEyODE_b2afb4bc-cfc5-4ee7-81ea-76395c689791"
      unitRef="usd">-1378000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i459c088c116949f6a7759e05b502302e_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMTAtNy0xLTEtNjEyODE_994f0794-aa1d-4c20-bf89-99126e1444ff"
      unitRef="usd">-1529000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMTEtMS0xLTEtNjEyODE_263830a1-65e2-486a-aac7-539a3f508d1b"
      unitRef="usd">525000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMTEtMy0xLTEtNjEyODE_2a52730c-904e-4bc9-9356-0f306d8e4903"
      unitRef="usd">305000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMTEtNS0xLTEtNjEyODE_54cedcd7-dc42-4be9-be20-71fb3de17e5d"
      unitRef="usd">1248000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RhYmxlOmJmM2IxYTlhZmMxZTQyODZiZTA4YWZiNGVlM2MxZmUzL3RhYmxlcmFuZ2U6YmYzYjFhOWFmYzFlNDI4NmJlMDhhZmI0ZWUzYzFmZTNfMTEtNy0xLTEtNjEyODE_af5bb7b9-ba18-4b93-9222-0b2adc0f5968"
      unitRef="usd">1462000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:AssetImpairmentCharges
      contextRef="ifb8b77375efd4b3b80608dbb0eff1722_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RleHRyZWdpb246ZGM3MzQwNzQ4YjE2NGQwZTgwNWI0ZmU5MjE2ZGIxODFfMzg0ODI5MDcwMzk1Nw_3d14a148-d309-4daf-83bc-f9f0c3334473"
      unitRef="usd">54000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="idd645833eba34cf7bc7e14df93e204c3_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RleHRyZWdpb246ZGM3MzQwNzQ4YjE2NGQwZTgwNWI0ZmU5MjE2ZGIxODFfMzg0ODI5MDcwMzk1Nw_59d8f043-7019-4de6-95ce-d5a3dcafdfeb"
      unitRef="usd">54000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="ibc4467fbe0ee44db93c2873c8d0afa22_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RleHRyZWdpb246ZGM3MzQwNzQ4YjE2NGQwZTgwNWI0ZmU5MjE2ZGIxODFfNjU5NzA2OTc2OTUxOA_ec107304-573a-4376-9368-17c4b8245039"
      unitRef="usd">296000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="i9157cafcaafb4b5db2bc2a4e28325ccd_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80Ni9mcmFnOmRjNzM0MDc0OGIxNjRkMGU4MDViNGZlOTIxNmRiMTgxL3RleHRyZWdpb246ZGM3MzQwNzQ4YjE2NGQwZTgwNWI0ZmU5MjE2ZGIxODFfNjU5NzA2OTc2OTUxOA_ef99dd7c-bb3a-4398-9f24-99a32d0ebf0c"
      unitRef="usd">296000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RleHRyZWdpb246ZTE5YjVhNGQ2OWE1NDliNjg2YmJjNzFmYzdmODZkMjhfNzMx_caedf7d8-95df-4e5b-a822-d34948352cbb">Benefit Plans&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has defined benefit pension plans covering certain employees in the United States and certain international locations.  The measurement date used for these plans is September&#160;30.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net pension cost included the following components for the three and six-month periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts provided above for amortization of prior service credit and amortization of loss represent the reclassifications of prior service credits and net actuarial losses that were recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in prior periods.  All components of the Company&#x2019;s net periodic pension cost, aside from service cost, are recorded to&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other (expense) income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;on its condensed consolidated statements of income.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RleHRyZWdpb246ZTE5YjVhNGQ2OWE1NDliNjg2YmJjNzFmYzdmODZkMjhfNzM1_81893eff-5b72-4a14-a0a5-b3c385d76df9">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net pension cost included the following components for the three and six-month periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ief564af42a4c42e893aff8bd1fbca00a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfMi0xLTEtMS02MTI4MQ_33e31bc9-2d61-42c3-808f-4912771f7061"
      unitRef="usd">34000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i779636b30adc455b80382ee10bb0ad6b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfMi0zLTEtMS02MTI4MQ_3eeb6b29-d690-46cb-8bff-4e57ec66e8ce"
      unitRef="usd">36000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i00226f2a049945c4926cc6902c33c132_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfMi01LTEtMS02MTI4MQ_65db7822-404d-4f9b-ae25-fbb6969746be"
      unitRef="usd">69000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie28fdaf2e6bb47bf9633a15831cda54b_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfMi03LTEtMS02MTI4MQ_98194ce0-658d-47fe-8a81-b1f1ff9c7d98"
      unitRef="usd">79000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ief564af42a4c42e893aff8bd1fbca00a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfMy0xLTEtMS02MTI4MQ_e122bf17-a893-4ba1-995f-4edc8bf6045a"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i779636b30adc455b80382ee10bb0ad6b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfMy0zLTEtMS02MTI4MQ_eb7e4158-74d1-4d7c-bfda-9480188a6f92"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i00226f2a049945c4926cc6902c33c132_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfMy01LTEtMS02MTI4MQ_fb465f56-6ebb-4fa0-825e-88f3fead56fa"
      unitRef="usd">38000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie28fdaf2e6bb47bf9633a15831cda54b_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfMy03LTEtMS02MTI4MQ_5414aae5-a2ae-481d-a708-b225794f6aef"
      unitRef="usd">37000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ief564af42a4c42e893aff8bd1fbca00a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNC0xLTEtMS02MTI4MQ_148b6839-c042-4201-bc54-65696ee98784"
      unitRef="usd">46000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i779636b30adc455b80382ee10bb0ad6b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNC0zLTEtMS02MTI4MQ_7bd08180-dd84-4d83-9a7f-c60fdba878ac"
      unitRef="usd">41000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i00226f2a049945c4926cc6902c33c132_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNC01LTEtMS02MTI4MQ_b94605b3-794e-4e46-80c0-a8ca64f1d2ae"
      unitRef="usd">94000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ie28fdaf2e6bb47bf9633a15831cda54b_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNC03LTEtMS02MTI4MQ_41b607dc-9729-4285-9107-41b9caa944ee"
      unitRef="usd">89000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ief564af42a4c42e893aff8bd1fbca00a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNS0xLTEtMS02MTI4MQ_1f6ee821-bd07-4899-9921-cdeb926d4511"
      unitRef="usd">-4000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i779636b30adc455b80382ee10bb0ad6b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNS0zLTEtMS02MTI4MQ_a90e8cc5-863f-41dd-a0e7-f57b052583fc"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i00226f2a049945c4926cc6902c33c132_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNS01LTEtMS02MTI4MQ_94241698-8c11-4633-929b-2710780b6edd"
      unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ie28fdaf2e6bb47bf9633a15831cda54b_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNS03LTEtMS02MTI4MQ_ed507584-263b-4a73-9921-3cbe6c79a751"
      unitRef="usd">-7000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ief564af42a4c42e893aff8bd1fbca00a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNi0xLTEtMS02MTI4MQ_c63e8fa8-4cb4-4d7c-bc53-431747a42121"
      unitRef="usd">-15000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i779636b30adc455b80382ee10bb0ad6b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNi0zLTEtMS02MTI4MQ_5fab023f-6b81-480c-874c-77a62d443ff1"
      unitRef="usd">-23000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i00226f2a049945c4926cc6902c33c132_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNi01LTEtMS02MTI4MQ_d379ea5f-c094-4fce-93f4-f859a29f0027"
      unitRef="usd">-31000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ie28fdaf2e6bb47bf9633a15831cda54b_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNi03LTEtMS02MTI4MQ_b52ef9f2-dfbf-4949-93c8-cca2bd41bdf2"
      unitRef="usd">-50000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="ief564af42a4c42e893aff8bd1fbca00a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNy0xLTEtMS02MTI4MQ_391e3417-9fbc-4206-989b-c823caf1481c"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i779636b30adc455b80382ee10bb0ad6b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNy0zLTEtMS02MTI4MQ_f1569ea9-2553-4386-9108-746845ca7c8a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i00226f2a049945c4926cc6902c33c132_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNy01LTEtMS02MTI4MQ_11885280-80b0-4eff-a915-c06955922bd9"
      unitRef="usd">-6000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="ie28fdaf2e6bb47bf9633a15831cda54b_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfNy03LTEtMS02MTI4MQ_e9c98356-d724-49da-907b-69069fa02b7e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ief564af42a4c42e893aff8bd1fbca00a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfOC0xLTEtMS02MTI4MQ_c709214b-ee0d-4b01-bf3b-c36d8152a737"
      unitRef="usd">18000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i779636b30adc455b80382ee10bb0ad6b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfOC0zLTEtMS02MTI4MQ_7f9a3aa6-8041-474d-bb66-202d427047c9"
      unitRef="usd">32000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i00226f2a049945c4926cc6902c33c132_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfOC01LTEtMS02MTI4MQ_4fc87802-c706-4eb4-87f3-a7a9122ae8de"
      unitRef="usd">42000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ie28fdaf2e6bb47bf9633a15831cda54b_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV80OS9mcmFnOmUxOWI1YTRkNjlhNTQ5YjY4NmJiYzcxZmM3Zjg2ZDI4L3RhYmxlOmQ1ZWM1OTI0M2NkNzQyZjM5YjI4ZjFmOTZmMzY1ZGExL3RhYmxlcmFuZ2U6ZDVlYzU5MjQzY2Q3NDJmMzliMjhmMWY5NmYzNjVkYTFfOC03LTEtMS02MTI4MQ_ad9c2b55-d9c4-4a75-a80d-5a50a61c9f79"
      unitRef="usd">69000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RleHRyZWdpb246ZmMzNzE4YTIwZWY1NDI5ODhhMjkxN2RkMWFiMjU5YjVfNTgx_0bd657f2-ed85-43f3-9c99-80483d793c75">Business Restructuring Charges&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company incurred restructuring costs during the six months ended March&#160;31, 2022, primarily in connection with the Company's simplification and other cost saving initiatives, which were largely recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition-related integration and restructuring expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  These simplification and other costs saving initiatives are focused on reducing complexity, enhancing product quality, refining customer experience, and improving cost efficiency across all of the Company&#x2019;s segments.  Restructuring liability activity for the six months ended March&#160;31, 2022 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.456%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.686%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee&lt;br/&gt;Termination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RleHRyZWdpb246ZmMzNzE4YTIwZWY1NDI5ODhhMjkxN2RkMWFiMjU5YjVfNTgz_31095348-1427-4ff8-93e9-adb6e8ad4fed">Restructuring liability activity for the six months ended March&#160;31, 2022 was as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.456%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.686%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee&lt;br/&gt;Termination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i0c9691d61a39453087be7034f4483fbc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfMS0xLTEtMS02MTI4MQ_adb600d7-e29e-4f53-a5e1-75890dd763bc"
      unitRef="usd">14000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ifeff7a1ec077409a9bc93ab1ff3aefb4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfMS0zLTEtMS02MTI4MQ_68f1e793-8961-4f78-b874-acdabda31f6c"
      unitRef="usd">5000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfMS01LTEtMS02MTI4MQ_ff481b67-71a6-45a7-acad-67b4533fc58a"
      unitRef="usd">19000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i720075ccfd224b55a2643c326f989fbb_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfMy0xLTEtMS02MTI4MQ_a8f4f86f-7307-4bd6-867b-dda796171838"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ice9b08a1614b40ec92a118dec841b8fc_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfMy0zLTEtMS02MTI4MQ_7f7e5f24-e17d-467f-8c6e-5a47b86b5874"
      unitRef="usd">30000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfMy01LTEtMS02MTI4MQ_a5ade528-6d5b-49bd-a5e0-60085386e65d"
      unitRef="usd">34000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i720075ccfd224b55a2643c326f989fbb_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfNC0xLTEtMS02MTI4MQ_55a42532-419d-445e-b5d5-bcad3e870e6e"
      unitRef="usd">6000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ice9b08a1614b40ec92a118dec841b8fc_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfNC0zLTEtMS02MTI4MQ_ade13db0-02d1-40a8-87c2-42519b5dcfb2"
      unitRef="usd">32000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfNC01LTEtMS02MTI4MQ_9bbca45f-4157-4df3-bab7-24253a5125f6"
      unitRef="usd">38000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i535aa5beb8df4def94ad38003c699670_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfNy0xLTEtMS02MTI4MQ_af385a0e-ecc1-4763-91bc-14dfa6817c38"
      unitRef="usd">12000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ibceac69f309e466680f1ada28542ef16_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfNy0zLTEtMS02MTI4MQ_73ea9132-c308-457a-92a9-f85eede6c615"
      unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81Mi9mcmFnOmZjMzcxOGEyMGVmNTQyOTg4YTI5MTdkZDFhYjI1OWI1L3RhYmxlOjgyZjNiZWIzMDRhNzQ2ZmNhZWE3YjRhNzdiNTAwMGUwL3RhYmxlcmFuZ2U6ODJmM2JlYjMwNGE3NDZmY2FlYTdiNGE3N2I1MDAwZTBfNy01LTEtMS02MTI4MQ_8ee3671a-5618-4ff6-a48a-ec5dcb3ef2d4"
      unitRef="usd">15000000</us-gaap:RestructuringReserve>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RleHRyZWdpb246YmVmOTQ3NjIzMWU1NGJkYWIwMjhhMWQwMjc3Mjg3MzNfMzYw_36f8469c-d303-45fc-b402-60b4bcf5ae4a">Intangible Assets&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired in-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible amortization expense for the three months ended&#160;March&#160;31, 2022 and 2021&#160;was $352 million&#160;and $350 million, respectively.  Intangible amortization expense for the six months ended&#160;March&#160;31, 2022 and 2021&#160;was $707 million&#160;and $698 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of goodwill by business segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life&#160;Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price allocation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represents goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RleHRyZWdpb246YmVmOTQ3NjIzMWU1NGJkYWIwMjhhMWQwMjc3Mjg3MzNfMzcx_1ef2b23f-8d44-4f54-a458-be3e9aebd19b">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired in-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia886aaf5c1bb402ab373ae9e4fcf70f5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMy0xLTEtMS02MTI4MQ_e8d27b93-b5d2-49f9-acb2-c9f7a939555f"
      unitRef="usd">14535000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia886aaf5c1bb402ab373ae9e4fcf70f5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMy0zLTEtMS02MTI4MQ_59fb91ed-7d26-4463-9b70-a12a8db8e184"
      unitRef="usd">5491000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia886aaf5c1bb402ab373ae9e4fcf70f5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMy01LTEtMS02MTI4MQ_30d5c07f-8bf0-440b-87ae-fc61b12f4e73"
      unitRef="usd">9044000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if19b6df31d1041d988f2b6d0d6f8be9a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMy03LTEtMS02MTI4MQ_e0012ffe-0d85-45a1-93a9-58129e1ca279"
      unitRef="usd">14399000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if19b6df31d1041d988f2b6d0d6f8be9a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMy05LTEtMS02MTI4MQ_24dab4a7-34e5-4620-a2a7-af880d0c201d"
      unitRef="usd">4983000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if19b6df31d1041d988f2b6d0d6f8be9a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMy0xMS0xLTEtNjEyODE_8474c3d5-8022-48d1-860a-5585ccbf8200"
      unitRef="usd">9417000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iff71ea0dd54b4de39f65ab020e2a67d5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNC0xLTEtMS02MTI4MQ_be4a4cd2-b903-4105-bf82-4d3470560d67"
      unitRef="usd">4686000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iff71ea0dd54b4de39f65ab020e2a67d5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNC0zLTEtMS02MTI4MQ_4def9180-2cb2-4512-9a5b-ef4d28095adc"
      unitRef="usd">2005000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iff71ea0dd54b4de39f65ab020e2a67d5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNC01LTEtMS02MTI4MQ_c111f44d-40dc-431e-85cb-184d9099273d"
      unitRef="usd">2681000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if1bf7117c8f74af382b1902e9716b58b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNC03LTEtMS02MTI4MQ_898583e3-c964-4ebc-a4ad-daee5f9cac4b"
      unitRef="usd">4658000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if1bf7117c8f74af382b1902e9716b58b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNC05LTEtMS02MTI4MQ_d24f3cac-866f-4510-b75b-0fd3415916ba"
      unitRef="usd">1839000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if1bf7117c8f74af382b1902e9716b58b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNC0xMS0xLTEtNjEyODE_aa5fd793-7f71-4256-814f-6540f46d7de1"
      unitRef="usd">2818000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ifcba64985bd94892898f333e81f805c3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNS0xLTEtMS02MTI4MQ_1025803b-0a09-496b-bd29-1db63883cf04"
      unitRef="usd">115000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifcba64985bd94892898f333e81f805c3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNS0zLTEtMS02MTI4MQ_8719b474-dfba-4d0a-b4ec-598fae34ed3f"
      unitRef="usd">82000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ifcba64985bd94892898f333e81f805c3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNS01LTEtMS02MTI4MQ_94400ac5-68d1-4289-8cf6-150d2b55abfe"
      unitRef="usd">33000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7852dda3e9644e0b9e2ced2925cb5cbc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNS03LTEtMS02MTI4MQ_07145b5a-61f1-4272-8c9e-1e45ac267c64"
      unitRef="usd">123000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7852dda3e9644e0b9e2ced2925cb5cbc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNS05LTEtMS02MTI4MQ_4cb86a80-7469-40d4-b0de-9db3ac0a5647"
      unitRef="usd">83000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7852dda3e9644e0b9e2ced2925cb5cbc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNS0xMS0xLTEtNjEyODE_e9900822-f77a-4e03-9293-5c3cd8f279e7"
      unitRef="usd">40000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i287c272785094449aeae5d0789e8dd30_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNi0xLTEtMS02MTI4MQ_528cf97e-cc37-4afe-90d5-f9833f761870"
      unitRef="usd">408000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i287c272785094449aeae5d0789e8dd30_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNi0zLTEtMS02MTI4MQ_0536423c-45b3-4eb0-a6e7-9cddfb99c012"
      unitRef="usd">146000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i287c272785094449aeae5d0789e8dd30_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNi01LTEtMS02MTI4MQ_6cd65c99-2be8-4fc4-af6b-a8f62397e0cd"
      unitRef="usd">262000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9f7c055feadd4023a2ccc660f06149c5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNi03LTEtMS02MTI4MQ_c3f999dc-3b50-44ed-95ea-8708ece6395b"
      unitRef="usd">409000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9f7c055feadd4023a2ccc660f06149c5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNi05LTEtMS02MTI4MQ_849ff7fa-2e2e-4fd7-a35b-d9149817186e"
      unitRef="usd">137000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9f7c055feadd4023a2ccc660f06149c5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNi0xMS0xLTEtNjEyODE_a92d5354-57e4-4da0-905f-1bffd4958377"
      unitRef="usd">271000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ice2f69b4e89a4d6d841af8ccf0210a6d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNy0xLTEtMS02MTI4MQ_7e70c95a-a0be-445e-bdea-d2187f2abbe5"
      unitRef="usd">543000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ice2f69b4e89a4d6d841af8ccf0210a6d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNy0zLTEtMS02MTI4MQ_a0d3bdf9-ea38-4dbc-83ab-5174147ac959"
      unitRef="usd">343000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ice2f69b4e89a4d6d841af8ccf0210a6d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNy01LTEtMS02MTI4MQ_77fb1758-abf4-413d-99af-179478f1c202"
      unitRef="usd">200000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9046b05ebed642d6a4080928d23692fd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNy03LTEtMS02MTI4MQ_e51c9305-3263-4589-b6c2-f9a76e08ebc5"
      unitRef="usd">533000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9046b05ebed642d6a4080928d23692fd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNy05LTEtMS02MTI4MQ_f7bd634c-312d-461a-8c88-5c8023effbd0"
      unitRef="usd">342000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9046b05ebed642d6a4080928d23692fd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfNy0xMS0xLTEtNjEyODE_043df392-36f1-48a2-a942-d13b2447c80d"
      unitRef="usd">191000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfOC0xLTEtMS02MTI4MQ_7aba219c-a133-4693-955c-cb024a354ee8"
      unitRef="usd">20287000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfOC0zLTEtMS02MTI4MQ_35545a7e-22a2-4900-9b88-7a20ee1169a2"
      unitRef="usd">8067000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfOC01LTEtMS02MTI4MQ_db250503-6520-472d-9de8-cd55c992c253"
      unitRef="usd">12220000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfOC03LTEtMS02MTI4MQ_ff2480a4-222a-4e0e-bf66-68912f8491e4"
      unitRef="usd">20122000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfOC05LTEtMS02MTI4MQ_4e39391c-a502-44ca-bdcf-c8eb8f40d9ab"
      unitRef="usd">7385000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfOC0xMS0xLTEtNjEyODE_3ef6a1fa-5f9d-44f8-9adb-ba8008e7c9a2"
      unitRef="usd">12737000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ibbbba24d92744e1995760747da6b3a07_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMTAtMS0xLTEtNjEyODE_01ac3990-b33e-41c6-8c72-6173bf807143"
      unitRef="usd">44000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ib93696a0600a4388af7001d55ce60a56_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMTAtNy0xLTEtNjEyODE_4756e03f-0a4d-42e3-9e19-4236b8f454ee"
      unitRef="usd">44000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i67af69e0e74849ab8b12161f932216a2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMTEtMS0xLTEtNjEyODE_8747201a-60e1-4df8-bfff-a3a0b4558839"
      unitRef="usd">2000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i09024c8954c042e89264bf944c8b11d6_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMTEtNy0xLTEtNjEyODE_1b81deb7-0378-4003-9f50-a558bea60867"
      unitRef="usd">2000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMTItMS0xLTEtNjEyODE_0868b866-1590-4483-a16a-c66b317094f3"
      unitRef="usd">46000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmU0MjQ4MmRjMDQ1MDQwYjI4MjYwNWRkOGIyMmJhNGQ2L3RhYmxlcmFuZ2U6ZTQyNDgyZGMwNDUwNDBiMjgyNjA1ZGQ4YjIyYmE0ZDZfMTItNy0xLTEtNjEyODE_7cd05071-ca16-4df5-82a9-917e7520c11d"
      unitRef="usd">46000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RleHRyZWdpb246YmVmOTQ3NjIzMWU1NGJkYWIwMjhhMWQwMjc3Mjg3MzNfMTM5_8b953fc7-cb88-4fb9-8346-87ca5870cd5a"
      unitRef="usd">352000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RleHRyZWdpb246YmVmOTQ3NjIzMWU1NGJkYWIwMjhhMWQwMjc3Mjg3MzNfMTQ2_6e6befa2-da36-4edf-8c6d-4c2533674bc6"
      unitRef="usd">350000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RleHRyZWdpb246YmVmOTQ3NjIzMWU1NGJkYWIwMjhhMWQwMjc3Mjg3MzNfMjc0ODc3OTA2OTk1Mw_2768f1d8-7eb5-48cd-b89a-6ffc822057f7"
      unitRef="usd">707000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RleHRyZWdpb246YmVmOTQ3NjIzMWU1NGJkYWIwMjhhMWQwMjc3Mjg3MzNfMjc0ODc3OTA2OTk1Nw_f96796d2-306c-4cc5-8efd-522342d7fb41"
      unitRef="usd">698000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RleHRyZWdpb246YmVmOTQ3NjIzMWU1NGJkYWIwMjhhMWQwMjc3Mjg3MzNfMzU5_7c2f63bd-5f6a-4cab-a51b-5f9da74aa83f">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of goodwill by business segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life&#160;Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price allocation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represents goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ieefa6c2ca96747e29b4e14f0c03cdff8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfMS0xLTEtMS02MTI4MQ_8903ce12-3772-4bd0-9a6c-d77761d5db1c"
      unitRef="usd">10255000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id060ca4c054d4caf9f5955f598b66769_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfMS0zLTEtMS02MTI4MQ_637b15b9-d7e9-4570-8c18-06220fb461bd"
      unitRef="usd">836000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib65ad792e22f44688a73a18522ef2873_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfMS01LTEtMS02MTI4MQ_cfef0cff-5c42-464c-bef1-9862ad27f78e"
      unitRef="usd">12810000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfMS03LTEtMS02MTI4MQ_bda2b99e-6c46-4a8c-892c-c1c0286df66d"
      unitRef="usd">23901000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i14595206756547be8dcca594e49423d1_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfMi0xLTEtMS02MTI4MQ_08ea051d-d9b0-49e2-95a9-72036bebe963"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i0368fb62ba6e46fc84e60d8e4f32776e_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfMi0zLTEtMS02MTI4MQ_c4bdb1ce-049d-4f5f-aa80-fdad5737f85c"
      unitRef="usd">71000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib8c068d6acc740b4a2839bff2df64cb2_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfMi01LTEtMS02MTI4MQ_0bce2d53-aca7-4025-b1e2-d6588ed8404c"
      unitRef="usd">205000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfMi03LTEtMS02MTI4MQ_f4d34e6a-a840-4ac3-802a-5ca32f59c416"
      unitRef="usd">276000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i14595206756547be8dcca594e49423d1_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNC0xLTEtMS02MTI4MQ_a6d64160-2a09-4f11-8856-cdf2eb831386"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i0368fb62ba6e46fc84e60d8e4f32776e_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNC0zLTEtMS02MTI4MQ_c3158cd3-ae96-4fdf-a34e-fccb02a630f2"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ib8c068d6acc740b4a2839bff2df64cb2_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNC01LTEtMS02MTI4MQ_bd166fbb-c3d1-4e96-95d8-f69fa9f16ec6"
      unitRef="usd">-2000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNC03LTEtMS02MTI4MQ_18a4cdc9-ca8e-4708-94f7-d672ac3e9c89"
      unitRef="usd">-2000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i14595206756547be8dcca594e49423d1_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNS0xLTEtMS02MTI4MQ_3313508e-2997-4d16-88c5-2d76b31c8380"
      unitRef="usd">32000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i0368fb62ba6e46fc84e60d8e4f32776e_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNS0zLTEtMS02MTI4MQ_fda12787-e4e4-4b2d-8081-36e150a1f806"
      unitRef="usd">6000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ib8c068d6acc740b4a2839bff2df64cb2_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNS01LTEtMS02MTI4MQ_eb203b7e-e32e-43a4-bbee-97da7b9a820e"
      unitRef="usd">42000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNS03LTEtMS02MTI4MQ_c1af93b7-d509-4c2e-9611-3cc49739e7e0"
      unitRef="usd">80000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="id36e592a22714e45927e00fe0abd06f9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNi0xLTEtMS02MTI4MQ_90157579-e477-4ad4-8429-e20e3d94e20d"
      unitRef="usd">10223000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i647adccb5a5d4a46861649299a5f578e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNi0zLTEtMS02MTI4MQ_a36f9bd8-3e3d-4bb0-b580-3e80b51838b7"
      unitRef="usd">902000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5bf06b24db6d4d5e95c8dc424db65f4e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNi01LTEtMS02MTI4MQ_dc9863ee-c225-4cd9-a8ad-c49b8054a6dd"
      unitRef="usd">12971000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81NS9mcmFnOmJlZjk0NzYyMzFlNTRiZGFiMDI4YTFkMDI3NzI4NzMzL3RhYmxlOmY1ZjRhMTlhNmFjNDRjYWY4ZGYzNWEzMmMyMTlkNzQxL3RhYmxlcmFuZ2U6ZjVmNGExOWE2YWM0NGNhZjhkZjM1YTMyYzIxOWQ3NDFfNi03LTEtMS02MTI4MQ_a4045601-5d8d-4fc7-bf0b-613f49a3d58e"
      unitRef="usd">24096000000</us-gaap:Goodwill>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RleHRyZWdpb246NWI2NTc3MzYyNTJkNDRlNGI1MTA5ODRkYzQwNzI3YjRfNjA1MQ_c5ed8383-4bd1-4fe6-a803-f18da3262afc">Derivative Instruments and Hedging Activities&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses derivative instruments to mitigate certain exposures.  The Company does not enter into derivative financial instruments for trading or speculative purposes.  The effects these derivative instruments and hedged items had on the Company&#x2019;s balance sheets and the fair values of the derivatives outstanding at March&#160;31, 2022 and September&#160;30, 2021 were not material.  The effects on the Company&#x2019;s financial performance and cash flows are provided below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Risks and Related Strategies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has foreign currency exposures throughout Europe, Greater Asia, Canada and Latin America.  Transactional currency exposures that arise from entering into transactions, generally on an intercompany basis, in non-hyperinflationary countries that are denominated in currencies other than the functional currency are mitigated primarily through the use of forward contracts.  In order to mitigate foreign currency exposure relating to its investments in certain foreign subsidiaries, the Company has hedged the currency risk associated with those investments with certain instruments, such as foreign currency-denominated debt and cross-currency swaps, which are designated as net investment hedges, as well as currency exchange contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts of the Company&#x2019;s foreign currency-related derivative instruments as of March&#160;31, 2022 and September&#160;30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.210%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.089%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedge Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Undesignated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables.  Gains and losses on these instruments are recognized immediately in income.  These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments.  Net amounts recognized in&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other (expense) income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, during the three and six months ended March&#160;31, 2022 and 2021 were immaterial to the Company's consolidated financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Represents foreign currency-denominated long-term notes outstanding which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represents cross-currency swaps which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains or losses relating to the net investment hedges, which are attributable to changes in the foreign currencies to U.S. dollar spot exchange rates, are recorded as accumulated foreign currency translation in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  Upon the termination of a net investment hedge, any net gain or loss included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relative to the investment hedge remains until the foreign subsidiary investment is disposed of or is substantially liquidated.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains (losses) recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relating to the Company's net investment hedges for the three and six-month periods were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risks and Related Strategies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a mix of fixed and variable rate debt to manage its interest rate exposure, and periodically uses interest rate swaps to manage such exposures.  Under these interest rate swaps, the Company exchanges, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. These swaps are designated as either cash flow or fair value hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of the interest rate swaps designated as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk) are recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  If interest rate derivatives designated as cash flow hedges are terminated, the balance in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss) &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;attributable to those derivatives is reclassified into earnings, within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; over the remaining life of the hedged debt. The amounts reclassified from accumulated other comprehensive income relating to cash flow hedges during the three and six months ended March&#160;31, 2022 and 2021, as well as the amounts expected to be reclassified within the next 12 months, are not material to the Company's consolidated financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded net after-tax gains of $43&#160;million and $78&#160;million during the three months ended March&#160;31, 2022 and 2021, respectively, and $39&#160;million and $105&#160;million during the six months ended March&#160;31, 2022 and 2021, respectively, in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relating to interest rate hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For interest rate swaps designated as fair value hedges (i.e., hedges against the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt due to changes in market interest rates.  Amounts recorded during the three and six months ended March&#160;31, 2022 and 2021 were immaterial to the Company's consolidated financial results. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts of the Company&#x2019;s interest rate-related derivative instruments as of March&#160;31, 2022 and September&#160;30, 2021 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedge Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represents fixed-to-floating interest rate swap agreements the Company entered into to convert the interest payments on certain long-term notes from the fixed rate to a floating interest rate based on LIBOR.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Represents interest rate derivatives entered into to mitigate exposure to interest rate risk related to future debt issuances.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Risk Exposures&lt;/span&gt;&lt;/div&gt;The Company purchases resins, which are oil-based components used in the manufacture of certain products.  Significant increases in world oil prices that lead to increases in resin purchase costs could impact future operating results.  From time to time, the Company has managed price risks associated with these commodity purchases through commodity derivative forward contracts.  The Company's outstanding commodity derivative forward contracts at March&#160;31, 2022 were immaterial to the Company's consolidated financial results and the Company had no outstanding commodity derivative forward contracts at September&#160;30, 2021.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RleHRyZWdpb246NWI2NTc3MzYyNTJkNDRlNGI1MTA5ODRkYzQwNzI3YjRfNjA0Nw_1304674e-ca4b-4485-bfff-57ced2e5a954">The Company uses derivative instruments to mitigate certain exposures.  The Company does not enter into derivative financial instruments for trading or speculative purposes.&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a mix of fixed and variable rate debt to manage its interest rate exposure, and periodically uses interest rate swaps to manage such exposures.  Under these interest rate swaps, the Company exchanges, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. These swaps are designated as either cash flow or fair value hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of the interest rate swaps designated as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk) are recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  If interest rate derivatives designated as cash flow hedges are terminated, the balance in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss) &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;attributable to those derivatives is reclassified into earnings, within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense,&lt;/span&gt; over the remaining life of the hedged debt.For interest rate swaps designated as fair value hedges (i.e., hedges against the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt due to changes in market interest rates.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RleHRyZWdpb246NWI2NTc3MzYyNTJkNDRlNGI1MTA5ODRkYzQwNzI3YjRfNjA2Mw_ca448734-5e8f-4bc7-9c0c-16cc2c3f986f">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts of the Company&#x2019;s foreign currency-related derivative instruments as of March&#160;31, 2022 and September&#160;30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.210%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.089%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedge Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Undesignated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables.  Gains and losses on these instruments are recognized immediately in income.  These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments.  Net amounts recognized in&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other (expense) income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, during the three and six months ended March&#160;31, 2022 and 2021 were immaterial to the Company's consolidated financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Represents foreign currency-denominated long-term notes outstanding which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represents cross-currency swaps which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts of the Company&#x2019;s interest rate-related derivative instruments as of March&#160;31, 2022 and September&#160;30, 2021 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedge Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represents fixed-to-floating interest rate swap agreements the Company entered into to convert the interest payments on certain long-term notes from the fixed rate to a floating interest rate based on LIBOR.  &lt;/span&gt;&lt;/div&gt;(b)Represents interest rate derivatives entered into to mitigate exposure to interest rate risk related to future debt issuances.</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i57f20120eb6d496fa8dff3eee45b0eea_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmY0ZGY0NGYxODI3YTRiMDA4NTcxYWVjN2I0MTJlYzg1L3RhYmxlcmFuZ2U6ZjRkZjQ0ZjE4MjdhNGIwMDg1NzFhZWM3YjQxMmVjODVfMS0zLTEtMS02MTI4MQ_a634f7c5-29b3-4897-8ac0-84bbe0f6d862"
      unitRef="usd">1486000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6a5fc6a2293a4c8cad09d8ce4967369a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmY0ZGY0NGYxODI3YTRiMDA4NTcxYWVjN2I0MTJlYzg1L3RhYmxlcmFuZ2U6ZjRkZjQ0ZjE4MjdhNGIwMDg1NzFhZWM3YjQxMmVjODVfMS01LTEtMS02MTI4MQ_b644f923-c0de-483c-86ce-1c9e734d7665"
      unitRef="usd">2735000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1831573910a04a449ed2198ba1794eb7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmY0ZGY0NGYxODI3YTRiMDA4NTcxYWVjN2I0MTJlYzg1L3RhYmxlcmFuZ2U6ZjRkZjQ0ZjE4MjdhNGIwMDg1NzFhZWM3YjQxMmVjODVfMi0zLTEtMS02MTI4MQ_176e66bc-c080-4d67-9888-37328bc54736"
      unitRef="usd">2419000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9044e5284eec498888c80d53fd6d7cac_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmY0ZGY0NGYxODI3YTRiMDA4NTcxYWVjN2I0MTJlYzg1L3RhYmxlcmFuZ2U6ZjRkZjQ0ZjE4MjdhNGIwMDg1NzFhZWM3YjQxMmVjODVfMi01LTEtMS02MTI4MQ_2ce5ab99-b3ab-45ca-a6a7-a7e8e26e6580"
      unitRef="usd">2543000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie7eeef21c695425a92ba5420343f8392_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmY0ZGY0NGYxODI3YTRiMDA4NTcxYWVjN2I0MTJlYzg1L3RhYmxlcmFuZ2U6ZjRkZjQ0ZjE4MjdhNGIwMDg1NzFhZWM3YjQxMmVjODVfMy0zLTEtMS02MTI4MQ_488b4e43-ed71-4d11-86c0-cf5e31cf1768"
      unitRef="usd">1958000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id3329662597a43ae9d4393dca9eb9b23_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmY0ZGY0NGYxODI3YTRiMDA4NTcxYWVjN2I0MTJlYzg1L3RhYmxlcmFuZ2U6ZjRkZjQ0ZjE4MjdhNGIwMDg1NzFhZWM3YjQxMmVjODVfMy01LTEtMS02MTI4MQ_c9102c8a-7505-42ba-940a-81400b15ce0b"
      unitRef="usd">1958000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RleHRyZWdpb246NWI2NTc3MzYyNTJkNDRlNGI1MTA5ODRkYzQwNzI3YjRfNjA2Ng_edf8ca7a-b9f8-4e49-8642-0e1793dab033">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains (losses) recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relating to the Company's net investment hedges for the three and six-month periods were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="idcc3814ef1924ae9ba38f953eba0d814_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmQ4ODhmN2VlYzA0NjQyYTI5MjQ5NGQxZDRjYzNmNzFhL3RhYmxlcmFuZ2U6ZDg4OGY3ZWVjMDQ2NDJhMjkyNDk0ZDFkNGNjM2Y3MWFfMi0xLTEtMS02MTI4MQ_6f6c67f8-1ed6-4e2b-a90c-027f5ae2ebb8"
      unitRef="usd">45000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9bb6311653a447e9a0a4ba8c0ad8ead6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmQ4ODhmN2VlYzA0NjQyYTI5MjQ5NGQxZDRjYzNmNzFhL3RhYmxlcmFuZ2U6ZDg4OGY3ZWVjMDQ2NDJhMjkyNDk0ZDFkNGNjM2Y3MWFfMi0zLTEtMS02MTI4MQ_c7ccc1dd-cfe0-43f8-bf2c-b8f8289dffff"
      unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ic331fa12abcc49f1ad32ee75878ba71b_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmQ4ODhmN2VlYzA0NjQyYTI5MjQ5NGQxZDRjYzNmNzFhL3RhYmxlcmFuZ2U6ZDg4OGY3ZWVjMDQ2NDJhMjkyNDk0ZDFkNGNjM2Y3MWFfMi01LTEtMS02MTI4MQ_0df0e0e7-1ef8-4e1b-ac39-6a33bdfa8dc6"
      unitRef="usd">94000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i72c4b04b5d954d97bccd5b64279416fd_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmQ4ODhmN2VlYzA0NjQyYTI5MjQ5NGQxZDRjYzNmNzFhL3RhYmxlcmFuZ2U6ZDg4OGY3ZWVjMDQ2NDJhMjkyNDk0ZDFkNGNjM2Y3MWFfMi03LTEtMS02MTI4MQ_3ff7ede9-ea2e-43ef-8820-9110e5e17376"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ifd8707ce2b41458880bbba5f3ae0a677_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmQ4ODhmN2VlYzA0NjQyYTI5MjQ5NGQxZDRjYzNmNzFhL3RhYmxlcmFuZ2U6ZDg4OGY3ZWVjMDQ2NDJhMjkyNDk0ZDFkNGNjM2Y3MWFfMy0xLTEtMS02MTI4MQ_2cf7f846-966d-40b3-b11b-22466c8cbbdf"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5436992d57d34fa79e5f22c386b9e551_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmQ4ODhmN2VlYzA0NjQyYTI5MjQ5NGQxZDRjYzNmNzFhL3RhYmxlcmFuZ2U6ZDg4OGY3ZWVjMDQ2NDJhMjkyNDk0ZDFkNGNjM2Y3MWFfMy0zLTEtMS02MTI4MQ_d774aa6b-6287-48db-9be1-6e2285daa91e"
      unitRef="usd">40000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i63b89c37783a44039baca463093a5ae6_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmQ4ODhmN2VlYzA0NjQyYTI5MjQ5NGQxZDRjYzNmNzFhL3RhYmxlcmFuZ2U6ZDg4OGY3ZWVjMDQ2NDJhMjkyNDk0ZDFkNGNjM2Y3MWFfMy01LTEtMS02MTI4MQ_1fedbd6a-eac5-417d-8938-e017dc753a41"
      unitRef="usd">46000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i8f5fc4cc7e7f4dc586a55406beefd6ac_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmQ4ODhmN2VlYzA0NjQyYTI5MjQ5NGQxZDRjYzNmNzFhL3RhYmxlcmFuZ2U6ZDg4OGY3ZWVjMDQ2NDJhMjkyNDk0ZDFkNGNjM2Y3MWFfMy03LTEtMS02MTI4MQ_14df27ff-c349-4454-9e83-cad35ab61f39"
      unitRef="usd">-84000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i1a1a0aef0db24a0987e1ebb88ed95290_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RleHRyZWdpb246NWI2NTc3MzYyNTJkNDRlNGI1MTA5ODRkYzQwNzI3YjRfMjc0ODc3OTA3NTY4Mg_512aa696-c160-41e2-910a-e093aac65622"
      unitRef="usd">43000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i54dd618396ea42518487e230f0e9e1b6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RleHRyZWdpb246NWI2NTc3MzYyNTJkNDRlNGI1MTA5ODRkYzQwNzI3YjRfNDIzMw_853535d9-5e91-4146-8f6d-bb86c080fcb1"
      unitRef="usd">78000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i73542df9b6064c0d93564b9e09ce34ef_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RleHRyZWdpb246NWI2NTc3MzYyNTJkNDRlNGI1MTA5ODRkYzQwNzI3YjRfMjc0ODc3OTA3NTc4NQ_c5b2e603-9eb5-4926-9c26-954bc1666043"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i8e68b8c00a5b4b0795a14cc4e86be66d_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RleHRyZWdpb246NWI2NTc3MzYyNTJkNDRlNGI1MTA5ODRkYzQwNzI3YjRfMjc0ODc3OTA3NTU3NA_602124a5-1ae6-427d-b7bf-2c6570a877c0"
      unitRef="usd">105000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i179698c711414fb0a6c8ff99db9ee285_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmZhZWYyZjI2Mzg5YTRiOWE5ODc1ZWVhOGQ0MjA3ZjM1L3RhYmxlcmFuZ2U6ZmFlZjJmMjYzODlhNGI5YTk4NzVlZWE4ZDQyMDdmMzVfMS0zLTEtMS02MTI4MQ_1165e220-6643-438d-8516-5f0da4961dd8"
      unitRef="usd">700000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id7bf11422da34344806862a0903b17bd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmZhZWYyZjI2Mzg5YTRiOWE5ODc1ZWVhOGQ0MjA3ZjM1L3RhYmxlcmFuZ2U6ZmFlZjJmMjYzODlhNGI5YTk4NzVlZWE4ZDQyMDdmMzVfMS01LTEtMS02MTI4MQ_29171a62-53a8-4ddc-af9e-ca8a7c31c6a5"
      unitRef="usd">700000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i413682d5f90848fd9283e81e36ef64c3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmZhZWYyZjI2Mzg5YTRiOWE5ODc1ZWVhOGQ0MjA3ZjM1L3RhYmxlcmFuZ2U6ZmFlZjJmMjYzODlhNGI5YTk4NzVlZWE4ZDQyMDdmMzVfMi0zLTEtMS02MTI4MQ_5a77af26-9e88-46ba-b170-48cbb33f54dc"
      unitRef="usd">1000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie68b5ca8e1784fe9bdac444023023ac8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RhYmxlOmZhZWYyZjI2Mzg5YTRiOWE5ODc1ZWVhOGQ0MjA3ZjM1L3RhYmxlcmFuZ2U6ZmFlZjJmMjYzODlhNGI5YTk4NzVlZWE4ZDQyMDdmMzVfMi01LTEtMS02MTI4MQ_7a9a3b01-0e12-4c4c-8cbf-f52d017ef6a9"
      unitRef="usd">1000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6435fd6a9e9049458f90d13308c412be_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV81OC9mcmFnOjViNjU3NzM2MjUyZDQ0ZTRiNTEwOTg0ZGM0MDcyN2I0L3RleHRyZWdpb246NWI2NTc3MzYyNTJkNDRlNGI1MTA5ODRkYzQwNzI3YjRfNTk4MA_485d6dd0-8d0c-4b9f-aeb1-dae92b95ee22"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMjY4NQ_171ed317-b820-4b91-b04c-edef353fef11">Financial Instruments and Fair Value Measurements&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following reconciles cash and equivalents and restricted cash reported within the Company's consolidated balance sheets at March&#160;31, 2022 and September&#160;30, 2021 to the total of these amounts shown on the Company's consolidated statements of cash flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:327.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:166.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase.  Restricted cash consists of cash restricted from withdrawal and usage except for certain product liability matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the Company&#x2019;s financial instruments are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.842%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Institutional money market accounts and ultra-short bond fund (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;These financial instruments are recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on the consolidated balance sheets.  The institutional money market accounts permit daily redemption.  The fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Long-term debt is recorded at amortized cost.  The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments are held to their maturities and are carried at cost, which approximates fair value.  The short-term investments consist of instruments with maturities greater than three months and less than one year.  All other instruments measured by the Company at fair value, including derivatives and contingent consideration liabilities, are immaterial to the Company's consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nonrecurring Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of fiscal year 2022, the Company recorded a noncash asset impairment charge of $54&#160;million to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the Medical segment.  In the first quarter of fiscal year 2021, the Company recorded charges to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of $34&#160;million to write down the carrying value of certain fixed assets.  The amounts recognized were recorded to adjust the carrying amount of assets to the assets' fair values, which were estimated, based upon a market participant's perspective, using Level 3 inputs, including values estimated using the income approach.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transfers of trade receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Over the normal course of its business activities, the Company transfers certain trade receivable assets to third parties under factoring agreements.  Per the terms of these agreements, the Company surrenders control over its trade receivables upon transfer.&#160; Accordingly, the Company accounts for the transfers as sales of trade receivables by recognizing an increase to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and a decrease to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade receivables, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; when proceeds from the transactions are received.&#160; The costs incurred by the Company in connection with factoring activities were not material to its consolidated financial results.  The amounts transferred and yet to be remitted under factoring arrangements are provided below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.253%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables transferred to third parties under factoring arrangements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.249%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.628%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts yet to be collected and remitted to the third parties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMjY5MA_751f0bfd-a394-4160-849e-44f8ea05a1c6">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following reconciles cash and equivalents and restricted cash reported within the Company's consolidated balance sheets at March&#160;31, 2022 and September&#160;30, 2021 to the total of these amounts shown on the Company's consolidated statements of cash flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:327.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:166.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjM1YmEzMzcxNjRlMzQ4NTZiOGUyNjA5MDQ1ZDA0ZjQ4L3RhYmxlcmFuZ2U6MzViYTMzNzE2NGUzNDg1NmI4ZTI2MDkwNDVkMDRmNDhfMS0xLTEtMS02MTI4MQ_8f6580d4-2df3-493c-89fb-199098ae5542"
      unitRef="usd">3147000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjM1YmEzMzcxNjRlMzQ4NTZiOGUyNjA5MDQ1ZDA0ZjQ4L3RhYmxlcmFuZ2U6MzViYTMzNzE2NGUzNDg1NmI4ZTI2MDkwNDVkMDRmNDhfMS0zLTEtMS02MTI4MQ_aeaaf961-a0c1-4d87-8039-812f87d97388"
      unitRef="usd">2283000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndInvestmentsCurrent
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjM1YmEzMzcxNjRlMzQ4NTZiOGUyNjA5MDQ1ZDA0ZjQ4L3RhYmxlcmFuZ2U6MzViYTMzNzE2NGUzNDg1NmI4ZTI2MDkwNDVkMDRmNDhfMi0xLTEtMS02MTI4MQ_3493a823-5d1e-4621-9181-404889e18194"
      unitRef="usd">173000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjM1YmEzMzcxNjRlMzQ4NTZiOGUyNjA5MDQ1ZDA0ZjQ4L3RhYmxlcmFuZ2U6MzViYTMzNzE2NGUzNDg1NmI4ZTI2MDkwNDVkMDRmNDhfMi0zLTEtMS02MTI4MQ_ba62f370-76b3-4713-8d0d-e28a72838814"
      unitRef="usd">109000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjM1YmEzMzcxNjRlMzQ4NTZiOGUyNjA5MDQ1ZDA0ZjQ4L3RhYmxlcmFuZ2U6MzViYTMzNzE2NGUzNDg1NmI4ZTI2MDkwNDVkMDRmNDhfMy0xLTEtMS02MTI4MQ_08c79f6e-a798-4def-811c-7b71ea431354"
      unitRef="usd">3320000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjM1YmEzMzcxNjRlMzQ4NTZiOGUyNjA5MDQ1ZDA0ZjQ4L3RhYmxlcmFuZ2U6MzViYTMzNzE2NGUzNDg1NmI4ZTI2MDkwNDVkMDRmNDhfMy0zLTEtMS02MTI4MQ_cf9540d7-0bfe-4fbd-bbc6-c07a894853f6"
      unitRef="usd">2392000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMjY4Mg_7e57df13-e723-4cb9-ba7a-bf9f4407cc72">Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMjY3Nw_123c9fe0-9db1-46d9-a524-a16d139d321f">Restricted cash consists of cash restricted from withdrawal and usage except for certain product liability matters.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMjY3NA_201dcbe7-0051-4f1c-864b-03d0b5faeab2">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the Company&#x2019;s financial instruments are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.842%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Institutional money market accounts and ultra-short bond fund (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;These financial instruments are recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on the consolidated balance sheets.  The institutional money market accounts permit daily redemption.  The fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Long-term debt is recorded at amortized cost.  The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.&lt;/span&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOmIwOWZlYmJkZDU5NjQ0YTZhMTEzMGYxZmVjMTQyNTk1L3RhYmxlcmFuZ2U6YjA5ZmViYmRkNTk2NDRhNmExMTMwZjFmZWMxNDI1OTVfMS0zLTEtMS02MTI4MQ_282fe6ce-b4d0-4bc0-88b9-57ddb9de824f"
      unitRef="usd">609000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOmIwOWZlYmJkZDU5NjQ0YTZhMTEzMGYxZmVjMTQyNTk1L3RhYmxlcmFuZ2U6YjA5ZmViYmRkNTk2NDRhNmExMTMwZjFmZWMxNDI1OTVfMS01LTEtMS02MTI4MQ_c798f097-84ed-4809-af54-43aaad112031"
      unitRef="usd">200000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOmIwOWZlYmJkZDU5NjQ0YTZhMTEzMGYxZmVjMTQyNTk1L3RhYmxlcmFuZ2U6YjA5ZmViYmRkNTk2NDRhNmExMTMwZjFmZWMxNDI1OTVfMi0zLTEtMS02MTI4MQ_466a14ee-299f-47f1-9293-3c79fd1aa28c"
      unitRef="usd">1056000000</bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm>
    <bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOmIwOWZlYmJkZDU5NjQ0YTZhMTEzMGYxZmVjMTQyNTk1L3RhYmxlcmFuZ2U6YjA5ZmViYmRkNTk2NDRhNmExMTMwZjFmZWMxNDI1OTVfMi01LTEtMS02MTI4MQ_2e640679-665d-496d-abeb-5aa342a7d487"
      unitRef="usd">503000000</bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm>
    <us-gaap:LoansPayableFairValueDisclosure
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOmIwOWZlYmJkZDU5NjQ0YTZhMTEzMGYxZmVjMTQyNTk1L3RhYmxlcmFuZ2U6YjA5ZmViYmRkNTk2NDRhNmExMTMwZjFmZWMxNDI1OTVfMy0zLTEtMS02MTI4MQ_ca9664ab-b226-4839-a11f-6d6ed4175089"
      unitRef="usd">17576000000</us-gaap:LoansPayableFairValueDisclosure>
    <us-gaap:LoansPayableFairValueDisclosure
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOmIwOWZlYmJkZDU5NjQ0YTZhMTEzMGYxZmVjMTQyNTk1L3RhYmxlcmFuZ2U6YjA5ZmViYmRkNTk2NDRhNmExMTMwZjFmZWMxNDI1OTVfMy01LTEtMS02MTI4MQ_d86cb756-1481-4d25-a315-2c3e7a687cbd"
      unitRef="usd">18537000000</us-gaap:LoansPayableFairValueDisclosure>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMjY4Mw_7e4293b5-8da9-4bd5-a8a2-82b54d59cf99">The fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions.Long-term debt is recorded at amortized cost.  The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.Short-term investments are held to their maturities and are carried at cost, which approximates fair value.  The short-term investments consist of instruments with maturities greater than three months and less than one year.</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <bdx:MaturityPeriodOfShortTermInvestment
      contextRef="i3374a91073fd4143896356601c7a0524_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMTI2Mw_6db9f998-5b82-4961-a7de-4ea8d25a1017">P3M</bdx:MaturityPeriodOfShortTermInvestment>
    <bdx:MaturityPeriodOfShortTermInvestment
      contextRef="i11df0428ff4c47c59e767601738aa11a_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMTI4MA_292709cd-807c-4aa4-aef6-a3e45e5514d0">P1Y</bdx:MaturityPeriodOfShortTermInvestment>
    <us-gaap:AssetImpairmentCharges
      contextRef="ifb8b77375efd4b3b80608dbb0eff1722_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMjc0ODc3OTA3MjI4Nw_e59fac69-51e5-44fc-88db-cf23b95ea9d1"
      unitRef="usd">54000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i1fe40a686952436da2991e9275d47220_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMTYwNw_c8c5231c-6515-4351-8a85-9e4d4789b0fe"
      unitRef="usd">34000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RleHRyZWdpb246ZGZmYWJlMjdmM2Q3NGU3Nzg1YmFjMDg0ODMyOGY5OGRfMjY3OA_2d6defd0-81df-478a-8c67-4ade6b6949e3">The amounts transferred and yet to be remitted under factoring arrangements are provided below.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.253%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables transferred to third parties under factoring arrangements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.249%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.628%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts yet to be collected and remitted to the third parties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock>
    <bdx:TransfersOfFinancialAssetsDuringThePeriod
      contextRef="id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjQ3ODg3MzMwNGU0NDQ5MGNiMWM4NWE1ZTk1ODNhYzQ4L3RhYmxlcmFuZ2U6NDc4ODczMzA0ZTQ0NDkwY2IxYzg1YTVlOTU4M2FjNDhfMi0xLTEtMS02MTI4MQ_ef94ba13-85ad-41b6-822d-b5d70bfa0361"
      unitRef="usd">323000000</bdx:TransfersOfFinancialAssetsDuringThePeriod>
    <bdx:TransfersOfFinancialAssetsDuringThePeriod
      contextRef="ia9971035716346c99974380b024f6257_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjQ3ODg3MzMwNGU0NDQ5MGNiMWM4NWE1ZTk1ODNhYzQ4L3RhYmxlcmFuZ2U6NDc4ODczMzA0ZTQ0NDkwY2IxYzg1YTVlOTU4M2FjNDhfMi0zLTEtMS02MTI4MQ_2dcf782e-c03e-4775-aeb8-45e492114298"
      unitRef="usd">364000000</bdx:TransfersOfFinancialAssetsDuringThePeriod>
    <bdx:TransfersOfFinancialAssetsDuringThePeriod
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjQ3ODg3MzMwNGU0NDQ5MGNiMWM4NWE1ZTk1ODNhYzQ4L3RhYmxlcmFuZ2U6NDc4ODczMzA0ZTQ0NDkwY2IxYzg1YTVlOTU4M2FjNDhfMi01LTEtMS02MTI4MQ_633f7aef-a911-4b19-a957-a23119d14b63"
      unitRef="usd">478000000</bdx:TransfersOfFinancialAssetsDuringThePeriod>
    <bdx:TransfersOfFinancialAssetsDuringThePeriod
      contextRef="i847168ba7901405bb61be4ecfe684012_D20201001-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjQ3ODg3MzMwNGU0NDQ5MGNiMWM4NWE1ZTk1ODNhYzQ4L3RhYmxlcmFuZ2U6NDc4ODczMzA0ZTQ0NDkwY2IxYzg1YTVlOTU4M2FjNDhfMi03LTEtMS02MTI4MQ_6d22b050-b41d-44ca-801c-aba0bb75f4d6"
      unitRef="usd">856000000</bdx:TransfersOfFinancialAssetsDuringThePeriod>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjQwMmM0MzM2M2FlNTQ4MWY5OWMwOTVkMWFmZDk3YjQxL3RhYmxlcmFuZ2U6NDAyYzQzMzYzYWU1NDgxZjk5YzA5NWQxYWZkOTdiNDFfMS0xLTEtMS02NDgwNA_e79d43b0-4940-4635-8b99-52ed442b6657"
      unitRef="usd">237000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82MS9mcmFnOmRmZmFiZTI3ZjNkNzRlNzc4NWJhYzA4NDgzMjhmOThkL3RhYmxlOjQwMmM0MzM2M2FlNTQ4MWY5OWMwOTVkMWFmZDk3YjQxL3RhYmxlcmFuZ2U6NDAyYzQzMzYzYWU1NDgxZjk5YzA5NWQxYWZkOTdiNDFfMS0zLTEtMS02NDgwNA_99d3ea65-9a12-4b1e-8d8b-98be5db4d7f7"
      unitRef="usd">130000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMTMwMA_936ed484-1a70-4fec-ab4f-e207309f82df">Debt&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2022, Embecta, as a wholly-owned subsidiary of the Company, issued $500&#160;million of 5.000% senior secured notes due February 15, 2030, in advance of the Company&#x2019;s spin-off of Embecta, which is further discussed in Note 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After the spin-off was effective on April 1, 2022, $200&#160;million of 6.750% senior secured notes issued by Embecta and due February 15, 2030 were exchanged for $199&#160;million of the aggregate principal amount outstanding on the Company&#x2019;s Floating Rate Notes due June 6, 2022, which were purchased through a tender offer.  The carrying value of the long-term notes tendered was $199&#160;million, and the Company recognized a loss on this debt extinguishment of $2&#160;million, which will be recorded in the third quarter of fiscal year 2022 within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other (expense) income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, on the Company&#x2019;s condensed consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also in connection with the spin-off, on March 31, 2022 Embecta issued a senior secured term loan facility with an aggregate principal amount of $950&#160;million and a senior secured revolving credit facility providing borrowings of up to $500&#160;million that was undrawn at March 31, 2022 and at the spin-off date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The borrowings from the 5.000% senior secured notes due February 15, 2030 and the senior secured term loan facility were included within the Company's condensed consolidated balance sheet at March 31, 2022.  The senior secured notes and credit agreement for the term loan and revolving credit facilities were guaranteed on an unsecured, unsubordinated basis solely by the Company prior to the spin-off date.  The Company&#x2019;s guarantees automatically and unconditionally terminated upon the consummation of the spin-off on April 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 31, 2022, Embecta used a portion of the proceeds from the financing transactions discussed above to make a cash distribution of approximately $1.266&#160;billion to the Company.  On April 1, 2022, an additional $197&#160;million was distributed to the Company through the exchange of the senior secured notes discussed above&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5845caed52ce4da4b4f7325c57203c22_I20220228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMTA0_e26ac9a4-8c57-48ec-93da-74e2d42180e0"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5845caed52ce4da4b4f7325c57203c22_I20220228"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMTEw_f0e9b55a-84bb-4809-96c8-9f0f161bf5a6"
      unitRef="number">0.05000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i26418175d8c34a61b6aa277d1076d5b4_I20220401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMjc0ODc3OTA3NDM3Ng_e6de284d-5e9b-4806-a4fe-ce1b3e56826f"
      unitRef="usd">200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i26418175d8c34a61b6aa277d1076d5b4_I20220401"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMjc0ODc3OTA3NDM5MA_5555f323-0628-424c-ab85-ac5547a11143"
      unitRef="number">0.06750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i624a854f791c444da897e1e70f2d8eaa_I20220401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMjc0ODc3OTA3NDM5OA_c0348da9-8385-46ea-abdb-a1069b9210c1"
      unitRef="usd">199000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ibf5d860aadcd4dc18e87ac829cc865d8_I20220401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMjc0ODc3OTA3NDQxMg_608a13df-8075-4e41-9cc2-78702f465463"
      unitRef="usd">199000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="if6c6a8360d284859b924495a95a1b82f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMjc0ODc3OTA3NDQyNA_e7f9163a-d5a3-4093-9379-b5140442d94a"
      unitRef="usd">-2000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib929424705fe416e91cbcae5e6409cf0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfOTMy_8b66a1df-4617-4c20-9520-4945a35c086b"
      unitRef="usd">950000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i9481af032d5d48ff9483bc7a0054b2a8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMTAxMg_dfa02c69-640b-4cb4-aeda-f392bcddbdaf"
      unitRef="usd">500000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5845caed52ce4da4b4f7325c57203c22_I20220228"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMTA5OTUxMTY0MjAwNw_f0e9b55a-84bb-4809-96c8-9f0f161bf5a6"
      unitRef="number">0.05000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i9439d04ae9f64d88879f7c48614cdf5f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMTI1MQ_2d60174b-f9e7-4d79-93e9-6739b643bf86"
      unitRef="usd">1266000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i8bb9f175be97441e81ee4fb5f8665671_I20220401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiMzZjOGIzYmQwYjQxNDU4ZDU1NzBkNDkyNDY5NjcxL3NlYzpjYjM2YzhiM2JkMGI0MTQ1OGQ1NTcwZDQ5MjQ2OTY3MV82NC9mcmFnOjg0YmExNDgyOTg5OTQyNzE5NzgxZTg0N2MwMDA0MWZjL3RleHRyZWdpb246ODRiYTE0ODI5ODk5NDI3MTk3ODFlODQ3YzAwMDQxZmNfMjc0ODc3OTA3OTkxMA_b6d5e01b-9e22-4bbe-8670-e3a577ec5c7e"
      unitRef="usd">197000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>58
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MR.WO.X?[GH-9H\8:'78&K'N[@(U5KS%<S')6N@;6KO=-KEIT;/:%RWU!71G
MNSBB3\!2VMC*V;S7!RY@0X1K*._B;.[:62(DX*IN:'OD3D&@B)!P6JW@)(!S
M0:3] </5KW_!3!KPNSBO6Y/W[)5<IE"V[#%+FM:[F6L624KWG2AT7(JFW^#?
MQ9G=.CQ)4YAE5'OO#T@],_A<]M<.EW1)0SIR)F&FN8?9-!W!'=02.ILS_0P.
M\[UX*7LMXG(7@/$GV$@^L2=>H19-EW 'M8G.8A?%&RF>LS+I+R6NB<:0FKY
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MF!E2U$]W/M@T7\MNA%FHLB:Y?()VP?L$QL!T'Z"Z&ZNK]AO.H[:PTVPOEU*
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MVNOM3?8OY&J9,$8B4:.THXPIV*KN96HS::_D,X=%1^M7).LPT3I,ESUQFM6
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MHV>C1\^21\_^;^;_ XSXN2$0OK1M)\U>F:V(1L9*!:I$:5$BX_-5GP7<U&/
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MM9K:9A')HZ,G=ZM*.C) J\<:&A/3@,K^W]W0,XHF?(8> ]\?)U>($7BT81'
MY,"$/# YH=DM%JO2W^-2\L'R0/5QOK.+@G"VVCW1QP'GH32)XD?OYN+MH#G3
M4/P1#U)/#@W(L0RL&D8LW%?XYLAST.C]H9DF=3UBT'U?;XO)-S02M4V_%'!/
M8RC*G]/CT_''B%7^!C^8YU\R<+IN69XUU5AZ,O_JBT*X_.M O@FV2U_D&QOP
M?9\N&TS Y-@ [VN+WNUO>(/Q)YJ+OP!02P,$%     @ "U^E5&.8!6IY"
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M:6C^NF5!'SRHK #=YU*:P\8:Z#^AEO\ 4$L#!!0    (  M?I50SK\FME!0
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M!,^4(CBE)(T,GA$8^Y'[[JT'8A1S(32D3FEP.VOT#[@"!Z32V':/W'JK1*9
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M$O/E6OIKA>&&&>>R2YF[,.^[<;$?0>3'H]ZMLR\\\K[HLUA>CZLIMPR\.#E
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MB]:[HLMC$-M:Y[60'F9KQ$1G783AL?:NJVHX4"@4HH(TC/N4UN2V5608ZP5
MT>Q$MA.W]Z-P0LHKE*T !9(*03@FXAYU0?E ;LS@^39,5FF;FZY0HE;2Q#HG
M\[2%X9%OAX]MO0N(CZ3?1I=*! 3+YDK07=*CB'KLY(@XHS1"PDC1I6TM45UR
M!85T (Z"G$",_*']2EGEL=%V&8AP+!Z4#)U7C"7L'J@C7N..-"BZDJPA\A2N
MRV+9&93"W'4V$B0EE<? %^6=]Z14P3V4.PYN[A'=*(P+ 5>HYQ:G*2I.9 0$
MBQ3";9!*I((!@)@FE5X6A$*N]$9FA@!_ZA#A07WQ0CE'7D7E4>6P2:6V(#;6
MB#;@8O!PDHWP##'AVB?R48!EN@2?>J5>AX]+QA"M*CA+%O CT10\YV> LI6^
M.#)H&I11VJ8NA\@N<9#H& 1#A7AP]E78@B&DG4"3D<WF])-M[/R4:B_-GNE.
M:?6EV-#J)Q@*'?@V M!KZ$8D]IF;@Y6H& 4C7&J+&^@<V(@^%?8R&J<K3[;Y
M@4/D3.BR7Q!ETBS%1@+JN*.8HLAWW$GGJ4KUR!>3UT$V8#1,<T6"AQ8[I*TW
M.T)X[Z:AF*FBIP;=QH$A)S2$&*XA!\G.#&XA["FA40=ZK#BP?9(C"G;?SS$=
MDCQ8*C-M--R"@0^4HV/;84U/JHVJR<#ILY-EJI%;$.'-Q?L+M&!C>)K N3<7
M[]X."TM"F+(#I<7LTO4:M^><I XP>(IHP[7F=3^7O:-3;3_@X/++3!BP1J$K
M2\[RJ5R(&\\%G*I(H"R[F]/F5AHFYA.-%4'<R59':2A09''JHSG*-^P*P8%?
M),2-E>L([\ <T+D$.J-,XG2ND'V@RZS$LM@#]Q$.^(.T,MDFGIQ)E1;Y5TF0
MA4_ W<[JE'RZ.9@,Z!@AV3WYE_7^\=@$?"#0Z!#X&J\,KD (H&QDZ\345.OD
MP''C "+5/FF!HA([E/S]Q) ,DMIK<+)!!9JT<1=(^O@Y':35T8!9"B6()X-?
M9M*!:+%OJ7QS=7NIYD^!LK]Q2+)A<NDLH*'"WON4RH-./2KG;,"=@('+)*ET
MZ'>5[-OL4(W5<Z0I '23Q."8^F1P9=R2!_0:@@,L/])N.8.^OV"$'B\87^/Z
M[RBI4W4AMWN6#^82&EC::'*!@\J]4E9>];G(:32TM5?K/0E\930>%0%"K/DP
M _;'"=@7ML\@[Q-APV'!D$0CW2R3"76:QU+;#""<Z>509,9A#^.11[/W&B/9
M_@B*R[Z4\)3ARVEJPW/ Z5!J57R.)R\&N12:_20"@]"9R>S)&<8<S;K25%G&
M*:?H_*06*:OV\WQ.*QG31#KR>"ANP&D%&O0 ]C/#.+/O\-:=*64'"(F6?B((
M:9[&I31TR1;;S[P$4-^LC]<B&WK2RVZV/[\GOT(J;'V]8+0:^0N<3UT^8FX9
M4W2L3A9I1].T2IZ#63\!LM\;T>7\P+TR(!?FJMGV]\C=RK.S]],;PNP L>Y6
MNW[$3A2AXH!<F7/3!,>/U&8P3>JF:S ^ QG,E*GHQ;[QE30>5NFW[]LT9537
MI'%K&,++CH:[O@4GD@6U=W+BJ2PP@ Y-Z@]1]A-:I6EJTGG N:.AV'^VI'(S
M_L,Y +I\D:+GARDZ8]R6YH5,?=)PT_M)_]*>*A-LJG7;-TXP\EX'6:&.)O_V
M7HUN:))ZL?GZK$0OCD%5J7:].G& $)5R8&F+Y._?" B$,6G!N7\Z3)EOCU_[
MI+":?:J!+Q5_D.I?,M)7FW%U_.9UDS[U3,?3!S, B6"AX:@2HB?'[RX6>#'A
MCU#I(;J6/_QD+@(X_HG76-1 .H#]TL'._H$N&+\$7O\&4$L#!!0    (  M?
MI52J [N+IP<  +X2   9    >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;-58
M6W/;O!']*Q@UT]HSBD6 ]WRV9V*GG6:F[N>)D_:ATP>8A"5.2$(EH,CNK^_9
M!2E+3N3T\M077@#L8L_9"Y8\W]KAJUL9X\5CU_;N8K;R?OUNL7#5RG3:G=FU
MZ3'S8(=.>[P.RX5;#T;7+-2U"Q5%V:+333^[/.>QV^'RW&Y\V_3F=A!NTW5Z
M>+HRK=U>S.1L&OC4+%>>!A:7YVN]-'?&?UG?#GA;[+3436=ZU]A>#.;A8O9>
MOKM*:#TO^$MCMF[O61"2>VN_TLO'^F(6D4&F-94G#1JW;^;:M"TI@AG_&'7.
M=EN2X/[SI/T/C!U8[K4SU[;]:U/[U<6LF(G:/.A-ZS_9[1_-B"<E?95M'5_%
M-JQ5Y4Q4&^=M-PK#@J[IPUT_CCSL"131$0$U"BBV.VS$5G[07E^>#W8K!EH-
M;?3 4%D:QC4].>7.#YAM(.<O[\P2%'M!PN<+#XTTOJA&Z:L@K8Y(9^+&]G[E
MQ._[VM2'\@M8LC-'3>9<J5<5WNCA3,1R+E2DU"OZXAV\F/7%/X'WR:SMX)M^
M*?[V_M[Y <'P]U?4)SOU":M/_DOV7I6F?'OGUKHR%S,DE#/#-S,[4"D^KXRX
MMMU:]T^_<P*II_OFGYK"6;<",#:5WPQ&-(XCLQ:;-0+=KP9C*!G:&K%DQ/W&
M86/GA NJW3MQ]4'<F+JIH.7DM[\IE(I^&=_Y3?YR.J<U?VH>C+BK&M-7QNU6
M'HQ.ZX7N:Q+YV'O"T8\V3C*'PY/0V0N DX%" Q1YR9ME4^T P :_TIYG.]VC
M9M0066M:USZ)>U/IC3/"Z&HE;&^0G-]0=-9N3JLW#YK)<FPI"M!7@XWJQB$J
M*B_6@ZW!9I@E5S0 =R8F;V!=U5H7Y+$]U1.Q-@-71?! _,,+E46U<IXDMHU?
MB89@$P_!7%8U3*%X@%Z8;[K= (@[4&L?1 .COG,AFZG;UE8L K/L9B G>0N.
M3 <\#3 V1,MS9(S2 B4=G%$V +OMS%QL5PU(@VD4AZ1_ '?]AE6#%RBX?YHX
M DHW6O"LR#SBF'!$V:=)$A+CAO.7H;OI&\\*EL8N![U><2B"6.T$L!.$,8S9
M'<WCVX[J#%'3V#JXH#9>-RU91B?+(9DKZ.DM6 ?]#32S'R;T$S02H2WV2YA
M 0(15(%.;IJVA;F.G%#;MM6#.^6Z1!<IO@ #!.X\>^!C\/2([[/UN/Y\Q92$
MX<['U ?3XI@:GL2=;3>>]W\CTJ+ -4DC7.4\BNDMC26-9?1<EN6^CIOG:'O6
MDF12R"06692()(F$5)E(LTQ\:/2](0.OB55),W$L5![CN<!S*E21B-N51DA6
M!LK(X+LG1'GGH"05<0Y%$91'D8BQ29*I$=Y+QMGZ6"9\EY'"7<T3F?$[RD1
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M3G$4^$F1-4^'@@#FI(Z/]]3 K*$""Z7 Y,?Y??WJ.IF\?4=ZL:!^24WZF[]
M2;&5+*!K@CRA=OY_B@RM($9'YHK:M[N!LUNI%.7*L8:,=H5UY_"!@C=[1/@S
M9.^3\4+!6BA* X+P\("UQVI+1]-Q )[ +S"9T7#)D]_Z_S0#;X8:S<@6IC/8
M"%="+?8A,CB[.H>S:<+#]?DQQ3>Z"96'*4\NX7NW.#YJFE2((CP-CK+>:-_U
MSV%W>'U67=/]:MX]7<1=2$J)PIQ<QQ=O+R.PW7/0+;RI0PO>&D]5#].27E"T
M;$#GN3'^L&""X4U>_@=02P,$%     @ "U^E5)QV2]>3!   (@H  !D   !X
M;"]W;W)K<VAE971S+W-H965T,30N>&ULI59A;]LV$/TK!Z\8'$"+)4JRY2P)
MX"1K5V 9@J3=/@S[0$NTQ%4259**X_WZ/5*VZZ:-T6(P+(F\N\=WQ[LCS]=*
M?S"5$):>FKHU%Z/*VNYL,C%Y)1IN3E4G6DA62C?<8JC+B>FTX(4W:NH)"\/I
MI.&R'5V>^[D[?7FN>EO+5MQI,GW3<+VY$K5:7XRBT6[B7I:5=1.3R_..E^)!
MV/?=G<9HLD<I9"-:(U5+6JPN1HOH["IQ^E[A#RG6YN";G"=+I3ZXP=OB8A0Z
M0J(6N74('*]'<2WJV@&!QL<MYFB_I#,\_-ZAO_:^PY<E-^):U7_*PE87HVQ$
MA5CQOK;W:OVKV/J3.KQ<U<8_:3WHIO&(\MY8U6R-P:"1[?#F3]LX'!ADX0L&
M;&O /.]A(<_RAEM^>:[5FK33!IK[\*YZ:Y"3K=N4!ZLAE;"SEV];R]M2+FM!
M"V.$-><3"U@GG.1;B*L!@KT ,:5;U=K*T"]M(8K/[2>@L^?$=IRNV%' 6ZY/
M*8X"8B%C1_#BO8^QQXM?P'NC5+&6=4V\+>@+A^E&FKQ6IM>"_EHLC=7(E+^/
M+)OLETW\LLG_">UW0AS2Y\-,KE AQHJ"U.J,$+N\V@>/'D1G1;,4FN+03T4T
MOD4H4! &^E2HNN;:G- ;K8RA19[W35]SA_8[.L(UUWHCVY(6C>I;^XU:>&DK
M_X54?L'V1CRB$72069%7K:I5N:%7%"5!&J?X&*=!,H].\#4/PB091/%\[D1)
M,,_B091$,[KVU0'7M  7YU$E.T-),,VF-&9!&*8GQ#"*W%R:T3@*LGCNYK(H
MHSNMBCZWI%W=&HJBE,89.Z$XIHC%^,9224CO-"_0!]$C,7(8R10(4X;1'*-X
MAM$LHCM$HP6,2S%E*[!*$X#$"5#0("F-_0CXT3PZ&J%7T ]8-G,>9T$XG3F/
M(Q8P%@ZR"/L*V2R(LW0KF\4S>M_R(ZB+_&,OM1?]U&F5"^RC%D;X='&DBV%C
MT&\M,'WD\3CPGN%W? U83(?'898.!GZ#2#SA,#&"<)@0@H2_%H*:H7T(USZ>
M)["CYM-VS;% G#(T09^^7H*)<#<1.'\ZX;M\O3G]9@Y&/GT'@UDX^YS!=)Z]
MQ.!=Y5:I<>ZYXI!(#BB@7'-9RX$+*K#<-:?EAI:]00/ SAA1NHTX>Z%8;T4A
M<U[3;W(EZ"&7HL5^.H>%?H09]"%\IRR>GWJ?A_A*/T "(=]25WQ9/!WR*8M\
MKL7!/(R&U#'25QB-^0G]^$/&(O8S(>U9F"+]IW37(V8X'*G3,D? X70^N,B+
M?U"GC2^.G>'N/48YN/]UKS5\V!!Z;VN&8D:U."F*;>RJ9IR%)\^=>;91@R,H
M732(D V.S&?.098$X7SJN=^+SJ6]8[./O-N4LO5)/;221V2FHEQHBUL-+@X'
M_J\KB377 H=%JRQ.8L1<(LZR+>2C+'IXOB%D%NQ<<O&RU**$TNG7#I3)P;F-
M1E;ZVXGKZ.BBPQ&^G]U?@!;#N?])?;@](1:E!+]:K& :GL[2T=#9=@.K.G\+
M6"J+KND_*USBA'8*D*^4LKN!6V!_+;S\#U!+ P04    "  +7Z547)@UH5@)
M  !''0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6S565MOV\@5_BL#
MU>C:@*R;Y<1);0..D^P:V'0#9],^%'T8D4-I8)+#G1E:5G]]OW.&5UT<I]VV
MZ(-IB3KWRW?.D)=K8Q_<2BDOGK(T=U>#E??%V_'812N523<RA<KQ2V)L)CV^
MVN78%5;)F)FR=#R;3%Z-,ZGSP?4EW_MLKR]-Z5.=J\]6N#++I-V\4ZE97PVF
M@_K&O5ZN/-T87U\6<JF^*/^U^&SQ;=Q(B76F<J=-+JQ*K@8WT[?OYD3/!'_1
M:NTZGP5YLC#F@;[<Q5>#"1FD4A5YDB#Q[U'=JC0E03#CMTKFH%%)C-W/M?2/
M[#M\64BG;DWZ5QW[U=7@8B!BE<@R]?=F_9.J_#DG>9%)'5_%.M"^ G%4.F^R
MBAD69#H/_^53%8<.P\7D ,.L8IBQW4$16_E>>GE]:<U:6**&-/K KC(WC-,Y
M)>6+M_A5@\]?OU=6/TJ*C+C+G;<E NZ=D'DL?E+Q4N=+<4.!TUXK=SGV4$F,
MXZ@2_RZ(GQT0_TI\,KE?.?$ACU7<YQ_#U,;>66WON]FS C]).Q)GTZ&836:S
M9^2=-?Z?L;RSW\-_\5Z[*#6NM$K\[68!<A35WY^Q8MY8,6<KYO^I+/R.XL6O
M*R5N35;(?"-*AQMQRZX[[-Z@(+U>2J]$I*P' @CU5'!XW*@G)C80DQLOP*@L
MI("W(S71N<PC+=.>?"".0(1C,@\?7:&B,@T,16FAI]:BD@0]#H-6RJE#UI*S
M*SBK8J&]RIQ8R5@ %GQKYA__<#&;OOZ30YNGL$<);JO 2F2)U%8\RK2$,R;A
M6ZTRW"J]\Z E>Z47J-1HU90J"_FB"JA>( )G$[X]%6N%6J+( & @2Z9]EPX8
MV :L4):1F<PE%9%T*Y$ :F$V)!?6/&ITGE@0_(X$D PXE8O;TEJ51QMQK]U#
M\/!>(;B@1.'@_W*[$E:2,\+<4<W=I!M66E,N5XB!^%!:S(RA^!%#@K)]X[0<
MBEN9RUBRII\1L%S<9/ WDO#7RMQ)!FDXM%<VPBFM1G(3:[)01!1EKB/?LKNA
M6*I<69FF&PJ=S(E$V:CR ?"M00/EN<E/5YN"Q"144U!M-R(R9>ZM;E52@G,#
MV.7(Z,9S(C%(C"7"D**DS'=<( %UB\3(A<;<TS"M"A;SH<.HF!#:M;3('^"2
M4 6E?9>C[&/2T6FT@RG A"1'$!60:Y2.SE&4/A0_65YU:"W E0NG8RW)W6&W
MR#C35:?0[483$O @I',&A4?^K+4G%]"'/5U\N];6Z< A5*(A]I31:3?(L5KX
M4,G6.'?::'=K64#&>J5)"&?&00CS0&:._:6U(M@/<ORRQL2G_YV(14C:4G5C
M396.+@SYDQG50=/C.\VW;;ZM.N<0\K"D[X ##E%*/?Q6''_2:4JE33)BW)76
MG3!J*_&^B@!M-UOB]XBN6W_7?7$L3\37O!/0(S$=SB]>X?]L^/KLO.$]G+'C
MQ8GX\[X<0,)\^@;7\_F9N-V34W$<'6*=#M^<7U17LO%>8?%T'0+*4 \]DFTG
M6Q3!'S8U:I"V$1E.>A!1R(U<I"I HE610D;I^TC\B'H.M[$!T%@,V.RVDLV=
M&)EEKO]!D)%E*J9V@3)N!^A17&[@6VY+)&8D>$G4)DD<@K+8[))50Z%$QFRZ
M(8^Z@ZU7]$2WJD9\9!Q7XW8#'QJ9(\Y*W0Q=IW+Q"X/?,:*+_5R=5(X-N0V'
M(BX9GDDTH$Z%R>3TD\C",JAH&=S7$6T/('#50"0\Z[3A#XX*UYE4Q^Q$.PI#
M@F$VU6)3*M^ F]3DRU,HRJC]MX9XP!HV)\QC"A""BDB0@*A3A7WXZ0%N'T5^
M<'L1>,1=T#%Z'_K]=PVBY(?2P_)555YWQI", ZC;@K3TF*>+TE,/$5/H2C:'
MAV8_-3QYC?@Z^C*JL Y;'VV-=3?39D(%7C69C0/XRR@JLS* \,Z 9( (,[ZM
M7&IWJU9TN.2BI^H5Q^3EB1B)KT758E08ND)8A$WN=1CV #CR*EQUM$AH6L:A
M76XZ!IIO&A"B_*CJ*&\K!$'&B4%CZK07R":%FRZ7Q@ZO'6W,,;D!"W&'2%'I
M7O.VE.K?RM!1W<P?A[R?M-&&2?^*,VW)M&6WMWC"UK\-'*<,'+3L:A.[W2GY
M*Q-WCYKB"^"F=V/_)&7H8=AI/WU[VAV)^3DN9W1Y,\?E>#8]V3_=IJ_$?$(,
M-$V/+^8GV.M05O!:W--"]^(%G(]B$IO@$^^+^HEJ'VR/Z%=N+^(*YM'"B'4;
ME1(6P4H?$]0#<<C,(:)8PZD&6$.?.OC0RN,5KG/(HZW!-F-PA[._6-9M3!WL
M^3RG$\T- D:<JRKR6 /;*(0*IQ:_5BKO>(NC32BG1EL]H.!#5%4EAJ95M0P8
MCQ5=+E$A\6E)G=TL>E@$ #I%L_+5@SEXO;MD*AW*O3YC42>UA\*J@D?B=@OD
M6HH*>O?%N*^I55&UQ;$>J=&PF>4DI=G\X6$H IUJSWL&S>6(T;#T1-$Y%?+)
M!NV_C<P2JX_UFD)H>=4_Z</L"Z'S+MGRKGM"_H:/I*]&7!6'8JB/XM\-HMO^
MA8-*UQK-2TV*A:@I0R.4M#D"3$,,R8;6IENK76<HS&,H^0J&*1VI3IKD5KL8
M-6(X5W0VJ%89;Y[R91YU(70G:/_6KK6S*]:V-@4$E0O5-[T*3)C_3UY,9Y6N
M,)B[#S.^?W?K(EY3>S0I9 *1IUX^U4M)(HYPHL@"J+-'1Z\OFN\[87E9.&!'
M$?:J=!,0\NCL35_)='*^3\O+0][7\7Q?]0[UO;ZJP>:CL2_ DQV4Z@(*M1X'
MU>_@RO:^UH,R@E5'AQ28(-$#-0#15^Q:F)H^5$QA+*]0Y*?B-GDI!@V?M^ 0
MF%:'IV_RAKG2#LZXW/8:!\4'WE,Z2A#UF\ZIB$OT?WSD^9[G%SU?_D\>7MSM
M23(]$?BX4]='XO5D4ET_5@_5L.?:_M+0%8/3XNTVJDZ'$_"':^_)@PLU<^K-
MZ>XJTD@-ZT;UF+R[ 3%E-6JHT SV7^O[=5S(3> T[9EM^YC*XV.K@KF!#AA%
M+Z[X<??/=^]^N=\Y(A\>V=L6-P\BNRC19^?GA'59X==J!^$&T\Z5-,]1L@'U
M:/T5'^J%<M^KE''GY5:F[))?X;GPK#:\YVKN-F\);\++L98\O&)$G2UI=J0J
M >MD]/I\ &OYM5WXXDW!K\H6QGN3\<>5DH@'$>#WQ"#ZU1=2T+P[O?XG4$L#
M!!0    (  M?I53\56$I)0<  +02   9    >&PO=V]R:W-H965T<R]S:&5E
M=#$V+GAM;+58VW+;1A+]E2EN*G:J&/&F6[R2JB1E7>NJ*'%9WN0AM0]#H$G,
M>H"!9P:BN%^_IWM $*1)V?N0%Y(@IKM/=Y^^ %<KYS^%@BBJY])6X7I0Q%B_
M&8U"5E"IPXFKJ<*=A?.ECKCTRU&H/>E<A$H[FH['YZ-2FVIP<R7_O?<W5ZZ)
MUE3TWJO0E*7VZSNR;G4]F PV?WPPRR+R'Z.;JUHOZ9'BO^KW'E>C3DMN2JJ"
M<97RM+@>W$[>W)WR>3GPNZ%5Z/U6[,G<N4]\\2Z_'HP9$%G*(FO0^'JB>[*6
M%0'&YU;GH#/)@OW?&^UOQ7?X,M>![IW]P^2QN!Y<#E1."]W8^,&M_DFM/V>L
M+W,VR*=:I;-GXX'*FA!=V0H#06FJ]*V?VSCT!"Z/"4Q;@:G@3H8$Y<\ZZILK
M[U;*\VEHXQ_BJD@#G*DX*8_1XZZ!7+QY:RI=949;]:X*T3>(=PQ*5[EZJXU7
MOVO;D'H@'1I/<N]J%&&6A4=9:^(NF9@>,7&N'EP5BZ#^4>64[\J/ +?#/-U@
MOIN^J/!!^Q,UFPS5=#R=OJ!OUL5@)OIFQV*P]?1G$S+KV-F@_KR=(R*@S;]?
ML'':V3@5&Z=_99Q?-,'E^R;4.J/K >HSD'^BP?]O5WTL2"V<1;6::HFZRQSD
M+>*1Z5"()'UNS).VG288B]YDD?)TQE/M/%^M3"Q,I2(TWKNRUM7Z%=2X*CAK
M<LTGYMH"'BDA,+1%A>1F19==T?](=:1R3E[-QO+W1$4G6J.+\,PM^"*0TJ5K
M&%0HW*I2[D7+(>(K>0QYP;V S^&->OU@K$7'D!LY(J%]^&$?UP%,]X?B\YV:
M#2>G%_B>#J>7,_5A+U:3BYF:C'\Z+'PHN*QP-AV+PME/TR38%V(O38@,7ENK
M"K0ENU;6X$BN3/4$?<EMSH[2:":Q\2:N4Q@]D2I3N3JOD'9)2D0?YOMU@R"@
M!YY\X4=K=1O,'NZ%=Z58R[U>(5_L5A/0\A4]9X@CZ.951CYBAJC:N[S)(@#K
MN;&,"P C^7"2F,FL?6+6AC;OFP1__[?+Z>3B[T$M.LJ;/N4]^!%:9A_-\IV&
M%_S/UHXJM]7Q#2S@,C.QX9$#! @EL0?^$^:KSK+$3PF 16_Y$4SU4<T=_E@T
M^'BM?U"_T!-9-4&&ST$,Y'D\5O>-]VR?"XN'&1!:5RU_1&!*#*%Y5*_G&\FI
MF@S'9^?J;#Q3O[QPZ&)X=G&N)I?#L]F%&/XH170\?-P+?+ZMZX.<;:ONA2I/
MB33?$*<:P$U4N39@L*><RIK/'V-"H!U^,V0>V(AUW:+ZW#C&4X.8D#*;I: U
M')A\3X8]G*_E?.%LSEUP-R8M;#@B\=P-,>C3Q0F5@Y:$C/V7R\2%N(_\0!XA
MWQ(N[Z/_&G(NH6!* QKW\W:B'IEA2?]^< JR>=M) :CM X82/_E IKTWR0]&
M/U2KPH#^ND:<G@T$<';K3'(N'+;7ZTI]6DD/ZEE>8K&$+"#I:K<;,29I1W(+
M=%%KXCW@%CW.P8,=MWLA7/=[!'NR!3R$2&8;R7!.'A3FD"93P!OQ/]><0,=]
M+96WZ4M .Y0@F9(#X9D<[53ZIEEWHGYU%9B"PF;[QZ;QNT3<P&,X!PNTY_!P
M@\*F I,<!.E%PQT_MQ14%>:W%&H(J"V#^\9++T,G]TNAX'=GI]@MI1VR#_<N
M):IMQ9BG* /5#O('R@T;#K1D+2<;A OC(74<X.0(P(0B'+?+^&8[^%8@"Z%G
MK]I6 Y:N.89=26UFR<(\<PC8\;;K;#8$-K^LI"Y7U&]M4*_S_V#OWE6=Y&2F
MBK9-JM/5JWXSVE2)Z 7_I4[R8;^8]:;3U8B6R0PB$E])NPLU25T/,2#9;FK6
M,P2_;F+H$[;M?)V!5B!*:\T<YK64J<X*>.YU%1;0+HW2ZUP<)A!^SHO=;T]2
M<02JX#G'@K6-#Q)( T_GK%CV $;6$K^?RMAIW\1]W\1.T(S/D]^PC)$'TPMH
M=E(%&O5/;>-ZWX+B5M+K\-LCNRB"3,A<8*!V/9ZD'/O%+GSI<IH(+7 TD8S3
M#P1VO:NU&T7<7P5-YRR6B: M'8GI?-UQ3!RK."MH;H&$Z<>V/8U&M#WV<5_M
M4%5@S:H@V9,RHCRD[:J#IN5AMYO7$*0\49\[.$\.[CA?-D9D#6&KVF=E:<N]
MM'293ZRN7%3]IF?B7JO;SDNL@=AT]JIO$T3&P5ZOX134S!DR!KZP>9\9'C)+
MV@ZO[:CF%PNLGX=%_TFSMZP]FN=CMP[O@;+=R3ZW_?5%-G;\^#JW^QY@BY_.
M^//\%)^G%Y?XO,3.]O7]\K:-X39F&4"3+-KI>:&-X.81:0<4MLD9/XQ,9F-U
MZ*EVU'N34!(:,[\OX>3"9GJIT/W;O9*Y36\BML?3^QRXLL1(QM!>0'1\<G$V
M4#Z](TD7T=7R7F+N8G2E_"P((?9\ /<7#BM/>\$&NA=5-_\#4$L#!!0    (
M  M?I50"5/0!! 4  "D,   9    >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM
M;)57:6_<-A#]*X.M>P&;/>0K26T#/F(D!9(828\/13]0$B41IDB%I+S>_OJ^
MH;2RO/&ZS1>O*''>O'ESD#Y967?K*RD#W=?:^--)%4+S>C[W625KX6>VD09?
M"NMJ$;!TY=PW3HH\&M5ZGBP61_-:*#,Y.XGO;MS9B6V#5D;>./)M70NWOI#:
MKDXGR\GFQ2=55H%?S,].&E'*SS+\WMPXK.8#2JYJ:;RRAIPL3B?GR]<7![P_
M;OA#R94?/1-'DEI[RXMW^>EDP82DEEE@!(&?.WDIM68@T/C28TX&EVPX?MZ@
M7\?8$4LJO+RT^D^5A^IT\G)"N2Q$J\,GNWHK^W@.&2^SVL>_M.KV)L<3REH?
M;-T;@T&M3/<K[GL=1@8O%SL,DMX@B;P[1Y'EE0CB[,39%3G>#31^B*%&:Y!3
MAI/R.3A\5; +9U<R#2?S "1>S[/>ZJ*S2G98'=%[:T+EZ8W)9?[8?@X& XUD
M0^,B>1;PO7 SVE].*5DDR3-X^T-8^Q%O_YFPZ$KY3%O?.DE_G:<^.)3 W\^
M'PS@!Q'\X!LU^V\K>F?H6J:N1?W'4*?TIDY1H&)*PI.@566U7K^P*R-S-$KJ
M5:YXKRTH5)(N;=T(LYZ2\K[%CKW#Q0)5H347./8<SA:+Q??DI5$6G2<SQ)Z3
ML4%ZREOYX'MYR%+O+X"$SLCOA,GDEI,?OGN9+(]_\>0;95[8HN#O ]M5I;(*
M-*AH'8P<Y1"[]1[N@/@!'FDYH_,BX!.##B KQ"F+0L9N)- ^;YS2U*=^2GO)
MXY".9L>'NT+J54C7&UXD3/YTH+22* -YGU7"E+#!.*.]Y:M78U?,4Y2EDZ4
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M]Q(JNX'6,RG-86(-="^PQ7]02P,$%     @ "U^E5'6*C2?E!@  XA   !D
M  !X;"]W;W)K<VAE971S+W-H965T,C$N>&ULU5A;;QLW%OXKA!"@-J!80P[G
M%M@&8J?=!JBW1IQL'Q;[0(]HB>AHJ"5'L=U?O]\Y'"E*:BE;[-,^>,3AG-MW
M;CST^:,/O\>EM8-X6G5]O)@LAV']9C:+[=*N3#SS:]OCRX,/*S/@-2QF<1VL
MF3/3JINI+"MG*^/ZR>4Y[]V&RW._&3K7V]L@XF:U,N'YRG;^\6(B)]N-#VZQ
M'&AC=GF^-@M[9X=/Z]N M]E.RMRM;!^=[T6P#Q>3M_+-54'T3/ /9Q_CWEH0
MDGOO?Z>7]_.+248&V<ZV TDP^/ELKVW7D2"8\>]1YF2GDACWUUOI/S%V8+DW
MT5[[[C<W'Y87DWHBYO;!;+KA@W_\V8YXV,#6=Y&?XC'1%M#8;N+@5R,SWE>N
M3[_F:?3#'D.='6!0(X-BNY,BMO*=&<SE>?"/(A UI-&"H3(WC',]!>5N"/CJ
MP#=<WMD%7#P(8A8G'\U]9^/I^6R :"*8M:.8JR1&'1!3BAO?#\LH?NSG=OXU
M_PPF[>Q26[NNU%&!-R:<B5Q.A<J4.B(OW^',65[^'9P?[-J'P?4+\<^W]W$(
MR(I_'1&O=^(UB]<'Q'^PGVV_L>(A^)7X\6FPH3>=N.;XV1#%_;/XF_6+8-9+
MUXJW*)^7?'Q4!Y7GF[@VK;V8H/ZB#9_M9*N8-<2$<2I0HZ9W?QC*>YBQZ=T@
M3#\7BYT)V#4P(@J4M1B6%G_!6B:*[NGUBH(IUC8X/X]$B40?C.OL7-Q3'9^)
MC^"Y]JNUZ9_%$G)ZCZP$; ?)KL=B- :%FPPD%E*QGR<"46Z7'.:3&]=U,#<*
M_R#FONM,B*<<?'I(\0D8P' W0$D4[WOV\(COHQ_P_#[%C9TS\O3+3>&=[= 4
MPK.X\]UF8/VO1%'7>.HBPU-.LYS>BES27DGKIFGV9=R8'NV+P7Z1HDLII,Y%
MF6FA=2:D*D51EN*=,_>6#+PFKTKZDN="53G6-=:%4+46MTN#CM-:"".#[Y[C
M8%<10@J15Q"407B6B1Q*=*E&>-]ZG*W/I>9?F2G\JJF6);\K-:)K)._G4HI?
MW(,5=ZVS?3MZ$-E"/H71B]Y'&/.5GTJ9/*.2!O:7+DA?G55)"PR\<CYN94K5
M()RER(%3(JH*WLD!ZB" 2I.@BD,@I[HN2&&5(&0R02CJ,H4;7&.\[S9A05$%
M,HY812;FFNB5(HDE"5*-$K=(V?72!C#MRQ *Q H** L4DE VM=#PV:?@.[]X
MYDJY#B[%AV.I\D;4"G"(L:*E L\19(0B+\?P2 I#6?*>+D9\<F3?%MH>NYHF
M'ZLI^1!.87*.<#E&FA7H:0.Z._?T_U!X2!@&U4@.SU0J-29I0[M9S;L8-[Y;
M?HVF0BI)(@JW03Q459.?FV]+4*$ 5"51G)(#EM;-H1)4JA9EE8D:I++.1 D7
MU9D\'&<U+:L4&*D5!Z26>0I0HQ.>BMO-M$"6_M42)'RCC\:PJR9ECRZ;]%LT
MO-_ \/U25 42&LV@K#2278H<GBGSZE@OT4TJ.%VE0#1E*LMJ+,2Z(-7YM$!U
M'2S(0K-=!5E;9=Q4:][)B;E4^F!)ZJ(2&OE1ESFWF1SE6R/)#Y>D!H6$D27U
M262$1"1*8#Z*,?6+L;94<F;.)T+9C E8EX<+LYB6['$]S;EWR8P3ECX434J
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MIA32C3J]#'[-M]A[/^!.Q<NE-7,;B #?'[P?MB^D8/=OC<O_ %!+ P04
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M]8A.6UE0]8+".9D&)SS4FGKLK1^<+OVH&6M'@ZN_S>B? AI>0-_GFF32/'"
M]K_'[#]02P,$%     @ "U^E5"<Q;?BQ!P  0RD  !D   !X;"]W;W)K<VAE
M971S+W-H965T,C<N>&ULQ5K;;MLX$/T5PEOLID 32Z1NSB8!:LM6\] B:-KN
MLV+1L5!=7(E.VL5^_%*76!8YHIA-@,U#;,EGAC/#X<PAI8O'O/A>;BEEZ&>:
M9.7E9,O8[GPZ+==;FH;E6;ZC&?]EDQ=IR/AE<3\M=P4-HUHH3:;8,)QI&L;9
MY.JBOG=37%WD>Y;$&;TI4+E/T[#X-:=)_G@Y,2=/-S[']UM6W9A>7>S">WI+
MV=?=3<&OI@<M49S2K(SS#!5T<SEY;YY?6[5 C?@6T\?RZ#NJ7+G+\^_5Q75T
M.3$JBVA"UZQ2$?*/![J@25)IXG;\:)5.#F-6@L??G[2O:N>Y,W=A21=Y\E<<
ML>WEQ)N@B&["?<(^YX\?:.N07>E;YTE9_T>/+=:8H/6^9'G:"G,+TCAK/L.?
M;2".!+@>6 "W E@4L 8$2"M = 6L5L#2%;!; 5O7!Z<5<'1'<%L!5U? :P4\
M78%9*S"KTZ&9OWKR_9"%5Q=%_HB*"LVU55_J#*JE^9S'697LMZS@O\9<CEW=
M;L.";O,DHD7Y!UK^V,?L%SI%BVV8W=,2Q1E:T(*%U6>>[O*,9JQ$^0:!<B<^
MY="D?,LU?+WUT<F;M^@-FJ*R M?*OF8Q*]\=W?BRS?=EF$7\YIOJ^F.<)'P1
ME!=3QKVK;)RN6T_FC2=XP!."/N89VY9HF44T N17:GE'(3_E43V$%C^%=HZ5
M"C^&Q1DBYCN$#8P!>Q9J<9^N#^(F(.[KCPZ)+_5'-Z!@OLSWX&7&?U"+?\H?
MN+@Q*'ZM%K^ENS.$K4K<)(I$((<U1FI]UH"^.;V/LRS.[GE93L)L3:%D:%0X
MM8JJ0SU<8>*X[L7TX3CJ8ZB>?=;!/DMIWR?>4^-LG:>087-+&M*RK;Y9OHS!
MLYE@>H.QCS"F2<P^*) 5F<3 L'OVP3U;Z1Y?S^K8SVW9?,O&MN# &*IGG',P
MSE$:Y\</<41Y_4,[6E0U-N4,H"ZNZ*0JH=7=NEJ^A0QO=+M')AEGGI S"QV0
M#X)('[34 :UDD'GF"@D30"#'@4/I'D+IJM-XG][Q:/'FU+:7<,^V>1'_32/$
M<G1'.3G;[8OUEG.C")WP9M/@H,A>NW*V&OP/MM [6.AI6AA&45R1O3!Y!6,_
M>,\Q=G8P=J8T]BD76;[^_OMOIF/\B:[+<L^M"5ES?1,6S9=O8;*GBD)I&AT;
M,5Y<*N>MCN.52!QAM2YT0+X.:*D#6NF @A%0/V9'#,Y\87UK%=CJ@&F ?!W0
M4@>TT@$%(Z!^P' 7,*S.[' 7,[[R^*):_ES3LFRRF"]+_8SN>K_Y\N8_;W7T
M5O#,(M(403#L8G&2(!@Q3'&:8&V&.%%:@P:CVOKQZ[B)J28G;1DJJS*$XJ8
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M)/\8$AR0- /([]>,B9>';('J?P*S?P!02P,$%     @ "U^E5,??$+7[ P
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M0Q*N N#]EC%Y>E #M+?2R?]02P,$%     @ "U^E5+C2YW#J @  _@@  !D
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MG/?TJ2:JRT,U4;RP_7?.E>[F=KC4%RX4QD"O+SA7VXEIZ>X*-_H+4$L#!!0
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M((57Q@3(XD77G +QN(=B\!X=]I[C%%](FC5XA1XA,=*=>ZW#$R--Y3P24TR
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M B0T7B93(-6SF$K 9Y*PSQR2>E'!M> $=H3 R8*^V^&!DZ5V%N$5,@G"WDJ
MO&J7.0&2?3=R+#B*#3O*W7.Y;&^YGKOOQ8+ VQ$2)@O2;H<G3-:/?*07&1(@
M87$N08!BG'#,"9 1/?NP+9B)#9L),'C9C;P6U-Z.D#19T'4[/&FR1$T8OAD^
MI4!XD]*, &F%ZR,(D$IZED 6G,2&G008O>S>--NI*ANEK*Q;5W9.89F?^L1X
M84N!#%X142"N\<*61,F^LC+6J2MC1W(F5V9/CPV#JP/.SN:5LT[-&1NCZ(QU
MJL[8&65GS$]]_ TN),JOA2%0B<&%GB1*]96=L4[=&0O;3#^WEU5ESCJ5:VR$
MT*FY\NMT>$;Q&J/JTGRNJ43)*UXC4$KC#6LTJL=O.>M4K[&P ?5S?5F]YJQ3
MX,;&J'!CG1(W=D:-&R-*SO"N[RF%XOAFSHQ"*6]S(H62O86*W8+G(Q7/7\IB
M52R_1VE^'TW+;'N'(+1=XG1V#RJ21XB9>+<TF0\/FE[;'J8/'KL$2OCL$BCC
M;9X@4;Q/M;LET4=JHD/L7EBWNS7,?(0TBG=+G/GP/.JU[0&/$F<7)(KC-36%
M4OA::DZB5&]9?\>>CM16A]B^L')W:Z'Y"#$5[]9"\^%!U6O;[F-+$F^M?0)H
M1H&X_P@'"N7MNIAT'DVT=LW%4?M,J"I:%,]YO7T2S?[3_8.GWF^>MH0^_\#?
M3CGQ^:Q]4-7F44AP^.U3KF[3<IGE5;1R#TU7[$U[GZ_</C=J^Z8NGC8/1OI:
MU'6QWKQ\=.F]*UM \_>'HJA?W[0=[!_?=?-_4$L#!!0    (  M?I50](3?J
M_ 0  / 6   9    >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;+U874_K.!#]
M*U9UI04)2.PT:8M*)>B'%@GN173O[L-J'TSBMM9-XJ[M4I#VQZ^=A*1U7(/N
M;GF!)#TSGIDS.1-[N&7\AU@1(L%+EN;BJK.2<GWI>2)>D0R+"[8FN?IEP7B&
MI;KE2T^L.<%)892E'O+]R,LPS3NC8?'L@8^&;"-3FI,'#L0FRS!_O2$IVUYU
M8.?MP2-=KJ1^X(V&:[PD<R*_KQ^XNO-J+PG-2"XHRP$GBZO.-;R<!;XV*!"_
M4[(5.]= I_+$V ]]<YM<=7P=$4E)++4+K/X]DS%)4^U)Q?%WY;13KZD-=Z_?
MO,^*Y%4R3UB0,4O_H(E<777Z'9"0!=ZD\I%M?R550J'V%[-4%'_!ML+Z'1!O
MA&199:PBR&A>_L<O52%V#)0?NP&J#)!IT#U@$%0&P4<-NI5!]Z,AA95!^-$5
MHLH@*FI?%JNH] 1+/!IRM@5<HY4W?5'055BK M-<=]9<<O4K579R-"=+U2<2
M:&-P#F8TQWE,<0IN\[)M-?WJ"HQ9ML;YZR\"5"8"G$R(Q#0]57;?YQ-P\N44
M? $T!_<T3969&'I21:C7\>(JFILR&G0@F@#<LURN!)CF"4DL]E.W?>2P]U1E
MZO*@M_+<(*?#>\PO0 #/ /(1LL0S_K@YM)A/W.83$M?FOJT:_RWXV4\'OU?+
MH&ZUH/ 7O--JCV3-N*3Y<J_'_KQ3<' K22;^<BS6K1?K%HMU#RQVFTNRY*5K
MG"=*!(7DFUANN%Z8O"AE%L36H*7;J'"K9?EY=([Z0^]YEW0+)D3[F*D%$QF8
MF04#_0:TEWA8)QZ^DWC,,@)NB"JMJF=Y]QM^(=;7L?05[D00HM#(MHT)? ,S
M;6,@ZAIEFUE W>A NE&=;N1,=\R$!&P!YC@U,]SSUZO]]8[?I/UZL;XS^&LA
MU+?#K1)6RHM5QRO,EW:F^FVFNOOUG?1;[108D*G3RUX.@SJ'@3.';W)%./BV
M)OIE*\I5=-S)M'S%3AUE@GXSI/SCLP)W9B)TYO3 6:*T J04/]&4RE?U 13S
M#4[/@,J3LL0A(./*]VZ-T2 R7H5W0/MQHR9NY.:B9N%M1KO*T>@V_ 3AAHUR
MP_>DN^R@.R;$Z4>%K/*Y)RY!SS>DS(H:F-)M0:%^OVM2V$8%00 /<-C(-W3K
M=YM#\ ^X)PF-<>HJ;R.8,/H$-AL]A;TCL-EKU3:"YERR@5J"9P'!798J+FTH
MWS_ 92/OT*WO5B[OZ(* >4Q)'CLG%FP4& Z.SRAJQ!CY_S^CE<_="G=[)J,6
M4&A^14PM(.C[ X-1&RI$!]Y.U$P&Y)X,5D;UMR9_5C>JW,Z7%#5*CM G4-HH
M/ J.0&E@D4E3<6T@DZRI!11V3;VU@> A0IMA@]S#IBETS-3&-RU*K0OKJFLC
MYBC\!!H;:4?NC^&?WO14?G=KV][UV$"M;8\-U-KWV$ '-SZH&37(/6J^JH]I
MJM]%E;8SV[;:J^5;G6M#H5:^-M0@-!.VH%#0/Y!P,U^0>[Z,&5=]A24Y U]9
M?EYUFZN5FIF"/F&F!,U,"8XP4RJ?>_OG'NP9/-I0 Q@8/-I0Z@/2W,):82$:
M&$QZ.P=R&5%;.GUT*D#,-KDL#TSJI_7Q['5Q*&D\OX&7$VAY/H67L_+PM7%?
MG@7?JQTDS05(R4(MY5_T5-/Q\GBUO)%L71P'/C$I659<K@A."-< ]?N",?EV
MHQ>H#[E'_P)02P,$%     @ "U^E5.]-KQYE P  \ L  !D   !X;"]W;W)K
M<VAE971S+W-H965T,S4N>&ULI59=C]HZ$/TK5M2'5KJ[^23 "I 6R-5=J5NA
MKMH^5'WPD@&L.G&N;99M?WUM)V3!,>GVWA?BCW-F?#S#>"8'QK^+'8!$SP4M
MQ=3;25G=^+Y8[Z# XII54*J=#>,%EFK*M[ZH..#<D KJ1T&0^@4FI3>;F+45
MGTW87E)2PHHCL2\*S'_,@;+#U N]X\)'LMU)O>#/)A7>P@/(3]6*JYG?6LE)
M :4@K$0<-E/O-KS)PD 3#.(S@8,X&2,MY9&Q[WIRET^]0)\(**RE-H'5YPD6
M0*FVI,[Q;V/4:WUJXNGX:/UO(UZ)><0"%HQ^(;G<3;V1AW+8X#V5']GA'V@$
M#;2]-:/"_*)#C4UC#ZWW0K*B(:L3%*2LO_BYN8@3@K+C)D0-(;()R05"W!#B
MUWI(&D+R6@^#AF"D^[5V<W%++/%LPMD!<8U6UO3 W+YAJ_LBI4Z4!\G5+E$\
M.9M#"1LBT8KB4J"W2Y"8T'?H"JV:9*@WKM"GAR5Z^^8=>H-(B>X)I6I33'RI
MSJ M^>O&W[SV%UWP%Z-[5LJ=0%F90^[@+_OY:0_?5]K;"XB.%S"/>@W>8WZ-
MXO O% 51Y#C/XO7TT"7G_WG/_K/WL\N(VVR(C;WX@KVERH42<G2:%6A)Q)HR
ML>> OKY7V^A.0B&^];A+6G>)<9=<</< _(FL :V9D*Y4JMFI8>N*]S2+DXG_
M=!H=!R0]ARR[D'1\#LFZD.$+Y$S:H)4VZ)5V5TK@(.1%;35]<.(RM$ZU<$"&
MEK8N)!Y9VAR0H5M;VFI+>[5ESY4J\RI-.,@]+Y&J$I5.%"P$2&=-2#MGN$JL
M,"U<F-"2Z\",K8S(')C1A6 .6\'#7L&W!>.2_,3F:6,;5''"U&-[S%X..7'&
M>.B09*EV0&)+M -BQ]@!N1#C42MY]$>250%P1G;4S=&!);$+B6R)74ALA3[K
M0@:!6^*XE3C^3?61DH)J>MPY.^XJLX1U$8&EJXNPLC[KLW&F*@Q>7O2@5]<'
MU5Y6S>M]J?HT)DXK7F@EU<*!B2-+H .36)C,@4GM/Z1_TL$4P+>F=13J^/M2
MUL]7N]JVI[>F*;/6Y^'-(G2L+W4[:SJF%_-U+ZS>T"U1+0Z%C7(57 ]5,'C=
M7M83R2K3/STRJ;HQ,]RIEARX!JC]#6/R.-$.VB9_]@M02P,$%     @ "U^E
M5")&_/(# P  ]PH  !D   !X;"]W;W)K<VAE971S+W-H965T,S8N>&ULM59=
M;YLP%/TK%NI#*VT%0SZK)%+3;MH>JE7INCU,>W#A)E@U-K--DO[[V4 @68!6
MROJ2V,;WG.O+\>%.-D(^JQA HVW"N)HZL=;IE>NJ,(:$J$N1 C=/ED(F1)NI
M7+DJE4"B/"AAKN]Y S<AE#NS2;YV+V<3D6E&.=Q+I+(D(?)E#DQLI@YV=@L+
MNHJU77!GDY2LX 'T8WHOS<RM4"*: %=4<"1A.76N\=4<CVU ON,'A8W:&R-[
ME"<AGNWD:S1U/)L1, BUA2#F;PTWP)A%,GG\*4&=BM,&[H]WZ)_SPYO#/!$%
M-X+]I)&.I\[(01$L2<;T0FR^0'F@OL4+!5/Y+]H4>_L]!X69TB(I@TT&">7%
M/]F6A=@+\'%+@%\&^'G>!5&>Y2W19#:18H.DW6W0[" _:AYMDJ/<OI4'+<U3
M:N+T;)XILZ(46H#2,@MU)BE?H9N8R!4H='X+FE!V@<X0Y>B.,F9*J2:N-M06
MP U+FGE!X[?0#-"=X#I6Z!./(#J,=TW*5=[^+N^YWPEX1^0E"O 'Y'N^__AP
MB\[/+CI@@ZH<00X;M, >5L',0*X!_5H(QI!1P8;(Z'<'3:^BZ>4TO;:JPXIR
M;BGFA!$>0E-%"XA!#F$OUWJ&QQ-WW4#;KVC[G;3%6XV0%@BVYEZK1MX"H[_'
M&_2:>0<5[Z";EZ@8I>3%W&;=*)[!$>7'8-3,.:PXAYV<1FBOU'=X1(K[S9RC
MBG/4S9FD3+P H.\@S5TEUG<ZU#*N8,?O*4KLU5[@G2[+$N.@;BWZP'LNA/^#
M,DN0?>HV9K]F]D_39AE_(,Y!"VMM,S@X49TEP$&9_1;:VG9PM^]\TS'(+JG4
M3H+[[ZK)VCIPMW>\39/'!M)RE7'M'[C;0-XHR6,7";P6ZMI&<+>/O*[)48-A
MMJFCMAD\/E64XZ-O4O /J[O7BR1@*F@[+H5"D7%=M"75:M7571>]3+V]: G-
M-]Z\>X48+$VH=SDTYY5%EU5,M$CSSN9):-,GY</8=*8@[0;S?"F$WDTL0=7K
MSOX"4$L#!!0    (  M?I53Q1"?1H@0  '87   9    >&PO=V]R:W-H965T
M<R]S:&5E=#,W+GAM;,6846^C.!#'OXH5[<.N="W8AH2LTDC=5'M7:7NJMM>[
MA],]N,1)K 7,&B?9WJ<_&R@F8+PY";4O"8:9\=_#^&?LQ9&+;\6.4@E^I$E6
M7$UV4N8?/:^(=S0EQ27/:::>;+A(B51-L?6*7%"R+IW2Q$.^/_52PK+)<E'>
MNQ?+!=_+A&7T7H!BGZ9$/'^B"3]>3>#DY<97MMU)?<-;+G*RI0]4/N;W0K6\
M)LJ:I30K&,^ H)NKR37\N,(S[5!:_,GHL6A= SV4)\Z_Z<;M^FKB:T4TH;'4
M(8CZ.] 531(=2>GX7@>=-'UJQ_;U2_3/Y>#58)Y(05<\^8NMY>YJ$DW FF[(
M/I%?^?$W6@\HU/%BGA3E+SC6MOX$Q/M"\K1V5@I2EE7_Y$>=B)8## 8<4.V
MSG7 M0,N!UHI*X=U0R19+@0_ J&M531]4>:F]%:C89E^C0]2J*=,^<GE;29)
MMF5/"07714%E 2[ BJ<YSVBF&GP#^A;O;Z@D+/F@3!\?;L#[=Q_ .\ R<,>2
M1+V:8N%)I4S']^):Q:=*!1I0<4?$)<#P%X!\A"SN*[?[ \V5NU^ZPU-W3^6C
M20IJDH+*>'@@WF>6,:F&FZW5Z%5-5,TOJM[6EG3\_46Y@UM)T^(?1^>XZ1R7
MG0<#G?\J>%& %1'BF65;<)WR?29M*:W"3,LP>K8>EFKXT6SA'=J9LUE!G>2#
M16/0: R<&J_C>)_N$R)50I1 (=F_1,]*F\PJ4M@2<!'YTZY,B]4,1Z%=9MC(
M#)TR?U<8/".18:]OE2#D=Q3:K&9X9E<X;11.G0H?,U*E3R62F<HB9679M$Y[
M*H)I1ZC3Y$3EK%$Y^\GK_KYGHI1XD0L>4U6@@A:4B'@'B)HE:WI0"T*N\"X=
M,R!JNHM>?_K-F\[GX[Z1>3_=0>>-.$U.5$+?<-MWZOQ#D+5:T=5J[Q@T;"T#
M\/5S#@UP(1HWZW6\=DY1)^M.DU.=ALW0#>>;JM"52DGC7<83OGUV)<  %09O
MD'\#2N@FY=F+#K1@, AQV,V]S0S/YP/Y-[B$;E[^GX4']D%X$09SV)5J,0OF
M$1Z0:I@)W= \<_&IH[2[G_L]@MBL CBP^$ #6A@Y-:[*#TPJ%,V3,H_%CN5.
MH!B,POGK%S0R>$1N/)Y=T'6<T^4RZJZI5JLPLN<?&>HB.%HYUZ%.ZE1MUKHS
MSV8&(SPP\U#KD]A-Z#/+&5F@.XVZ<\YF%<&A=!HZ(S>=[P5?[V,)A-Z[N<H8
M&2ZC-^ R,EQ&(W$968 +>[5A^X8= !TR3$;C,1E98!MU%VZKT9!,PV,T"H]1
MG[08=P7V;0)_0)]A,7*S^*P/.F3XB]Z O]CP%X_$7VPAJQ]U-[$VHP&D84-?
M/!Y]L0VKO:V7U6IHCX@->_$H[,4V]G8GE\UH!@<4MLXL?D)>E41]7J0W@USN
MJ' 5D8$O?@/X8@-?/!)\<9^K8="%ALT(#U -&_CB\>"++5S%?9U6JX&=$S;X
MQ:/@MXYR>E[5/8JQ&,%YMX:]UJ&H/I&^(V++L@(D=*.\_,N9&J&H#GFKAN1Y
M>4[ZQ*7Z*"XO=U0Q66@#]7S#N7QIZ*/7YJA]^1]02P,$%     @ "U^E5-L9
MN-Z  @  O08  !D   !X;"]W;W)K<VAE971S+W-H965T,S@N>&ULI55=3]LP
M%/TK5L0#2!M)D] RU$9JFV[C 0F!V!ZF/;C);6/AV)WM$K9?OVL[S0J$#FTO
MB3_N.<?W^N9DW$AUKRL 0QYK+O0DJ(S97(2A+BJHJ3Z5&Q"XLY*JI@:G:AWJ
MC0):.E#-PSB*AF%-F0BRL5N[5ME8;@UG JX5T=NZINKG#+AL)L$@V"W<L'5E
M[$*8C3=T#;=@[C;7"F=AQU*R&H1F4A %JTDP'5PL4AOO KXP:/3>F-A,EE+>
MV\EE.0DB>R#@4!C+0/'U '/@W!+A,7ZTG$$G:8'[XQW[1Y<[YK*D&N:2?V6E
MJ2;!>4!*6-$M-S>R^0QM/F>6KY!<NR=I?.QH&)!BJXVL6S">H&;"O^EC6X<]
M /+T ^(6$#\'I*\ DA:0O%4A;0'I6Q7.6H!+/?2YN\+EU-!LK&1#E(U&-CMP
MU7=HK!<3MD]NC<)=ACB370I#Q9HM.9"IUF T>4^F9<GL+5).+H5O17NGQSD8
MRO@)1MS=YN3XZ(0<$2;(%>,<]_4X-'@@2QL6K?C,B\>OB"?D2@I3:;(0)90]
M^/PP?G@ 'V(ANFK$NVK,XH.$5U2=DF3PCL11'/><9_YV^* OG?]37_RS^I-B
M)%UK)(XO>87ODY1E@W=+J"C)RS[)F2ZXU%L%Y-MTJ8W";_[[ =FTDTV=;/KW
MCJ2U5(;]\NT'C^B-&OJZS!,.':$UQH<L.<,"/NS?7%],]#0F?QDSBD9/8Q8O
M8X8?SKL8GW&X]SW6H-;."#4IY%887_]NM?/:J;.89^NSP<5\T+.>HS=[*_U#
M[XT=FV#-A"8<5B@5G8[0+I0W2S\Q<N/<8"D->HL;5OA_ 64#<'\EI=E-K$#W
MQ\I^ U!+ P04    "  +7Z54G:J=R=P#   G$   &0   'AL+W=O<FMS:&5E
M=',O<VAE970S.2YX;6RU6&MOVS84_2N$5@PMT$3B]5.=;2!.]BBP $&,;A^&
M?: EVN9*D2Y)Q<V_'_6(Z$(2HVSI%^O%>^XA><^1KA<GJ3[K Z4&?<VXT,O@
M8,SQ0QCJY$ SHB_ED0K[9"=51HR]5/M0'Q4E:1F4\1"B:!IFA(E@M2COW:G5
M0N:&,T'O%-)YEA'UN*9<GI8!#IYNW+/]P10WPM7B2/9T0\VGXYVR5V&#DK*,
M"LVD0(KNEL$5_K"&N @H1_S!Z$F?G:-B*ELI/Q<7']-E$!6,**>)*2"(/3S0
M:\IY@61Y?*E!@R9G$7A^_H3^2SEY.YDMT?1:\C]9:@[+8!Z@E.Y(SLV]//U&
MZPE-"KQ$<EW^HE,]-@I0DFLCLSK8,LB8J([D:[T09P& >P*@#H"2=Y6H9'E#
M#%DME#PA58RV:,5).=4RVI)CHMB5C5'V*;-Q9O51&"+V;,LINM*:&HTNT#U-
MI$@89Z1<.+E#OTJ9GACG:/N(UKFV&%JC#=W;[3'H[0TUA/%WZ UB MW:839*
M+T)CZ15)PJ2FLJZH0 ^5*;J5PAPT^EFD-/TV/K33:N8&3W-;@Q?PEJA+-,+O
M$40 GS8WZ.V;=Q[84;-DHQ)VU /;+,9?]]+^VN(X$97^[4$>-\CC$GG\#/)[
MM*5[)@03>UMRG(B$=BUG!38MP0KU/:Q@%$=X$3YT<)@T'"9>#E?)EYQI9OKV
ML(J>G">=3;M33IN44V_*NUPE!ZLL=%0LH8AP+I.J]$CZCY5 466=7*8M+A?0
M36764)EYJ5SG2E&1/"*CB-"\9-&5>=;./(^Z4\^;U/.!FT]%^LS.S]N;,([B
MGFV(&P*QE\ M35E"N*>.<>1<)7IEC> SQ\*OJ9(:[7RQ< 232?=B87 TX'\)
MI0X_S]M3(=@Y#QY]'Z74N$/(.+/"?K<:JI4:YANQC'ITBIU-8;]/O40NN&U:
MM@1@U,/!^1;V&]?O;$=__ %/HY\V";-+0;6OP)T'X=EKB\>9#![J,L/$TW::
M^:C'9[ S&NQWFF>E$[>RSGI>:^ L":+OHYT:=X!VP'D8^#ULJ':@;5X7/<L/
MSKG [UPOD0ZT72R.>L0+SL? [V/VJY.J![O@=MK>-PXX-X+Q*XL&G-? 4*\9
M)!KHL!N8X[ZB<78#?KMY3C;0_AZ"J.<]!\Z-P/])]-]UT_&1U%<YSK_ [U^#
MA=,VKHMQ7W9G7. WKA<I)VY]GF.(6SX6GO5N&57[LD/5*)&Y,%4;U]QMNN"K
MJO=SPZL6VO8[MCHUXG1G0Z/+F9V]JKK2ZL+(8]D);J6Q?65Y>K"=/%7% /M\
M)Z5YNB@2-/\-K/X%4$L#!!0    (  M?I52H_Q+P)P,  )8+   9    >&PO
M=V]R:W-H965T<R]S:&5E=#0P+GAM;,566VO;,!3^*\+LH86MON;2D 1R98%U
ME(9N#V,/:GP2B]J6)RE)"_OQ.Y(=-Q?79+10/\32\?F^<XUTNELN'F4$H,A3
M$J>R9T5*91W;EHL($BJO> 8I?EERD5"%6[&R92: A@:4Q+;G.$T[H2RU^ETC
MNQ7]+E^KF*5P*XA<)PD5ST.(^;9GN=9.<,=6D=("N]_-Z KFH.ZS6X$[NV0)
M60*I9#PE I8]:^!VIJX!&(T?#+9R;TUT* ^</^K-+.Q9CO8(8E@H34'QM8$1
MQ+%F0C_^%*16:5,#]]<[]JD)'H-YH!)&//[)0A7UK+9%0EC2=:SN^/8K% $U
M--^"Q]+\DFVAZUADL9:*)P48/4A8FK_I4Y&(/0#R5 .\ N = X)7 'X!\,^U
M$!2 X%P+C0+0.-="LP T3>[S9)E,CZFB_:[@6R*T-K+IA2F706."6:H[:ZX$
M?F6(4_TQ"+:ANKIDEDHEUM@U2A*:AN0KA"N6KLA %Y\I!I)\(8,P9+HE:(SZ
M>6/K!KD8@Z(LOD2-^_F87'RZ[-H*W=-&[$7ARC!WQ7O%%9_<\%1%DDS2$,(*
M_+@>WZS!VYB6,C?>+C=#KY;PAHHKXKN?B>=X7H4_H_/A;E4X;[,^>9OU:3U\
M#AG"G2KX02[]LL]\P^>_2Y^-F5S$7*X%KG]]0RHR4Y#(WS6.!*4C@7$D>,61
M$9416>*!2B*T"[*J3W.&IF'01_.F'P2.>;KV9K\!3A7;?I7B^%31;U4I3DX5
M7=<]TCR(NU'&W:B->Y8JP'0J<D<5D/F69N0OJ4_&@9UF::?YL85NE8ZTWESH
MG*&Q7^C*^HU:)V5IM2L+?<KH7U<6^I31=1IUA6Z7<;=KX_[.B_.9)GR=*L*7
M>-/N:E*5A':%)[OG*+KS5:=GJ1X$>%T&>%U?6)XD'&^A9S+"\U[@;/)_G>PZ
M+W>C\[&][.Y=T^Z[5G5:\.T7X#CO]M[8D(!8F0%/DH4VD)_LI;0<(@=F=#J2
M#]W.R*V0C]W.)!\17^CSB15O)TR?)#$LT91SU<)_C,B'P'RC>&:&E@>N< 0R
MRP@'9Q!: ;\O.5>[C390CN+]?U!+ P04    "  +7Z54-/N4,40#  #\"P
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M3G@NW:U>?L0RH:;G&VMIBU]8EK%1 ./<.IV58%*0";6Z\H>R$#4 :[P"B$M
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M<FMS:&5E=',O<VAE970T,BYX;6S-5]MNVS@0_15"Z$,"Q-'%LN,$MH'$<ML
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M^.ZH>GZM%T8NW8#V* V.>^ZVP)D?E#7 YPLIS69A [3_(J;_ E!+ P04
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M*WV.V6&N[S(0!J#GUYRK]\ <9NWMF/P%4$L#!!0    (  M?I52Q_\>KJ0(
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MX/+B"BZ 2YAR(4ABIAM:*L<E%29EZO=%ZM&1U&.8*FE7!L8RQ;0&/SJ-[YS
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MRE_)OAC;]1RRS)0620G&#A*>%N_LJ13B ( \IP&T!-#_ CH-@'8):)\+Z)2
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M2!1UY^#!>11LSJE@^P^"V2]02P,$%     @ "U^E5)>*NQS     $P(   L
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M#!I32?V$\E8JEXHTITR0,ZM@ :N0LE"Q/V<._H,@*UXL4>SQZ&7*1SD@9Y;
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M&^IM!'H;ZFT$>EOOL(1 ;T.]C4!O0[V-0&]#O8U ;T.]C4!O0[V-0&]#O8U
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ME/7=F.5?__AJ[VFMR^:0S[J_B]-/4$L! A0#%     @ "U^E5 =!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    "  +7Z54\)D\+>X    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    "  +7Z54F5R<(Q &  "<)P  $P
M        @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (  M?
MI53EN6S$,P@  $(Q   8              " @0T(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    "  +7Z54MXX.HZ\%  #@%P  &
M        @(%V$   >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%
M  @ "U^E5!4RHSY^ P  V L  !@              ("!6Q8  'AL+W=O<FMS
M:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    (  M?I52MWMJKK 8  !(<   8
M              " @0\:  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"
M% ,4    "  +7Z542X(6VH(%  !V%0  &               @('Q(   >&PO
M=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ "U^E5/-ONVP9!P
MKA$  !@              ("!J28  'AL+W=O<FMS:&5E=',O<VAE970V+GAM
M;%!+ 0(4 Q0    (  M?I51CF 5J>0@  * =   8              " @?@M
M  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    "  +7Z54XJNE
MX/$#  !."0  &               @(&G-@  >&PO=V]R:W-H965T<R]S:&5E
M=#@N>&UL4$L! A0#%     @ "U^E5#.OR:V4%   "SL  !@
M ("!SCH  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    (  M?
MI51*!.@YKP<  !44   9              " @9A/  !X;"]W;W)K<VAE971S
M+W-H965T,3 N>&UL4$L! A0#%     @ "U^E5*H#NXNG!P  OA(  !D
M         ("!?E<  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
M    "  +7Z54@U!:S]L#  !T"   &0              @(%<7P  >&PO=V]R
M:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    (  M?I53Z2'28:P,  )\'
M   9              " @6YC  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL
M4$L! A0#%     @ "U^E5)QV2]>3!   (@H  !D              ("!$&<
M 'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    "  +7Z547)@U
MH5@)  !''0  &0              @('::P  >&PO=V]R:W-H965T<R]S:&5E
M=#$U+GAM;%!+ 0(4 Q0    (  M?I53\56$I)0<  +02   9
M  " @6EU  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @
M"U^E5 )4] $$!0  *0P  !D              ("!Q7P  'AL+W=O<FMS:&5E
M=',O<VAE970Q-RYX;6Q02P$"% ,4    "  +7Z54AXS[LU8)  "Y&   &0
M            @($ @@  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4
M Q0    (  M?I51$[;*N8P<  !<9   9              " @8V+  !X;"]W
M;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ "U^E5.'THBP,!
MC0D  !D              ("!)Y,  'AL+W=O<FMS:&5E=',O<VAE970R,"YX
M;6Q02P$"% ,4    "  +7Z54=8J-)^4&  #B$   &0              @(%J
MEP  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (  M?I52+
M#1'>Y (  !P&   9              " @8:>  !X;"]W;W)K<VAE971S+W-H
M965T,C(N>&UL4$L! A0#%     @ "U^E5#Q#M,BE @  I 4  !D
M     ("!H:$  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  M?I53>Y*@[(@4  !\8   9              "
M@<"[  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ "U^E
M5,??$+7[ P  H0X  !D              ("!&<$  'AL+W=O<FMS:&5E=',O
M<VAE970R.2YX;6Q02P$"% ,4    "  +7Z54N-+G<.H"  #^"   &0
M        @(%+Q0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0
M   (  M?I50OI5PHY0(  ,X)   9              " @6S(  !X;"]W;W)K
M<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ "U^E5.N]^\$4 @  <00
M !D              ("!B,L  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q0
M2P$"% ,4    "  +7Z54FT&6!$<*  #*2P  &0              @('3S0
M>&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    (  M?I50](3?J
M_ 0  / 6   9              " @5'8  !X;"]W;W)K<VAE971S+W-H965T
M,S0N>&UL4$L! A0#%     @ "U^E5.]-KQYE P  \ L  !D
M ("!A-T  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    "  +
M7Z54(D;\\@,#  #W"@  &0              @($@X0  >&PO=V]R:W-H965T
M<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    (  M?I53Q1"?1H@0  '87   9
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M970T,2YX;6Q02P$"% ,4    "  +7Z54$=EC?6@#  !1#   &0
M    @('6]@  >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    (
M  M?I518VT3;C (  "D'   9              " @77Z  !X;"]W;W)K<VAE
M971S+W-H965T-#,N>&UL4$L! A0#%     @ "U^E5+'_QZNI @  0P8  !D
M             ("!./T  'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"
M% ,4    "  +7Z54<Z!6EQ0#  #P"0  &0              @($8  $ >&PO
M=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    (  M?I53*LJ5A @,
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M<F5L<R\N<F5L<U!+ 0(4 Q0    (  M?I53WX7%?Y@,  "D?   /
M      "  2</ 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  +7Z54N2/:
M-[(!  !4'   &@              @ $Z$P$ >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    "  +7Z549>&9M;<!  !E'   $P
M    @ $D%0$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     -P W /@.   ,
%%P$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>347</ContextCount>
  <ElementCount>205</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>76</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/CondensedConsolidatedStatementsofIncome</Role>
      <ShortName>Condensed Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2106103 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2109104 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2112105 - Disclosure - Revenues</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/Revenues</Role>
      <ShortName>Revenues</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2114106 - Disclosure - Segment Data</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SegmentData</Role>
      <ShortName>Segment Data</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2119107 - Disclosure - Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BenefitPlans</Role>
      <ShortName>Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2122108 - Disclosure - Business Restructuring Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BusinessRestructuringCharges</Role>
      <ShortName>Business Restructuring Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2125109 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2130110 - Disclosure - Derivative Instruments and Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities</Role>
      <ShortName>Derivative Instruments and Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2135111 - Disclosure - Financial Instruments and Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements</Role>
      <ShortName>Financial Instruments and Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2141112 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2210201 - Disclosure - Contingencies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ContingenciesPolicies</Role>
      <ShortName>Contingencies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/ShareholdersEquity</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2307302 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/EarningsPerShare</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2315303 - Disclosure - Segment Data (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SegmentDataTables</Role>
      <ShortName>Segment Data (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/SegmentData</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2320304 - Disclosure - Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BenefitPlansTables</Role>
      <ShortName>Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/BenefitPlans</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2323305 - Disclosure - Business Restructuring Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BusinessRestructuringChargesTables</Role>
      <ShortName>Business Restructuring Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/BusinessRestructuringCharges</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2326306 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/IntangibleAssets</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2331307 - Disclosure - Derivative Instruments and Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables</Role>
      <ShortName>Derivative Instruments and Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2336308 - Disclosure - Financial Instruments and Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables</Role>
      <ShortName>Financial Instruments and Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails</Role>
      <ShortName>Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Shareholders' Equity - Accumulated Other Comprehensive Income (Loss) - Components and Changes of Accumulated Other Comprehensive Income (Loss) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail</Role>
      <ShortName>Shareholders' Equity - Accumulated Other Comprehensive Income (Loss) - Components and Changes of Accumulated Other Comprehensive Income (Loss) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Earnings Per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings per Share (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail</Role>
      <ShortName>Earnings Per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings per Share (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2411404 - Disclosure - Contingencies (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ContingenciesDetail</Role>
      <ShortName>Contingencies (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bd.com/role/ContingenciesPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2413405 - Disclosure - Revenues (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/RevenuesDetails</Role>
      <ShortName>Revenues (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bd.com/role/Revenues</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2416406 - Disclosure - Segment Data - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SegmentDataAdditionalInformationDetail</Role>
      <ShortName>Segment Data - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2417407 - Disclosure - Segment Data - Revenues by Geographic Areas (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail</Role>
      <ShortName>Segment Data - Revenues by Geographic Areas (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2418408 - Disclosure - Segment Data - Financial Information for Company's Segments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail</Role>
      <ShortName>Segment Data - Financial Information for Company's Segments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2421409 - Disclosure - Benefit Plans (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BenefitPlansDetail</Role>
      <ShortName>Benefit Plans (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bd.com/role/BenefitPlansTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2424410 - Disclosure - Business Restructuring Charges (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BusinessRestructuringChargesDetail</Role>
      <ShortName>Business Restructuring Charges (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bd.com/role/BusinessRestructuringChargesTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2427411 - Disclosure - Intangible Assets - Components of Intangible Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail</Role>
      <ShortName>Intangible Assets - Components of Intangible Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2428412 - Disclosure - Intangible Assets - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail</Role>
      <ShortName>Intangible Assets - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2429413 - Disclosure - Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail</Role>
      <ShortName>Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2432414 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2433415 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2434416 - Disclosure - Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2437417 - Disclosure - Financial Instruments and Fair Value Measurements - Cash and Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Cash and Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2438418 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2439419 - Disclosure - Financial Instruments and Fair Value Measurements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2440420 - Disclosure - Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="bdx-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2442421 - Disclosure - Debt (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DebtDetail</Role>
      <ShortName>Debt (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bd.com/role/Debt</ParentRole>
      <Position>47</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="bdx-20220331.htm">bdx-20220331.htm</File>
    <File>bdx-20220331.xsd</File>
    <File>bdx-20220331_cal.xml</File>
    <File>bdx-20220331_def.xml</File>
    <File>bdx-20220331_lab.xml</File>
    <File>bdx-20220331_pre.xml</File>
    <File>ex2203312022.htm</File>
    <File>ex3103312022.htm</File>
    <File>ex3203312022.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="739">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="59">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>63
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bdx-20220331.htm": {
   "axisCustom": 1,
   "axisStandard": 23,
   "contextCount": 347,
   "dts": {
    "calculationLink": {
     "local": [
      "bdx-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bdx-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bdx-20220331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bdx-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bdx-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bdx-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 386,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 5
   },
   "keyCustom": 14,
   "keyStandard": 191,
   "memberCustom": 32,
   "memberStandard": 42,
   "nsprefix": "bdx",
   "nsuri": "http://www.bd.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.bd.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112105 - Disclosure - Revenues",
     "role": "http://www.bd.com/role/Revenues",
     "shortName": "Revenues",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114106 - Disclosure - Segment Data",
     "role": "http://www.bd.com/role/SegmentData",
     "shortName": "Segment Data",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119107 - Disclosure - Benefit Plans",
     "role": "http://www.bd.com/role/BenefitPlans",
     "shortName": "Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122108 - Disclosure - Business Restructuring Charges",
     "role": "http://www.bd.com/role/BusinessRestructuringCharges",
     "shortName": "Business Restructuring Charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125109 - Disclosure - Intangible Assets",
     "role": "http://www.bd.com/role/IntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130110 - Disclosure - Derivative Instruments and Hedging Activities",
     "role": "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities",
     "shortName": "Derivative Instruments and Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135111 - Disclosure - Financial Instruments and Fair Value Measurements",
     "role": "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements",
     "shortName": "Financial Instruments and Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141112 - Disclosure - Debt",
     "role": "http://www.bd.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2210201 - Disclosure - Contingencies (Policies)",
     "role": "http://www.bd.com/role/ContingenciesPolicies",
     "shortName": "Contingencies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Shareholders' Equity (Tables)",
     "role": "http://www.bd.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Statements of Income",
     "role": "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome",
     "shortName": "Condensed Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307302 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.bd.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315303 - Disclosure - Segment Data (Tables)",
     "role": "http://www.bd.com/role/SegmentDataTables",
     "shortName": "Segment Data (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320304 - Disclosure - Benefit Plans (Tables)",
     "role": "http://www.bd.com/role/BenefitPlansTables",
     "shortName": "Benefit Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323305 - Disclosure - Business Restructuring Charges (Tables)",
     "role": "http://www.bd.com/role/BusinessRestructuringChargesTables",
     "shortName": "Business Restructuring Charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2326306 - Disclosure - Intangible Assets (Tables)",
     "role": "http://www.bd.com/role/IntangibleAssetsTables",
     "shortName": "Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331307 - Disclosure - Derivative Instruments and Hedging Activities (Tables)",
     "role": "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables",
     "shortName": "Derivative Instruments and Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336308 - Disclosure - Financial Instruments and Fair Value Measurements (Tables)",
     "role": "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables",
     "shortName": "Financial Instruments and Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Details)",
     "role": "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails",
     "shortName": "Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "iefdb0b0a3f294705ae8463fd402aa8f3_D20211001-20211231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i88e64c73fc1047fa8d2dbbd0264a3c84_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Shareholders' Equity - Accumulated Other Comprehensive Income (Loss) - Components and Changes of Accumulated Other Comprehensive Income (Loss) (Detail)",
     "role": "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail",
     "shortName": "Shareholders' Equity - Accumulated Other Comprehensive Income (Loss) - Components and Changes of Accumulated Other Comprehensive Income (Loss) (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i6f49a7b80b0c4a37acc78faacd1def8e_I20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Earnings Per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings per Share (Detail)",
     "role": "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail",
     "shortName": "Earnings Per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings per Share (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income",
     "role": "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411404 - Disclosure - Contingencies (Detail)",
     "role": "http://www.bd.com/role/ContingenciesDetail",
     "shortName": "Contingencies (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i9439d04ae9f64d88879f7c48614cdf5f_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:ContractWithCustomerRebateLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413405 - Disclosure - Revenues (Details)",
     "role": "http://www.bd.com/role/RevenuesDetails",
     "shortName": "Revenues (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i9439d04ae9f64d88879f7c48614cdf5f_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:ContractWithCustomerRebateLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416406 - Disclosure - Segment Data - Additional Information (Detail)",
     "role": "http://www.bd.com/role/SegmentDataAdditionalInformationDetail",
     "shortName": "Segment Data - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417407 - Disclosure - Segment Data - Revenues by Geographic Areas (Detail)",
     "role": "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail",
     "shortName": "Segment Data - Revenues by Geographic Areas (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ibd9d0f9e33a441088614cd71f9e278ef_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:AcquisitionRelatedCostsAndRestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418408 - Disclosure - Segment Data - Financial Information for Company's Segments (Detail)",
     "role": "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
     "shortName": "Segment Data - Financial Information for Company's Segments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ibc4467fbe0ee44db93c2873c8d0afa22_D20210101-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProductLiabilityAccrualPeriodExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ief564af42a4c42e893aff8bd1fbca00a_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421409 - Disclosure - Benefit Plans (Detail)",
     "role": "http://www.bd.com/role/BenefitPlansDetail",
     "shortName": "Benefit Plans (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ief564af42a4c42e893aff8bd1fbca00a_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424410 - Disclosure - Business Restructuring Charges (Detail)",
     "role": "http://www.bd.com/role/BusinessRestructuringChargesDetail",
     "shortName": "Business Restructuring Charges (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i9439d04ae9f64d88879f7c48614cdf5f_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427411 - Disclosure - Intangible Assets - Components of Intangible Assets (Detail)",
     "role": "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail",
     "shortName": "Intangible Assets - Components of Intangible Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i9439d04ae9f64d88879f7c48614cdf5f_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428412 - Disclosure - Intangible Assets - Additional Information (Detail)",
     "role": "http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail",
     "shortName": "Intangible Assets - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i228b2e701bc44f8ab51d7ceb4b6c616b_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429413 - Disclosure - Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail)",
     "role": "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail",
     "shortName": "Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i9439d04ae9f64d88879f7c48614cdf5f_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.bd.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i9439d04ae9f64d88879f7c48614cdf5f_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432414 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail)",
     "role": "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
     "shortName": "Derivative Instruments and Hedging Activities - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i1a1a0aef0db24a0987e1ebb88ed95290_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i57f20120eb6d496fa8dff3eee45b0eea_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433415 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail)",
     "role": "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail",
     "shortName": "Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i57f20120eb6d496fa8dff3eee45b0eea_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434416 - Disclosure - Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details)",
     "role": "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails",
     "shortName": "Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "idcc3814ef1924ae9ba38f953eba0d814_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i9439d04ae9f64d88879f7c48614cdf5f_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437417 - Disclosure - Financial Instruments and Fair Value Measurements - Cash and Equivalents and Restricted Cash (Details)",
     "role": "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails",
     "shortName": "Financial Instruments and Fair Value Measurements - Cash and Equivalents and Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i9439d04ae9f64d88879f7c48614cdf5f_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438418 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)",
     "role": "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
     "shortName": "Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i9439d04ae9f64d88879f7c48614cdf5f_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ifb8b77375efd4b3b80608dbb0eff1722_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439419 - Disclosure - Financial Instruments and Fair Value Measurements - Additional Information (Detail)",
     "role": "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
     "shortName": "Financial Instruments and Fair Value Measurements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i3374a91073fd4143896356601c7a0524_D20211001-20220331",
      "decimals": null,
      "lang": "en-US",
      "name": "bdx:MaturityPeriodOfShortTermInvestment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:TransfersOfFinancialAssetsDuringThePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440420 - Disclosure - Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details)",
     "role": "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails",
     "shortName": "Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "id409f2921c1c4ca2a92452f4e12b5d17_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:TransfersOfFinancialAssetsDuringThePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i9439d04ae9f64d88879f7c48614cdf5f_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442421 - Disclosure - Debt (Detail)",
     "role": "http://www.bd.com/role/DebtDetail",
     "shortName": "Debt (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "i9439d04ae9f64d88879f7c48614cdf5f_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation",
     "role": "http://www.bd.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - Shareholders' Equity",
     "role": "http://www.bd.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106103 - Disclosure - Earnings Per Share",
     "role": "http://www.bd.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109104 - Disclosure - Contingencies",
     "role": "http://www.bd.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220331.htm",
      "contextRef": "ia87163d79a334aeb8b2c137317ce1e89_D20211001-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 76,
   "tag": {
    "bdx_AcquisitionRelatedCostsAndRestructuringCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; business integration costs, systems integration and conversion costs, and severance and other employee-related costs; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Additionally includes the amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Acquisition Related Costs And Restructuring Charges",
        "negatedLabel": "Integration and restructuring expense",
        "verboseLabel": "Acquisition-related integration and restructuring expense"
       }
      }
     },
     "localname": "AcquisitionRelatedCostsAndRestructuringCharges",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_BiosciencesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biosciences [Member]",
        "label": "Biosciences [Member]",
        "terseLabel": "Biosciences"
       }
      }
     },
     "localname": "BiosciencesMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_CommonStockHeldInTrustsAcquired": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Held in Trusts, Acquired",
        "label": "Common Stock Held in Trusts, Acquired",
        "negatedTerseLabel": "Common stock held in trusts, net"
       }
      }
     },
     "localname": "CommonStockHeldInTrustsAcquired",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_CommonStockHeldInTrustsNetShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common stock shares held in trust.",
        "label": "Common Stock Held In Trusts Net Shares",
        "terseLabel": "Common stock held in trusts, net (in shares)"
       }
      }
     },
     "localname": "CommonStockHeldInTrustsNetShares",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_CommonStockSharesHeldInEmployeeTrust1": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of common stock issued to a trust (for example, but not limited to, rabbi trust) set up specifically to accumulate stock for the sole purpose of distribution to participating employees.",
        "label": "Common Stock, Shares Held in Employee Trust1",
        "terseLabel": "Deferred compensation"
       }
      }
     },
     "localname": "CommonStockSharesHeldInEmployeeTrust1",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_ConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumables [Member]",
        "label": "Consumables [Member]",
        "terseLabel": "Consumables"
       }
      }
     },
     "localname": "ConsumablesMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_ContractWithCustomerRebateLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Rebate Liability",
        "label": "Contract With Customer, Rebate Liability",
        "terseLabel": "Rebate liability"
       }
      }
     },
     "localname": "ContractWithCustomerRebateLiability",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_CoreAndDevelopedTechnologyNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets arising from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date.",
        "label": "Core And Developed Technology Net",
        "terseLabel": "Developed Technology, Net"
       }
      }
     },
     "localname": "CoreAndDevelopedTechnologyNet",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DiabetesCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diabetes Care [Member]",
        "label": "Diabetes Care [Member]",
        "terseLabel": "Diabetes Care"
       }
      }
     },
     "localname": "DiabetesCareMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Of Debt Classified From Long Term To Short Term",
        "label": "Fair Value Of Debt Classified From Long Term To Short Term",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "FairValueOfDebtClassifiedFromLongTermToShortTerm",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite And Indefinite Lived Intangible Assets [Line Items]",
        "label": "Finite And Indefinite Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite And Indefinite Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteAndIndefiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite And Indefinite Lived Intangible Assets [Table]",
        "label": "Finite And Indefinite Lived Intangible Assets [Table]",
        "terseLabel": "Finite And Indefinite Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "FiniteAndIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bdx_FiniteLivedCustomerRelationshipsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net carrying amount as of the balance sheet date of an asset acquired in a business combination representing a favorable existing relationship with customers having a finite beneficial life.",
        "label": "Finite Lived Customer Relationships Net",
        "terseLabel": "Customer Relationships, Net"
       }
      }
     },
     "localname": "FiniteLivedCustomerRelationshipsNet",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_FixedToFloatingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed To Floating [Member]",
        "label": "Fixed To Floating [Member]",
        "terseLabel": "Interest Rate Swaps"
       }
      }
     },
     "localname": "FixedToFloatingMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_FloatingRateNotesDueJune62022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating Rate Notes Due June62022",
        "label": "Floating Rate Notes Due June62022 [Member]",
        "terseLabel": "Floating Rate Notes Due June62022"
       }
      }
     },
     "localname": "FloatingRateNotesDueJune62022Member",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_ForeignCurrencyDenominatedDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign-Currency Denominated Debt [Member]",
        "label": "Foreign Currency-Denominated Debt [Member]",
        "terseLabel": "Foreign Currency-Denominated Debt"
       }
      }
     },
     "localname": "ForeignCurrencyDenominatedDebtMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_HerniaProductClaimsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HerniaProductClaims [Member]",
        "label": "HerniaProductClaims [Member]",
        "terseLabel": "Hernia Product Claims"
       }
      }
     },
     "localname": "HerniaProductClaimsMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_IncreaseDecreaseinPensionBenefitObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for pension benefits.",
        "label": "Increase (Decrease) in Pension Benefit Obligation",
        "terseLabel": "Pension obligation"
       }
      }
     },
     "localname": "IncreaseDecreaseinPensionBenefitObligation",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_IntegratedDiagnosticSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Integrated Diagnostic Solutions [Member]",
        "label": "Integrated Diagnostic Solutions [Member]",
        "terseLabel": "Integrated Diagnostic Solutions"
       }
      }
     },
     "localname": "IntegratedDiagnosticSolutionsMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_InterventionalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interventional [Member]",
        "label": "Interventional [Member]",
        "terseLabel": "Interventional",
        "verboseLabel": "Interventional"
       }
      }
     },
     "localname": "InterventionalMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_LifeSciencesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Life Sciences [Member]",
        "label": "Life Sciences [Member]",
        "terseLabel": "Life Sciences",
        "verboseLabel": "Life\u00a0Sciences"
       }
      }
     },
     "localname": "LifeSciencesMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_MaturityPeriodOfShortTermInvestment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maturity period of time deposits classified as short-term investments in the consolidated balance sheet.",
        "label": "Maturity Period Of Short Term Investment",
        "terseLabel": "Maturity period of short-term investments at the time of purchase"
       }
      }
     },
     "localname": "MaturityPeriodOfShortTermInvestment",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "bdx_MedicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical.",
        "label": "Medical [Member]",
        "terseLabel": "Medical"
       }
      }
     },
     "localname": "MedicalMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_MedicationDeliverySolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medication Delivery Solutions [Member]",
        "label": "Medication Delivery Solutions [Member]",
        "terseLabel": "Medication Delivery Solutions"
       }
      }
     },
     "localname": "MedicationDeliverySolutionsMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_MedicationManagementSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medication Management Solutions [Member]",
        "label": "Medication Management Solutions [Member]",
        "terseLabel": "Medication Management Solutions"
       }
      }
     },
     "localname": "MedicationManagementSolutionsMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes0.632dueJune42023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 0.632% due June 4, 2023 [Member]",
        "label": "Notes 0.632% due June 4, 2023 [Member]",
        "terseLabel": "Notes 0.632% due June 4, 2023"
       }
      }
     },
     "localname": "Notes0.632dueJune42023Member",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes0000DueAugust132023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 0.000% due August 13, 2023",
        "label": "Notes 0.000% due August 13, 2023 [Member]",
        "terseLabel": "Notes 0.000% due August 13, 2023"
       }
      }
     },
     "localname": "Notes0000DueAugust132023Member",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes0034DueAugust132025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 0.034% due August 13, 2025",
        "label": "Notes 0.034% due August 13, 2025 [Member]",
        "terseLabel": "Notes 0.034% due August 13, 2025"
       }
      }
     },
     "localname": "Notes0034DueAugust132025Member",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes1.000dueDecember152022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 1.000% due December 15, 2022 [Member]",
        "label": "Notes 1.000% due December 15, 2022 [Member]",
        "terseLabel": "Notes 1.000% due December 15, 2022"
       }
      }
     },
     "localname": "Notes1.000dueDecember152022Member",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes1.208dueJune42026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 1.208% due June 4, 2026 [Member]",
        "label": "Notes 1.208% due June 4, 2026 [Member]",
        "terseLabel": "Notes 1.208% due June 4, 2026"
       }
      }
     },
     "localname": "Notes1.208dueJune42026Member",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes1.401dueMay242023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 1.401% due May 24, 2023 [Member]",
        "label": "Notes 1.401% due May 24, 2023 [Member]",
        "terseLabel": "Notes 1.401% due May 24, 2023"
       }
      }
     },
     "localname": "Notes1.401dueMay242023Member",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes1.900dueDecember152026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 1.900% due December 15, 2026 [Member]",
        "label": "Notes 1.900% due December 15, 2026 [Member]",
        "terseLabel": "Notes 1.900% due December 15, 2026"
       }
      }
     },
     "localname": "Notes1.900dueDecember152026Member",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes1213NotesDueFebruary122036Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 1.213% Notes due February 12, 2036",
        "label": "Notes 1.213% Notes due February 12, 2036 [Member]",
        "terseLabel": "Notes 1.213% Notes due February 12, 2036"
       }
      }
     },
     "localname": "Notes1213NotesDueFebruary122036Member",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes3.020dueMay242025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 3.020% due May 24, 2025 [Member]",
        "label": "Notes 3.020% due May 24, 2025 [Member]",
        "terseLabel": "Notes 3.020% due May 24, 2025"
       }
      }
     },
     "localname": "Notes3.020dueMay242025Member",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes5000DueFebruary152030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 5.000% due February 15, 2030",
        "label": "Notes 5.000% due February 15, 2030 [Member]",
        "terseLabel": "Notes 5.000% due February 15, 2030"
       }
      }
     },
     "localname": "Notes5000DueFebruary152030Member",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes6750DueFebruary152030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 6.750% due February 15, 2030",
        "label": "Notes 6.750% due February 15, 2030 [Member]",
        "terseLabel": "Notes 6.750% due February 15, 2030"
       }
      }
     },
     "localname": "Notes6750DueFebruary152030Member",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_NumberOfEtOSterilizationLawsuitsFiled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of EtO Sterilization Lawsuits Filed",
        "label": "Number Of EtO Sterilization Lawsuits Filed",
        "terseLabel": "Number of EtO lawsuits filed"
       }
      }
     },
     "localname": "NumberOfEtOSterilizationLawsuitsFiled",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "bdx_OrganizationalUnitAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organizational Unit [Axis]",
        "label": "Organizational Unit [Axis]",
        "terseLabel": "Organizational Unit [Axis]"
       }
      }
     },
     "localname": "OrganizationalUnitAxis",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bdx_OrganizationalUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Organizational Unit [Axis]",
        "label": "Organizational Unit [Domain]",
        "terseLabel": "Organizational Unit [Domain]"
       }
      }
     },
     "localname": "OrganizationalUnitDomain",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_PeripheralInterventionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Peripheral Intervention [Member]",
        "label": "Peripheral Intervention [Member]",
        "terseLabel": "Peripheral Intervention"
       }
      }
     },
     "localname": "PeripheralInterventionMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_PharmaceuticalSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceutical Systems [Member]",
        "label": "Pharmaceutical Systems [Member]",
        "terseLabel": "Pharmaceutical Systems"
       }
      }
     },
     "localname": "PharmaceuticalSystemsMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer, and term loans",
        "label": "Proceeds from Issuance of Long-Term Debt and Term Loans",
        "terseLabel": "Proceeds from long-term debt"
       }
      }
     },
     "localname": "ProceedsfromIssuanceofLongTermDebtandTermLoans",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_ProductRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired technological intellectual property and know how, as well as product marketing rights.",
        "label": "Product Rights [Member]",
        "terseLabel": "Product rights"
       }
      }
     },
     "localname": "ProductRightsMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_ProductsandorServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Products and/or Services [Member]",
        "label": "Products and/or Services [Member]",
        "terseLabel": "Products and/or Services"
       }
      }
     },
     "localname": "ProductsandorServicesMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_ShareBasedCompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation [Member]",
        "label": "Share Based Compensation [Member]",
        "terseLabel": "Share Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program, Number of Additional Shares Authorized to be Repurchased",
        "label": "Stock Repurchase Program, Number of Additional Shares Authorized to be Repurchased",
        "terseLabel": "Number of additional shares authorized to be repurchased (in shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_SurgeryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgery [Member]",
        "label": "Surgery [Member]",
        "terseLabel": "Surgery"
       }
      }
     },
     "localname": "SurgeryMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_TermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facility [Member]",
        "label": "Term Loan Facility [Member]",
        "terseLabel": "Term Loan Facility"
       }
      }
     },
     "localname": "TermLoanFacilityMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_TransfersOfFinancialAssetsDuringThePeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfers of financial assets during the period.",
        "label": "Transfers of financial assets during the period.",
        "terseLabel": "Trade receivables transferred to third parties under factoring arrangements"
       }
      }
     },
     "localname": "TransfersOfFinancialAssetsDuringThePeriod",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_UrologyandCriticalCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Urology and Critical Care [Member]",
        "label": "Urology and Critical Care [Member]",
        "terseLabel": "Urology and Critical Care"
       }
      }
     },
     "localname": "UrologyandCriticalCareMember",
     "nsuri": "http://www.bd.com/20220331",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "verboseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingsExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Listings, Exchange [Axis]",
        "terseLabel": "Entity Listings, Exchange [Axis]"
       }
      }
     },
     "localname": "EntityListingsExchangeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_ExchangeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.",
        "label": "Exchange [Domain]",
        "terseLabel": "Exchange [Domain]"
       }
      }
     },
     "localname": "ExchangeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "exch_XNYS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW YORK STOCK EXCHANGE, INC. [Member]",
        "terseLabel": "NEW YORK STOCK EXCHANGE, INC."
       }
      }
     },
     "localname": "XNYS",
     "nsuri": "http://xbrl.sec.gov/exch/2021",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r102",
      "r147",
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r167",
      "r171",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r247",
      "r248",
      "r250",
      "r252",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r102",
      "r147",
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r167",
      "r171",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r247",
      "r248",
      "r250",
      "r252",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r0",
      "r106",
      "r111",
      "r117",
      "r185",
      "r436",
      "r437",
      "r438",
      "r444",
      "r445",
      "r483",
      "r484",
      "r485",
      "r486",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Effect of change in accounting principles"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r0",
      "r106",
      "r111",
      "r117",
      "r185",
      "r436",
      "r437",
      "r438",
      "r444",
      "r445",
      "r483",
      "r484",
      "r485",
      "r486",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r0",
      "r106",
      "r111",
      "r117",
      "r185",
      "r436",
      "r437",
      "r438",
      "r444",
      "r445",
      "r483",
      "r484",
      "r485",
      "r486",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r258",
      "r293",
      "r425",
      "r430",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r524",
      "r564",
      "r567",
      "r588",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r258",
      "r293",
      "r425",
      "r430",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r524",
      "r564",
      "r567",
      "r588",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r174",
      "r332",
      "r334",
      "r526",
      "r563",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r174",
      "r332",
      "r334",
      "r526",
      "r563",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r258",
      "r293",
      "r369",
      "r425",
      "r430",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r524",
      "r564",
      "r567",
      "r588",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r258",
      "r293",
      "r369",
      "r425",
      "r430",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r524",
      "r564",
      "r567",
      "r588",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r175",
      "r176",
      "r332",
      "r335",
      "r566",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r175",
      "r176",
      "r332",
      "r335",
      "r566",
      "r574",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "stpr_GA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GEORGIA",
        "terseLabel": "GEORGIA"
       }
      }
     },
     "localname": "GA",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Payables, accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r6",
      "r20",
      "r181",
      "r182"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade receivables, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r49",
      "r53",
      "r60",
      "r61",
      "r62",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Benefit\u00a0Plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r32",
      "r206"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less allowances for depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r53",
      "r60",
      "r61",
      "r62",
      "r63",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Cash Flow Hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r23",
      "r51",
      "r52",
      "r53",
      "r551",
      "r572",
      "r573"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r60",
      "r61",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r48",
      "r53",
      "r60",
      "r61",
      "r62",
      "r456",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Capital in excess of par value"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r436",
      "r437",
      "r438",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Capital in Excess\u00a0of Par\u00a0Value"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r432",
      "r433",
      "r440",
      "r441"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to net income to derive net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r89",
      "r194",
      "r200"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Intangible amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Share equivalents excluded from the diluted shares outstanding calculation (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r89",
      "r204"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Asset Impairment Charges",
        "verboseLabel": "Asset impairment charge"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r99",
      "r155",
      "r162",
      "r169",
      "r184",
      "r240",
      "r241",
      "r242",
      "r244",
      "r245",
      "r246",
      "r247",
      "r249",
      "r251",
      "r253",
      "r254",
      "r453",
      "r457",
      "r496",
      "r512",
      "r514",
      "r532",
      "r550"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r45",
      "r99",
      "r184",
      "r240",
      "r241",
      "r242",
      "r244",
      "r245",
      "r246",
      "r247",
      "r249",
      "r251",
      "r253",
      "r254",
      "r453",
      "r457",
      "r496",
      "r512",
      "r514"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r30",
      "r91"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and equivalents",
        "verboseLabel": "Cash and equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Institutional money market accounts and ultra-short bond fund"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r10",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ContingenciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r10",
      "r92",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ContingenciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r86",
      "r91",
      "r93"
     ],
     "calculation": {
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Closing Cash and Equivalents and Restricted Cash",
        "periodStartLabel": "Opening Cash and Equivalents and Restricted Cash",
        "totalLabel": "Cash and equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r86",
      "r497"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash flow hedges"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r96",
      "r99",
      "r121",
      "r122",
      "r125",
      "r128",
      "r130",
      "r139",
      "r140",
      "r141",
      "r184",
      "r240",
      "r245",
      "r246",
      "r247",
      "r253",
      "r254",
      "r291",
      "r292",
      "r295",
      "r299",
      "r496",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r40",
      "r227",
      "r536",
      "r555"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r236",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r239",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ContingenciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommodityContractMember": {
     "auth_ref": [
      "r370",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices.",
        "label": "Commodity Contract [Member]",
        "terseLabel": "Commodity Contract"
       }
      }
     },
     "localname": "CommodityContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends per Common Share (USD per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock\u00a0 Issued at\u00a0Par\u00a0Value",
        "verboseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CoverPage",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r19",
      "r514"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r56",
      "r58",
      "r59",
      "r69",
      "r541",
      "r559"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r291",
      "r292",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r171",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate, Non-Segment"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r72",
      "r526"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total Operating Costs and Expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Cross-Currency Swaps"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "terseLabel": "Current debt obligations"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r95",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r272",
      "r279",
      "r280",
      "r282",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r98",
      "r102",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r262",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r283",
      "r284",
      "r285",
      "r286",
      "r510",
      "r533",
      "r534",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r255",
      "r283",
      "r284",
      "r508",
      "r510",
      "r511"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount of debt"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r37",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r38",
      "r98",
      "r102",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r262",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r283",
      "r284",
      "r285",
      "r286",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Repurchased face amount of debt"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r38",
      "r98",
      "r102",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r262",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r281",
      "r283",
      "r284",
      "r285",
      "r286",
      "r306",
      "r307",
      "r308",
      "r309",
      "r507",
      "r508",
      "r510",
      "r511",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual obligation to pay money on demand or on fixed or determinable dates.",
        "label": "Debt [Member]",
        "terseLabel": "Foreign Currency-Denominated Debt"
       }
      }
     },
     "localname": "DebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCompensationShareBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred compensation arrangements (such as stock or unit options and share or unit awards) that are equity-based payments with individual employees. The arrangements are generally based on employment contracts between the entity and one or more selected officers or key employees, and contain a promise by the employer to pay certain amounts or benefits at designated future dates, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Other \"sub-members\" can be added as necessary.",
        "label": "Deferred Compensation, Share-based Payments [Member]",
        "terseLabel": "Deferred Compensation"
       }
      }
     },
     "localname": "DeferredCompensationShareBasedPaymentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r346",
      "r385",
      "r409",
      "r415",
      "r416"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Amortization of loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r346",
      "r386",
      "r410",
      "r415",
      "r416"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "terseLabel": "Amortization of prior service credit"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r346",
      "r384",
      "r408",
      "r415",
      "r416"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r346",
      "r351",
      "r383",
      "r407",
      "r415",
      "r416"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r381",
      "r405",
      "r415",
      "r416"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net pension cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1": {
     "auth_ref": [
      "r347",
      "r388",
      "r412"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r349",
      "r382",
      "r406",
      "r415",
      "r416"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r89",
      "r150"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r46",
      "r469",
      "r470",
      "r471",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r482",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments and Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r467",
      "r469",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r467",
      "r469",
      "r471",
      "r477",
      "r478",
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r461",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount of derivative"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r101",
      "r460",
      "r462",
      "r467",
      "r468",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ContingenciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r332",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Distributions"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r310"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Common dividends"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPreferredStock": {
     "auth_ref": [
      "r310",
      "r547"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Preferred Stock",
        "negatedTerseLabel": "Preferred dividends"
       }
      }
     },
     "localname": "DividendsPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r70",
      "r109",
      "r110",
      "r111",
      "r112",
      "r113",
      "r118",
      "r121",
      "r128",
      "r129",
      "r130",
      "r135",
      "r136",
      "r486",
      "r487",
      "r542",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic Earnings per Share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r70",
      "r109",
      "r110",
      "r111",
      "r112",
      "r113",
      "r121",
      "r128",
      "r129",
      "r130",
      "r135",
      "r136",
      "r486",
      "r487",
      "r542",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted Earnings per Share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r131",
      "r133",
      "r134",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r497"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Termination"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r60",
      "r61",
      "r62",
      "r103",
      "r104",
      "r105",
      "r108",
      "r114",
      "r116",
      "r138",
      "r185",
      "r305",
      "r310",
      "r436",
      "r437",
      "r438",
      "r444",
      "r445",
      "r485",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504",
      "r568",
      "r569",
      "r570",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAxis": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument.",
        "label": "Extinguishment of Debt [Axis]",
        "terseLabel": "Extinguishment of Debt [Axis]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExtinguishmentOfDebtGainLossNetOfTax": {
     "auth_ref": [
      "r287"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax.",
        "label": "Extinguishment of Debt, Gain (Loss), Net of Tax",
        "terseLabel": "Loss on debt extinguishment"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExtinguishmentOfDebtTypeDomain": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of debt extinguished.",
        "label": "Extinguishment of Debt, Type [Domain]",
        "terseLabel": "Extinguishment of Debt, Type [Domain]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r489",
      "r490",
      "r491",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Financial Instruments and Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair value hedges"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r494",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ContingenciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r199"
     ],
     "calculation": {
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r195",
      "r197",
      "r199",
      "r202",
      "r527",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r199",
      "r528"
     ],
     "calculation": {
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r195",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r199",
      "r527"
     ],
     "calculation": {
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r46",
      "r370",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r187",
      "r188",
      "r514",
      "r531"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r189"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r190"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "negatedTerseLabel": "Currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r191",
      "r448"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Purchase price allocation adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r66",
      "r155",
      "r161",
      "r165",
      "r168",
      "r171",
      "r529",
      "r538",
      "r545",
      "r561"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income Before Income Taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r155",
      "r161",
      "r165",
      "r168",
      "r171"
     ],
     "calculation": {
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "verboseLabel": "Income (Loss) Before Income Taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r208",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r100",
      "r115",
      "r116",
      "r153",
      "r443",
      "r446",
      "r447",
      "r562"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapital": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.",
        "label": "Increase (Decrease) in Operating Capital",
        "negatedLabel": "Change in operating assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "auth_ref": [
      "r123",
      "r124",
      "r130"
     ],
     "calculation": {
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock",
        "terseLabel": "Dilutive share equivalents from Series C preferred shares (shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r196",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r201"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Unamortized intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r196",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntellectualPropertyMember": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.",
        "label": "Intellectual Property [Member]",
        "terseLabel": "Patents and other"
       }
      }
     },
     "localname": "IntellectualPropertyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r64",
      "r149",
      "r506",
      "r509",
      "r544"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r543"
     ],
     "calculation": {
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "terseLabel": "Net interest expense"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap",
        "verboseLabel": "Forward Starting Interest Rate Swaps"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r27",
      "r186"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished products"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r5",
      "r43",
      "r514"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "terseLabel": "Inventories:"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r29",
      "r186"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r28",
      "r186"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r74",
      "r148"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r26",
      "r99",
      "r184",
      "r496",
      "r514",
      "r535",
      "r553"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r36",
      "r99",
      "r184",
      "r240",
      "r241",
      "r242",
      "r245",
      "r246",
      "r247",
      "r249",
      "r251",
      "r253",
      "r254",
      "r454",
      "r457",
      "r458",
      "r496",
      "r512",
      "r513",
      "r514"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r34"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Borrowing capacity of credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansPayableFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of contractual obligation to pay money on demand or on fixed or determinable dates.",
        "label": "Loans Payable, Fair Value Disclosure",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LoansPayableFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-term Debt [Member]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Carrying value of long-term notes",
        "verboseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r227",
      "r228",
      "r229",
      "r231",
      "r232",
      "r233",
      "r235",
      "r237",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r227",
      "r228",
      "r229",
      "r231",
      "r232",
      "r233",
      "r235",
      "r237",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss contingency accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r227",
      "r230",
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Damages awarded"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyLossInPeriod": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.",
        "label": "Loss Contingency, Loss in Period",
        "terseLabel": "Product liability-related charge"
       }
      }
     },
     "localname": "LossContingencyLossInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r227",
      "r228",
      "r229",
      "r231",
      "r232",
      "r233",
      "r235",
      "r237",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Pending claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ContingenciesDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Segment Reconciling Items"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net Cash Provided by (Used for) Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net Cash Used for Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r86",
      "r87",
      "r90"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net Cash Provided by Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r54",
      "r57",
      "r62",
      "r67",
      "r90",
      "r99",
      "r107",
      "r109",
      "r110",
      "r111",
      "r112",
      "r115",
      "r116",
      "r126",
      "r155",
      "r161",
      "r165",
      "r168",
      "r171",
      "r184",
      "r240",
      "r241",
      "r242",
      "r245",
      "r246",
      "r247",
      "r249",
      "r251",
      "r253",
      "r254",
      "r487",
      "r496",
      "r539",
      "r557"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "netLabel": "Net income",
        "terseLabel": "Net Income",
        "totalLabel": "Net Income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r112",
      "r118",
      "r119",
      "r127",
      "r130",
      "r155",
      "r161",
      "r165",
      "r168",
      "r171"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net income applicable to common shareholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net investment hedges"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of principal business segments (segment)"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/SegmentDataAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r155",
      "r161",
      "r165",
      "r168",
      "r171"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating Income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r3",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r44",
      "r514"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r53",
      "r60",
      "r61",
      "r63",
      "r498",
      "r500",
      "r504"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent",
        "terseLabel": "Cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments",
        "verboseLabel": "Net gains (losses) recorded to Accumulated other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r472"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Net gains (losses) recorded to Accumulated other comprehensive income (loss), gross"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r55",
      "r58",
      "r60",
      "r61",
      "r63",
      "r68",
      "r305",
      "r498",
      "r503",
      "r504",
      "r540",
      "r558"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other Comprehensive Income, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other Comprehensive Income (Loss), Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r50",
      "r51"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Defined benefit pension and postretirement plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.",
        "label": "Other Intangible Assets, Net",
        "terseLabel": "Other Intangibles, Net"
       }
      }
     },
     "localname": "OtherIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Deferred Income Taxes and Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other (expense) income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other operating income (expense).",
        "label": "Other Operating Income (Expense) [Member]",
        "terseLabel": "Other Operating Income (Expense)"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedTerseLabel": "Other operating expense, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [
      "r212",
      "r213",
      "r219",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherShortTermInvestments": {
     "auth_ref": [
      "r44",
      "r537",
      "r556"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term investments classified as other.",
        "label": "Other Short-term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "OtherShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r76",
      "r79"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r85",
      "r213"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r369",
      "r371",
      "r377",
      "r394",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r415",
      "r417",
      "r418",
      "r419",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r16",
      "r344",
      "r345",
      "r368",
      "r415"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "terseLabel": "Long-Term Employee Benefit Obligations"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r342",
      "r344",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r395",
      "r398",
      "r402",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r419",
      "r420",
      "r426",
      "r427",
      "r428",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plans"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockDividendsIncomeStatementImpact": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.",
        "label": "Preferred Stock Dividends, Income Statement Impact",
        "negatedTerseLabel": "Preferred stock dividends"
       }
      }
     },
     "localname": "PreferredStockDividendsIncomeStatementImpact",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r18",
      "r514"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of long-term debt classified as other.",
        "label": "Proceeds from Issuance of Other Long-term Debt",
        "terseLabel": "Proceeds from debt issued in connection with the spin-off (see Note 12)"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r81",
      "r84"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductLiabilityAccrualPeriodExpense": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loss reported during the period pertaining to product liability.",
        "label": "Product Liability Accrual, Period Expense",
        "terseLabel": "Product liability accrual, period expense"
       }
      }
     },
     "localname": "ProductLiabilityAccrualPeriodExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r31",
      "r205"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r11",
      "r12",
      "r207",
      "r514",
      "r546",
      "r554"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r53",
      "r60",
      "r61",
      "r63",
      "r498",
      "r502",
      "r504"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified into income, net of taxes"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemablePreferredStockMember": {
     "auth_ref": [
      "r9",
      "r99",
      "r184",
      "r240",
      "r245",
      "r246",
      "r247",
      "r253",
      "r254",
      "r290",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable preferred stock. For instance, cumulative preferred stock, noncumulative preferred stock, convertible or series.",
        "label": "Redeemable Preferred Stock [Member]",
        "terseLabel": "Redeemable Preferred Stock"
       }
      }
     },
     "localname": "RedeemablePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Payments of debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r442",
      "r525",
      "r590"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndInvestmentsCurrent": {
     "auth_ref": [
      "r30",
      "r575",
      "r576"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.",
        "label": "Restricted Cash and Investments, Current",
        "terseLabel": "Restricted cash",
        "verboseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndInvestmentsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r211",
      "r213",
      "r216",
      "r222",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Business Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringCharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r89",
      "r210",
      "r217",
      "r219"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Charged to expense"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r212",
      "r213",
      "r219",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r213",
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r22",
      "r310",
      "r439",
      "r514",
      "r552",
      "r571",
      "r573"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r103",
      "r104",
      "r105",
      "r108",
      "r114",
      "r116",
      "r185",
      "r436",
      "r437",
      "r438",
      "r444",
      "r445",
      "r485",
      "r568",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r342",
      "r343",
      "r344",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r395",
      "r398",
      "r402",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r342",
      "r343",
      "r344",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r395",
      "r398",
      "r402",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r94",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ContingenciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r322",
      "r323",
      "r333",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/Revenues"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Geographic Area"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/SegmentDataTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r320"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, remaining performance obligation, amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction (in years)"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r65",
      "r99",
      "r146",
      "r147",
      "r160",
      "r166",
      "r167",
      "r174",
      "r175",
      "r179",
      "r184",
      "r240",
      "r241",
      "r242",
      "r245",
      "r246",
      "r247",
      "r249",
      "r251",
      "r253",
      "r254",
      "r496",
      "r545"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r53",
      "r503",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r401",
      "r402",
      "r403",
      "r404",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r489",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r192",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r192",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Reconciliation of Goodwill by Business Segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Components of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Net Pension and Postretirement Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.",
        "label": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions"
       }
      }
     },
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r212",
      "r213",
      "r214",
      "r215",
      "r219",
      "r220",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r213",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Summary of Restructuring Accrual Activity"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r155",
      "r158",
      "r164",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r155",
      "r158",
      "r164",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Financial Information for Company's Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/SegmentDataTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "terseLabel": "Schedule of Shareholders Equity"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r142",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r171",
      "r179",
      "r215",
      "r221",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r142",
      "r144",
      "r145",
      "r155",
      "r159",
      "r165",
      "r169",
      "r170",
      "r171",
      "r172",
      "r174",
      "r178",
      "r179",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Data"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/SegmentData"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r1",
      "r142",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r171",
      "r179",
      "r192",
      "r209",
      "r215",
      "r221",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r17",
      "r18",
      "r19",
      "r96",
      "r99",
      "r121",
      "r122",
      "r125",
      "r128",
      "r130",
      "r139",
      "r140",
      "r141",
      "r184",
      "r240",
      "r245",
      "r246",
      "r247",
      "r253",
      "r254",
      "r291",
      "r292",
      "r295",
      "r299",
      "r305",
      "r496",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r42",
      "r60",
      "r61",
      "r62",
      "r103",
      "r104",
      "r105",
      "r108",
      "r114",
      "r116",
      "r138",
      "r185",
      "r305",
      "r310",
      "r436",
      "r437",
      "r438",
      "r444",
      "r445",
      "r485",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504",
      "r568",
      "r569",
      "r570",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r138",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r18",
      "r19",
      "r305",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Common stock issued for share-based compensation and other plans, net (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r18",
      "r19",
      "r310",
      "r434",
      "r435"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Common stock issued for share-based compensation and other plans, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Number of shares authorized to be repurchased (in shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r19",
      "r24",
      "r25",
      "r99",
      "r183",
      "r184",
      "r496",
      "r514"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r97",
      "r292",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r310",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Effect of change in accounting principles"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r505",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r505",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r505",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/DebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks",
        "verboseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized": {
     "auth_ref": [
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.",
        "label": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized",
        "terseLabel": "Amounts yet to be collected and remitted to the third parties"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.",
        "label": "Transfer of Financial Assets Accounted for as Sales [Table Text Block]",
        "terseLabel": "Transfer of Financial Assets Accounted for as Sales"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r41",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r41",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Ending balance (shares)",
        "negatedPeriodStartLabel": "Beginning balance (shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r19",
      "r305",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r41",
      "r311",
      "r312"
     ],
     "calculation": {
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r305",
      "r310",
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "terseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r212",
      "r213",
      "r219",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs of contractual or legal rights meeting the criteria for capitalization as intangible assets apart from goodwill, which have indefinite life and that are not otherwise specified in the taxonomy.",
        "label": "Unclassified Indefinite-lived Intangible Assets [Member]",
        "terseLabel": "Acquired in-process research and development"
       }
      }
     },
     "localname": "UnclassifiedIndefinitelivedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Dilutive share equivalents from share-based plans (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r120",
      "r130"
     ],
     "calculation": {
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Average common and common equivalent shares outstanding - assuming dilution (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r118",
      "r130"
     ],
     "calculation": {
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Average common shares outstanding (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2029-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=7516071&loc=d3e13374-112631"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "44",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5558-128473"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.5)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r591": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r592": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r593": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r594": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r595": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r596": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r597": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>64
<FILENAME>0000010795-22-000040-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000010795-22-000040-xbrl.zip
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M,CDM*8>^^-Z[8V\?LUR<*G9I^U:_N\79D8O?+VYRX[V&^F2[5:.S*LIF;Q,
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M+RYQ<>SB]W:-3R>J(,[:1*.SSI#)4&PS;RJP-LD5?=8I;Z0=EG?PR[1IC)?
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M5^QF15*W^57A"4FA%:D9C2N@BDXNY@A%Z>1KX,(K \V"2KW,:^I/ID"2'NB
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M9:/0C\'-@7>$/F-NFU 3IHA*R5\'@MKYK@LKAMM"5?[\2D ELFA)BV\$*Q)
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MMNL?&G!YEN>$4-L&7B6;',#H-DVE4I4TB14']G711%^S;A591[H$+ YU\@;
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MZ&**!B Z:B-I"4T]GX4"%]F!7^;N@-4AY?<JW0\(\IG$Q?^A:^![2L5$$\%
M4$XR&.U9@EX2Y>O8@XJY=J!8^)TQE\'T+N7!@3S6.PHUHWXPHN'%D8YT#$=
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MS>TOY/8''5V<%49TJ9]2Q#[X3*+D<Q/VAL"3$#[CM5M_,TK_?66ZG"^=I*T
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M)A?366.,LD&229)LTW10FFJEU,3AQ4JI<]VC:8Y/_F8(CD&D)-DI(FL>4FW
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MSHPU",YKGSUT%+KIC^\K"3?C3SN]SG T&%?5"%_.<JFQ!\4!;AB&]:.FVN,
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MG]*X9RW2<8SO<B8*Q=R+8O9F'&G$ ],*1R"4Y?L$R9$V:=K 84(5XPC[D,L
M->CF4[FVV/1#]P+6NL Z90]008-C-"2+/6M^RZ# >(O!LB"M#;E:7P'KFH.U
M?J^Z@+46L$Z[UUX;17.R+I4V D.&))RR",CGBEPJ.=^Y#$Z3*G<7L#;]I+N
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M\S1^DRLS_=YP/'GCUU53M_=E-#!I"CH],[C8'X7382*UW,I!O]NM:*W$'!_
M: >S.>R"*HH,!L$# ::$ 6.<!$Z3+1DY4AY7Q;KJBCJ6:W1KQ14+.+8O7-$8
MKIBV?@PGDB('&K%<V,]IT)0+0)$BX55@R0+:V**H<$7ABL?)&E@@5Y2KN_41
MR734@S,7O/,2O,NWYVS08 -!('&TU <L _?Y[BYA=54A+U2R5E2R@)R&0B6K
M0273.1,QS;ZTB4!,UOJRFH(FA "RQ'B'(M="C85 5D;MZVG( %1AFI'YTCH;
M]#]UAFD^GEA"Q?(C,HG&)H'A%Z$78J=X2/=CHS]GHBG16"\527Z1XSX?PTJP
M%E' RNK(I$ \X(TM.2L(4&HGKPU8%Q02*6"=&ZQ3IH,FW#EN+-A$K\ (3K U
M5H%A.?\R,..IV=B:6SVH8+7!6%U,2*)@=5ZL3D<,0F3(&)G J;Q)6 T1+/8"
MDB44+-:&4\R2F8_KDAPO:&T@6A?D]1>TSHW6Z9V5,Y( 2<$1%X%1K4"9Y)E;
M0S7%WE$<=$*KF+L0Z>KE22P5:^TP*NK_C7+$TXP44? '\LZ;&?<;)^N \T0Y
M+EETP(PTR?TF'C277OADX%.35<%Y404OZ'X,S[V@>RYT3X?Z,;=!"0*6.@$L
M\2M8Y2DH%ZFRCEBOLA#1#5)A!=T%W?7[^E/H+J=\]4%_VOU7C#HDA09JI >&
MA03%F002A$C>'V>69!W/34SG#JT7\*\C^&L/'13P+P[\T_M^R#J#GD/,P7J&
ME,S1! LHQ$"ITUCB'$W8I*@<\3<(G:\&:7X&@Y"'N^\^MGSG4\>'GG_8M8S5
M#7 N5?+_:A*.\ASL7D[!F+J.1F84*AV7T[/4MD)4]R*JMS/A!TTM05EG*?F0
M+!&5MZ ]CV"LP8YBQ;E/1$5FBZ*7RYQK@=[:XP<%O8M$[_3M!AZX\1$#IUX!
M2TY&0B_R8*7"1'!",/4%O6N,WKKC P6]"T3O=(0 <8Y<<!*20V" N>PD:,Z!
M2:=19,1QI'/HOZ!W/=%;NX-?T+M(]$[MO8%PK96E@(/7";V>@<$D@%::)5?(
M>B%"<]#[5%(%QF*'+7-VUDW-LMW0&O53AT]/$Q2')V803OI='P8S#OUBXY"-
M&ZK_65S_F\W/C4F<V/YD.MV\0(_[.]7RK#A[LCI?F&''%8:^%T.[F=B&X"PH
M*M+T,)OL*Z$=&$*J:U=<(I/L8^5RP?6G=OY2N*YPW:.FD12NJY_KIBM>11RM
MXQ*DP"*GD4FP42'P+,C@K$N.A<PJN$^MM'SANL)UCYI4<Q>N*R?O]1'A=%!-
M.F*%<A$0]PZ84@I,U@K3Q!-"D4K_52?O2,U]2ZY08:'"U:;"Q:88%2I\9"J<
MKB1.J95(&'"*Q[%DD18B@L+8TD"B<))7DD5\9:S"21CSLB&7ZYY71%?W"<4=
M/N-:AVGJDN^?YY#C=(_G^8;2RI5O92V+]JXYM>4SUNLSGD+:964+M/;,H)=:
M/&R=A4'K*)_5S'-0MFY&ZDU=7%T[]%485#-<[Y$+F39'+Y?4Y==]'VM$Q:[\
M9[ORP_;LE56L$>+< G<D /-9XB)*!UA@IWP4@3B<[,IG? TUHPH%K3D%S7D2
M4BAH,10TY=HJHUR4G@/!,;FV(6#0DE#P."I!M!=6BXTM]$S/K>M=**A0T&-3
MT'P'%(6"%D)!TP<-U B*'9'@ O7 *.&@491 /0E.2,R-SI4%GJEB!14*6C4*
MFO-@H%#08BAH.NE#6NEL))"V!Y,H" 705!.P) 9O@A (R8TM]HS.?<FX9"+?
M"W&[G>[Y*/AY0EJS)RH_"#>O(\_>?P#6CH47'0Z;+-/"P_?BX;V9@)@R)!CN
M$$B)$3##.5A/"'#*J/&21DQY%1";6SSRWJ!8G9R30F]/C=X6'6HK]/9 >ILV
M,PT*(4T 6(T9,!<8&,LC^!@)0T8$Q7@5;%N 1F6AMR:!O-!;@\)XA=X>1F_3
M@3POHHY(>H@LF7 ,>P^6<078"*M)%(9*E@-Y<@&%_0J]-0GDA=X:%"(L]/9
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M+A4RR7/=V")EIU]CT-<0K"B@;S+HI\,62/&8_O/ +1;C<L?&,P(!6>:93:O
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M1[IP4'T<]'[&##$,,2X0!NZ5!Q:=!!N1!8%I9-I0SU5RG C;1+JN>P,E7-)
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M,9!S UKW.O*\@P.V;GD>S4A"OR7CHW#7O-PU>X7-&<.\(01TFD%@!B,PDD5
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MR],]VS'CT?Y:H;&^4PTP?P57#]MU-=KN<:Q;4M5'#U5 :FIW3_K5X_/%QU4
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MF5(76H# 7%M VHOS=:/Y-BS\:_2S%,F)CL=#!RL)6V30LZ'"BOK16=<*C7?
M 'Y@X86]X_7&;YEA*7XU^K3ZB[SZ%[P<.&8?,#YSR:#7<L,Q7)^[LF+T2]YV
MU,V+"OI7WGQO-L\NK;CGH-L.F0,S4^8>@R&/?K2#,SM6V_EL9O"D2M-NY'7*
MJU4+J]&H1P_(X#4>^8B_QLMY-GH86;<31PS\:QH7AYN9(\L*D%>9K\;?Y7NJ
M,;[9;'2'@W[N952Q=/\7ZYT-! ;P^?P\X:L(#QN)*T"N=BL.\WUIY#S-J'?V
MALN&-9K2V5X Q>N,G6&!_PL0VTJG]288V!\H]6+,U.CT1W[]/*U*G*08LOC)
MX-T]BOGB\\@W?G<K U_&EW@<L[P9O+AR2Z6N'_:KI865'FW-7YK'BPI 8=%
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ME+Y<0.ZI08Y,@!SSUG-G&/*:),25%4AKQI C1&BG%>-5:RKZ0IEY-8TL(%=
M;I$F/DO%+X9Q@KL<<XH'+4V@QGBF(V&P(HH5<_2Q<(Q-FJ,"1$Y4!#$@$>*@
MLB$="$4JT B6J-=6Y&:9[)EAV-DS;E%<]7YXMGA\/6O6, =9&+W73 AN*77
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M'I!-J&M"&2.P\LA))1%7%BS2F"W2I)U+$C1NQ4H/]0<$M,5C[!FCRI(6BI#
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M;OS']>"^2]XZ09?:FTY9]!RGX$1*G$MFI)=$>Q8E\4Q:MG9_[+STO8)X)WC
M.?N-^Q0U-<G@( 33W!LOGPISW2)A+N-Y 3]%P(!^Q=LC" #PBL OH3$\AO5,
MK0Z@43\.!NT* C)[9YSS/K9CSP[&T)%19]CS![8?&W:_%ZN+7U1XF-&BXL*Z
M1<2)[84,H[$Z"LIG 2\:%1/%#&H .^$7/*;NL <8=C4\$D",G<L6]<HSA,<B
M=@;WB84!],O(>F1#;,!G_:&%]<PX>W!A^8Y[W?V>/6K8X>"@VX-7@J@YK2YZ
MT\UK!ZNP.18Q&4$_QV. ?P?K0WF&4<*J3ARS12]H[WCTSBD=%?>16<.T==(D
M[D(BJ8H#)0P;RF\1T/3I;#(?Z[D ?L/XME,=SO#Z;&([W3?QU\5AI<_JVO&/
M3Z=[7\.QHUPVO^Y]WZ5-M@7W[+W?A?%]X,VO?W[??K]+]MXW?VYM?CK8VOG[
M=.OGE[1UN,N_:::%#CXB%7 NWNH"<M8:%!PG1'+B4E)K&P1?$=4$&[R=-T%-
M^Q?5!CDY:/E*/X ]V>HW.MU&_''<ZM4X&H!=@;<^=!I;W7]&NPO8[<55^_#<
M9CVG'>3=?6YG#X\K!0/@XZR XXS;E+!@F0V\"E<&H').,"NIB,IZ9XFK#XP)
M[-3+MVFN)W#]%OU56[)LUCMLUNW-=^Q;\"[GWD0DM;8(B,40_ D_B&.<N5P8
MPMYZL^9]]F;S@@9\Z?X%2G<OV\1GVLJ4ZGBFN?S2,"_N-JL5D2PH8QGC-CKM
MJ"=,,:)\)%&;NHP%*$E5&0M:QRE,X*$_B&'8CK"QO!\>#2LQN)T'G5FD%P_
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M3'C%@=I>EHC&9\'LADM0P@U/F@<9'<>"*:V!_D$HFHI&OKA,/>EHX-0+$5E
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MQ]FI#/6!"VR1U@HC;@A&UEJ)O,3:!>\2:,,YEI2]$'RZ*7 !AV</#H^4AU+
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M(Y(A:40FD95+)G&/B-=.$!]\4 8)$>6 A$A>=^=<\5U,"A58$.XN4%JCI)T
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MP!^KEA*CA@U^>(8_?/0_C_ZQ"(0X/P2NSGB#3G_M3GT"@[/WHUEN2:UK*JZ
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M1AN,-AA=K5L-.J) *A4M&O5:6,1)2K-V3)H@+&]QF\V T24VZCSG#+0FE&I
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M\\E>&9)E !$I-P(<VF'*)F\E9)!!94$;\=D$)/JPW+G-TIQHN4D<D*XB%)E
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M&Q^[D,[K< :O+R9GZ;BE1U\++]HJKGB*(CO4^0H5#1K'.E,TI"5R =X,YW7
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M[A-P*+W4U+I:6%'&&D9K&*UA],;:6%%DY93@1B;)D[56Q&AH*-:^"[F&T>6
MT>D('R62TL9*(H%G@AL7B%6JE- *68#30OO*JM?BSM4%:ABM8;2&T9_!J$2K
MW@9O'&62JA T"R A9M!64L9K&%T*&)T)(_*&"Y>H)JB3(I@*SDF0# @U043M
MI( 4*[.>\T6UV'A\(*VB#?XU]/A2_#>UOVY64RL$W>Z>^&INUWR"%T[%)DF%
M?'3<&[3+!2_ZT,$KO\+OI^TT/)CPT*6[QE.F%[?X@+,[&=Y\RZ6)12B=\!X>
M"G@9$Y/GVSQ:KTM_'YR';!W[?2"A#_X+&C4XV!>^<^K/!FO_NC*GHW:77%[
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MG+'_&GI\'?Z;VE\W)Y-JG1PA9<7-?^.'DRD<^?Y^NUN-Q568^< <R L'[AQ
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MC\ -2+V3\MSI_;DQU&81X3KU*.M1/I]1/H\ FOA_)^U^A57DN-^+,!@T^C
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MDJ62<NJ"BQ:IT0EG*3<S#>9*/[=7O2,DIK/&R0!))5VP2?L2FZ :<82<432
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M;_US74M#KX7,II1@<$$0:9TAUD=*K P!:-;):KZVR=:EO?>FAD\P1*P&N.<
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M=S!.;XJ]0168.!UI?%/2!(ZS*)Z3P,C+T^I>Y;"'SA&XGF2WJ]#QWW#/H3N
M_QFO]GJ)87X\4E[;7&^DJD-KM=+#@SZ,\C,&[6^-([SY8-" ;DG,N"E6]"(P
M%*EIDJ9;(O0OHE3_>U $7^7WKS;V(BMD1/:#6^5[+'T6=E@B2!)R*@O[A]'W
MG1[>B5MW5.*-IY*%+F5BCY)]"ALBZR*[E0?$2VAW-1K_2O[!U;#E_QY<FY"
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M'S704RQ[-TS*]9_9AYBL<VJ3/5\\QOTBU9T4_!5S':3KRD2 U>X78.VD:-%
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M&%3L,>_5YTX[T1_Y4.L_F\M%SS2\4,7.R)%MAJ[K.E[D!*9K:V801E:T:8+
M<B/[JGQ-\OP!R,:<D).X:=S5&.<WC9]OP.!^\^WF6_#U_>??DYMOOYGO/WZ*
M;W_^S\/[SU?6S?5OVJ?K*_73Y]_,^9O&FV]_Q']]O/GV_ML;'8SW;S"^]G[\
MSH3WZS?77^[?7__QY>;Z]_'[ZQ$FA\UW0G$CVW+5T)3U,#)DTS,"V?4B7]8\
M3_5<0L%OTU_\: PTTQ%][H3:NVRUI^NNKU-'U?P G5WB6UKH!-0W?3NP-=O?
M-*="J+WG5GOS25*$$A)YMB83-=!D.,(<V54-3W8U/7*=T',,UWWQHS[0W55
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M[A'5%CSU:8$]'>G7@(*ZA)-TOC"G ]$,;%?2O%C@I(7,Y6?)*&[RW*\03KH
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M?W_U-W6\T#1\538]$_ZQ#4MV?<^3+9V&IJG[MFV!8:7O#=M,^.%"S_5@U4<
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MQY&=G\#_06Z[CH,O,3 _5P+U9%^B)M'5'WZZ9C]H/_P+L]"(-$PR'YO15WW
M2AJ,4ICP\$&J) .V;$B&[052B,U\L@G*T  X.9TB:"4R)KX-&Y\POTCR\PSD
M-*]-D'K\8CJ9)*QA#(R#+7X'4@*V!RBG#*0<^XRPD7F"2$R&:5: R]PV[6+N
M'7CE(TJ2<A2P]H^=_N4#:3("M0BBCC\G<02&3Q C V-;"8H^(T5F#(!\;#[-
MRYLF-A.0FS$)Z)2YZC!Z. 6#ZZ&)E@QI"KHT 3GTDSA0NF[_/T'7YD.2QM](
M9<UC\(M3!X@]T[D=@;G;VXVFI4[5APWF\M-UTYRMWKOJ]WH#V7=^P35^X&LL
MFF_._+79<%P"/,(B<7?P%C['^IG9/]</+4KGVC/U2*Q_W9R3#:<@:W38DU<+
ML[9[]UF>A&!,4$6Z!34U]P2VM&JY_3_@?<%O+&#)E6R,9$I)&[6IC&Z$@)A0
MA@,Q&R9 .SRE25'Q= YBBH]EJ MEX.><-06"?>&CMZ/P+D)P^G#=S7NC*M*?
MM.8RRM1LUISM+/\%UK5LYD5UKA:OI#<W;ZZDEU4F*@_J%=*;:0X#<1&XB<,0
MY/@-*;@@7D4Y\-V_?I!^KGHW7Q4Q61B!%8&A'"'MZF^^A@.3#*1_$^"*@?0!
M)CAB3U<_4WP%__U_,WAD(%VAM('URW/$D#\^48PAAO#Z7S!S1[IB]0R+[[^A
M7^,@&TBO@58HH-7WJKY-!/;#IU6\L)H'_P(,S!0EV%PA8>2MW5[<)#AN"_AI
MF&?W\$@V05, 7?)JG6!+X(DTK/N3-QF^?%8\U-08-$.:#7,R@6_ M@YQRUXQ
M*@-#K=J 047]P=SJ672TL2MJRE>AV>X^L17Q5BC@EN<@?#"A@.E19,[%(49@
M773U:_$ $QQS\:!?)SR]ZO&+D+Z=VAT=\0$#J+<\,_LZ)CY%"0$.H?TVCC],
M_0).2%0-E<7(K*F(:8'9GKJ#)4G8H&'P2$\H-U<Q)# A54]EKIIF8YM-SCH&
M>= TA!'^6<P2K#FX,"$>NP[6@P(C\P,R>9!9$[2PMB? JKQJPUVM88N:;DAR
MGKN'"^JDS^-LE[]WMLE/DT)?JV^>WP<3>]TX!J^[CD'K.GUH'(.-\C&.Q\?_
M2Q^DC]C7K@#-P%+N,9EQ5U?/.%Y>2<$<KBKT-&![OLWAW7@47YD[-'<4#KBE
M^8"G;\SYNS(]<\8/=Z )LVG1F+\DR#.4H&P,NIG#L!?<MJM^J=[&O"=^>0^#
MC[&G+#:A#LIHFM1^3S4+V):JE=GRT^#51G?)!H:;>,6MC+7WKXP&AJH"G9(U
M]VB;R*Q$^X?CI6#-TD8S.?[6NS1*&!_43#(B1=-G,:PB!067EYS<-YWIT#,
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ME#FC=:TF.9/#ON(A23@_-]!5B*Y5R<Q^I')0\=DLUA@P"&IDQI#PQ8#BKT!
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M+/@"?U(DZ<,*0E5[LPG1.5%;E(P.68%B1$K@]?@+G%E8-HUKF4XF\+5@A-
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M>D_/XR+Y':\9Z8=I/J3Y@ZAZN<S$5,/<,3E!9%@+1N[3PG5//V]&WB;GY=P
ML#1;Z6%QWC$H<?1TJG-CK9>:H@IH-<%5>U98CE!8:U#[=BXTZ;T[]2L\-AG1
MG"0SEVP[U6,L6?N)L+]I;>M5+-_G@]I;F]8PG>D6Z6*+>KY%CK)MR>A^MNCX
MQX3@CPU-5W-STU7PQB7QAKNU_7DN_''V$?O_Y/"BX0/+S'N=QVQ2TFN2K[Y'
M.]DJJ4=*?(]35R<*V;8(RNX(122VZ/F,3/.<"@O['>8Z0?[8SL@4O'%)O.$J
MQU'OQ^>/LX]C\NZ.<W4"6[=WG(7XJ;+V#=CP,)MB#4"]CHN]A-\_@?HM1=I
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M7DCSI-^U+A5N >;N9DCVDF>CG%\L! =<#_%'YZJCJ8SR# \O6+$E):/U$$&
MOVI^HT)-DJI"GABII]#S*NL^K&82%<C. $MJ5HFX97"ILKRB=CZPY@4O6E^A
MY06R#=.DK>2%4X-.L/+3=$_E8$DVWD>Q*,*5S^%6C? OH7V)@F%RK9B\!NZ"
M! 2VSDH%RE[A=E_GZ36)#?R8@!CS[&8H;R"LL0INQDD\#F[@1*.D)@5Q8]D$
M":B90R)O4W./$$!$&?3SHB F#I*<>HJR\9>]SI%1%"%#*DHUC9"$!H5M)TU
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M[WU'>VNU%R='NWOKM!?[=*7O@W(#7;#3%=$G51Z!EAU$,S:/X-(4IJIO=53
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M&']*9Z"?0'&6R3!!6NV(HE@-G2FJ\B:OTX&8K.9(.AZI$\LCIFU#PJ0O"O@
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M.+>1F&9GT8PVF-G?R,T3VQW:,;$;(3JFP2-?9];'<LZ[IE1D'1W/,%] ?Z6
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MKH1O]5HTZQ[,(2%B\X$EIFOI&WWJ4I@8RK(&(]-2SVGTP7:DS2TM/VTO>5]
M0>P_56#_\E1#3-MDZO,1EE3M%,2S/@IP%<7(0X;+E4\"^9GJ^_#O.]B1DA#V
MIP;[Z25MYRGQ#660J0G&D9XZ^V=@HPA7;G9!<P&%IZS 74(99\,;O 6Z;3@>
M?]8AC0YZ+0?S]D#$D@[WP4M(%N^],+_XCTQ7&F)^GVIAX""\^U;CSCN)1U)@
M7#DG(<DUCT>B\N6F77T%+J2+(+-&I)L)]$J;ZB(>Z_H!4D$X_CS^*NS\3I;K
MSO36TGC(]8B/W28LB#Z$J5ZZJS,G*LM,E\GO>7M,0!'+?7:PL#V:ENHW_8]3
MT#W3-)K]EF0T5/K2J3Q+HI MI2PT"_ZSQ-=.3CH'AUT,L54%_&^@7RS1MPY%
MWUY7@_F_]0X[A[WCA7_>[70?^+>#WOZ#OGG;8+N]SE'OH0/:#/:G&FQOJ<>^
MIO/ 9P).'9[>_WS5>V5CVH1#_FUO^CWH^FH*H<ES-61TYAY;=1W?I;DH>/Y>
M(,Y@>BELWIA5X])5S('6R49'R=K<,NU=G/2KI3[:LD*LR-=IC;[D8*KQ#?6Q
MMEB^?$C&V=48/(*2?Z75_"#8ZF[_PBMVQGT:9%'0]:&ENHR2 4*3[+K]PFOT
M *FBOT0E9R;D@Y=4UI;.Z =P:G.,40[DBUA%1'^ 4WZI69Q^X37_$'U/)O7$
M775>GB'_REUUC$7QOSY$O+K_1U7!&Q7XV_$'VGKZ&\I9=]E.?H%9_*T]7R_<
M<9/TP>4=@5.<#79DB6)P)(;#4[']R(F;5@%EVP.]?O>\?^ ASV\WTW[\(\IJ
MC,=U X*0=4_O<]TL7)L[I7?O$==W-VA992)K?Q[!7W*EN^'>[K[O53>LG$<1
M-5J,W>67XC&W]VFW]/D,MR5W]"]/MH_WV+]53'SOX+#3._ZY9?E75E5T%>R=
M;C;X9]W@[FYX=- +N[WNFN[QO8VR(?W?R[&[WJM^T3"\]HY_P/!JS/]!PMZR
MAB]$GGN[)_<4Y'9Y>5)]]&MOT=Y!KW.XN]FE]=ZEA]W\FVUZ*??W(^[40^,F
M+^:*YNC[^@5&7J"\_I!#\4)]ALTV;;9ILTV_\#;]J).]\:.7S>&MVF.6<(@
M>^8C(C]=^"@\Z/8>9GD^VE*MV,%8K4B\X%3(HZ_/>A^5O8.#SO$#O;2?Y:QL
M5.D3!5PV O+S"\B/AGI6+B-D@KXF!/3=<'*//[9G .::6W>%=5$.G' %^':?
M=GB_T]LG8ETNBBH#,LB"DK!3I@Y@T(;X3ZA55Z:KZ:@22C>:%]Y=[JSGLXP9
M?JFWR )2$,'(!-FO(U/R]EE5TELJ>,-TS/ KY)SECR BBS[7/3DY#-["1ZDV
M3!XLST7N&/C<LMQ4ZRPN>VLL+J)0M,#HGBW(HL^BHVFS;5L6TZ?A31X51')G
MMA"KX!HDFWO[&"KM]K@T%%08S!;_]XAO_)A?TPN#GO!Y!@'33Q"-,9:1)2)Y
M6'5+17,JT?U!\4VWT=C\>O0RQX]"+W/\*]/+O#1.85"Y$96&_S&E$YPE<$;N
M5Q+5U+C[)\SXOI*=^(C,ZEC<'Z.M\6!^WY/N'26;J[M47BZ][P>L(;_BSFP.
M7?4O*V/[+Z$L^."%"=DGNMXO;('L+RM>1VWB!8.*=V"FV-GVM[*>P"+,3M=,
MKQV^,)%[]YWZXRY69&T&WDLI(3[LG!P=/GZ19^?D>+D:S_L\]?BH<[2_7"VK
MY,0:MCY3'3]:,=9#/_JX=:V<E[O--AX.GRQV==NY^8^H52LI/DZG*Q]@,"[4
M$&2CJJ;E;Z]?W]S<=&"<G5%^_?H,'%;P LO7:C"*BM?@74:ON[M')P>O8;3=
M[DD/B0;W=H]W#P[V7P_V3GK[Q_L#];W7[8RK"7A:__$Z:GHP3UT&N#8IV[T#
M.(7G.!#D9JJ(F>,M<=\;EJ@K191WY\$_:G)(+FV+A&P4?%8#I2:D/R\+'8JZ
M(I*++8^WUB6LQ1"6*.J@U^D:"DII>YY5MN>"L%$Q)Q&&&=Z#+1$<[_Q7P$RZ
MC G;$R38=L<OY6S7+(<;S;+1+$W-HKZ#CNB!KD"R%5(,""Q<(\VPDH *JH<K
MW;IB%@AU"VB%O]78Z[52U,]'1R@Z+8O5?@0/-D=P<P3GCV"OZQ_!7O=!1_ E
M #3:7*D7;DS0O*PQP6RKPX?U39K6!?:HI%:%5^_.35NC8"?H[F]%VYTE[OF-
M![%1,FU*IG'/]QYVSV^4S$^E9'P%T]^F;UY)"ZEN[V"7WQ)-,6E_V,.?OB05
M?N=8<^D22?AY/E"_N'):#2JG^_@"OCF[3P$0I[[,V)"!2:2%?S<8%OG$;X##
M:0-A4D_^Y\WGWX.M"PJ^!NI_*FS\CF&'-\+]+#$"?.CO43:JHY':_BW82K:Y
M06%[(YXW44J-L*_&2B%A[59R^^>==CUPZ"^R.)\H^M9]OH9(G4*-<0*@J>Q#
MKN_SC*@<!^^QJP5#.K;@RP_I.K2,JOJ)G;75J*K]9^,;6Z^9GU/OPTLXF2#U
M<.ZYU4#P-JHB$$XXRUOVR$=E(&>=#KY02R/C+NL#'3\$Q=_F#"S$-SX;DJ@U
MN[<V\**3QX 7P:17B2]:-\S6U<7?/IY]^>/SNZME\MS=O4:B>V^_<[2Z3/>E
M8PMS,/Y;+?!1TTWWCA;"82.*3PTS!C4RYT=U27U^S>V.KY&V$-B=.:.&(7TU
MCM*AAAF2ZZ;;\"*2L,ZP90<^SV(2ET*FKH@H^OB@]Y L[\'^DZ1Y]_<ZQWO+
M400O>=/^/%?3;7&--PAQS4(VQ-\F\=<$3*J,?X1;B?^!)EV4S>[#8_GP5234
M__YQ9^]@?5?TU5^W/AM%T,+ON4S]P='*E.%;M)=_"SY$,P%>28_IC;+9*)M'
M.!JOR]?!^;B TY%/$2'WCT[P5J6?"H5QJ2?2(3\'.^YSK]I#@_,-O>"<Y3E-
ML8IEM''2?\+:(7*C3 :Z1=B"<.GBW.ZO='2W+HLD0_1+.K]"K336SQCV_06W
M S7IES$\IT1U<#7-P4U(-QKTUO#K\ZS6BUD0J;/Q%6&(D5-L\IEZ.:2SF'K
M8HRYJ15_T=5S].'\XMS'[O_E*OSV=Q>'X%[W\\$,_C.N)NE?_S]02P,$%
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MB+4:W8$D4DHT @[=P<=L=WE&M=[5YNR-'O_#4J)N-/D=6=Z6#U; 5]]ZBTM
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MTD2SS#&*+E=#<$,D.$U\N>@F97#&2>Y5;E,JL"70?8WHC:_[WLN>IG\NUS<
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MWB5QLE**"<1?SD=??\51D$G.RC=%F@M);A][(=[#9K3:-#_A9WN>2L.] V(
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MA NJ:19.TMCM0.KF:,^>T8-%MX'#3J&PDJ<W>/]Y-%P=FX@<60X04(VH1;O
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M"-&F>L>>0!]!PUJ1OJY<#1EK$+G?AO$EY-$8#9]8*F7V<S_.(XC7T)T.0<<
M!$!'(FGI;:^5)1QT$#0RI;?V(3Y<V3J /EW%.Q:3#8X/UH&]1B'N\!XM^W,O
M7(3K%XHYET3,)=V^M(*5@C@5#%'.6I.=SD#;Y&C7G,7IJNFC<=W@T&+OM=ZK
MY*T61 C0:+2@/^S*?0E%F:1><FY\F_L2G7;G9G)91+(C$]J%E$D0IEAR$4C(
M21-=2J64A0=DFYRA?5 >*ROUN'9P*YJ>1T:K5KJ\<I%8*M'R*E=!K:"2Y(C"
M\RZR &TVBB>9T=I.&?;*=]V'E*.E->X"ZD>^Z][T[93?>(CLCZ88D%F<7S=F
MW%LT0BPG3O 2ZN8V981-U]N;/#^%Z)3O6E\?]A%Y SVXL4Q^&OOA9. WGDH8
M"UFG6+I4>K1.$QIY-J#-!TY"CJBMVC:W]+;@>RK9+'N1>;_U4HN)M@&\5T7,
MD%["$+^9OA\@YCMH@Q'"N9Q(=N4>4BBW6PVBC9H;':FA.C7*G]T+YXGI3VUF
MVJX[?\.9+[VU4FOT]6#TY[]!.H>%O[Y*"/64:>44T=$J(DWI.:,4)S'$TBQ!
M2-LH]79/H">F2=6YN3?:5NG(>I5'O+IG_^_0/_^,$WGQ%<;^');7#^8W6?^.
M?MNBS/YLNH@?CO)+/^E'/TRO^H/9]#HK^<O5K?T#CZ:/ JO3$?3Q!;=VU&R-
MTY"#33%;"<(&%5D"(?'_$U K>T=!V'%5&T[[J3P??<R/$&?C>8>FW[[%P0PG
M6D*#-S"]R^LSN@Z#:":9%AI7HR@UD50I8I-SQ'DIM&(1=:M1$*G2##KO#]UP
MO+@8S8;37N @61:EA$XJQI)!<QU7/Z)S1 ->TYR%>HIB7,!_A*#Y8^COG>WG
MZ-0WL),_QL^09@-XESM.9Q&@8CX(JX,@0$MR? Z^I,D+0B77F5O+;&A4S;KJ
M/(X6=GX*>OR(*O!4 M8=)_[R<O,#%NF\S);ZAY)8B(E(P0+QB5N2N1=&,Y%0
MO9[BVKYM4H]V&>,15;7NZE]-95KXO!N1_>$O5BWF=L'7-"[_$,+'"=$_&978
M254[\OD8>J> ,B[0;0\>(I&JG.,S].<]6&G1^<K:[G0=X)GHVP,G ,]6W?:A
ML4GIC"%ZXM,^[@"WN\<LPT0T!RJB#T0#-42"2\1;;TBPSE/AP5!HHV4/ 'LJ
M;M:A3-ZIL%&/AHJ.T;S2W,:^'4M<.CL?N91$&!Z(Q/>$!!=*#;F N +/GJ[5
M:]M<T6_+&"?"=%51WKL05 K(HCJ6QL<PC#CQ@^.GFY[2*=SY(*RUZ*1 =X\+
MJC*NT5)8E&#TALK@?"@U:J"WZ8'=UM/%+9D;3[UV2T5,FG.);R["00/;1H)H
M!$DA22UU+ UOFBRE]V/JNGO<?O+E>Q0^?GLV\/V+R:(692_S:((0@>2(6Z;D
M8(FC"??2&#VS$2 TJL;U,+;CKRR5M&-]]ZA,0X/(VAK"5_["GZ-U51)Y(2V[
MY3#M8[F#("75I#3,($% (H$;I6VF$!NE3#^,[505I2L-%>W1LCVNJM?^-GWW
M<0KC_J#_W_,-\JW_<S+K3R>O^P-(/5U*CSC'B$OE4B^D2%Q6DB3FDP\&;'1J
M!Y-CI\&>/?%MQ-K@]L6:9KZ(<3SS@Q?3,S\>7^(O%\J)1I 1EC&B.-"BH:7A
M$A@24W)*!.%YC,=8(S;#>_;:THZ,!O<>[LQ]$<9,N*-9&3/"L&A&QQB)Y>BQ
M2XXZK$Q&%6^3]+89S[$.3XZB"0<)^:D<:]R9RLO+/_QT-H9W^::NEX /!*I1
M+IEPW!;1OV/E:I&V)!E.%8#CTK?)J-T=XV,=.M10B(=TK XQ#8)E:^OB N4J
M=VL':$V/ ;: >YP3@%:\;M^L.I-R9+W)+D8I4PGJ65%2'C()EBJ"FZBDF5NJ
M'3T-?7D@@O\$U&4?+BK[/O\&XV'?OQ^/TBQ.%Y[[,BZ808 WZ(;1;-!S9\81
MY[PEU@3(5BIO<]K!W[EW@,>V6CM0,*HMOXJ1CU)'ZNI:RM^@M&?Y\KD?T8R>
M'RG)0&F2D?!(.>Z25I>&<4!","HFGJ7>[=K?3K6\[H5Q D9$/3%7KB'Y<6&U
MWH2T.F#> 53ULI'WPCE^I<A*=(U:R;IRG;_[P=$0@RB]XYPQI3$C.M#>:TJT
MF??Z$EGZG1)=GZ(";*G[>$S^]Q%Q3=ZG7\:]O[WH*:N49JYL-IGBBL83&BHI
M$&$UI0*"$F%;.ZL)Q%_.1U]_+8];,%R^F[.[X'4QS'%K+U82]NAP2;6NH/@!
MOL)PMCH0G!QP\KG^A$ZGGEOAK)UX<A6SCPX\Q" 9[IA2,Z%S$!Q-Y6Q];_UA
M'4ON]R?^_'P,Y\NTFN73KV-/7..>36GIC(G:(&EI-:.4(9!=\L&YD&6;:-Q#
MR+KUT1Y.QSY._[T__7PVFTQ'%S#^  %7M;=]'_J#TG17,NX4=T# ,WP7HBJK
M6 22K0":&6@AP@Y6^PY#'=]^K\KZ[>[:=07;X"!S.=</4"2%]NM[&.?1^,(/
M([P+@_Y")#WADK;&"2) ^Y*![DE(Z'W$'+AF8)).O(G:[P3O1#2F'25-FM/L
M /*W;U\@EJOD_0O\R+O\$7\[P?6\_&U1=(KUHHW"R7*O02E)I$Y K(UEHW0,
MT%V*E#VB:NTP@^]1^VH3VZ)[SF8A+1L]4#2^G:,D"4!LT2.VR"2AR@II>8P:
M&G7+V8+J6$=K3=6GFMB?RC%;Y_<!W</Q]!7N^7.7,#./;H#7!&BI3&H3RI9Q
M1;A DU;0H#)M<^)?=QZ/%6FKIUZUE[W#::X<GUG&C-^-/\+X:S\N\#A!%2\%
M6[@L!?VU"\1ZZPGC1FL*QDB^4U79G4(SFQ"<C,)4$7'EV.P2S^3%,"T1398A
MC%U 58_-W@OG^+'9[DS=I;V2F-N\]AO J0@LVY(E*P(E,B=>3A<E<9:I4BV,
M:K-3GO93Y'Y+6/9(U.\CW<IGK"M0?IA&JUE>=1[4--K ##$4MQW)J2 ^F^(C
M:N>UX/C'M7M.&^,U6X8X;I2V$@&C^M*K?#WI;#2<S"[*]K0"P]%K@D@MH:6$
MO10E\RUX3[B7*N7,,E4[AMYN/_BY$]A-4JVO'*T%IGMKY[*'A-U[K&K@?1W2
M6NA=:YZMH*5^ML,W %UVQR6PJ*)Q#F1>#[WCXWX$WW\$WY]$,.M'\/U'\/U'
M\/U'\/TDM>]'\/U'\/W$@^\_XIC/-8[9*(;U(X[Y(X[Y(X[Y(X[Y(X[Y(X[Y
M(XYYS#CF,CWZE9_Z5< O7%XG2[\8@^_0+'WWAW=K;7[@)-9"HCXZ16W4-A@O
MG9?>AHB+, N&!VF#[NTQ3L?*SHN!/L"7T;A<.WHSG/N)2YDL70ET 9FRDA.M
MBB>8\(O5)I.8M4N(6C*Y+5N_0[WF'=!5BH%,>@&L<![7.&_ H_$; D%Z(JYQ
MG#+G= Z^346_%8+CQR"JLW]/'&(_X38M8+YERB\OEW]<.$-9!&,21>_'>(;+
ML()26E 3;47V/+-2':J-UN\/]EA1A^8*TYJHQPY(E'WZW?C<#Y>UAOS@[\C4
MW!0/(3LTN"TQNCC?O-ST83P3187B2F=GK-C!K-G\],>OQ=V(SU%5N59V2.XB
M6IIXNV#:'(;8D?/'B"_4XF KI1T$>"QR:5 Z6.4(RZ6IG0^E *I!C\EE#DF9
MQ,(NA=B.2^H]@8-C<KJ/W"IS^3ND9<?S5S#H?X7QY<=1J7.+'M55A[G2'+P$
M1(,#(HVEQ'MFB0N",8/;F[%Y!U(?'.AX1F ]+D:M!%DYE' -[G<_].?S'7T=
MGI8:S5&-\*0H=W710G-@(U$Q>FIYUE0_Y(SN.-3),%U'F)7?Z%=]_'D*DS,_
MAA4:&X4H%<*%U8@&LB4AN$ALILPF;KECN[S"=Y_\S)GL**J*Q[[S,.1GCV9A
M!%2DZ <?+R?%IUBM';BS:$6!1%PIT#*,Z$]*Q,:R5)DF"#+978*X]P_QS*FL
M);R*92D+K#?H0YV/Y\U<^_Y\.)H@O/6UPF9KA#2<<(=;@K3>$1]I)%0Z[1A/
MD0FV [<[#/7,.:XMS+M<RRY<O^R/)K$/P^O# ^6U3$E2HJG!B7*%.SZUB@C'
M@K>2J0"[O+5W'OS,>>PFJ+NLJ4[-+&;C<S365DN% ["R]-((#I=_)DVI-Z,(
MSU['>=41;G9@[-9#GSE;APOH+E.ZT_X(X_Z7SS#V@[(0C+^BV=6_ZI4AM(@^
M:T<06^F#[15Q.3H2'1-E 0@Q^%TVR"UC/',>JXGO+JVF"ZU_1XF,SB_],)V5
MMBJX>]\TQY2D'O\CR3A7U UPZP9*#-<6I"[M.W8)#6X;XYG36DU\=VFU;2H=
M>AVH2-J0+)(L5<(S<9YKPD)*'A07J(S5LE">7*7#8\6%ZW%PM#*(NX#Z/LL@
M[D773F7P#I'UT<H@1A,2,+0JF"W1DQ0S"49F=,(CM3%D!NMQY.>C  >50:S/
M_SXBKLA[+$V]QY>]OW_L1<J3C*60+PB/<W*6!(T^6[99,)UP&Q3;3IE7E1"7
M3USPO/SANA[B]7A/I23B7H(?=9):@W2"/T;#OU_G6(6<8Y8EE4&6#H2*6.,M
M430)<#;H&-NDC=P \9Q9[2K3RLMQ2:(;#?II;H#,\QGF2X^V.G(1 DE)H.TA
MHB".6T$4BZ6#GG9JMQ2HG=;BS1B^!U.M@O0KABXW(UKJ^BZ8JIMI]Z$YOI56
M@ZFMQ'<0<_,E896$H+7TOM@C-%ET5DL%?>\C88[%G++.*=IG2OT6^^Q8S.\C
MW09W8]_A$NG+*K=<V*Y2X4$SW.(BX3E!R:GFQ L7<;(<IRFC,[1-7Y)[ !UW
M[Z_#UJB^J%LDC:X<D9>S27\(D\D*WES?&14J&K0^F2]9^@K]$._!$Y>,I4E"
M,-#FRO-66*=N)-3GIN+QUUJ6[/+-V 5,TP98M^ \3LNKBG2M*T)G63?8.VZ#
M4AZ$+O4=*!69H-MJB"MWLGETC&<NC6][?>(1>U<=B_=]1-PD=7"PW+*8Y9(G
M!\10QXFTEI/ O219XK[(!&2W'M7?DCXV>*Q&5!V$>R=#[!#)5,[[>]O/\/'V
M43MPCO:H%D0'A7N/"HQ8RAQA+" .ZF.@NYQPWWWR<R6KHXPJOU0WSV:O-(CZ
M[-'),(3/D])BU,3Z#,1)- T58PH$WX&S3<]^KJQUEM.]IUKU;WV^[@_],/;+
MP?N518C?G(TNOOCAY=7.4.,.Z'Y#U;H1VF&"=[O5\!1H-B$K:9W%URX&;A,U
MF6G@HG?PJ$>X+0J"@: LH#4B=+D7D(D-PA# M<0[EQ43N:6YT_2VZ)LA,@^E
M3]]K?*47O?IFI7K2PH5%[_@EX*BP^-PG_PU7T_YP-.Y/+^?O*DRF+X;I]E-^
M^Z\9_OEWF'X>X5^^XD?FC/4<+@8Q&$F85J5!(Z,D)*5)H-+8<FE8T9UZ(>XM
MR"-.\HG>>=U'A]<MTZ>J(I6-JA<1,4WF9'V 04E'/1M-YN4,/B"\\2Q.9V.<
M]=EG/SZ'24]'&JD%=/:I]T1J)4B0J'HLYRRMEBFJ79) ]QOUA+2KL<@;.,$K
M95YH<BDV-YS 'S#M>2$-LR:CGP<X?08*31.FB=#H!<1B=6;?:%W;C.B$U*2J
M\!L4]#M@<?SMVW3L<7RT<\:7<\G\,1J6:]DH\,%<=HNIXF+HG++@293&H+YG
M@5-S@3@AN)6&)\5WJNMTC/URUTF=I&H^#16H>%"\FMJ+R02F;]#P[H^+#%<+
M,425K&.6Z++\2EQYB646U<@R)I-E2?,V1T:;\9R@3E40?(-S@&6)IZLRT2]B
M',_\8%%;=;DF]X2D40O$Z',I^92C)!9X(DH)G5(6CM$VN^$NZ$Y05:J34O$F
M3I?3M*AB+%?\B$DA$AFE*"&D3" ")):IB:W<[F=>KJ:+,K4FZK'+U6S)]U!)
M6@^"$_ I$^F8(=9Q16A@UN5R^Y#N5![I.\F(VXOUAS/B]I'^L=*A=L'T_67$
M[<74+GE1AXCY6"K <=-T GU*;?"+-!9-;S2R"(U2)EQ(9?+U2NL^]8RXZLSO
M(]TC9L2IS#+G21+G2J7YE'&>+$O">);XI^0BW^F>RHEEQ.W%UHX9<?N(ND%&
MW.\>_>R^'WP M#-B?^YZWZ@PH8#QZ%PDU'/TOJVSQ"$N8FC.GFDJO-\I'W9O
M1=B.ZP3TH:+@&RP,9Z,QVC\(\8_1<*FPJWOR(5,;DR)9!5P"LZ#$9F6(<MEZ
MYUW@HDWJT[V03D 9ZHB[07!W>[:7X3$J+2,Q.B,X5C(2K,8?8V)<A%(%MLWJ
M<#()LX?X$/6Y::$XMY)A=@'S?2?,[D77UL3)0V3=/&$V>^NCU)0 ,YY(4(H$
MP21),3 6%$N\46.GIYXP6X_W?43<-&$V.\=IL(PXFC21$IVDX" 04#&'4JDJ
MQ5W*?CVIA-F]A'MOPNP^DFF?,,N"T8IJ-"WFM:F85*7YAR Y.!]D$B*[79IN
M/+V$V4/)ZBBCHR3,*NJRBXH8%M!;=$82[R,E'J$H3B47F>[ V5-,F#V4M<YR
M:I83<;7ROQTMRJK.5WRII0P1G3H12@Q)XG?!@$2D$H3*/* /T3"G82.H[\5D
MKL5+@T2#>Z M7XY=P#4UH+?">QR#NAJ9NRE)!R::I.)M YF35<9 ))E)7/X8
M(@V))V(<S510H9F-IZ(F#YC?CZ,E^Q#0)'PWF9;NOS?ZABEO4]2.6%UNYE(>
MB(O<$] I4&NCQWVR4=AN#<KQ[8R*5-V)VW61<X-P_KOI9QA?'37<2A5= I3H
M4L;2\H]JL*4A;"+>28,3ISD;I3QS;9:&!Z&=DF+4Y:%U([^7,,0G3-\/_/#P
MRUH;'M+I&M9#H-8N6&F*(M0N)H5. _+DA<!7SD#R5' M=&_#\[J]:Z_*E"#=
M>.ZK_J2D\,S&-YMV,W1G,E"BDB]5:-&#]):CS6J],1Y_YT.;3-&=X'7NYGYG
MD&7GR[(R]B#ABP*4XH::!)'>6V(%<,(B.M4N2<O8L>9^ ];QUYGZFG*GO7LU
M'AIL2G?!K;*[Y^AL=A"#*G6%D$SIT5</C@%Z=2$Y1:GVLLVEN.VXO@\U.9B)
M!E;K771ERXQ32!]@.AL/WPW+[^:)X9.>I\9("JC.EG(B#46=ML:AVRB3=(%Y
M8\V1M.9^E-^'#E5BJ4$<[B[6%Q<EOK0H4_XNOQ_WKQICES?@; RI/^T%!HJB
M%4^"$&CY&46)C6B;1>NCM5[@<MJF .AA>+\/+:O.7(,@WD.H_X;"G91[4C#I
M20F:"6.(*I75)'6.>$!/403@S--$5:-$FCU ?H^:=2A'#6X;W85:LL7.A_W_
MAO0'3 O2 O35##Z-/L)TNK@B4&X/G\W&Q<.9_\C0_@,HQXOX0I2W0NI  F/E
M%(O3H/&E\.E8%M9!$_@^U+ ]MPWN-=V=!H)?W+SJQ^5OY[:EU-JFY!41I>H0
MRHJ1@-"("E%J%)2]T^BMF0YN1OA]*%D%=BIV/[I[#G@7\>1:*)/%":#G@FGP
ME&1NBIN2''HH,I&<<M 9A->AC>F_%\QCW8AKKT7MV'GLRW"K&:+GTA_/'UGF
M] G_U:([!;>B]+<GI5<4D1Q?B&"<(LG[;$#DJ'V;K+7->![_E+XZ_Z/J/#2(
M2]Q%M>HULP.NIJ?R]R%[G /Y&NP]J! =1'],U9"**\\B$"@I^S+E4L&)>N*<
M1'B.1XCI!%3B@</W8VK$/A)OH GO%R)9'B_=7"97*6E"IL2<(-PK5V[T(+08
M,TDL"8@R.2ED$XUX"-GQ#=\Z'*Y7@:A)P+VG(+5.7)>YX)NJ?!U^ OOP0[N=
MR.X)>NV$-@N=M0]:)Q%E.6AP6B5%<V*>9A9\;X?G=UVM;SYX-*_*A[\KZ:/7
MEK)($10'0;30"AUJ4WJDN_)6R<29E#+SG;HX'K!R/XRN^WYU8XSEPS^,!H/7
MH_&??IQZPN'2ZX(D3MERW<P:$K+G1'D/G!K&>:,3VP> /<8:55E7[FYD]:AH
M<&B["5Y/9,JU9I%D6FZKE-T[2&5)BI:"=$$I>H1W8XGFD76B*V4[J,->\FYB
MW6ZH0<DEU4RI1 P-I;@.;J,A:DU8-ADQ09*^S;G%TR@'>C0=.$3>#8Y0W_O+
M>:09YW<+7L]Q;L';2)Q4N/8Y]/BM04O>&^X@,,%SH\2F^Q"=EBY4D7N#(\Z-
MZU1468O$,HF&>R*5L#CE[,J=&]#*BJCX$=:$C?M"EV#TK:?/]__K$KV+8!>%
M1".^@P2E+I ,QXD+F1( 1;T./H-K= -^=Y#'"D0WMYA:$?-THM#W"G >-N$Q
M2.H!U:%T69&!9W1@E21): I>12=4FV/<!X ]?ERZLCYLW9:[\=+ 2BOQDS41
MK$J2[ "L:7SZ7FB/%:"N2.2H)0M'59-@-;H3V1!7*LM(GA4)+D9B+ TN.).-
M;G,EY,CJ\6"P^C&T8Q_A-]"*WRZ^#$:7 !_A*XS],*ZNIV2PDJID"?4,)YOP
M.R<7V9N&AQB956WNB]T#Z/C&?27*1O7EW>K>V*VYK@H@)!UIIH8H5IK 6BCU
MMIDB3&7F-#,AIS:UK.]#="J*4$7BK2^&O1E._?"\CP;4(I^[M* :#8M;.LKK
M?SOXV.* 03H=8W2=U-JQAG-&&&:EC0*DMLEYHV)RQB1OE9*V=\!XAU<->5V$
M ?-N0TO)H//U%=+Z0-<>&3?!<JHTL524S"#/24CXA94Z1%%ZM(]WZ<&W]\!=
MEZS7]X_QM_%H,NDI1Q7/VA-P?%X%/)% <R0A9HI;-;5)MO'-'T)VO"6LO4:L
M+VM566FPT6W!]R+&V<5L[CC>S CO04S9*U5*,)I I,)=V3/GB852Y)'AZP]M
MS./]L7ZGFE6#N0:V]1;$I6\3,&Z38"B"D!*1HE@/: 42I:CD*IH@99L ^G9<
MWZD.[<M(DZI16T7PV[<XF"4T%/\V&J4_^X-!CW.!LP8HQ29*.[@@B(_ERE/)
MNDPL109MCF/W17K*.M64M8H'./M(9A$SY<8)P[T@4;F(RR?@+NV$)-;;G"A3
M7L6';/N]!VU]6'$\_6@K[Z=R9K%E17UY^;O_S]'X;. GBUJGV2E@I9AB0K\9
M3;]YE1Q<8XU#-YHZ'J1H<WZQ!\ACGV4TUI+=][].;!W7>+H&^H>_6*6.[@*W
MZ5G'GH ?YP2DF0+LKFC5V'L"2J<C9.<$)](J_*)422E6I?^J\Y1:KEO5\GP2
MRO; ><I3U;5]2&M2Y>0K#$9?('V"^'DX&HS.+S_TSS]?-83)6@OJ5";19EV<
MUD0\MQ8]D6B!>G1<0YN(^P/ CA]X;TKLG9NR]5AI$+8ZFTVFHXMR8#!8--3]
MW/^R@A:M!JDEE+.B<F#@$94%3;A(0@DKM8<V%TNV@#IM9:G%1N6*X<L^J+?T
MEDM&93!H(YH@T=D4F7B&TS0>M,XYXDS]#C[<AD>?)L4UY-@@-/1I[!-<^/$_
M5G@D]]:HT@@H4H%S"Z4*MM'E/G<&G0WUM,T=^'4DIZD&5>3>I$KX% 8#B-/2
MWWB,^]5X>KE:> */TD@$%4J>N*2*V.QI.486X 0ZAHWN9MR/Z;1UHQ(7#>H&
M/1!'N&-]NP0IET8)!F*)>U,@(7-!(D]"6A.X#FTLB#V!GG9PIB5KQS^MV/BZ
M[0*Y<1N#O4$_5G.#ALJPG^)58[))&X3]H0L=-$0?">-0SE\,)5[C3+1-&A*5
ME#%^VLKW8,N$IZU[^Q#80.?^/HP%4#_WX<:F,-@(?VD.**I#Y)*@<ZC0U$"C
MT5(EB4K191NIS+E-,9"]H3Y&#?[&"C Z)GL-0C]W7!#&A3/9,P*03*G2K(E%
M,Y: 4I&SP"FH-NO7X[M^QU:63K(_=G+N52?I>4QJE%<)!^%RK?-DM4S=?4>L
MFK;;:;IK.;PTY&B!,25IE%1'RR@7W%J*KKVP(._D\.X[>+<E8/7TMU<)"4%2
MP72D)2%!$@E,D:"H)S0K8P,(U.HV'ML=*%V7M]4#;]Z;CB93,-$1S@W.3L9,
M;)+X\GK-N:-.1-:F_O8&,,=?Y+JQO;Z$=95O@QWM*A,*A(G4.(9K<<G/M'-'
M.3#<6:5.3GB-OVK*\^.1>S =]]"[ERP;&,4K'"_B?\WZ8TBOYE=:%J5F>UQ(
M%3U5Y98W3BM%05Q"5X'Y*%GPT8A&'M<V5*?#?6>9-X@.K;"]GXWC9S^!%S&.
M9L/2#.M%^L_99#JO;=$S,2=FC2(X58NVF53$LBQ)-DY*-+%LUFUN&>X$[W0T
MI!X+#<XT5B!QPM _'Y[-QF,8QDNTO8>3Q?GJJAAZSP*N;LERHD [(H4VJ-3<
MDDPY@%,)O&^3,K\[QM-1FLI\-#CGN-K\)%54BB1(CJ5\.7?HEGG/22SU)*-0
MQH=\1$-B_YE<E[)8/7%QGH"D41EM("SR5 Z2,O$N<&*5M.BS!&]UFYWS'D#'
MJB53UP:N(=VGDG!]U:URS=%<A&)%Z?@ (1)&#262"48"-X+P%'.VF6?:J*G,
M5EB/7R"F ^_KNE1-_@VL\%70817Y>AA,T].V6W >YQRM(EWKBM!9ULT5@ ;4
M:)\*GE)G.Y>F#QE?':_1):19XQ[9:#5H3_P#9UC'XGT?$5=.]_L=4C_ZP2I!
M+=GD+9I 3@5?T&3BG/>$<1%H2"PQMW;&M#'1[]9#CV_+=A#NJ(9D*D:["I"W
M_0P?8Q_-YZL&X2)99G0LETK1XY)9:\1E(J'*9<L\3TK*'7BZ^^3G2E9'&55^
MJ>;]4+_BK%!R5QH4%'A6BM''7'PH1C7.BFDB:<I,I9"D%CMPMNG9SY6USG*Z
M-^94Z73L%8S[7]%;_0IOAJ7(SGSQ]\/T;Y#.2_PCXI_P\3!YD5)_,8LWPSP:
M7RQ:P!]Z1%9EV$[G9/4GOMYI74=%@PG"FEA:1[L4>!:ECU0N;ZGN54'0]9+-
M!@@O-D"XT;[HVM?4W#DNP1*0IJ1O.B AXH]):2ETN:J4VYRN=8)=I098*4XT
MAL_%RBH@4*N@1'K._.3SZ\'HSP($5N&?%WE:[D"L\BGBG#Y$^\E_>^_'"+VG
MA9%&\-+O=[X,0":6>TZ,$1E !&%"F_AN_;D\1GO 8^GPQMIDCZ<)#8X<KV7Y
MQVBQXKRX*)'PGDI>!M"EV0S%+<O:4G(/#%'6F1 3VHZJ343Y/D3?DYY58:7)
M%<W]);*(+#DMF/%!$VK1G93H2**:9T_0;'4JJ>0L;=7E]$#(QVM3^?A:UI+-
MIQ(?WC3;#_W)/^9Q#^E!0KF[9C)^D<XIXCA+Q.K(J$?[G#4JB;<-U6-%AX^D
M%SMHXT'\-%WWSE YQSY.;_9FVP%;TVCR-G2/$URNQ^6]2E*)B&,KBQ>202Y%
MU&+"]3J'2 ($28('II+!?;Q1S<3C*\D#@>C'T9%]Y-_D6@[Z S"9?O!3^/BG
M_[*,#WD133*:$V\H+]G3ACB1<"L7)D:E';>QU<V;37@>T]3NRMF&NZ@=!=ZB
M:L7HXF*4^M/+U6R7L!0 #5XIW#43JKT$1T)F@H1D3.("/-@V^;WW #HA1:@A
M\F-Y5*OHP<O+I<EULY[&HE$P35E&I%)Q;M 9%))X2)0DXRP724<C6M7".03O
M#TNV,J<-$E,WP%J]=CL :VK@W@OMZ5BWM?D=M22GP3IV/T!<J[G/$(GVK*S<
M#(A77!/!93;&!A5SFUR+(VO- >;NHRG-/IPT4):;H?+K_AZX_S*NRR&IPOE*
M)3WQ,1C"6*1@0^D"TZ9RST8XQS=]*M&U;O=TEO6]]N^Q#Z1768NC?#LJ/AGE
M=[/I9(K_IK2@N7K<^]%D#NOP#BQ'@W:<@^VJ EP[_ :3,C56&J:--#RX+)-)
M(80H&$O"[7[XW17E8QZ09^N982H30/^22&?Q336,$B^288Y9S5R;BWN/>D!^
M[W&5E3Q"BBB$F .1P7AB<;$A@>*2%6Q(5K06Q_,^1-Q'GW8^1-R'E:9'SOLZ
M9>CU9XK_(TR%>8]<=,J4<"0F[V246=IC>KVG<XA81\M:LOET#A'#]'J><PN=
M:6ZX8I9$5HPS+1GQ*#82A,T6C'7XUT9*N8[E^859]M*!.YK7B8LFP;R;B&Z4
M6MD%5^,CPLW('BN THVYK8K04>S'5 LK(6LO$\GHR".^.%]R%3%*9A>I2=2V
MN9UY7'5X,#)R'&W81]J-M&#I?:.+S8TPQ8L/I?T:5\2! $(=9Y9QY5ALE6T2
M'O%DIP8O&\@^0*A'LFJOCK.!ABR2-D0R6:J?)E1EB]BT"TY$*4L[U!_I18VM
MA4K\-#AZV7KHN0NV'^E%!W*Y3^K((40<.[V(14.]@$!"])K(:$H5=H4_,F\"
MM3QXTWJA>0[I1<UT9!_YMVC3M*A,\MNW^-D/SV$MU8%+%8R1N"4:F4NK!DY*
M^R "0@M9"OII:)-=LA76$\LQV8O!]89+U<3?I%/.HES-S2PHQK*D@1%C([X+
M-'."$XS$T\!EM*5[3YMXVETL)Z0%'05=^=[NZ_XW2)]&KP<C/[T^_[.>"RM$
M)@":$>G0U;*<.N*CD,E#ACL)A_=T,-WP\!.@LH[@FO06V)C.2'7*221*%"]+
M"XM 0F !43FAC>/<-:IN\RSR1[N\S!4$WJ RW('))(+;TF2E5,%$:4BC!*+6
M$LD-C@L>/:Y&/[(&GY"#6IG3!IIX?]+*+L!^9 W6Y7?G!+!#R#EJUB#CBD6)
M[ZOT"0$*A\:R $&2C)D*8W$/;G-/YB2R!MLHS3Z<-%"6/V#Z9O@5%L59;Z>S
MJ:BXIRX35AKD2N4I"4;AXFLSY3'8 +'-QG8_IJ>4/[@7<:,F4F_@T+[V_?'_
M]H,9W$:%MEC*H3098PDM=!J+H8>3E4RA&("ES-NL')OQG(H>5)#VT3*)/5CJ
ME(@D"Z=*9Q-%?*"9"",3-])8GAM=HWKJF<1=-*"[K)],::MKP[WLI9.RF<)D
M-+RSUL$RIW32,G=X?S#'R1;N**2U_&!F,C/"I)29E=Y;;QDDR:BB-O'$X^[Y
MP?OC:NALO[U*HA,T1!J$(<YD3B0/Y4HIMP0 7RVGF<*WZ_C.]=MC%,':5!#=
MQU6IH^ORZ->U]9&L=_F3_];3P5F1!2=,.(N6:KEYB6(D/ 6G,I5>4M9$:FWF
M\T3RB[MIYSY5KXY$?0/S<=NL[JXE5SX79)SQYHI>O>Q<%KJH6\#)2&=*F%\Z
M$A5-/AI(O%&:1_VY?'>*? 3*G\3U\9>7BSE?U8%^.UI,Z.7E?4?FRQO1V0L;
M92108N?26DVL"(Y0;3@//()P</S]K>H<'S5;OZZJ/U'%>#IY_%NR0P23BFF<
MAA-FGI"(&Y.5A@0'3IGLO:&M2Q\^\6R])Z!(^Z3W[4/HL3.V=L'V([WO0"[W
M2=TZA(AC*TM,4@EJ F%AWF77*N(B+;6Q:,K&<&I<ZP/<YY#>UTQ']I%_[3R>
MVX[6*QB.+OI#7&'3C1SX*)*2@6O$ES.1 ==2ZXS#'YDH-004I6L)79O3>G88
MZXGE>.S%S*BA6(^3N9>ID:!BT7"T#R4OES4U+WW=0 M*91"A3=CDR6?N':((
ME01][QM?*;S]&A5S&/NE*<#- .G5R<SOX$M4=)&N4K5Y0ZV1.P6NFTQ_+4HM
M!207F)&",IF$<$'QD$&56CLN)]^K!:+2T>>BZ?J+87K;]Z$_F,?'EQ#2N^$'
MB*C1)7@^3'^,AN/5CR_]I'_#SPQ&J1!4(IH)(+*4%W=4,9*821 E8\*V*;Q3
M=1J=.D;YZ6S<GUXN6@2_RQ\_C\;33S"^N X)];(3,0 88JE";SP+3[QQZ$-%
M],4-VAN>JAWVUAV&.OZ*^GCZ=*L[5646&FS%<_F\N?B"\BIPSC[[\3E,>J X
M<)LXR?-.6B7)VT4M<)=@-G)O3)!MWJ#->+Y'!:K(4(N+.17DLVK1"9K3DF\3
M,R5HZ^12N4L2+P+Z.<%$Q]ITCJDVA6-%69^.3CX.^X\=:YV,I[T/Y1[4XDJ_
M$)+[J C.0.,+2$NQ98I"U";%#.#H;AWM\:DW=!9_6M?76\,^5M3TD1@?=95\
MQ:7O"L0J4VP'&/L$.G=7A/I^ZL.QS X4K)/807X-Z1191#2V,K$JE!LPMJ08
M&T6XD,%#SLZMAYJ>,HWW1!OKL[B/V"JS]SM*ZF)VL03B9,XRI%+I*S $$@SQ
MP0C"O4\);2*MZ$ZAY)WXNS7T\:S33L(?U9!<11=D#L1_NP'$4YI*GUX2N$ND
MU&Q%(,RB21(X1,6EW>TT8#<*;P[]#"D\6')-NH!L/!]==#Z1/CLM*:'>Y.*H
M2!) :,*C%\8&ZU2C!C%;0'V?5E1MMII<!]X(;54V>@=P38^6M\)[G+/E:F3N
MIB0=F#C>NK,$J9)'* Q=6DXCD48(W.%D)CH999P$9GR;:A"/H"8/G"X_CI;L
M0T"+NS2CR?1=_N@'5^WFF??6@/#$I>C*5 5^ES(!&;0!C_^Q5NV(UJ </Z)9
MD:H[G8BZR+E]-?XP[5 O_^H?=[RCLAG$VFD=93YD00%4E%+$Z#0KC=>URM0J
M9ECOQG-JEO"\C@I*YB+8X@M \04T?G'2<UP;- N"9>]$FS?D'D!U2Y6^]A%6
MC8<==4RF1+0R'@TH=("#4IDX='JD41:B;E7)?3.BQRY@>9@.;"]6>J"\FU2S
MO(GK5A&4LB*F]VC$XQ_\.?0"\RQIG"]G&DK6)@HBL4P4#T4 +BC9JBC[KAA/
M45>J<=*\X/$'^#(;Q\]^ NFF@ON,#ID1)$M3KJ-R02Q#?0\R>ID#RRH=8^7<
M".X4]:4["PW\U[>CX7DYX"]0T7./\_RK:4_CL)%K0[S4DDA&.7Z7/4G91*M4
MI-&U*:F_&<]IJ$,%63>H'_3;MU)<;=:??"XS?9<+NM7M@JN;@DPX386AQ+G2
MY#[[0(*+F21M55;6&V[;7#W:!=UI:$=U'N[JBNR\6N!,W^6S,:1^,95*'/!R
MD;(Y?3D:CT=_X@S._!?\R_2RET5P3"%6J3GJ=0CHH94&GHGKY'4(FKDVM?7W
M07D:NM.,E[LZI#J;)OW)E]'$#_XV'LV^H(\_F,V;B?4G)?FA/YQ!>O<%QG-7
M_VPTG/33\H<>1?<R&VI(E/AEWC'/2BN(%CK'K+D*KI&9>R#BT]"MH_!U5\]T
M71-X61W0I8"[:BQ)9P)5'RCZ=,P38S+3WH4L5;NV#VM@CG?5M;5AN[]L'SLQ
M:O,\YL'EY$-*RJ/'+W(DDGMT^RW%O=8X2GETG,G3;R;5D=V'VT3M(^5C]@/:
M!=?WW29J+^9V;0QTB-B/J18(0'&F4?L3;F#2E%:-4+HA92:LMH#?M\DN?^IM
MHIIHPS[2KGS'\X_1%":*4OIJ!J\AC&=^?(E@J*"K%@)9RZ2#)MI*P'70(;8D
M2]T<!BPP#\[O<@?EH7$>VW0\E(U1(U%6#+!?8=-&W8N-)FYU3JC(WI?[R\*@
MF41+MHI@VN2DHG&[TKQEG%.AN98H:]_87G8.*!'Z.4[$^#]GPY*(Q/D27G#H
MHGC4/;1O<-X<ES&ODR31**\=]8ZKA\Y<=QSJ!,BN+="* >W;B<*X]X!)GA&5
M&2J=@TQ*AUV"JXIFUCBT6=/IW'6H9; ?+L,61*[6CQU@G.JMA;THN"??_1#Y
MM;R$8K73RCA"G<\E;\<2'Z(BN.Y$*:U@;+WOS5.F<:=;"S58W$=LM6\MW$K<
M3MEYCDL(D<J5Z@ZXQN.2SHGB/'+C#>>[G0P^IY3WO81_;\K[/I)K4</DUNG
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MCWQ<Y\B-B09 ?F!:.@2]U;FJ*U7MX%BU@9G]A\@J'HZ=/)$*2E6NLD?E+4]
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MM"[!SN;L]PIVOZEGGL:&E^KO&_/M>?7-_,<6(ZC[=LRR-$<PQP)PIA5 1"2
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M,H15AKV"23K%38V<]UI3L3W%(_7='MGZ%D?M1MJ-1</A-S ][BMJZ>^HRU?
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M)%@:DZ/'S>IQ65;:R,*6;N=5F1-[XR-;K0M1/#*[1(E4@VKY<ZCRBQZ3UUF
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M_0<>U3B TGUDXS+ %<F-UL4L[)NLCGF>"0+S7& "D@QF ,4Q!XQ*!B#,\EA
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M2G!B?DT%3;A6&MK:7<LUF[LM$2\)]*+GK=@!M\>MC&A/ZRHQNVJKT>C]3_]
M8)+_2U3K[]G@ZQ+\;LO&D* .3-C/D;R FG\K+T<HPC;RNB1TW#9>CA <-?%R
MO6\8JKGE9561=28E28C,&(B5;0N3Z 2P+%$ :H&0)H0JJ;UZ!CH*GIIG^*-(
M9SL18<BG#[P_A(2B+ZVJ 8\S?=$9E9>VPB?%3\\A\>6IH_O[\94-."D6]_N%
MZYN:NH:(-+'-X6DNA/&)I*UGRF, $2)"8I&*V(N@SDJ:&B,UBAXTR^C9P/D\
MNFZL$P2S@6FF'US>%',1BJ"<<E[:J"1RT>CGK''YAKZ]X\V3I\KU1[96GWYG
MC\W),$(Y9#'G0#!LG!@<*T -.P!$4T;SG&/JEG[>+69J!-%J&5DU(ZNG;UOW
MDV!*G#.9YPQDR#;QH'%NJ#>1(&;0@ EIKA+F5USU>CC'J:?:Q,[;X[-5D_+T
M'&'/J+@S$+NQ[O6P#4RYQ_ ,D!/6C4+@!O8G18W<H[[+W.,V])U77U'E>B/6
MFU5%X:5:?5/[>4H\@X8+,@CB+$4 93(&7&,"A%#(T$.<">*5\W5!WM1H]T#=
MJ-'WJF2P2X"[T45 & ?FC:L0[%=^^3(NX4LO=\@<O^SR90!.EEQVN*T?R31Q
MK>4']F3#6<W:TGRRVBBYM^!LRY"G:6[\NXR!O$HR93P!'&H$$I3F$*5QDA.O
M):"'[*F13Z-R>6.KHUF5(U5G^-9[*\LJ/$@TU03G.W/\",EG<MS(:2#(!R:J
M5NNH4;O"N%%\_YAB@*+Q/0 +RF ^\D=ELQ[ /&>V/D/T8[EW:FU#N3ZLEM\*
MJ>2+IS^72KY9G(KXJFK4;LQGS1_-JGF[-XRUR/-441 3:E:UB3(>5V+F+(XY
M10)C1+%77E,8M:;&C:>B(OUX+]!TN5'B^),P,%O:+-8J!K4U*>)/T4_6JJA8
M_/%<T.K6MFAGW""' V'Q#DJV@50;E8?#POF<H@./WH^]7['5PHQ;?E"KZCAP
M+]$T3S.,,@XP1 P@E4E 4*Z XJDMK:2P0%Y-GLY*FAK'MHI&!NOZC-2/8<]#
MZD::08 :F >W&'UH,1JH:>U%,(*2U'EIH_+.1:.?4\GE&_KFJ2M6;E9/U9GH
M?[+Y1MTVK=7OEN7Z-[7^NI0SH1*<4\5L'3:;D2XXH$3;CD)(<$,2*63(+R/]
MLM"I<<9']6B&^LK*JM:%6#X\+!=1:0WP33%W -R-1D+#.#"CM.I&E;XW4:7Q
M3=3J;+VH<AW5:H=,#G<'*7 :N(/@D1.^W:$X3NWVN->_[<!OQ:)XV#RT]68)
ME,R6WTYC"0'*<@&XE@F@,(=,&RZ"W"G"_VCDJ9%*HYQ[.X!#G+IIXBKK!^:"
M1J_ Y?E/6GMU[?W#44<KK'_2F/VJ^:<OZ)D O-?(V:Q%RN6\D-4OMPOYP4Q\
MFSJP5]EAF]57OBQ*,5\:=MASA*&06#$B0$J1#6'0PF[V0( 91KG()--4>.4)
M!U9P:DSP@I5%:3V+?6,\,XM#SZ&;%_(C9V9@EMHWK=KDV1E7;:+OFW=8#&=G
M8;0S<: %U% 3$#;W.;22XZ9(#P3Q42;U4')Z;AU5W5C>ZU??ZWY&-D#C_<)N
M:=G_V]#9;VQN11\UMCW\8._*&1$ZPP0KD.54 B2P-B\&S6V*4!QG$*=0^VTZ
MA==Q:N^&75LIU1@9K6RL4OVS>6LLJL[9%26IG1G5[ZMKNFL/,?^..V0_=E:'
MWEO;3FAK7QU\9B;2*MT4P=C3_28ZU?#[^6=[-P3<GAMN)L)N[ V@Y[A;@L,!
M?;29.*"HOB'1;17.UP:84Z<A+Y1>KIIJG9_9=U6:Y<]R5:R?VNC!JIWZ_BAU
M:D>]-;'7:'V6:B@%SA!(N68 Q3 #G-$4B#35*,,REQ#YA@:/IKT/BXT3;WQ8
MO;<VM"WI6YGJ&VP\WC?![5TTT=D=^!UU.*V6KLZ<<O-ZQIN$N-JDO3K0YMVU
M_V6XB=X9.C0#&1OF^]'I(6.M1Y^OP '<X^D_<E3XZ!-S'&H^O@H]FQ>HZOGX
M52V,9G,;W24?BD5A0P*J1IEUP.1,2\&3F#.@B<@!8HP#3C)B7FN,QII"@E*O
MHSDWL5-;(35:5UXQ.U"XC2SU;!C@!K[;^R,\I -3?Z/P3=2H7 >,'L+ZZ@*L
M_J7YO5 *6VS?3?2XY?.]X#@JB.]W=U^?72IM1EVKMV9,0WUK\R4J;"AJ5?/Y
MQ=-O[*_+U=V<E>7M]Z*<295"!G,%(-490)0+P"G#(,L3A%"2B(PIO_Q&+_E3
MXZR=^F!N]8]V!K2UU+]8O3W3<'QGQ=4''@SKP?W8:V'NX8#V BNP$^FGP\B.
M8"^ CIVY?L/XAR=<;%!NGR3,42HDU0 3H@$B60)HS'/ $>*&Z"!6VBG!QU7@
MU AMIW-4*WT3U6K;C<Y6<2].<X;^<B!$:$ '9JT@6'K%3O@ ='5(A9.PT2(M
M?$S?#\#PNB]<%O.,2D6SE I J)1FS9<S0"#.01QG),]I(G.I9X^5,E41 #=W
MZI0HGR?BN< !8R74?;&PT;#1"V;^(#P7=R<Q37$.%43$?%&Q,I@*6K< %1D5
MBBI*.:$-IJ\6<DQ$6W$#'D<M9%@PW7S*:^$9F()/YG</F] ]B"=X4M /3]T^
MY]-U7NM?-O[SBMGO]J>G![Z<SRA$ F<Q!T(2"% *S4,N$@:T2"#)M$PRMVY
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MN3Y[74]'H"C9_?W*'M)6)74^JF]JL5%OBX5ZLU8/Y0Q#1!.)<X!T;)[M.*&
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MTCQ)\BS'YJE>KMG<]0SA4(#70[T5,]RW][.5T7:I6-Q7K87K_?!68]_3@V>
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MAF'P#4N95^HT+J^& ?"(? ,-VW?C?EVLJM0B6T[ALQFDB@Y+B1*00@HR@5.
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MD*3]8AH=I$^-@O9#Y4[M!NSG3Y5->)SG.L5O=MP8:S#,!R:OL'!?$8+H =M
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M?:+;.B#"=.U9FWLJ]^+^9S"UV]-AD!IY@_>%C#HI1ZCS<AF,X+T SDPW>5N
M8;5/=0BX\(9GLX"RH@\/&]-6HW;>/LMO<K63;:0(HUF:0 Y(1BE E&& ,U*
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M0FVGH!O>V $ &7E/=U@TXEV^@++[/%E7K+L2G(FJU'55TJ*MY(^K]7+]4-=
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M73)6HUX=RF565*L8D@C# Q^83 ,*.#$AAX?VF-1'F,,S&KY<R3OU=B-%N?U
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M6#)0=*35V@SP\_#[DU&UE1I]UK9[P??<A&T/)FROQ#/.E,*9=E T<PN )&:
MHIB:HC092SGAD#N5X3\WT?SHFVU[[NK--66USX)K>VAP/62CN_A>:'EX]<-0
M!/;!STPVL<<\K/*Q?WOA>?=[Z2^2UT'82<KNR^U2+B"#199A A@O8NV0%AG
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M@@3E\U$$G?2+8$RH7W^#C#J79X:%7%7:7/ND-TSU3BIMHXDW<J5_Z&(!:5[
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M3CM>;BPW4KJ\$1R.EV07;N@O\[184HR]D<;FE=Z;Q3DY4-_?+#).O"A%JH!
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MMFBMXIL4<KZ:&&92*N3P"ND%N;[6@8].@L+Z>BZD'.)I=<6/K;X?3E[6+>@
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M" IS J=% :&\2"SFVAZ@]57N@]2=:J->K58DW$M>74#4VDC0:&7-V68(63M
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MKYOM:W<,&[M]CS GJ0B3?"TK1&1U('LD\VT3:*Y*]IJ5I-HT;CV0T''+HGI
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M\S<1?>=0VFVVHK6A^)4VFU,>:(,(\+$V+$TZ1F&8"6RO6Z1!P#3F14 ;#!P
ML",4TCG$KGKX[BRQ+R6Z),D2!R%!J3HU.7H'4B#9?"T=L\]HN6Y1UR_LCD'&
M(9;M%#5UX&-='@"_4K3R"WVY(B\QY9R<!:4-IT/ ((6V(H%./*HZJ)NG5MFC
MV[1TTL!JP OQX\3<!5#NS,(6FDD3E0 K*@<*,X2<"FB17:ACUSU_KN+&3NZ_
MC]3NTS/N#Q%U-T^*;L03FZ"4Y%)L*C(RR"XB.0#!@*O/7.CHSR(G)FS,33!S
M#S&=N-[#@.9489_:Z.3]P."Y.0J8,UX<(U%(S!&4S09(, )20,X%U]QCFXEW
MA\]G;G\<#0.8XP5\ E2&P<9E*Y]KV9[ZC&VB8RE9IPC&.P*\,.1\:4]"T<5*
MGDT4KDU:_R&*.FF<, QB!A%[/[V[+MEY?T''AJ,)E\R6E"Q8*<F#-[4[BK<>
MHG5)^<2"UHU!=).@3IH)#(RA$X3>#X0VM-=&BIC?GB^G\[/M*?@_P^P<'YA%
MZYGE65-HZ!-6X:$%ETQ]<)&5D"*D6-KDW0ZGM9/'_0,ZU>U4U4N$=I?#K2_X
M (L\L\2\(HF::.@/R<'Q[,%RYF-&%V6PSXG&QXCMY+5^4S@.IJP.\'AC"MD#
M)14;3N-M3C\@1;VKZ1H_XO+;-.%6-G60V=E\\RF;73M1V186)".WH_8R4\Q"
M5#E *D8QP8S-I<W]0VO.QIT>-S#2NX+!R'W<KSG._XHSXO_3DF13!]OL(O;H
M!,? -!@=:NN8VN#1.P8A!!>+Y1;=/IW;GUIG+X#YS@$VN$ [L)DW;G$V\+Z8
M=?1FL5K_%=>?%WF"T2@EZ!P@P9"P(IT#,5MR4[(Q3+.0A6P3H.Q#W7XWL:QS
M;#731V\8VVZ3RX%:5A7!DM80%*-(7GG:+@$CI.2-$3GH5E?ZCQ"U'Z)>RN7^
M4-+O\R2[9*4PE8+F#%*H>R)A (_TK<G:LY(Y>G["0788-'J_PA]:GIW=C]S(
M9&W>STX46BL9"Q!)W766L "O2P+#;8K(F-;8,.R\2]!^.'HI-_M#2+UG#$V\
MX2%Q.F89TC&KHA'@(GK@:'2=FT>":E,$>FSB^:7<\)\HZT'; 0Z;=RZ1!<ZL
M@ZQ4G;-4L+;C3, <CSIY89QHDT \-N_,7\J-_JG2'B;Q/!1VKIW#5ZD*7&[X
M>HMI%NIAS(TF&3D!DM6+82LW8V<1!%>..R68]XVZ6.]!W7[H>BG7]H/KHX,
M;,/-!_QZODR?PZK.XSY;AB^_G=?ZP7=E%Q.<4VBYG/XGG:2+UWCURWDB8U)<
M!@O&5$]0)(2@I0>9@^&R:,Z%;'?X'4OV?JA\4;?WSZ+!D<.\QQF]NLU]BF6O
M8J+0CD)9VHV@7'TSF1)]92RJG'+=KGN$@P.1LQ\8>[]@'TL_+Z%7T9X=FZXZ
M%81YWK7W6>S;[FG;X.>F5(YL</2,Y [>%6DL43]3M\14Z@/="-R&"(KIVLL_
MD\$N2F)");5LU62H92NE0SJ:32C\,S[F E%:7SLH(+E7V8"IM3G:!(FJ3:N3
M0Z@<NP)\,!3=R9^V4E47GO!CC6.,-DK4\7:.J4S,8 0GF8*2+.;@Z6AL-"RH
MXR9-[=!P4 NG0U33 <[N?RN-A:?-=3H7P8&*%$!Z*>K#,.%R(?;8[3'I_Z>V
M<#I(W7NU<#I$]AT Z-JV^[0,\]4LW/OXSSHL)M,VRS(44+G4=MUH +W:3$\)
MQK6Y9=R/OAZ;/1T$A(>/QJ&TTA?6WF*I361>XYR^6+^?$8]WN(M62N]+AN)K
M_!CKY9<E[I(1UB1FF<F-6D(=1&>//:(&PM[06NH+@W\A25678C?]M8ZI^E?,
M9_A^(_B+OD:!<:.]!I-<G2# Z^,/+2#%)+G-4KE&W:0.)+3'-E,#H7!P/?4%
MP\>\W:M[M,BUT%8JD,BJQUL\>",\D)MB8E"L%-?F<OQ02L<UA\\613158 \
M???FEU?K]7(:S]>;[N^+[7:C3?BN? I_?%C,9C\OEK^'99X8D7G,T8,LM1]\
M"1P<TK<80@P,I8F-'B<>0.2+"&Z/1,MM:#9270^HW$^.%YQ.M'.IMH:#J!R%
M=W7F1@@F@Q$Q.RV%E++-H_P#"1T9G:T <YS-/$I[W?2&>(RSUU@62_Q0L_NK
MU;1,TT;%5PQ[$Z-)$0'1)%"L#M:H$Z(%FBA9XO5,:@+7$X@>^;Q_)N@^EU8[
ML+&W&?F9A+['SGUSOJR"WQ8M76UA[GV6J=3ZN@A**PE>1PO:.V>+-P59FYON
M(;D8-[9Z+HB/IO=^*G(//J""SG7$($B)AKPTS\#7:D#-N&*A7BR'YK>B@[D7
MS4IYNW4O#M!>G_/ +WIP7]0-'E&R<><C3BRC>)RD@4H;;B]RE8XF:T/P<>!*
MK&&3]Q!8BL"Q#CY6,9)2VR2^'J#HY/S>K<^]&L+FT<M@8@(F"YE9I3D$G@PP
MSS4OII;A-1K3\A!)(R=AAL#$G13?(.+OKZ[L#E_'SI5]X(,&-B(-9\H^"!N?
MC$%=,O"0$522IO8;%U"8STXZII1J<ZG5RI1<37W\-YR>?:93\M4W7(8SO%G=
M>VO6HPS!\V T\$Q[1@4;(=". B^XT85+Q7.C5IC'D-NI"3H$2P\/ZVREMO[-
MTRW.=T\G-GS_;85Y.[#R?+OB:E%>AQ7%,//\=CH[7U]-*OEZ^;KBR/+69R%K
M8-/97G3-#;'R+$3. 7VL4%8!G(SDM0L?I+ 4+]RNL._<$#^ZC]^=KU=K4@ M
MO-'%I#8@M#XDB+[4*(7"Z:C(D>$IFOJTU46KF[!_$)F]&MX#L'/;\+934P>7
M?/<RM]OT=SB\JOF8,$L'E_/$H==YVQ$D**Y!1QD5D\';1O/]CB1XY.*<9\/E
MP*KK *&_S--R4[<99M</K9L726\6<Y+"BM3YKMSJNUD89YR\(##!59ZSAXCD
M =$?C 7:CW?Z= R$U!,)'[F0IP5BGU.5'2#W@8/CH2TZB3&BMJZ 1J]J"WS:
MF#XX$!*5*<XK%9[1ICY,Z,@3YI[QC!]$5<<C<4$;99A7*)>QXZOY>IHK5]-O
M^!'3^7*ZGN+JIS_2[)Q<]YKJN18'O"OW7L!,>(C2&1(MLCIXK<10PU@)3 E3
MA'/<Q48=?@?E8^3I=BUP/**B.S"X)_+\^OO]'["=Z\5=;5VFP&$BKTGR""$+
M!T4$:0V7.6.CVK9V3(W\(&=$K-[.&'8"G&[WT&_A"^Z*N34R+B1'DBXF4+IF
M2[G7$- IEY$5X_::TC;01KBB;.3:N5X@M!>TC]1G!_C<A@?K*6WYF]'!KOZ?
ME<AD"A$,,@L*?8;@@H7H?*#@%BW#-O!\@K >T7DL"NYT,!I.)6-W@[FW+_V.
M#U-\2$(ID%:08T9[$J*/M8]()#ZB*('=ZI1P?XN71]88N8BR!4H&%6L'!NA$
M0__K96F_X8H;:<B0)&5JRP0-+GL/GKP6HWDBW#1J.C$0!R-/E_LOXSX>!XF7
MOQ5>?5F<S]>3*%#Q(FO3UEP?+]L(]54@F)(<4X:5(MLDM@8AO\=SO37RAH7_
M$3#HKU*!?* U,87S-#VJ?NKFOS\Q]_\(,0,EZ>OU_70[\N35/-]8[^UTE6:+
MU?FU&RT=BQ48$H0BZO0\'\![F0&Y,E(9DXQJ,V_Y(#*':*SZY&)7E3DY^YRX
M\\!,D.3V1 1O4P%N&**-FIM&_7H/HW-<^]8.9_>U86VDO<ZMU?O%;#J$U;K\
MG"&MU_W$C6+%L*8?F4[ T#E0RG(*44( )HH-/#.+I8V_WHL5V^CB^[7:0LL2
M)J:!VT)Q/1<.HA$23*33FW9$0=WF4>W^-+XDZW4(O@ZP7J=HK8,8XP-^P_DY
M;KW(^492_S9=?WYSOEHOON#R-G<8O1$B6W \9/)CO84@B3MNR8G43EC%VK@:
MA]$Y;NC\?+ALJ+T.L/D6E]-OH88]=W:911ZED1YB(@=$"8JL@B')69MR+IS'
M(E,3'#Y,T[@%1<^'N8&TT@&^:I>C*BSZ3VVL]"W,JOCN,.4E*X*\7LOI#X6T
M?0)3##)ZK8QW7(DVU1A[D3=NL= SGL"#ZZI; 'Y DM<TK3$_QO0D^62YHWT6
M1*(024J*QHHW8(SPB9>@BVPSP^@4JL>M"1H;K@TTVP&*?P[3Y6:RY;OR\W0>
M2)QA]LN<.#W_<HTI$XLMT1KP7NLZ"YV8"M:!25DA2Q3B-^ILNA=YXTZJ?SY<
M#J^KSF]?CGZ$=M^G#'GSTO")UV%P"ABR\Z( .H6[MCFD9$#E>(RTIYAH=(X\
MY[W+=H+$M26V:<GL4G(J%4C915 I)7""TU?"HM.V>,_;6*7[Z7E)]RF'X.:V
M&1I &QT<?'>X>/W]M[ F&;TK5S_^OBDQP\B,H;,;!&UO4)K7?BO&0;:":40O
M6KT]V)_&<;$W!"*> MDPZND.>#NN=C5$Q:>D5*Z%8$[6/&^!Z)B&G+VBV,@Q
MX]O<T#U"5&?0&@@'C\+M>*6,7*+WK[B<3\/[Y2*?I_6;69A^6>T*R0I*#%8H
M8(5\0<6M)_\P.' V8G%*!U?R$T[5HPOTA)(3U+<86I8C F*U7%\-]O@+UMEP
M7S]/4YAMZZ959"RK!"(Q02;9F3H8&B%&JU,619G]QNO0*M?,#'UWV\0\2L:X
M=_T#GEO#"7MLQ.#9;19V&XG%%&6=KNJMK;.@6:R=9AD8NYEH*8L*>]6B[8>8
MA\@8Q] ,J-[%T+(>$S#KK\O)7UY-M-/:<%]-8&&T8T2FHS='D,[0:ABUC(_-
MR5MA^O/9XMN/]>.VT*A?;6"Q!<1VF1%5/XRB%L=+K3O'E:SEKY<5DC)E(X3*
M$'C-'167(%@F(<>LC"*GC#4: /(P3>-F])XC(CI._-T!Z?M[W+P;W[I8V]?E
MDR*2C5)&*$F0BR70@2<+"R2_P%U"C+Q-/='3M/7DZ1Z/@L?CGU-5TA_(WH8O
MX0Q7KVH#7<R;6_2)XB:DVCI?*6;H#_+HHZ30,0JKC2L,4Z.^VT_3UIE?W 1D
MIZIDY%C[H@_&3^MW'^D3I[/I?VX3"N'WU?ETO?IY.L,\,;*40&8=?%:^)K43
M^*(59!YRB&3UD[_E--\;=^^U6&='WFF@:2/B_@S3JY26YQ1'K-^$Y?([_7"[
M$40)5CK.00MD=3=$<!XM.0[9DU\H@TAM:J3V(F_<PI7G,4\#**:_].JNYO"8
M>O;+?WIB(O5^$@;*GCY14WF9_RI2%"^\!2Y5()PH#5$7#8ZAE]:F(O>[RQBZ
M%':HC.D3RUP573F=5?:;R1.YSB:W) A4U<ESC&#M?*O<UKX4CNMNM\#3@77
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M.Z-V!E9)?W;SVO8]>B[XW<\8SJ8TG ;^(&*R">3/V00Y.49J+05"3!RTY(+
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ML#DFVDMU'@]G!3 A9EZ83;*T$<)_F6>=A^!HB&>=AZBLNRS#YL)!9^7(:Q6
M(9/+ZLF4.R\TL,B=+[4NF.WUEKAUKJJKQY\'J?WI7-4A.N@.1;O01QC)O40-
MQM(?RKH(/AL!+"F5-:?-%X:;_O!B<E4':7:?7-4A8N[ (7\H::(++T)D!=[7
M_JJYD%QX44!1LJ*_RCZ)-MUD7DZNZB!-[YFK.D3L':#GKZ'.Y@VS#Y@6Y+C.
MJDV^]KY)(Q?)^P0L" O*>0>>^ #+2@G<,!E"F]%VC],U7FU.$RP-J(0.(/5F
ML:33G5CZ;3'?;8Z+UQ*Q,)>RAJ(CF>HB&;BB+6A?7/#!1R';7$T]2-(X-YO-
M@#2,Z#O T.,9/"M2TD8EL*80,[S>V#I#WZ;,A8SU4J2-53H]A=Y5:?HQ/O;P
M&NH!;C=2#"6XD)1A@-P&4*@U1,D5Y!0YCYIGT6BDZ8M)H1^DWD=3Z(?(NJL4
M>O%>L.@X>)8-*$5A1_08 74JL;[HS6F?I]+=IM /4LR#*?1#I-1?"IU':S0S
M=&ANWO#R.A@\&PDE^A!5EK+X?68:]9U"/U;1)\JKRQ2Z9K[XI,'R&&MK>P4A
M) :!2->"*2$+VT/?O:?0C]7XR3+KX*3_99X67_#R=/MUL6WSLSG5E%$J)@JQ
M9*PW28J^BA85<:90ZB(B>>5-SOU'B'IYCPQ.<2J'TDZ_0+O8@MEI:S%!X8IV
M#2>.8A89K&>%228-=VU&FCQ*UKC^QV#*WP]41VBB UB]6:S6=935M4&E.KB<
MC*\MH3DH)B+X) *@R9$YEP+9Y4:7*K=(Z1(^QZCYSJW**3+O #3OUI]Q>7EA
MO154G8XV7UUT*% 4LJ4ZVY@9='72:8;@E25!L5*LUH'[-O;H2=+&=97;@6I8
MG70 LKT*HE!RE(Q'@H$TM9]K 1>E!53&!.^+YJWJ+X8J3NSJ#<Q)%WA#ZZL#
M#&ZWT:^+U:K.#*H3=:?S\SK\<;O/%O/5:R0N<?M[G\(?9-&G\\5RNOZ^"6YP
MM7XUSS<_Y:?_.*>__BNN/R_H;[[1KVQG*'BB/T4*=[C1M#TY9[3YM8'(E'5!
M!:=9FQ$6S\AD%Q=2 R+T7L^P/[B,VH^A1OJO$G&QVDS%^8"SVMJP^D K8O8#
M,;0\3^OS)<GIS>>P/,/5Q"26F"-WG+$00!E=2\((N+R4HIQ1.>E]&@0>MFH7
M=VC#8[.Q^ ^'EM]":UXG^>Y^]W0SO=T\-[R>WW ]"5)9[FP!GY$$QE&#5]R
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M([U]O/% ;D(Q/E/)Q?^_O2OK<2I9TN_S7T+*?7D9B8:FAQ$-+1K-:RER \^
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M7_CE.C]>!9D*J80ZEYTG7@<P53N$F*.X)K9EGHIH--YY*SVG]?W:8&@"SG>
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M\2WY[TM-=7VY#OCG])H8^W8Q__0Q7W[]N/C[\^+RJGYYH23]A\Q!BI*#JGD
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M,)?B_6:=XEC8G+)H<83(-H4^@'\G%ON?L_GLZ_77->%>E:)"JFUR CDO/%C
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M%%SO$SRW%T':,!_000G$(25E@5!(OW(1DA:!'$+1IF'53I).>Y)-(O!?@V@
M]_N#T5J1YL*05'("BZ1#54$!J%($Z1//3C >2YO WE9RNH//$%$_#Z !?.\
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M+W#SS_B]?P!02P$"% ,4    "  +7Z54WY59JN(3 @""G1H $
M    @ $     8F1X+3(P,C(P,S,Q+FAT;5!+ 0(4 Q0    (  M?I52R'0B)
M8PX  %2,   0              "  1 4 @!B9'@M,C R,C S,S$N>'-D4$L!
M A0#%     @ "U^E5 <4W/HX&@  -_$  !0              ( !H2(" &)D
M>"TR,#(R,#,S,5]C86PN>&UL4$L! A0#%     @ "U^E5,>_0*&!0P   \T"
M !0              ( !"ST" &)D>"TR,#(R,#,S,5]D968N>&UL4$L! A0#
M%     @ "U^E5$;8%$+_KP  M"8' !0              ( !OH " &)D>"TR
M,#(R,#,S,5]L86(N>&UL4$L! A0#%     @ "U^E5&>_FZ!09@  )78$ !0
M             ( ![S # &)D>"TR,#(R,#,S,5]P<F4N>&UL4$L! A0#%
M  @ "U^E5%YQTESD @  " L  !               ( !<9<# &5X,C(P,S,Q
M,C R,BYH=&U02P$"% ,4    "  ,7Z54N?"48<X(  "@2@  $
M    @ &#F@, 97@S,3 S,S$R,#(R+FAT;5!+ 0(4 Q0    (  Q?I50:HC]W
MZP0  .<?   0              "  7^C P!E>#,R,#,S,3(P,C(N:'1M4$L%
3!@     )  D /@(  )BH P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
